Page last updated: 2024-08-02 10:15:45

mocetinostat

Description

mocetinostat: undergoing phase II clinical trials for treatment of cancer [MeSH]

mocetinostat : A benzamide obtained by formal condensation of the carboxy group of 4-({[4-(pyridin-3-yl)pyrimidin-2-yl]amino}methyl)benzoic acid with one of the amino groups of benzene-1,2-diamine. It is an orally active and isotype-selective HDAC inhibitor which exhibits antitumour activity (IC50 = 0.15, 0.29, 1.66 and 0.59 muM for HDAC1, HDAC2, HDAC3 and HDAC11). [CHeBI]

Cross-References

ID SourceID
PubMed CID9865515
CHEMBL ID272980
SCHEMBL ID157027
CHEBI ID94525
MeSH IDM0514040

Synonyms (74)

Synonym
726169-73-9
n-(2-aminophenyl)-4-([[4-(pyridin-3-yl)pyrimidin-2-yl]amino]methyl)benzamide
HY-12164
peroxidase
9003-99-0
mg-0103
mgcd0103 ,
chembl272980 ,
mgcd-0103
bdbm24624
n-(2-aminophenyl)-4-({[4-(pyridin-3-yl)pyrimidin-2-yl]amino}methyl)benzamide
mg 0103
mgcd 0103
n-(2-aminophenyl)-4-((4-pyridin-3-ylpyrimidin-2-ylamino)methyl)benzamide
mocetinostat
mg0103
n-(2-aminophenyl)-4-[[(4-pyridin-3-ylpyrimidin-2-yl)amino]methyl]benzamide
myeloperoxidase (usan)
D09641
D09643
mocetinostat (usan/inn)
BCP9000925
unii-a6gwb8t96j
mocetinostat [usan:inn]
a6gwb8t96j ,
benzamide, n-(2-aminophenyl)-4-(((4-(3-pyridinyl)-2-pyrimidinyl)amino)methyl)-
BCPP000163
mgcd010,3mocetinostat
NCGC00263182-02
NCGC00263182-01
CS-0502
S1122
mocetinostat [usan]
mocetinostat [who-dd]
mocetinostat [inn]
AKOS016340325
gtpl7008
BRD-K16485616-001-01-4
CCG-208763
smr004701289
MLS006010181
n-(2-aminophenyl)-4-([[4-(pyridin-3-yl)pyrimidin-2-yl]amino]methyl)benzamide;mgcd0103;mocetinostat;mgcd0103(mocetinostat)
SCHEMBL157027
BD-0114
n-(2-aminophenyl)-4-[[[4-(3-pyridyl)pyrimidin-2-yl]amino]methyl]benzamide
DTXSID80222945
n-(2-aminophenyl)-4-((4-(pyridin-3-yl)pyrimidin-2-ylamino)methyl)benzamide
n-(2-aminophenyl)-4-(((4-(pyridin-3-yl)pyrimidin-2-yl)amino)methyl)benzamide
AC-30281
mocetinostat (mgcd0103)
J-522866
EX-A049
CHEBI:94525
HMS3654K06
HRNLUBSXIHFDHP-UHFFFAOYSA-N
mfcd10565970
NCGC00263182-11
SW218130-2
mgcd0103 (mocetinostat)
DB11830
FT-0741876
Q424869
n-(2-aminophenyl)-4-[(4-pyridin-3-ylpyrimidin-2-ylamino)methyl]benzamide
mocetinostat (mgcd-0103)
726169-73-9 (free base)
BCP01814
BRD-K16485616-001-04-8
SB16666
HMS3426I07
FT-0627651
n-(2-aminophenyl)-4-({[4-(3-pyridinyl)-2-pyrimidinyl]amino}methyl)benzamide
AU-004/43508107
nsc760143
nsc-760143

Roles (6)

RoleDescription
EC 3.5.1.98 (histone deacetylase) inhibitorAn EC 3.5.1.* (non-peptide linear amide C-N hydrolase) inhibitor that interferes with the function of histone deacetylase (EC 3.5.1.98).
antineoplastic agentA substance that inhibits or prevents the proliferation of neoplasms.
cardioprotective agentAny protective agent that is able to prevent damage to the heart.
hepatotoxic agentA role played by a chemical compound exihibiting itself through the ability to induce damage to the liver in animals.
apoptosis inducerAny substance that induces the process of apoptosis (programmed cell death) in multi-celled organisms.
autophagy inducerAny compound that induces the process of autophagy (the self-digestion of one or more components of a cell through the action of enzymes originating within the same cell).

Drug Classes (6)

ClassDescription
aminopyrimidineA member of the class of pyrimidines that is pyrimidine substituted by at least one amino group and its derivatives.
pyridinesAny organonitrogen heterocyclic compound based on a pyridine skeleton and its substituted derivatives.
benzamides
substituted aniline
secondary carboxamideA carboxamide resulting from the formal condensation of a carboxylic acid with a primary amine; formula RC(=O)NHR(1).
secondary amino compoundA compound formally derived from ammonia by replacing two hydrogen atoms by organyl groups.

Protein Targets (27)

Potency Measurements

ProteinTaxonomyMeasurementAverage (mM)Bioassay(s)
PPM1D proteinHomo sapiens (human)Potency7.3876AID1347411
cytochrome P450 family 3 subfamily A polypeptide 4Homo sapiens (human)Potency0.7564AID1645841
EWS/FLI fusion proteinHomo sapiens (human)Potency1.0884AID1259252; AID1259253; AID1259255; AID1259256
GVesicular stomatitis virusPotency5.3547AID1645842
cytochrome P450 2D6Homo sapiens (human)Potency4.7724AID1645840
Interferon betaHomo sapiens (human)Potency6.8794AID1347411; AID1645842
HLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)Potency5.3547AID1645842
Inositol hexakisphosphate kinase 1Homo sapiens (human)Potency5.3547AID1645842
cytochrome P450 2C9, partialHomo sapiens (human)Potency5.3547AID1645842

Inhibition Measurements

ProteinTaxonomyMeasurementAverage (mM)Bioassay(s)
Histone deacetylase 3Homo sapiens (human)IC503.4180AID1201721; AID1241514; AID1740022; AID1798452; AID1798526; AID316931; AID324949; AID344094; AID367305; AID762203; AID780587
Histone deacetylase 3Homo sapiens (human)Ki0.2650AID496803
Nuclear receptor corepressor 1Homo sapiens (human)IC500.0220AID762203
Integrin beta-1Homo sapiens (human)IC5010.0000AID344099
Cytochrome P450 3A4Homo sapiens (human)IC500.5700AID609494
Leukotriene A-4 hydrolaseHomo sapiens (human)IC5010.0000AID1441630; AID1441631
Cytochrome P450 2D6Homo sapiens (human)IC500.1020AID708216
Integrin alpha-4Homo sapiens (human)IC5010.0000AID344099
Cytochrome P450 2C19Homo sapiens (human)IC500.1020AID708216
Histone deacetylase 4Homo sapiens (human)IC506.2287AID1740024; AID1798452; AID1798526; AID344096; AID440821
Potassium voltage-gated channel subfamily H member 2Homo sapiens (human)IC5030.0000AID609493; AID613341
Histone deacetylase 1Homo sapiens (human)IC502.4892AID1201719; AID1241511; AID1740020; AID1798452; AID1798526; AID1810051; AID1907399; AID316892; AID324948; AID344092; AID367297; AID440819; AID609489; AID708216; AID721037; AID762201; AID780588
Histone deacetylase 1Homo sapiens (human)Ki0.0090AID496801
Histone deacetylase 7Homo sapiens (human)IC507.3350AID1740026; AID1798452; AID344099; AID367308; AID440823
Histone deacetylase 2Homo sapiens (human)IC503.5691AID1201720; AID1241513; AID1740021; AID1798452; AID344093; AID367304; AID440820; AID762204; AID780579
Histone deacetylase 2Homo sapiens (human)Ki0.0324AID496802
Histone deacetylase 11 Homo sapiens (human)IC504.9592AID1467232; AID1740028; AID1798452; AID344095
Histone deacetylase 8Homo sapiens (human)IC5011.7306AID1241517; AID1740023; AID1798452; AID316893; AID344100; AID367309; AID762202
Histone deacetylase 6Homo sapiens (human)IC508.6016AID1740027; AID1798452; AID1798526; AID1810052; AID316899; AID344098; AID367307; AID708215; AID762205
Histone deacetylase 5Homo sapiens (human)IC507.3350AID1740025; AID1798452; AID344097; AID367306; AID440822
Nuclear receptor corepressor 2Homo sapiens (human)IC500.0450AID1241514

Bioassays (250)

Assay IDTitleYearJournalArticle
AID1347159Primary screen GU Rhodamine qHTS for Zika virus inhibitors: Unlinked NS2B-NS3 protease assay2020Proceedings of the National Academy of Sciences of the United States of America, 12-08, Volume: 117, Issue:49
ISSN: 1091-6490
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
AID1296008Cytotoxic Profiling of Annotated Libraries Using Quantitative High-Throughput Screening2020SLAS discovery : advancing life sciences R & D, 01, Volume: 25, Issue:1
ISSN: 2472-5560
Cytotoxic Profiling of Annotated and Diverse Chemical Libraries Using Quantitative High-Throughput Screening.
AID1346987P-glycoprotein substrates identified in KB-8-5-11 adenocarcinoma cell line, qHTS therapeutic library screen2019Molecular pharmacology, 11, Volume: 96, Issue:5
ISSN: 1521-0111
A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein.
AID1347414qHTS to identify inhibitors of the type 1 interferon - major histocompatibility complex class I in skeletal muscle: Secondary screen by immunofluorescence2020ACS chemical biology, 07-17, Volume: 15, Issue:7
ISSN: 1554-8937
High-Throughput Screening to Identify Inhibitors of the Type I Interferon-Major Histocompatibility Complex Class I Pathway in Skeletal Muscle.
AID1346986P-glycoprotein substrates identified in KB-3-1 adenocarcinoma cell line, qHTS therapeutic library screen2019Molecular pharmacology, 11, Volume: 96, Issue:5
ISSN: 1521-0111
A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein.
AID1347160Primary screen NINDS Rhodamine qHTS for Zika virus inhibitors2020Proceedings of the National Academy of Sciences of the United States of America, 12-08, Volume: 117, Issue:49
ISSN: 1091-6490
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
AID1347112qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Confirmatory screen for BT-12 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
ISSN: 1949-2553
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347102qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for Rh18 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
ISSN: 1949-2553
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1745845Primary qHTS for Inhibitors of ATXN expression2022The Journal of biological chemistry, 08, Volume: 298, Issue:8
ISSN: 1083-351X
AID1347086qHTS for Inhibitors of the Functional Ribonucleoprotein Complex (vRNP) of Lymphocytic Choriomeningitis Arenaviruses (LCMV): LCMV Primary Screen - GLuc reporter signal2020Antiviral research, 01, Volume: 173ISSN: 1872-9096A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity.
AID1347128qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Confirmatory screen for OHS-50 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
ISSN: 1949-2553
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347106qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for control Hh wild type fibroblast cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
ISSN: 1949-2553
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347091qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for SJ-GBM2 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
ISSN: 1949-2553
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347114qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Confirmatory screen for DAOY cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
ISSN: 1949-2553
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347119qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Confirmatory screen for MG 63 (6-TG R) cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
ISSN: 1949-2553
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347108qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for Rh41 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
ISSN: 1949-2553
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347125qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Confirmatory screen for Rh18 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
ISSN: 1949-2553
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1508630Primary qHTS for small molecule stabilizers of the endoplasmic reticulum resident proteome: Secreted ER Calcium Modulated Protein (SERCaMP) assay2021Cell reports, 04-27, Volume: 35, Issue:4
ISSN: 2211-1247
A target-agnostic screen identifies approved drugs to stabilize the endoplasmic reticulum-resident proteome.
AID1347127qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Confirmatory screen for Saos-2 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
ISSN: 1949-2553
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347083qHTS for Inhibitors of the Functional Ribonucleoprotein Complex (vRNP) of Lassa (LASV) Arenavirus: Viability assay - alamar blue signal for LASV Primary Screen2020Antiviral research, 01, Volume: 173ISSN: 1872-9096A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity.
AID1347116qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Confirmatory screen for SJ-GBM2 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
ISSN: 1949-2553
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347093qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for SK-N-MC cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
ISSN: 1949-2553
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347082qHTS for Inhibitors of the Functional Ribonucleoprotein Complex (vRNP) of Lassa (LASV) Arenavirus: LASV Primary Screen - GLuc reporter signal2020Antiviral research, 01, Volume: 173ISSN: 1872-9096A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity.
AID1347107qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for Rh30 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
ISSN: 1949-2553
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347154Primary screen GU AMC qHTS for Zika virus inhibitors2020Proceedings of the National Academy of Sciences of the United States of America, 12-08, Volume: 117, Issue:49
ISSN: 1091-6490
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
AID1347123qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Confirmatory screen for Rh41 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
ISSN: 1949-2553
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347097qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for Saos-2 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
ISSN: 1949-2553
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347121qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Confirmatory screen for control Hh wild type fibroblast cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
ISSN: 1949-2553
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347122qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Confirmatory screen for U-2 OS cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
ISSN: 1949-2553
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347090qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for DAOY cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
ISSN: 1949-2553
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347103qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for OHS-50 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
ISSN: 1949-2553
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347101qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for BT-12 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
ISSN: 1949-2553
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347109qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Confirmatory screen for NB1643 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
ISSN: 1949-2553
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347096qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for U-2 OS cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
ISSN: 1949-2553
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347098qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for SK-N-SH cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
ISSN: 1949-2553
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347100qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for LAN-5 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
ISSN: 1949-2553
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347126qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Confirmatory screen for Rh30 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
ISSN: 1949-2553
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347104qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for RD cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
ISSN: 1949-2553
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347115qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Confirmatory screen for NB-EBc1 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
ISSN: 1949-2553
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347092qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for A673 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
ISSN: 1949-2553
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347118qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Confirmatory screen for TC32 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
ISSN: 1949-2553
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347089qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for TC32 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
ISSN: 1949-2553
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347124qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Confirmatory screen for RD cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
ISSN: 1949-2553
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347113qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Confirmatory screen for LAN-5 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
ISSN: 1949-2553
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347129qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Confirmatory screen for SK-N-SH cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
ISSN: 1949-2553
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347117qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Confirmatory screen for BT-37 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
ISSN: 1949-2553
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347095qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for NB-EBc1 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
ISSN: 1949-2553
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347105qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for MG 63 (6-TG R) cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
ISSN: 1949-2553
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347099qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for NB1643 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
ISSN: 1949-2553
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347111qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Confirmatory screen for SK-N-MC cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
ISSN: 1949-2553
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347094qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for BT-37 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
ISSN: 1949-2553
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347110qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Confirmatory screen for A673 cells)2018Oncotarget, Jan-12, Volume: 9, Issue:4
ISSN: 1949-2553
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID708215Inhibition of human recombinant HDAC6 expressed in Sf9 cells incubated for 2 hrs using RHKK-Ac fluorogenic substrate2012Journal of medicinal chemistry, Nov-26, Volume: 55, Issue:22
ISSN: 1520-4804
Selective histone deacetylase 6 inhibitors bearing substituted urea linkers inhibit melanoma cell growth.
AID609490Antiproliferative activity against human HCT116 cells2011Bioorganic & medicinal chemistry letters, Aug-15, Volume: 21, Issue:16
ISSN: 1464-3405
The design, synthesis and structure-activity relationships of novel isoindoline-based histone deacetylase inhibitors.
AID721034Cytotoxicity against human A549 cells after 72 hrs by MTT assay2013Bioorganic & medicinal chemistry letters, Jan-01, Volume: 23, Issue:1
ISSN: 1464-3405
Design, synthesis and bioevalution of novel benzamides derivatives as HDAC inhibitors.
AID316941Inhibition of HDAC92008Journal of medicinal chemistry, Mar-27, Volume: 51, Issue:6
ISSN: 0022-2623
Histone deacetylase inhibitors: from bench to clinic.
AID344378Volume of distribution at steady state in Beagle dog at 10 mg/kg, iv and 7 to 30 mg/kg, po2008Journal of medicinal chemistry, Jul-24, Volume: 51, Issue:14
ISSN: 1520-4804
Discovery of N-(2-aminophenyl)-4-[(4-pyridin-3-ylpyrimidin-2-ylamino)methyl]benzamide (MGCD0103), an orally active histone deacetylase inhibitor.
AID762189Cytotoxicity against human A549 cells assessed as growth inhibition by measuring cellular ATP level after 72 hrs by cell-titer glo assay2013Journal of medicinal chemistry, Aug-08, Volume: 56, Issue:15
ISSN: 1520-4804
Discovery of potent, isoform-selective inhibitors of histone deacetylase containing chiral heterocyclic capping groups and a N-(2-aminophenyl)benzamide binding unit.
AID496803Inhibition of human HDAC32010Nature chemical biology, Mar, Volume: 6, Issue:3
ISSN: 1552-4469
Chemical phylogenetics of histone deacetylases.
AID762183Cell cycle arrest in human Jurkat cells assessed as accumulation at sub-G1 phase at 10 uM after 24 hrs by FITC/propidium iodide staining-based FACS flow cytometric analysis (Rvb = 2%)2013Journal of medicinal chemistry, Aug-08, Volume: 56, Issue:15
ISSN: 1520-4804
Discovery of potent, isoform-selective inhibitors of histone deacetylase containing chiral heterocyclic capping groups and a N-(2-aminophenyl)benzamide binding unit.
AID367309Inhibition of HDAC82009Bioorganic & medicinal chemistry letters, Feb-01, Volume: 19, Issue:3
ISSN: 1464-3405
SAR and biological evaluation of analogues of a small molecule histone deacetylase inhibitor N-(2-aminophenyl)-4-((4-(pyridin-3-yl)pyrimidin-2-ylamino)methyl)benzamide (MGCD0103).
AID1907399Inhibition of HDAC1 (unknown origin) using trypsin and LGK(Ac)-AMC as substrates incubated for 1 hr and measured by fluorescence assay2022European journal of medicinal chemistry, Jun-05, Volume: 236ISSN: 1768-3254Dual-acting antitumor agents targeting the A
AID344390Antitumor activity against human DU145 cells xenografted in CD1 nude mouse at 40 mg/kg/day, po2008Journal of medicinal chemistry, Jul-24, Volume: 51, Issue:14
ISSN: 1520-4804
Discovery of N-(2-aminophenyl)-4-[(4-pyridin-3-ylpyrimidin-2-ylamino)methyl]benzamide (MGCD0103), an orally active histone deacetylase inhibitor.
AID316892Inhibition of HDAC12008Journal of medicinal chemistry, Mar-27, Volume: 51, Issue:6
ISSN: 0022-2623
Histone deacetylase inhibitors: from bench to clinic.
AID708216Inhibition of human recombinant HDAC1 expressed in Sf9 cells incubated for 2 hrs using RHKK-Ac fluorogenic substrate2012Journal of medicinal chemistry, Nov-26, Volume: 55, Issue:22
ISSN: 1520-4804
Selective histone deacetylase 6 inhibitors bearing substituted urea linkers inhibit melanoma cell growth.
AID762174Induction of apoptosis in human HeLa cells assessed as PARP cleavage at 1 to 10 uM after 24 hrs by Western blot analysis2013Journal of medicinal chemistry, Aug-08, Volume: 56, Issue:15
ISSN: 1520-4804
Discovery of potent, isoform-selective inhibitors of histone deacetylase containing chiral heterocyclic capping groups and a N-(2-aminophenyl)benzamide binding unit.
AID344124Clearance in Beagle dog at 10 mg/kg, iv and 7 to 30 mg/kg, po2008Journal of medicinal chemistry, Jul-24, Volume: 51, Issue:14
ISSN: 1520-4804
Discovery of N-(2-aminophenyl)-4-[(4-pyridin-3-ylpyrimidin-2-ylamino)methyl]benzamide (MGCD0103), an orally active histone deacetylase inhibitor.
AID1241542Induction of cell cycle arrest in human U937 cells assessed as accumulation at S phase at 10 uM incubated for 24 hrs by FITC/propidium iodide staining based flow cytometry (Rvb = 28.2%)2015Journal of medicinal chemistry, Sep-10, Volume: 58, Issue:17
ISSN: 1520-4804
Potent and Selective Inhibitors of Histone Deacetylase-3 Containing Chiral Oxazoline Capping Groups and a N-(2-Aminophenyl)-benzamide Binding Unit.
AID316934Inhibition of HDAC42008Journal of medicinal chemistry, Mar-27, Volume: 51, Issue:6
ISSN: 0022-2623
Histone deacetylase inhibitors: from bench to clinic.
AID1441631Inhibition of recombinant human LTA4H Epoxide Hydrolase expressed in Escherichia coli BL21 (DE3) pLysS preincubated for 10 mins followed by addition of LTA4 as substrate measured after 15 mins by reverse-phase HPLC analysis2017Journal of medicinal chemistry, 03-09, Volume: 60, Issue:5
ISSN: 1520-4804
Drug Repurposing of Histone Deacetylase Inhibitors That Alleviate Neutrophilic Inflammation in Acute Lung Injury and Idiopathic Pulmonary Fibrosis via Inhibiting Leukotriene A4 Hydrolase and Blocking LTB4 Biosynthesis.
AID316899Inhibition of HDAC62008Journal of medicinal chemistry, Mar-27, Volume: 51, Issue:6
ISSN: 0022-2623
Histone deacetylase inhibitors: from bench to clinic.
AID316936Inhibition of HDAC72008Journal of medicinal chemistry, Mar-27, Volume: 51, Issue:6
ISSN: 0022-2623
Histone deacetylase inhibitors: from bench to clinic.
AID1201731Cytotoxicity against human SNU16 cells assessed as growth inhibition after 72 hrs by MTT assay2015European journal of medicinal chemistry, May-05, Volume: 95ISSN: 1768-3254Design, synthesis and biological evaluation of colchicine derivatives as novel tubulin and histone deacetylase dual inhibitors.
AID344110Clearance in CD1 mouse at 2.5 to 15 mg/kg, iv and po2008Journal of medicinal chemistry, Jul-24, Volume: 51, Issue:14
ISSN: 1520-4804
Discovery of N-(2-aminophenyl)-4-[(4-pyridin-3-ylpyrimidin-2-ylamino)methyl]benzamide (MGCD0103), an orally active histone deacetylase inhibitor.
AID721035Cytotoxicity against human MCF7 cells after 72 hrs by MTT assay2013Bioorganic & medicinal chemistry letters, Jan-01, Volume: 23, Issue:1
ISSN: 1464-3405
Design, synthesis and bioevalution of novel benzamides derivatives as HDAC inhibitors.
AID1241529Solubility by CLND method2015Journal of medicinal chemistry, Sep-10, Volume: 58, Issue:17
ISSN: 1520-4804
Potent and Selective Inhibitors of Histone Deacetylase-3 Containing Chiral Oxazoline Capping Groups and a N-(2-Aminophenyl)-benzamide Binding Unit.
AID1201719Inhibition of recombinant human HDAC1 expressed in baculovirus infected insect High5 cells using Ac-Lys-Tyr-Lys (epsilon-acetyl)-AMC as substrate after 24 hrs by fluorescence assay2015European journal of medicinal chemistry, May-05, Volume: 95ISSN: 1768-3254Design, synthesis and biological evaluation of colchicine derivatives as novel tubulin and histone deacetylase dual inhibitors.
AID344117Clearance in Sprague-Dawley rat at 2.5 to 5 mg/kg, iv and 2.5 to 50 mg/kg, po2008Journal of medicinal chemistry, Jul-24, Volume: 51, Issue:14
ISSN: 1520-4804
Discovery of N-(2-aminophenyl)-4-[(4-pyridin-3-ylpyrimidin-2-ylamino)methyl]benzamide (MGCD0103), an orally active histone deacetylase inhibitor.
AID1467232Inhibition of recombinant full length human C-terminal FLAG-tagged HDAC11 expressed in baculovirus infected Sf9 cells using Boc-Lys(epsilon-Ac)-AMC as substrate pretreated for 10 mins followed by substrate addition by fluorometric method2017Bioorganic & medicinal chemistry letters, 07-01, Volume: 27, Issue:13
ISSN: 1464-3405
Stabilizing HDAC11 with SAHA to assay slow-binding benzamide inhibitors.
AID613298In vitro cardiac safety index, ratio of IC50 for human ERG to IC50 for human HCT116 cells2011Journal of medicinal chemistry, Jul-14, Volume: 54, Issue:13
ISSN: 1520-4804
Optimization of the in vitro cardiac safety of hydroxamate-based histone deacetylase inhibitors.
AID392407Inhibition of HDAC1 in human 293T cells after 16 hrs by fluorimetry relative to SAHA2009Bioorganic & medicinal chemistry letters, Jan-15, Volume: 19, Issue:2
ISSN: 1464-3405
Sulfamides as novel histone deacetylase inhibitors.
AID440823Inhibition of human recombinant N-terminal FLAG-tagged HDAC7 (438-915) expressed in baculovirus after 10 mins by fluorimetric analysis2009Bioorganic & medicinal chemistry letters, Oct-01, Volume: 19, Issue:19
ISSN: 1464-3405
Diphenylmethylene hydroxamic acids as selective class IIa histone deacetylase inhibitors.
AID344095Inhibition of human recombinant HDAC11 homogeneous fluorescence release assay2008Journal of medicinal chemistry, Jul-24, Volume: 51, Issue:14
ISSN: 1520-4804
Discovery of N-(2-aminophenyl)-4-[(4-pyridin-3-ylpyrimidin-2-ylamino)methyl]benzamide (MGCD0103), an orally active histone deacetylase inhibitor.
AID344120Cmax in Sprague-Dawley rat at 2.5 to 50 mg/kg, po2008Journal of medicinal chemistry, Jul-24, Volume: 51, Issue:14
ISSN: 1520-4804
Discovery of N-(2-aminophenyl)-4-[(4-pyridin-3-ylpyrimidin-2-ylamino)methyl]benzamide (MGCD0103), an orally active histone deacetylase inhibitor.
AID1740025Inhibition of human NH2-terminal His6-tagged HDAC5 expressed in sf9 cells using Boc-Lys(Ac)-AMC as substrate preincubated for 10 mins followed by substrate addition by fluorometry2020Journal of medicinal chemistry, 11-12, Volume: 63, Issue:21
ISSN: 1520-4804
Thirty Years of HDAC Inhibitors: 2020 Insight and Hindsight.
AID1241531Binding affinity to human serum albumin2015Journal of medicinal chemistry, Sep-10, Volume: 58, Issue:17
ISSN: 1520-4804
Potent and Selective Inhibitors of Histone Deacetylase-3 Containing Chiral Oxazoline Capping Groups and a N-(2-Aminophenyl)-benzamide Binding Unit.
AID1441700Inhibition of recombinant human LTA4H Epoxide Hydrolase expressed in Escherichia coli BL21 (DE3) pLysS at 10 uM preincubated for 10 mins followed by addition of LTA4 as substrate measured after 15 mins by reverse-phase HPLC analysis2017Journal of medicinal chemistry, 03-09, Volume: 60, Issue:5
ISSN: 1520-4804
Drug Repurposing of Histone Deacetylase Inhibitors That Alleviate Neutrophilic Inflammation in Acute Lung Injury and Idiopathic Pulmonary Fibrosis via Inhibiting Leukotriene A4 Hydrolase and Blocking LTB4 Biosynthesis.
AID367302Induction of p21WAF1/CIP1 expression in human HCT116 cells assessed as tubulin level after 16 hrs by luciferase assay2009Bioorganic & medicinal chemistry letters, Feb-01, Volume: 19, Issue:3
ISSN: 1464-3405
SAR and biological evaluation of analogues of a small molecule histone deacetylase inhibitor N-(2-aminophenyl)-4-((4-(pyridin-3-yl)pyrimidin-2-ylamino)methyl)benzamide (MGCD0103).
AID344098Inhibition of human recombinant HDAC6 homogeneous fluorescence release assay2008Journal of medicinal chemistry, Jul-24, Volume: 51, Issue:14
ISSN: 1520-4804
Discovery of N-(2-aminophenyl)-4-[(4-pyridin-3-ylpyrimidin-2-ylamino)methyl]benzamide (MGCD0103), an orally active histone deacetylase inhibitor.
AID316931Inhibition of HDAC32008Journal of medicinal chemistry, Mar-27, Volume: 51, Issue:6
ISSN: 0022-2623
Histone deacetylase inhibitors: from bench to clinic.
AID1241527Lipophilicity, log P of the compound2015Journal of medicinal chemistry, Sep-10, Volume: 58, Issue:17
ISSN: 1520-4804
Potent and Selective Inhibitors of Histone Deacetylase-3 Containing Chiral Oxazoline Capping Groups and a N-(2-Aminophenyl)-benzamide Binding Unit.
AID1241535Inhibition of HDAC in human PC3 cells assessed as reduction in cyclin E expression in at 10 uM incubated for 24 hrs by Western blotting method2015Journal of medicinal chemistry, Sep-10, Volume: 58, Issue:17
ISSN: 1520-4804
Potent and Selective Inhibitors of Histone Deacetylase-3 Containing Chiral Oxazoline Capping Groups and a N-(2-Aminophenyl)-benzamide Binding Unit.
AID496802Inhibition of human HDAC22010Nature chemical biology, Mar, Volume: 6, Issue:3
ISSN: 1552-4469
Chemical phylogenetics of histone deacetylases.
AID721037Inhibition of HDAC1 (unknown origin)2013Bioorganic & medicinal chemistry letters, Jan-01, Volume: 23, Issue:1
ISSN: 1464-3405
Design, synthesis and bioevalution of novel benzamides derivatives as HDAC inhibitors.
AID440820Inhibition of recombinant C-terminal FLAG-tagged HDAC2 expressed in baculovirus after 10 mins by fluorimetric analysis2009Bioorganic & medicinal chemistry letters, Oct-01, Volume: 19, Issue:19
ISSN: 1464-3405
Diphenylmethylene hydroxamic acids as selective class IIa histone deacetylase inhibitors.
AID1740021Inhibition of human C-terminal Flag-tagged HDAC2 expressed in sf9 cells using Boc-Lys(Ac)-AMC as substrate preincubated for 10 mins followed by substrate addition by fluorometry2020Journal of medicinal chemistry, 11-12, Volume: 63, Issue:21
ISSN: 1520-4804
Thirty Years of HDAC Inhibitors: 2020 Insight and Hindsight.
AID609497Half life in rat liver microsomes2011Bioorganic & medicinal chemistry letters, Aug-15, Volume: 21, Issue:16
ISSN: 1464-3405
The design, synthesis and structure-activity relationships of novel isoindoline-based histone deacetylase inhibitors.
AID344096Inhibition of human recombinant HDAC4 homogeneous fluorescence release assay2008Journal of medicinal chemistry, Jul-24, Volume: 51, Issue:14
ISSN: 1520-4804
Discovery of N-(2-aminophenyl)-4-[(4-pyridin-3-ylpyrimidin-2-ylamino)methyl]benzamide (MGCD0103), an orally active histone deacetylase inhibitor.
AID1441630Inhibition of recombinant human LTA4H aminopeptidase activity expressed in Escherichia coli BL21 (DE3) pLysS assessed as formation of p-NA from Ala-p-NA preincubated for 10 mins followed by substrate addition measured after 10 mins2017Journal of medicinal chemistry, 03-09, Volume: 60, Issue:5
ISSN: 1520-4804
Drug Repurposing of Histone Deacetylase Inhibitors That Alleviate Neutrophilic Inflammation in Acute Lung Injury and Idiopathic Pulmonary Fibrosis via Inhibiting Leukotriene A4 Hydrolase and Blocking LTB4 Biosynthesis.
AID762181Cell cycle arrest in human Jurkat cells assessed as accumulation at S phase at 10 uM after 24 hrs by FITC/propidium iodide staining-based FACS flow cytometric analysis (Rvb = 15.3%)2013Journal of medicinal chemistry, Aug-08, Volume: 56, Issue:15
ISSN: 1520-4804
Discovery of potent, isoform-selective inhibitors of histone deacetylase containing chiral heterocyclic capping groups and a N-(2-aminophenyl)benzamide binding unit.
AID1201734Cytotoxicity against human SJSA1 cells assessed as growth inhibition after 72 hrs by MTT assay2015European journal of medicinal chemistry, May-05, Volume: 95ISSN: 1768-3254Design, synthesis and biological evaluation of colchicine derivatives as novel tubulin and histone deacetylase dual inhibitors.
AID1241513Inhibition of His-tagged recombinant HDAC2 (1 to 488 residues) (unknown origin) pre-incubated for 3 hrs before substrate addition by homogeneous fluorogenic HDAC assay2015Journal of medicinal chemistry, Sep-10, Volume: 58, Issue:17
ISSN: 1520-4804
Potent and Selective Inhibitors of Histone Deacetylase-3 Containing Chiral Oxazoline Capping Groups and a N-(2-Aminophenyl)-benzamide Binding Unit.
AID762173Induction of apoptosis in human Jurkat cells assessed as PARP cleavage at 1 to 10 uM after 24 hrs by Western blot analysis2013Journal of medicinal chemistry, Aug-08, Volume: 56, Issue:15
ISSN: 1520-4804
Discovery of potent, isoform-selective inhibitors of histone deacetylase containing chiral heterocyclic capping groups and a N-(2-aminophenyl)benzamide binding unit.
AID762204Inhibition of recombinant His-tagged HDAC2 (1 to 488) (unknown origin) using MAL as substrate incubated for 3 hrs prior to substrate addition measured after 60 mins by fluorescence plate reader analysis2013Journal of medicinal chemistry, Aug-08, Volume: 56, Issue:15
ISSN: 1520-4804
Discovery of potent, isoform-selective inhibitors of histone deacetylase containing chiral heterocyclic capping groups and a N-(2-aminophenyl)benzamide binding unit.
AID316935Inhibition of HDAC52008Journal of medicinal chemistry, Mar-27, Volume: 51, Issue:6
ISSN: 0022-2623
Histone deacetylase inhibitors: from bench to clinic.
AID762188Cytotoxicity against human HCT116 cells assessed as growth inhibition by measuring cellular ATP level after 72 hrs by cell-titer glo assay2013Journal of medicinal chemistry, Aug-08, Volume: 56, Issue:15
ISSN: 1520-4804
Discovery of potent, isoform-selective inhibitors of histone deacetylase containing chiral heterocyclic capping groups and a N-(2-aminophenyl)benzamide binding unit.
AID1907401Antiproliferative activity against mouse CT26 cells after 72 hrs by CCK-8 assay2022European journal of medicinal chemistry, Jun-05, Volume: 236ISSN: 1768-3254Dual-acting antitumor agents targeting the A
AID1241541Induction of cell cycle arrest in human U937 cells assessed as accumulation at G0/G1 phase at 10 uM incubated for 24 hrs by FITC/propidium iodide staining based flow cytometry (Rvb = 56.1%)2015Journal of medicinal chemistry, Sep-10, Volume: 58, Issue:17
ISSN: 1520-4804
Potent and Selective Inhibitors of Histone Deacetylase-3 Containing Chiral Oxazoline Capping Groups and a N-(2-Aminophenyl)-benzamide Binding Unit.
AID1241537Induction of cell cycle arrest in human PC3 cells assessed as accumulation at G0/G1 phase at 10 uM incubated for 24 hrs by FITC/propidium iodide staining based flow cytometry (Rvb = 65.5%)2015Journal of medicinal chemistry, Sep-10, Volume: 58, Issue:17
ISSN: 1520-4804
Potent and Selective Inhibitors of Histone Deacetylase-3 Containing Chiral Oxazoline Capping Groups and a N-(2-Aminophenyl)-benzamide Binding Unit.
AID1241533Inhibition of HDAC3 in human PC3 cells assessed as increase in histone H3 lysine-9 acetylation at 10 uM incubated for 24 hrs by Western blotting method2015Journal of medicinal chemistry, Sep-10, Volume: 58, Issue:17
ISSN: 1520-4804
Potent and Selective Inhibitors of Histone Deacetylase-3 Containing Chiral Oxazoline Capping Groups and a N-(2-Aminophenyl)-benzamide Binding Unit.
AID344379Tmax in Beagle dog at 7 to 30 mg/kg, po2008Journal of medicinal chemistry, Jul-24, Volume: 51, Issue:14
ISSN: 1520-4804
Discovery of N-(2-aminophenyl)-4-[(4-pyridin-3-ylpyrimidin-2-ylamino)methyl]benzamide (MGCD0103), an orally active histone deacetylase inhibitor.
AID1201729Cytotoxicity against human MHCC97H cells assessed as growth inhibition after 72 hrs by MTT assay2015European journal of medicinal chemistry, May-05, Volume: 95ISSN: 1768-3254Design, synthesis and biological evaluation of colchicine derivatives as novel tubulin and histone deacetylase dual inhibitors.
AID324952Inhibition of HDAC4 H976Y mutant expressed in Escherichia coli at 5 uM2008Bioorganic & medicinal chemistry letters, Mar-15, Volume: 18, Issue:6
ISSN: 1464-3405
Probing the elusive catalytic activity of vertebrate class IIa histone deacetylases.
AID344093Inhibition of human recombinant HDAC2 homogeneous fluorescence release assay2008Journal of medicinal chemistry, Jul-24, Volume: 51, Issue:14
ISSN: 1520-4804
Discovery of N-(2-aminophenyl)-4-[(4-pyridin-3-ylpyrimidin-2-ylamino)methyl]benzamide (MGCD0103), an orally active histone deacetylase inhibitor.
AID1241539Induction of cell cycle arrest in human PC3 cells assessed as accumulation at G2/M phase at 10 uM incubated for 24 hrs by FITC/propidium iodide staining based flow cytometry (Rvb = 11.9%)2015Journal of medicinal chemistry, Sep-10, Volume: 58, Issue:17
ISSN: 1520-4804
Potent and Selective Inhibitors of Histone Deacetylase-3 Containing Chiral Oxazoline Capping Groups and a N-(2-Aminophenyl)-benzamide Binding Unit.
AID324954Inhibition of wild type HDAC4 expressed in Escherichia coli at 10 uM2008Bioorganic & medicinal chemistry letters, Mar-15, Volume: 18, Issue:6
ISSN: 1464-3405
Probing the elusive catalytic activity of vertebrate class IIa histone deacetylases.
AID344105Induction of H3 histone acetylation in human T24 cells relative to MS2752008Journal of medicinal chemistry, Jul-24, Volume: 51, Issue:14
ISSN: 1520-4804
Discovery of N-(2-aminophenyl)-4-[(4-pyridin-3-ylpyrimidin-2-ylamino)methyl]benzamide (MGCD0103), an orally active histone deacetylase inhibitor.
AID344118Volume of distribution at steady state in Sprague-Dawley rat at 2.5 to 5 mg/kg, iv and 2.5 to 50 mg/kg, po2008Journal of medicinal chemistry, Jul-24, Volume: 51, Issue:14
ISSN: 1520-4804
Discovery of N-(2-aminophenyl)-4-[(4-pyridin-3-ylpyrimidin-2-ylamino)methyl]benzamide (MGCD0103), an orally active histone deacetylase inhibitor.
AID1241511Inhibition of C-flagged recombinant HDAC1 (unknown origin) pre-incubated for 1 hr before substrate addition by homogeneous fluorogenic HDAC assay2015Journal of medicinal chemistry, Sep-10, Volume: 58, Issue:17
ISSN: 1520-4804
Potent and Selective Inhibitors of Histone Deacetylase-3 Containing Chiral Oxazoline Capping Groups and a N-(2-Aminophenyl)-benzamide Binding Unit.
AID344387Antitumor activity against human A431 cells xenografted in CD1 nude mouse at 90 mg/kg/day, po2008Journal of medicinal chemistry, Jul-24, Volume: 51, Issue:14
ISSN: 1520-4804
Discovery of N-(2-aminophenyl)-4-[(4-pyridin-3-ylpyrimidin-2-ylamino)methyl]benzamide (MGCD0103), an orally active histone deacetylase inhibitor.
AID762177Cell cycle arrest in human Jurkat cells assessed as accumulation at S phase at 1 uM after 24 hrs by FITC/propidium iodide staining-based FACS flow cytometric analysis (Rvb = 22.3%)2013Journal of medicinal chemistry, Aug-08, Volume: 56, Issue:15
ISSN: 1520-4804
Discovery of potent, isoform-selective inhibitors of histone deacetylase containing chiral heterocyclic capping groups and a N-(2-aminophenyl)benzamide binding unit.
AID344123Half life in Beagle dog at 10 mg/kg, iv2008Journal of medicinal chemistry, Jul-24, Volume: 51, Issue:14
ISSN: 1520-4804
Discovery of N-(2-aminophenyl)-4-[(4-pyridin-3-ylpyrimidin-2-ylamino)methyl]benzamide (MGCD0103), an orally active histone deacetylase inhibitor.
AID344386Antitumor activity against human A431 cells xenografted in CD1 nude mouse at 60 mg/kg/day, po2008Journal of medicinal chemistry, Jul-24, Volume: 51, Issue:14
ISSN: 1520-4804
Discovery of N-(2-aminophenyl)-4-[(4-pyridin-3-ylpyrimidin-2-ylamino)methyl]benzamide (MGCD0103), an orally active histone deacetylase inhibitor.
AID344108Induction of apoptosis in HCT116 cells at 1 uM2008Journal of medicinal chemistry, Jul-24, Volume: 51, Issue:14
ISSN: 1520-4804
Discovery of N-(2-aminophenyl)-4-[(4-pyridin-3-ylpyrimidin-2-ylamino)methyl]benzamide (MGCD0103), an orally active histone deacetylase inhibitor.
AID1241543Induction of cell cycle arrest in human U937 cells assessed as accumulation at G2/M phase at 10 uM incubated for 24 hrs by FITC/propidium iodide staining based flow cytometry (Rvb = 15.4%)2015Journal of medicinal chemistry, Sep-10, Volume: 58, Issue:17
ISSN: 1520-4804
Potent and Selective Inhibitors of Histone Deacetylase-3 Containing Chiral Oxazoline Capping Groups and a N-(2-Aminophenyl)-benzamide Binding Unit.
AID344114AUC in CD1 mouse at 2.5 to 15 mg/kg, po2008Journal of medicinal chemistry, Jul-24, Volume: 51, Issue:14
ISSN: 1520-4804
Discovery of N-(2-aminophenyl)-4-[(4-pyridin-3-ylpyrimidin-2-ylamino)methyl]benzamide (MGCD0103), an orally active histone deacetylase inhibitor.
AID1441699Inhibition of recombinant human LTA4H aminopeptidase activity expressed in Escherichia coli BL21 (DE3) pLysS assessed as formation of p-NA from Ala-p-NA at 10 uM preincubated for 10 mins followed by substrate addition measured after 10 mins2017Journal of medicinal chemistry, 03-09, Volume: 60, Issue:5
ISSN: 1520-4804
Drug Repurposing of Histone Deacetylase Inhibitors That Alleviate Neutrophilic Inflammation in Acute Lung Injury and Idiopathic Pulmonary Fibrosis via Inhibiting Leukotriene A4 Hydrolase and Blocking LTB4 Biosynthesis.
AID344099Inhibition of human recombinant HDAC7 homogeneous fluorescence release assay2008Journal of medicinal chemistry, Jul-24, Volume: 51, Issue:14
ISSN: 1520-4804
Discovery of N-(2-aminophenyl)-4-[(4-pyridin-3-ylpyrimidin-2-ylamino)methyl]benzamide (MGCD0103), an orally active histone deacetylase inhibitor.
AID1241538Induction of cell cycle arrest in human PC3 cells assessed as accumulation at S phase at 10 uM incubated for 24 hrs by FITC/propidium iodide staining based flow cytometry (Rvb = 22.4%)2015Journal of medicinal chemistry, Sep-10, Volume: 58, Issue:17
ISSN: 1520-4804
Potent and Selective Inhibitors of Histone Deacetylase-3 Containing Chiral Oxazoline Capping Groups and a N-(2-Aminophenyl)-benzamide Binding Unit.
AID1740026Inhibition of human NH2-terminal His6-tagged HDAC7 expressed in sf9 cells using Boc-Lys(Ac)-AMC as substrate preincubated for 10 mins followed by substrate addition by fluorometry2020Journal of medicinal chemistry, 11-12, Volume: 63, Issue:21
ISSN: 1520-4804
Thirty Years of HDAC Inhibitors: 2020 Insight and Hindsight.
AID344101Antiproliferative activity against human HCT116 cells after 72 hrs by MTT assay2008Journal of medicinal chemistry, Jul-24, Volume: 51, Issue:14
ISSN: 1520-4804
Discovery of N-(2-aminophenyl)-4-[(4-pyridin-3-ylpyrimidin-2-ylamino)methyl]benzamide (MGCD0103), an orally active histone deacetylase inhibitor.
AID1907400Antiproliferative activity against mouse MC38 cells after 72 hrs by CCK-8 assay2022European journal of medicinal chemistry, Jun-05, Volume: 236ISSN: 1768-3254Dual-acting antitumor agents targeting the A
AID1241528Distribution coefficient, log D of the compound by HPLC method2015Journal of medicinal chemistry, Sep-10, Volume: 58, Issue:17
ISSN: 1520-4804
Potent and Selective Inhibitors of Histone Deacetylase-3 Containing Chiral Oxazoline Capping Groups and a N-(2-Aminophenyl)-benzamide Binding Unit.
AID1201720Inhibition of recombinant human HDAC2 expressed in baculovirus infected insect High5 cells using Ac-Lys-Tyr-Lys (epsilon-acetyl)-AMC as substrate after 24 hrs by fluorescence assay2015European journal of medicinal chemistry, May-05, Volume: 95ISSN: 1768-3254Design, synthesis and biological evaluation of colchicine derivatives as novel tubulin and histone deacetylase dual inhibitors.
AID344115Oral bioavailability in CD1 mouse at 2.5 to 15 mg/kg2008Journal of medicinal chemistry, Jul-24, Volume: 51, Issue:14
ISSN: 1520-4804
Discovery of N-(2-aminophenyl)-4-[(4-pyridin-3-ylpyrimidin-2-ylamino)methyl]benzamide (MGCD0103), an orally active histone deacetylase inhibitor.
AID609498Half life in human liver microsomes2011Bioorganic & medicinal chemistry letters, Aug-15, Volume: 21, Issue:16
ISSN: 1464-3405
The design, synthesis and structure-activity relationships of novel isoindoline-based histone deacetylase inhibitors.
AID324949Inhibition of HDAC3 in HEK293 cells2008Bioorganic & medicinal chemistry letters, Mar-15, Volume: 18, Issue:6
ISSN: 1464-3405
Probing the elusive catalytic activity of vertebrate class IIa histone deacetylases.
AID1740027Inhibition of human NH2-terminal His-tagged HDAC6 expressed in sf9 cells using Boc-Lys(Ac)-AMC as substrate preincubated for 10 mins followed by substrate addition by fluorometry2020Journal of medicinal chemistry, 11-12, Volume: 63, Issue:21
ISSN: 1520-4804
Thirty Years of HDAC Inhibitors: 2020 Insight and Hindsight.
AID762205Inhibition of recombinant His-tagged HDAC6 (unknown origin) using Fluor-de-Lys SIRT1 as substrate incubated for 3 hrs prior to substrate addition measured after 60 mins by fluorescence plate reader analysis2013Journal of medicinal chemistry, Aug-08, Volume: 56, Issue:15
ISSN: 1520-4804
Discovery of potent, isoform-selective inhibitors of histone deacetylase containing chiral heterocyclic capping groups and a N-(2-aminophenyl)benzamide binding unit.
AID344097Inhibition of human recombinant HDAC5 homogeneous fluorescence release assay2008Journal of medicinal chemistry, Jul-24, Volume: 51, Issue:14
ISSN: 1520-4804
Discovery of N-(2-aminophenyl)-4-[(4-pyridin-3-ylpyrimidin-2-ylamino)methyl]benzamide (MGCD0103), an orally active histone deacetylase inhibitor.
AID780587Inhibition of human recombinant HDAC3 expressed in baculovirus infected insect high5 cells using Ac-Lys-Tyr-Lys (epsilon-acetyl)-AMC as substrate after 3 to 24 hrs by fluorescence assay2013Bioorganic & medicinal chemistry, Nov-15, Volume: 21, Issue:22
ISSN: 1464-3391
The discovery and optimization of novel dual inhibitors of topoisomerase II and histone deacetylase.
AID316898Inhibition of HDAC22008Journal of medicinal chemistry, Mar-27, Volume: 51, Issue:6
ISSN: 0022-2623
Histone deacetylase inhibitors: from bench to clinic.
AID344092Inhibition of human recombinant HDAC1 homogeneous fluorescence release assay2008Journal of medicinal chemistry, Jul-24, Volume: 51, Issue:14
ISSN: 1520-4804
Discovery of N-(2-aminophenyl)-4-[(4-pyridin-3-ylpyrimidin-2-ylamino)methyl]benzamide (MGCD0103), an orally active histone deacetylase inhibitor.
AID613343Inhibition of human ERG at 30 uM2011Journal of medicinal chemistry, Jul-14, Volume: 54, Issue:13
ISSN: 1520-4804
Optimization of the in vitro cardiac safety of hydroxamate-based histone deacetylase inhibitors.
AID344392Antitumor activity against human DU145 cells xenografted in CD1 nude mouse at 80 mg/kg2008Journal of medicinal chemistry, Jul-24, Volume: 51, Issue:14
ISSN: 1520-4804
Discovery of N-(2-aminophenyl)-4-[(4-pyridin-3-ylpyrimidin-2-ylamino)methyl]benzamide (MGCD0103), an orally active histone deacetylase inhibitor.
AID1201726Cytotoxicity against human SW620 cells assessed as growth inhibition after 72 hrs by MTT assay2015European journal of medicinal chemistry, May-05, Volume: 95ISSN: 1768-3254Design, synthesis and biological evaluation of colchicine derivatives as novel tubulin and histone deacetylase dual inhibitors.
AID1241540Induction of apoptosis in human U937 cells assessed as accumulation at subG1 phase at 10 uM incubated for 24 hrs by FITC/propidium iodide staining based flow cytometry (Rvb = 0.3%)2015Journal of medicinal chemistry, Sep-10, Volume: 58, Issue:17
ISSN: 1520-4804
Potent and Selective Inhibitors of Histone Deacetylase-3 Containing Chiral Oxazoline Capping Groups and a N-(2-Aminophenyl)-benzamide Binding Unit.
AID1740024Inhibition of human NH2-terminal His6-tagged HDAC4 expressed in sf9 cells using Boc-Lys(Ac)-AMC as substrate preincubated for 10 mins followed by substrate addition by fluorometry2020Journal of medicinal chemistry, 11-12, Volume: 63, Issue:21
ISSN: 1520-4804
Thirty Years of HDAC Inhibitors: 2020 Insight and Hindsight.
AID762184Inhibition of HDAC in human HeLa cells assessed as increase in H3K9Ac level at 1 to 10 uM after 24 hrs by Western blot analysis2013Journal of medicinal chemistry, Aug-08, Volume: 56, Issue:15
ISSN: 1520-4804
Discovery of potent, isoform-selective inhibitors of histone deacetylase containing chiral heterocyclic capping groups and a N-(2-aminophenyl)benzamide binding unit.
AID344094Inhibition of human recombinant HDAC3 homogeneous fluorescence release assay2008Journal of medicinal chemistry, Jul-24, Volume: 51, Issue:14
ISSN: 1520-4804
Discovery of N-(2-aminophenyl)-4-[(4-pyridin-3-ylpyrimidin-2-ylamino)methyl]benzamide (MGCD0103), an orally active histone deacetylase inhibitor.
AID344102Antiproliferative activity against human A549 cells after 72 hrs by MTT assay2008Journal of medicinal chemistry, Jul-24, Volume: 51, Issue:14
ISSN: 1520-4804
Discovery of N-(2-aminophenyl)-4-[(4-pyridin-3-ylpyrimidin-2-ylamino)methyl]benzamide (MGCD0103), an orally active histone deacetylase inhibitor.
AID780581Antiproliferative activity against human A549 cells assessed as cell viability after 72 hrs by MTT assay2013Bioorganic & medicinal chemistry, Nov-15, Volume: 21, Issue:22
ISSN: 1464-3391
The discovery and optimization of novel dual inhibitors of topoisomerase II and histone deacetylase.
AID613295Antiproliferative activity against human HCT116 cells assessed as growth inhibition2011Journal of medicinal chemistry, Jul-14, Volume: 54, Issue:13
ISSN: 1520-4804
Optimization of the in vitro cardiac safety of hydroxamate-based histone deacetylase inhibitors.
AID367298Antiproliferative activity against human HCT116 cells by MTT assay2009Bioorganic & medicinal chemistry letters, Feb-01, Volume: 19, Issue:3
ISSN: 1464-3405
SAR and biological evaluation of analogues of a small molecule histone deacetylase inhibitor N-(2-aminophenyl)-4-((4-(pyridin-3-yl)pyrimidin-2-ylamino)methyl)benzamide (MGCD0103).
AID1241530Permeability by artificial membrane permeability assay2015Journal of medicinal chemistry, Sep-10, Volume: 58, Issue:17
ISSN: 1520-4804
Potent and Selective Inhibitors of Histone Deacetylase-3 Containing Chiral Oxazoline Capping Groups and a N-(2-Aminophenyl)-benzamide Binding Unit.
AID721036Cytotoxicity against human HCT116 cells after 72 hrs by MTT assay2013Bioorganic & medicinal chemistry letters, Jan-01, Volume: 23, Issue:1
ISSN: 1464-3405
Design, synthesis and bioevalution of novel benzamides derivatives as HDAC inhibitors.
AID1740023Inhibition of human NH2-terminal His-tagged HDAC8 expressed in sf9 cells using Boc-Lys(Ac)-AMC as substrate preincubated for 10 mins followed by substrate addition by fluorometry2020Journal of medicinal chemistry, 11-12, Volume: 63, Issue:21
ISSN: 1520-4804
Thirty Years of HDAC Inhibitors: 2020 Insight and Hindsight.
AID762203Inhibition of recombinant HDAC3-NCoR1 (unknown origin) using MAL as substrate incubated for 3 hrs prior to substrate addition measured after 60 mins by fluorescence plate reader analysis2013Journal of medicinal chemistry, Aug-08, Volume: 56, Issue:15
ISSN: 1520-4804
Discovery of potent, isoform-selective inhibitors of histone deacetylase containing chiral heterocyclic capping groups and a N-(2-aminophenyl)benzamide binding unit.
AID367308Inhibition of HDAC72009Bioorganic & medicinal chemistry letters, Feb-01, Volume: 19, Issue:3
ISSN: 1464-3405
SAR and biological evaluation of analogues of a small molecule histone deacetylase inhibitor N-(2-aminophenyl)-4-((4-(pyridin-3-yl)pyrimidin-2-ylamino)methyl)benzamide (MGCD0103).
AID613341Inhibition of human ERG by automated Q-patch assay2011Journal of medicinal chemistry, Jul-14, Volume: 54, Issue:13
ISSN: 1520-4804
Optimization of the in vitro cardiac safety of hydroxamate-based histone deacetylase inhibitors.
AID1241532Inhibition of HDAC3 in human U937 cells assessed as increase in histone H3 lysine-9 acetylation at 10 uM incubated for 24 hrs by Western blotting method2015Journal of medicinal chemistry, Sep-10, Volume: 58, Issue:17
ISSN: 1520-4804
Potent and Selective Inhibitors of Histone Deacetylase-3 Containing Chiral Oxazoline Capping Groups and a N-(2-Aminophenyl)-benzamide Binding Unit.
AID344100Inhibition of human recombinant HDAC8 homogeneous fluorescence release assay2008Journal of medicinal chemistry, Jul-24, Volume: 51, Issue:14
ISSN: 1520-4804
Discovery of N-(2-aminophenyl)-4-[(4-pyridin-3-ylpyrimidin-2-ylamino)methyl]benzamide (MGCD0103), an orally active histone deacetylase inhibitor.
AID344381AUC in Beagle dog at 7 to 30 mg/kg, po2008Journal of medicinal chemistry, Jul-24, Volume: 51, Issue:14
ISSN: 1520-4804
Discovery of N-(2-aminophenyl)-4-[(4-pyridin-3-ylpyrimidin-2-ylamino)methyl]benzamide (MGCD0103), an orally active histone deacetylase inhibitor.
AID344113Cmax in CD1 mouse at 2.5 to 15 mg/kg, po2008Journal of medicinal chemistry, Jul-24, Volume: 51, Issue:14
ISSN: 1520-4804
Discovery of N-(2-aminophenyl)-4-[(4-pyridin-3-ylpyrimidin-2-ylamino)methyl]benzamide (MGCD0103), an orally active histone deacetylase inhibitor.
AID1740022Inhibition of human C-terminal Flag-tagged HDAC3 expressed in sf9 cells using Boc-Lys(Ac)-AMC as substrate preincubated for 10 mins followed by substrate addition by fluorometry2020Journal of medicinal chemistry, 11-12, Volume: 63, Issue:21
ISSN: 1520-4804
Thirty Years of HDAC Inhibitors: 2020 Insight and Hindsight.
AID762201Inhibition of recombinant C-terminal FLAG-tagged HDAC1 (unknown origin) expressed in Escherichia coli BL21 using MAL as substrate incubated for 1 hr prior to substrate addition measured after 60 mins by fluorescence plate reader analysis2013Journal of medicinal chemistry, Aug-08, Volume: 56, Issue:15
ISSN: 1520-4804
Discovery of potent, isoform-selective inhibitors of histone deacetylase containing chiral heterocyclic capping groups and a N-(2-aminophenyl)benzamide binding unit.
AID344109Half life in CD1 mouse at 2.5 to 15 mg/kg, iv2008Journal of medicinal chemistry, Jul-24, Volume: 51, Issue:14
ISSN: 1520-4804
Discovery of N-(2-aminophenyl)-4-[(4-pyridin-3-ylpyrimidin-2-ylamino)methyl]benzamide (MGCD0103), an orally active histone deacetylase inhibitor.
AID1810050Antiproliferative activity against mouse MC38 cells measured after 72 hrs by CCK8 assay2021Journal of medicinal chemistry, 11-25, Volume: 64, Issue:22
ISSN: 1520-4804
AID1241536Induction of apoptosis in human PC3 cells assessed as accumulation at subG1 phase at 10 uM incubated for 24 hrs by FITC/propidium iodide staining based flow cytometry (Rvb = 0.2%)2015Journal of medicinal chemistry, Sep-10, Volume: 58, Issue:17
ISSN: 1520-4804
Potent and Selective Inhibitors of Histone Deacetylase-3 Containing Chiral Oxazoline Capping Groups and a N-(2-Aminophenyl)-benzamide Binding Unit.
AID367304Inhibition of HDAC22009Bioorganic & medicinal chemistry letters, Feb-01, Volume: 19, Issue:3
ISSN: 1464-3405
SAR and biological evaluation of analogues of a small molecule histone deacetylase inhibitor N-(2-aminophenyl)-4-((4-(pyridin-3-yl)pyrimidin-2-ylamino)methyl)benzamide (MGCD0103).
AID613340Antiproliferative activity against human H1299 cells2011Journal of medicinal chemistry, Jul-14, Volume: 54, Issue:13
ISSN: 1520-4804
Optimization of the in vitro cardiac safety of hydroxamate-based histone deacetylase inhibitors.
AID609495Ratio of IC50 for CYP3A4 to IC50 for human HCT116 cells2011Bioorganic & medicinal chemistry letters, Aug-15, Volume: 21, Issue:16
ISSN: 1464-3405
The design, synthesis and structure-activity relationships of novel isoindoline-based histone deacetylase inhibitors.
AID344112Tmax in CD1 mouse at 2.5 to 15 mg/kg, po2008Journal of medicinal chemistry, Jul-24, Volume: 51, Issue:14
ISSN: 1520-4804
Discovery of N-(2-aminophenyl)-4-[(4-pyridin-3-ylpyrimidin-2-ylamino)methyl]benzamide (MGCD0103), an orally active histone deacetylase inhibitor.
AID344388Antitumor activity against human A549 cells xenografted in CD1 nude mouse at 40 mg/kg/day, po2008Journal of medicinal chemistry, Jul-24, Volume: 51, Issue:14
ISSN: 1520-4804
Discovery of N-(2-aminophenyl)-4-[(4-pyridin-3-ylpyrimidin-2-ylamino)methyl]benzamide (MGCD0103), an orally active histone deacetylase inhibitor.
AID609489Inhibition of purified recombinant HDAC12011Bioorganic & medicinal chemistry letters, Aug-15, Volume: 21, Issue:16
ISSN: 1464-3405
The design, synthesis and structure-activity relationships of novel isoindoline-based histone deacetylase inhibitors.
AID344106Induction of p21cip/waf1 protein expression in human HCT116 cells relative to MS2752008Journal of medicinal chemistry, Jul-24, Volume: 51, Issue:14
ISSN: 1520-4804
Discovery of N-(2-aminophenyl)-4-[(4-pyridin-3-ylpyrimidin-2-ylamino)methyl]benzamide (MGCD0103), an orally active histone deacetylase inhibitor.
AID762180Cell cycle arrest in human Jurkat cells assessed as accumulation at G2/M phase at 10 uM after 24 hrs by FITC/propidium iodide staining-based FACS flow cytometric analysis (Rvb = 13.2%)2013Journal of medicinal chemistry, Aug-08, Volume: 56, Issue:15
ISSN: 1520-4804
Discovery of potent, isoform-selective inhibitors of histone deacetylase containing chiral heterocyclic capping groups and a N-(2-aminophenyl)benzamide binding unit.
AID1241516Inhibition of His-flagged recombinant HDAC6 (unknown origin) at 20 uM pre-incubated for 1 hr before substrate addition by homogeneous fluorogenic HDAC assay2015Journal of medicinal chemistry, Sep-10, Volume: 58, Issue:17
ISSN: 1520-4804
Potent and Selective Inhibitors of Histone Deacetylase-3 Containing Chiral Oxazoline Capping Groups and a N-(2-Aminophenyl)-benzamide Binding Unit.
AID1201721Inhibition of recombinant human HDAC3 expressed in baculovirus infected insect High5 cells using Ac-Lys-Tyr-Lys (epsilon-acetyl)-AMC as substrate after 3 hrs by fluorescence assay2015European journal of medicinal chemistry, May-05, Volume: 95ISSN: 1768-3254Design, synthesis and biological evaluation of colchicine derivatives as novel tubulin and histone deacetylase dual inhibitors.
AID1201724Cytotoxicity against human A549 cells assessed as growth inhibition after 72 hrs by MTT assay2015European journal of medicinal chemistry, May-05, Volume: 95ISSN: 1768-3254Design, synthesis and biological evaluation of colchicine derivatives as novel tubulin and histone deacetylase dual inhibitors.
AID762176Cell cycle arrest in human Jurkat cells assessed as accumulation at G2/M phase at 1 uM after 24 hrs by FITC/propidium iodide staining-based FACS flow cytometric analysis (Rvb = 14.4%)2013Journal of medicinal chemistry, Aug-08, Volume: 56, Issue:15
ISSN: 1520-4804
Discovery of potent, isoform-selective inhibitors of histone deacetylase containing chiral heterocyclic capping groups and a N-(2-aminophenyl)benzamide binding unit.
AID1201728Cytotoxicity against human HepG2 cells assessed as growth inhibition after 72 hrs by MTT assay2015European journal of medicinal chemistry, May-05, Volume: 95ISSN: 1768-3254Design, synthesis and biological evaluation of colchicine derivatives as novel tubulin and histone deacetylase dual inhibitors.
AID344382Oral bioavailability in Beagle dog at 7 to 30 mg/kg2008Journal of medicinal chemistry, Jul-24, Volume: 51, Issue:14
ISSN: 1520-4804
Discovery of N-(2-aminophenyl)-4-[(4-pyridin-3-ylpyrimidin-2-ylamino)methyl]benzamide (MGCD0103), an orally active histone deacetylase inhibitor.
AID1441632Binding affinity to recombinant human LTA4H hydrolase assessed as change in melting temperature at 50 uM by SYPRO orange dye-based thermofluor assay2017Journal of medicinal chemistry, 03-09, Volume: 60, Issue:5
ISSN: 1520-4804
Drug Repurposing of Histone Deacetylase Inhibitors That Alleviate Neutrophilic Inflammation in Acute Lung Injury and Idiopathic Pulmonary Fibrosis via Inhibiting Leukotriene A4 Hydrolase and Blocking LTB4 Biosynthesis.
AID762178Cell cycle arrest in human Jurkat cells assessed as accumulation at G0/G1 phase at 1 uM after 24 hrs by FITC/propidium iodide staining-based FACS flow cytometric analysis (Rvb = 55.5%)2013Journal of medicinal chemistry, Aug-08, Volume: 56, Issue:15
ISSN: 1520-4804
Discovery of potent, isoform-selective inhibitors of histone deacetylase containing chiral heterocyclic capping groups and a N-(2-aminophenyl)benzamide binding unit.
AID1810053Displacement of [3H]SCH58261 from adenosine A2A receptor membrane (unknown origin) measured after 60 mins by scintillation counting analysis2021Journal of medicinal chemistry, 11-25, Volume: 64, Issue:22
ISSN: 1520-4804
AID721023Oral bioavailability in rat2013Bioorganic & medicinal chemistry letters, Jan-01, Volume: 23, Issue:1
ISSN: 1464-3405
Design, synthesis and bioevalution of novel benzamides derivatives as HDAC inhibitors.
AID762187Cytotoxicity against human DU145 cells assessed as growth inhibition by measuring cellular ATP level after 72 hrs by cell-titer glo assay2013Journal of medicinal chemistry, Aug-08, Volume: 56, Issue:15
ISSN: 1520-4804
Discovery of potent, isoform-selective inhibitors of histone deacetylase containing chiral heterocyclic capping groups and a N-(2-aminophenyl)benzamide binding unit.
AID344111Volume of distribution in CD1 mouse at 2.5 to 15 mg/kg, iv and po2008Journal of medicinal chemistry, Jul-24, Volume: 51, Issue:14
ISSN: 1520-4804
Discovery of N-(2-aminophenyl)-4-[(4-pyridin-3-ylpyrimidin-2-ylamino)methyl]benzamide (MGCD0103), an orally active histone deacetylase inhibitor.
AID762186Cytotoxicity against human MCF7 cells assessed as growth inhibition by measuring cellular ATP level after 72 hrs by cell-titer glo assay2013Journal of medicinal chemistry, Aug-08, Volume: 56, Issue:15
ISSN: 1520-4804
Discovery of potent, isoform-selective inhibitors of histone deacetylase containing chiral heterocyclic capping groups and a N-(2-aminophenyl)benzamide binding unit.
AID1891409Inhibition of SARS-CoV-2 main protease expressed in Escherichia coli using DABCYL-KTSAVLQ1SGFRKM-E(EDANS)-NH2 peptide as substrate at 100 uM incubated for 30 mins by FRET based assay relative to control2022Bioorganic & medicinal chemistry letters, 06-15, Volume: 66ISSN: 1464-3405
AID780585Antiproliferative activity against human HCT116 cells assessed as cell viability after 72 hrs by MTT assay2013Bioorganic & medicinal chemistry, Nov-15, Volume: 21, Issue:22
ISSN: 1464-3391
The discovery and optimization of novel dual inhibitors of topoisomerase II and histone deacetylase.
AID496801Inhibition of human HDAC12010Nature chemical biology, Mar, Volume: 6, Issue:3
ISSN: 1552-4469
Chemical phylogenetics of histone deacetylases.
AID367301Induction of histone H4 hyperacetylation in human T24 cells after 16 hrs by immunoblotting2009Bioorganic & medicinal chemistry letters, Feb-01, Volume: 19, Issue:3
ISSN: 1464-3405
SAR and biological evaluation of analogues of a small molecule histone deacetylase inhibitor N-(2-aminophenyl)-4-((4-(pyridin-3-yl)pyrimidin-2-ylamino)methyl)benzamide (MGCD0103).
AID762185Inhibition of HDAC in human Jurkat cells assessed as increase in H3K9Ac level at 1 to 10 uM after 24 hrs by Western blot analysis2013Journal of medicinal chemistry, Aug-08, Volume: 56, Issue:15
ISSN: 1520-4804
Discovery of potent, isoform-selective inhibitors of histone deacetylase containing chiral heterocyclic capping groups and a N-(2-aminophenyl)benzamide binding unit.
AID367305Inhibition of HDAC32009Bioorganic & medicinal chemistry letters, Feb-01, Volume: 19, Issue:3
ISSN: 1464-3405
SAR and biological evaluation of analogues of a small molecule histone deacetylase inhibitor N-(2-aminophenyl)-4-((4-(pyridin-3-yl)pyrimidin-2-ylamino)methyl)benzamide (MGCD0103).
AID344104Antiproliferative activity against HMEC after 72 hrs by MTT assay2008Journal of medicinal chemistry, Jul-24, Volume: 51, Issue:14
ISSN: 1520-4804
Discovery of N-(2-aminophenyl)-4-[(4-pyridin-3-ylpyrimidin-2-ylamino)methyl]benzamide (MGCD0103), an orally active histone deacetylase inhibitor.
AID440821Inhibition of human recombinant N-terminal FLAG-tagged HDAC4 (612-1034) expressed in baculovirus after 10 mins by fluorimetric analysis2009Bioorganic & medicinal chemistry letters, Oct-01, Volume: 19, Issue:19
ISSN: 1464-3405
Diphenylmethylene hydroxamic acids as selective class IIa histone deacetylase inhibitors.
AID762202Inhibition of recombinant HDAC8 (unknown origin) expressed in Escherichia coli BL21 using MAL as substrate incubated for 15 mins prior to substrate addition measured after 60 mins by fluorescence plate reader analysis2013Journal of medicinal chemistry, Aug-08, Volume: 56, Issue:15
ISSN: 1520-4804
Discovery of potent, isoform-selective inhibitors of histone deacetylase containing chiral heterocyclic capping groups and a N-(2-aminophenyl)benzamide binding unit.
AID762182Cell cycle arrest in human Jurkat cells assessed as accumulation at G0/G1 phase at 10 uM after 24 hrs by FITC/propidium iodide staining-based FACS flow cytometric analysis (Rvb = 69.5%)2013Journal of medicinal chemistry, Aug-08, Volume: 56, Issue:15
ISSN: 1520-4804
Discovery of potent, isoform-selective inhibitors of histone deacetylase containing chiral heterocyclic capping groups and a N-(2-aminophenyl)benzamide binding unit.
AID344380Cmax in Beagle dog at 7 to 30 mg/kg, po2008Journal of medicinal chemistry, Jul-24, Volume: 51, Issue:14
ISSN: 1520-4804
Discovery of N-(2-aminophenyl)-4-[(4-pyridin-3-ylpyrimidin-2-ylamino)methyl]benzamide (MGCD0103), an orally active histone deacetylase inhibitor.
AID344116Half life in Sprague-Dawley rat at 2.5 to 5 mg/kg, iv2008Journal of medicinal chemistry, Jul-24, Volume: 51, Issue:14
ISSN: 1520-4804
Discovery of N-(2-aminophenyl)-4-[(4-pyridin-3-ylpyrimidin-2-ylamino)methyl]benzamide (MGCD0103), an orally active histone deacetylase inhibitor.
AID367307Inhibition of HDAC62009Bioorganic & medicinal chemistry letters, Feb-01, Volume: 19, Issue:3
ISSN: 1464-3405
SAR and biological evaluation of analogues of a small molecule histone deacetylase inhibitor N-(2-aminophenyl)-4-((4-(pyridin-3-yl)pyrimidin-2-ylamino)methyl)benzamide (MGCD0103).
AID316893Inhibition of HDAC82008Journal of medicinal chemistry, Mar-27, Volume: 51, Issue:6
ISSN: 0022-2623
Histone deacetylase inhibitors: from bench to clinic.
AID721024Oral bioavailability in mouse2013Bioorganic & medicinal chemistry letters, Jan-01, Volume: 23, Issue:1
ISSN: 1464-3405
Design, synthesis and bioevalution of novel benzamides derivatives as HDAC inhibitors.
AID1241517Inhibition of His-flagged recombinant HDAC8 (unknown origin) expressed in Escherichia coli BL21 pre-incubated for 15 mins before substrate addition by homogeneous fluorogenic HDAC assay2015Journal of medicinal chemistry, Sep-10, Volume: 58, Issue:17
ISSN: 1520-4804
Potent and Selective Inhibitors of Histone Deacetylase-3 Containing Chiral Oxazoline Capping Groups and a N-(2-Aminophenyl)-benzamide Binding Unit.
AID344122Oral bioavailability in Sprague-Dawley rat at 2.5 to 50 mg/kg2008Journal of medicinal chemistry, Jul-24, Volume: 51, Issue:14
ISSN: 1520-4804
Discovery of N-(2-aminophenyl)-4-[(4-pyridin-3-ylpyrimidin-2-ylamino)methyl]benzamide (MGCD0103), an orally active histone deacetylase inhibitor.
AID762179Cell cycle arrest in human Jurkat cells assessed as accumulation at sub-G1 phase at 1 uM after 24 hrs by FITC/propidium iodide staining-based FACS flow cytometric analysis (Rvb = 6.8%)2013Journal of medicinal chemistry, Aug-08, Volume: 56, Issue:15
ISSN: 1520-4804
Discovery of potent, isoform-selective inhibitors of histone deacetylase containing chiral heterocyclic capping groups and a N-(2-aminophenyl)benzamide binding unit.
AID344107Cell cycle arrest in human HCT116 cells assessed as accumulation at G2/M phase2008Journal of medicinal chemistry, Jul-24, Volume: 51, Issue:14
ISSN: 1520-4804
Discovery of N-(2-aminophenyl)-4-[(4-pyridin-3-ylpyrimidin-2-ylamino)methyl]benzamide (MGCD0103), an orally active histone deacetylase inhibitor.
AID324948Inhibition of HDAC1 in HEK293 cells2008Bioorganic & medicinal chemistry letters, Mar-15, Volume: 18, Issue:6
ISSN: 1464-3405
Probing the elusive catalytic activity of vertebrate class IIa histone deacetylases.
AID1201725Cytotoxicity against human HCT116 cells assessed as growth inhibition after 72 hrs by MTT assay2015European journal of medicinal chemistry, May-05, Volume: 95ISSN: 1768-3254Design, synthesis and biological evaluation of colchicine derivatives as novel tubulin and histone deacetylase dual inhibitors.
AID1740020Inhibition of human C-terminal Flag-tagged HDAC1 expressed in sf9 cells using Boc-Lys(Ac)-AMC as substrate preincubated for 10 mins followed by substrate addition by fluorometry2020Journal of medicinal chemistry, 11-12, Volume: 63, Issue:21
ISSN: 1520-4804
Thirty Years of HDAC Inhibitors: 2020 Insight and Hindsight.
AID1740028Inhibition of human C-terminal Flag-tagged HDAC11 expressed in sf9 cells using Boc-Lys(Ac)-AMC as substrate preincubated for 10 mins followed by substrate addition by fluorometry2020Journal of medicinal chemistry, 11-12, Volume: 63, Issue:21
ISSN: 1520-4804
Thirty Years of HDAC Inhibitors: 2020 Insight and Hindsight.
AID780580Inhibition of Topoisomerase 2 (unknown origin) assessed as impairment of pBR322 DNA decatenation at 100 uM after 30 mins by agarose gel electrophoresis2013Bioorganic & medicinal chemistry, Nov-15, Volume: 21, Issue:22
ISSN: 1464-3391
The discovery and optimization of novel dual inhibitors of topoisomerase II and histone deacetylase.
AID1241514Inhibition of recombinant HDAC3/NCOR2 (unknown origin) pre-incubated for 3 hrs before substrate addition by homogeneous fluorogenic HDAC assay2015Journal of medicinal chemistry, Sep-10, Volume: 58, Issue:17
ISSN: 1520-4804
Potent and Selective Inhibitors of Histone Deacetylase-3 Containing Chiral Oxazoline Capping Groups and a N-(2-Aminophenyl)-benzamide Binding Unit.
AID609493Inhibition of human ERG by automated patch clamp assay2011Bioorganic & medicinal chemistry letters, Aug-15, Volume: 21, Issue:16
ISSN: 1464-3405
The design, synthesis and structure-activity relationships of novel isoindoline-based histone deacetylase inhibitors.
AID324958Inhibition of HDAC6 in HEK293 cells at 2 uM2008Bioorganic & medicinal chemistry letters, Mar-15, Volume: 18, Issue:6
ISSN: 1464-3405
Probing the elusive catalytic activity of vertebrate class IIa histone deacetylases.
AID1810051Inhibition of HDAC1 (unknown origin) assessed as release of 7-amino-4-methylcoumarin incubated in room temperature for 15 min measured by Spectra max microtitre plate reader2021Journal of medicinal chemistry, 11-25, Volume: 64, Issue:22
ISSN: 1520-4804
AID344389Antitumor activity against human A549 cells xenografted in CD1 nude mouse at 60 mg/kg/day, po2008Journal of medicinal chemistry, Jul-24, Volume: 51, Issue:14
ISSN: 1520-4804
Discovery of N-(2-aminophenyl)-4-[(4-pyridin-3-ylpyrimidin-2-ylamino)methyl]benzamide (MGCD0103), an orally active histone deacetylase inhibitor.
AID344391Antitumor activity against human DU145 cells xenografted in CD1 nude mouse at 70 mg/kg/day, po2008Journal of medicinal chemistry, Jul-24, Volume: 51, Issue:14
ISSN: 1520-4804
Discovery of N-(2-aminophenyl)-4-[(4-pyridin-3-ylpyrimidin-2-ylamino)methyl]benzamide (MGCD0103), an orally active histone deacetylase inhibitor.
AID1201727Cytotoxicity against human Hep3B cells assessed as growth inhibition after 72 hrs by MTT assay2015European journal of medicinal chemistry, May-05, Volume: 95ISSN: 1768-3254Design, synthesis and biological evaluation of colchicine derivatives as novel tubulin and histone deacetylase dual inhibitors.
AID609494Inhibition of CYP3A42011Bioorganic & medicinal chemistry letters, Aug-15, Volume: 21, Issue:16
ISSN: 1464-3405
The design, synthesis and structure-activity relationships of novel isoindoline-based histone deacetylase inhibitors.
AID367306Inhibition of HDAC52009Bioorganic & medicinal chemistry letters, Feb-01, Volume: 19, Issue:3
ISSN: 1464-3405
SAR and biological evaluation of analogues of a small molecule histone deacetylase inhibitor N-(2-aminophenyl)-4-((4-(pyridin-3-yl)pyrimidin-2-ylamino)methyl)benzamide (MGCD0103).
AID1201730Cytotoxicity against human SNU5 cells assessed as growth inhibition after 72 hrs by MTT assay2015European journal of medicinal chemistry, May-05, Volume: 95ISSN: 1768-3254Design, synthesis and biological evaluation of colchicine derivatives as novel tubulin and histone deacetylase dual inhibitors.
AID1241534Inhibition of HDAC in human U937 cells assessed as reduction in cyclin E expression in at 10 uM incubated for 24 hrs by Western blotting method2015Journal of medicinal chemistry, Sep-10, Volume: 58, Issue:17
ISSN: 1520-4804
Potent and Selective Inhibitors of Histone Deacetylase-3 Containing Chiral Oxazoline Capping Groups and a N-(2-Aminophenyl)-benzamide Binding Unit.
AID1810052Inhibition of HDAC6 (unknown origin) assessed as release of 7-amino-4-methylcoumarin incubated in room temperature for 15 min measured by Spectra max microtitre plate reader2021Journal of medicinal chemistry, 11-25, Volume: 64, Issue:22
ISSN: 1520-4804
AID367297Inhibition of human recombinant HDAC12009Bioorganic & medicinal chemistry letters, Feb-01, Volume: 19, Issue:3
ISSN: 1464-3405
SAR and biological evaluation of analogues of a small molecule histone deacetylase inhibitor N-(2-aminophenyl)-4-((4-(pyridin-3-yl)pyrimidin-2-ylamino)methyl)benzamide (MGCD0103).
AID609496Cardiac safety index, Ratio of IC50 for human ERG to IC50 for human HCT116 cells2011Bioorganic & medicinal chemistry letters, Aug-15, Volume: 21, Issue:16
ISSN: 1464-3405
The design, synthesis and structure-activity relationships of novel isoindoline-based histone deacetylase inhibitors.
AID1810049Antiproliferative activity against mouse CT26 cells measured after 72 hrs by CCK8 assay2021Journal of medicinal chemistry, 11-25, Volume: 64, Issue:22
ISSN: 1520-4804
AID367299Antiproliferative activity against HMEC by MTT assay2009Bioorganic & medicinal chemistry letters, Feb-01, Volume: 19, Issue:3
ISSN: 1464-3405
SAR and biological evaluation of analogues of a small molecule histone deacetylase inhibitor N-(2-aminophenyl)-4-((4-(pyridin-3-yl)pyrimidin-2-ylamino)methyl)benzamide (MGCD0103).
AID1201732Cytotoxicity against human MKN45 cells assessed as growth inhibition after 72 hrs by MTT assay2015European journal of medicinal chemistry, May-05, Volume: 95ISSN: 1768-3254Design, synthesis and biological evaluation of colchicine derivatives as novel tubulin and histone deacetylase dual inhibitors.
AID1201733Cytotoxicity against human PANC1 cells assessed as growth inhibition after 72 hrs by MTT assay2015European journal of medicinal chemistry, May-05, Volume: 95ISSN: 1768-3254Design, synthesis and biological evaluation of colchicine derivatives as novel tubulin and histone deacetylase dual inhibitors.
AID440822Inhibition of human recombinant N-terminal FLAG-tagged HDAC5 (620-1122) expressed in baculovirus after 10 mins by fluorimetric analysis2009Bioorganic & medicinal chemistry letters, Oct-01, Volume: 19, Issue:19
ISSN: 1464-3405
Diphenylmethylene hydroxamic acids as selective class IIa histone deacetylase inhibitors.
AID440819Inhibition of recombinant C-terminal FLAG-tagged HDAC1 expressed in baculovirus after 10 mins by fluorimetric analysis2009Bioorganic & medicinal chemistry letters, Oct-01, Volume: 19, Issue:19
ISSN: 1464-3405
Diphenylmethylene hydroxamic acids as selective class IIa histone deacetylase inhibitors.
AID344103Antiproliferative activity against human Du145 cells after 72 hrs by MTT assay2008Journal of medicinal chemistry, Jul-24, Volume: 51, Issue:14
ISSN: 1520-4804
Discovery of N-(2-aminophenyl)-4-[(4-pyridin-3-ylpyrimidin-2-ylamino)methyl]benzamide (MGCD0103), an orally active histone deacetylase inhibitor.
AID344119Tmax in Sprague-Dawley rat at 2.5 to 50 mg/kg, po2008Journal of medicinal chemistry, Jul-24, Volume: 51, Issue:14
ISSN: 1520-4804
Discovery of N-(2-aminophenyl)-4-[(4-pyridin-3-ylpyrimidin-2-ylamino)methyl]benzamide (MGCD0103), an orally active histone deacetylase inhibitor.
AID344121AUC in Sprague-Dawley rat at 2.5 to 50 mg/kg, po2008Journal of medicinal chemistry, Jul-24, Volume: 51, Issue:14
ISSN: 1520-4804
Discovery of N-(2-aminophenyl)-4-[(4-pyridin-3-ylpyrimidin-2-ylamino)methyl]benzamide (MGCD0103), an orally active histone deacetylase inhibitor.
AID780588Inhibition of human recombinant HDAC1 expressed in baculovirus infected insect high5 cells using Ac-Lys-Tyr-Lys (epsilon-acetyl)-AMC as substrate after 3 to 24 hrs by fluorescence assay2013Bioorganic & medicinal chemistry, Nov-15, Volume: 21, Issue:22
ISSN: 1464-3391
The discovery and optimization of novel dual inhibitors of topoisomerase II and histone deacetylase.
AID609492Thermodynamic solubility of the compound at pH 6.82011Bioorganic & medicinal chemistry letters, Aug-15, Volume: 21, Issue:16
ISSN: 1464-3405
The design, synthesis and structure-activity relationships of novel isoindoline-based histone deacetylase inhibitors.
AID780579Inhibition of HDAC2 (unknown origin)2013Bioorganic & medicinal chemistry, Nov-15, Volume: 21, Issue:22
ISSN: 1464-3391
The discovery and optimization of novel dual inhibitors of topoisomerase II and histone deacetylase.
AID686947qHTS for small molecule inhibitors of Yes1 kinase: Primary Screen2013Bioorganic & medicinal chemistry letters, Aug-01, Volume: 23, Issue:15
ISSN: 1464-3405
Identification of potent Yes1 kinase inhibitors using a library screening approach.
AID1745855NCATS anti-infectives library activity on the primary C. elegans qHTS viability assay2023Disease models & mechanisms, 03-01, Volume: 16, Issue:3
ISSN: 1754-8411
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
AID1347412qHTS assay to identify inhibitors of the type 1 interferon - major histocompatibility complex class I in skeletal muscle: Counter screen cell viability and HiBit confirmation2020ACS chemical biology, 07-17, Volume: 15, Issue:7
ISSN: 1554-8937
High-Throughput Screening to Identify Inhibitors of the Type I Interferon-Major Histocompatibility Complex Class I Pathway in Skeletal Muscle.
AID1745854NCATS anti-infectives library activity on HEK293 viability as a counter-qHTS vs the C. elegans viability qHTS2023Disease models & mechanisms, 03-01, Volume: 16, Issue:3
ISSN: 1754-8411
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
AID1347411qHTS to identify inhibitors of the type 1 interferon - major histocompatibility complex class I in skeletal muscle: primary screen against the NCATS Mechanism Interrogation Plate v5.0 (MIPE) Libary2020ACS chemical biology, 07-17, Volume: 15, Issue:7
ISSN: 1554-8937
High-Throughput Screening to Identify Inhibitors of the Type I Interferon-Major Histocompatibility Complex Class I Pathway in Skeletal Muscle.
AID1798452HDAC Enzyme Inhibition Assay from Article 10.1021/jm800251w: \\Discovery of N-(2-aminophenyl)-4-[(4-pyridin-3-ylpyrimidin-2-ylamino)methyl]benzamide (MGCD0103), an orally active histone deacetylase inhibitor.\\2008Journal of medicinal chemistry, Jul-24, Volume: 51, Issue:14
ISSN: 1520-4804
Discovery of N-(2-aminophenyl)-4-[(4-pyridin-3-ylpyrimidin-2-ylamino)methyl]benzamide (MGCD0103), an orally active histone deacetylase inhibitor.
AID1798526HDAC Activity Assay from Article 10.1016/j.bmcl.2008.02.025: \\Probing the elusive catalytic activity of vertebrate class IIa histone deacetylases.\\2008Bioorganic & medicinal chemistry letters, Mar-15, Volume: 18, Issue:6
ISSN: 1464-3405
Probing the elusive catalytic activity of vertebrate class IIa histone deacetylases.
AID1346134Human histone deacetylase 1 (3.5.1.- Histone deacetylases (HDACs))2010Nature chemical biology, Mar, Volume: 6, Issue:3
ISSN: 1552-4469
Chemical phylogenetics of histone deacetylases.
AID1346077Human histone deacetylase 3 (3.5.1.- Histone deacetylases (HDACs))2010Nature chemical biology, Mar, Volume: 6, Issue:3
ISSN: 1552-4469
Chemical phylogenetics of histone deacetylases.
AID1346082Human histone deacetylase 2 (3.5.1.- Histone deacetylases (HDACs))2010Nature chemical biology, Mar, Volume: 6, Issue:3
ISSN: 1552-4469
Chemical phylogenetics of histone deacetylases.

Research

Studies (20,895)

TimeframeStudies, This Drug (%)All Drugs %
pre-19902162 (10.35)18.7374
1990's3425 (16.39)18.2507
2000's5967 (28.56)29.6817
2010's7386 (35.35)24.3611
2020's1955 (9.36)2.80

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials390 (1.79%)5.53%
Reviews870 (4.00%)6.00%
Case Studies760 (3.50%)4.05%
Observational53 (0.24%)0.25%
Other19,662 (90.46%)84.16%
SubstanceStudiesClassesRolesFirst YearLast YearAverage AgeRelationship StrengthTrialspre-19901990's2000's2010'spost-2020
cytosineaminopyrimidine;
pyrimidine nucleobase;
pyrimidone
Escherichia coli metabolite;
human metabolite;
mouse metabolite;
Saccharomyces cerevisiae metabolite
1997202114.2low002112
toxopyrimidineaminopyrimidine;
aromatic primary alcohol
Escherichia coli metabolite;
Saccharomyces cerevisiae metabolite
00low000000
benphothiamineaminopyrimidine;
formamides;
organic phosphate;
thioester
antioxidant;
immunological adjuvant;
nutraceutical;
protective agent;
provitamin B1
00low000000
flucytosineaminopyrimidine;
nucleoside analogue;
organofluorine compound;
pyrimidine antifungal drug;
pyrimidone
prodrug00low000000
pyrimethamineaminopyrimidine;
monochlorobenzenes
antimalarial;
antiprotozoal drug;
EC 1.5.1.3 (dihydrofolate reductase) inhibitor
201920195.0low000010
sb 220025aminopyrimidine;
imidazoles;
organofluorine compound;
piperidines
angiogenesis inhibitor;
anti-inflammatory agent;
EC 2.7.11.24 (mitogen-activated protein kinase) inhibitor
00low000000
trimethoprimaminopyrimidine;
methoxybenzenes
antibacterial drug;
diuretic;
drug allergen;
EC 1.5.1.3 (dihydrofolate reductase) inhibitor;
environmental contaminant;
xenobiotic
1999199925.0low001000
2-aminopyrimidineaminopyrimidine00low000000
2-amino-4,6-dimethyl pyrimidineaminopyrimidine00low000000
2,4,6-triaminopyrimidineaminopyrimidine00low000000
diaveridineaminopyrimidineantiparasitic agent;
drug allergen
00low000000
2-amino-4-chloro-6-methylpyrimidineaminopyrimidinenitrification inhibitor00low000000
pirimicarbaminopyrimidine;
carbamate ester;
tertiary amino compound
agrochemical;
carbamate insecticide;
EC 3.1.1.7 (acetylcholinesterase) inhibitor;
environmental contaminant;
insecticide;
xenobiotic
00low000000
pirimiphos methylaminopyrimidine;
organic thiophosphate
acaricide;
agrochemical;
EC 3.1.1.7 (acetylcholinesterase) inhibitor;
environmental contaminant;
insecticide
00low000000
bupirimateaminopyrimidine;
pyrimidine fungicide;
secondary amino compound;
sulfamate ester
androgen antagonist;
antifungal agrochemical
00low000000
nimustineaminopyrimidine;
N-nitrosoureas;
organochlorine compound
alkylating agent;
antineoplastic agent
00low000000
isocytosineaminopyrimidine;
pyrimidine nucleobase;
pyrimidone
00low000000
2,4-diaminopyrimidineaminopyrimidine00low000000
brodimoprimaminopyrimidine;
bromobenzenes;
methoxybenzenes
antibacterial drug;
antiinfective agent;
EC 1.5.1.3 (dihydrofolate reductase) inhibitor
00low000000
4-aminopyrimidineaminopyrimidine00low000000
5-hydroxymethylcytosineaminopyrimidine;
aromatic primary alcohol;
nucleobase analogue;
pyrimidone
human metabolite;
mouse metabolite
00low000000
isaxonineaminopyrimidine00low000000
sofosbuviraminopyrimidine;
aromatic carboxylic acid;
nucleobase analogue;
pyrimidone
metabolite00low000000
1-methylcytosineaminopyrimidine;
methylcytosine;
pyrimidone
metabolite00low000000
mepanipyrimacetylenic compound;
aminopyrimidine;
anilinopyrimidine fungicide;
secondary amino compound
antifungal agrochemical;
aryl hydrocarbon receptor agonist;
hepatotoxic agent
00low000000
cyprodinilaminopyrimidine;
anilinopyrimidine fungicide;
cyclopropanes;
secondary amino compound
antifungal agrochemical;
aryl hydrocarbon receptor agonist;
environmental contaminant;
xenobiotic
00low000000
pyrimethanilaminopyrimidine;
anilinopyrimidine fungicide;
secondary amino compound
antifungal agrochemical;
aryl hydrocarbon receptor agonist;
environmental contaminant;
xenobiotic
00low000000
4,6-diamino-5-n-formamidopyrimidineaminopyrimidine;
formamidopyrimidine
00low000000
n(4)-methylcytosineaminopyrimidine;
methylcytosine;
pyrimidone
metabolite00low000000
3-methylcytosineaminopyrimidine;
methylcytosine;
pyrimidone
metabolite00low000000
4-amino-2-methoxypyrimidineaminopyrimidine;
aromatic ether;
methylcytosine
metabolite00low000000
etravirineaminopyrimidine;
aromatic ether;
dinitrile;
organobromine compound
antiviral agent;
HIV-1 reverse transcriptase inhibitor
00low000000
iclaprimaminopyrimidine;
chromenes;
cyclopropanes
00low000000
nsc 23766aminopyrimidine;
aminoquinoline;
primary amino compound;
secondary amino compound;
tertiary amino compound
antiviral agent;
apoptosis inducer;
EC 3.6.5.2 (small monomeric GTPase) inhibitor;
muscarinic antagonist
00low000000
2-(3,5-dimethyl-1-pyrazolyl)-N,6-dimethyl-4-pyrimidinamineaminopyrimidine00low000000
2-[[2-(3,5-dimethyl-1-pyrazolyl)-6-methyl-4-pyrimidinyl]amino]ethanolaminopyrimidine00low000000
4-methyl-6-(2,2,3,3,4,4,5,5-octafluoropentoxy)-2-pyrimidinamineaminopyrimidine00low000000
7-methylpyrimido[4,5-d]pyrimidin-4-amineaminopyrimidine00low000000
4-(5-methyl-3-phenylisoxazol-4-yl)pyrimidin-2-amineaminopyrimidine;
isoxazoles
00low000000
thiamine disulfideaminopyrimidine;
formamides;
homoallylic alcohol;
organic disulfide
00low000000
dasatinib1,3-thiazoles;
aminopyrimidine;
monocarboxylic acid amide;
N-(2-hydroxyethyl)piperazine;
N-arylpiperazine;
organochlorine compound;
secondary amino compound;
tertiary amino compound
anticoronaviral agent;
antineoplastic agent;
tyrosine kinase inhibitor
201620168.0low000010
4-(2-furanyl)-N-(3-pyridinylmethyl)-6-(trifluoromethyl)-2-pyrimidinamineaminopyrimidine00low000000
annomontinealkaloid;
aminopyrimidine;
beta-carbolines
antiparasitic agent;
metabolite
00low000000
rilpivirineaminopyrimidine;
nitrile
EC 2.7.7.49 (RNA-directed DNA polymerase) inhibitor;
HIV-1 reverse transcriptase inhibitor
00low000000
chir 99021aminopyridine;
aminopyrimidine;
cyanopyridine;
diamine;
dichlorobenzene;
imidazoles;
secondary amino compound
EC 2.7.11.26 (tau-protein kinase) inhibitor00low000000
pazopanibaminopyrimidine;
indazoles;
sulfonamide
angiogenesis modulating agent;
antineoplastic agent;
tyrosine kinase inhibitor;
vascular endothelial growth factor receptor antagonist
00low000000
5-formylcytosineaminopyrimidine;
heteroarenecarbaldehyde;
nucleobase analogue;
pyrimidone
metabolite00low000000
bay 63-2521aminopyrimidine;
carbamate ester;
organofluorine compound;
pyrazolopyridine
antihypertensive agent;
soluble guanylate cyclase activator
00low000000
4-(3-cyclohexyl-5-(4-fluoro-phenyl)-3h-imidazol-4-yl)pyrimidin-2-ylamineaminopyrimidine;
imidazoles;
monofluorobenzenes
EC 2.7.11.1 (non-specific serine/threonine protein kinase) inhibitor00low000000
bay 60-4552aminopyrimidine;
carbamate ester;
monofluorobenzenes;
pyrazolopyridine
antihypertensive agent;
drug metabolite;
soluble guanylate cyclase activator;
vasodilator agent
00low000000
2-({2-[(3-hydroxyphenyl)amino]pyrimidin-4-yl}amino)benzamideaminopyrimidine;
benzamides
protein kinase inhibitor00low000000
buparlisibaminopyridine;
aminopyrimidine;
morpholines;
organofluorine compound
antineoplastic agent;
EC 2.7.1.137 (phosphatidylinositol 3-kinase) inhibitor
00low000000
n-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamideaminopyrimidine;
benzamides;
morpholines;
nitrile;
secondary amino compound;
tertiary amino compound
anti-anaemic agent;
antineoplastic agent;
apoptosis inducer;
EC 2.7.10.2 (non-specific protein-tyrosine kinase) inhibitor
00low000000
TAK-5801,3-thiazolecarboxamide;
aminopyrimidine;
chloropyridine;
organofluorine compound;
pyrimidinecarboxamide;
secondary carboxamide
antineoplastic agent;
apoptosis inducer;
B-Raf inhibitor
00low000000
dabrafenib1,3-thiazoles;
aminopyrimidine;
organofluorine compound;
sulfonamide
anticoronaviral agent;
antineoplastic agent;
B-Raf inhibitor
00low000000
3-(2,6-dichloro-3,5-dimethoxyphenyl)-1-(6-(4-(4-ethylpiperazin-1-yl)-phenylamino)pyrimidin-4-yl)-1-methylureaaminopyrimidine;
dichlorobenzene;
N-alkylpiperazine;
N-arylpiperazine;
phenylureas
antineoplastic agent;
fibroblast growth factor receptor antagonist
00low000000
chir 98014aminopyrimidine;
C-nitro compound;
diaminopyridine;
dichlorobenzene;
imidazoles;
secondary amino compound
antineoplastic agent;
apoptosis inducer;
EC 2.7.11.26 (tau-protein kinase) inhibitor;
hypoglycemic agent;
tau aggregation inhibitor;
Wnt signalling activator
00low000000
vericiguataminopyrimidine;
carbamate ester;
organofluorine compound;
pyrazolopyridine
antihypertensive agent;
soluble guanylate cyclase activator;
vasodilator agent
00low000000
AZD3463aminopiperidine;
aminopyrimidine;
indoles;
monomethoxybenzene;
organochlorine compound;
secondary amino compound;
tertiary amino compound
antineoplastic agent;
apoptosis inducer;
autophagy inducer;
EC 2.7.10.1 (receptor protein-tyrosine kinase) inhibitor
00low000000
ceritinibaminopyrimidine;
aromatic ether;
organochlorine compound;
piperidines;
secondary amino compound;
sulfone
antineoplastic agent;
EC 2.7.10.1 (receptor protein-tyrosine kinase) inhibitor
00low000000
HG-10-102-01aminopyrimidine;
aromatic ether;
monocarboxylic acid amide;
morpholines;
organochlorine compound;
secondary amino compound
EC 2.7.11.1 (non-specific serine/threonine protein kinase) inhibitor00low000000
osimertinibacrylamides;
aminopyrimidine;
biaryl;
indoles;
monomethoxybenzene;
secondary amino compound;
secondary carboxamide;
substituted aniline;
tertiary amino compound
antineoplastic agent;
epidermal growth factor receptor antagonist
00low000000
hg-9-91-01aminopyrimidine;
dimethoxybenzene;
N-alkylpiperazine;
N-arylpiperazine;
phenylureas;
secondary amino compound
antineoplastic agent;
salt-inducible kinase 2 inhibitor
00low000000
praliciguataminopyrimidine;
isoxazoles;
monofluorobenzenes;
organofluorine compound;
pyrazoles;
secondary amino compound;
tertiary alcohol
anti-inflammatory agent;
antihypertensive agent;
soluble guanylate cyclase activator;
vasodilator agent
00low000000
THZ531aminopyrimidine;
enamide;
indoles;
N-acylpiperidine;
organochlorine compound;
secondary amino compound;
secondary carboxamide
antineoplastic agent;
apoptosis inducer;
EC 2.7.11.22 (cyclin-dependent kinase) inhibitor
00low000000
n(5)-methyl-n(5)-formyl-2,5,6-triamino-4-hydroxypyrimidineaminopyrimidine;
formamidopyrimidine;
hydroxypyrimidine
00low000000
2-amino-6-methylpyrimidin-4-oneaminopyrimidine;
hydroxypyrimidine;
pyrimidone
00low000000
6-hydroxy-2,4,5-triaminopyrimidineaminopyrimidine;
hydroxypyrimidine
antioxidant;
chromophore
00low000000
ethirimolaminopyrimidine;
pyrimidine fungicide;
pyrimidone;
secondary amino compound
antifungal agrochemical00low000000
3-cyanopyridinenitrile;
pyridines
00low000000
2-(3-pyridine)acetic acidmonocarboxylic acid;
pyridines
human xenobiotic metabolite00low000000
nicotine 1-n-oxidepyridines;
pyrrolidine N-oxides
00low000000
norcotininepyridines;
pyrrolidines
00low000000
4-oxo-4-(3-pyridyl)butanoic acidaromatic ketone;
monocarboxylic acid;
pyridines
00low000000
pyridineazaarene;
mancude organic heteromonocyclic parent;
monocyclic heteroarene;
pyridines
environmental contaminant;
NMR chemical shift reference compound
00low000000
carbinoxaminemonochlorobenzenes;
pyridines;
tertiary amino compound
anti-allergic agent;
antiparkinson drug;
H1-receptor antagonist;
muscarinic antagonist
00low000000
chlorpheniraminemonochlorobenzenes;
pyridines;
tertiary amino compound
anti-allergic agent;
antidepressant;
antipruritic drug;
H1-receptor antagonist;
histamine antagonist;
serotonin uptake inhibitor
2003200520.0low000200
disopyramidemonocarboxylic acid amide;
pyridines;
tertiary amino compound
anti-arrhythmia drug00low000000
doxylaminepyridines;
tertiary amine
anti-allergic agent;
antiemetic;
antitussive;
cholinergic antagonist;
H1-receptor antagonist;
histamine antagonist;
sedative
00low000000
fusaric acidaromatic carboxylic acid;
pyridines
00low000000
iproniazidcarbohydrazide;
pyridines
1991199133.0low001000
lansoprazolebenzimidazoles;
pyridines;
sulfoxide
anti-ulcer drug;
EC 3.6.3.10 (H(+)/K(+)-exchanging ATPase) inhibitor
1997202115.9low101621
entinostatbenzamides;
carbamate ester;
primary amino compound;
pyridines;
substituted aniline
antineoplastic agent;
apoptosis inducer;
EC 3.5.1.98 (histone deacetylase) inhibitor
00low000000
niflumic acidaromatic carboxylic acid;
pyridines
00low000000
omeprazolearomatic ether;
benzimidazoles;
pyridines;
sulfoxide
1994202116.6low10515101
pantoprazolearomatic ether;
benzimidazoles;
organofluorine compound;
pyridines;
sulfoxide
anti-ulcer drug;
EC 3.6.3.10 (H(+)/K(+)-exchanging ATPase) inhibitor;
environmental contaminant;
xenobiotic
2005200618.5low000200
pheniraminepyridines;
tertiary amino compound
00low000000
pinacidilpyridines1993200425.5low001100
pioglitazonearomatic ether;
pyridines;
thiazolidinediones
antidepressant;
cardioprotective agent;
EC 2.7.1.33 (pantothenate kinase) inhibitor;
EC 6.2.1.3 (long-chain-fatty-acid--CoA ligase) inhibitor;
ferroptosis inhibitor;
geroprotector;
hypoglycemic agent;
insulin-sensitizing drug;
PPARgamma agonist;
xenobiotic
2002201813.6low000660
pirbuterolpyridines00low000000
pyridinolcarbamatepyridines00low000000
quipazinepiperazines;
pyridines
00low000000
rabeprazolebenzimidazoles;
pyridines;
sulfoxide
anti-ulcer drug;
EC 3.6.3.10 (H(+)/K(+)-exchanging ATPase) inhibitor
2002200222.0low100100
sb 202190imidazoles;
organofluorine compound;
phenols;
pyridines
apoptosis inducer;
EC 2.7.11.24 (mitogen-activated protein kinase) inhibitor
00low000000
risedronic acidpyridines00low000000
imatinibaromatic amine;
benzamides;
N-methylpiperazine;
pyridines;
pyrimidines
antineoplastic agent;
apoptosis inducer;
tyrosine kinase inhibitor
00low000000
streptonigrinpyridines;
quinolone
antimicrobial agent;
antineoplastic agent
00low000000
sulfapyridinepyridines;
substituted aniline;
sulfonamide antibiotic;
sulfonamide
antiinfective agent;
dermatologic drug;
drug allergen;
environmental contaminant;
xenobiotic
1979200834.2low030100
tazaroteneacetylenic compound;
ethyl ester;
pyridines;
retinoid;
thiochromane
keratolytic drug;
prodrug;
teratogenic agent
00low000000
n,n,n',n'-tetrakis(2-pyridylmethyl)ethylenediamineN-substituted diamine;
pyridines;
tertiary amino compound
apoptosis inducer;
chelator;
copper chelator
00low000000
thurfyl nicotinatearomatic carboxylic acid;
pyridines
00low000000
brompheniramineorganobromine compound;
pyridines
anti-allergic agent;
H1-receptor antagonist
00low000000
methyl nicotinatearomatic carboxylic acid;
pyridines
00low000000
citrazinic acidaromatic carboxylic acid;
pyridines
00low000000
nicotinyl alcoholaromatic primary alcohol;
pyridines
antilipemic drug;
vasodilator agent
00low000000
beta-nicotyrinepyridines00low000000
3-ethylpyridinepyridines00low000000
2-Pyridinylmethanolpyridines00low000000
nicoboxilaromatic carboxylic acid;
pyridines
00low000000
clopyralidorganochlorine pesticide;
pyridines
herbicide00low000000
oxiniacic acidaromatic carboxylic acid;
pyridines
00low000000
2-(aminomethyl)pyridinepyridines00low000000
propirampyridines00low000000
n'-nitrosonornicotinepyridines;
pyrrolidines
00low000000
[4-(2-pyridinyl)-1-piperazinyl]-(3,4,5-trimethoxyphenyl)methanonepiperazines;
pyridines
00low000000
5-hydroxynicotinic acidaromatic carboxylic acid;
pyridines
00low000000
n-cyano-n'-(1,1-dimethylpropyl)-n''-(3-pyridinyl)guanidinepyridines00low000000
4-(n-methyl-n-nitrosamino)-1-(3-pyridyl)-1-butanonenitrosamine;
pyridines
00low000000
haloxyfoparomatic ether;
monocarboxylic acid;
organochlorine compound;
organofluorine compound;
pyridines
00low000000
fluazifop-butylaromatic ether;
carboxylic ester;
organofluorine compound;
pyridines
00low000000
imazapyr, (+-)-isomerimidazolines;
imidazolone;
pyridinemonocarboxylic acid;
pyridines
00low000000
imazethapyraromatic carboxylic acid;
pyridines
00low000000
2,2'-dipyridyl disulfideorganic disulfide;
pyridines
oxidising agent00low000000
droxicamorganic heterotricyclic compound;
pyridines
cyclooxygenase 1 inhibitor;
hepatotoxic agent;
non-narcotic analgesic;
non-steroidal anti-inflammatory drug;
platelet aggregation inhibitor;
prodrug
00low000000
methyridinepyridines00low000000
picosulfate sodiumaryl sulfate;
pyridines
00low000000
2-hydroxynicotinic acidaromatic carboxylic acid;
pyridines
00low000000
ethylnicotinatearomatic carboxylic acid;
pyridines
00low000000
nicametatearomatic carboxylic acid;
pyridines
00low000000
nicotinamide n-oxidepyridines00low000000
nicosulfuronN-sulfonylurea;
pyridines;
pyrimidines
environmental contaminant;
herbicide;
xenobiotic
201620196.5low000020
4,4'-dipyridyl disulfideorganic disulfide;
pyridines
00low000000
2-Chloronicotinic acidaromatic carboxylic acid;
pyridines
00low000000
4-methoxymethylpyridoxinepyridines00low000000
6-chloronicotinic acidaromatic carboxylic acid;
pyridines
00low000000
2-pyridylacetic acidpyridines00low000000
fluazifoparomatic ether;
monocarboxylic acid;
organofluorine compound;
pyridines
00low000000
pyriproxyfenaromatic ether;
pyridines
juvenile hormone mimic00low000000
dithiopyrorganofluorine compound;
pyridines;
thioester
00low000000
thiazopyraromatic carboxylic acid;
pyridines
00low000000
dpx e9636aromatic ether;
N-sulfonylurea;
pyridines;
pyrimidines;
sulfone
environmental contaminant;
herbicide;
xenobiotic
00low000000
clodinafop-propargylaromatic ether;
carboxylic ester;
organochlorine compound;
organofluorine compound;
propyzamide;
pyridines
agrochemical;
EC 6.4.1.2 (acetyl-CoA carboxylase) inhibitor;
herbicide
00low000000
flazasulfuronpyridines;
sulfonamide
00low000000
2,6-dichloroisonicotinic acidmonocarboxylic acid;
organochlorine compound;
pyridines
EC 1.11.1.11 (L-ascorbate peroxidase) inhibitor00low000000
difenpiramidebiphenyls;
monocarboxylic acid amide;
pyridines
antipyretic;
non-narcotic analgesic;
non-steroidal anti-inflammatory drug
00low000000
4-(methylnitrosamino)-1-(3-pyridyl)-1-butan-1-olnitrosamine;
pyridines;
secondary alcohol
biomarker;
carcinogenic agent;
human urinary metabolite
00low000000
hydroxycotinineN-alkylpyrrolidine;
pyridines;
pyrrolidin-2-ones;
pyrrolidine alkaloid
00low000000
5-hydroxymethylomeprazolearomatic ether;
benzimidazoles;
pyridines;
sulfoxide
drug metabolite00low000000
forasartanbenzenes;
pyridines;
tetrazoles;
triazoles
angiotensin receptor antagonist;
antihypertensive agent
00low000000
abiraterone3beta-hydroxy-Delta(5)-steroid;
3beta-sterol;
pyridines
antineoplastic agent;
EC 1.14.99.9 (steroid 17alpha-monooxygenase) inhibitor
00low000000
agn 190299monocarboxylic acid;
pyridines;
retinoid;
thiochromane
keratolytic drug;
teratogenic agent
00low000000
vatalanibmonochlorobenzenes;
phthalazines;
pyridines;
secondary amino compound
angiogenesis inhibitor;
antineoplastic agent;
EC 2.7.10.1 (receptor protein-tyrosine kinase) inhibitor;
vascular endothelial growth factor receptor antagonist
00low000000
metyrapolpyridines00low000000
sb 203580imidazoles;
monofluorobenzenes;
pyridines;
sulfoxide
EC 2.7.11.1 (non-specific serine/threonine protein kinase) inhibitor;
EC 2.7.11.24 (mitogen-activated protein kinase) inhibitor;
geroprotector;
Hsp90 inhibitor;
neuroprotective agent
00low000000
aminopyralidaromatic amine;
organochlorine pesticide;
pyridines
herbicide00low000000
dabigatran etexilatearomatic amide;
benzimidazoles;
beta-alanine derivative;
carboxamidine;
carboxylic ester;
pyridines
anticoagulant;
EC 3.4.21.5 (thrombin) inhibitor;
prodrug
00low000000
dabigatranaromatic amide;
benzimidazoles;
beta-alanine derivative;
carboxamidine;
pyridines
anticoagulant;
EC 1.10.99.2 [ribosyldihydronicotinamide dehydrogenase (quinone)] inhibitor;
EC 3.4.21.5 (thrombin) inhibitor
00low000000
alpha-(trichloromethyl)-4-pyridineethanolpyridines00low000000
6-methyl-2-oxo-4-(trifluoromethyl)-1H-pyridine-3-carbonitrilenitrile;
pyridines
00low000000
gant58pyridines00low000000
3-(3-pyridinyl)propanoic acidpyridines00low000000
rosoxacinpyridines;
quinolinemonocarboxylic acid;
quinolone antibiotic
antibacterial drug;
antiinfective agent
00low000000
gant 61aminal;
dialkylarylamine;
pyridines;
substituted aniline;
tertiary amino compound
antineoplastic agent;
apoptosis inducer;
glioma-associated oncogene inhibitor;
Hedgehog signaling pathway inhibitor
00low000000
e 3040benzothiazoles;
organic hydroxy compound;
pyridines;
secondary amino compound
anti-inflammatory drug;
EC 1.13.11.34 (arachidonate 5-lipoxygenase) inhibitor;
uricosuric drug
00low000000
E3040 glucuronidebenzothiazoles;
beta-D-glucosiduronic acid;
pyridines;
secondary amino compound
xenobiotic metabolite00low000000
cerivastatindihydroxy monocarboxylic acid;
pyridines;
statin (synthetic)
00low000000
hts 466284pyrazoles;
pyridines;
quinolines
TGFbeta receptor antagonist00low000000
prinomastataromatic ether;
hydroxamic acid;
pyridines;
sulfonamide;
thiomorpholines
antineoplastic agent;
EC 3.4.24.35 (gelatinase B) inhibitor;
matrix metalloproteinase inhibitor
00low000000
6-methyl-2-oxo-5-[oxo-(1-phenylethylamino)methyl]-1H-pyridine-3-carboxylic acid ethyl esteraromatic carboxylic acid;
pyridines
00low000000
5-(2-furanyl)-3-(3-pyridinyl)-1,2,4-oxadiazolepyridines00low000000
1-(2-pyridin-4-yl-1-oxa-3,4-diazaspiro[4.6]undec-2-en-4-yl)ethanonepyridines00low000000
s 1033(trifluoromethyl)benzenes;
imidazoles;
pyridines;
pyrimidines;
secondary amino compound;
secondary carboxamide
anticoronaviral agent;
antineoplastic agent;
tyrosine kinase inhibitor
00low000000
2-pyridinecarboxylic acid [2-(2,3-dichloroanilino)-2-oxoethyl] esteraromatic carboxylic acid;
pyridines
00low000000
N-methyl-N-(5-pyridin-4-yl-1,3,4-thiadiazol-2-yl)-3-oxolanecarboxamidepyridines00low000000
5-(4-propylcyclohexyl)-3-(3-pyridinyl)-1,2,4-oxadiazolepyridines00low000000
N-methyl-N-[5-(2-pyridinyl)-1,3,4-thiadiazol-2-yl]-3-oxolanecarboxamidepyridines00low000000
2-methoxy-N-methyl-N-[5-(2-pyridinyl)-1,3,4-thiadiazol-2-yl]acetamidepyridines00low000000
6-methyl-2-[4-[oxo(thiophen-2-yl)methyl]-1-piperazinyl]-3-quinolinecarbonitrilepiperazines;
pyridines
00low000000
[5-(2-furanyl)-7-(trifluoromethyl)-2-pyrazolo[1,5-a]pyrimidinyl]-[4-(2-pyridinyl)-1-piperazinyl]methanonepiperazines;
pyridines
00low000000
6-hydroxy-1-(3-hydroxypropyl)-4-methyl-2-oxo-5-(1-piperidinylmethyl)-3-pyridinecarbonitrilenitrile;
pyridines
00low000000
5,8-dimethoxy-4-(4-methyl-1-piperazinyl)-2-(trifluoromethyl)quinolinepiperazines;
pyridines
00low000000
5-ethyl-4,6-dimethyl-2-sulfanylidene-1H-pyridine-3-carbonitrilenitrile;
pyridines
00low000000
8-(2-furanyl)-6-[4-[2-furanyl(oxo)methyl]-1-piperazinyl]-3,3-dimethyl-1,4-dihydrothiopyrano[3,4-c]pyridine-5-carbonitrilepiperazines;
pyridines
00low000000
N-(4-{[2-(pyridin-3-yl)piperidin-1-yl]sulfonyl}phenyl)acetamideacetamides;
piperidines;
pyridines;
sulfonamide
00low000000
2-(pyridin-4-yl)-4-(pyrrolidin-1-yl)quinazolinepyridines;
pyrrolidines;
quinazolines
00low000000
2-methyl-3-phenyl-5-propyl-7-[4-(2-pyridinyl)-1-piperazinyl]pyrazolo[1,5-a]pyrimidinepiperazines;
pyridines
00low000000
prothionamidepyridines00low000000
N2-(4-fluorophenyl)-6-[[4-(2-pyridinyl)-1-piperazinyl]methyl]-1,3,5-triazine-2,4-diaminepiperazines;
pyridines
00low000000
1-(4-methyl-1,2,5-oxadiazol-3-yl)-3-(3-pyridinyl)ureapyridines00low000000
N-(3-fluorophenyl)-2-(pyridin-4-yl)quinazolin-4-aminearomatic amine;
monofluorobenzenes;
pyridines;
quinazolines;
secondary amino compound;
substituted aniline
00low000000
5-cyano-2-methyl-6-sulfanylidene-1H-pyridine-3-carboxylic acid ethyl esteraromatic carboxylic acid;
pyridines
00low000000
2-(1H-imidazol-1-yl)-5-(trifluoromethyl)pyridinepyridines00low000000
5-(3-pyridinylmethyl)-1,3,5-triazinane-2-thionepyridines00low000000
2-amino-5-ethyl-4-(2-furanyl)-6-propyl-3-pyridinecarbonitrilenitrile;
pyridines
00low000000
4-(methoxymethyl)-6-methyl-2-(2-methylanilino)-3-pyridinecarbonitrilenitrile;
pyridines
00low000000
GS4012 free basearyl sulfide;
monomethoxybenzene;
pyridines
VEGF activator00low000000
5-(phenylmethyl)-3-(2-pyridinyl)-1,2,4-oxadiazolepyridines00low000000
4-(methoxymethyl)-6-methyl-2-(4-phenyl-1-piperazinyl)-3-pyridinecarbonitrilepiperazines;
pyridines
00low000000
1-[[4-(2-pyridinyl)-1-piperazinyl]methyl]-2-benzo[cd]indolonepiperazines;
pyridines
00low000000
cotinineN-alkylpyrrolidine;
pyridines;
pyrrolidin-2-ones;
pyrrolidine alkaloid
antidepressant;
biomarker;
human xenobiotic metabolite;
plant metabolite
2009201411.8low100130
1-propylsulfonyl-4-(2-pyridinyl)piperazinepiperazines;
pyridines
00low000000
2-(2-phenylethylthio)-3-pyridinecarboxylic acidaromatic carboxylic acid;
pyridines
00low000000
1,3-benzothiazol-2-yl-[4-(2-pyridinyl)-1-piperazinyl]methanonepiperazines;
pyridines
00low000000
2-(2,6-dichloroanilino)-3-pyridinesulfonamidepyridines;
sulfonamide
00low000000
4-(4-chloroanilino)-3-pyridinesulfonamidepyridines;
sulfonamide
00low000000
6-(2-oxopropylthio)-3-pyridinecarboxylic acidaromatic carboxylic acid;
pyridines
00low000000
6-chloro-N-(2-hydroxyphenyl)-3-pyridinesulfonamidepyridines;
sulfonamide
00low000000
3-(phenylmethyl)-6-pyridin-4-yl-[1,2,4]triazolo[3,4-b][1,3,4]thiadiazolepyridines;
triazolothiadiazole
00low000000
6-(4-benzoyl-1-piperazinyl)-3,3-dimethyl-8-propan-2-yl-1,4-dihydropyrano[3,4-c]pyridine-5-carbonitrilepiperazines;
pyridines
00low000000
5-bromo-6-chloro-N-(4-methyl-2-pyridinyl)-3-pyridinesulfonamidepyridines;
sulfonamide
00low000000
pyrabactinnaphthalenes;
organobromine compound;
pyridines;
sulfonamide
abscisic acid receptor agonist;
hormone;
plant growth regulator
00low000000
4-[4-(benzenesulfonyl)-1-piperazinyl]-2-methylquinolinepiperazines;
pyridines
00low000000
2-(4-bromophenyl)-1-[4-(2-pyridinyl)-1-piperazinyl]ethanonepiperazines;
pyridines
00low000000
(4-chlorophenyl)-[4-(7-chloro-4-quinolinyl)-1-piperazinyl]methanonepiperazines;
pyridines
00low000000
7-chloro-4-[4-(3,4-dimethylphenyl)sulfonyl-1-piperazinyl]quinolinepiperazines;
pyridines
00low000000
1-ethyl-3-sulfanylidene-5,6,7,8-tetrahydro-2H-isoquinoline-4-carbonitrilepyridines00low000000
7-methoxy-2-[4-[(2-methylphenyl)-oxomethyl]-1-piperazinyl]-3-quinolinecarbonitrilepiperazines;
pyridines
00low000000
6-tert-butyl-2-oxo-4-(trifluoromethyl)-1H-pyridine-3-carbonitrilenitrile;
pyridines
00low000000
5-cyano-2-phenyl-6-[4-(2-pyridinyl)-1-piperazinyl]-3-pyridinecarboxylic acid ethyl esterpiperazines;
pyridines
00low000000
N,N-dibutyl-2-(pyridin-4-yl)quinazolin-4-aminepyridines;
quinazolines;
tertiary amino compound
00low000000
4,6-dimethyl-2-[3-(4-morpholinyl)propylamino]-3-pyridinecarbonitrilenitrile;
pyridines
00low000000
2-ethoxy-3-pyridinecarboxylic acid [2-[1-(2-furanylmethyl)-2,5-dimethyl-3-pyrrolyl]-2-oxoethyl] esteraromatic carboxylic acid;
pyridines
00low000000
mcb-613cyclic ketone;
enone;
pyridines
antineoplastic agent;
steroid receptor coactivator stimulator
00low000000
5,6-dichloro-3-pyridinecarboxylic acid [2-(2-furanylmethylamino)-2-oxoethyl] esteraromatic carboxylic acid;
pyridines
00low000000
4-pyridinecarboxylic acid [2-[1-(2-furanylmethyl)-2,5-dimethyl-3-pyrrolyl]-2-oxoethyl] esteraromatic carboxylic acid;
pyridines
00low000000
2-oxo-1H-pyridine-3-carboxylic acid [2-(2,5-dimethyl-1-propyl-3-pyrrolyl)-2-oxoethyl] esteraromatic carboxylic acid;
pyridines
00low000000
2-thiopyridinearyl thiol;
pyridines
allergen;
fluorescence quencher
00low000000
2-(methylamino)-6-thiophen-2-yl-4-(trifluoromethyl)-3-pyridinecarbonitrilenitrile;
pyridines
00low000000
2-(1-piperidinyl)-6-thiophen-2-yl-4-(trifluoromethyl)-3-pyridinecarbonitrilenitrile;
pyridines
00low000000
N-benzyl-N'-methyl-N-(pyridin-3-ylmethyl)thioureapyridines00low000000
3-Chloro-5-(trifluoromethyl)pyridine-2-carbothioamidepyridines00low000000
2,6-dimethyl-4-(3-thienyl)pyridine-3,5-dicarboxylic acidaromatic carboxylic acid;
pyridines
00low000000
N-tert-butyl-4-[3-(trifluoromethyl)-2-pyridinyl]-1-piperazinecarboxamidepiperazines;
pyridines
00low000000
5-cyano-2-(methoxymethyl)-6-sulfanylidene-1H-pyridine-3-carboxylic acid methyl esteraromatic carboxylic acid;
pyridines
00low000000
ethionamidepyridines;
thiocarboxamide
antilipemic drug;
antitubercular agent;
fatty acid synthesis inhibitor;
leprostatic drug;
prodrug
00low000000
2-amino-6-[4-(6-chloro-2-pyridinyl)-1-piperazinyl]pyridine-3,5-dicarbonitrilepiperazines;
pyridines
00low000000
2-(propylthio)nicotinic acidaromatic carboxylic acid;
pyridines
00low000000
5-Chloro-2-hydroxy-4,6-dimethylnicotinonitrilenitrile;
pyridines
00low000000
3-[1-(2,4-dichlorophenyl)sulfonyl-2-pyrrolidinyl]pyridinepyridines;
pyrrolidines
00low000000
(3,5-dichlorophenyl)-[4-[2-(trifluoromethyl)-4-quinolinyl]-1-piperazinyl]methanonepiperazines;
pyridines
00low000000
3-[5-[[4-(2-pyridinyl)-1-piperazinyl]sulfonyl]-2-thiophenyl]isoxazolepiperazines;
pyridines
00low000000
2-oxo-4,6-dithiophen-2-yl-1H-pyridine-3-carbonitrilenitrile;
pyridines
00low000000
4-[4-(3-bromophenyl)sulfonyl-1-piperazinyl]-7-chloroquinolinepiperazines;
pyridines
00low000000
3,7-dimethyl-2-[4-(2-pyridinyl)-1-piperazinyl]quinolinepiperazines;
pyridines
00low000000
3-phenyl-1-[4-(2-pyridinyl)-1-piperazinyl]-1-propanonepiperazines;
pyridines
00low000000
4-phenoxy-1-[4-(2-pyridinyl)-1-piperazinyl]-1-butanonepiperazines;
pyridines
00low000000
2-[4-(2-methyl-4-quinolinyl)-1-piperazinyl]-4-phenylthiazolepiperazines;
pyridines
00low000000
6-(2,3-dihydro-1,4-benzodioxin-3-ylmethylamino)-N-ethyl-N-phenyl-3-pyridinesulfonamidepyridines;
sulfonamide
00low000000
alpha-nicotyrinepyridines00low000000
dapiprazoleN-alkylpiperazine;
N-arylpiperazine;
pyridines
alpha-adrenergic antagonist;
antipsychotic agent;
miotic;
ophthalmology drug
00low000000
glucitol hexanicotinatearomatic carboxylic acid;
pyridines
00low000000
6,8-difluoro-4-(pyridin-3-yl)-3a,4,5,9b-tetrahydro-3H-cyclopenta[c]quinolineorganic heterotricyclic compound;
organofluorine compound;
pyridines;
secondary amino compound
00low000000
N-(1,3-benzodioxol-5-ylmethyl)-N-[2-(cyclohexylamino)-2-oxo-1-pyridin-4-ylethyl]-2,2,2-trifluoroacetamidebenzodioxoles;
pyridines;
secondary carboxamide;
tertiary carboxamide;
trifluoroacetamide
00low000000
1-methyl-4-[[2-oxo-2-[4-(2-pyridinyl)-1-piperazinyl]ethyl]thio]-2-quinolinonepiperazines;
pyridines
00low000000
1-(4-amino-1,2,5-oxadiazol-3-yl)-5-[(2-pyridinylthio)methyl]-4-triazolecarboxylic acid propan-2-yl esteraryl sulfide;
azole;
isopropyl ester;
oxadiazole;
pyridines
00low000000
6-bromo-3-[4-oxo-4-[4-(2-pyridinyl)-1-piperazinyl]butyl]-2-sulfanylidene-1H-quinazolin-4-onepiperazines;
pyridines
00low000000
N-[4-methyl-2-(4-methyl-1-piperazinyl)-6-quinolinyl]-1,3-benzodioxole-5-carboxamidepiperazines;
pyridines
00low000000
4-[2-(1-cyclohexenyl)ethyl]-1-cyclohexyl-3-pyridin-4-ylpiperazine-2,5-dionepiperazines;
pyridines
00low000000
ml012piperazines;
pyridines
00low000000
[4-(2-pyrimidinyl)-1-piperazinyl]-[1-[4-(2-pyrimidinyl)-1-piperazinyl]-4-isoquinolinyl]methanonepiperazines;
pyridines
00low000000
N-(2-furanylmethyl)-N'-[4-methyl-2-(4-methyl-1-piperazinyl)-6-quinolinyl]butanediamidepiperazines;
pyridines
00low000000
[3-(4-methylphenyl)-1-phenyl-4-pyrazolyl]-[4-(2-pyridinyl)-1-piperazinyl]methanonepiperazines;
pyridines
00low000000
2-pyridinecarboxylic acid [2-(5-chloro-2-thiophenyl)-2-oxoethyl] esteraromatic carboxylic acid;
pyridines
00low000000
2-[[2-[(2-methoxyphenyl)methylamino]-2-oxoethyl]thio]-3-pyridinecarboxylic acid [2-[(2-methoxyphenyl)methylamino]-2-oxoethyl] esteraromatic carboxylic acid;
pyridines
00low000000
2-[(5-formyl-2-methoxyphenyl)methylthio]-3-pyridinecarboxylic acidaromatic carboxylic acid;
pyridines
00low000000
[3-(2,3-dihydroindol-1-ylsulfonyl)phenyl]-[4-(2-pyridinyl)-1-piperazinyl]methanonepiperazines;
pyridines
00low000000
3-(4-benzoyl-1-piperazinyl)-1-(2-methylpropyl)-6,7-dihydro-5H-cyclopenta[c]pyridine-4-carbonitrilepiperazines;
pyridines
00low000000
5-cyano-6-[4-(4-methoxyphenyl)-1-piperazinyl]-2-oxo-1H-pyridine-3-carboxylic acid ethyl esterpiperazines;
pyridines
00low000000
2-[4-(3-chlorophenyl)-1-piperazinyl]-3-pyridinecarboxylic acid propan-2-yl esterisopropyl ester;
piperazines;
pyridines
00low000000
3-(1-hydroxy-5,5-dimethyl-4-phenyl-2H-imidazol-2-yl)pyridinepyridines00low000000
[4-[(2-chlorophenyl)methylsulfonyl]-3-nitrophenyl]-[4-(2-pyridinyl)-1-piperazinyl]methanonepiperazines;
pyridines
00low000000
2-pyridinecarboxylic acid [2-[2-(difluoromethoxy)anilino]-2-oxoethyl] esteraromatic carboxylic acid;
pyridines
00low000000
hydroxypioglitazonearomatic ether;
pyridines;
thiazolidinediones
human xenobiotic metabolite00low000000
2-(2-fluoroanilino)-3-pyridinecarboxylic acid [2-[(1,1-dioxo-3-thiolanyl)-methylamino]-2-oxoethyl] esteraromatic carboxylic acid;
pyridines
00low000000
3-(4-ethylphenyl)-4-hydroxy-4-[oxo-[4-(2-pyridinyl)-1-piperazinyl]methyl]-1H-quinazolin-2-onepiperazines;
pyridines
00low000000
4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1h-imidazol-2-yl)benzamidebenzamides;
benzodioxoles;
imidazoles;
pyridines
EC 2.7.10.1 (receptor protein-tyrosine kinase) inhibitor00low000000
N-(1-benzylpiperidin-4-yl)-2-(pyridin-3-yl)quinazolin-4-aminearomatic amine;
piperidines;
pyridines;
quinazolines;
secondary amino compound;
tertiary amino compound
00low000000
abt724piperazines;
pyridines
00low000000
2-(4-acetyl-1-piperazinyl)-6-amino-4-(cyanomethyl)pyridine-3,5-dicarbonitrilepiperazines;
pyridines
00low000000
triprolidineN-alkylpyrrolidine;
olefinic compound;
pyridines
H1-receptor antagonist00low000000
pibutidinearomatic ether;
cyclobutenones;
olefinic compound;
piperidines;
primary amino compound;
pyridines;
secondary amino compound
anti-ulcer drug;
H2-receptor antagonist
00low000000
acrivastinealpha,beta-unsaturated monocarboxylic acid;
N-alkylpyrrolidine;
olefinic compound;
pyridines
H1-receptor antagonist00low000000
2-[3-(diethylamino)propylamino]-4-(methoxymethyl)-6-methyl-3-pyridinecarbonitrilenitrile;
pyridines
00low000000
[2-(1-piperidinyl)-1,3-benzothiazol-6-yl]-[4-(2-pyridinyl)-1-piperazinyl]methanonepiperazines;
pyridines
00low000000
N-[2-(4-ethyl-1-piperazinyl)-4-methyl-6-quinolinyl]-2-pyrazinecarboxamidepiperazines;
pyridines
00low000000
clodinafoparomatic ether;
monocarboxylic acid;
organochlorine compound;
organofluorine compound;
pyridines
EC 6.4.1.2 (acetyl-CoA carboxylase) inhibitor;
phenoxy herbicide
00low000000
3-(3-pyridinyl)-1-(4-pyridinyl)-2-propen-1-oneenone;
pyridines
angiogenesis inhibitor;
antineoplastic agent;
apoptosis inducer;
autophagy inducer;
EC 2.7.1.105 (6-phosphofructo-2-kinase) inhibitor
00low000000
[4-(3-chlorophenyl)sulfonyl-3-nitrophenyl]-[4-(2-pyridinyl)-1-piperazinyl]methanonepiperazines;
pyridines
00low000000
axitinibaryl sulfide;
benzamides;
indazoles;
pyridines
antineoplastic agent;
tyrosine kinase inhibitor;
vascular endothelial growth factor receptor antagonist
00low000000
2-[4-(2-pyrimidinyl)-1-piperazinyl]quinolinepiperazines;
pyridines
00low000000
(2-Chloro-4-pyridinyl)methanolorganohalogen compound;
pyridines
00low000000
pymetrozine1,2,4-triazines;
pyridines
antifeedant;
environmental contaminant;
TRPV channel modulator;
xenobiotic
00low000000
abiraterone acetatepyridines;
sterol ester
antineoplastic agent;
EC 1.14.99.9 (steroid 17alpha-monooxygenase) inhibitor;
prodrug
00low000000
n-(4-tert-butylphenyl)-4-(3-chloropyridin-2-yl)tetrahydropyrazine-1(2h)-carboxamidepiperazines;
pyridines
00low000000
4-(1H-imidazol-5-ylmethyl)pyridinepyridines00low000000
680c91fluoroindole;
olefinic compound;
pyridines
EC 1.13.11.11 (tryptophan 2,3-dioxygenase) inhibitor00low000000
masitinib1,3-thiazoles;
benzamides;
N-alkylpiperazine;
pyridines
antineoplastic agent;
antirheumatic drug;
tyrosine kinase inhibitor
00low000000
vorapaxarcarbamate ester;
lactone;
naphthofuran;
organofluorine compound;
pyridines
cardiovascular drug;
platelet aggregation inhibitor;
protease-activated receptor-1 antagonist
00low000000
azd2858aromatic amine;
N-methylpiperazine;
pyrazines;
pyridines;
secondary carboxamide;
sulfonamide
antineoplastic agent;
bone density conservation agent;
EC 2.7.11.26 (tau-protein kinase) inhibitor;
Wnt signalling activator
00low000000
ciclonicatearomatic carboxylic acid;
pyridines
00low000000
tedizolidcarbamate ester;
organofluorine compound;
oxazolidinone;
primary alcohol;
pyridines;
tetrazoles
antimicrobial agent;
drug metabolite;
protein synthesis inhibitor
00low000000
chlorantranilipolemonochlorobenzenes;
organobromine compound;
pyrazole insecticide;
pyrazoles;
pyridines;
secondary carboxamide
ryanodine receptor agonist00low000000
picoxystrobinaromatic ether;
enoate ester;
enol ether;
methoxyacrylate strobilurin antifungal agent;
organofluorine compound;
pyridines
antifungal agrochemical;
mitochondrial cytochrome-bc1 complex inhibitor
00low000000
tedizolid phosphatecarbamate ester;
organofluorine compound;
oxazolidinone;
phosphate monoester;
pyridines;
tetrazoles
antimicrobial agent;
prodrug;
protein synthesis inhibitor
00low000000
dorsomorphinaromatic ether;
piperidines;
pyrazolopyrimidine;
pyridines
bone morphogenetic protein receptor antagonist;
EC 2.7.11.31 {[hydroxymethylglutaryl-CoA reductase (NADPH)] kinase} inhibitor
00low000000
cyantraniliprolenitrile;
organobromine compound;
organochlorine compound;
pyrazole insecticide;
pyridines;
secondary carboxamide
ryanodine receptor agonist00low000000
GDC-0879indanes;
ketoxime;
primary alcohol;
pyrazoles;
pyridines
antineoplastic agent;
B-Raf inhibitor
00low000000
bgt226aromatic ether;
imidazoquinoline;
N-arylpiperazine;
organofluorine compound;
pyridines
antineoplastic agent;
EC 2.7.1.137 (phosphatidylinositol 3-kinase) inhibitor;
mTOR inhibitor
00low000000
[4-(3-chlorophenyl)-1-piperazinyl]-[1-[4-(2-pyridinyl)-1-piperazinyl]-4-isoquinolinyl]methanonepiperazines;
pyridines
00low000000
dafadine Caromatic amide;
aromatic ether;
difluorobenzene;
isoxazoles;
N-acylpiperidine;
pyridines
P450 inhibitor00low000000
dafadine Baromatic amide;
aromatic ether;
isoxazoles;
monochlorobenzenes;
monofluorobenzenes;
N-acylpiperidine;
pyridines
P450 inhibitor00low000000
1-butyl-3-[2-(4-ethyl-1-piperazinyl)-4-methyl-6-quinolinyl]-1-methylthioureapiperazines;
pyridines
00low000000
lumacaftoraromatic amide;
benzodioxoles;
benzoic acids;
cyclopropanes;
organofluorine compound;
pyridines
CFTR potentiator;
orphan drug
00low000000
ro5126766aryloxypyrimidine;
coumarins;
organofluorine compound;
pyridines;
sulfamides
antineoplastic agent;
EC 2.7.11.24 (mitogen-activated protein kinase) inhibitor
00low000000
sulfoxaflornitrile;
organofluorine compound;
pyridines;
sulfoximide
00low000000
cnf 20242-aminopurines;
aromatic ether;
organochlorine compound;
pyridines
antineoplastic agent;
Hsp90 inhibitor
00low000000
gdc 0449benzamides;
monochlorobenzenes;
pyridines;
sulfone
antineoplastic agent;
Hedgehog signaling pathway inhibitor;
SMO receptor antagonist;
teratogenic agent
00low000000
bms 754807pyrazoles;
pyridines;
pyrrolidines;
pyrrolotriazine
antineoplastic agent;
EC 2.7.10.1 (receptor protein-tyrosine kinase) inhibitor
00low000000
4-(1-((5-((2,6-dimethylphenoxy)methyl)-3-isoxazolyl)carbonyl)-4-piperidinyl)pyridinearomatic amide;
aromatic ether;
isoxazoles;
N-acylpiperidine;
pyridines
geroprotector;
P450 inhibitor
00low000000
dafadine Daromatic amide;
aromatic ether;
isoxazoles;
N-acylpiperidine;
organofluorine compound;
pyridines
P450 inhibitor00low000000
dafadine Oaromatic amide;
aromatic ether;
isoxazoles;
N-acylpiperidine;
pyridines;
ring assembly
P450 inhibitor00low000000
florbetapir f 18(18)F radiopharmaceutical;
aromatic ether;
organofluorine compound;
pyridines;
substituted aniline
radioactive imaging agent00low000000
sch772984biaryl;
indazoles;
N-acylpiperazine;
N-alkylpyrrolidine;
N-arylpiperazine;
pyridines;
pyrimidines;
pyrrolidinecarboxamide;
secondary carboxamide;
tertiary amino compound;
tertiary carboxamide
analgesic;
antineoplastic agent;
apoptosis inducer;
EC 2.7.11.24 (mitogen-activated protein kinase) inhibitor
00low000000
gsk 2126458aromatic ether;
difluorobenzene;
pyridazines;
pyridines;
quinolines;
sulfonamide
anticoronaviral agent;
antineoplastic agent;
autophagy inducer;
EC 2.7.1.137 (phosphatidylinositol 3-kinase) inhibitor;
mTOR inhibitor;
radiosensitizing agent
00low000000
1-(2,3-dihydro-1,4-benzodioxin-6-ylsulfonyl)-4-(2-pyridinylsulfonyl)piperazinepyridines;
sulfonamide
00low000000
ml228 probe1,2,4-triazines;
biphenyls;
pyridines;
secondary amino compound
hypoxia-inducible factor pathway activator00low000000
lgk974bipyridines;
pyrazines;
pyridines;
secondary carboxamide
Wnt signalling inhibitor00low000000
N-(4,6-dimethyl-2-pyridinyl)-4-[5-(trifluoromethyl)-2-pyridinyl]-1-piperazinecarbothioamidepiperazines;
pyridines
00low000000
afidopyropencyclopropanecarboxylate ester;
organic heterotetracyclic compound;
pyridines;
secondary alcohol
agrochemical;
insecticide;
TRPV channel modulator
00low000000
piroxicambenzothiazine;
monocarboxylic acid amide;
pyridines
analgesic;
antirheumatic drug;
cyclooxygenase 1 inhibitor;
EC 1.14.99.1 (prostaglandin-endoperoxide synthase) inhibitor;
non-steroidal anti-inflammatory drug
1985202322.3low015511
mobiflexheteroaryl hydroxy compound;
monocarboxylic acid amide;
pyridines;
thienothiazine
antipyretic;
EC 1.14.99.1 (prostaglandin-endoperoxide synthase) inhibitor;
non-narcotic analgesic;
non-steroidal anti-inflammatory drug
00low000000
lornoxicamheteroaryl hydroxy compound;
monocarboxylic acid amide;
organochlorine compound;
pyridines;
thienothiazine
antipyretic;
non-narcotic analgesic;
non-steroidal anti-inflammatory drug
00low000000
MK-8353aromatic ether;
dihydropyridine;
indazoles;
methyl sulfide;
N-alkylpyrrolidine;
pyridines;
pyrrolidinecarboxamide;
secondary carboxamide;
tertiary carboxamide;
triazoles
antineoplastic agent;
apoptosis inducer;
EC 2.7.11.24 (mitogen-activated protein kinase) inhibitor
00low000000
gsk-2816126piperazines;
pyridines
00low000000
acp-196aromatic amine;
benzamides;
imidazopyrazine;
pyridines;
pyrrolidinecarboxamide;
secondary carboxamide;
tertiary carboxamide;
ynone
antineoplastic agent;
apoptosis inducer;
EC 2.7.10.2 (non-specific protein-tyrosine kinase) inhibitor
00low000000
GSK1059615pyridines;
quinolines;
thiazolidinone
antineoplastic agent;
EC 2.7.1.137 (phosphatidylinositol 3-kinase) inhibitor
00low000000
pf-06687252azabicycloalkane;
enone;
phenols;
pyridines
00low000000
2-hydroxy-3-(5-((morpholin-4-yl)methyl)pyridin-2-yl)-1h-indole-5-carbonitrilehydroxyindoles;
morpholines;
nitrile;
pyridines;
tertiary amino compound
antineoplastic agent;
apoptosis inducer;
EC 2.7.11.26 (tau-protein kinase) inhibitor;
tau aggregation inhibitor
00low000000
sb-590885aromatic ether;
imidazoles;
ketoxime;
pyridines;
tertiary amino compound
00low000000
dabigatran etexilatearomatic amide;
benzimidazoles;
beta-alanine derivative;
carboxamidine;
carboxylic ester;
pyridines
anticoagulant;
EC 3.4.21.5 (thrombin) inhibitor;
prodrug
00low000000
3-aminobenzamidebenzamides;
substituted aniline
EC 2.4.2.30 (NAD(+) ADP-ribosyltransferase) inhibitor00low000000
dan 2163aromatic amide;
aromatic amine;
benzamides;
pyrrolidines;
sulfone
environmental contaminant;
second generation antipsychotic;
xenobiotic
00low000000
benzamidebenzamides00low000000
bromopridebenzamides00low000000
ci 994acetamides;
benzamides;
substituted aniline
antineoplastic agent;
EC 3.5.1.98 (histone deacetylase) inhibitor
00low000000
cisapridebenzamides00low000000
2-hexyloxybenzamidearomatic ether;
benzamides
antifungal agent00low000000
itopridebenzamides00low000000
labetalolbenzamides;
benzenes;
phenols;
primary carboxamide;
salicylamides;
secondary alcohol;
secondary amino compound
00low000000
lorglumidebenzamides;
dicarboxylic acid monoamide;
dichlorobenzene;
glutamic acid derivative
00low000000
4-(dimethylamino)-n-(7-(hydroxyamino)-7-oxoheptyl)benzamidebenzamides;
hydroxamic acid;
secondary carboxamide;
tertiary amino compound
antineoplastic agent;
apoptosis inducer;
EC 3.5.1.98 (histone deacetylase) inhibitor
00low000000
metoclopramidebenzamides;
monochlorobenzenes;
substituted aniline;
tertiary amino compound
antiemetic;
dopaminergic antagonist;
environmental contaminant;
gastrointestinal drug;
xenobiotic
00low000000
moclobemidebenzamides;
monochlorobenzenes;
morpholines
antidepressant;
environmental contaminant;
xenobiotic
00low000000
deetbenzamides;
monocarboxylic acid amide
environmental contaminant;
insect repellent;
xenobiotic
00low000000
acecainideacetamides;
benzamides
anti-arrhythmia drug1995200822.5low001100
nemonapridebenzamides;
monochlorobenzenes;
monomethoxybenzene;
N-alkylpyrrolidine;
secondary amino compound;
secondary carboxamide;
substituted aniline
00low000000
niclosamidebenzamides;
C-nitro compound;
monochlorobenzenes;
salicylanilides;
secondary carboxamide
anthelminthic drug;
anticoronaviral agent;
antiparasitic agent;
apoptosis inducer;
molluscicide;
piscicide;
STAT3 inhibitor
00low000000
picotamidebenzamides00low000000
procainamidebenzamidesanti-arrhythmia drug;
platelet aggregation inhibitor;
sodium channel blocker
1994200822.8low002200
procarbazinebenzamides;
hydrazines
antineoplastic agent1991199332.0low002000
proglumetacinaromatic ether;
benzamides;
carboxylic ester;
monochlorobenzenes;
N-acylindole;
N-alkylpiperazine
antipyretic;
EC 1.14.99.1 (prostaglandin-endoperoxide synthase) inhibitor;
lipoxygenase inhibitor;
non-narcotic analgesic;
non-steroidal anti-inflammatory drug;
prodrug
00low000000
proglumidebenzamides;
dicarboxylic acid monoamide;
glutamine derivative;
racemate
anti-ulcer drug;
cholecystokinin antagonist;
cholinergic antagonist;
delta-opioid receptor agonist;
drug metabolite;
gastrointestinal drug;
opioid analgesic;
xenobiotic metabolite
2005201016.5low000200
sulpiridebenzamides;
N-alkylpyrrolidine;
sulfonamide
antidepressant;
antiemetic;
antipsychotic agent;
dopaminergic antagonist
201920195.0low000010
tiapridebenzamides00low000000
trimethobenzamidebenzamides;
tertiary amino compound
antiemetic00low000000
troxipidebenzamides00low000000
zm 336372benzamides00low000000
iodohippuric acidbenzamides;
N-acylglycine;
organoiodine compound
00low000000
benzoylarginine-2-naphthylamidearginine derivative;
benzamides;
N-(2-naphthyl)carboxamide
00low000000
4-(benzoylamino)-2-hydroxybenzoic acidbenzamides00low000000
ameltolidebenzamides00low000000
antimycin abenzamides;
formamides;
macrodiolide;
phenols
antifungal agent;
mitochondrial respiratory-chain inhibitor;
piscicide
00low000000
rebemidebenzamides00low000000
2,6-dichlorobenzamidebenzamides;
dichlorobenzene
herbicide;
marine xenobiotic metabolite
00low000000
fluorophenebenzamides00low000000
2-toluanilidebenzamides;
benzanilide fungicide
00low000000
2-bromo-N-phenylbenzamidebenzamides00low000000
xipamidebenzamides00low000000
capobenic acidbenzamides00low000000
pronamidebenzamides;
dichlorobenzene;
terminal acetylenic compound
agrochemical;
herbicide
00low000000
clanobutinbenzamides00low000000
nitazoxanidebenzamides;
carboxylic ester
00low000000
Flampropbenzamides00low000000
N-[4-(dimethylamino)phenyl]-3,4,5-trimethoxybenzamidebenzamides00low000000
endralazinebenzamides00low000000
flutolanil(trifluoromethyl)benzenes;
aromatic ether;
benzamides;
benzanilide fungicide
antifungal agrochemical;
EC 1.3.5.1 [succinate dehydrogenase (quinone)] inhibitor
00low000000
encainidebenzamides;
piperidines
anti-arrhythmia drug;
sodium channel blocker
00low000000
nelfinaviraryl sulfide;
benzamides;
organic heterobicyclic compound;
phenols;
secondary alcohol;
tertiary amino compound
antineoplastic agent;
HIV protease inhibitor
00low000000
n-benzoylpiperidinebenzamides;
N-acylpiperidine
00low000000
pancopridebenzamides00low000000
octyloniumbenzamides00low000000
parsalmidebenzamides00low000000
isoxabenbenzamides;
isoxazoles
cellulose synthesis inhibitor;
herbicide
00low000000
4-aminobenzamidebenzamides00low000000
4-Methoxybenzamidebenzamides00low000000
benzoyltyrosine ethyl esterbenzamides;
ethyl ester;
L-tyrosine derivative;
phenols
chromogenic compound00low000000
salifunginbenzamides00low000000
n-benzoyl-l-argininebenzamides;
N-acyl-L-arginine
00low000000
gr 1279351,2,4-oxadiazole;
benzamides;
N-alkylpiperazine;
N-arylpiperazine
00low000000
zacopridebenzamides00low000000
mozavaptanbenzamidesaquaretic00low000000
mosapridearomatic ether;
benzamides;
monochlorobenzenes;
monofluorobenzenes;
morpholines;
secondary carboxamide;
substituted aniline;
tertiary amino compound
00low000000
zoxamidealpha-chloroketone;
benzamides;
dichlorobenzene
00low000000
procainamide 4-hydroxylaminebenzamides;
hydroxylamines
drug metabolite00low000000
ly 188544benzamides00low000000
gr 55562benzamides00low000000
n-(2,6-dimethylphenyl)-4-(((diethylamino)acetyl)amino)benzamidebenzamides00low000000
tariquidarbenzamides00low000000
n-benzoyltyrosinebenzamides;
N-acyl-L-tyrosine
00low000000
rp 73401aromatic ether;
benzamides;
chloropyridine;
monocarboxylic acid amide
anti-asthmatic drug;
anti-inflammatory agent;
bronchodilator agent;
phosphodiesterase IV inhibitor
00low000000
brovanexinebenzamides00low000000
aminopotentidinearomatic ether;
benzamides;
guanidines;
nitrile;
piperidines;
substituted aniline
H2-receptor antagonist00low000000
asperphenamatebenzamides;
carboxylic ester;
L-phenylalanine derivative
antineoplastic agent00low000000
N-(3-fluorophenyl)benzamidebenzamides00low000000
benzoylphenylalaninebenzamides;
N-acyl-amino acid
00low000000
2-methoxy-N-[2-(methylthio)phenyl]benzamidebenzamides00low000000
2-(4-fluorobenzoylamino)benzoic acid methyl esterbenzamides00low000000
xv 6381,3-thiazoles;
benzamides;
diazepanone;
diol;
secondary alcohol;
secondary carboxamide;
ureas
HIV protease inhibitor00low000000
roflumilastaromatic ether;
benzamides;
chloropyridine;
cyclopropanes;
organofluorine compound
anti-asthmatic drug;
phosphodiesterase IV inhibitor
00low000000
2-(3-benzamidophenoxy)acetic acidbenzamides00low000000
ck-0944666benzamides;
indoles;
organofluorine compound
actin polymerisation inhibitor00low000000
gw9662benzamides00low000000
N-[2-(1-cyclohexenyl)ethyl]-4-(4-morpholinylmethyl)benzamidebenzamides00low000000
2-methoxy-N-[6-(1-oxobutylamino)-3-pyridinyl]benzamidebenzamides00low000000
N-[4-chloro-2-[(2,4-dimethoxyanilino)-oxomethyl]phenyl]-2-furancarboxamidebenzamides00low000000
[3-[3-(5-methyl-2-furanyl)-1,2,4-oxadiazol-5-yl]-1-piperidinyl]-phenylmethanonebenzamides;
N-acylpiperidine
00low000000
4-methyl-N-[2-[4-(2-methyl-1-oxopropyl)-1-piperazinyl]phenyl]benzamidebenzamides00low000000
N-[2-(2-ethyl-5-tetrazolyl)phenyl]-3-(1-tetrazolyl)benzamidebenzamides00low000000
N-[2-(2-ethyl-5-tetrazolyl)phenyl]-4-(1-tetrazolyl)benzamidebenzamides00low000000
N-[2,5-diethoxy-4-[[oxo-(3,4,5-trimethoxyphenyl)methyl]amino]phenyl]-2-furancarboxamidebenzamides00low000000
(2,4-difluorophenyl)-[3-[3-(4-methylphenyl)-1,2,4-oxadiazol-5-yl]-1-piperidinyl]methanonebenzamides;
N-acylpiperidine
00low000000
2-ethoxy-N-[4-(4-morpholinylsulfonyl)phenyl]benzamidebenzamides00low000000
4-methyl-N-(2-methyl-5-tetrazolyl)benzamidebenzamides00low000000
N-[2,5-dimethoxy-4-[[2-(4-morpholinyl)-1-oxoethyl]amino]phenyl]benzamidebenzamides00low000000
N-(4-fluorophenyl)-4-(2-oxolanylmethylsulfamoyl)benzamidebenzamides00low000000
azidopinebenzamides00low000000
4-methoxy-N1,N3-bis(3-pyridinyl)benzene-1,3-dicarboxamidebenzamides00low000000
2,3,4,5,6-pentafluoro-N-(phenylmethyl)benzamidebenzamides00low000000
N-(1,1-dioxo-3-thiolanyl)-N-(thiophen-2-ylmethyl)benzamidebenzamides00low000000
N-(3-methoxyphenyl)-2-[3-(4-methoxyphenyl)-1,2,4-oxadiazol-5-yl]benzamidebenzamides00low000000
2-[[(4-acetyloxy-3-methoxyphenyl)-oxomethyl]amino]-5-hydroxybenzoic acidbenzamides00low000000
N-(3-acetamidophenyl)-4-methoxybenzamidebenzamides00low000000
N-(3-acetamidophenyl)-3-chlorobenzamidebenzamides00low000000
4-methoxy-N-(5-methyl-3-isoxazolyl)benzamidebenzamides00low000000
4-tert-butyl-N-[4-(4-morpholinyl)phenyl]benzamidebenzamides00low000000
N-(2-fluorophenyl)-4-phenylmethoxybenzamidebenzamides00low000000
4-methyl-N-(5-methyl-1,3,4-thiadiazol-2-yl)benzamidebenzamides00low000000
4-methyl-N-[4-(4-morpholinyl)phenyl]benzamidebenzamides00low000000
4-methoxy-N-(3-pyridinylmethyl)benzamidebenzamides00low000000
2-methoxy-N-(2-pyridinyl)benzamidebenzamides00low000000
N-[3-(4-oxo-3,1-benzoxazin-2-yl)phenyl]benzamidebenzamides00low000000
N-[(4-pyrimidinylthio)methyl]benzamidebenzamides00low000000
N-(5-ethyl-1,3,4-thiadiazol-2-yl)-3-methoxybenzamidebenzamides00low000000
N-(4-acetamidophenyl)-2-bromobenzamidebenzamides00low000000
N-(5-acetyl-4-methyl-2-thiazolyl)-4-tert-butylbenzamidebenzamides00low000000
N-(5-acetyl-4-methyl-2-thiazolyl)-2-methylbenzamidebenzamides00low000000
2-ethoxy-N-[5-(methoxymethyl)-1,3,4-thiadiazol-2-yl]benzamidebenzamides00low000000
N-(3,4-dimethoxyphenyl)-4-methoxybenzamidebenzamides00low000000
N-[2-[(4-methylanilino)-oxomethyl]phenyl]-3-pyridinecarboxamidebenzamides00low000000
N-[4-(2,5-dimethyl-1-pyrrolyl)phenyl]benzamidebenzamides00low000000
N-[4-chloro-3-(trifluoromethyl)phenyl]-3-methoxybenzamidebenzamides00low000000
N-[4-(2-methyl-4-thiazolyl)phenyl]benzamidebenzamides00low000000
N-(3-acetamidophenyl)-2-chlorobenzamidebenzamides00low000000
3-ethoxy-N-(2-thiazolyl)benzamidebenzamides00low000000
2-bromo-N-(3-methoxyphenyl)benzamidebenzamides00low000000
N-(2,4-difluorophenyl)-3-methoxybenzamidebenzamides00low000000
4-[[(4-acetyloxy-3-methoxyphenyl)-oxomethyl]amino]benzoic acidbenzamides00low000000
acetic acid [4-[(4-hydroxyanilino)-oxomethyl]-2-methoxyphenyl] esterbenzamides00low000000
N-(4-benzamido-2-chlorophenyl)-2-furancarboxamidebenzamides00low000000
2-(hydroxymethyl)-N-(phenylmethyl)benzamidebenzamides00low000000
2-[[(3-methylphenyl)-oxomethyl]amino]-5,6-dihydro-4H-cyclopenta[b]thiophene-3-carboxylic acidbenzamides00low000000
2-chloro-4-methyl-N-[4-(4-methyl-1-piperazinyl)phenyl]benzamidebenzamides00low000000
2-ethoxy-N-(2-hydroxyphenyl)benzamidebenzamides00low000000
3-[[(3-chloro-4-ethoxyphenyl)-oxomethyl]amino]benzoic acidbenzamides00low000000
2-methoxy-N-(4-methylphenyl)-4-(methylthio)benzamidebenzamides00low000000
3-[[(4-methoxyphenyl)-oxomethyl]amino]-2-thiophenecarboxylic acid methyl esterbenzamides00low000000
2-methoxy-3-methyl-N-[4-(4-morpholinylmethyl)phenyl]benzamidebenzamides00low000000
N-(4-anilinophenyl)-3,4-dimethoxybenzamidebenzamides00low000000
N-[5-(ethylthio)-1,3,4-thiadiazol-2-yl]-4-methylbenzamidebenzamides00low000000
N-[[(6-methyl-4-pyrimidinyl)thio]methyl]benzamidebenzamides00low000000
N-(3-acetamidophenyl)-2-methoxybenzamidebenzamides00low000000
2-bromo-N-[3-(1-oxopropylamino)phenyl]benzamidebenzamides00low000000
N-(3-acetylphenyl)-3-ethoxybenzamidebenzamides00low000000
2-[[(3-bromophenyl)-oxomethyl]amino]-5-hydroxybenzoic acidbenzamides00low000000
1-azepanyl-[4-[(phenylthio)methyl]phenyl]methanonebenzamides00low000000
4-chloro-N-[4-(2-imidazo[1,2-a]pyridinyl)phenyl]benzamidebenzamides00low000000
3,4,5-triethoxy-N-(1H-1,2,4-triazol-5-yl)benzamidebenzamides00low000000
3-[[[3-(4-methoxyphenyl)phenyl]-oxomethyl]amino]benzoic acidbenzamides00low000000
3-[(4-ethoxyphenoxy)methyl]-N,N-diethylbenzamidebenzamides00low000000
2-[[anilino(oxo)methyl]amino]-N-(phenylmethyl)benzamidebenzamides00low000000
4-tert-butyl-N-(4-methyl-3-nitrophenyl)benzamidebenzamides00low000000
N-(3-methoxyphenyl)-4-[(2-methyl-1-oxopropyl)amino]benzamidebenzamides00low000000
N-[(5-ethyl-1,2,4-oxadiazol-3-yl)methyl]-3,4,5-trimethoxybenzamidebenzamides00low000000
4-chloro-3-[[(2-methyl-3-nitrophenyl)-oxomethyl]amino]benzoic acid methyl esterbenzamides00low000000
N-[3-chloro-4-(1-pyrrolidinyl)phenyl]-2-nitrobenzamidebenzamides00low000000
N-(4-methoxyphenyl)-2-(methylthio)benzamidebenzamides00low000000
N-[3-[[(3,5-dimethoxyphenyl)-oxomethyl]amino]phenyl]carbamic acid ethyl esterbenzamides00low000000
2,4-dimethyl-N-[4-(1-pyrrolidinyl)phenyl]benzamidebenzamides00low000000
N-(7-bromo-3,4-dihydro-2H-1,5-benzodioxepin-8-yl)-3-methoxybenzamidebenzamides00low000000
5-chloro-N-(2-furanylmethyl)-2-[[(4-methoxyphenyl)-oxomethyl]amino]benzamidebenzamides00low000000
4-[(2-bromophenoxy)methyl]-N-[4-[(3,5-dimethyl-1-pyrazolyl)methyl]phenyl]benzamidebenzamides00low000000
3-bromo-5-ethoxy-N-(4-fluorophenyl)-4-methoxybenzamidebenzamides00low000000
2-chloro-N-[3-(5-methyl-1,3-benzoxazol-2-yl)phenyl]-5-(1,2,4-triazol-4-yl)benzamidebenzamides00low000000
3-[[(3,5-dichloro-4-ethoxyphenyl)-oxomethyl]amino]benzoic acidbenzamides00low000000
4-[4-[[(3,4-dimethylphenyl)-oxomethyl]amino]phenoxy]phthalic acidbenzamides00low000000
5-ethyl-2-[[oxo-(3,4,5-trimethoxyphenyl)methyl]amino]-3-thiophenecarboxylic acid ethyl esterbenzamides00low000000
2-bromo-N-[3-(1-oxobutylamino)phenyl]benzamidebenzamides00low000000
3-chloro-N-[3-nitro-5-(2-pyridinylthio)phenyl]benzamidebenzamides00low000000
N-[4-chloro-2-[(2-ethoxyanilino)-oxomethyl]phenyl]-2-furancarboxamidebenzamides00low000000
4-[[[3-(4-morpholinylsulfonyl)phenyl]-oxomethyl]amino]benzoic acid ethyl esterbenzamides00low000000
3,4-dimethoxy-N-[4-[oxo(1-piperidinyl)methyl]phenyl]benzamidebenzamides00low000000
2-fluoro-N-[4-[4-[2-furanyl(oxo)methyl]-1-piperazinyl]phenyl]benzamidebenzamides00low000000
N-(4-benzamido-3-methylphenyl)-1,3-benzodioxole-5-carboxamidebenzamides00low000000
N-(3-benzamidophenyl)-1,3-benzodioxole-5-carboxamidebenzamides00low000000
N-[2,2-dichloro-1-(4-chlorophenyl)sulfonylethenyl]benzamidebenzamides00low000000
2-[[[3-[2-(4-methylphenyl)sulfonylethylthio]phenyl]-oxomethyl]amino]benzoic acidbenzamides00low000000
4-chloro-N-[3-chloro-4-(4-morpholinyl)phenyl]benzamidebenzamides00low000000
N-(3-methoxyphenyl)-4-(1-oxopropylamino)benzamidebenzamides00low000000
N-[5-(4-tert-butylphenyl)-1,3,4-thiadiazol-2-yl]-4-methylbenzamidebenzamides00low000000
[2-methoxy-4-(methylthio)phenyl]-[4-(phenylmethyl)-1-piperidinyl]methanonebenzamides;
N-acylpiperidine
00low000000
N-[2,5-diethoxy-4-[[(3-methoxyanilino)-sulfanylidenemethyl]amino]phenyl]-4-methylbenzamidebenzamides00low000000
N-[4-[[anilino(sulfanylidene)methyl]amino]-2,5-diethoxyphenyl]-4-methoxybenzamidebenzamides00low000000
N-[4-[[anilino(sulfanylidene)methyl]amino]-2,5-diethoxyphenyl]benzamidebenzamides00low000000
2-(4-chloro-3-methylphenoxy)acetic acid [4-[(4-methylanilino)-oxomethyl]phenyl] esterbenzamides00low000000
2-(3-chlorophenoxy)acetic acid [4-[(4-methylanilino)-oxomethyl]phenyl] esterbenzamides00low000000
2-(4-chloro-2-methylphenoxy)acetic acid [4-[(4-methylanilino)-oxomethyl]phenyl] esterbenzamides00low000000
3-(1,3-dioxo-2-isoindolyl)propanoic acid [4-[(4-methylanilino)-oxomethyl]phenyl] esterbenzamides00low000000
5-bromo-2-furancarboxylic acid (3-benzamidophenyl) esterbenzamides00low000000
(4-ethoxyphenyl)-[4-[(4-ethoxyphenyl)-oxomethyl]-1,4-diazepan-1-yl]methanonebenzamides00low000000
[4-[(2-bromophenoxy)methyl]phenyl]-(1-piperidinyl)methanonebenzamides;
N-acylpiperidine
00low000000
3-[(4-bromophenoxy)methyl]-N-(5-methyl-3-isoxazolyl)benzamidebenzamides00low000000
3-methyl-N-[4-[(4-methyl-1-piperazinyl)sulfonyl]phenyl]benzamidebenzamides00low000000
N-[4-[methyl(phenyl)sulfamoyl]phenyl]benzamidebenzamides00low000000
N-[4-[(N-methylanilino)-oxomethyl]phenyl]-2-furancarboxamidebenzamides00low000000
3-[[[3-(1-azepanylsulfonyl)-4-chlorophenyl]-oxomethyl]amino]benzoic acidbenzamides00low000000
2-[2-nitro-4-(trifluoromethyl)phenoxy]-N-phenylbenzamidebenzamides00low000000
4-chloro-N-[2-(4-methylsulfonyl-1-piperazinyl)phenyl]benzamidebenzamides00low000000
2-[[[(4-methoxyphenyl)-oxomethyl]amino]methyl]-5-phenyl-3-furancarboxylic acidbenzamides00low000000
N-(3,5-dichlorophenyl)-2-(methanesulfonamido)benzamidebenzamides00low000000
N-(5-chloro-2-methylphenyl)-4-[(4-chloro-1-pyrazolyl)methyl]benzamidebenzamides00low000000
2-[[2-[(4-chlorophenyl)thio]-1-oxoethyl]amino]-N-(4-methoxyphenyl)benzamidebenzamides00low000000
4-methoxy-N-[2-(4-morpholinyl)phenyl]-3-nitrobenzamidebenzamides00low000000
2-bromo-N-[4-(4-methyl-1-piperazinyl)phenyl]benzamidebenzamides00low000000
N-[4-[[[(5-bromo-2-furanyl)-oxomethyl]hydrazo]-oxomethyl]phenyl]benzamidebenzamides00low000000
5-bromo-2-methoxy-3-methyl-N-[4-(4-methylsulfonyl-1-piperazinyl)phenyl]benzamidebenzamides00low000000
4-methoxy-N-[4-[[(1-oxopropylamino)-sulfanylidenemethyl]amino]phenyl]benzamidebenzamides00low000000
2-[[(3,5-dimethoxyphenyl)-oxomethyl]amino]-4,5-dimethoxybenzoic acid methyl esterbenzamides00low000000
2,4,5-trimethoxy-N-(2-phenylphenyl)benzamidebenzamides00low000000
3-ethoxy-N-[3-(5-phenyl-1,3,4-oxadiazol-2-yl)phenyl]benzamidebenzamides00low000000
2-[[[3-methyl-4-[[2-(3-nitrophenoxy)-1-oxoethyl]amino]phenyl]-oxomethyl]amino]benzoic acidbenzamides00low000000
4-methyl-N-[2-methyl-1,3-bis[(4-methyl-1,2,5-oxadiazol-3-yl)oxy]propan-2-yl]benzamidebenzamides00low000000
[4-[(2,4-dichlorophenoxy)methyl]phenyl]-(4-methyl-1-piperazinyl)methanonebenzamides00low000000
N-(2-furanylmethyl)-2-[[[2-[(4-methylphenyl)sulfonyl-(phenylmethyl)amino]phenyl]-oxomethyl]amino]benzamidebenzamides00low000000
2-[(2-cyanophenyl)thio]-N-[4-[dimethylamino(oxo)methyl]phenyl]benzamidebenzamides00low000000
N-(2-furanylmethyl)-2-[[oxo-(3,4,5-trimethoxyphenyl)methyl]amino]-4,5,6,7-tetrahydro-1-benzothiophene-3-carboxamidebenzamides00low000000
N-[3-[[(4-nitrophenyl)-oxomethyl]amino]phenyl]-2-furancarboxamidebenzamides00low000000
N-[(3-benzamidoanilino)-sulfanylidenemethyl]-2-thiophenecarboxamidebenzamides00low000000
3-chloro-N-[4-[(1-oxo-2-phenylethyl)amino]phenyl]benzamidebenzamides00low000000
N-(3,4-dimethoxyphenyl)-4-[(4-phenyl-1-piperazinyl)methyl]benzamidebenzamides00low000000
4-cyano-N-methyl-N-[5-(2-pyridinyl)-1,3,4-thiadiazol-2-yl]benzamidebenzamides00low000000
4-tert-butyl-N-[2,5-dimethoxy-4-[[1-oxo-2-(1-piperidinyl)ethyl]amino]phenyl]benzamidebenzamides00low000000
(2,6-difluorophenyl)-[4-(5-fluoro-2-methyl-1-benzimidazolyl)-1-piperidinyl]methanonebenzamides;
N-acylpiperidine
00low000000
4-chloro-N-[3-cyano-4-(phenylthio)phenyl]benzamidebenzamides00low000000
(4-chlorophenyl)-[4-[[(2,4-dichlorophenyl)thio]methyl]-4-hydroxy-1-piperidinyl]methanonebenzamides;
N-acylpiperidine
00low000000
N-(4-bromo-2,6-dimethylphenyl)-2-methoxybenzamidebenzamides00low000000
4-[[(3,6-dichloro-2-methoxyphenyl)-oxomethyl]amino]benzoic acid propyl esterbenzamides00low000000
N-(2,4-dichlorophenyl)-4-phenylbenzamidebenzamides00low000000
4-butoxy-N-[4-[4-(2-methyl-1-oxopropyl)-1-piperazinyl]phenyl]benzamidebenzamides00low000000
fm19g11benzamides00low000000
N-[4-[(4,6-dimethyl-2-pyrimidinyl)sulfamoyl]phenyl]-2-nitrobenzamidebenzamides00low000000
3-[(2,5-dichlorophenoxy)methyl]-N-(2,6-dimethylphenyl)benzamidebenzamides00low000000
2-[[[(3-methyl-1-oxobutyl)amino]-sulfanylidenemethyl]amino]-N-phenylbenzamidebenzamides00low000000
acetic acid [4-[[3-[5-(2-furanyl)-1,3,4-oxadiazol-2-yl]anilino]-oxomethyl]phenyl] esterbenzamides00low000000
4-[[(4-tert-butylphenyl)-oxomethyl]amino]-3-methyl-2-sulfanylidene-5-thiazolecarboxylic acid ethyl esterbenzamides00low000000
3-methoxy-N-(2,3,4-trifluorophenyl)benzamidebenzamides00low000000
2-phenylacetic acid [2-[4-[(4-ethoxyanilino)-oxomethyl]anilino]-2-oxoethyl] esterbenzamides00low000000
4-[[(2-nitrophenyl)-oxomethyl]amino]benzoic acid propyl esterbenzamides00low000000
2-[[oxo-(2,3,4,5,6-pentafluorophenyl)methyl]amino]benzoic acid ethyl esterbenzamides00low000000
2-bromo-N-[3-(1-oxopentylamino)phenyl]benzamidebenzamides00low000000
4-[(2,4-dichlorophenoxy)methyl]-N-[2-(dimethylamino)ethyl]benzamidebenzamides00low000000
3-methoxy-N-[2-(3-methoxyphenoxy)ethyl]benzamidebenzamides00low000000
N-[4-(diethylsulfamoyl)phenyl]-4-(4-morpholinylmethyl)benzamidebenzamides00low000000
3,5-dimethyl-N-[4-[(1-oxo-2-phenylethyl)amino]phenyl]benzamidebenzamides00low000000
3-[[[3-[(3-nitrophenyl)sulfamoyl]phenyl]-oxomethyl]amino]benzoic acidbenzamides00low000000
2-[3-(4-fluorophenyl)-1,2,4-oxadiazol-5-yl]-N-(3-methoxyphenyl)benzamidebenzamides00low000000
4-chloro-3-[(2,5-dimethylphenyl)sulfamoyl]-N-(2-phenylphenyl)benzamidebenzamides00low000000
4-methyl-N-(2-phenylphenyl)-3-(phenylsulfamoyl)benzamidebenzamides00low000000
2-[2-[[3-(1,3-benzoxazol-2-yl)anilino]-oxomethyl]phenyl]benzoic acidbenzamides00low000000
3,4-dimethoxy-N-[4-(2,2,3,3-tetrafluoropropoxy)-3-(trifluoromethyl)phenyl]benzamidebenzamides00low000000
1-azepanyl-[2-[4-(difluoromethylthio)anilino]phenyl]methanonebenzamides00low000000
3-[[(4-tert-butylphenyl)-oxomethyl]amino]-1H-1,2,4-triazole-5-carboxylic acid methyl esterbenzamides00low000000
2-bromo-N-(4-ethylphenyl)benzamidebenzamides00low000000
4-amino-N-(2-methoxyphenyl)benzamidebenzamides00low000000
4-(difluoromethoxy)-N-[5-[[4-(difluoromethylthio)phenyl]methyl]-2-thiazolyl]benzamidebenzamides00low000000
2-[(4-ethoxyphenyl)sulfonylamino]-N-[2-(4-morpholinyl)phenyl]benzamidebenzamides00low000000
4-(dimethylamino)-N-[2-(1,2,4-triazol-1-yl)-5-(trifluoromethyl)phenyl]benzamidebenzamides00low000000
2-[(2,5-dimethylphenyl)sulfonylamino]-N-[4-(2-pyrimidinylsulfamoyl)phenyl]benzamidebenzamides00low000000
2-[(5-chloro-2-thiophenyl)sulfonylamino]-N-(2-methoxy-5-methylphenyl)benzamidebenzamides00low000000
4-methoxy-N-[1-methyl-2-oxo-6-(trifluoromethyl)-3-pyridinyl]benzamidebenzamides00low000000
N-[4-bromo-3-(trifluoromethyl)phenyl]-2,4,6-trimethylbenzamidebenzamides00low000000
4-methyl-N-[1-methyl-2-oxo-6-(trifluoromethyl)-3-pyridinyl]benzamidebenzamides00low000000
4-[2-(4-fluoroanilino)-2-oxoethoxy]-3-methoxy-N-[4-(4-methoxyphenyl)-5-methyl-2-thiazolyl]benzamidebenzamides00low000000
3-[3-[2-(2-carbamoylphenoxy)-1-oxoethyl]-2,5-dimethyl-1-pyrrolyl]propanoic acid methyl esterbenzamides00low000000
4-methyl-N-[4-(2-methyl-4-thiazolyl)phenyl]benzamidebenzamides00low000000
5-(dimethylsulfamoyl)-N-(diphenylmethyl)-2-(1-pyrrolidinyl)benzamidebenzamides00low000000
2-[(3-fluoro-4-methoxyphenyl)methoxy]benzamidebenzamides00low000000
N-(4-chloro-2-methoxy-5-methylphenyl)-4-[(3,4-difluorophenyl)sulfonylamino]benzamidebenzamides00low000000
2-[[(3-methylphenyl)-oxomethyl]amino]benzoic acid (3,5-dimethyl-4-isoxazolyl)methyl esterbenzamides00low000000
4-(dimethylsulfamoyl)-N-(3-methylphenyl)benzamidebenzamides00low000000
N-[5-chloro-2-(4-methyl-1-piperazinyl)phenyl]-3-(dimethylsulfamoyl)benzamidebenzamides00low000000
3-methoxy-N-(4-methyl-2-thiazolyl)benzamidebenzamides00low000000
3-(diethylsulfamoyl)-N-(3,5-dimethylphenyl)benzamidebenzamides00low000000
3,4-dimethyl-N-[4-(4-methylpiperazino)benzyl]benzamidebenzamides00low000000
N-[4-(5-oxazolyl)phenyl]benzamidebenzamides00low000000
N1-(2,6-dimorpholino-3-pyridyl)-4-methylbenzamidebenzamides00low000000
2-chloro-N-[3-cyano-4-[(4-methoxyphenyl)thio]phenyl]benzamidebenzamides00low000000
N-[4-[(1,1-dioxo-1,4-thiazinan-4-yl)methyl]phenyl]-3,4-dimethylbenzamidebenzamides00low000000
sirtinolaldimine;
benzamides;
naphthols
anti-inflammatory agent;
EC 3.5.1.98 (histone deacetylase) inhibitor;
Sir2 inhibitor
00low000000
N-[1-(3-methoxyphenyl)-3-(1-naphthalenylamino)-3-oxopropyl]benzamidebenzamides00low000000
N-[3-(1-naphthalenylamino)-3-oxo-1-phenylpropyl]benzamidebenzamides00low000000
4-chloro-3-(diethylsulfamoyl)-N-(2-nitrophenyl)benzamidebenzamides00low000000
3,4,5-trimethoxy-N-[4-[(2-methyl-1-piperidinyl)sulfonyl]phenyl]benzamidebenzamides00low000000
N-(4-methoxy-2-nitrophenyl)-3-[(2-methyl-1-oxopropyl)amino]benzamidebenzamides00low000000
3,4,5-triethoxy-N-[4-(4-methylsulfonyl-1-piperazinyl)phenyl]benzamidebenzamides00low000000
2-[[[4-[[2-(4-chloro-2-methylphenoxy)-1-oxopropyl]amino]phenyl]-oxomethyl]amino]benzoic acidbenzamides00low000000
N-(5-chloro-2-hydroxyphenyl)-2-ethoxybenzamidebenzamides00low000000
N-[2-[(2-furanylmethylamino)-oxomethyl]phenyl]-4-methyl-3-(1-piperidinylsulfonyl)benzamidebenzamides00low000000
4-methoxy-N-[4-[1-[(4-methoxyanilino)-oxomethyl]cyclopentyl]phenyl]benzamidebenzamides00low000000
N-[3-chloro-2-(1-piperidinyl)phenyl]-4-(4-morpholinyl)-3-nitrobenzamidebenzamides00low000000
N-[4-(6-imidazo[2,1-b]thiazolyl)phenyl]-4-methoxy-3-(4-morpholinylsulfonyl)benzamidebenzamides00low000000
norcisapridebenzamides00low000000
prucalopridebenzamides00low000000
Dihydroalatamidebenzamides00low000000
4-methoxy-N-[2,2,2-trichloro-1-(4-methylanilino)ethyl]benzamidebenzamides00low000000
N-(2-hydroxy-5-nitrophenyl)-3-nitrobenzamidebenzamides00low000000
N-[3-(1,3-benzothiazol-2-ylthio)-5-nitrophenyl]-2-fluorobenzamidebenzamides00low000000
N-[2-[5-[(4-tert-butylphenyl)methylthio]-1,3,4-oxadiazol-2-yl]phenyl]benzamidebenzamides00low000000
N-butan-2-yl-4-[4-oxo-3-(phenylmethyl)-2-thiazolidinyl]benzamidebenzamides00low000000
4-[3-(2-furanylmethyl)-4-oxo-2-thiazolidinyl]-N-(3-propan-2-yloxypropyl)benzamidebenzamides00low000000
2-methyl-N-[1-(4-prop-2-enyl-5-sulfanylidene-1H-1,2,4-triazol-3-yl)ethyl]benzamidebenzamides00low000000
N-[4-(4-methoxyphenyl)-2-thiazolyl]-N-(2-oxolanylmethyl)benzamidebenzamides00low000000
3-chloro-4-ethoxy-N-[3-(2-oxazolo[5,4-b]pyridinyl)phenyl]benzamidebenzamides00low000000
4-[[(3-methoxyphenyl)-oxomethyl]amino]benzoic acidbenzamides00low000000
3-[[oxo-[3-(1-piperidinylsulfonyl)phenyl]methyl]amino]benzoic acidbenzamides00low000000
N-(4-ethoxyphenyl)-2-(hydroxymethyl)benzamidebenzamides00low000000
N-(5-acetyl-2-phenyl-4-sulfanylidene-1H-pyrimidin-6-yl)benzamidebenzamides00low000000
sb-2242891,2,4-oxadiazole;
azaspiro compound;
benzamides;
organic heterotetracyclic compound
serotonergic antagonist00low000000
N-[(4-methylphenyl)methyl]-4-(1-pyrrolyl)benzamidebenzamides00low000000
1-[(4-chlorophenyl)-oxomethyl]-N-[4-(1-piperidinylsulfonyl)phenyl]-3-piperidinecarboxamidebenzamides;
N-acylpiperidine
00low000000
N-(4-bromophenyl)-2-[(5,6-dimethyl-4-thieno[2,3-d]pyrimidinyl)thio]benzamidebenzamides;
thienopyrimidine
00low000000
4-(3,5-dimethyl-1-pyrazolyl)-N-[2-methoxy-5-(4-morpholinylsulfonyl)phenyl]benzamidebenzamides00low000000
N-[5-ethyl-3-[(4-fluorophenyl)-(4-morpholinyl)methyl]-2-thiophenyl]benzamidebenzamides00low000000
N-cycloheptyl-4-(2-oxolanylmethoxy)benzamidebenzamides00low000000
2-(4-methoxyphenyl)acetic acid [2-[4-[(4-ethoxyanilino)-oxomethyl]anilino]-2-oxoethyl] esterbenzamides00low000000
2-methyl-3-nitro-N-[4-[[(1-oxopropylamino)-sulfanylidenemethyl]amino]phenyl]benzamidebenzamides00low000000
N-[2-(3-methyl-1-oxobutyl)-3-oxo-1,2,4-thiadiazol-5-yl]benzamidebenzamides00low000000
2-[4-[[(3-chlorophenyl)-oxomethyl]amino]phenyl]propanedioic acid dimethyl esterbenzamides00low000000
N-(3,5-dimethylphenyl)-2-(2-nitroethyl)benzamidebenzamides00low000000
N-[4-[[(4-tert-butylphenyl)-oxomethyl]amino]phenyl]-2-furancarboxamidebenzamides00low000000
N-[3-[(4-ethoxyphenyl)-[4-(2-hydroxyethyl)-1-piperazinyl]methyl]-4,5-dimethyl-2-thiophenyl]benzamidebenzamides00low000000
2-methoxy-N-(5-phenyl-1,2,4-thiadiazol-3-yl)benzamidebenzamides00low000000
N-(3-chlorophenyl)-4-fluoro-3-(thiophen-2-ylmethylsulfamoyl)benzamidebenzamides00low000000
3-acetamido-N-[(4-ethoxy-3-methoxyphenyl)methyl]-4-[(4-methylphenyl)thio]benzamidebenzamides00low000000
N-[3-(4-morpholinylsulfonyl)phenyl]-4-(2-oxo-1-pyrrolidinyl)benzamidebenzamides00low000000
N,N-dimethylsulfamic acid [3-[(4-methoxyanilino)-oxomethyl]phenyl] esterbenzamides00low000000
N-[1-(benzenesulfonyl)-2,2-dichloroethenyl]-4-methylbenzamidebenzamides00low000000
N-[4-chloro-3-[(4-chlorophenyl)sulfamoyl]phenyl]-4-propan-2-yloxybenzamidebenzamides00low000000
N-[3-[(2-bromo-5-methylphenyl)sulfamoyl]-4-methoxyphenyl]-4-fluorobenzamidebenzamides00low000000
N-[2,5-diethoxy-4-(4-morpholinyl)phenyl]-4-[(3,5-dimethyl-4-isoxazolyl)methoxy]-3-methoxybenzamidebenzamides00low000000
4-methyl-N-[2-[(5-oxo-2,3-dihydrothiazolo[2,3-b]quinazolin-3-yl)methylthio]phenyl]benzamidebenzamides00low000000
4-cyano-N-[4-thiophen-2-yl-5-(2,2,2-trifluoro-1-oxoethyl)-2-thiazolyl]benzamidebenzamides00low000000
4-(1-azepanylsulfonyl)-N-[5-[(4-chlorophenyl)sulfamoyl]-2-hydroxyphenyl]benzamidebenzamides00low000000
N-[4-(4-fluorophenyl)-2-thiazolyl]-3-methoxy-4-[2-(4-morpholinyl)-2-oxoethoxy]benzamidebenzamides00low000000
N-[4-chloro-3-(4-morpholinylsulfonyl)phenyl]-4-(2-oxolanylmethoxy)benzamidebenzamides00low000000
N-[3-[(4-chlorophenyl)methylthio]-1H-1,2,4-triazol-5-yl]-4-cyanobenzamidebenzamides00low000000
2-(4-methylphenoxy)-N-[2-[oxo(1-piperidinyl)methyl]phenyl]acetamidebenzamides;
N-acylpiperidine
00low000000
imd 0354benzamides00low000000
N-(3-chlorophenyl)-3-[ethyl(phenyl)sulfamoyl]-4-fluorobenzamidebenzamides00low000000
4-tert-butyl-N-[3-[4-[3-[[(4-tert-butylphenyl)-oxomethyl]amino]propyl]-1-piperazinyl]propyl]benzamidebenzamides00low000000
2-nitro-4-[(6-nitro-4-quinolinyl)amino]-N-[4-(pyridin-4-ylamino)phenyl]benzamidebenzamides00low000000
4-amino-5-chloro-N-[(3R,4S)-1-[3-(4-fluorophenoxy)propyl]-3-methoxy-4-piperidinyl]-2-methoxybenzamidebenzamides00low000000
tiapridexbenzamides00low000000
[2-methoxy-5-[[4-(4-methylphenyl)-1-phthalazinyl]amino]phenyl]-(1-piperidinyl)methanonebenzamides;
N-acylpiperidine
00low000000
4-[(2,4-dioxo-1H-thieno[3,2-d]pyrimidin-3-yl)methyl]-N-(3-ethylphenyl)benzamidebenzamides00low000000
LSM-32377benzamides00low000000
ispinesibbenzamides00low000000
fk 866benzamides;
N-acylpiperidine
00low000000
4-acetamido-N-(2-amino-5-thiophen-2-ylphenyl)benzamidebenzamides00low000000
[4-[[4-(1-benzothiophen-2-yl)-2-pyrimidinyl]amino]phenyl]-[4-(1-pyrrolidinyl)-1-piperidinyl]methanonebenzamides;
N-acylpiperidine
00low000000
midostaurinbenzamides;
gamma-lactam;
indolocarbazole;
organic heterooctacyclic compound
antineoplastic agent;
EC 2.7.11.13 (protein kinase C) inhibitor
00low000000
bms201038(trifluoromethyl)benzenes;
benzamides;
fluorenes;
piperidines
anticholesteremic drug;
MTP inhibitor
00low000000
cgp 74588benzamides00low000000
zm 447439aromatic ether;
benzamides;
morpholines;
polyether;
quinazolines;
secondary amino compound;
tertiary amino compound
antineoplastic agent;
apoptosis inducer;
Aurora kinase inhibitor
00low000000
tak-715benzamides00low000000
N-(3-cyanophenyl)-2'-methyl-5'-(5-methyl-1,3,4-oxadiazol-2-yl)biphenyl-4-carboxamide1,3,4-oxadiazoles;
benzamides;
biphenyls;
nitrile
EC 2.7.11.24 (mitogen-activated protein kinase) inhibitor00low000000
betrixabanbenzamides;
guanidines;
monochloropyridine;
monomethoxybenzene;
secondary carboxamide
anticoagulant;
EC 3.4.21.6 (coagulation factor Xa) inhibitor
00low000000
nigerloxinaromatic ether;
benzamides;
benzoic acids;
phenols;
styrenes
antioxidant;
Aspergillus metabolite;
EC 1.1.1.21 (aldehyde reductase) inhibitor;
lipoxygenase inhibitor;
radical scavenger
00low000000
myxochelin bbenzamides;
catechols
bacterial metabolite;
siderophore
00low000000
fluopicolidebenzamide fungicide;
benzamides;
dichlorobenzene;
monochloropyridine;
organofluorine compound
antifungal agrochemical00low000000
eluxadolineamino acid amide;
benzamides;
imidazoles;
L-phenylalanine derivative;
methoxybenzoic acid
delta-opioid receptor antagonist;
gastrointestinal drug;
kappa-opioid receptor agonist;
mu-opioid receptor agonist
00low000000
N-[4-(2-tert-butylphenyl)sulfonylphenyl]-2,3,4-trihydroxy-5-[(2-propan-2-ylphenyl)methyl]benzamidebenzamides00low000000
N-[5-[[5-[(4-acetyl-1-piperazinyl)-oxomethyl]-4-methoxy-2-methylphenyl]thio]-2-thiazolyl]-4-[(3,3-dimethylbutan-2-ylamino)methyl]benzamidebenzamides00low000000
chir 090acetylenic compound;
benzamides;
hydroxamic acid;
L-threonine derivative;
morpholines
antimicrobial agent;
EC 3.5.1.108 (UDP-3-O-acyl-N-acetylglucosamine deacetylase) inhibitor;
lipopolysaccharide biosynthesis inhibitor
00low000000
ki11502aromatic ether;
benzamides;
quinolines;
thioureas
antineoplastic agent;
apoptosis inducer;
EC 2.7.10.1 (receptor protein-tyrosine kinase) inhibitor
00low000000
az-628benzamides00low000000
at 13387benzamides;
isoindoles;
N-alkylpiperazine;
resorcinols;
tertiary carboxamide
antineoplastic agent;
Hsp90 inhibitor
00low000000
4-[[[2-(cyclohexylamino)-3,4-dioxo-1-cyclobutenyl]amino]methyl]-N-(4-ethoxyphenyl)benzamidebenzamides00low000000
chidamidebenzamides00low000000
N-(3,5-dichlorophenyl)-4-[(2,4-dioxo-1H-thieno[3,2-d]pyrimidin-3-yl)methyl]benzamidebenzamides00low000000
mdv 3100(trifluoromethyl)benzenes;
benzamides;
imidazolidinone;
monofluorobenzenes;
nitrile;
thiocarbonyl compound
androgen antagonist;
antineoplastic agent
00low000000
3-nitro-4-(2-oxolanylmethylamino)-N-(2-phenylethyl)benzamidebenzamides00low000000
azd 7545benzamides;
monochlorobenzenes;
organofluorine compound;
secondary carboxamide;
sulfone;
tertiary alcohol;
tertiary carboxamide
EC 2.7.11.2 - [pyruvate dehydrogenase (acetyl-transferring)] kinase inhibitor;
hypoglycemic agent
00low000000
N-[3-[2-(4-chloroanilino)-4-thiazolyl]phenyl]-3-(trifluoromethyl)benzamidebenzamides00low000000
3-(trifluoromethyl)-N-[4-[2-[3-(trifluoromethyl)anilino]-4-thiazolyl]phenyl]benzamidebenzamides00low000000
2-amino-N-[3-methoxy-5-[oxo-[3-(trifluoromethyl)anilino]methyl]phenyl]-5-oxazolecarboxamidebenzamides00low000000
2-amino-N-[3-methoxy-5-[oxo-[3-(trifluoromethyl)anilino]methyl]phenyl]-4-thiazolecarboxamidebenzamides00low000000
2-amino-N-[3-methoxy-5-[oxo-[3-(trifluoromethyl)anilino]methyl]phenyl]-4-pyridinecarboxamidebenzamides00low000000
3-(4-bromophenyl)-N-[5-[[4-[(4-ethyl-1-piperazinyl)methyl]-3-(trifluoromethyl)anilino]-oxomethyl]-2-methylphenyl]-1H-pyrazole-5-carboxamidebenzamides00low000000
N-[3-amino-1-[4-[2-(4-methoxyphenyl)ethylamino]-3-nitrophenyl]-3-oxopropyl]-4-bromobenzamidebenzamides00low000000
nvp-bhg712benzamides00low000000
respirantinbenzamides;
cyclodepsipeptide;
formamides;
phenols
antimicrobial agent;
antineoplastic agent;
metabolite
00low000000
N-[5-[[5-[(4-acetyl-1-piperazinyl)-oxomethyl]-4-methoxy-2-methylphenyl]thio]-2-thiazolyl]-4-[(3-methylbutan-2-ylamino)methyl]benzamidebenzamides00low000000
ph 797804aromatic ether;
benzamides;
organobromine compound;
organofluorine compound;
pyridone
anti-inflammatory agent;
EC 2.7.11.24 (mitogen-activated protein kinase) inhibitor
00low000000
2-[(6-chloro-3-pyridinyl)sulfonylamino]-N-[(4-methylphenyl)methyl]benzamidebenzamides00low000000
2-[[4-(2-hydroxyethylamino)-6-(1-pyrrolidinyl)-1,3,5-triazin-2-yl]amino]benzamidebenzamides00low000000
lde225aminopyridine;
aromatic ether;
benzamides;
biphenyls;
morpholines;
organofluorine compound;
tertiary amino compound
antineoplastic agent;
Hedgehog signaling pathway inhibitor;
SMO receptor antagonist
00low000000
3-[[1-[1-(methylthio)propan-2-yl]-4-piperidinyl]oxy]-N-(2-pyridinylmethyl)benzamidebenzamides00low000000
3-[[1-(dimethylsulfamoyl)-4-piperidinyl]oxy]-N-[(3-methyl-5-isoxazolyl)methyl]benzamidebenzamides00low000000
ponatinib(trifluoromethyl)benzenes;
acetylenic compound;
benzamides;
imidazopyridazine;
N-methylpiperazine
antineoplastic agent;
tyrosine kinase inhibitor
00low000000
N-cyclopropyl-3-{4-[(cyclopropylmethyl)carbamoyl]phenyl}-4-methylbenzamidebenzamides;
biphenyls;
cyclopropanes;
dicarboxylic acid diamide
EC 2.7.11.24 (mitogen-activated protein kinase) inhibitor00low000000
4-tert-butyl-N-[5-[[2-oxo-2-(2-oxolanylmethylamino)ethyl]thio]-1,3,4-thiadiazol-2-yl]benzamidebenzamides00low000000
4-ethoxy-N-[5-[[2-oxo-2-(2-oxolanylmethylamino)ethyl]thio]-1,3,4-thiadiazol-2-yl]benzamidebenzamides00low000000
GRL-0617benzamides;
naphthalenes;
secondary carboxamide;
substituted aniline
anticoronaviral agent;
protease inhibitor
00low000000
N-(2,6-difluorophenyl)-5-[3-[2-[5-ethyl-2-methoxy-4-[4-(4-methylsulfonyl-1-piperazinyl)-1-piperidinyl]anilino]-4-pyrimidinyl]-2-imidazo[1,2-a]pyridinyl]-2-methoxybenzamidebenzamides00low000000
entrectinibbenzamides;
difluorobenzene;
indazoles;
N-methylpiperazine;
oxanes;
secondary amino compound;
secondary carboxamide
antibacterial agent;
antineoplastic agent;
apoptosis inducer;
EC 2.7.10.1 (receptor protein-tyrosine kinase) inhibitor
00low000000
ixazomibbenzamides;
boronic acids;
dichlorobenzene;
glycine derivative
antineoplastic agent;
apoptosis inducer;
drug metabolite;
orphan drug;
proteasome inhibitor
00low000000
N-(2-chlorophenyl)-4-[[2-[4-[2-(4-ethyl-1-piperazinyl)-2-oxoethyl]anilino]-5-fluoro-4-pyrimidinyl]amino]benzamidebenzamides00low000000
N-[(2S,3S)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]-4-(2-thiazolyl)benzamidebenzamides00low000000
N-(2-aminophenyl)-4-[[[(2S,3S)-10-[[cyclohexyl(oxo)methyl]amino]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-2-yl]methyl-methylamino]methyl]benzamidebenzamides00low000000
KOM70144acetamides;
benzamides;
naphthalenes;
secondary carboxamide
anticoronaviral agent;
protease inhibitor
00low000000
iwr-1 endobenzamides;
bridged compound;
dicarboximide;
quinolines
axin stabilizer;
Wnt signalling inhibitor
00low000000
ulixacaltamidebenzamides;
monochlorobenzenes;
monofluorobenzenes;
piperidines;
secondary carboxamide
non-narcotic analgesic;
T-type calcium channel blocker
00low000000
xl765aromatic amine;
aromatic ether;
benzamides;
quinoxaline derivative;
sulfonamide
antineoplastic agent;
EC 2.7.1.137 (phosphatidylinositol 3-kinase) inhibitor;
mTOR inhibitor
00low000000
azd4547benzamides;
N-arylpiperazine;
pyrazoles
fibroblast growth factor receptor antagonist00low000000
N-[4-(1-benzoyl-4-piperidinyl)butyl]-3-(3-pyridinyl)-2-propenamidebenzamides;
N-acylpiperidine
00low000000
entecavirbenzamides;
N-acylpiperidine
00low000000
pf-06463922aminopyridine;
aromatic ether;
azamacrocycle;
benzamides;
cyclic ether;
monofluorobenzenes;
nitrile;
organic heterotetracyclic compound;
pyrazoles
antineoplastic agent;
EC 2.7.10.1 (receptor protein-tyrosine kinase) inhibitor
00low000000
DDR1-IN-1(trifluoromethyl)benzenes;
aromatic ether;
benzamides;
N-alkylpiperazine;
oxindoles;
secondary carboxamide
EC 2.7.10.1 (receptor protein-tyrosine kinase) inhibitor00low000000
N-[2-methyl-5-[oxo-[3-(1-oxoprop-2-enylamino)-5-(trifluoromethyl)anilino]methyl]phenyl]-5-isoxazolecarboxamidebenzamides00low000000
PF-06446846benzamides;
monochloropyridine;
piperidines;
tertiary carboxamide;
triazolopyridine
antilipemic drug;
EC 3.4.21.61 (kexin) inhibitor
00low000000
5,10-methylenetetrahydrofolic acidbenzamides;
methylenetetrahydrofolic acid
00low000000
N-cyclohexyl-3-methyl-N-[(4-oxo-1H-quinazolin-2-yl)methyl]benzamidebenzamides00low000000
kynureninearomatic ketone;
non-proteinogenic alpha-amino acid;
substituted aniline
human metabolite1950201436.3low031120
alminoprofenamino acid;
monocarboxylic acid;
secondary amino compound;
substituted aniline
antipyretic;
antirheumatic drug;
cyclooxygenase 2 inhibitor;
EC 1.13.11.34 (arachidonate 5-lipoxygenase) inhibitor;
EC 3.1.1.4 (phospholipase A2) inhibitor;
non-narcotic analgesic;
non-steroidal anti-inflammatory drug
00low000000
amfenacamino acid;
benzophenones;
oxo monocarboxylic acid;
primary amino compound;
substituted aniline
antipyretic;
cyclooxygenase 1 inhibitor;
cyclooxygenase 2 inhibitor;
non-narcotic analgesic;
non-steroidal anti-inflammatory drug
00low000000
aminoglutethimidedicarboximide;
piperidones;
substituted aniline
adrenergic agent;
anticonvulsant;
antineoplastic agent;
EC 1.14.14.14 (aromatase) inhibitor
2006201514.7low000210
benefinC-nitro compound;
organofluorine compound;
substituted aniline;
tertiary amino compound
agrochemical;
herbicide
00low000000
benzocainebenzoate ester;
substituted aniline
allergen;
antipruritic drug;
sensitiser;
topical anaesthetic
00low000000
bromhexineorganobromine compound;
substituted aniline;
tertiary amino compound
mucolytic2003200321.0low000100
butambenamino acid ester;
benzoate ester;
primary amino compound;
substituted aniline
local anaesthetic00low000000
clenbuterolamino alcohol;
dichlorobenzene;
ethanolamines;
primary arylamine;
secondary amino compound;
substituted aniline
beta-adrenergic agonist;
bronchodilator agent;
sympathomimetic agent
201920223.5low000011
dapsonesubstituted aniline;
sulfone
anti-inflammatory drug;
antiinfective agent;
antimalarial;
leprostatic drug
1978202227.7low079521
benoxinateamino acid ester;
benzoate ester;
substituted aniline;
tertiary amino compound
drug allergen;
local anaesthetic;
topical anaesthetic
00low000000
pd168393acrylamides;
bromobenzenes;
quinazolines;
secondary carboxamide;
substituted aniline
epidermal growth factor receptor antagonist00low000000
procainebenzoate ester;
substituted aniline;
tertiary amino compound
central nervous system depressant;
drug allergen;
local anaesthetic;
peripheral nervous system drug
1986201022.7low010200
sulfadiazinepyrimidines;
substituted aniline;
sulfonamide antibiotic;
sulfonamide
antiinfective agent;
antimicrobial agent;
antiprotozoal drug;
coccidiostat;
drug allergen;
EC 1.1.1.153 [sepiapterin reductase (L-erythro-7,8-dihydrobiopterin forming)] inhibitor;
EC 2.5.1.15 (dihydropteroate synthase) inhibitor;
environmental contaminant;
xenobiotic
201720234.0low100011
sulfacetamideN-sulfonylcarboxamide;
substituted aniline
antibacterial drug;
antiinfective agent;
antimicrobial agent;
EC 2.5.1.15 (dihydropteroate synthase) inhibitor
00low000000
sulfadimethoxinearomatic ether;
pyrimidines;
substituted aniline;
sulfonamide antibiotic;
sulfonamide
antiinfective agent;
antimicrobial agent;
drug allergen;
environmental contaminant;
xenobiotic
201720196.3low000030
sulfamethoxazoleisoxazoles;
substituted aniline;
sulfonamide antibiotic;
sulfonamide
antibacterial agent;
antiinfective agent;
antimicrobial agent;
drug allergen;
EC 1.1.1.153 [sepiapterin reductase (L-erythro-7,8-dihydrobiopterin forming)] inhibitor;
EC 2.5.1.15 (dihydropteroate synthase) inhibitor;
environmental contaminant;
epitope;
P450 inhibitor;
xenobiotic
1990201916.4low001220
sulfanilamidesubstituted aniline;
sulfonamide antibiotic;
sulfonamide
antibacterial agent;
drug allergen;
EC 4.2.1.1 (carbonic anhydrase) inhibitor
00low000000
sulfaphenazoleprimary amino compound;
pyrazoles;
substituted aniline;
sulfonamide antibiotic;
sulfonamide
antibacterial drug;
EC 1.14.13.181 (13-deoxydaunorubicin hydroxylase) inhibitor;
EC 1.14.13.67 (quinine 3-monooxygenase) inhibitor;
P450 inhibitor
00low000000
sulfathiazole1,3-thiazoles;
substituted aniline;
sulfonamide antibiotic;
sulfonamide
antiinfective agent;
drug allergen;
EC 2.5.1.15 (dihydropteroate synthase) inhibitor;
environmental contaminant;
xenobiotic
00low000000
trifluralin(trifluoromethyl)benzenes;
C-nitro compound;
substituted aniline
agrochemical;
environmental contaminant;
herbicide;
xenobiotic
00low000000
phentolamineimidazoles;
phenols;
substituted aniline;
tertiary amino compound
alpha-adrenergic antagonist;
vasodilator agent
1983201523.8low011210
methyl n-methylanthranilatebenzoate ester;
methyl ester;
secondary amino compound;
substituted aniline
animal metabolite;
fungal metabolite;
plant metabolite
00low000000
2,4,6-trimethylanilinesubstituted aniline00low000000
anthranilamidesubstituted aniline00low000000
2-anisidinemonomethoxybenzene;
primary amino compound;
substituted aniline
genotoxin;
reagent
00low000000
3,3'-diaminobenzidinebiphenyls;
substituted aniline
histological dye1975202327.9low11010731
benzidinebiphenyls;
substituted aniline
carcinogenic agent00low000000
phenetidinearomatic ether;
substituted aniline
00low000000
5-nitro-2-methoxyaniline4-nitroanisoles;
substituted aniline
00low000000
dimethyl-4-phenylenediaminediamine;
substituted aniline
00low000000
4-(dimethylamino)benzaldehydebenzaldehydes;
substituted aniline;
tertiary amino compound
chromogenic compound00low000000
3-hydroxydiphenylaminesubstituted aniline00low000000
benzonatatebenzoate ester;
secondary amino compound;
substituted aniline
anaesthetic;
antitussive
00low000000
4-anisidinemethoxybenzenes;
primary amino compound;
substituted aniline
genotoxin;
reagent
00low000000
2-aminothiophenolaryl thiol;
substituted aniline
plant metabolite00low000000
2,4,5-trimethylanilinesubstituted aniline00low000000
4,4'-thiodianilinesubstituted aniline00low000000
anileridineethyl ester;
piperidinecarboxylate ester;
substituted aniline
opioid analgesic;
opioid receptor agonist
00low000000
phenetidinearomatic ether;
primary amino compound;
substituted aniline
drug metabolite00low000000
4-trifluoromethylaniline(trifluoromethyl)benzenes;
substituted aniline
metabolite00low000000
3-anisidinearomatic ether;
substituted aniline
00low000000
oxophenarsinesubstituted aniline00low000000
c.i. solvent yellow 56azobenzenes;
substituted aniline;
tertiary amino compound
dye;
mutagen
00low000000
asulamcarbamate ester;
primary amino compound;
substituted aniline;
sulfonamide
agrochemical;
EC 2.5.1.15 (dihydropteroate synthase) inhibitor;
environmental contaminant;
herbicide;
xenobiotic
00low000000
st 91substituted aniline00low000000
4-hexyloxyanilinearomatic ether;
substituted aniline
00low000000
pendimethalinC-nitro compound;
secondary amino compound;
substituted aniline
agrochemical;
environmental contaminant;
herbicide
00low000000
bromfenacaromatic amino acid;
benzophenones;
organobromine compound;
substituted aniline
non-narcotic analgesic;
non-steroidal anti-inflammatory drug
00low000000
sulfametrolearomatic ether;
substituted aniline;
sulfonamide antibiotic;
thiadiazoles
00low000000
sulfaperinepyrimidines;
substituted aniline;
sulfonamide antibiotic
antibacterial drug00low000000
2-(1H-benzimidazol-2-yl)anilinebenzimidazoles;
primary arylamine;
substituted aniline
geroprotector00low000000
aclonifenaromatic ether;
C-nitro compound;
monochlorobenzenes;
primary amino compound;
substituted aniline
agrochemical;
carotenoid biosynthesis inhibitor;
EC 1.3.3.4 (protoporphyrinogen oxidase) inhibitor;
herbicide
00low000000
ezogabinecarbamate ester;
organofluorine compound;
secondary amino compound;
substituted aniline
anticonvulsant;
potassium channel modulator
00low000000
1-(2-(4-aminophenyl)ethyl)-4-(3-trifluoromethylphenyl)piperazine(trifluoromethyl)benzenes;
N-alkylpiperazine;
N-arylpiperazine;
primary arylamine;
substituted aniline
geroprotector;
serotonergic agonist
00low000000
4-aminophenyl alpha-d-mannopyranosidealpha-D-mannoside;
substituted aniline
00low000000
4-aminobenzoylglutamic aciddicarboxylic acid;
dipeptide;
N-acyl-L-alpha-amino acid;
substituted aniline
00low000000
2-[2-[2-(2-aminophenoxy)ethoxy]ethoxy]anilinearomatic ether;
substituted aniline
00low000000
6-(2-chloroanilino)-4-oxo-2-(4-pyridyl)-3,4-dihydro-2H-1,3-thiazine-5-carbonitrilesubstituted aniline00low000000
N2-phenyl-5-methyl-4,5-dihydro-1,3-thiazol-2-aminesubstituted aniline00low000000
3-(2,4-difluoroanilino)-5,5-dimethyl-1-cyclohex-2-enonesubstituted aniline00low000000
cgp 60474substituted aniline00low000000
4,4-dimethyl-N2-(2-methylphenyl)-1H-1,3,5-triazine-2,6-diaminesubstituted aniline00low000000
brd32048methoxybenzenes;
substituted aniline
00low000000
stf 62247substituted aniline00low000000
4-chloro-N-(3,4,5-trimethoxyphenyl)-5-dithiazoliminemethoxybenzenes;
substituted aniline
00low000000
5-amino-3-(4-methoxyphenyl)-4-oxo-1-thieno[3,4-d]pyridazinecarboxylic acid ethyl estermethoxybenzenes;
substituted aniline
00low000000
6-anilino-1,3-dimethyl-1,2,3,4-tetrahydropyrimidine-2,4-dionesubstituted aniline00low000000
3-(2-Methyl-1,3-thiazol-4-yl)anilinesubstituted aniline00low000000
N-phenyl-4-pyridin-4-yl-2-thiazolaminesubstituted aniline00low000000
4-(4-(4-chloro-phenyl)thiazol-2-ylamino)phenolsubstituted aniline00low000000
1-[[(1,5-dimethyl-3-pyrazolyl)-oxomethyl]amino]-3-(2-methoxyphenyl)thioureamethoxybenzenes;
substituted aniline
00low000000
1-(4-methoxyphenyl)-3-[[oxo(thiophen-2-yl)methyl]amino]thioureamethoxybenzenes;
substituted aniline
00low000000
N2,N4-bis(4-methoxyphenyl)pyrimidine-2,4-diaminemethoxybenzenes;
substituted aniline
00low000000
N4-(4-methoxyphenyl)-1,3,5-triazaspiro[5.5]undeca-1,4-diene-2,4-diaminemethoxybenzenes;
substituted aniline
00low000000
4-mercapto-5-(4-methoxyphenyl)-2-oxo-1,5-diazaspiro[5.5]undec-3-ene-3-carbonitrilemethoxybenzenes;
substituted aniline
00low000000
4-[2-(3-methoxyanilino)-4-thiazolyl]phenolmethoxybenzenes;
substituted aniline
00low000000
2-(4-methylanilino)-4-pyrido[3,2-e][1,3]thiazinonesubstituted aniline00low000000
N-(3-chloro-4-methoxyphenyl)-4,6-dimethoxy-1,3,5-triazin-2-aminemethoxybenzenes;
substituted aniline
00low000000
6-[[(4,6-dimethyl-2-pyrimidinyl)thio]methyl]-N2-(4-methoxyphenyl)-1,3,5-triazine-2,4-diaminemethoxybenzenes;
substituted aniline
00low000000
N-(4-fluorophenyl)-4-(3-pyridinyl)-2-thiazolaminesubstituted aniline00low000000
3-(4-methoxyphenyl)-2-(4-methoxyphenyl)imino-4-thiazolidinonemethoxybenzenes;
substituted aniline
00low000000
3-(4-methoxyphenyl)-2,4-dihydrothiazolo[3,2-a][1,3,5]triazin-6-onemethoxybenzenes;
substituted aniline
00low000000
7-anilino-3-(4-bromophenyl)-5-(4-morpholinyl)-1,4-thiazepine-6-carbonitrilesubstituted aniline00low000000
4,6-bis(1-imidazolyl)-N,N-diphenyl-1,3,5-triazin-2-aminesubstituted aniline00low000000
1-(3-methoxyphenyl)-3-[[3-(4-nitro-1-pyrazolyl)-1-oxopropyl]amino]thioureamethoxybenzenes;
substituted aniline
00low000000
N-(5-chloro-2-methoxyphenyl)-5-pyridin-4-yl-1,3,4-thiadiazol-2-aminemethoxybenzenes;
substituted aniline
00low000000
1-[[(4-bromo-2-methyl-3-pyrazolyl)-oxomethyl]amino]-3-(2-methoxy-5-methylphenyl)thioureamethoxybenzenes;
substituted aniline
00low000000
N-(4-chlorophenyl)-4-methyl-2-thiazolaminesubstituted aniline00low000000
N4-(2-methoxyphenyl)benzene-1,4-diaminearomatic ether;
substituted aniline
00low000000
N-{3-[(2-phenylquinazolin-4-yl)amino]phenyl}acetamideacetamide;
aromatic amine;
quinazolines;
secondary amino compound;
substituted aniline
00low000000
1-[2-[[5-(2-methoxyanilino)-1,3,4-thiadiazol-2-yl]thio]-1-oxoethyl]-2-pyrrolidinonemethoxybenzenes;
substituted aniline
00low000000
5-anilino-3-oxo-4-isothiazolecarbonitrilesubstituted aniline00low000000
5-(4-chloroanilino)-3-oxo-4-isothiazolecarbonitrilesubstituted aniline00low000000
5-(2-chloroanilino)-3-oxo-4-isothiazolecarbonitrilesubstituted aniline00low000000
N-(2-chlorophenyl)-4-(1-pyrrolyl)-1,3,5-triazin-2-aminesubstituted aniline00low000000
1-(3-methoxyphenyl)-3-(methyl-oxo-phenyl-$l^{6}-sulfanylidene)thioureamethoxybenzenes;
substituted aniline
00low000000
5-(4-methoxyanilino)-2-[(3-methylphenoxy)methyl]-4-oxazolecarbonitrilemethoxybenzenes;
substituted aniline
00low000000
sulfathioureasubstituted aniline;
sulfonamide antibiotic;
thioureas
antibacterial drug;
EC 2.5.1.15 (dihydropteroate synthase) inhibitor
00low000000
u 0126aryl sulfide;
dinitrile;
enamine;
substituted aniline
antineoplastic agent;
antioxidant;
apoptosis inducer;
EC 2.7.11.24 (mitogen-activated protein kinase) inhibitor;
osteogenesis regulator;
vasoconstrictor agent
00low000000
2-(4-ethoxy-3-methoxyphenyl)-4-mercapto-3-(4-methoxyphenyl)-6-oxo-1,2-dihydropyrimidine-5-carbonitrilemethoxybenzenes;
substituted aniline
00low000000
N4-(2-furanylmethyl)-N2-(3-methoxyphenyl)-5-nitropyrimidine-2,4,6-triaminemethoxybenzenes;
substituted aniline
00low000000
ferrostatin-1ethyl ester;
primary arylamine;
substituted aniline
antifungal agent;
antioxidant;
ferroptosis inhibitor;
neuroprotective agent;
radiation protective agent;
radical scavenger
00low000000
1-[[2-(2,4-dichlorophenoxy)-1-oxoethyl]amino]-3-(4-methoxyphenyl)thioureamethoxybenzenes;
substituted aniline
00low000000
sb 415286C-nitro compound;
maleimides;
monochlorobenzenes;
phenols;
secondary amino compound;
substituted aniline
antioxidant;
apoptosis inducer;
EC 2.7.11.26 (tau-protein kinase) inhibitor;
neuroprotective agent
00low000000
2-[[6-amino-2-(4-methoxyanilino)-5-nitro-4-pyrimidinyl]amino]ethanolmethoxybenzenes;
substituted aniline
00low000000
N-(3-{[2-(2-fluorophenyl)quinazolin-4-yl]amino}phenyl)acetamideacetamide;
aromatic amine;
monofluorobenzenes;
quinazolines;
secondary amino compound;
substituted aniline
00low000000
1-amino-3-(4-chloro-2-methoxy-5-methylphenyl)thioureamethoxybenzenes;
substituted aniline
00low000000
5-(3-chloroanilino)-3H-1,3,4-thiadiazole-2-thionesubstituted aniline00low000000
2-(2-methoxyanilino)-2-(2-phenylmethoxyphenyl)acetonitrilearomatic ether;
substituted aniline
00low000000
1-[2,5-dimethyl-1-(2-oxolanylmethyl)-3-pyrrolyl]-2-[[5-(4-methoxyanilino)-1,3,4-thiadiazol-2-yl]thio]ethanonemethoxybenzenes;
substituted aniline
00low000000
bibx 1382bssubstituted aniline00low000000
solabegroncarboxybiphenyl;
monochlorobenzenes;
secondary alcohol;
secondary amino compound;
substituted aniline
beta-adrenergic agonist00low000000
6-[[5-fluoro-2-(3,4,5-trimethoxyanilino)-4-pyrimidinyl]amino]-2,2-dimethyl-4H-pyrido[3,2-b][1,4]oxazin-3-onemethoxybenzenes;
substituted aniline
00low000000
cardiogenol cmethoxybenzenes;
substituted aniline
00low000000
bay94 9172(18)F radiopharmaceutical;
aromatic ether;
polyether;
secondary amino compound;
stilbenoid;
substituted aniline
radioactive imaging agent00low000000
N-[5-[2-(2-methoxyanilino)-4-thiazolyl]-4-methyl-2-thiazolyl]-2-methylpentanamidemethoxybenzenes;
substituted aniline
00low000000
N-[5-[2-(5-chloro-2-methoxyanilino)-4-thiazolyl]-4-methyl-2-thiazolyl]hexanamidemethoxybenzenes;
substituted aniline
00low000000
N-[5-[2-(3-methoxyanilino)-4-thiazolyl]-4-methyl-2-thiazolyl]-3-methylbutanamidemethoxybenzenes;
substituted aniline
00low000000
N-[5-[2-(2-methoxyanilino)-4-thiazolyl]-4-methyl-2-thiazolyl]heptanamidemethoxybenzenes;
substituted aniline
00low000000
N-[5-[2-(2-methoxyanilino)-4-thiazolyl]-4-methyl-2-thiazolyl]pentanamidemethoxybenzenes;
substituted aniline
00low000000
N-[5-[2-(3-methoxyanilino)-4-thiazolyl]-4-methyl-2-thiazolyl]heptanamidemethoxybenzenes;
substituted aniline
00low000000
zm323881aromatic ether;
benzyl ether;
fluorophenol;
halophenol;
monofluorobenzenes;
organic cation;
quinazolines;
secondary amino compound;
substituted aniline
vascular endothelial growth factor receptor antagonist00low000000
jsh 23diamine;
substituted aniline
NF-kappaB inhibitor00low000000
2-[[4-(5-chloro-2-methoxyanilino)-6-(1-piperidinyl)-1,3,5-triazin-2-yl]amino]ethanolmethoxybenzenes;
substituted aniline
00low000000
2-[[4-(2-methoxyanilino)-6-(1-pyrrolidinyl)-1,3,5-triazin-2-yl]amino]ethanolmethoxybenzenes;
substituted aniline
00low000000
2-[[4-(3-methoxyanilino)-6-(1-pyrrolidinyl)-1,3,5-triazin-2-yl]amino]ethanolmethoxybenzenes;
substituted aniline
00low000000
2-[[4-(4-methoxyanilino)-6-(1-pyrrolidinyl)-1,3,5-triazin-2-yl]amino]ethanolmethoxybenzenes;
substituted aniline
00low000000
4-[[4-(2-methoxyanilino)-6-(1-pyrrolidinyl)-1,3,5-triazin-2-yl]amino]-1-butanolmethoxybenzenes;
substituted aniline
00low000000
(5S)-1-heptyl-5-(2-methylpropyl)-N-phenyl-4,5-dihydroimidazol-2-aminesubstituted aniline00low000000
SL-327(trifluoromethyl)benzenes;
enamine;
nitrile;
organic sulfide;
primary amino compound;
substituted aniline
EC 2.7.12.2 (mitogen-activated protein kinase kinase) inhibitor;
neuroprotective agent
00low000000
poziotinibacrylamides;
aromatic ether;
dichlorobenzene;
diether;
monofluorobenzenes;
N-acylpiperidine;
quinazolines;
secondary amino compound;
substituted aniline
antineoplastic agent;
apoptosis inducer;
epidermal growth factor receptor antagonist
00low000000
GDC-0623hydroxamic acid ester;
imidazopyridine;
monofluorobenzenes;
organoiodine compound;
primary alcohol;
secondary amino compound;
substituted aniline
antineoplastic agent;
apoptosis inducer;
EC 2.7.12.2 (mitogen-activated protein kinase kinase) inhibitor
00low000000
ML355benzothiazoles;
monomethoxybenzene;
phenols;
secondary amino compound;
substituted aniline;
sulfonamide
EC 1.13.11.31 (arachidonate 12-lipoxygenase) inhibitor;
platelet aggregation inhibitor
00low000000
((5z)5-(1,3-benzodioxol-5-yl)methylene-2-phenylamino-3,5-dihydro-4h-imidazol-4-one)benzodioxoles;
imidazolone;
substituted aniline
autophagy inducer;
EC 2.7.11.22 (cyclin-dependent kinase) inhibitor;
EC 2.7.12.1 (dual-specificity kinase) inhibitor;
neuroprotective agent;
nootropic agent
00low000000
1-(3-methoxyphenyl)-2-[4-oxo-6-(trifluoromethyl)-1H-pyrimidin-2-yl]guanidinemethoxybenzenes;
substituted aniline
00low000000
2-(4-fluoroanilino)-6-methyl-5-(3-methylbutyl)-1H-pyrimidin-4-onesubstituted aniline00low000000
butoctamide succinatedicarboxylic acid monoester;
hemisuccinate;
secondary carboxamide
00low000000
cl 387785bromobenzenes;
quinazolines;
secondary carboxamide;
ynamide
antineoplastic agent;
EC 2.7.10.1 (receptor protein-tyrosine kinase) inhibitor;
epidermal growth factor receptor antagonist
00low000000
iodipamidebenzoic acids;
organoiodine compound;
secondary carboxamide
radioopaque medium00low000000
pilsicainideorganic heterobicyclic compound;
secondary carboxamide
anti-arrhythmia drug;
sodium channel blocker
00low000000
pj-34phenanthridines;
secondary carboxamide;
tertiary amino compound
angiogenesis inhibitor;
anti-inflammatory agent;
antiatherosclerotic agent;
antineoplastic agent;
apoptosis inducer;
cardioprotective agent;
EC 2.4.2.30 (NAD(+) ADP-ribosyltransferase) inhibitor;
neuroprotective agent
00low000000
opc 12759secondary carboxamide00low000000
suraminnaphthalenesulfonic acid;
phenylureas;
secondary carboxamide
angiogenesis inhibitor;
antinematodal drug;
antineoplastic agent;
apoptosis inhibitor;
EC 2.7.11.13 (protein kinase C) inhibitor;
GABA antagonist;
GABA-gated chloride channel antagonist;
purinergic receptor P2 antagonist;
ryanodine receptor agonist;
trypanocidal drug
1996201916.5low001010
2-[[3-(3,4-dimethoxyphenyl)-1-oxoprop-2-enyl]amino]benzoic acidamidobenzoic acid;
cinnamamides;
secondary carboxamide
00low000000
acedapsoneacetamides;
anilide;
secondary carboxamide;
sulfone
antimalarial;
antimicrobial drug
00low000000
salicylurateN-acylglycine;
secondary carboxamide
human xenobiotic metabolite;
uremic toxin
00low000000
monoacetyldapsoneacetamides;
anilide;
secondary carboxamide;
sulfone
00low000000
n-methylolacrylamidesecondary carboxamide00low000000
win 18446organochlorine compound;
secondary carboxamide
EC 1.2.1.3 [aldehyde dehydrogenase (NAD(+))] inhibitor00low000000
carboxinanilide fungicide;
anilide;
enamide;
organosulfur heterocyclic compound;
oxacycle;
secondary carboxamide
antifungal agrochemical;
EC 1.3.5.1 [succinate dehydrogenase (quinone)] inhibitor
00low000000
tromantadinesecondary carboxamide00low000000
aureothricindithiolopyrrolone antibiotic;
secondary carboxamide
angiogenesis inhibitor;
antibacterial agent;
bacterial metabolite;
EC 2.7.7.6 (RNA polymerase) inhibitor
00low000000
morphazinamidemorpholines;
pyrazines;
secondary carboxamide
00low000000
amperozidediarylmethane;
monofluorobenzenes;
N-alkylpiperazine;
secondary carboxamide;
ureas
anxiolytic drug;
dopamine uptake inhibitor;
geroprotector;
second generation antipsychotic;
serotonergic antagonist
00low000000
n-acetyltryptophanamideacetamides;
L-tryptophan derivative;
primary carboxamide;
secondary carboxamide
00low000000
gamma-glutamyltyrosinedicarboxylic acid;
dipeptide;
phenols;
primary amino compound;
secondary carboxamide
human metabolite00low000000
n-acetyldopamineacetamides;
catechols;
N-(fatty acyl)-dopamine;
secondary carboxamide
human urinary metabolite;
marine metabolite
00low000000
n-acetylcytidineacetamides;
cytidines;
secondary carboxamide
metabolite00low000000
florfenicolorganochlorine compound;
organofluorine compound;
secondary alcohol;
secondary carboxamide;
sulfone
antimicrobial agent00low000000
marimastathydroxamic acid;
secondary carboxamide
antineoplastic agent;
matrix metalloproteinase inhibitor
00low000000
n-(3-oxohexanoyl)-3-aminodihydro-2(3h)-furanoneN-acyl homoserine lactone;
secondary carboxamide
00low000000
benzyloxycarbonylphenylalanylphenylalanine diazomethyl ketonecarboxylic ester;
diazo compound;
L-phenylalanine derivative;
secondary carboxamide
cathepsin L (EC 3.4.22.15) inhibitor00low000000
yh 439aromatic amide;
isopropyl ester;
secondary carboxamide
00low000000
cyc 682nitrile;
nucleoside analogue;
secondary carboxamide
antimetabolite;
antineoplastic agent;
DNA synthesis inhibitor;
prodrug
00low000000
sceptrinpyrroles;
secondary carboxamide
00low000000
n(beta)-alanyldopaminecatechols;
primary amino compound;
secondary carboxamide
00low000000
monoacetylcadaverineacetamides;
N-substituted cadaverine;
primary amino compound;
secondary carboxamide
human metabolite00low000000
N-(1-phenylethyl)acetamideacetamides;
secondary carboxamide
00low000000
2,2,2-trifluoro-N-[2-(1H-indol-3-yl)ethyl]acetamideindoles;
secondary carboxamide;
trifluoroacetamide
00low000000
vibriobactin1,3-oxazoles;
secondary carboxamide
siderophore00low000000
bms 195614benzoic acids;
quinolines;
secondary carboxamide
retinoic acid receptor alpha antagonist00low000000
tempaceaminoxyls;
piperidinecarboxamide;
secondary carboxamide
radiation protective agent;
radical scavenger
00low000000
dimethyloxalylglycineglycine derivative;
methyl ester;
secondary carboxamide
EC 1.14.11.29 (hypoxia-inducible factor-proline dioxygenase) inhibitor;
neuroprotective agent
00low000000
3-methyl-2-[[oxo-(4-pentoxyphenyl)methyl]amino]butanoic acidsecondary carboxamide00low000000
cinromidecinnamamides;
secondary carboxamide
00low000000
4-[[2-furanyl(oxo)methyl]amino]benzoic acid propan-2-yl esteraromatic amide;
furans;
isopropyl ester;
secondary carboxamide
00low000000
2,2,2-trifluoro-N-(2-methyl-8-quinolinyl)acetamidequinolines;
secondary carboxamide;
trifluoroacetamide
00low000000
N-(3-carbamoyl-4,5,6,7-tetrahydro-1-benzothiophen-2-yl)-2-pyrazinecarboxamideprimary carboxamide;
pyrazines;
secondary carboxamide
00low000000
2-[[oxo(thiophen-2-yl)methyl]amino]-4,5,6,7-tetrahydro-1-benzothiophene-3-carboxylic acid propan-2-yl esteraromatic amide;
isopropyl ester;
secondary carboxamide;
thiophenes
00low000000
N-[1-[(4-chlorophenyl)methyl]-4-pyrazolyl]-2-pyrazinecarboxamidepyrazines;
secondary carboxamide
00low000000
4-[[(4-bromo-2-ethyl-3-pyrazolyl)-oxomethyl]amino]benzoic acid propan-2-yl esteraromatic amide;
isopropyl ester;
secondary carboxamide
00low000000
(2S)-2-[[(2-chlorophenyl)-oxomethyl]amino]-3-methylbutanoic acid (6-nitro-4H-1,3-benzodioxin-8-yl)methyl estersecondary carboxamide00low000000
N-[(2S)-1-(1H-benzimidazol-2-ylamino)-3-methyl-1-oxobutan-2-yl]-3,5-dimethoxybenzamidesecondary carboxamide00low000000
2-(2,4-dioxo-1H-pyrimidin-6-yl)-N-[2-(4-morpholinyl)ethyl]acetamidemorpholines;
pyrimidone;
secondary carboxamide;
tertiary amino compound
00low000000
N-[(4-chlorophenyl)methyl]-2-(2,4-dioxo-1H-pyrimidin-6-yl)acetamidemonochlorobenzenes;
pyrimidone;
secondary carboxamide
00low000000
N-[(2S)-1-(1H-benzimidazol-2-ylamino)-3-methyl-1-oxobutan-2-yl]-3-methylbenzamidesecondary carboxamide00low000000
2,2,2-trifluoro-N-(5-oxo-1-phenyl-4H-pyrazol-3-yl)acetamidepyrazoles;
secondary carboxamide;
trifluoroacetamide
00low000000
N-(2-anilino-2-oxoethyl)-2-methoxybenzamidesecondary carboxamide00low000000
N-[5-[(2,6-dichlorophenyl)methylthio]-1,3,4-thiadiazol-2-yl]-5-methyl-2-pyrazinecarboxamidepyrazines;
secondary carboxamide
00low000000
(2S)-3-methyl-2-[[(3-methylphenyl)-oxomethyl]amino]butanoic acid (4-oxo-2-pyrimido[2,1-b][1,3]benzothiazolyl)methyl estersecondary carboxamide00low000000
n-(1-oxyl-2,2,6,6-tetramethyl-4-piperidinyl)iodoacetamideaminoxyls;
organoiodine compound;
piperidinecarboxamide;
secondary carboxamide
radical scavenger;
spin label
00low000000
ANA-121-benzothiophenes;
caprolactams;
secondary carboxamide
antidepressant;
anxiolytic drug;
tropomyosin-related kinase B receptor antagonist
00low000000
N-([biphenyl]-2-yl)-3-cyclopentylpropanamidebiphenyls;
cyclopentanes;
secondary carboxamide
00low000000
bms 3870321,3-oxazoles;
1,3-thiazoles;
organic sulfide;
piperidinecarboxamide;
secondary carboxamide
angiogenesis inhibitor;
antineoplastic agent;
apoptosis inducer;
EC 2.7.11.22 (cyclin-dependent kinase) inhibitor
00low000000
sr 144528bridged compound;
monochlorobenzenes;
pyrazoles;
secondary carboxamide
CB2 receptor antagonist;
EC 2.3.1.26 (sterol O-acyltransferase) inhibitor
00low000000
N-[2-(cyclohexylamino)-2-oxo-1-thiophen-2-ylethyl]-2,2,2-trifluoro-N-(4-methylphenyl)acetamidesecondary carboxamide;
tertiary carboxamide;
thiophenes;
trifluoroacetamide
00low000000
ML162monochlorobenzenes;
monomethoxybenzene;
organochlorine compound;
secondary carboxamide;
tertiary carboxamide;
thiophenes
EC 1.11.1.9 (glutathione peroxidase) inhibitor;
ferroptosis inducer
00low000000
N-[3-(N-(2-chloro-1-oxoethyl)-4-nitroanilino)propyl]-2,2,2-trifluoroacetamideC-nitro compound;
secondary carboxamide;
tertiary carboxamide;
trifluoroacetamide
00low000000
2-[[2-(3,4-dimethoxyanilino)-2-oxoethyl]thio]-3-pyridinecarboxylic acid propan-2-yl esterdimethoxybenzene;
isopropyl ester;
secondary carboxamide
00low000000
fagaramidecinnamamides;
secondary carboxamide
00low000000
arachidonyl dopaminecatechols;
fatty amide;
N-(fatty acyl)-dopamine;
secondary carboxamide
00low000000
n-oleoyldopaminecatechols;
fatty amide;
N-(fatty acyl)-dopamine;
secondary carboxamide
TRPV1 agonist00low000000
tranilastamidobenzoic acid;
cinnamamides;
dimethoxybenzene;
secondary carboxamide
anti-allergic agent;
anti-asthmatic drug;
antineoplastic agent;
aryl hydrocarbon receptor agonist;
calcium channel blocker;
hepatoprotective agent;
nephroprotective agent
00low000000
arachidonyl-2-chloroethylamidefatty amide;
organochlorine compound;
secondary carboxamide;
synthetic cannabinoid
CB1 receptor agonist;
CB2 receptor agonist;
neuroprotective agent
00low000000
l796778benzenes;
C-nitro compound;
L-lysine derivative;
L-phenylalanine derivative;
methyl ester;
oligopeptide;
secondary carboxamide;
ureas
somatostatin receptor agonist00low000000
l803087benzenes;
fluoroindole;
guanidines;
L-arginine derivative;
methyl ester;
phenylindole;
secondary carboxamide
somatostatin receptor agonist00low000000
n-cinnamoyltyraminecinnamamides;
phenols;
secondary carboxamide
allelochemical;
antimicrobial agent;
phytoalexin;
platelet aggregation inhibitor
00low000000
ag-490catechols;
enamide;
monocarboxylic acid amide;
nitrile;
secondary carboxamide
anti-inflammatory agent;
antioxidant;
apoptosis inducer;
EC 2.7.10.2 (non-specific protein-tyrosine kinase) inhibitor;
geroprotector;
STAT3 inhibitor
00low000000
4-amylcinnamoylanthranilic acidamidobenzoic acid;
cinnamamides;
secondary carboxamide
EC 3.1.1.4 (phospholipase A2) inhibitor;
TRP channel blocker
00low000000
batimastathydroxamic acid;
L-phenylalanine derivative;
organic sulfide;
secondary carboxamide;
thiophenes;
triamide
angiogenesis inhibitor;
antineoplastic agent;
matrix metalloproteinase inhibitor
00low000000
pipercallosidinealkaloid;
benzodioxoles;
enamide;
secondary carboxamide
apoptosis inducer;
metabolite;
plant metabolite
00low000000
pederincyclic ketal;
diol;
oxanes;
polyketide;
secondary alcohol;
secondary carboxamide
antimitotic;
antineoplastic agent;
bacterial metabolite;
vesicant
00low000000
streptogramin a1,3-oxazoles;
cyclic ketone;
enamide;
lactam;
macrolide antibiotic;
macrolide;
pyrroline;
secondary alcohol;
secondary carboxamide;
tertiary carboxamide
antibacterial drug;
Mycoplasma genitalium metabolite
00low000000
cinanserinaryl sulfide;
cinnamamides;
secondary carboxamide;
tertiary amino compound
anticoronaviral agent;
antiviral agent;
EC 3.4.22.69 (SARS coronavirus main proteinase) inhibitor
00low000000
pepstatinpentapeptide;
secondary carboxamide
bacterial metabolite;
EC 3.4.23.* (aspartic endopeptidase) inhibitor
00low000000
ximelagatranamidoxime;
azetidines;
carboxamide;
ethyl ester;
hydroxylamines;
secondary amino compound;
secondary carboxamide;
tertiary carboxamide
anticoagulant;
EC 3.4.21.5 (thrombin) inhibitor;
prodrug;
serine protease inhibitor
00low000000
(6R,7R)-7-[[(2R)-2-carboxy-2-(4-hydroxyphenyl)-1-oxoethyl]amino]-7-methoxy-3-[[(1-methyl-5-tetrazolyl)thio]methyl]-8-oxo-5-oxa-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic aciddicarboxylic acid;
secondary carboxamide
00low000000
salubrinalaminal;
organochlorine compound;
quinolines;
secondary carboxamide;
thioureas
00low000000
DPI2benzenes;
morpholines;
secondary carboxamide;
tertiary amino compound;
thiazolidinone
ferroptosis inducer00low000000
su 1498enamide;
monocarboxylic acid amide;
nitrile;
phenols;
secondary carboxamide
vascular endothelial growth factor receptor antagonist00low000000
n-feruloylserotoninaromatic ether;
cinnamamides;
hydroxyindoles;
phenols;
secondary carboxamide
plant metabolite00low000000
oroidinpyrroles;
secondary carboxamide
metabolite00low000000
ro 42-5892cyclopropanes;
diol;
L-histidine derivative;
secondary carboxamide;
sulfone
antihypertensive agent;
EC 3.4.23.15 (renin) inhibitor;
peptidomimetic;
vasodilator agent
00low000000
s 10061,3-thiazoles;
carbamate ester;
carboxylic acid;
cephalosporin;
enamide;
secondary carboxamide
antibacterial drug00low000000
manumycinenamide;
epoxide;
organic heterobicyclic compound;
polyketide;
secondary carboxamide;
tertiary alcohol
antiatherosclerotic agent;
antimicrobial agent;
antineoplastic agent;
apoptosis inducer;
bacterial metabolite;
EC 1.8.1.9 (thioredoxin reductase) inhibitor;
EC 2.5.1.58 (protein farnesyltransferase) inhibitor;
marine metabolite
00low000000
asukamycinenamide;
epoxide;
organic heterobicyclic compound;
polyketide;
secondary carboxamide;
tertiary alcohol
antibacterial agent;
antifungal agent;
antimicrobial agent;
antineoplastic agent;
bacterial metabolite
00low000000
kalimantacin aalpha,beta-unsaturated monocarboxylic acid;
carbamate ester;
fatty acid derivative;
secondary carboxamide
antibacterial agent;
antimicrobial agent;
bacterial metabolite
00low000000
l 744832benzenes;
ether;
isopropyl ester;
secondary carboxamide;
sulfone;
thiol
antineoplastic agent;
EC 2.5.1.58 (protein farnesyltransferase) inhibitor;
geroprotector
00low000000
l 779976benzimidazoles;
indoles;
piperidinecarboxamide;
primary amino compound;
secondary carboxamide
neuroprotective agent;
somatostatin receptor agonist
00low000000
ustiloxin baromatic ether;
heterodetic cyclic peptide;
macrocycle;
phenols;
secondary alcohol;
secondary carboxamide;
sulfoxide
Aspergillus metabolite;
microtubule-destabilising agent;
mycotoxin
00low000000
dysidenin1,3-thiazoles;
organochlorine compound;
secondary carboxamide;
tertiary carboxamide
animal metabolite;
marine metabolite;
toxin
00low000000
avenanthramide bamidobenzoic acid;
cinnamamides;
monohydroxybenzoic acid;
monomethoxybenzene;
phenols;
secondary carboxamide
antineoplastic agent;
apoptosis inducer;
phytoalexin
00low000000
bibw 2992aromatic ether;
enamide;
furans;
monochlorobenzenes;
organofluorine compound;
quinazolines;
secondary carboxamide;
tertiary amino compound
antineoplastic agent;
tyrosine kinase inhibitor
00low000000
fr 900848cyclopropanes;
nucleoside analogue;
olefinic compound;
polyketide;
secondary carboxamide
antifungal agent;
bacterial metabolite
00low000000
pha 665752dichlorobenzene;
enamide;
indolones;
N-acylpyrrolidine;
pyrrolecarboxamide;
secondary carboxamide;
sulfone;
tertiary carboxamide
antineoplastic agent;
c-Met tyrosine kinase inhibitor
00low000000
n-benzylhexadecanamidemacamide;
secondary carboxamide
EC 3.5.1.99 (fatty acid amide hydrolase) inhibitor;
neuroprotective agent;
plant metabolite
00low000000
cenicrivirocaromatic ether;
benzazocine;
diether;
imidazoles;
secondary carboxamide;
sulfoxide
anti-HIV agent;
anti-inflammatory agent;
antirheumatic drug;
chemokine receptor 2 antagonist;
chemokine receptor 5 antagonist
00low000000
at 7519dichlorobenzene;
piperidines;
pyrazoles;
secondary carboxamide
antineoplastic agent;
EC 2.7.11.22 (cyclin-dependent kinase) inhibitor
00low000000
azd 1152anilide;
monoalkyl phosphate;
monofluorobenzenes;
pyrazoles;
quinazolines;
secondary amino compound;
secondary carboxamide;
tertiary amino compound
antineoplastic agent;
Aurora kinase inhibitor;
prodrug
00low000000
pf 00299804enamide;
monochlorobenzenes;
monofluorobenzenes;
piperidines;
quinazolines;
secondary amino compound;
secondary carboxamide;
tertiary amino compound
antineoplastic agent;
epidermal growth factor receptor antagonist
00low000000
MI-63azaspiro compound;
monochlorobenzenes;
monofluorobenzenes;
morpholines;
oxindoles;
pyrrolidines;
secondary carboxamide
apoptosis inducer00low000000
PF-00835231aromatic ether;
indolecarboxamide;
L-leucine derivative;
primary alcohol;
pyrrolidin-2-ones;
secondary carboxamide
anticoronaviral agent;
drug metabolite;
EC 3.4.22.69 (SARS coronavirus main proteinase) inhibitor
00low000000
VPC 23019aromatic amide;
D-serine derivative;
organic phosphate;
phosphoric ester;
secondary carboxamide
sphingosine-1-phosphate receptor 1 antagonist;
sphingosine-1-phosphate receptor 3 antagonist
00low000000
pd 0348292monochlorobenzenes;
monofluorobenzenes;
pyridone;
pyrrolidines;
secondary carboxamide;
ureas
anticoagulant;
EC 3.4.21.6 (coagulation factor Xa) inhibitor;
serine protease inhibitor
00low000000
narlaprevirazabicyclohexane;
cyclopropanes;
pyrrolidinecarboxamide;
secondary carboxamide;
sulfone;
tertiary carboxamide;
ureas
anticoronaviral agent;
antiviral drug;
EC 3.4.22.69 (SARS coronavirus main proteinase) inhibitor;
hepatitis C protease inhibitor
00low000000
tosedostatcarboxylic ester;
hydroxamic acid;
secondary carboxamide
00low000000
4-chloro-N-[1-[[5-(ethylthio)-1,3,4-thiadiazol-2-yl]amino]-3-methyl-1-oxobutan-2-yl]benzamidesecondary carboxamide00low000000
azd 1152-hqpaanilide;
monofluorobenzenes;
primary alcohol;
pyrazoles;
quinazolines;
secondary amino compound;
secondary carboxamide;
tertiary amino compound
antineoplastic agent;
Aurora kinase inhibitor
00low000000
CDN1163aromatic ether;
quinolines;
secondary carboxamide
SERCA activator00low000000
(2S)-2-[[[5-[[5-[[(2-methylpropan-2-yl)oxy-oxomethyl]amino]pentylamino]-oxomethyl]-1H-imidazol-4-yl]-oxomethyl]amino]propanoic acid tert-butyl estersecondary carboxamide;
tert-butyl ester
00low000000
(2S)-2-[[[5-[[methyl-(phenylmethyl)amino]-oxomethyl]-1H-imidazol-4-yl]-oxomethyl]amino]-6-[[(2-methylpropan-2-yl)oxy-oxomethyl]amino]hexanoic acid tert-butyl estersecondary carboxamide;
tert-butyl ester;
tertiary carboxamide
00low000000
(2S,3S,4R)-4-cyclopropyl-2-ethoxy-3-(3-hydroxypropyl)-N-prop-2-ynyl-3,4-dihydro-2H-pyran-6-carboxamidesecondary carboxamide00low000000
sid 26681509carbohydrazide;
L-tryptophan derivative;
secondary carboxamide;
tert-butyl ester;
thioester
antiplasmodial drug;
cathepsin L (EC 3.4.22.15) inhibitor
00low000000
sm 164benzenes;
organic heterobicyclic compound;
secondary carboxamide;
triazoles
antineoplastic agent;
apoptosis inducer;
radiosensitizing agent
00low000000
cx 5461diazepine;
naphthyridine derivative;
organic heterotetracyclic compound;
pyrazines;
secondary carboxamide
antineoplastic agent;
apoptosis inducer;
EC 2.7.7.6 (RNA polymerase) inhibitor
00low000000
monepantel(trifluoromethyl)benzenes;
aromatic ether;
aryl sulfide;
nitrile;
secondary carboxamide
anthelminthic drug;
nematicide
00low000000
EG00229benzothiadiazole;
dicarboxylic acid monoamide;
L-arginine derivative;
secondary carboxamide;
sulfonamide;
thiophenes
angiogenesis inhibitor;
antineoplastic agent;
neuropilin receptor antagonist
00low000000
tak-632(trifluoromethyl)benzenes;
aromatic ether;
benzothiazoles;
cyclopropylcarboxamide;
monofluorobenzenes;
nitrile;
secondary carboxamide
antineoplastic agent;
apoptosis inducer;
B-Raf inhibitor;
EC 2.7.11.26 (tau-protein kinase) inhibitor;
necroptosis inhibitor
00low000000
gsk-5498a(trifluoromethyl)benzenes;
difluorobenzene;
pyrazoles;
secondary carboxamide
calcium channel blocker00low000000
2-methoxy-N-[3-[4-[3-methyl-4-[(6-methyl-3-pyridinyl)oxy]anilino]-6-quinazolinyl]prop-2-enyl]acetamidearomatic ether;
methylpyridines;
olefinic compound;
quinazolines;
secondary amino compound;
secondary carboxamide;
toluenes
00low000000
raltegravir1,2,4-oxadiazole;
dicarboxylic acid amide;
hydroxypyrimidine;
monofluorobenzenes;
pyrimidone;
secondary carboxamide
antiviral drug;
HIV-1 integrase inhibitor
00low000000
lfm a13aromatic amide;
dibromobenzene;
enamide;
enol;
nitrile;
secondary carboxamide
antineoplastic agent;
apoptosis inducer;
EC 2.7.10.2 (non-specific protein-tyrosine kinase) inhibitor;
EC 2.7.11.21 (polo kinase) inhibitor;
geroprotector;
platelet aggregation inhibitor
00low000000
teriflunomide(trifluoromethyl)benzenes;
aromatic amide;
enamide;
enol;
nitrile;
secondary carboxamide
drug metabolite;
EC 1.3.98.1 [dihydroorotate oxidase (fumarate)] inhibitor;
hepatotoxic agent;
non-steroidal anti-inflammatory drug;
tyrosine kinase inhibitor
00low000000
gsk1265744difluorobenzene;
monocarboxylic acid amide;
organic heterotricyclic compound;
secondary carboxamide
HIV-1 integrase inhibitor00low000000
dolutegravirdifluorobenzene;
monocarboxylic acid amide;
organic heterotricyclic compound;
secondary carboxamide
HIV-1 integrase inhibitor00low000000
LimKi 31,3-thiazoles;
dichlorobenzene;
organofluorine compound;
pyrazoles;
secondary carboxamide
LIM kinase inhibitor00low000000
gsk343aminopyridine;
indazoles;
N-alkylpiperazine;
N-arylpiperazine;
pyridone;
secondary carboxamide
antineoplastic agent;
apoptosis inducer;
EC 2.1.1.43 (enhancer of zeste homolog 2) inhibitor
00low000000
ivosidenibcyanopyridine;
monochlorobenzenes;
organofluorine compound;
pyrrolidin-2-ones;
secondary carboxamide;
tertiary carboxamide
antineoplastic agent;
EC 1.1.1.42 (isocitrate dehydrogenase) inhibitor
00low000000
atogepantazaspiro compound;
organic heterotetracyclic compound;
piperidones;
secondary carboxamide;
trifluorobenzene
calcitonin gene-related peptide receptor antagonist00low000000
bictegravirmonocarboxylic acid amide;
organic heterotetracyclic compound;
secondary carboxamide;
trifluorobenzene
HIV-1 integrase inhibitor00low000000
AZ3451benzimidazoles;
benzodioxoles;
nitrile;
organobromine compound;
secondary carboxamide
anti-inflammatory agent;
autophagy inducer;
PAR2 negative allosteric modulator
00low000000
MMP-9-IN-1aromatic compound;
organic sulfide;
organofluorine compound;
pyrimidone;
secondary carboxamide
antineoplastic agent;
EC 3.4.24.35 (gelatinase B) inhibitor
00low000000
althiomycin1,3-thiazoles;
aldoxime;
ether;
gamma-lactam;
pentapeptide;
peptide antibiotic;
primary alcohol;
pyrroline;
secondary carboxamide;
tertiary carboxamide
antibacterial agent;
bacterial metabolite;
protein synthesis inhibitor
00low000000
colibactin1,3-thiazoles;
azaspiro compound;
polyketide;
pyrroline;
secondary carboxamide
alkylating agent;
carcinogenic agent;
Escherichia coli metabolite;
genotoxin
00low000000
N-[(2S)-3-cyclohexyl-1-oxo-1-({(2S)-1-oxo-3-[(3S)-2-oxopyrrolidin-3-yl]propan-2-yl}amino)propan-2-yl]-1H-indole-2-carboxamidealdehyde;
indolecarboxamide;
oligopeptide;
pyrrolidin-2-ones;
secondary carboxamide
anticoronaviral agent;
EC 3.4.22.69 (SARS coronavirus main proteinase) inhibitor
00low000000
3-fluoro-Nalpha-(1H-indol-2-ylcarbonyl)-N-{(2S)-1-oxo-3-[(3S)-2-oxopyrrolidin-3-yl]propan-2-yl}-L-phenylalaninamidealdehyde;
indolecarboxamide;
monofluorobenzenes;
oligopeptide;
pyrrolidin-2-ones;
secondary carboxamide
anticoronaviral agent;
EC 3.4.22.69 (SARS coronavirus main proteinase) inhibitor
00low000000
PF-07304814aromatic ether;
indolecarboxamide;
L-leucine derivative;
phosphate monoester;
pyrrolidin-2-ones;
secondary carboxamide
anticoronaviral agent;
EC 3.4.22.69 (SARS coronavirus main proteinase) inhibitor;
prodrug
00low000000
nirmatrelvirazabicyclohexane;
nitrile;
organofluorine compound;
pyrrolidin-2-ones;
pyrrolidinecarboxamide;
secondary carboxamide;
tertiary carboxamide
anticoronaviral agent;
EC 3.4.22.69 (SARS coronavirus main proteinase) inhibitor
00low000000
bupropionaromatic ketone;
monochlorobenzenes;
secondary amino compound
antidepressant;
environmental contaminant;
xenobiotic
00low000000
sk&f-38393benzazepine;
catechols;
secondary amino compound
00low000000
monomethylpropionaromatic ketone;
secondary amino compound
00low000000
acebutololaromatic amide;
ethanolamines;
ether;
monocarboxylic acid amide;
propanolamine;
secondary amino compound
anti-arrhythmia drug;
antihypertensive agent;
beta-adrenergic antagonist;
sympathomimetic agent
00low000000
albuterolphenols;
phenylethanolamines;
secondary amino compound
beta-adrenergic agonist;
bronchodilator agent;
environmental contaminant;
xenobiotic
1995201219.6low101310
alprenololsecondary alcohol;
secondary amino compound
anti-arrhythmia drug;
antihypertensive agent;
beta-adrenergic antagonist;
sympatholytic agent
1992199232.0low001000
amodiaquineaminoquinoline;
organochlorine compound;
phenols;
secondary amino compound;
tertiary amino compound
anticoronaviral agent;
antimalarial;
drug allergen;
EC 2.1.1.8 (histamine N-methyltransferase) inhibitor;
non-steroidal anti-inflammatory drug;
prodrug
1991201916.0low001120
benzylhydrochlorothiazidebenzenes;
benzothiadiazine;
organochlorine compound;
secondary amino compound;
sulfonamide
00low000000
betahistineaminoalkylpyridine;
secondary amino compound
H1-receptor agonist;
vasodilator agent
00low000000
carvedilolcarbazoles;
secondary alcohol;
secondary amino compound
alpha-adrenergic antagonist;
antihypertensive agent;
beta-adrenergic antagonist;
cardiovascular drug;
vasodilator agent
1992202119.0low007631
cgp 12177aromatic ether;
benzimidazoles;
secondary alcohol;
secondary amino compound
beta-adrenergic antagonist00low000000
chloroquineaminoquinoline;
organochlorine compound;
secondary amino compound;
tertiary amino compound
anticoronaviral agent;
antimalarial;
antirheumatic drug;
autophagy inhibitor;
dermatologic drug
1986202223.1low032111
clorprenalineethanolamines;
monochlorobenzenes;
secondary amino compound
00low000000
desipraminedibenzoazepine;
secondary amino compound
adrenergic uptake inhibitor;
alpha-adrenergic antagonist;
antidepressant;
cholinergic antagonist;
drug allergen;
EC 3.1.4.12 (sphingomyelin phosphodiesterase) inhibitor;
EC 3.4.21.26 (prolyl oligopeptidase) inhibitor;
H1-receptor antagonist;
serotonin uptake inhibitor
2008200816.0low000100
diclofenacamino acid;
aromatic amine;
dichlorobenzene;
monocarboxylic acid;
secondary amino compound
antipyretic;
drug allergen;
EC 1.14.99.1 (prostaglandin-endoperoxide synthase) inhibitor;
environmental contaminant;
non-narcotic analgesic;
non-steroidal anti-inflammatory drug;
xenobiotic
1990202315.9low0051192
fenfluramine(trifluoromethyl)benzenes;
secondary amino compound
appetite depressant;
serotonergic agonist;
serotonin uptake inhibitor
00low000000
berotekresorcinols;
secondary alcohol;
secondary amino compound
beta-adrenergic agonist;
bronchodilator agent;
sympathomimetic agent;
tocolytic agent
00low000000
fluoxetine(trifluoromethyl)benzenes;
aromatic ether;
secondary amino compound
2008201910.0low000140
formoterol fumarateformamides;
phenols;
phenylethanolamines;
secondary alcohol;
secondary amino compound
00low000000
glafenineaminoquinoline;
carboxylic ester;
glycol;
organochlorine compound;
secondary amino compound
inhibitor;
non-narcotic analgesic;
non-steroidal anti-inflammatory drug
00low000000
guazatinealiphatic nitrogen antifungal agent;
guanidines;
secondary amino compound
antifungal agrochemical00low000000
guvacinealpha,beta-unsaturated monocarboxylic acid;
beta-amino acid;
pyridine alkaloid;
secondary amino compound;
tetrahydropyridine
GABA reuptake inhibitor;
plant metabolite
00low000000
N-[2-(4-bromocinnamylamino)ethyl]isoquinoline-5-sulfonamidebromobenzenes;
isoquinolines;
olefinic compound;
secondary amino compound;
sulfonamide
EC 2.7.11.11 (cAMP-dependent protein kinase) inhibitor00low000000
hydroxychloroquineaminoquinoline;
organochlorine compound;
primary alcohol;
secondary amino compound;
tertiary amino compound
anticoronaviral agent;
antimalarial;
antirheumatic drug;
dermatologic drug
201520159.0low000010
isoproterenolcatechols;
secondary alcohol;
secondary amino compound
beta-adrenergic agonist;
bronchodilator agent;
cardiotonic drug;
sympathomimetic agent
1986202320.8low023641
ketaminecyclohexanones;
monochlorobenzenes;
secondary amino compound
analgesic;
environmental contaminant;
intravenous anaesthetic;
neurotoxin;
NMDA receptor antagonist;
xenobiotic
1983202114.0low011351
meclofenamic acidaminobenzoic acid;
organochlorine compound;
secondary amino compound
analgesic;
anticonvulsant;
antineoplastic agent;
antipyretic;
antirheumatic drug;
EC 1.13.11.34 (arachidonate 5-lipoxygenase) inhibitor;
EC 1.14.99.1 (prostaglandin-endoperoxide synthase) inhibitor;
non-steroidal anti-inflammatory drug
1992199530.5low002000
mefenamic acidaminobenzoic acid;
secondary amino compound
analgesic;
antipyretic;
antirheumatic drug;
EC 1.14.99.1 (prostaglandin-endoperoxide synthase) inhibitor;
environmental contaminant;
non-steroidal anti-inflammatory drug;
xenobiotic
201920195.0low000010
metaproterenolaralkylamino compound;
phenylethanolamines;
resorcinols;
secondary alcohol;
secondary amino compound
00low000000
metoprololaromatic ether;
propanolamine;
secondary alcohol;
secondary amino compound
antihypertensive agent;
beta-adrenergic antagonist;
environmental contaminant;
geroprotector;
xenobiotic
1996202217.6low102201
n(1), n(12)-diethylsperminepolyazaalkane;
secondary amino compound;
substituted spermine;
tetramine
antineoplastic agent00low000000
fenamic acidaminobenzoic acid;
secondary amino compound
membrane transport modulator00low000000
nisoxetinearomatic ether;
secondary amino compound
adrenergic uptake inhibitor;
antidepressant
00low000000
oxamniquinearomatic primary alcohol;
C-nitro compound;
quinolines;
secondary amino compound
00low000000
pd 153035aromatic amine;
aromatic ether;
bromobenzenes;
quinazolines;
secondary amino compound
EC 2.7.10.1 (receptor protein-tyrosine kinase) inhibitor;
epidermal growth factor receptor antagonist
00low000000
pd 158780aromatic amine;
bromobenzenes;
diamine;
pyridopyrimidine;
secondary amino compound
antineoplastic agent;
EC 2.7.10.1 (receptor protein-tyrosine kinase) inhibitor
00low000000
practololacetamides;
ethanolamines;
propanolamine;
secondary alcohol;
secondary amino compound
anti-arrhythmia drug;
beta-adrenergic antagonist
00low000000
propafenonearomatic ketone;
secondary alcohol;
secondary amino compound
anti-arrhythmia drug00low000000
salmeterol xinafoateether;
phenols;
primary alcohol;
secondary alcohol;
secondary amino compound
00low000000
sotalolethanolamines;
secondary alcohol;
secondary amino compound;
sulfonamide
anti-arrhythmia drug;
beta-adrenergic antagonist;
environmental contaminant;
xenobiotic
201920195.0low000010
tetrahydropapaverinearomatic ether;
benzylisoquinoline alkaloid;
benzyltetrahydroisoquinoline;
polyether;
secondary amino compound
00low000000
wb 4101aromatic ether;
benzodioxine;
secondary amino compound
alpha-adrenergic antagonist00low000000
xylazine1,3-thiazine;
methylbenzene;
secondary amino compound
alpha-adrenergic agonist;
analgesic;
emetic;
muscle relaxant;
sedative
1996201021.0low001100
phenylephrinephenols;
phenylethanolamines;
secondary amino compound
alpha-adrenergic agonist;
cardiotonic drug;
mydriatic agent;
nasal decongestant;
protective agent;
sympathomimetic agent;
vasoconstrictor agent
1983201924.7low047920
n,n'-diphenyl-4-phenylenediamineN-substituted diamine;
secondary amino compound
antioxidant00low000000
pseudoephedrinephenylethanolamines;
secondary alcohol;
secondary amino compound
anti-asthmatic drug;
bronchodilator agent;
central nervous system drug;
nasal decongestant;
plant metabolite;
sympathomimetic agent;
vasoconstrictor agent;
xenobiotic
00low000000
dyrenemonochlorobenzenes;
organochlorine pesticide;
secondary amino compound;
triazines
antifungal agrochemical00low000000
propylhexedrinesecondary amino compound00low000000
4-aminodiphenylaminearomatic amine;
secondary amino compound
allergen00low000000
cyclopentaminesecondary amino compound00low000000
diisopropanolamineaminodiol;
secondary alcohol;
secondary amino compound
buffer;
emulsifier;
surfactant
00low000000
megluminehexosamine;
secondary amino compound
201820186.0low000010
cytisinealkaloid;
bridged compound;
lactam;
organic heterotricyclic compound;
secondary amino compound
nicotinic acetylcholine receptor agonist;
phytotoxin;
plant metabolite
00low000000
octamylaminesecondary amino compound00low000000
noramidopyrinepyrazoles;
secondary amino compound
antipyretic;
drug metabolite;
EC 1.14.99.1 (prostaglandin-endoperoxide synthase) inhibitor;
non-narcotic analgesic;
non-steroidal anti-inflammatory drug;
opioid analgesic;
peripheral nervous system drug
00low000000
diphenylaminearomatic amine;
bridged diphenyl fungicide;
secondary amino compound
antifungal agrochemical;
antioxidant;
carotogenesis inhibitor;
EC 1.3.99.29 [phytoene desaturase (zeta-carotene-forming)] inhibitor;
ferroptosis inhibitor;
radical scavenger
2005200718.0low000200
spectinomycincyclic acetal;
cyclic hemiketal;
cyclic ketone;
pyranobenzodioxin;
secondary alcohol;
secondary amino compound
antibacterial drug;
antimicrobial agent;
bacterial metabolite
00low000000
isometheptenesecondary amino compound00low000000
n-methylaspartateamino dicarboxylic acid;
D-alpha-amino acid;
D-aspartic acid derivative;
secondary amino compound
neurotransmitter agent1996201615.2low001230
colterolcatechols;
ethanolamines;
secondary alcohol;
secondary amino compound;
triol
anti-asthmatic drug;
beta-adrenergic agonist;
bronchodilator agent
00low000000
acridine half-mustardaminoacridines;
aromatic ether;
organochlorine compound;
secondary amino compound
mutagen00low000000
metipranololacetate ester;
aromatic ether;
propanolamine;
secondary amino compound
anti-arrhythmia drug;
antiglaucoma drug;
antihypertensive agent;
beta-adrenergic antagonist
00low000000
du-21220benzyl alcohols;
polyphenol;
secondary alcohol;
secondary amino compound
00low000000
amoscanateC-nitro compound;
isothiocyanate;
secondary amino compound
schistosomicide drug00low000000
norflurazone(trifluoromethyl)benzenes;
organochlorine compound;
pyridazinone;
secondary amino compound
agrochemical;
carotenoid biosynthesis inhibitor;
herbicide
00low000000
amineptinamino acid;
carbocyclic fatty acid;
carbotricyclic compound;
secondary amino compound
antidepressant;
dopamine uptake inhibitor
00low000000
bitolterolcarboxylic ester;
diester;
ethanolamines;
secondary alcohol;
secondary amino compound
anti-asthmatic drug;
beta-adrenergic agonist;
bronchodilator agent;
prodrug
00low000000
torsemideaminopyridine;
N-sulfonylurea;
secondary amino compound
antihypertensive agent;
loop diuretic
202220222.0low000001
bopindololaromatic ether;
benzoate ester;
methylindole;
secondary amino compound
00low000000
atomoxetinearomatic ether;
secondary amino compound;
toluenes
adrenergic uptake inhibitor;
antidepressant;
environmental contaminant;
xenobiotic
00low000000
ractopaminebenzyl alcohols;
polyphenol;
secondary alcohol;
secondary amino compound
00low000000
esmololaromatic ether;
ethanolamines;
methyl ester;
secondary alcohol;
secondary amino compound
00low000000
temafloxacinamino acid;
monocarboxylic acid;
N-arylpiperazine;
organofluorine compound;
quinolone antibiotic;
quinolone;
secondary amino compound;
tertiary amino compound
00low000000
plerixaforazacycloalkane;
azamacrocycle;
benzenes;
crown amine;
secondary amino compound;
tertiary amino compound
anti-HIV agent;
antineoplastic agent;
C-X-C chemokine receptor type 4 antagonist;
immunological adjuvant
00low000000
sertralinedichlorobenzene;
secondary amino compound;
tetralins
antidepressant;
serotonin uptake inhibitor
201920195.0low000010
nebivololchromanes;
diol;
organofluorine compound;
secondary alcohol;
secondary amino compound
00low000000
aceclofenacamino acid;
carboxylic ester;
dichlorobenzene;
monocarboxylic acid;
secondary amino compound
EC 1.14.99.1 (prostaglandin-endoperoxide synthase) inhibitor;
non-narcotic analgesic;
non-steroidal anti-inflammatory drug
00low000000
tubulosinebeta-carbolines;
isoquinoline alkaloid;
isoquinolines;
phenols;
secondary amino compound;
tertiary amino compound
00low000000
2-(methylamino)isobutyric acidalanine derivative;
alpha-amino acid zwitterion;
non-proteinogenic alpha-amino acid;
secondary amino compound
human urinary metabolite00low000000
caldopentaminepolyazaalkane;
primary amino compound;
secondary amino compound
marine metabolite00low000000
fluazinam(trifluoromethyl)benzenes;
aminopyridine;
C-nitro compound;
chloropyridine;
monochlorobenzenes;
secondary amino compound
allergen;
antifungal agrochemical;
apoptosis inducer;
environmental contaminant;
xenobiotic
00low000000
2-(3,4-dimethoxyphenyl)-5-amino-2-isopropylvaleronitriledimethoxybenzene;
nitrile;
secondary amino compound
drug metabolite;
marine xenobiotic metabolite
00low000000
phenylisopropyladenosinearomatic amine;
benzenes;
hydrocarbyladenosine;
purine nucleoside;
secondary amino compound
adenosine A1 receptor agonist;
neuroprotective agent
00low000000
p-methoxy-n-methylphenethylaminearomatic ether;
secondary amino compound
metabolite1996201419.1low003820
norverapamilaromatic ether;
nitrile;
polyether;
secondary amino compound
00low000000
3,4-methylenedioxyethamphetaminebenzodioxoles;
secondary amino compound
00low000000
beta-n-methylamino-l-alaninediamino acid;
L-alanine derivative;
non-proteinogenic L-alpha-amino acid;
secondary amino compound
bacterial metabolite;
neurotoxin
00low000000
nopalineamino acid opine;
D-glutamic acid derivative;
guanidines;
L-arginine derivative;
secondary amino compound;
tricarboxylic acid
00low000000
octopineamino acid opine;
amino dicarboxylic acid;
D-alpha-amino acid zwitterion;
D-arginine derivative;
guanidines;
secondary amino compound
animal metabolite;
xenobiotic metabolite
00low000000
tafenoquine(trifluoromethyl)benzenes;
aminoquinoline;
aromatic ether;
primary amino compound;
secondary amino compound
00low000000
4'-hydroxydiclofenacdichlorobenzene;
monocarboxylic acid;
phenols;
secondary amino compound
allergen;
drug metabolite
00low000000
ym 12617aromatic ether;
secondary amino compound;
sulfonamide
00low000000
mannopineamino acid opine;
dicarboxylic acid monoamide;
hexitol derivative;
L-glutamine derivative;
non-proteinogenic L-alpha-amino acid;
secondary amino compound
plant metabolite00low000000
aj 76secondary amino compound;
tetralins
dopaminergic antagonist00low000000
gefitinibaromatic ether;
monochlorobenzenes;
monofluorobenzenes;
morpholines;
quinazolines;
secondary amino compound;
tertiary amino compound
antineoplastic agent;
epidermal growth factor receptor antagonist
00low000000
nsc 2240701,4-benzoquinones;
aziridines;
enamine;
primary alcohol;
secondary amino compound
alkylating agent;
antineoplastic agent
00low000000
als 8123carboxylic acid;
ethanolamines;
secondary amino compound
00low000000
7-nitrobenzoxadiazole-6-aminohexanoic acidbenzoxadiazole;
C-nitro compound;
epsilon-amino acid;
secondary amino compound
fluorochrome00low000000
5,5,7,12,12,14-hexamethyl-1,4,8,11-tetrazacyclotetradecanesecondary amino compound00low000000
cox 189amino acid;
monocarboxylic acid;
organochlorine compound;
organofluorine compound;
secondary amino compound
cyclooxygenase 2 inhibitor;
non-steroidal anti-inflammatory drug
00low000000
cinacalcet(trifluoromethyl)benzenes;
naphthalenes;
secondary amino compound
calcimimetic;
P450 inhibitor
2013201311.0low000010
guvacolinealpha,beta-unsaturated carboxylic ester;
beta-amino acid ester;
enoate ester;
methyl ester;
pyridine alkaloid;
secondary amino compound;
tetrahydropyridine
muscarinic agonist;
plant metabolite
00low000000
actinodaphineaporphine alkaloid;
aromatic ether;
organic heteropentacyclic compound;
phenols;
secondary amino compound
antibacterial agent;
antifungal agent;
antineoplastic agent;
apoptosis inducer;
plant metabolite;
platelet aggregation inhibitor;
topoisomerase inhibitor
00low000000
baeocystinorganic phosphate;
secondary amino compound;
tryptamine alkaloid
fungal metabolite;
hallucinogen
00low000000
erlotinibaromatic ether;
quinazolines;
secondary amino compound;
terminal acetylenic compound
antineoplastic agent;
epidermal growth factor receptor antagonist;
protein kinase inhibitor
00low000000
dizocilpinesecondary amino compound;
tetracyclic antidepressant
anaesthetic;
anticonvulsant;
neuroprotective agent;
nicotinic antagonist;
NMDA receptor antagonist
00low000000
melagatranazetidines;
carboxamidine;
dicarboxylic acid monoamide;
non-proteinogenic alpha-amino acid;
secondary amino compound
anticoagulant;
EC 3.4.21.5 (thrombin) inhibitor;
serine protease inhibitor
00low000000
alpha-putrescinylthymineN-substituted putrescine;
pyrimidine nucleobase;
pyrimidone;
secondary amino compound;
tertiary amino compound
00low000000
2-(4-morpholinoanilino)-6-cyclohexylaminopurinemorpholines;
purines;
secondary amino compound;
tertiary amino compound
adenosine A3 receptor antagonist;
antineoplastic agent;
Aurora kinase inhibitor;
cell dedifferentiation agent
00low000000
demecolcinealkaloid;
secondary amino compound
antineoplastic agent;
microtubule-destabilising agent
1990199034.0low001000
norbelladinecatechols;
phenethylamine alkaloid;
polyphenol;
secondary amino compound
plant metabolite00low000000
validamycin aantibiotic fungicide;
polyol;
secondary amino compound;
validamycins
antifungal agrochemical;
EC 2.4.1.231 [alpha,alpha-trehalose phosphorylase (configuration-retaining)] inhibitor;
EC 2.4.1.64 (alpha,alpha-trehalose phosphorylase) inhibitor;
EC 3.2.1.28 (alpha,alpha-trehalase) inhibitor
00low000000
ergonovineergot alkaloid;
monocarboxylic acid amide;
organic heterotetracyclic compound;
primary alcohol;
secondary amino compound;
tertiary amino compound
diagnostic agent;
fungal metabolite;
oxytocic;
toxin
00low000000
1-[4-carboxy-2-(3-pentylamino)phenyl]-5,5-bis(hydroxymethyl)pyrrolidin-2-onebenzoic acids;
primary alcohol;
pyrrolidin-2-ones;
secondary amino compound
00low000000
tolfenamic acidaminobenzoic acid;
organochlorine compound;
secondary amino compound
EC 1.14.99.1 (prostaglandin-endoperoxide synthase) inhibitor;
EC 2.7.1.33 (pantothenate kinase) inhibitor;
non-narcotic analgesic;
non-steroidal anti-inflammatory drug
00low000000
N-benzylquinazolin-4-aminebenzenes;
quinazolines;
secondary amino compound
00low000000
lolineloline alkaloid;
secondary amino compound
00low000000
Src Inhibitor-1aromatic ether;
polyether;
quinazolines;
secondary amino compound
EC 2.7.10.2 (non-specific protein-tyrosine kinase) inhibitor00low000000
SMER 28organobromine compound;
quinazolines;
secondary amino compound
autophagy inducer00low000000
amn082benzenes;
diamine;
diarylmethane;
secondary amino compound
metabotropic glutamate receptor agonist;
neuroprotective agent
00low000000
spiraprilatazaspiro compound;
dicarboxylic acid;
dipeptide;
dithioketal;
pyrrolidinecarboxylic acid;
secondary amino compound;
tertiary carboxamide
antihypertensive agent;
drug metabolite;
EC 3.4.15.1 (peptidyl-dipeptidase A) inhibitor
00low000000
5-hydroxydiclofenacdichlorobenzene;
monocarboxylic acid;
phenols;
secondary amino compound
allergen;
drug metabolite
00low000000
noribogainemonoterpenoid indole alkaloid;
organic heteropentacyclic compound;
secondary amino compound;
tertiary amino compound
kappa-opioid receptor agonist;
NMDA receptor antagonist;
psychotropic drug;
serotonin uptake inhibitor
00low000000
n,o-didesmethylvenlafaxinecyclohexanols;
phenols;
secondary amino compound
drug metabolite;
marine xenobiotic metabolite
00low000000
n-desmethylvenlafaxinecyclohexanols;
monomethoxybenzene;
secondary amino compound
drug metabolite;
marine xenobiotic metabolite
00low000000
chanoclavinebenzoindole;
ergot alkaloid;
organic heterotricyclic compound;
primary alcohol;
secondary amino compound
00low000000
purmorphaminearomatic ether;
morpholines;
purines;
secondary amino compound
osteogenesis regulator;
SMO receptor agonist
00low000000
17-(dimethylaminoethylamino)-17-demethoxygeldanamycin1,4-benzoquinones;
ansamycin;
carbamate ester;
secondary amino compound;
tertiary amino compound
Hsp90 inhibitor00low000000
spiraprilazaspiro compound;
dicarboxylic acid monoester;
dipeptide;
dithioketal;
ethyl ester;
pyrrolidinecarboxylic acid;
secondary amino compound;
tertiary carboxamide
antihypertensive agent;
EC 3.4.15.1 (peptidyl-dipeptidase A) inhibitor;
prodrug
00low000000
palbociclibaminopyridine;
aromatic ketone;
cyclopentanes;
piperidines;
pyridopyrimidine;
secondary amino compound;
tertiary amino compound
antineoplastic agent;
EC 2.7.11.22 (cyclin-dependent kinase) inhibitor
00low000000
trandolaprilatdicarboxylic acid;
dipeptide;
organic heterobicyclic compound;
secondary amino compound;
tertiary carboxamide
antihypertensive agent;
drug metabolite;
EC 3.4.15.1 (peptidyl-dipeptidase A) inhibitor;
human xenobiotic metabolite
00low000000
amocarzineC-nitro compound;
N-methylpiperazine;
secondary amino compound;
thioureas
antinematodal drug00low000000
imidaprildicarboxylic acid monoester;
dipeptide;
ethyl ester;
imidazolidines;
N-acylurea;
secondary amino compound
antihypertensive agent;
EC 3.4.15.1 (peptidyl-dipeptidase A) inhibitor;
prodrug
00low000000
imidaprilatdicarboxylic acid;
dipeptide;
imidazolidines;
N-acylurea;
secondary amino compound
antihypertensive agent;
drug metabolite;
EC 3.4.15.1 (peptidyl-dipeptidase A) inhibitor
00low000000
ici 118551aromatic ether;
indanes;
secondary alcohol;
secondary amino compound
beta-adrenergic antagonist00low000000
trandolaprildicarboxylic acid monoester;
dipeptide;
ethyl ester;
organic heterobicyclic compound;
secondary amino compound;
tertiary carboxamide
antihypertensive agent;
EC 3.4.15.1 (peptidyl-dipeptidase A) inhibitor;
prodrug
00low000000
GSK3-XIIIaromatic amine;
pyrazoles;
quinazolines;
secondary amino compound
EC 2.7.11.26 (tau-protein kinase) inhibitor00low000000
robenacoxibaromatic amino acid;
monocarboxylic acid;
organofluorine compound;
phenylacetic acids;
secondary amino compound
cyclooxygenase 2 inhibitor;
non-narcotic analgesic;
non-steroidal anti-inflammatory drug
00low000000
tanespimycin1,4-benzoquinones;
ansamycin;
carbamate ester;
organic heterobicyclic compound;
secondary amino compound
antineoplastic agent;
apoptosis inducer;
Hsp90 inhibitor
00low000000
indacaterolindanes;
monohydroxyquinoline;
quinolone;
secondary alcohol;
secondary amino compound
beta-adrenergic agonist;
bronchodilator agent
00low000000
panobinostatcinnamamides;
hydroxamic acid;
methylindole;
secondary amino compound
angiogenesis modulating agent;
antineoplastic agent;
EC 3.5.1.98 (histone deacetylase) inhibitor
00low000000
bis(7)-tacrinesecondary amino compoundapoptosis inhibitor;
EC 1.14.13.39 (nitric oxide synthase) inhibitor;
EC 3.1.1.7 (acetylcholinesterase) inhibitor;
neuroprotective agent
00low000000
r 115866aromatic amine;
benzothiazoles;
secondary amino compound;
triazoles
00low000000
pd 0325901difluorobenzene;
hydroxamic acid ester;
monofluorobenzenes;
organoiodine compound;
propane-1,2-diols;
secondary amino compound
antineoplastic agent;
EC 2.7.12.2 (mitogen-activated protein kinase kinase) inhibitor
00low000000
dysiherbaineamino dicarboxylic acid;
furopyran;
hydroxy carboxylic acid;
secondary amino compound
animal metabolite;
excitatory amino acid agonist;
marine metabolite;
neurotoxin
00low000000
cangreloradenosine 5'-phosphate;
aryl sulfide;
nucleoside triphosphate analogue;
organochlorine compound;
organofluorine compound;
secondary amino compound
P2Y12 receptor antagonist;
platelet aggregation inhibitor
00low000000
ticagreloraryl sulfide;
hydroxyether;
organofluorine compound;
secondary amino compound;
triazolopyrimidines
P2Y12 receptor antagonist;
platelet aggregation inhibitor
201020208.0low100120
rucaparibazepinoindole;
caprolactams;
organofluorine compound;
secondary amino compound
antineoplastic agent;
EC 2.4.2.30 (NAD(+) ADP-ribosyltransferase) inhibitor
00low000000
sch 51344aromatic amine;
aromatic ether;
primary alcohol;
pyrazoloquinoline;
secondary amino compound
antineoplastic agent00low000000
azd 6244benzimidazoles;
bromobenzenes;
hydroxamic acid ester;
monochlorobenzenes;
organofluorine compound;
secondary amino compound
anticoronaviral agent;
antineoplastic agent;
EC 2.7.11.24 (mitogen-activated protein kinase) inhibitor
00low000000
vilanterolbenzyl alcohols;
dichlorobenzene;
ether;
phenols;
secondary amino compound
beta-adrenergic agonist;
bronchodilator agent
00low000000
binimetinibbenzimidazoles;
bromobenzenes;
hydroxamic acid ester;
monofluorobenzenes;
secondary amino compound
antineoplastic agent;
apoptosis inducer;
EC 2.7.11.24 (mitogen-activated protein kinase) inhibitor
00low000000
3-epi-fagomineamino monosaccharide;
hydroxypiperidine;
primary alcohol;
secondary alcohol;
secondary amino compound;
triol
EC 3.2.1.10 (oligo-1,6-glucosidase) inhibitor;
EC 3.2.1.23 (beta-galactosidase) inhibitor;
plant metabolite
00low000000
saracatinibaromatic ether;
benzodioxoles;
diether;
N-methylpiperazine;
organochlorine compound;
oxanes;
quinazolines;
secondary amino compound
anticoronaviral agent;
antineoplastic agent;
apoptosis inducer;
autophagy inducer;
EC 2.7.10.2 (non-specific protein-tyrosine kinase) inhibitor;
radiosensitizing agent
00low000000
ethaboxam1,3-thiazoles;
aromatic amide;
aromatic amine;
nitrile;
secondary amino compound;
thiophenes
00low000000
abt-737aromatic amine;
aryl sulfide;
biphenyls;
C-nitro compound;
monochlorobenzenes;
N-arylpiperazine;
N-sulfonylcarboxamide;
secondary amino compound;
tertiary amino compound
anti-allergic agent;
anti-inflammatory agent;
antineoplastic agent;
apoptosis inducer;
B-cell lymphoma 2 inhibitor
00low000000
validoxylamine aamino cyclitol;
secondary amino compound
animal metabolite;
antibiotic insecticide;
bacterial metabolite;
EC 3.2.1.28 (alpha,alpha-trehalase) inhibitor
00low000000
ceratamine aalkaloid;
aromatic ether;
cyclic ketone;
organic heterobicyclic compound;
organobromine compound;
secondary amino compound;
tertiary amine
antimitotic;
metabolite
00low000000
azd 8931aromatic ether;
monochlorobenzenes;
monofluorobenzenes;
piperidines;
quinazolines;
secondary amino compound;
tertiary amino compound
EC 2.7.10.1 (receptor protein-tyrosine kinase) inhibitor;
epidermal growth factor receptor antagonist
00low000000
olodaterolaromatic ether;
benzoxazine;
phenols;
secondary alcohol;
secondary amino compound
beta-adrenergic agonist;
bronchodilator agent
00low000000
finafloxacincyclopropanes;
monocarboxylic acid;
nitrile;
organofluorine compound;
quinolone;
secondary amino compound;
tertiary amino compound
antibacterial drug;
antimicrobial agent
00low000000
idelalisibaromatic amine;
organofluorine compound;
purines;
quinazolines;
secondary amino compound
antineoplastic agent;
apoptosis inducer;
EC 2.7.1.137 (phosphatidylinositol 3-kinase) inhibitor
00low000000
sarpagineindole alkaloid;
phenols;
primary alcohol;
secondary amino compound;
tertiary amino compound
00low000000
vizamyl(18)F radiopharmaceutical;
aromatic amine;
benzothiazoles;
secondary amino compound
radioactive imaging agent00low000000
pamapimodaromatic amine;
aromatic ether;
difluorobenzene;
diol;
primary alcohol;
pyridopyrimidine;
secondary amino compound
antirheumatic drug;
EC 2.7.11.24 (mitogen-activated protein kinase) inhibitor
00low000000
gdc-0973aromatic amine;
difluorobenzene;
N-acylazetidine;
organoiodine compound;
piperidines;
secondary amino compound;
tertiary alcohol
antineoplastic agent;
EC 2.7.11.24 (mitogen-activated protein kinase) inhibitor
00low000000
pevonedistatcyclopentanols;
indanes;
pyrrolopyrimidine;
secondary amino compound;
sulfamidate
antineoplastic agent;
apoptosis inducer
00low000000
tg101209N-alkylpiperazine;
N-arylpiperazine;
pyrimidines;
secondary amino compound;
sulfonamide
antineoplastic agent;
apoptosis inducer;
EC 2.7.10.2 (non-specific protein-tyrosine kinase) inhibitor
00low000000
WAY-316606(trifluoromethyl)benzenes;
piperidines;
secondary amino compound;
sulfonamide;
sulfone
secreted frizzled-related protein 1 inhibitor00low000000
navitoclaxaryl sulfide;
monochlorobenzenes;
morpholines;
N-sulfonylcarboxamide;
organofluorine compound;
piperazines;
secondary amino compound;
sulfone;
tertiary amino compound
antineoplastic agent;
apoptosis inducer;
B-cell lymphoma 2 inhibitor
00low000000
asp3026aromatic amine;
diamino-1,3,5-triazine;
monomethoxybenzene;
N-methylpiperazine;
piperidines;
secondary amino compound;
sulfone
antimalarial;
antineoplastic agent;
apoptosis inducer;
EC 2.7.10.1 (receptor protein-tyrosine kinase) inhibitor;
EC 6.1.1.6 (lysine--tRNA ligase) inhibitor
00low000000
pexidartinibaminopyridine;
organochlorine compound;
organofluorine compound;
pyrrolopyridine;
secondary amino compound
antineoplastic agent;
EC 2.7.10.1 (receptor protein-tyrosine kinase) inhibitor
00low000000
(R)-DRF0532,6-diaminopurines;
phenylpyridine;
primary alcohol;
secondary amino compound
EC 2.7.11.22 (cyclin-dependent kinase) inhibitor00low000000
cblc137aromatic ketone;
carbazoles;
methyl ketone;
secondary amino compound;
tertiary amino compound
antineoplastic agent;
apoptosis inducer;
NF-kappaB inhibitor;
p53 activator
00low000000
mephedroneamphetamines;
aromatic ketone;
secondary amino compound
environmental contaminant;
xenobiotic
00low000000
lrrk2-in1aromatic amine;
aromatic ether;
N-acylpiperidine;
N-alkylpiperazine;
pyrimidobenzodiazepine;
secondary amino compound;
tertiary amino compound
antineoplastic agent;
EC 2.7.11.1 (non-specific serine/threonine protein kinase) inhibitor
00low000000
gilteritinibaromatic amine;
monomethoxybenzene;
N-methylpiperazine;
oxanes;
piperidines;
primary carboxamide;
pyrazines;
secondary amino compound
antineoplastic agent;
apoptosis inducer;
EC 2.7.10.1 (receptor protein-tyrosine kinase) inhibitor
00low000000
ML240aromatic amine;
aromatic ether;
benzimidazoles;
primary amino compound;
quinazolines;
secondary amino compound
antineoplastic agent00low000000
gsk2879552benzenes;
benzoic acids;
cyclopropanes;
monocarboxylic acid;
piperidines;
secondary amino compound;
tertiary amino compound
antineoplastic agent;
EC 1.14.99.66 (lysine-specific histone demethylase 1A) inhibitor
00low000000
ly3009120aminotoluene;
aromatic amine;
biaryl;
monofluorobenzenes;
phenylureas;
pyridopyrimidine;
secondary amino compound
antineoplastic agent;
apoptosis inducer;
autophagy inducer;
B-Raf inhibitor;
necroptosis inhibitor
00low000000
as 1842856organofluorine compound;
primary amino compound;
quinolinemonocarboxylic acid;
quinolone;
secondary amino compound;
tertiary amino compound
anti-obesity agent;
antineoplastic agent;
apoptosis inducer;
autophagy inhibitor;
forkhead box protein O1 inhibitor;
hypoglycemic agent
00low000000
ldc4297aromatic ether;
piperidines;
pyrazoles;
pyrazolotriazine;
secondary amino compound
antineoplastic agent;
antiviral agent;
apoptosis inducer;
EC 2.7.11.22 (cyclin-dependent kinase) inhibitor
00low000000
chrysopineamino acid opine;
carboxamide;
delta-lactone;
secondary amino compound;
spiroketal;
triol
plant metabolite00low000000
enasidenib1,3,5-triazines;
aminopyridine;
aromatic amine;
organofluorine compound;
secondary amino compound;
tertiary alcohol
antineoplastic agent;
EC 1.1.1.42 (isocitrate dehydrogenase) inhibitor
00low000000
BDA-366anthraquinone;
epoxide;
secondary alcohol;
secondary amino compound;
tertiary amino compound
antineoplastic agent;
apoptosis inducer
00low000000
indolmycin1,3-oxazoles;
indoles;
secondary amino compound
antibacterial agent;
antimicrobial agent;
bacterial metabolite;
EC 6.1.1.2 (tryptophan--tRNA ligase) inhibitor
00low000000
liproxstatin-1azaspiro compound;
monochlorobenzenes;
organic heterotricyclic compound;
secondary amino compound
antioxidant;
cardioprotective agent;
ferroptosis inhibitor;
radical scavenger
00low000000
SubstanceStudiesClassesRolesFirst YearLast YearAverage AgeRelationship StrengthTrialspre-19901990's2000's2010'spost-2020
niacinamidepyridine alkaloid;
pyridinecarboxamide;
vitamin B3
anti-inflammatory agent;
antioxidant;
cofactor;
EC 2.4.2.30 (NAD(+) ADP-ribosyltransferase) inhibitor;
EC 3.5.1.98 (histone deacetylase) inhibitor;
Escherichia coli metabolite;
geroprotector;
human urinary metabolite;
metabolite;
mouse metabolite;
neuroprotective agent;
Saccharomyces cerevisiae metabolite;
Sir2 inhibitor
1995202118.9low004121
caffeic acidcatechols;
hydroxycinnamic acid
antioxidant;
EC 1.13.11.33 (arachidonate 15-lipoxygenase) inhibitor;
EC 1.13.11.34 (arachidonate 5-lipoxygenase) inhibitor;
EC 2.5.1.18 (glutathione transferase) inhibitor;
EC 3.5.1.98 (histone deacetylase) inhibitor;
plant metabolite
00low000000
carbamazepinedibenzoazepine;
ureas
analgesic;
anticonvulsant;
antimanic drug;
drug allergen;
EC 3.5.1.98 (histone deacetylase) inhibitor;
environmental contaminant;
glutamate transporter activator;
mitogen;
non-narcotic analgesic;
sodium channel blocker;
xenobiotic
1993201615.8low001120
ci 994acetamides;
benzamides;
substituted aniline
antineoplastic agent;
EC 3.5.1.98 (histone deacetylase) inhibitor
00low000000
valproic acidbranched-chain fatty acid;
branched-chain saturated fatty acid
anticonvulsant;
antimanic drug;
EC 3.5.1.98 (histone deacetylase) inhibitor;
GABA agent;
neuroprotective agent;
psychotropic drug;
teratogenic agent
201220208.5low0000140
4-(dimethylamino)-n-(7-(hydroxyamino)-7-oxoheptyl)benzamidebenzamides;
hydroxamic acid;
secondary carboxamide;
tertiary amino compound
antineoplastic agent;
apoptosis inducer;
EC 3.5.1.98 (histone deacetylase) inhibitor
00low000000
entinostatbenzamides;
carbamate ester;
primary amino compound;
pyridines;
substituted aniline
antineoplastic agent;
apoptosis inducer;
EC 3.5.1.98 (histone deacetylase) inhibitor
00low000000
4-phenylbutyric acidmonocarboxylic acidantineoplastic agent;
apoptosis inducer;
EC 3.5.1.98 (histone deacetylase) inhibitor;
prodrug
00low000000
4-phenylbutyric acid, sodium saltorganic sodium saltEC 3.5.1.98 (histone deacetylase) inhibitor;
geroprotector;
neuroprotective agent;
orphan drug;
prodrug
00low000000
vorinostatdicarboxylic acid diamide;
hydroxamic acid
antineoplastic agent;
apoptosis inducer;
EC 3.5.1.98 (histone deacetylase) inhibitor
2009201412.5low000220
sulforaphaneisothiocyanate;
sulfoxide
antineoplastic agent;
antioxidant;
EC 3.5.1.98 (histone deacetylase) inhibitor;
plant metabolite
00low000000
tributyrinbutyrate ester;
triglyceride
antineoplastic agent;
apoptosis inducer;
EC 3.5.1.98 (histone deacetylase) inhibitor;
prodrug;
protective agent
00low000000
hc toxinhomodetic cyclic peptide;
tetrapeptide
antineoplastic agent;
EC 3.5.1.98 (histone deacetylase) inhibitor;
metabolite;
phytotoxin
00low000000
trapoxin aepoxide;
homodetic cyclic peptide;
ketone
antineoplastic agent;
EC 3.5.1.98 (histone deacetylase) inhibitor;
fungal metabolite
00low000000
methylselenic acidone-carbon compound;
organoselenium compound
antineoplastic agent;
EC 3.5.1.98 (histone deacetylase) inhibitor;
human xenobiotic metabolite
00low000000
trichostatin aantibiotic antifungal agent;
hydroxamic acid;
trichostatin
bacterial metabolite;
EC 3.5.1.98 (histone deacetylase) inhibitor;
geroprotector
00low000000
CHIC-35aromatic compound;
organic heterotricyclic compound;
organochlorine compound;
primary carboxamide
EC 3.5.1.98 (histone deacetylase) inhibitor00low000000
curcuminaromatic ether;
beta-diketone;
diarylheptanoid;
enone;
polyphenol
anti-inflammatory agent;
antifungal agent;
antineoplastic agent;
biological pigment;
contraceptive drug;
dye;
EC 1.1.1.205 (IMP dehydrogenase) inhibitor;
EC 1.1.1.21 (aldehyde reductase) inhibitor;
EC 1.1.1.25 (shikimate dehydrogenase) inhibitor;
EC 1.6.5.2 [NAD(P)H dehydrogenase (quinone)] inhibitor;
EC 1.8.1.9 (thioredoxin reductase) inhibitor;
EC 2.7.10.2 (non-specific protein-tyrosine kinase) inhibitor;
EC 3.5.1.98 (histone deacetylase) inhibitor;
flavouring agent;
food colouring;
geroprotector;
hepatoprotective agent;
immunomodulator;
iron chelator;
ligand;
lipoxygenase inhibitor;
metabolite;
neuroprotective agent;
nutraceutical;
radical scavenger
2003202311.1low10024434
sirtinolaldimine;
benzamides;
naphthols
anti-inflammatory agent;
EC 3.5.1.98 (histone deacetylase) inhibitor;
Sir2 inhibitor
00low000000
sodium butyrateorganic sodium saltEC 3.5.1.98 (histone deacetylase) inhibitor;
geroprotector
00low000000
romidepsincyclodepsipeptide;
heterocyclic antibiotic;
organic disulfide
antineoplastic agent;
EC 3.5.1.98 (histone deacetylase) inhibitor
00low000000
3',4'-dihydroxyauronecatechols;
hydroxyaurone
EC 3.5.1.98 (histone deacetylase) inhibitor00low000000
belinostathydroxamic acid;
olefinic compound;
sulfonamide
antineoplastic agent;
EC 3.5.1.98 (histone deacetylase) inhibitor
00low000000
panobinostatcinnamamides;
hydroxamic acid;
methylindole;
secondary amino compound
angiogenesis modulating agent;
antineoplastic agent;
EC 3.5.1.98 (histone deacetylase) inhibitor
00low000000
bml 210dicarboxylic acid diamideantineoplastic agent;
EC 3.5.1.98 (histone deacetylase) inhibitor
00low000000
bl1521enamide;
hydroxamic acid;
monocarboxylic acid amide
antineoplastic agent;
apoptosis inducer;
EC 3.5.1.98 (histone deacetylase) inhibitor
00low000000
depudecinpolyketideEC 3.5.1.98 (histone deacetylase) inhibitor;
fungal metabolite
00low000000
spiruchostatin bmacrocyclic lactone;
organic disulfide;
organic heterobicyclic compound;
spiruchostatin
antineoplastic agent;
bacterial metabolite;
EC 3.5.1.98 (histone deacetylase) inhibitor
00low000000
tubastatin ahydroxamic acid;
pyridoindole;
tertiary amino compound
EC 3.5.1.98 (histone deacetylase) inhibitor00low000000
pracinostatbenzimidazole;
hydroxamic acid;
olefinic compound;
tertiary amino compound
antimalarial;
antineoplastic agent;
apoptosis inducer;
EC 3.5.1.98 (histone deacetylase) inhibitor
00low000000
protocatechuic acidcatechols;
dihydroxybenzoic acid
antineoplastic agent;
EC 1.1.1.25 (shikimate dehydrogenase) inhibitor;
EC 1.14.11.2 (procollagen-proline dioxygenase) inhibitor;
human xenobiotic metabolite;
plant metabolite
00low000000
aminolevulinic acid4-oxo monocarboxylic acid;
amino acid zwitterion;
delta-amino acid
antineoplastic agent;
dermatologic drug;
Escherichia coli metabolite;
human metabolite;
mouse metabolite;
photosensitizing agent;
plant metabolite;
prodrug;
Saccharomyces cerevisiae metabolite
1987202216.1low011231
gallic acidtrihydroxybenzoic acidantineoplastic agent;
antioxidant;
apoptosis inducer;
astringent;
cyclooxygenase 2 inhibitor;
EC 1.13.11.33 (arachidonate 15-lipoxygenase) inhibitor;
geroprotector;
human xenobiotic metabolite;
plant metabolite
1981202315.3low022694
perillic acidalpha,beta-unsaturated monocarboxylic acid;
cyclohexenecarboxylic acid
antineoplastic agent;
human metabolite;
mouse metabolite
00low000000
pk 11195aromatic amide;
isoquinolines;
monocarboxylic acid amide;
monochlorobenzenes
antineoplastic agent00low000000
pd 173074aromatic amine;
biaryl;
dimethoxybenzene;
pyridopyrimidine;
tertiary amino compound;
ureas
antineoplastic agent;
EC 2.7.10.1 (receptor protein-tyrosine kinase) inhibitor;
fibroblast growth factor receptor antagonist
00low000000
aminopropionitrileaminopropionitrileantineoplastic agent;
antirheumatic drug;
collagen cross-linking inhibitor;
plant metabolite
00low000000
5-(n,n-hexamethylene)amiloridearomatic amine;
azepanes;
guanidines;
monocarboxylic acid amide;
organochlorine compound;
pyrazines
antineoplastic agent;
apoptosis inducer;
odorant receptor antagonist;
sodium channel blocker
00low000000
7,8-dihydroxyflavonedihydroxyflavoneantidepressant;
antineoplastic agent;
antioxidant;
plant metabolite;
tropomyosin-related kinase B receptor agonist
00low000000
ro 48-8071aromatic ether;
aromatic ketone;
bromobenzenes;
monofluorobenzenes;
olefinic compound;
tertiary amino compound
antineoplastic agent;
EC 5.4.99.7 (lanosterol synthase) inhibitor
00low000000
rtki cpdaromatic ether;
monochlorobenzenes;
quinazolines
antineoplastic agent;
antiviral agent;
epidermal growth factor receptor antagonist;
geroprotector
00low000000
alfuzosinmonocarboxylic acid amide;
quinazolines;
tetrahydrofuranol
alpha-adrenergic antagonist;
antihypertensive agent;
antineoplastic agent
00low000000
am 251amidopiperidine;
carbohydrazide;
dichlorobenzene;
organoiodine compound;
pyrazoles
antidepressant;
antineoplastic agent;
apoptosis inducer;
CB1 receptor antagonist
00low000000
am 580amidobenzoic acid;
tetralins
antineoplastic agent;
retinoic acid receptor alpha/beta agonist
00low000000
aminoglutethimidedicarboximide;
piperidones;
substituted aniline
adrenergic agent;
anticonvulsant;
antineoplastic agent;
EC 1.14.14.14 (aromatase) inhibitor
2006201514.7low000210
amsacrineacridines;
aromatic ether;
sulfonamide
antineoplastic agent;
EC 5.99.1.3 [DNA topoisomerase (ATP-hydrolysing)] inhibitor
1992199232.0low001000
anastrozolenitrile;
triazoles
antineoplastic agent;
EC 1.14.14.14 (aromatase) inhibitor
00low000000
azathioprinearyl sulfide;
C-nitro compound;
imidazoles;
thiopurine
antimetabolite;
antineoplastic agent;
carcinogenic agent;
DNA synthesis inhibitor;
hepatotoxic agent;
immunosuppressive agent;
prodrug
1988202115.2low313681
azelaic acidalpha,omega-dicarboxylic acid;
dicarboxylic fatty acid
antibacterial agent;
antineoplastic agent;
dermatologic drug;
plant metabolite
00low000000
berberinealkaloid antibiotic;
berberine alkaloid;
botanical anti-fungal agent;
organic heteropentacyclic compound
antilipemic drug;
antineoplastic agent;
antioxidant;
EC 1.1.1.141 [15-hydroxyprostaglandin dehydrogenase (NAD(+))] inhibitor;
EC 1.1.1.21 (aldehyde reductase) inhibitor;
EC 1.13.11.52 (indoleamine 2,3-dioxygenase) inhibitor;
EC 1.21.3.3 (reticuline oxidase) inhibitor;
EC 2.1.1.116 [3'-hydroxy-N-methyl-(S)-coclaurine 4'-O-methyltransferase] inhibitor;
EC 2.1.1.122 [(S)-tetrahydroprotoberberine N-methyltransferase] inhibitor;
EC 2.7.11.10 (IkappaB kinase) inhibitor;
EC 3.1.1.4 (phospholipase A2) inhibitor;
EC 3.1.1.7 (acetylcholinesterase) inhibitor;
EC 3.1.1.8 (cholinesterase) inhibitor;
EC 3.1.3.48 (protein-tyrosine-phosphatase) inhibitor;
EC 3.4.14.5 (dipeptidyl-peptidase IV) inhibitor;
EC 3.4.21.26 (prolyl oligopeptidase) inhibitor;
geroprotector;
hypoglycemic agent;
metabolite;
potassium channel blocker
1993202112.0low0021101
buforminbiguanidesantineoplastic agent;
antiviral agent;
geroprotector;
hypoglycemic agent;
radiosensitizing agent
00low000000
busulfanmethanesulfonate esteralkylating agent;
antineoplastic agent;
carcinogenic agent;
insect sterilant;
teratogenic agent
201420226.0low000011
camostatbenzoate ester;
carboxylic ester;
diester;
guanidines;
tertiary carboxamide
anti-inflammatory agent;
anticoronaviral agent;
antifibrinolytic drug;
antihypertensive agent;
antineoplastic agent;
antiviral agent;
serine protease inhibitor
00low000000
carmustineN-nitrosoureas;
organochlorine compound
alkylating agent;
antineoplastic agent
1983199237.0low021000
cgs 15943aromatic amine;
biaryl;
furans;
organochlorine compound;
primary amino compound;
quinazolines;
triazoloquinazoline
adenosine A1 receptor antagonist;
adenosine A2A receptor antagonist;
antineoplastic agent;
central nervous system stimulant
00low000000
chelerythrinebenzophenanthridine alkaloid;
organic cation
antibacterial agent;
antineoplastic agent;
EC 2.7.11.13 (protein kinase C) inhibitor
00low000000
chlorambucilaromatic amine;
monocarboxylic acid;
nitrogen mustard;
organochlorine compound;
tertiary amino compound
alkylating agent;
antineoplastic agent;
carcinogenic agent;
drug allergen;
immunosuppressive agent
00low000000
ciglitazonearomatic ether;
thiazolidinone
antineoplastic agent;
insulin-sensitizing drug
00low000000
cl 387785bromobenzenes;
quinazolines;
secondary carboxamide;
ynamide
antineoplastic agent;
EC 2.7.10.1 (receptor protein-tyrosine kinase) inhibitor;
epidermal growth factor receptor antagonist
00low000000
clioquinolmonohydroxyquinoline;
organochlorine compound;
organoiodine compound
antibacterial agent;
antifungal agent;
antimicrobial agent;
antineoplastic agent;
antiprotozoal drug;
chelator;
copper chelator
00low000000
clofibric acidaromatic ether;
monocarboxylic acid;
monochlorobenzenes
anticholesteremic drug;
antilipemic drug;
antineoplastic agent;
herbicide;
marine xenobiotic metabolite;
PPARalpha agonist
00low000000
dacarbazineimidazoles;
monocarboxylic acid amide;
triazene derivative
alkylating agent;
antineoplastic agent;
carcinogenic agent;
prodrug
00low000000
dequaliniumquinolinium ionantifungal agent;
antineoplastic agent;
antiseptic drug;
mitochondrial NADH:ubiquinone reductase inhibitor
00low000000
3,3'-diindolylmethaneindolesantineoplastic agent;
P450 inhibitor
00low000000
disulfiramorganic disulfide;
organosulfur acaricide
angiogenesis inhibitor;
antineoplastic agent;
apoptosis inducer;
EC 1.2.1.3 [aldehyde dehydrogenase (NAD(+))] inhibitor;
EC 3.1.1.1 (carboxylesterase) inhibitor;
EC 3.1.1.8 (cholinesterase) inhibitor;
EC 5.99.1.2 (DNA topoisomerase) inhibitor;
ferroptosis inducer;
fungicide;
NF-kappaB inhibitor
1950201036.7low010200
doxazosinaromatic amine;
benzodioxine;
monocarboxylic acid amide;
N-acylpiperazine;
N-arylpiperazine;
quinazolines
alpha-adrenergic antagonist;
antihyperplasia drug;
antihypertensive agent;
antineoplastic agent;
vasodilator agent
00low000000
ebselenbenzoselenazoleanti-inflammatory drug;
antibacterial agent;
anticoronaviral agent;
antifungal agent;
antineoplastic agent;
antioxidant;
apoptosis inducer;
EC 1.13.11.33 (arachidonate 15-lipoxygenase) inhibitor;
EC 1.13.11.34 (arachidonate 5-lipoxygenase) inhibitor;
EC 1.3.1.8 [acyl-CoA dehydrogenase (NADP(+))] inhibitor;
EC 1.8.1.12 (trypanothione-disulfide reductase) inhibitor;
EC 2.5.1.7 (UDP-N-acetylglucosamine 1-carboxyvinyltransferase) inhibitor;
EC 2.7.10.1 (receptor protein-tyrosine kinase) inhibitor;
EC 3.1.3.25 (inositol-phosphate phosphatase) inhibitor;
EC 3.4.22.69 (SARS coronavirus main proteinase) inhibitor;
EC 3.5.4.1 (cytosine deaminase) inhibitor;
EC 5.1.3.2 (UDP-glucose 4-epimerase) inhibitor;
enzyme mimic;
ferroptosis inhibitor;
genotoxin;
hepatoprotective agent;
neuroprotective agent;
radical scavenger
00low000000
ellipticineindole alkaloid;
organic heterotetracyclic compound;
organonitrogen heterocyclic compound;
polycyclic heteroarene
antineoplastic agent;
plant metabolite
00low000000
embelindihydroxy-1,4-benzoquinonesantimicrobial agent;
antineoplastic agent;
hepatitis C protease inhibitor;
plant metabolite
00low000000
emodintrihydroxyanthraquinoneantineoplastic agent;
laxative;
plant metabolite;
tyrosine kinase inhibitor
2007202211.2low000561
etanidazoleC-nitro compound;
imidazoles;
monocarboxylic acid amide
alkylating agent;
antineoplastic agent;
prodrug;
radiosensitizing agent
00low000000
etidronate1,1-bis(phosphonic acid)antineoplastic agent;
bone density conservation agent;
chelator
1993199331.0low001000
fluorouracilnucleobase analogue;
organofluorine compound
antimetabolite;
antineoplastic agent;
environmental contaminant;
immunosuppressive agent;
radiosensitizing agent;
xenobiotic
1992202213.5low10413212
flutamide(trifluoromethyl)benzenes;
monocarboxylic acid amide
androgen antagonist;
antineoplastic agent
1983200922.6low011500
miltefosinephosphocholines;
phospholipid
anti-inflammatory agent;
anticoronaviral agent;
antifungal agent;
antineoplastic agent;
antiprotozoal drug;
apoptosis inducer;
immunomodulator;
protein kinase inhibitor
00low000000
beta-thujaplicincyclic ketone;
enol;
monoterpenoid
antibacterial agent;
antifungal agent;
antineoplastic agent;
antiplasmodial drug;
plant metabolite
00low000000
hydroxyureaone-carbon compound;
ureas
antimetabolite;
antimitotic;
antineoplastic agent;
DNA synthesis inhibitor;
EC 1.17.4.1 (ribonucleoside-diphosphate reductase) inhibitor;
genotoxin;
immunomodulator;
radical scavenger;
teratogenic agent
1984201926.7low156410
ifosfamideifosfamidesalkylating agent;
antineoplastic agent;
environmental contaminant;
immunosuppressive agent;
xenobiotic
2007200717.0low000100
indole-3-carbinolindolyl alcoholantineoplastic agent;
plant metabolite
00low000000
beta-lapachonebenzochromenone;
orthoquinones
anti-inflammatory agent;
antineoplastic agent;
plant metabolite
00low000000
leflunomide(trifluoromethyl)benzenes;
isoxazoles;
monocarboxylic acid amide
antineoplastic agent;
antiparasitic agent;
EC 1.3.98.1 [dihydroorotate oxidase (fumarate)] inhibitor;
EC 3.1.3.16 (phosphoprotein phosphatase) inhibitor;
hepatotoxic agent;
immunosuppressive agent;
non-steroidal anti-inflammatory drug;
prodrug;
pyrimidine synthesis inhibitor;
tyrosine kinase inhibitor
1995201516.3low001410
letrozolenitrile;
triazoles
antineoplastic agent;
EC 1.14.14.14 (aromatase) inhibitor
201720177.0low000010
lomustineN-nitrosoureas;
organochlorine compound
alkylating agent;
antineoplastic agent
00low000000
6-anilino-5,8-quinolinedioneaminoquinoline;
aromatic amine;
p-quinones;
quinolone
antineoplastic agent;
EC 4.6.1.2 (guanylate cyclase) inhibitor
00low000000
meclofenamic acidaminobenzoic acid;
organochlorine compound;
secondary amino compound
analgesic;
anticonvulsant;
antineoplastic agent;
antipyretic;
antirheumatic drug;
EC 1.13.11.34 (arachidonate 5-lipoxygenase) inhibitor;
EC 1.14.99.1 (prostaglandin-endoperoxide synthase) inhibitor;
non-steroidal anti-inflammatory drug
1992199530.5low002000
vitamin k 31,4-naphthoquinones;
vitamin K
angiogenesis inhibitor;
antineoplastic agent;
EC 3.4.22.69 (SARS coronavirus main proteinase) inhibitor;
human urinary metabolite;
nutraceutical
200520219.0low000111
methoxsalenaromatic ether;
psoralens
antineoplastic agent;
cross-linking reagent;
dermatologic drug;
photosensitizing agent;
plant metabolite
201920195.0low000010
nocodazolearomatic ketone;
benzimidazoles;
carbamate ester;
thiophenes
antimitotic;
antineoplastic agent;
microtubule-destabilising agent;
tubulin modulator
00low000000
midazolamimidazobenzodiazepine;
monofluorobenzenes;
organochlorine compound
anticonvulsant;
antineoplastic agent;
anxiolytic drug;
apoptosis inducer;
central nervous system depressant;
GABAA receptor agonist;
general anaesthetic;
muscle relaxant;
sedative
1995200524.0low001100
mitoxantronedihydroxyanthraquinoneanalgesic;
antineoplastic agent
1992201723.0low003210
n(1), n(12)-diethylsperminepolyazaalkane;
secondary amino compound;
substituted spermine;
tetramine
antineoplastic agent00low000000
nilutamide(trifluoromethyl)benzenes;
C-nitro compound;
imidazolidinone
androgen antagonist;
antineoplastic agent
00low000000
nortriptylineorganic tricyclic compound;
secondary amine
adrenergic uptake inhibitor;
analgesic;
antidepressant;
antineoplastic agent;
apoptosis inducer;
drug metabolite
00low000000
n-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamidearomatic ether;
C-nitro compound;
sulfonamide
antineoplastic agent;
cyclooxygenase 2 inhibitor
00low000000
oxyphenbutazonephenols;
pyrazolidines
antimicrobial agent;
antineoplastic agent;
antipyretic;
drug metabolite;
gout suppressant;
non-narcotic analgesic;
non-steroidal anti-inflammatory drug;
xenobiotic metabolite
00low000000
pd 158780aromatic amine;
bromobenzenes;
diamine;
pyridopyrimidine;
secondary amino compound
antineoplastic agent;
EC 2.7.10.1 (receptor protein-tyrosine kinase) inhibitor
00low000000
oxophenylarsinearsine oxidesantineoplastic agent;
apoptosis inducer;
EC 3.1.3.48 (protein-tyrosine-phosphatase) inhibitor
00low000000
phloretindihydrochalconesantineoplastic agent;
plant metabolite
201620168.0low000010
pipobromanN-acylpiperazine;
organobromine compound;
tertiary carboxamide
alkylating agent;
antineoplastic agent
00low000000
pj-34phenanthridines;
secondary carboxamide;
tertiary amino compound
angiogenesis inhibitor;
anti-inflammatory agent;
antiatherosclerotic agent;
antineoplastic agent;
apoptosis inducer;
cardioprotective agent;
EC 2.4.2.30 (NAD(+) ADP-ribosyltransferase) inhibitor;
neuroprotective agent
00low000000
procarbazinebenzamides;
hydrazines
antineoplastic agent1991199332.0low002000
salicylsalicylic acidbenzoate ester;
benzoic acids;
phenols;
salicylates
antineoplastic agent;
antirheumatic drug;
EC 3.5.2.6 (beta-lactamase) inhibitor;
hypoglycemic agent;
non-narcotic analgesic;
non-steroidal anti-inflammatory drug;
prodrug
00low000000
semustineN-nitrosoureas;
organochlorine compound
alkylating agent;
antineoplastic agent;
carcinogenic agent
00low000000
imatinibaromatic amine;
benzamides;
N-methylpiperazine;
pyridines;
pyrimidines
antineoplastic agent;
apoptosis inducer;
tyrosine kinase inhibitor
00low000000
streptonigrinpyridines;
quinolone
antimicrobial agent;
antineoplastic agent
00low000000
SU6656oxindoles;
sulfonamide
antineoplastic agent;
Aurora kinase inhibitor;
EC 2.7.10.2 (non-specific protein-tyrosine kinase) inhibitor
00low000000
suraminnaphthalenesulfonic acid;
phenylureas;
secondary carboxamide
angiogenesis inhibitor;
antinematodal drug;
antineoplastic agent;
apoptosis inhibitor;
EC 2.7.11.13 (protein kinase C) inhibitor;
GABA antagonist;
GABA-gated chloride channel antagonist;
purinergic receptor P2 antagonist;
ryanodine receptor agonist;
trypanocidal drug
1996201916.5low001010
temozolomideimidazotetrazine;
monocarboxylic acid amide;
triazene derivative
alkylating agent;
antineoplastic agent;
prodrug
00low000000
terazosinfurans;
piperazines;
primary amino compound;
quinazolines
alpha-adrenergic antagonist;
antihypertensive agent;
antineoplastic agent
00low000000
2,2'-thiodiethanolaliphatic sulfide;
diol
antineoplastic agent;
antioxidant;
metabolite;
solvent
00low000000
tiloronearomatic ether;
diether;
fluoren-9-ones;
tertiary amino compound
anti-inflammatory agent;
antineoplastic agent;
antiviral agent;
interferon inducer;
nicotinic acetylcholine receptor agonist
00low000000
troglitazonechromanes;
thiazolidinone
anticoagulant;
anticonvulsant;
antineoplastic agent;
antioxidant;
EC 6.2.1.3 (long-chain-fatty-acid--CoA ligase) inhibitor;
ferroptosis inhibitor;
hypoglycemic agent;
platelet aggregation inhibitor;
vasodilator agent
2004200519.5low000200
3-(5'-hydroxymethyl-2'-furyl)-1-benzylindazolearomatic primary alcohol;
furans;
indazoles
antineoplastic agent;
apoptosis inducer;
platelet aggregation inhibitor;
soluble guanylate cyclase activator;
vasodilator agent
00low000000
mitomycinmitomycinalkylating agent;
antineoplastic agent
1995202319.2low102301
prednisolone11beta-hydroxy steroid;
17alpha-hydroxy steroid;
20-oxo steroid;
21-hydroxy steroid;
3-oxo-Delta(1),Delta(4)-steroid;
C21-steroid;
glucocorticoid;
primary alpha-hydroxy ketone;
tertiary alpha-hydroxy ketone
adrenergic agent;
anti-inflammatory drug;
antineoplastic agent;
drug metabolite;
environmental contaminant;
immunosuppressive agent;
xenobiotic
1959202218.5low652949353
floxuridinenucleoside analogue;
organofluorine compound;
pyrimidine 2'-deoxyribonucleoside
antimetabolite;
antineoplastic agent;
antiviral drug;
radiosensitizing agent
00low000000
prednisone11-oxo steroid;
17alpha-hydroxy steroid;
20-oxo steroid;
21-hydroxy steroid;
3-oxo-Delta(1),Delta(4)-steroid;
C21-steroid;
glucocorticoid;
primary alpha-hydroxy ketone;
tertiary alpha-hydroxy ketone
adrenergic agent;
anti-inflammatory drug;
antineoplastic agent;
immunosuppressive agent;
prodrug
1956202220.5low254673
estrone17-oxo steroid;
3-hydroxy steroid;
phenolic steroid;
phenols
antineoplastic agent;
bone density conservation agent;
estrogen;
human metabolite;
mouse metabolite
1961198952.0low050000
azauridineN-glycosyl-1,2,4-triazineantimetabolite;
antineoplastic agent;
drug metabolite
00low000000
mechlorethamine hydrochloridehydrochlorideantineoplastic agent00low000000
allyl isothiocyanatealkenyl isothiocyanate;
isothiocyanate
antimicrobial agent;
antineoplastic agent;
apoptosis inducer;
lachrymator;
metabolite
00low000000
vincristineacetate ester;
formamides;
methyl ester;
organic heteropentacyclic compound;
organic heterotetracyclic compound;
tertiary alcohol;
tertiary amino compound;
vinca alkaloid
antineoplastic agent;
drug;
microtubule-destabilising agent;
plant metabolite;
tubulin modulator
00low000000
methyltestosterone17beta-hydroxy steroid;
3-oxo-Delta(4) steroid;
enone
anabolic agent;
androgen;
antineoplastic agent
00low000000
dromostanolone17beta-hydroxy steroid;
3-oxo-5alpha-steroid;
anabolic androgenic steroid
anabolic agent;
antineoplastic agent
00low000000
bromodeoxyuridinepyrimidine 2'-deoxyribonucleosideantimetabolite;
antineoplastic agent
1993201421.8low003210
ethyl methanesulfonatemethanesulfonate esteralkylating agent;
antineoplastic agent;
carcinogenic agent;
genotoxin;
mutagen;
teratogenic agent
1990200127.0low002100
triaziquone1,4-benzoquinones;
aziridines
alkylating agent;
antineoplastic agent
00low000000
tubercidinantibiotic antifungal agent;
N-glycosylpyrrolopyrimidine;
ribonucleoside
antimetabolite;
antineoplastic agent;
bacterial metabolite
1986198638.0low010000
cytarabinebeta-D-arabinoside;
monosaccharide derivative;
pyrimidine nucleoside
antimetabolite;
antineoplastic agent;
antiviral agent;
immunosuppressive agent
1986201924.5low139830
trifluridinenucleoside analogue;
organofluorine compound;
pyrimidine 2'-deoxyribonucleoside
antimetabolite;
antineoplastic agent;
antiviral drug;
EC 2.1.1.45 (thymidylate synthase) inhibitor
202320231.0low100001
medroxyprogesterone acetate20-oxo steroid;
3-oxo-Delta(4) steroid;
acetate ester;
corticosteroid;
steroid ester
adjuvant;
androgen;
antineoplastic agent;
antioxidant;
female contraceptive drug;
inhibitor;
progestin;
synthetic oral contraceptive
2005201215.5low000110
fluoxymesterone11beta-hydroxy steroid;
17beta-hydroxy steroid;
3-oxo-Delta(4) steroid;
anabolic androgenic steroid;
fluorinated steroid
anabolic agent;
antineoplastic agent
00low000000
rotenoneorganic heteropentacyclic compound;
rotenones
antineoplastic agent;
metabolite;
mitochondrial NADH:ubiquinone reductase inhibitor;
phytogenic insecticide;
piscicide;
toxin
1988201916.7low010440
acetopyrrothineacetamides;
dithiolopyrrolone antibiotic
angiogenesis inhibitor;
antibacterial agent;
antifungal agent;
antineoplastic agent;
bacterial metabolite;
chelator;
EC 2.7.7.6 (RNA polymerase) inhibitor;
marine metabolite;
protein synthesis inhibitor;
toxin
00low000000
phenforminbiguanidesantineoplastic agent;
geroprotector;
hypoglycemic agent
00low000000
dibenzoylmethanearomatic ketone;
beta-diketone
antimutagen;
antineoplastic agent;
metabolite
00low000000
suramin sodiumorganic sodium saltangiogenesis inhibitor;
antinematodal drug;
antineoplastic agent;
apoptosis inhibitor;
EC 2.7.11.13 (protein kinase C) inhibitor;
GABA antagonist;
GABA-gated chloride channel antagonist;
purinergic receptor P2 antagonist;
ryanodine receptor agonist;
trypanocidal drug
00low000000
pyrazolanthroneanthrapyrazole;
aromatic ketone;
cyclic ketone
antineoplastic agent;
c-Jun N-terminal kinase inhibitor;
geroprotector
00low000000
diazooxonorleucineamino acid zwitterion;
diazo compound;
ketone;
non-proteinogenic L-alpha-amino acid
analgesic;
antibacterial agent;
antimetabolite;
antineoplastic agent;
antiviral agent;
apoptosis inducer;
bacterial metabolite;
EC 2.4.2.14 (amidophosphoribosyltransferase) inhibitor;
EC 3.5.1.2 (glutaminase) inhibitor;
EC 6.3.4.2 [CTP synthase (glutamine hydrolyzing)] inhibitor;
EC 6.3.5.1 [NAD(+) synthase (glutamine-hydrolysing)] inhibitor;
EC 6.3.5.2 [GMP synthase (glutamine-hydrolysing)] inhibitor;
EC 6.3.5.3 (phosphoribosylformylglycinamidine synthase) inhibitor;
EC 6.3.5.4 [asparagine synthase (glutamine-hydrolysing)] inhibitor;
EC 6.3.5.5 [carbamoyl-phosphate synthase (glutamine-hydrolysing)] inhibitor;
glutamine antagonist
2007200816.5low000200
azacitidineN-glycosyl-1,3,5-triazine;
nucleoside analogue
antineoplastic agent201720177.0low000010
diazomethanediazo compoundalkylating agent;
antineoplastic agent;
carcinogenic agent;
poison
00low000000
procarbazine hydrochloridehydrochlorideantineoplastic agent00low000000
naphthazarinhydroxy-1,4-naphthoquinoneacaricide;
antibacterial agent;
antineoplastic agent;
apoptosis inducer;
geroprotector;
plant metabolite
00low000000
liriodeninealkaloid antibiotic;
cyclic ketone;
organic heteropentacyclic compound;
oxacycle;
oxoaporphine alkaloid
antifungal agent;
antimicrobial agent;
antineoplastic agent;
EC 3.1.1.7 (acetylcholinesterase) inhibitor;
EC 3.2.1.20 (alpha-glucosidase) inhibitor;
metabolite
00low000000
lucanthonethioxanthenesadjuvant;
antineoplastic agent;
EC 5.99.1.2 (DNA topoisomerase) inhibitor;
EC 5.99.1.3 [DNA topoisomerase (ATP-hydrolysing)] inhibitor;
mutagen;
photosensitizing agent;
prodrug;
schistosomicide drug
00low000000
plumbaginhydroxy-1,4-naphthoquinone;
phenols
anticoagulant;
antineoplastic agent;
immunological adjuvant;
metabolite
00low000000
aloe emodinaromatic primary alcohol;
dihydroxyanthraquinone
antineoplastic agent;
plant metabolite
00low000000
emetineisoquinoline alkaloid;
pyridoisoquinoline
antiamoebic agent;
anticoronaviral agent;
antiinfective agent;
antimalarial;
antineoplastic agent;
antiprotozoal drug;
antiviral agent;
autophagy inhibitor;
emetic;
expectorant;
plant metabolite;
protein synthesis inhibitor
2000200024.0low001000
thymoquinone1,4-benzoquinonesadjuvant;
anti-inflammatory agent;
antidepressant;
antineoplastic agent;
antioxidant;
cardioprotective agent;
plant metabolite
00low000000
podophyllotoxinfuronaphthodioxole;
lignan;
organic heterotetracyclic compound
antimitotic;
antineoplastic agent;
keratolytic drug;
microtubule-destabilising agent;
plant metabolite;
tubulin modulator
00low000000
physcionedihydroxyanthraquinoneanti-inflammatory agent;
antibacterial agent;
antifungal agent;
antineoplastic agent;
apoptosis inducer;
hepatoprotective agent;
metabolite
00low000000
dequalinium chlorideorganic chloride saltantifungal agent;
antineoplastic agent;
antiseptic drug;
mitochondrial NADH:ubiquinone reductase inhibitor
00low000000
4-methyl-1-(1-methylethyl)-3-cyclohexen-1-olterpineol;
tertiary alcohol
anti-inflammatory agent;
antibacterial agent;
antineoplastic agent;
antioxidant;
antiparasitic agent;
apoptosis inducer;
plant metabolite;
volatile oil component
00low000000
formestane17-oxo steroid;
3-oxo-Delta(4) steroid;
enol;
hydroxy steroid
antineoplastic agent;
EC 1.14.14.14 (aromatase) inhibitor
00low000000
chlorotrianisenechloroalkeneantineoplastic agent;
estrogen receptor modulator;
xenoestrogen
00low000000
megestrol acetate20-oxo steroid;
3-oxo-Delta(4) steroid;
acetate ester;
steroid ester
antineoplastic agent;
appetite enhancer;
contraceptive drug;
progestin;
synthetic oral contraceptive
00low000000
toyocamycinantibiotic antifungal agent;
N-glycosylpyrrolopyrimidine;
nitrile;
ribonucleoside
antimetabolite;
antineoplastic agent;
apoptosis inducer;
bacterial metabolite
00low000000
2-hydroxyacetanilideacetamides;
phenols
anti-inflammatory agent;
antineoplastic agent;
antirheumatic drug;
apoptosis inducer;
platelet aggregation inhibitor;
xenobiotic metabolite
00low000000
methoxyacetic acidether;
monocarboxylic acid
antineoplastic agent;
apoptosis inducer;
human xenobiotic metabolite;
mutagen
00low000000
hadacidinaldehyde;
monocarboxylic acid;
N-hydroxy-alpha-amino-acid
antimicrobial agent;
antineoplastic agent;
Penicillium metabolite;
teratogenic agent
00low000000
2-fluoroadenineorganofluorine compound;
purines
antineoplastic agent00low000000
tetramethylpyrazinealkaloid;
pyrazines
antineoplastic agent;
apoptosis inhibitor;
bacterial metabolite;
neuroprotective agent;
platelet aggregation inhibitor;
vasodilator agent
00low000000
guanazolearomatic amine;
triazoles
antineoplastic agent;
DNA synthesis inhibitor;
EC 1.17.4.1 (ribonucleoside-diphosphate reductase) inhibitor
1984198440.0low010000
diallyl trisulfideorganic trisulfideanti-inflammatory agent;
antilipemic drug;
antineoplastic agent;
antioxidant;
antiprotozoal drug;
apoptosis inducer;
estrogen receptor antagonist;
insecticide;
platelet aggregation inhibitor;
vasodilator agent
00low000000
diallyl disulfideorganic disulfideantifungal agent;
antineoplastic agent;
plant metabolite
00low000000
phenethyl isothiocyanateisothiocyanateantineoplastic agent;
EC 1.2.1.3 [aldehyde dehydrogenase (NAD(+))] inhibitor;
metabolite
00low000000
glaucineaporphine alkaloid;
organic heterotetracyclic compound;
polyether;
tertiary amino compound
antibacterial agent;
antineoplastic agent;
antitussive;
muscle relaxant;
NF-kappaB inhibitor;
plant metabolite;
platelet aggregation inhibitor;
rat metabolite
00low000000
acadesine1-ribosylimidazolecarboxamide;
aminoimidazole;
nucleoside analogue
antineoplastic agent;
platelet aggregation inhibitor
00low000000
doxifluridineorganofluorine compound;
pyrimidine 5'-deoxyribonucleoside
antimetabolite;
antineoplastic agent;
prodrug
00low000000
megestrol17alpha-hydroxy steroid;
20-oxo steroid;
3-oxo-Delta(4) steroid;
tertiary alpha-hydroxy ketone
antineoplastic agent;
appetite enhancer;
contraceptive drug;
progestin;
synthetic oral contraceptive
00low000000
mitomycin aether;
mitomycin
alkylating agent;
antimicrobial agent;
antineoplastic agent;
toxin
00low000000
cladribineorganochlorine compound;
purine 2'-deoxyribonucleoside
antineoplastic agent;
immunosuppressive agent
00low000000
tabersoninealkaloid ester;
methyl ester;
monoterpenoid indole alkaloid;
organic heteropentacyclic compound
antineoplastic agent;
metabolite
00low000000
vidarabinebeta-D-arabinoside;
purine nucleoside
antineoplastic agent;
bacterial metabolite;
nucleoside antibiotic
2004200420.0low000100
cyclophosphamidehydratealkylating agent;
antineoplastic agent;
carcinogenic agent;
immunosuppressive agent
00low000000
helenalincyclic ketone;
gamma-lactone;
organic heterotricyclic compound;
secondary alcohol;
sesquiterpene lactone
anti-inflammatory agent;
antineoplastic agent;
metabolite;
plant metabolite
00low000000
etidronate disodiumorganic sodium saltantineoplastic agent;
bone density conservation agent;
chelator
00low000000
camptothecindelta-lactone;
pyranoindolizinoquinoline;
quinoline alkaloid;
tertiary alcohol
antineoplastic agent;
EC 5.99.1.2 (DNA topoisomerase) inhibitor;
genotoxin;
plant metabolite
200820208.6low000170
isopentenyladenosineN-ribosyl-N(6)-isopentenyladenine;
nucleoside analogue
antineoplastic agent;
plant growth regulator;
plant metabolite
00low000000
nsc-145,668hydrochlorideantimetabolite;
antineoplastic agent
00low000000
ancitabinediol;
organic heterotricyclic compound
antimetabolite;
antineoplastic agent;
prodrug
00low000000
clodronic acid1,1-bis(phosphonic acid);
one-carbon compound;
organochlorine compound
antineoplastic agent;
bone density conservation agent
1990201225.0low003110
tetradecanoylphorbol acetateacetate ester;
diester;
phorbol ester;
tertiary alpha-hydroxy ketone;
tetradecanoate ester
antineoplastic agent;
apoptosis inducer;
carcinogenic agent;
mitogen;
plant metabolite;
protein kinase C agonist;
reactive oxygen species generator
1980202225.9low18312971574
streptozocinN-acylglucosamine;
N-nitrosoureas
antimicrobial agent;
antineoplastic agent;
DNA synthesis inhibitor;
metabolite
00low000000
daunorubicinaminoglycoside antibiotic;
anthracycline;
p-quinones;
tetracenequinones
antineoplastic agent;
bacterial metabolite
1986201024.5low113700
fludarabine phosphatenucleoside analogue;
organofluorine compound;
purine arabinonucleoside monophosphate
antimetabolite;
antineoplastic agent;
antiviral agent;
DNA synthesis inhibitor;
immunosuppressive agent;
prodrug
00low000000
2,6-diaminopurine2,6-diaminopurines;
primary amino compound
antineoplastic agent00low000000
silybinaromatic ether;
benzodioxine;
flavonolignan;
polyphenol;
secondary alpha-hydroxy ketone
antineoplastic agent;
antioxidant;
hepatoprotective agent;
plant metabolite
00low000000
glucaric acidglucaric acidantineoplastic agent2012201212.0low000010
paclitaxeltaxane diterpenoid;
tetracyclic diterpenoid
antineoplastic agent;
human metabolite;
metabolite;
microtubule-stabilising agent
2004201216.3low100210
etoposidebeta-D-glucoside;
furonaphthodioxole;
organic heterotetracyclic compound
antineoplastic agent;
DNA synthesis inhibitor
1994201718.2low102830
promegestone20-oxo steroid;
3-oxo-Delta(4) steroid
antineoplastic agent;
progesterone receptor agonist;
progestin
00low000000
perfosfamidenitrogen mustard;
organochlorine compound;
peroxol;
phosphorodiamide
alkylating agent;
antineoplastic agent;
drug allergen;
immunosuppressive agent;
metabolite
00low000000
nimustineaminopyrimidine;
N-nitrosoureas;
organochlorine compound
alkylating agent;
antineoplastic agent
00low000000
lonidaminedichlorobenzene;
indazoles;
monocarboxylic acid
antineoplastic agent;
antispermatogenic agent;
EC 2.7.1.1 (hexokinase) inhibitor;
geroprotector
00low000000
vindesinemethyl ester;
organic heteropentacyclic compound;
organic heterotetracyclic compound;
primary carboxamide;
tertiary alcohol;
tertiary amino compound;
vinca alkaloid
antineoplastic agent00low000000
epirubicinaminoglycoside;
anthracycline antibiotic;
anthracycline;
deoxy hexoside;
monosaccharide derivative;
p-quinones;
primary alpha-hydroxy ketone;
tertiary alpha-hydroxy ketone
antimicrobial agent;
antineoplastic agent;
EC 5.99.1.3 [DNA topoisomerase (ATP-hydrolysing)] inhibitor
00low000000
diaziquone1,4-benzoquinones;
aziridines;
carbamate ester;
enamine
alkylating agent;
antineoplastic agent
00low000000
midazolam hydrochloridehydrochloride;
imidazobenzodiazepine
anticonvulsant;
antineoplastic agent;
anxiolytic drug;
apoptosis inducer;
central nervous system depressant;
GABAA receptor agonist;
general anaesthetic;
muscle relaxant;
sedative
00low000000
oltipraz1,2-dithiole;
pyrazines
angiogenesis modulating agent;
antimutagen;
antineoplastic agent;
antioxidant;
EC 3.1.3.48 (protein-tyrosine-phosphatase) inhibitor;
neurotoxin;
protective agent;
schistosomicide drug
00low000000
fazarabineN-glycosyl-1,3,5-triazine;
nucleoside analogue
antineoplastic agent00low000000
mitoxantrone hydrochloridehydrochlorideantineoplastic agent00low000000
bisantreneanthracenes;
hydrazone;
imidazolidines
antineoplastic agent00low000000
swainsonineindolizidine alkaloidantineoplastic agent;
EC 3.2.1.114 (mannosyl-oligosaccharide 1,3-1,6-alpha-mannosidase) inhibitor;
immunological adjuvant;
plant metabolite
00low000000
lovastatindelta-lactone;
fatty acid ester;
hexahydronaphthalenes;
polyketide;
statin (naturally occurring)
anticholesteremic drug;
antineoplastic agent;
Aspergillus metabolite;
prodrug
00low000000
cabergolineN-acylureaantineoplastic agent;
antiparkinson drug;
dopamine agonist
00low000000
nitrogenase stabilizing-protective protein, bacteriaN-[4-cyano-3-(trifluoromethyl)phenyl]-3-[(4-fluorophenyl)sulfonyl]-2-hydroxy-2-methylpropanamideandrogen antagonist;
antineoplastic agent
00low000000
bmy 25067C-nitro compound;
organic disulfide
antineoplastic agent00low000000
brequinarbiphenyls;
monocarboxylic acid;
monofluorobenzenes;
quinolinemonocarboxylic acid
anticoronaviral agent;
antimetabolite;
antineoplastic agent;
antiviral agent;
EC 1.3.5.2 [dihydroorotate dehydrogenase (quinone)] inhibitor;
immunosuppressive agent;
pyrimidine synthesis inhibitor
00low000000
imiquimodimidazoquinolineantineoplastic agent;
interferon inducer
201220217.6low000041
aromasil17-oxo steroid;
3-oxo-Delta(1),Delta(4)-steroid
antineoplastic agent;
EC 1.14.14.14 (aromatase) inhibitor;
environmental contaminant;
xenobiotic
00low000000
cidofovir anhydrousphosphonic acids;
pyrimidone
anti-HIV agent;
antineoplastic agent;
antiviral drug;
photosensitizing agent
00low000000
topotecanpyranoindolizinoquinolineantineoplastic agent;
EC 5.99.1.2 (DNA topoisomerase) inhibitor
201720186.5low000020
gemcitabine hydrochloridehydrochloride;
organofluorine compound
anticoronaviral agent;
antimetabolite;
antineoplastic agent;
antiviral drug;
EC 1.17.4.1 (ribonucleoside-diphosphate reductase) inhibitor;
immunosuppressive agent;
radiosensitizing agent
00low000000
gemcitabineorganofluorine compound;
pyrimidine 2'-deoxyribonucleoside
antimetabolite;
antineoplastic agent;
antiviral drug;
DNA synthesis inhibitor;
EC 1.17.4.1 (ribonucleoside-diphosphate reductase) inhibitor;
environmental contaminant;
immunosuppressive agent;
photosensitizing agent;
prodrug;
radiosensitizing agent;
xenobiotic
202220222.0low000001
irinotecancarbamate ester;
delta-lactone;
N-acylpiperidine;
pyranoindolizinoquinoline;
ring assembly;
tertiary alcohol;
tertiary amino compound
antineoplastic agent;
apoptosis inducer;
EC 5.99.1.2 (DNA topoisomerase) inhibitor;
prodrug
200820218.5low000161
capecitabinecarbamate ester;
cytidines;
organofluorine compound
antimetabolite;
antineoplastic agent;
prodrug
202320231.0low000001
nelfinavir mesylatemethanesulfonate saltantineoplastic agent;
HIV protease inhibitor
00low000000
nelfinaviraryl sulfide;
benzamides;
organic heterobicyclic compound;
phenols;
secondary alcohol;
tertiary amino compound
antineoplastic agent;
HIV protease inhibitor
00low000000
betulinic acidhydroxy monocarboxylic acid;
pentacyclic triterpenoid
anti-HIV agent;
anti-inflammatory agent;
antimalarial;
antineoplastic agent;
EC 5.99.1.3 [DNA topoisomerase (ATP-hydrolysing)] inhibitor;
plant metabolite
201020218.2low000122
baicalindihydroxyflavone;
glucosiduronic acid;
glycosyloxyflavone;
monosaccharide derivative
antiatherosclerotic agent;
antibacterial agent;
anticoronaviral agent;
antineoplastic agent;
antioxidant;
cardioprotective agent;
EC 2.7.7.48 (RNA-directed RNA polymerase) inhibitor;
EC 3.4.21.26 (prolyl oligopeptidase) inhibitor;
ferroptosis inhibitor;
neuroprotective agent;
non-steroidal anti-inflammatory drug;
plant metabolite;
prodrug
00low000000
ro 5-33351,4-benzodiazepinone;
organochlorine compound;
pyrroles
anti-HIV-1 agent;
antineoplastic agent;
HIV-1 Tat inhibitor;
RUNX1 inhibitor
00low000000
plerixaforazacycloalkane;
azamacrocycle;
benzenes;
crown amine;
secondary amino compound;
tertiary amino compound
anti-HIV agent;
antineoplastic agent;
C-X-C chemokine receptor type 4 antagonist;
immunological adjuvant
00low000000
epigallocatechin gallateflavans;
gallate ester;
polyphenol
antineoplastic agent;
antioxidant;
apoptosis inducer;
geroprotector;
Hsp90 inhibitor;
neuroprotective agent;
plant metabolite
00low000000
salvinabietane diterpenoid;
carbotricyclic compound;
catechols;
monocarboxylic acid
angiogenesis modulating agent;
anti-inflammatory agent;
antineoplastic agent;
antioxidant;
apoptosis inducer;
food preservative;
HIV protease inhibitor;
plant metabolite
00low000000
1,2,3,4,6-pentakis-O-galloyl-beta-D-glucosegallate ester;
galloyl beta-D-glucose
anti-inflammatory agent;
antineoplastic agent;
geroprotector;
hepatoprotective agent;
plant metabolite;
radiation protective agent;
radical scavenger
00low000000
pyrrolidine dithiocarbamatedithiocarbamic acids;
pyrrolidines
anticonvulsant;
antineoplastic agent;
geroprotector;
neuroprotective agent;
NF-kappaB inhibitor;
radical scavenger
00low000000
triptonidebutenolide;
cyclic ketone;
diterpene triepoxide;
organic heteroheptacyclic compound
anti-inflammatory agent;
antineoplastic agent;
immunosuppressive agent
00low000000
3'-deoxyadenosine 5'-triphosphatepurine ribonucleoside 5'-triphosphateantifungal agent;
antimetabolite;
antineoplastic agent;
antiviral agent
00low000000
2-methoxyestradiol17beta-hydroxy steroid;
3-hydroxy steroid
angiogenesis modulating agent;
antimitotic;
antineoplastic agent;
human metabolite;
metabolite;
mouse metabolite
00low000000
toxoflavincarbonyl compound;
pyrimidotriazine
antibacterial agent;
antineoplastic agent;
apoptosis inducer;
bacterial metabolite;
toxin;
virulence factor;
Wnt signalling inhibitor
00low000000
lupulonbeta-bitter acidangiogenesis inhibitor;
antimicrobial agent;
antineoplastic agent;
apoptosis inducer
00low000000
pinocembrin(2S)-flavan-4-one;
dihydroxyflavanone
antineoplastic agent;
antioxidant;
metabolite;
neuroprotective agent;
vasodilator agent
00low000000
tangeretinpentamethoxyflavoneantineoplastic agent;
plant metabolite
00low000000
ethinylestradiol-3-sulfate17beta-hydroxy steroid;
steroid sulfate
antineoplastic agent;
estrogen
00low000000
lonazolacmonocarboxylic acid;
monochlorobenzenes;
pyrazoles
antineoplastic agent;
EC 1.14.99.1 (prostaglandin-endoperoxide synthase) inhibitor;
non-narcotic analgesic;
non-steroidal anti-inflammatory drug
00low000000
bromopyruvate2-oxo monocarboxylic acid;
organobromine compound;
oxo carboxylic acid
alkylating agent;
antineoplastic agent
00low000000
enrofloxacincyclopropanes;
N-alkylpiperazine;
N-arylpiperazine;
organofluorine compound;
quinolinemonocarboxylic acid;
quinolone
antibacterial agent;
antimicrobial agent;
antineoplastic agent
1997201717.0low001010
dexrazoxanerazoxaneantineoplastic agent;
cardiovascular drug;
chelator;
immunosuppressive agent
00low000000
masoprocolnordihydroguaiaretic acidantineoplastic agent;
hypoglycemic agent;
lipoxygenase inhibitor;
metabolite
1987201328.0low016110
dw a 2114rplatinum coordination entity;
pyrrolidines
antineoplastic agent00low000000
prednisolone phosphate11beta-hydroxy steroid;
17alpha-hydroxy steroid;
20-oxo steroid;
3-oxo-Delta(1),Delta(4)-steroid;
glucocorticoid;
steroid phosphate;
tertiary alpha-hydroxy ketone
anti-inflammatory agent;
antineoplastic agent;
glucocorticoid receptor agonist;
prodrug
00low000000
hesperetin3'-hydroxyflavanones;
4'-methoxyflavanones;
monomethoxyflavanone;
trihydroxyflavanone
antineoplastic agent;
antioxidant;
plant metabolite
00low000000
sesaminbenzodioxoles;
furofuran;
lignan
antineoplastic agent;
neuroprotective agent;
plant metabolite
00low000000
betulindiol;
pentacyclic triterpenoid
analgesic;
anti-inflammatory agent;
antineoplastic agent;
antiviral agent;
metabolite
00low000000
nobiletinmethoxyflavoneantineoplastic agent;
plant metabolite
00low000000
picropodophyllinfuronaphthodioxole;
lignan;
organic heterotetracyclic compound
antineoplastic agent;
insulin-like growth factor receptor 1 antagonist;
plant metabolite;
tyrosine kinase inhibitor
00low000000
alantolactonenaphthofuran;
olefinic compound;
sesquiterpene lactone
antineoplastic agent;
apoptosis inducer;
plant metabolite
00low000000
kaurenoic acident-kaurane diterpenoidanti-HIV-1 agent;
antineoplastic agent;
plant metabolite
00low000000
dehydrocostus lactonegamma-lactone;
guaiane sesquiterpenoid;
organic heterotricyclic compound;
sesquiterpene lactone
antimycobacterial drug;
antineoplastic agent;
apoptosis inducer;
cyclooxygenase 2 inhibitor;
metabolite;
trypanocidal drug
00low000000
xanthomicroldihydroxyflavone;
trimethoxyflavone
antineoplastic agent;
plant metabolite
00low000000
voacaminealkaloid ester;
methyl ester;
monoterpenoid indole alkaloid;
organic heteropentacyclic compound;
tertiary amino compound
angiogenesis inhibitor;
antineoplastic agent;
plant metabolite
00low000000
brazilincatechols;
organic heterotetracyclic compound;
tertiary alcohol
anti-inflammatory agent;
antibacterial agent;
antineoplastic agent;
antioxidant;
apoptosis inducer;
biological pigment;
hepatoprotective agent;
histological dye;
NF-kappaB inhibitor;
plant metabolite
00low000000
uvaretinaromatic ether;
dihydrochalcones;
polyketide;
resorcinol
antineoplastic agent;
plant metabolite
00low000000
fangchinolinearomatic ether;
bisbenzylisoquinoline alkaloid;
macrocycle
anti-HIV-1 agent;
anti-inflammatory agent;
antineoplastic agent;
antioxidant;
neuroprotective agent;
plant metabolite
00low000000
maslinic aciddihydroxy monocarboxylic acid;
pentacyclic triterpenoid
anti-inflammatory agent;
antineoplastic agent;
antioxidant;
plant metabolite
00low000000
tetrazolium violetorganic chloride saltantineoplastic agent;
apoptosis inducer;
dye
00low000000
irinotecan hydrochloridehydrochlorideantineoplastic agent;
apoptosis inducer;
EC 5.99.1.2 (DNA topoisomerase) inhibitor;
prodrug
00low000000
5-(3-methyl-1-triazeno)imidazole-4-carboxamideimidazoles;
monocarboxylic acid amide;
triazene derivative
alkylating agent;
antineoplastic agent
00low000000
hydroxyguanidineguanidines;
one-carbon compound
antineoplastic agent;
antiviral agent
00low000000
cryptolepineindole alkaloid;
organic heterotetracyclic compound;
organonitrogen heterocyclic compound
anti-inflammatory agent;
antimalarial;
antineoplastic agent;
cysteine protease inhibitor;
plant metabolite
00low000000
bexarotenebenzoic acids;
naphthalenes;
retinoid
antineoplastic agent00low000000
3,4-dihydroxyphenylethanolcatechols;
primary alcohol
antineoplastic agent;
antioxidant;
metabolite
00low000000
terreic acidarene epoxide;
diketone;
monohydroxy-1,4-benzoquinones;
tertiary alpha-hydroxy ketone
antibacterial agent;
antineoplastic agent;
Aspergillus metabolite;
EC 2.3.1.* (acyltransferase transferring other than amino-acyl group) inhibitor;
EC 2.5.1.7 (UDP-N-acetylglucosamine 1-carboxyvinyltransferase) inhibitor;
EC 2.7.10.2 (non-specific protein-tyrosine kinase) inhibitor;
mycotoxin
00low000000
4-methylumbelliferyl glucuronidebeta-D-glucosiduronic acid;
coumarins;
monosaccharide derivative
antineoplastic agent;
chromogenic compound;
hyaluronan synthesis inhibitor
00low000000
9-hydroxyellipticineorganic heterotetracyclic compound;
organonitrogen heterocyclic compound
antineoplastic agent00low000000
nimustinehydrochlorideantineoplastic agent00low000000
beta-peltatinfuronaphthodioxole;
gamma-lactone;
lignan;
organic heterotetracyclic compound;
phenols
antineoplastic agent;
plant metabolite
00low000000
alpha-peltatinfuronaphthodioxole;
gamma-lactone;
lignan;
organic heterotetracyclic compound;
phenols
antineoplastic agent;
metabolite
00low000000
cryptopleurinealkaloid antibiotic;
alkaloid;
aromatic ether;
organic heteropentacyclic compound
antineoplastic agent;
antiviral agent;
protein synthesis inhibitor
00low000000
sugiolabietane diterpenoid;
carbotricyclic compound;
cyclic terpene ketone;
meroterpenoid;
phenols
antineoplastic agent;
antioxidant;
antiviral agent;
plant metabolite;
radical scavenger
00low000000
eupatorindihydroxyflavone;
polyphenol;
trimethoxyflavone
anti-inflammatory agent;
antineoplastic agent;
apoptosis inducer;
Brassica napus metabolite;
calcium channel blocker;
P450 inhibitor;
vasodilator agent
00low000000
1-methyltryptophannon-proteinogenic alpha-amino acid;
tryptophan derivative
antineoplastic agent;
EC 1.13.11.52 (indoleamine 2,3-dioxygenase) inhibitor
00low000000
atromentindihydroxy-1,4-benzoquinones;
polyphenol
antibacterial agent;
anticoagulant;
antineoplastic agent;
apoptosis inducer;
biological pigment;
EC 1.3.1.9 [enoyl-[acyl-carrier-protein] reductase (NADH)] inhibitor;
fungal metabolite
00low000000
diosgenin3beta-sterol;
hexacyclic triterpenoid;
sapogenin;
spiroketal
antineoplastic agent;
antiviral agent;
apoptosis inducer;
metabolite
201420187.2low000040
alpha-glutamyltryptophandipeptideangiogenesis modulating agent;
antineoplastic agent;
immunomodulator;
metabolite
00low000000
fulvestrant17beta-hydroxy steroid;
3-hydroxy steroid;
organofluorine compound;
sulfoxide
antineoplastic agent;
estrogen antagonist;
estrogen receptor antagonist
1996201418.4low001610
ici 16438417beta-hydroxy steroid;
3-hydroxy steroid;
tertiary carboxamide
anti-estrogen;
antineoplastic agent;
estrogen receptor antagonist
00low000000
sn 38delta-lactone;
phenols;
pyranoindolizinoquinoline;
tertiary alcohol
antineoplastic agent;
apoptosis inducer;
drug metabolite;
EC 5.99.1.2 (DNA topoisomerase) inhibitor
00low000000
deguelinaromatic ether;
diether;
organic heteropentacyclic compound;
rotenones
angiogenesis inhibitor;
anti-inflammatory agent;
antineoplastic agent;
antiviral agent;
apoptosis inducer;
EC 2.7.11.1 (non-specific serine/threonine protein kinase) inhibitor;
mitochondrial NADH:ubiquinone reductase inhibitor;
plant metabolite
00low000000
fingolimodaminodiol;
primary amino compound
antineoplastic agent;
CB1 receptor antagonist;
immunosuppressive agent;
prodrug;
sphingosine-1-phosphate receptor agonist
00low000000
cafestolditerpenoid;
furans;
organic heteropentacyclic compound;
primary alcohol;
tertiary alcohol
angiogenesis inhibitor;
anti-inflammatory agent;
antineoplastic agent;
antioxidant;
apoptosis inducer;
hypoglycemic agent;
plant metabolite
00low000000
tamibarotenedicarboxylic acid monoamide;
retinoid;
tetralins
antineoplastic agent;
retinoic acid receptor alpha/beta agonist
00low000000
ecteinascidin 743acetate ester;
azaspiro compound;
bridged compound;
hemiaminal;
isoquinoline alkaloid;
lactone;
organic heteropolycyclic compound;
organic sulfide;
oxaspiro compound;
polyphenol;
tertiary amino compound
alkylating agent;
angiogenesis modulating agent;
anti-inflammatory agent;
antineoplastic agent;
marine metabolite
00low000000
homoorientinflavone C-glycoside;
tetrahydroxyflavone
antineoplastic agent;
radical scavenger
00low000000
kahweolditerpenoid;
furans;
organic heteropentacyclic compound;
primary alcohol;
tertiary alcohol
angiogenesis inhibitor;
anti-inflammatory agent;
antineoplastic agent;
antioxidant;
apoptosis inducer;
plant metabolite
00low000000
selenomethylselenocysteinenon-proteinogenic alpha-amino acid;
selenocysteines
antineoplastic agent;
human metabolite
00low000000
tephrosinaromatic ether;
cyclic ketone;
organic heteropentacyclic compound;
rotenones
antineoplastic agent;
metabolite;
pesticide
00low000000
5-(tetradecyloxy)-2-furancarboxylic acidaromatic ether;
furoic acid
antineoplastic agent;
apoptosis inducer;
EC 6.4.1.2 (acetyl-CoA carboxylase) inhibitor;
PPARalpha agonist
00low000000
sc 58125organofluorine compound;
pyrazoles;
sulfone
antineoplastic agent;
cyclooxygenase 2 inhibitor
00low000000
marimastathydroxamic acid;
secondary carboxamide
antineoplastic agent;
matrix metalloproteinase inhibitor
00low000000
1'-acetoxychavicol acetateacetate ester;
phenylpropanoid
antineoplastic agent;
NF-kappaB inhibitor;
plant metabolite
00low000000
clofarabineadenosines;
organofluorine compound
antimetabolite;
antineoplastic agent
00low000000
dioscinhexacyclic triterpenoid;
spiroketal;
spirostanyl glycoside;
trisaccharide derivative
anti-inflammatory agent;
antifungal agent;
antineoplastic agent;
antiviral agent;
apoptosis inducer;
EC 1.14.18.1 (tyrosinase) inhibitor;
hepatoprotective agent;
metabolite
00low000000
ginsenoside rh212beta-hydroxy steroid;
20-hydroxy steroid;
beta-D-glucoside;
ginsenoside;
tetracyclic triterpenoid
antineoplastic agent;
apoptosis inducer;
bone density conservation agent;
cardioprotective agent;
hepatoprotective agent;
plant metabolite
00low000000
celastrolmonocarboxylic acid;
pentacyclic triterpenoid
anti-inflammatory drug;
antineoplastic agent;
antioxidant;
EC 5.99.1.3 [DNA topoisomerase (ATP-hydrolysing)] inhibitor;
Hsp90 inhibitor;
metabolite
00low000000
4'-demethylepipodophyllotoxinfuronaphthodioxole;
organic heterotetracyclic compound;
phenols
antineoplastic agent00low000000
imatinib mesylatemethanesulfonate saltanticoronaviral agent;
antineoplastic agent;
apoptosis inducer;
tyrosine kinase inhibitor
201520159.0low000010
aminolevulinic acid hydrochloridehydrochlorideantineoplastic agent;
dermatologic drug;
photosensitizing agent;
prodrug
00low000000
gefitinibaromatic ether;
monochlorobenzenes;
monofluorobenzenes;
morpholines;
quinazolines;
secondary amino compound;
tertiary amino compound
antineoplastic agent;
epidermal growth factor receptor antagonist
00low000000
cgp 42112abenzyl ester;
oligopeptide;
pyridinecarboxamide
angiotensin receptor agonist;
anti-inflammatory agent;
antineoplastic agent;
neuroprotective agent;
vasodilator agent
00low000000
vadimezanmonocarboxylic acid;
xanthones
antineoplastic agent00low000000
rubimaillinbenzochromene;
methyl ester;
phenols
acyl-CoA:cholesterol acyltransferase 2 inhibitor;
anti-inflammatory agent;
antineoplastic agent;
apoptosis inducer;
neuroprotective agent;
NF-kappaB inhibitor;
plant metabolite
00low000000
4-carbamoylimidazolium 5-olatehydroxyimidazole;
monocarboxylic acid amide
antineoplastic agent00low000000
nsc 2240701,4-benzoquinones;
aziridines;
enamine;
primary alcohol;
secondary amino compound
alkylating agent;
antineoplastic agent
00low000000
psorosperminepoxide;
organic heterotetracyclic compound;
xanthones
antineoplastic agent;
plant metabolite
00low000000
ay 25545acetate ester;
aromatic ether;
C-glycosyl compound;
naphthoisochromene;
olefinic compound;
phenols;
tertiary amine
antimicrobial agent;
antineoplastic agent;
bacterial metabolite
00low000000
methotrexatedicarboxylic acid;
monocarboxylic acid amide;
pteridines
abortifacient;
antimetabolite;
antineoplastic agent;
antirheumatic drug;
dermatologic drug;
DNA synthesis inhibitor;
EC 1.5.1.3 (dihydrofolate reductase) inhibitor;
immunosuppressive agent
1992202115.1low101017232
3,7-dihydroxytropolonealpha-hydroxy ketone;
cyclic ketone;
enol;
triol
antineoplastic agent;
bacterial metabolite
00low000000
delphinidin5-hydroxyanthocyanidinantineoplastic agent;
biological pigment;
plant metabolite
00low000000
tamsulosin5-(2-{[2-(2-ethoxyphenoxy)ethyl]amino}propyl)-2-methoxybenzenesulfonamidealpha-adrenergic antagonist;
antineoplastic agent
00low000000
saintopintetracenequinonesantineoplastic agent;
EC 5.99.1.2 (DNA topoisomerase) inhibitor;
fungal metabolite;
intercalator
00low000000
6-bromo-3-(bromomethyl)-7-methyl-2,3,7-trichloro-1-octenemonoterpenoid;
organobromine compound;
organochlorine compound
algal metabolite;
antineoplastic agent;
marine metabolite
00low000000
ilomastathydroxamic acid;
L-tryptophan derivative;
N-acyl-amino acid
anti-inflammatory agent;
antibacterial agent;
antineoplastic agent;
EC 3.4.24.24 (gelatinase A) inhibitor;
neuroprotective agent
00low000000
abiraterone3beta-hydroxy-Delta(5)-steroid;
3beta-sterol;
pyridines
antineoplastic agent;
EC 1.14.99.9 (steroid 17alpha-monooxygenase) inhibitor
00low000000
yakuchinone-aketone;
monomethoxybenzene;
phenols
antineoplastic agent;
cyclooxygenase 1 inhibitor;
cyclooxygenase 2 inhibitor;
EC 1.14.13.39 (nitric oxide synthase) inhibitor;
metabolite
00low000000
pomalidomidearomatic amine;
dicarboximide;
isoindoles;
piperidones
angiogenesis inhibitor;
antineoplastic agent;
immunomodulator
00low000000
tempolaminoxyls;
hydroxypiperidine
anti-inflammatory agent;
antineoplastic agent;
apoptosis inducer;
catalyst;
hepatoprotective agent;
nephroprotective agent;
neuroprotective agent;
radical scavenger
00low000000
selenomethylselenocysteineamino acid zwitterion;
L-selenocysteine derivative;
non-proteinogenic L-alpha-amino acid;
Se-methylselenocysteine
antineoplastic agent00low000000
10-propargyl-10-deazaaminopterinN-acyl-L-glutamic acid;
pteridines;
terminal acetylenic compound
antimetabolite;
antineoplastic agent;
EC 1.5.1.3 (dihydrofolate reductase) inhibitor
00low000000
docetaxelhydrate;
secondary alpha-hydroxy ketone
antineoplastic agent00low000000
docetaxel anhydroussecondary alpha-hydroxy ketone;
tetracyclic diterpenoid
antimalarial;
antineoplastic agent;
photosensitizing agent
201820186.0low000010
lonafarnib4-{2-[4-(3,10-dibromo-8-chloro-6,11-dihydro-5H-benzo[5,6]cyclohepta[1,2-b]pyridin-11-yl)piperidin-1-yl]-2-oxoethyl}piperidine-1-carboxamideantineoplastic agent;
EC 2.5.1.58 (protein farnesyltransferase) inhibitor
00low000000
aclacinomycinaminoglycoside;
anthracycline;
deoxy hexoside;
methyl ester;
monosaccharide derivative;
phenols;
polyketide;
tertiary alcohol;
tetracenequinones;
zwitterion
antimicrobial agent;
antineoplastic agent;
metabolite
00low000000
6-azauridine-5'-monophosphateN-glycosyl-1,2,4-triazine;
nucleoside monophosphate analogue
antineoplastic agent;
EC 4.1.1.23 (orotidine-5'-phosphate decarboxylase) inhibitor
00low000000
ptk 787succinate saltangiogenesis inhibitor;
antineoplastic agent;
EC 2.7.10.1 (receptor protein-tyrosine kinase) inhibitor;
vascular endothelial growth factor receptor antagonist
00low000000
vatalanibmonochlorobenzenes;
phthalazines;
pyridines;
secondary amino compound
angiogenesis inhibitor;
antineoplastic agent;
EC 2.7.10.1 (receptor protein-tyrosine kinase) inhibitor;
vascular endothelial growth factor receptor antagonist
00low000000
cyc 682nitrile;
nucleoside analogue;
secondary carboxamide
antimetabolite;
antineoplastic agent;
DNA synthesis inhibitor;
prodrug
00low000000
canertinibmonochlorobenzenes;
morpholines;
organofluorine compound;
quinazolines
antineoplastic agent;
tyrosine kinase inhibitor
00low000000
methyl 5-aminolevulinate hydrochloridehydrochlorideantineoplastic agent;
dermatologic drug;
photosensitizing agent;
prodrug
00low000000
methyl 5-aminolevulinatedelta-amino acid esterantineoplastic agent;
dermatologic drug;
photosensitizing agent;
prodrug
00low000000
tipifarnibimidazoles;
monochlorobenzenes;
primary amino compound;
quinolone
antineoplastic agent;
apoptosis inducer;
EC 2.5.1.58 (protein farnesyltransferase) inhibitor
00low000000
aklavinoneanthracycline;
methyl ester;
tertiary alcohol;
tetracenequinones
antineoplastic agent00low000000
actinodaphineaporphine alkaloid;
aromatic ether;
organic heteropentacyclic compound;
phenols;
secondary amino compound
antibacterial agent;
antifungal agent;
antineoplastic agent;
apoptosis inducer;
plant metabolite;
platelet aggregation inhibitor;
topoisomerase inhibitor
00low000000
i-677L-serine derivative;
non-proteinogenic L-alpha-amino acid
antimetabolite;
antimicrobial agent;
antineoplastic agent;
metabolite
00low000000
anonaineaporphine alkaloid;
organic heteropentacyclic compound;
oxacycle
antineoplastic agent;
antiplasmodial drug;
trypanocidal drug
00low000000
4'-demethyldesoxypodophyllotoxinfuronaphthodioxole;
gamma-lactone;
lignan;
methoxybenzenes;
phenols
antineoplastic agent;
antioxidant;
immunosuppressive agent;
plant metabolite
00low000000
salvigeninmonohydroxyflavone;
trimethoxyflavone
antilipemic drug;
antineoplastic agent;
apoptosis inhibitor;
autophagy inducer;
hypoglycemic agent;
immunomodulator;
neuroprotective agent;
plant metabolite
00low000000
deferrioxamine ecyclic desferrioxamine;
cyclic hydroxamic acid;
macrocycle
antineoplastic agent;
bacterial metabolite;
marine metabolite;
siderophore
00low000000
ampelopsindihydromyricetin;
secondary alpha-hydroxy ketone
antineoplastic agent;
antioxidant;
metabolite
00low000000
acetyl aleuritolic acidacetate ester;
monocarboxylic acid;
pentacyclic triterpenoid
antineoplastic agent;
plant metabolite
00low000000
withanolide d20-hydroxy steroid;
4-hydroxy steroid;
delta-lactone;
enone;
epoxy steroid;
ergostanoid;
secondary alcohol;
tertiary alcohol;
withanolide
antineoplastic agent00low000000
myricanonearomatic ether;
cyclic ketone;
diarylheptanoid;
methoxybenzenes;
phenols
antineoplastic agent;
plant metabolite
00low000000
cirsilineoldihydroxyflavone;
trimethoxyflavone
antineoplastic agent;
plant metabolite
00low000000
pannarinaldehyde;
aromatic ether;
depsidones;
organic heterotricyclic compound;
organochlorine compound;
phenols
antimicrobial agent;
antineoplastic agent;
apoptosis inducer;
lichen metabolite
00low000000
6-methylthiohexyl isothiocyanateisothiocyanate;
methyl sulfide
antineoplastic agent;
Arabidopsis thaliana metabolite;
EC 4.1.1.17 (ornithine decarboxylase) inhibitor;
neuroprotective agent
00low000000
pectolinarindimethoxyflavone;
disaccharide derivative;
glycosyloxyflavone;
monohydroxyflavanone;
rutinoside
anti-inflammatory agent;
antineoplastic agent;
antioxidant;
apoptosis inducer;
EC 3.4.22.69 (SARS coronavirus main proteinase) inhibitor;
plant metabolite
00low000000
albicanolcarbobicyclic compound;
homoallylic alcohol;
primary alcohol;
sesquiterpenoid
antifeedant;
antifungal agent;
antineoplastic agent;
fungal metabolite;
mammalian metabolite;
marine metabolite;
plant metabolite
00low000000
5-o-methylembelinenol ether;
monohydroxy-1,4-benzoquinones
antileishmanial agent;
antineoplastic agent;
hepatitis C protease inhibitor;
metabolite
00low000000
asperphenamatebenzamides;
carboxylic ester;
L-phenylalanine derivative
antineoplastic agent00low000000
erlotinibaromatic ether;
quinazolines;
secondary amino compound;
terminal acetylenic compound
antineoplastic agent;
epidermal growth factor receptor antagonist;
protein kinase inhibitor
00low000000
erlotinib hydrochloridehydrochloride;
terminal acetylenic compound
antineoplastic agent;
protein kinase inhibitor
202320231.0low100001
corynolinebenzophenanthridine alkaloid;
cyclic acetal;
isoquinolines;
organic heterohexacyclic compound;
secondary alcohol
antineoplastic agent;
EC 3.1.1.7 (acetylcholinesterase) inhibitor;
hepatoprotective agent;
metabolite
00low000000
helioxanthinbenzodioxoles;
furonaphthodioxole;
lignan
anti-HBV agent;
antineoplastic agent;
plant metabolite
00low000000
top 53furonaphthodioxole;
gamma-lactone;
organic heterotetracyclic compound;
phenols;
tertiary amino compound
antineoplastic agent;
EC 5.99.1.3 [DNA topoisomerase (ATP-hydrolysing)] inhibitor
00low000000
5-heptadecylresorcinol5-alkylresorcinolantineoplastic agent;
plant metabolite
00low000000
minquartynoic acidacetylenic fatty acid;
hydroxy polyunsaturated fatty acid;
long-chain fatty acid;
straight-chain fatty acid;
tetrayne
antimalarial;
antineoplastic agent;
antiviral agent
00low000000
scutellaringlucosiduronic acid;
glycosyloxyflavone;
monosaccharide derivative;
trihydroxyflavone
antineoplastic agent;
proteasome inhibitor
00low000000
ergolideacetate ester;
cyclic ketone;
gamma-lactone;
organic heterotricyclic compound;
sesquiterpene lactone
anti-inflammatory agent;
antineoplastic agent;
metabolite;
NF-kappaB inhibitor;
plant metabolite
00low000000
2,5-dihydroxybenzyl alcoholaromatic primary alcohol;
phenols
antineoplastic agent;
antioxidant;
apoptosis inhibitor;
fungal metabolite
00low000000
chrysosplenol ctrihydroxyflavone;
trimethoxyflavone
antineoplastic agent;
antiviral agent;
plant metabolite
00low000000
lanperisone2-methyl-3-(pyrrolidin-1-yl)-1-[4-(trifluoromethyl)phenyl]propan-1-oneantineoplastic agent;
calcium channel blocker;
ferroptosis inducer;
muscle relaxant;
voltage-gated sodium channel blocker
00low000000
(-)-gallocatechin gallatecatechin;
gallate ester;
polyphenol
antineoplastic agent;
EC 3.4.22.69 (SARS coronavirus main proteinase) inhibitor;
human xenobiotic metabolite;
plant metabolite
00low000000
orantinibmonocarboxylic acid;
oxindoles;
pyrroles
antineoplastic agent;
EC 2.7.10.1 (receptor protein-tyrosine kinase) inhibitor;
vascular endothelial growth factor receptor antagonist
00low000000
lapatinibfurans;
organochlorine compound;
organofluorine compound;
quinazolines
antineoplastic agent;
tyrosine kinase inhibitor
00low000000
firocoxibbutenolide;
cyclopropanes;
enol ether;
sulfone
antineoplastic agent;
cyclooxygenase 2 inhibitor;
non-narcotic analgesic;
non-steroidal anti-inflammatory drug
00low000000
2-(4-morpholinoanilino)-6-cyclohexylaminopurinemorpholines;
purines;
secondary amino compound;
tertiary amino compound
adenosine A3 receptor antagonist;
antineoplastic agent;
Aurora kinase inhibitor;
cell dedifferentiation agent
00low000000
sorafenib(trifluoromethyl)benzenes;
aromatic ether;
monochlorobenzenes;
phenylureas;
pyridinecarboxamide
angiogenesis inhibitor;
anticoronaviral agent;
antineoplastic agent;
EC 2.7.11.1 (non-specific serine/threonine protein kinase) inhibitor;
ferroptosis inducer;
tyrosine kinase inhibitor
202120213.0low000001
lenalidomidearomatic amine;
dicarboximide;
isoindoles;
piperidones
angiogenesis inhibitor;
antineoplastic agent;
immunomodulator
201720177.0low000010
lasofoxifenearomatic ether;
N-alkylpyrrolidine;
naphthols;
tetralins
antineoplastic agent;
bone density conservation agent;
cardioprotective agent;
estrogen receptor agonist;
estrogen receptor antagonist
00low000000
l 778,123hydrochlorideantineoplastic agent;
EC 2.5.1.58 (protein farnesyltransferase) inhibitor;
EC 2.5.1.59 (protein geranylgeranyltransferase type I) inhibitor;
radiosensitizing agent
00low000000
l 778,123imidazoles;
monochlorobenzenes;
nitrile;
piperazinone;
tertiary amino compound
antineoplastic agent;
EC 2.5.1.58 (protein farnesyltransferase) inhibitor;
EC 2.5.1.59 (protein geranylgeranyltransferase type I) inhibitor
00low000000
n-(3-chloro-7-indolyl)-1,4-benzenedisulphonamidechloroindole;
organochlorine compound;
sulfonamide
antineoplastic agent;
EC 4.2.1.1 (carbonic anhydrase) inhibitor
00low000000
diflomotecanepsilon-lactone;
organic heteropentacyclic compound;
organofluorine compound;
organonitrogen heterocyclic compound;
tertiary alcohol
antineoplastic agent;
EC 5.99.1.2 (DNA topoisomerase) inhibitor
00low000000
demecolcinealkaloid;
secondary amino compound
antineoplastic agent;
microtubule-destabilising agent
1990199034.0low001000
dromostanolone propionate3-oxo-5alpha-steroid;
steroid ester
antineoplastic agent00low000000
vincaleukoblastineacetate ester;
indole alkaloid fundamental parent;
methyl ester;
organic heteropentacyclic compound;
organic heterotetracyclic compound;
tertiary alcohol;
tertiary amino compound;
vinca alkaloid
antineoplastic agent;
immunosuppressive agent;
microtubule-destabilising agent;
plant metabolite
00low000000
vincristine sulfateorganic sulfate saltantineoplastic agent;
geroprotector
00low000000
anisomycinmonohydroxypyrrolidine;
organonitrogen heterocyclic antibiotic
anticoronaviral agent;
antimicrobial agent;
antineoplastic agent;
antiparasitic agent;
bacterial metabolite;
DNA synthesis inhibitor;
protein synthesis inhibitor
00low000000
estramustine17beta-hydroxy steroid;
carbamate ester;
organochlorine compound
alkylating agent;
antineoplastic agent;
radiation protective agent
00low000000
withaferin a27-hydroxy steroid;
4-hydroxy steroid;
delta-lactone;
enone;
epoxy steroid;
ergostanoid;
primary alcohol;
secondary alcohol;
withanolide
antineoplastic agent;
apoptosis inducer
00low000000
noscapinearomatic ether;
benzylisoquinoline alkaloid;
cyclic acetal;
isobenzofuranone;
organic heterobicyclic compound;
organic heterotricyclic compound;
tertiary amino compound
antineoplastic agent;
antitussive;
apoptosis inducer;
plant metabolite
202120232.0low000002
homoharringtoninealkaloid ester;
enol ether;
organic heteropentacyclic compound;
tertiary alcohol
anticoronaviral agent;
antineoplastic agent;
apoptosis inducer;
protein synthesis inhibitor
00low000000
acivicinisoxazoles;
non-proteinogenic L-alpha-amino acid;
organochlorine compound
antileishmanial agent;
antimetabolite;
antimicrobial agent;
antineoplastic agent;
EC 2.3.2.2 (gamma-glutamyltransferase) inhibitor;
glutamine antagonist;
metabolite
00low000000
elesclomolcarbohydrazide;
thiocarbonyl compound
antineoplastic agent;
apoptosis inducer
00low000000
wortmanninacetate ester;
cyclic ketone;
delta-lactone;
organic heteropentacyclic compound
anticoronaviral agent;
antineoplastic agent;
autophagy inhibitor;
EC 2.7.1.137 (phosphatidylinositol 3-kinase) inhibitor;
geroprotector;
Penicillium metabolite;
radiosensitizing agent
1997202114.5low0011081
rocaglamidemonocarboxylic acid amide;
monomethoxybenzene;
organic heterotricyclic compound
antileishmanial agent;
antineoplastic agent;
metabolite
00low000000
anthricinfuronaphthodioxole;
gamma-lactone;
lignan;
methoxybenzenes
antineoplastic agent;
apoptosis inducer;
plant metabolite
00low000000
acronineacridone derivatives;
alkaloid
antineoplastic agent;
metabolite
00low000000
taiwanin cbenzodioxoles;
furonaphthodioxole;
lignan
antineoplastic agent;
plant metabolite;
platelet aggregation inhibitor
00low000000
o-(chloroacetylcarbamoyl)fumagillolcarbamate ester;
organochlorine compound;
semisynthetic derivative;
sesquiterpenoid;
spiro-epoxide
angiogenesis inhibitor;
antineoplastic agent;
EC 1.5.1.3 (dihydrofolate reductase) inhibitor;
methionine aminopeptidase 2 inhibitor;
retinoic acid receptor alpha antagonist
00low000000
bortezomibamino acid amide;
L-phenylalanine derivative;
pyrazines
antineoplastic agent;
antiprotozoal drug;
protease inhibitor;
proteasome inhibitor
2011201113.0low000010
gant 61aminal;
dialkylarylamine;
pyridines;
substituted aniline;
tertiary amino compound
antineoplastic agent;
apoptosis inducer;
glioma-associated oncogene inhibitor;
Hedgehog signaling pathway inhibitor
00low000000
carnosineamino acid zwitterion;
dipeptide
anticonvulsant;
antineoplastic agent;
antioxidant;
Daphnia magna metabolite;
geroprotector;
human metabolite;
mouse metabolite;
neuroprotective agent
1990201723.6low004210
puromycinpuromycinsantiinfective agent;
antimicrobial agent;
antineoplastic agent;
EC 3.4.11.14 (cytosol alanyl aminopeptidase) inhibitor;
EC 3.4.14.2 (dipeptidyl-peptidase II) inhibitor;
nucleoside antibiotic;
protein synthesis inhibitor
1978197846.0low010000
pentostatincoformycinsantimetabolite;
antineoplastic agent;
Aspergillus metabolite;
bacterial metabolite;
EC 3.5.4.4 (adenosine deaminase) inhibitor
1994199430.0low001000
canalineamino acid zwitterion;
non-proteinogenic L-alpha-amino acid
antimetabolite;
antineoplastic agent;
phytogenic insecticide;
plant metabolite
00low000000
hippeastrinedelta-lactone;
indole alkaloid;
organic heteropentacyclic compound;
secondary alcohol
antineoplastic agent;
metabolite
00low000000
peonidin5-hydroxyanthocyanidinantineoplastic agent;
antioxidant;
apoptosis inducer;
metabolite
00low000000
glaucarubinonecarboxylic ester;
organic heteropentacyclic compound;
quassinoid;
secondary alpha-hydroxy ketone;
tertiary alpha-hydroxy ketone;
tetrol
antimalarial;
antineoplastic agent;
geroprotector;
plant metabolite
00low000000
helveticoside14beta-hydroxy steroid;
5beta-hydroxy steroid;
cardenolide glycoside;
digitoxoside;
monosaccharide derivative;
steroid aldehyde;
steroid lactone
antineoplastic agent;
apoptosis inducer;
plant metabolite
00low000000
ginsenoside re12beta-hydroxy steroid;
3beta-hydroxy-4,4-dimethylsteroid;
3beta-hydroxy steroid;
beta-D-glucoside;
disaccharide derivative;
ginsenoside;
tetracyclic triterpenoid
anti-inflammatory agent;
antineoplastic agent;
antioxidant;
nephroprotective agent;
neuroprotective agent;
plant metabolite
00low000000
ginsenoside rf12beta-hydroxy steroid;
20-hydroxy steroid;
3beta-hydroxy-4,4-dimethylsteroid;
3beta-hydroxy steroid;
beta-D-glucoside;
disaccharide derivative;
ginsenoside;
tetracyclic triterpenoid
antineoplastic agent;
apoptosis inducer;
plant metabolite
00low000000
ferruginolabietane diterpenoid;
carbotricyclic compound;
meroterpenoid;
phenols
antibacterial agent;
antineoplastic agent;
plant metabolite;
protective agent
00low000000
steviosidebeta-D-glucoside;
bridged compound;
diterpene glycoside;
ent-kaurane diterpenoid;
tetracyclic diterpenoid
anti-inflammatory agent;
antineoplastic agent;
antioxidant;
hypoglycemic agent;
plant metabolite;
sweetening agent
00low000000
decursinolcyclic ether;
delta-lactone;
organic heterotricyclic compound;
secondary alcohol
analgesic;
antineoplastic agent;
EC 3.1.1.7 (acetylcholinesterase) inhibitor;
metabolite
00low000000
naringin(2S)-flavan-4-one;
4'-hydroxyflavanones;
dihydroxyflavanone;
disaccharide derivative;
neohesperidoside
anti-inflammatory agent;
antineoplastic agent;
metabolite
00low000000
eugeniinbeta-D-glucoside;
ellagitannin;
gallate ester;
lactone
anti-HSV-1 agent;
antifungal agent;
antineoplastic agent;
EC 3.2.1.20 (alpha-glucosidase) inhibitor;
metabolite
00low000000
knipholonearomatic ketone;
dihydroxyanthraquinone;
methoxybenzenes;
methyl ketone;
polyphenol;
resorcinols
antineoplastic agent;
antioxidant;
antiplasmodial drug;
leukotriene antagonist;
metabolite
00low000000
gingerolbeta-hydroxy ketone;
guaiacols
antineoplastic agent;
plant metabolite
00low000000
mucronulatolhydroxyisoflavans;
methoxyisoflavan
antineoplastic agent;
plant metabolite
00low000000
syringaresinolsyringaresinolantineoplastic agent00low000000
enkephalin, methioninepentapeptide;
peptide zwitterion
analgesic;
antineoplastic agent;
delta-opioid receptor agonist;
human metabolite;
mu-opioid receptor agonist
00low000000
devazepide1,4-benzodiazepinone;
indolecarboxamide
antineoplastic agent;
apoptosis inducer;
cholecystokinin antagonist;
gastrointestinal drug
00low000000
sodium arsenitearsenic molecular entity;
inorganic sodium salt
antibacterial agent;
antifungal agent;
antineoplastic agent;
carcinogenic agent;
herbicide;
insecticide;
rodenticide
00low000000
surfactin ccyclodepsipeptide;
lipopeptide antibiotic;
macrocyclic lactone
antibacterial agent;
antifungal agent;
antineoplastic agent;
antiviral agent;
metabolite;
platelet aggregation inhibitor;
surfactant
00low000000
kerriamycin bangucycline antibioticantineoplastic agent00low000000
carubicinaminoglycoside antibiotic;
anthracycline antibiotic;
p-quinones;
tertiary alpha-hydroxy ketone;
tetracenequinones
antineoplastic agent;
apoptosis inducer
00low000000
tretinoinretinoic acid;
vitamin A
anti-inflammatory agent;
antineoplastic agent;
antioxidant;
AP-1 antagonist;
human metabolite;
keratolytic drug;
retinoic acid receptor agonist;
retinoid X receptor agonist;
signalling molecule
1984202324.4low0416641
docosahexaenoatedocosahexaenoic acid;
omega-3 fatty acid
algal metabolite;
antineoplastic agent;
Daphnia tenebrosa metabolite;
human metabolite;
mouse metabolite;
nutraceutical
00low000000
eicosapentaenoic acidicosapentaenoic acid;
omega-3 fatty acid
anticholesteremic drug;
antidepressant;
antineoplastic agent;
Daphnia galeata metabolite;
fungal metabolite;
micronutrient;
mouse metabolite;
nutraceutical
1993201816.7low203440
mycophenolic acid2-benzofurans;
gamma-lactone;
monocarboxylic acid;
phenols
anticoronaviral agent;
antimicrobial agent;
antineoplastic agent;
EC 1.1.1.205 (IMP dehydrogenase) inhibitor;
environmental contaminant;
immunosuppressive agent;
mycotoxin;
Penicillium metabolite;
xenobiotic
2005202211.3low100662
formycinformycinantineoplastic agent00low000000
neocarzinostatin chromophorecyclopentacyclononaoxirene;
D-galactosaminide;
dioxolane;
monosaccharide derivative;
naphthoate ester
antineoplastic agent00low000000
epothilone bepothilone;
epoxide
antineoplastic agent;
apoptosis inducer;
microtubule-stabilising agent
00low000000
adenosine-5'-(n-ethylcarboxamide)adenosines;
monocarboxylic acid amide
adenosine A1 receptor agonist;
adenosine A2A receptor agonist;
antineoplastic agent;
EC 3.1.4.* (phosphoric diester hydrolase) inhibitor;
vasodilator agent
1996201020.7low001200
n(1)-guanyl-1,7-diaminoheptaneguanidines;
primary amino compound
antineoplastic agent;
EC 2.5.1.46 (deoxyhypusine synthase) inhibitor
00low000000
diethylstilbestrololefinic compound;
polyphenol
antifungal agent;
antineoplastic agent;
autophagy inducer;
calcium channel blocker;
carcinogenic agent;
EC 1.1.1.146 (11beta-hydroxysteroid dehydrogenase) inhibitor;
EC 3.6.3.10 (H(+)/K(+)-exchanging ATPase) inhibitor;
endocrine disruptor;
xenoestrogen
1955202132.0low043401
bms 214662benzenes;
benzodiazepine;
imidazoles;
nitrile;
sulfonamide;
thiophenes
antineoplastic agent;
apoptosis inducer;
EC 2.5.1.58 (protein farnesyltransferase) inhibitor
00low000000
epothilone aepothilone;
epoxide
antineoplastic agent;
metabolite;
microtubule-stabilising agent;
tubulin modulator
00low000000
8-(2-chloro-3,4,5-trimethoxybenzyl)-2-fluoro-9-pent-4-yn-1-yl-9H-purin-6-amine6-aminopurines;
acetylenic compound;
methoxybenzenes;
monochlorobenzenes;
organofluorine compound
antineoplastic agent;
Hsp90 inhibitor
00low000000
alitretinoinretinoic acidantineoplastic agent;
keratolytic drug;
metabolite;
retinoid X receptor agonist
00low000000
afimoxifenephenols;
tertiary amino compound
antineoplastic agent;
estrogen receptor antagonist;
metabolite
00low000000
aclarubicinaminoglycoside;
anthracycline;
methyl ester;
phenols;
polyketide;
tetracenequinones;
trisaccharide derivative;
zwitterion
antimicrobial agent;
antineoplastic agent;
apoptosis inducer;
bacterial metabolite;
EC 5.99.1.3 [DNA topoisomerase (ATP-hydrolysing)] inhibitor
00low000000
teniposidearomatic ether;
beta-D-glucoside;
cyclic acetal;
furonaphthodioxole;
gamma-lactone;
monosaccharide derivative;
phenols;
thiophenes
antineoplastic agent;
EC 5.99.1.3 [DNA topoisomerase (ATP-hydrolysing)] inhibitor
00low000000
steviolbridged compound;
ent-kaurane diterpenoid;
monocarboxylic acid;
tertiary allylic alcohol;
tetracyclic diterpenoid
antineoplastic agent00low000000
tiazofurin1,3-thiazoles;
C-glycosyl compound;
monocarboxylic acid amide
antineoplastic agent;
EC 1.1.1.205 (IMP dehydrogenase) inhibitor;
prodrug
00low000000
aphidicolintetracyclic diterpenoidantimicrobial agent;
antimitotic;
antineoplastic agent;
antiviral drug;
apoptosis inducer;
Aspergillus metabolite;
DNA synthesis inhibitor;
EC 2.7.7.7 (DNA-directed DNA polymerase) inhibitor;
fungal metabolite
00low000000
azaserinecarboxylic ester;
diazo compound;
L-serine derivative;
non-proteinogenic L-alpha-amino acid
antifungal agent;
antimetabolite;
antimicrobial agent;
antineoplastic agent;
glutamine antagonist;
immunosuppressive agent;
metabolite
00low000000
melphalanL-phenylalanine derivative;
nitrogen mustard;
non-proteinogenic L-alpha-amino acid;
organochlorine compound
alkylating agent;
antineoplastic agent;
carcinogenic agent;
drug allergen;
immunosuppressive agent
1986201821.7low010110
prinomastataromatic ether;
hydroxamic acid;
pyridines;
sulfonamide;
thiomorpholines
antineoplastic agent;
EC 3.4.24.35 (gelatinase B) inhibitor;
matrix metalloproteinase inhibitor
00low000000
rubitecanC-nitro compound;
delta-lactone;
pyranoindolizinoquinoline;
semisynthetic derivative;
tertiary alcohol
antineoplastic agent;
EC 5.99.1.2 (DNA topoisomerase) inhibitor;
prodrug
00low000000
arsenic trioxidearsenic oxideantineoplastic agent;
insecticide
00low000000
rhapontinrhaponticinangiogenesis inhibitor;
anti-allergic agent;
anti-inflammatory agent;
antilipemic drug;
antineoplastic agent;
apoptosis inducer;
EC 2.3.1.85 (fatty acid synthase) inhibitor;
hypoglycemic agent;
neuroprotective agent;
plant metabolite
00low000000
isoliquiritigeninchalconesantineoplastic agent;
biological pigment;
EC 1.14.18.1 (tyrosinase) inhibitor;
GABA modulator;
geroprotector;
metabolite;
NMDA receptor antagonist
00low000000
antofinealkaloid antibiotic;
alkaloid;
aromatic ether;
organic heteropentacyclic compound
angiogenesis inhibitor;
anti-inflammatory agent;
antimicrobial agent;
antineoplastic agent;
antiviral agent;
phytotoxin;
plant metabolite
00low000000
xanthohumolaromatic ether;
chalcones;
polyphenol
anti-HIV-1 agent;
antineoplastic agent;
antiviral agent;
apoptosis inducer;
EC 2.3.1.20 (diacylglycerol O-acyltransferase) inhibitor;
metabolite
00low000000
vedelianincyclic ether;
organic heterotricyclic compound;
resorcinols;
stilbenoid
antineoplastic agent;
plant metabolite
00low000000
s 1033(trifluoromethyl)benzenes;
imidazoles;
pyridines;
pyrimidines;
secondary amino compound;
secondary carboxamide
anticoronaviral agent;
antineoplastic agent;
tyrosine kinase inhibitor
00low000000
amygdalinamygdalinantineoplastic agent;
apoptosis inducer;
plant metabolite
00low000000
trilostane17beta-hydroxy steroid;
3-hydroxy steroid;
androstanoid;
epoxy steroid;
nitrile
abortifacient;
antineoplastic agent;
EC 1.1.1.210 [3beta(or 20alpha)-hydroxysteroid dehydrogenase] inhibitor
00low000000
leuprolide acetateacetate saltantineoplastic agent;
gonadotropin releasing hormone agonist
00low000000
leuprolideoligopeptideanti-estrogen;
antineoplastic agent;
gonadotropin releasing hormone agonist
00low000000
mercaptopurinearyl thiol;
purines;
thiocarbonyl compound
anticoronaviral agent;
antimetabolite;
antineoplastic agent
1993200226.5low101100
3,3',4,5'-tetrahydroxystilbenecatechols;
polyphenol;
resorcinols;
stilbenol
antineoplastic agent;
apoptosis inducer;
geroprotector;
hypoglycemic agent;
plant metabolite;
protein kinase inhibitor;
tyrosine kinase inhibitor
00low000000
iFSP1aromatic amine;
nitrile;
primary amino compound;
pyridobenzimidazole;
toluenes
antineoplastic agent;
ferroptosis inducer;
ferroptosis suppressor protein 1 inhibitor
00low000000
4-iodo-6-phenylpyrimidinebiaryl;
organoiodine compound;
pyrimidines
antineoplastic agent;
apoptosis inducer;
macrophage migration inhibitory factor inhibitor
00low000000
oncrasin-1arenecarbaldehyde;
indoles;
monochlorobenzenes
antineoplastic agent;
apoptosis inducer
00low000000
cct018159benzodioxine;
pyrazoles;
resorcinols
antineoplastic agent;
apoptosis inducer;
Hsp90 inhibitor
00low000000
sulindacmonocarboxylic acid;
organofluorine compound;
sulfoxide
analgesic;
antineoplastic agent;
antipyretic;
apoptosis inducer;
EC 1.14.99.1 (prostaglandin-endoperoxide synthase) inhibitor;
non-narcotic analgesic;
non-steroidal anti-inflammatory drug;
prodrug;
tocolytic agent
2014201410.0low000010
auraptencoumarins;
monoterpenoid
antihypertensive agent;
antineoplastic agent;
antioxidant;
apoptosis inducer;
dopaminergic agent;
EC 2.7.11.24 (mitogen-activated protein kinase) inhibitor;
gamma-secretase modulator;
gastrointestinal drug;
hepatoprotective agent;
matrix metalloproteinase inhibitor;
neuroprotective agent;
plant metabolite;
PPARalpha agonist;
vulnerary
00low000000
xl147aromatic amine;
benzothiadiazole;
quinoxaline derivative;
sulfonamide
antineoplastic agent;
EC 2.7.1.137 (phosphatidylinositol 3-kinase) inhibitor
00low000000
mcb-613cyclic ketone;
enone;
pyridines
antineoplastic agent;
steroid receptor coactivator stimulator
00low000000
thioguanine anhydrous2-aminopurinesanticoronaviral agent;
antimetabolite;
antineoplastic agent
1986200330.0low011100
tamoxifenstilbenoid;
tertiary amino compound
angiogenesis inhibitor;
antineoplastic agent;
bone density conservation agent;
EC 1.2.3.1 (aldehyde oxidase) inhibitor;
EC 2.7.11.13 (protein kinase C) inhibitor;
estrogen antagonist;
estrogen receptor antagonist;
estrogen receptor modulator
1989201919.8low111310
stattic1-benzothiophenes;
C-nitro compound;
sulfone
antineoplastic agent;
radiosensitizing agent;
STAT3 inhibitor
00low000000
krn 7000glycophytoceramide;
N-acyl-beta-D-galactosylphytosphingosine
allergen;
antigen;
antineoplastic agent;
epitope;
immunological adjuvant
00low000000
10058-F4olefinic compound;
thiazolidinone
antineoplastic agent;
apoptosis inducer
00low000000
monastrolenoate ester;
ethyl ester;
phenols;
racemate;
thioureas
antileishmanial agent;
antimitotic;
antineoplastic agent;
EC 3.5.1.5 (urease) inhibitor
00low000000
toremifenearomatic ether;
organochlorine compound;
tertiary amine
antineoplastic agent;
bone density conservation agent;
estrogen antagonist;
estrogen receptor modulator
00low000000
u 0126aryl sulfide;
dinitrile;
enamine;
substituted aniline
antineoplastic agent;
antioxidant;
apoptosis inducer;
EC 2.7.11.24 (mitogen-activated protein kinase) inhibitor;
osteogenesis regulator;
vasoconstrictor agent
00low000000
beauvericincyclodepsipeptideantibiotic insecticide;
antifungal agent;
antineoplastic agent;
apoptosis inhibitor;
fungal metabolite;
ionophore;
mycotoxin;
P450 inhibitor
00low000000
nelarabinebeta-D-arabinoside;
monosaccharide derivative;
purine nucleoside
antineoplastic agent;
DNA synthesis inhibitor;
prodrug
00low000000
bms 3870321,3-oxazoles;
1,3-thiazoles;
organic sulfide;
piperidinecarboxamide;
secondary carboxamide
angiogenesis inhibitor;
antineoplastic agent;
apoptosis inducer;
EC 2.7.11.22 (cyclin-dependent kinase) inhibitor
00low000000
manoollabdane diterpenoid;
tertiary alcohol
antibacterial agent;
antineoplastic agent;
plant metabolite
00low000000
amrubicinanthracycline antibiotic;
methyl ketone;
primary amino compound;
quinone;
tetracenes
antineoplastic agent;
prodrug;
topoisomerase II inhibitor
00low000000
ospemifenearomatic ether;
organochlorine compound;
primary alcohol
anti-inflammatory agent;
antineoplastic agent;
estrogen receptor modulator
00low000000
tandutinibaromatic ether;
N-arylpiperazine;
N-carbamoylpiperazine;
phenylureas;
piperidines;
quinazolines;
tertiary amino compound
antineoplastic agent;
EC 2.7.10.1 (receptor protein-tyrosine kinase) inhibitor
00low000000
dasatinib1,3-thiazoles;
aminopyrimidine;
monocarboxylic acid amide;
N-(2-hydroxyethyl)piperazine;
N-arylpiperazine;
organochlorine compound;
secondary amino compound;
tertiary amino compound
anticoronaviral agent;
antineoplastic agent;
tyrosine kinase inhibitor
201620168.0low000010
emetine dihydrochloridehydrochlorideanticoronaviral agent;
antimalarial;
antineoplastic agent;
antiprotozoal drug;
antiviral agent;
autophagy inhibitor;
emetic;
protein synthesis inhibitor
00low000000
bigelovinacetate ester;
cyclic ketone;
gamma-lactone;
organic heterotricyclic compound;
sesquiterpene lactone
antineoplastic agent;
apoptosis inducer;
immunomodulator;
plant metabolite
00low000000
zd 6474aromatic ether;
organobromine compound;
organofluorine compound;
piperidines;
quinazolines;
secondary amine
antineoplastic agent;
tyrosine kinase inhibitor
00low000000
l 663536aryl sulfide;
indoles;
monocarboxylic acid;
monochlorobenzenes
antineoplastic agent;
EC 1.13.11.34 (arachidonate 5-lipoxygenase) inhibitor;
leukotriene antagonist
00low000000
4-benzyl-2-methyl-1,2,4-thiadiazolidine-3,5-dionebenzenes;
thiadiazolidine
anti-inflammatory agent;
antineoplastic agent;
apoptosis inducer;
EC 2.7.11.26 (tau-protein kinase) inhibitor;
neuroprotective agent
00low000000
sc 560aromatic ether;
monochlorobenzenes;
organofluorine compound;
pyrazoles
angiogenesis modulating agent;
antineoplastic agent;
apoptosis inducer;
cyclooxygenase 1 inhibitor;
non-steroidal anti-inflammatory drug
00low000000
alsterpaulloneC-nitro compound;
caprolactams;
organic heterotetracyclic compound
anti-HIV-1 agent;
antineoplastic agent;
apoptosis inducer;
EC 2.7.11.1 (non-specific serine/threonine protein kinase) inhibitor;
EC 2.7.11.22 (cyclin-dependent kinase) inhibitor;
EC 2.7.11.26 (tau-protein kinase) inhibitor
00low000000
ginkgetinbiflavonoid;
hydroxyflavone;
methoxyflavone;
ring assembly
anti-HSV-1 agent;
antineoplastic agent;
cyclooxygenase 2 inhibitor;
EC 1.13.11.34 (arachidonate 5-lipoxygenase) inhibitor;
metabolite
00low000000
eupatilindihydroxyflavone;
trimethoxyflavone
anti-inflammatory agent;
anti-ulcer drug;
antineoplastic agent;
EC 1.13.11.34 (arachidonate 5-lipoxygenase) inhibitor;
metabolite
00low000000
quercetin7-hydroxyflavonol;
pentahydroxyflavone
antibacterial agent;
antineoplastic agent;
antioxidant;
Aurora kinase inhibitor;
chelator;
EC 1.10.99.2 [ribosyldihydronicotinamide dehydrogenase (quinone)] inhibitor;
geroprotector;
phytoestrogen;
plant metabolite;
protein kinase inhibitor;
radical scavenger
1988202314.2low12327276
biochanin a4'-methoxyisoflavones;
7-hydroxyisoflavones
antineoplastic agent;
EC 3.5.1.99 (fatty acid amide hydrolase) inhibitor;
phytoestrogen;
plant metabolite;
tyrosine kinase inhibitor
00low000000
vitexinC-glycosyl compound;
trihydroxyflavone
antineoplastic agent;
EC 3.2.1.20 (alpha-glucosidase) inhibitor;
plant metabolite;
platelet aggregation inhibitor
00low000000
apigenintrihydroxyflavoneantineoplastic agent;
metabolite
200720219.2low000261
luteolin3'-hydroxyflavonoid;
tetrahydroxyflavone
angiogenesis inhibitor;
anti-inflammatory agent;
antineoplastic agent;
apoptosis inducer;
c-Jun N-terminal kinase inhibitor;
EC 2.3.1.85 (fatty acid synthase) inhibitor;
immunomodulator;
nephroprotective agent;
plant metabolite;
radical scavenger;
vascular endothelial growth factor receptor antagonist
1990202217.0low001101
calcitriolD3 vitamins;
hydroxycalciol;
triol
antineoplastic agent;
antipsoriatic;
bone density conservation agent;
calcium channel agonist;
calcium channel modulator;
hormone;
human metabolite;
immunomodulator;
metabolite;
mouse metabolite;
nutraceutical
1987202117.9low011221
herbacetin7-hydroxyflavonol;
pentahydroxyflavone
angiogenesis inhibitor;
anti-inflammatory agent;
antilipemic drug;
antineoplastic agent;
apoptosis inducer;
EC 3.4.22.69 (SARS coronavirus main proteinase) inhibitor;
EC 4.1.1.17 (ornithine decarboxylase) inhibitor;
plant metabolite
00low000000
hymecromonehydroxycoumarinantineoplastic agent;
hyaluronic acid synthesis inhibitor
1986199732.5low011000
chrysoeriolmonomethoxyflavone;
trihydroxyflavone
antineoplastic agent;
antioxidant;
metabolite
00low000000
dexmedetomidinetrihydroxyflavone;
trimethoxyflavone
antineoplastic agent;
metabolite
00low000000
bryostatin 1acetate ester;
bryostatins;
cyclic hemiketal;
enoate ester;
methyl ester;
organic heterotetracyclic compound;
secondary alcohol
alpha-secretase activator;
anti-HIV-1 agent;
antineoplastic agent;
marine metabolite;
protein kinase C agonist
00low000000
quercetin 3-o-glucopyranosidebeta-D-glucoside;
monosaccharide derivative;
quercetin O-glucoside;
tetrahydroxyflavone
antineoplastic agent;
antioxidant;
antipruritic drug;
bone density conservation agent;
geroprotector;
histamine antagonist;
osteogenesis regulator;
plant metabolite
00low000000
9-deoxy-9,10-didehydro-12,13-didehydro-13,14-dihydroprostaglandin d2prostaglandins J;
secondary alcohol
antineoplastic agent;
antiviral agent
00low000000
genistein7-hydroxyisoflavonesantineoplastic agent;
EC 5.99.1.3 [DNA topoisomerase (ATP-hydrolysing)] inhibitor;
geroprotector;
human urinary metabolite;
phytoestrogen;
plant metabolite;
tyrosine kinase inhibitor
1998201618.5low002720
pyrviniumquinolinium ionanthelminthic drug;
antineoplastic agent
00low000000
cyclobenzaprine9,11,13-octadecatrienoic acidantineoplastic agent;
plant metabolite
00low000000
buteinchalcones;
polyphenol
antineoplastic agent;
antioxidant;
EC 1.1.1.21 (aldehyde reductase) inhibitor;
geroprotector;
hypoglycemic agent;
plant metabolite;
radiosensitizing agent;
tyrosine kinase inhibitor
00low000000
cucurbitacin icucurbitacin;
tertiary alpha-hydroxy ketone
antineoplastic agent;
plant metabolite
00low000000
daphnoretinaromatic ether;
hydroxycoumarin
antineoplastic agent;
antiviral agent;
metabolite
00low000000
costunolidegermacranolide;
heterobicyclic compound
anthelminthic drug;
antiinfective agent;
antineoplastic agent;
antiparasitic agent;
antiviral drug;
metabolite
00low000000
eupatolidegamma-lactone;
germacranolide;
homoallylic alcohol;
secondary alcohol
antineoplastic agent;
plant metabolite
00low000000
oleuropeinbeta-D-glucoside;
catechols;
diester;
methyl ester;
pyrans;
secoiridoid glycoside
anti-inflammatory agent;
antihypertensive agent;
antineoplastic agent;
antioxidant;
apoptosis inducer;
NF-kappaB inhibitor;
nutraceutical;
plant metabolite;
radical scavenger
00low000000
agathisflavonebiaryl;
biflavonoid;
hydroxyflavone
antineoplastic agent;
antiviral agent;
hepatoprotective agent;
metabolite
00low000000
baicaleintrihydroxyflavoneangiogenesis inhibitor;
anti-inflammatory agent;
antibacterial agent;
anticoronaviral agent;
antifungal agent;
antineoplastic agent;
antioxidant;
apoptosis inducer;
EC 1.13.11.31 (arachidonate 12-lipoxygenase) inhibitor;
EC 1.13.11.33 (arachidonate 15-lipoxygenase) inhibitor;
EC 3.4.21.26 (prolyl oligopeptidase) inhibitor;
EC 3.4.22.69 (SARS coronavirus main proteinase) inhibitor;
EC 4.1.1.17 (ornithine decarboxylase) inhibitor;
ferroptosis inhibitor;
geroprotector;
hormone antagonist;
plant metabolite;
prostaglandin antagonist;
radical scavenger
00low000000
chrysin7-hydroxyflavonol;
dihydroxyflavone
anti-inflammatory agent;
antineoplastic agent;
antioxidant;
EC 2.7.11.18 (myosin-light-chain kinase) inhibitor;
hepatoprotective agent;
plant metabolite
00low000000
diosmetin3'-hydroxyflavonoid;
monomethoxyflavone;
trihydroxyflavone
angiogenesis inhibitor;
anti-inflammatory agent;
antineoplastic agent;
antioxidant;
apoptosis inducer;
bone density conservation agent;
cardioprotective agent;
plant metabolite;
tropomyosin-related kinase B receptor agonist;
vasodilator agent
00low000000
hinokiflavonearomatic ether;
biflavonoid;
hydroxyflavone
antineoplastic agent;
metabolite;
neuroprotective agent
00low000000
hispidulinmonomethoxyflavone;
trihydroxyflavone
anti-inflammatory agent;
anticonvulsant;
antineoplastic agent;
antioxidant;
apoptosis inducer;
plant metabolite
00low000000
gartaninpolyphenol;
xanthones
antineoplastic agent;
plant metabolite
00low000000
mangostinaromatic ether;
phenols;
xanthones
antimicrobial agent;
antineoplastic agent;
antioxidant;
plant metabolite
00low000000
norathyriolpolyphenol;
xanthones
antineoplastic agent;
EC 2.7.11.13 (protein kinase C) inhibitor;
plant metabolite
00low000000
morin7-hydroxyflavonol;
pentahydroxyflavone
angiogenesis modulating agent;
anti-inflammatory agent;
antibacterial agent;
antihypertensive agent;
antineoplastic agent;
antioxidant;
EC 5.99.1.2 (DNA topoisomerase) inhibitor;
hepatoprotective agent;
metabolite;
neuroprotective agent
00low000000
morusinextended flavonoid;
trihydroxyflavone
antineoplastic agent;
plant metabolite
00low000000
myricetin7-hydroxyflavonol;
hexahydroxyflavone
antineoplastic agent;
antioxidant;
cyclooxygenase 1 inhibitor;
food component;
geroprotector;
hypoglycemic agent;
plant metabolite
00low000000
robustaflavonebiflavonoid;
hydroxyflavone;
ring assembly
anti-HBV agent;
antineoplastic agent;
antioxidant;
metabolite
00low000000
tricetinpentahydroxyflavoneantineoplastic agent;
metabolite
00low000000
wogonindihydroxyflavone;
monomethoxyflavone
angiogenesis inhibitor;
antineoplastic agent;
cyclooxygenase 2 inhibitor;
plant metabolite
00low000000
daidzein7-hydroxyisoflavonesantineoplastic agent;
EC 2.7.7.7 (DNA-directed DNA polymerase) inhibitor;
EC 3.2.1.20 (alpha-glucosidase) inhibitor;
phytoestrogen;
plant metabolite
00low000000
astringinbeta-D-glucoside;
monosaccharide derivative;
polyphenol;
stilbenoid
antineoplastic agent;
antioxidant;
metabolite
00low000000
pterostilbenediether;
methoxybenzenes;
stilbenol
anti-inflammatory agent;
antineoplastic agent;
antioxidant;
apoptosis inducer;
hypoglycemic agent;
neuroprotective agent;
neurotransmitter;
plant metabolite;
radical scavenger
00low000000
irilonehydroxyisoflavone;
organic heterotricyclic compound;
oxacycle
antineoplastic agent;
immunomodulator;
metabolite
00low000000
caffeic acid phenethyl esteralkyl caffeate esteranti-inflammatory agent;
antibacterial agent;
antineoplastic agent;
antioxidant;
antiviral agent;
immunomodulator;
metabolite;
neuroprotective agent
00low000000
wedelolactonearomatic ether;
coumestans;
delta-lactone;
polyphenol
antineoplastic agent;
apoptosis inducer;
EC 5.99.1.3 [DNA topoisomerase (ATP-hydrolysing)] inhibitor;
hepatoprotective agent;
metabolite
00low000000
maytansinealpha-amino acid ester;
carbamate ester;
epoxide;
maytansinoid;
organic heterotetracyclic compound;
organochlorine compound
antimicrobial agent;
antimitotic;
antineoplastic agent;
plant metabolite;
tubulin modulator
00low000000
rottlerinaromatic ketone;
benzenetriol;
chromenol;
enone;
methyl ketone
anti-allergic agent;
antihypertensive agent;
antineoplastic agent;
apoptosis inducer;
K-ATP channel agonist;
metabolite
00low000000
tectochrysinmonohydroxyflavone;
monomethoxyflavone
antidiarrhoeal drug;
antineoplastic agent;
plant metabolite
00low000000
plaunotolditerpenoid;
primary alcohol
anti-ulcer drug;
antibacterial agent;
antineoplastic agent;
apoptosis inducer;
nephroprotective agent;
plant metabolite;
vulnerary
00low000000
tranilastamidobenzoic acid;
cinnamamides;
dimethoxybenzene;
secondary carboxamide
anti-allergic agent;
anti-asthmatic drug;
antineoplastic agent;
aryl hydrocarbon receptor agonist;
calcium channel blocker;
hepatoprotective agent;
nephroprotective agent
00low000000
tocotrienol, betatocotrienol;
vitamin E
antineoplastic agent;
apoptosis inducer;
plant metabolite
00low000000
gamma-tocotrienoltocotrienol;
vitamin E
antineoplastic agent;
antioxidant;
apoptosis inducer;
hepatoprotective agent;
plant metabolite;
radiation protective agent
00low000000
tocotrienol, deltatocotrienol;
vitamin E
anti-inflammatory agent;
antineoplastic agent;
apoptosis inducer;
bone density conservation agent;
NF-kappaB inhibitor;
plant metabolite;
radiation protective agent;
Saccharomyces cerevisiae metabolite
00low000000
4'-hydroxychalconechalcones;
phenols
anti-inflammatory agent;
antineoplastic agent
00low000000
isotretinoinretinoic acidantineoplastic agent;
keratolytic drug;
teratogenic agent
2013201311.0low000010
9,11-linoleic acidoctadeca-9,11-dienoic acidanti-inflammatory agent;
antiatherogenic agent;
antineoplastic agent;
apoptosis inducer;
bacterial xenobiotic metabolite;
human metabolite
00low000000
camostat mesylatemethanesulfonate saltanti-inflammatory agent;
anticoronaviral agent;
antifibrinolytic drug;
antihypertensive agent;
antineoplastic agent;
antiviral agent;
serine protease inhibitor
00low000000
sirolimusantibiotic antifungal drug;
cyclic acetal;
cyclic ketone;
ether;
macrolide lactam;
organic heterotricyclic compound;
secondary alcohol
antibacterial drug;
anticoronaviral agent;
antineoplastic agent;
bacterial metabolite;
geroprotector;
immunosuppressive agent;
mTOR inhibitor
1992201817.6low002230
3',4',7-trihydroxyisoflavone7-hydroxyisoflavonesantineoplastic agent;
EC 1.3.1.22 [3-oxo-5alpha-steroid 4-dehydrogenase (NADP(+))] inhibitor;
metabolite
00low000000
alvocidibdihydroxyflavone;
hydroxypiperidine;
monochlorobenzenes;
tertiary amino compound
antineoplastic agent;
antirheumatic drug;
apoptosis inducer;
EC 2.7.11.22 (cyclin-dependent kinase) inhibitor
00low000000
fenretinidemonocarboxylic acid amide;
retinoid
antineoplastic agent;
antioxidant
00low000000
geldanamycin1,4-benzoquinones;
ansamycin;
carbamate ester;
organic heterobicyclic compound
antimicrobial agent;
antineoplastic agent;
antiviral agent;
cysteine protease inhibitor;
Hsp90 inhibitor
00low000000
4-oxoretinolcyclic ketone;
enone;
primary allylic alcohol;
retinoid
antineoplastic agent00low000000
4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acidbenzoic acids;
naphthalenes;
retinoid
antineoplastic agent;
retinoic acid receptor agonist;
teratogenic agent
00low000000
vinorelbineacetate ester;
methyl ester;
organic heteropentacyclic compound;
organic heterotetracyclic compound;
ring assembly;
vinca alkaloid
antineoplastic agent;
photosensitizing agent
00low000000
centaureidintrihydroxyflavone;
trimethoxyflavone
antineoplastic agent;
cyclooxygenase 1 inhibitor;
cyclooxygenase 2 inhibitor;
plant metabolite
00low000000
3,3'-di-o-methylquercetin3'-methoxyflavones;
dimethoxyflavone;
trihydroxyflavone
antibacterial agent;
antineoplastic agent;
apoptosis inducer;
plant metabolite
00low000000
ethyl caffeatealkyl caffeate ester;
ethyl ester;
hydroxycinnamic acid
anti-inflammatory agent;
antineoplastic agent;
metabolite
00low000000
andrographolidecarbobicyclic compound;
gamma-lactone;
labdane diterpenoid;
primary alcohol;
secondary alcohol
anti-HIV agent;
anti-inflammatory drug;
antineoplastic agent;
metabolite
00low000000
isoginkgetinaromatic ether;
biflavonoid
antineoplastic agent;
EC 3.4.24.35 (gelatinase B) inhibitor;
plant metabolite
00low000000
cudraflavone ctetrahydroxyflavoneantibacterial agent;
antineoplastic agent;
plant metabolite
00low000000
neobavaisoflavone7-hydroxyisoflavonesantineoplastic agent;
EC 2.7.7.7 (DNA-directed DNA polymerase) inhibitor;
plant metabolite;
platelet aggregation inhibitor
00low000000
neoglycyrolaromatic ether;
coumestans;
delta-lactone;
polyphenol
antineoplastic agent;
plant metabolite
00low000000
5,7-dihydroxy-6-methoxy-2-phenylchromen-4-onedihydroxyflavone;
monomethoxyflavone
antineoplastic agent;
EC 1.14.13.39 (nitric oxide synthase) inhibitor
00low000000
spiraeosidebeta-D-glucoside;
flavonols;
monosaccharide derivative;
quercetin O-glucoside;
tetrahydroxyflavone
antineoplastic agent;
antioxidant;
plant metabolite
00low000000
rhamnazinaromatic ether;
dimethoxyflavone;
phenols;
trihydroxyflavone
antineoplastic agent;
plant metabolite
00low000000
oridonincyclic hemiketal;
enone;
ent-kaurane diterpenoid;
organic heteropentacyclic compound;
secondary alcohol
angiogenesis inhibitor;
anti-asthmatic agent;
antibacterial agent;
antineoplastic agent;
apoptosis inducer;
plant metabolite
00low000000
pd 166866biaryl;
dimethoxybenzene;
primary arylamine;
pyridopyrimidine;
ureas
angiogenesis inhibitor;
antineoplastic agent;
apoptosis inducer;
EC 2.7.10.1 (receptor protein-tyrosine kinase) inhibitor
00low000000
bosutinibaminoquinoline;
aromatic ether;
dichlorobenzene;
N-methylpiperazine;
nitrile;
tertiary amino compound
antineoplastic agent;
tyrosine kinase inhibitor
00low000000
semaxinibolefinic compound;
oxindoles;
pyrroles
angiogenesis modulating agent;
antineoplastic agent;
EC 2.7.10.1 (receptor protein-tyrosine kinase) inhibitor;
vascular endothelial growth factor receptor antagonist
00low000000
su 11248monocarboxylic acid amide;
pyrroles
angiogenesis inhibitor;
antineoplastic agent;
EC 2.7.10.1 (receptor protein-tyrosine kinase) inhibitor;
immunomodulator;
neuroprotective agent;
vascular endothelial growth factor receptor antagonist
00low000000
palbociclibaminopyridine;
aromatic ketone;
cyclopentanes;
piperidines;
pyridopyrimidine;
secondary amino compound;
tertiary amino compound
antineoplastic agent;
EC 2.7.11.22 (cyclin-dependent kinase) inhibitor
00low000000
mitoguazoneguanidines;
hydrazone
antineoplastic agent;
apoptosis inducer;
EC 4.1.1.50 (adenosylmethionine decarboxylase) inhibitor
00low000000
reumycincarbonyl compound;
pyrimidotriazine
antimicrobial agent;
antineoplastic agent;
bacterial metabolite
00low000000
ergosterol-5,8-peroxide3beta-sterol;
ergostanoid;
organic peroxide;
phytosterols
antimycobacterial drug;
antineoplastic agent;
metabolite;
trypanocidal drug
00low000000
ermanindihydroxyflavone;
dimethoxyflavone
anti-inflammatory agent;
antimycobacterial drug;
antineoplastic agent;
apoptosis inducer;
plant metabolite
00low000000
sulindac sulfidearyl sulfide;
monocarboxylic acid;
organofluorine compound
antineoplastic agent;
apoptosis inducer;
non-steroidal anti-inflammatory drug
00low000000
bay 11-7085benzenes;
nitrile;
sulfone
anti-inflammatory agent;
antibacterial agent;
antineoplastic agent;
apoptosis inducer;
autophagy inducer;
EC 2.7.11.10 (IkappaB kinase) inhibitor;
ferroptosis inducer;
NF-kappaB inhibitor
00low000000
macluraxanthone bphenols;
xanthones
anti-HIV agent;
antineoplastic agent;
metabolite
00low000000
flavokawain bchalcones;
dimethoxybenzene;
phenols
anti-inflammatory agent;
antileishmanial agent;
antineoplastic agent;
apoptosis inducer;
metabolite
00low000000
tamsulosin hydrochloridehydrochloridealpha-adrenergic antagonist;
antineoplastic agent
00low000000
batimastathydroxamic acid;
L-phenylalanine derivative;
organic sulfide;
secondary carboxamide;
thiophenes;
triamide
angiogenesis inhibitor;
antineoplastic agent;
matrix metalloproteinase inhibitor
00low000000
glyceryl behenate1-monoglyceride;
fatty acid ester
antineoplastic agent;
plant metabolite
00low000000
jaceosidindimethoxyflavone;
trihydroxyflavone
anti-allergic agent;
anti-inflammatory agent;
antineoplastic agent;
apoptosis inducer;
metabolite
00low000000
5,7,3'-trihydroxy-3,4'-dimethoxyflavonedimethoxyflavone;
trihydroxyflavone
antineoplastic agent;
metabolite
00low000000
pederincyclic ketal;
diol;
oxanes;
polyketide;
secondary alcohol;
secondary carboxamide
antimitotic;
antineoplastic agent;
bacterial metabolite;
vesicant
00low000000
artocarpin lectinmonomethoxyflavone;
trihydroxyflavone
antineoplastic agent;
metabolite
00low000000
cisplatindiamminedichloroplatinumantineoplastic agent;
apoptosis inducer;
cross-linking reagent;
ferroptosis inducer;
genotoxin;
mutagen;
nephrotoxin;
photosensitizing agent
00low000000
bleomycinbleomycinantineoplastic agent;
metabolite
00low000000
beta-aminopropionitrile fumarate (2:1)fumarate saltantineoplastic agent;
antirheumatic drug;
collagen cross-linking inhibitor;
plant metabolite
00low000000
gamma-mangostinphenols;
xanthones
antineoplastic agent;
plant metabolite;
protein kinase inhibitor
00low000000
demethoxycurcuminbeta-diketone;
diarylheptanoid;
enone;
polyphenol
anti-inflammatory agent;
antineoplastic agent;
metabolite
00low000000
cystothiazole a1,3-thiazoles;
biaryl;
enoate ester;
enol ether;
methyl ester;
organonitrogen heterocyclic antibiotic
antifungal agent;
antineoplastic agent;
bacterial metabolite
00low000000
lespenefrilalpha-L-rhamnoside;
dihydroxyflavone;
glycosyloxyflavone;
monosaccharide derivative;
polyphenol
anti-inflammatory agent;
antidepressant;
antineoplastic agent;
apoptosis inducer;
bone density conservation agent;
hypoglycemic agent;
immunomodulator;
plant metabolite
00low000000
baohuoside iglycosyloxyflavoneanti-inflammatory agent;
antineoplastic agent;
apoptosis inducer;
plant metabolite
00low000000
arglabinepoxide;
gamma-lactone;
organic heterotetracyclic compound;
sesquiterpene lactone
antineoplastic agent;
metabolite
00low000000
3-(3-pyridinyl)-1-(4-pyridinyl)-2-propen-1-oneenone;
pyridines
angiogenesis inhibitor;
antineoplastic agent;
apoptosis inducer;
autophagy inducer;
EC 2.7.1.105 (6-phosphofructo-2-kinase) inhibitor
00low000000
ma-1carboxamidine;
organochlorine compound;
pyrimidone;
pyrrolidines
antineoplastic agent;
EC 2.4.2.4 (thymidine phosphorylase) inhibitor
00low000000
apratoxin a1,3-thiazoles;
apratoxin
antineoplastic agent;
metabolite
00low000000
coronardinealkaloid ester;
methyl ester;
monoterpenoid indole alkaloid;
organic heteropentacyclic compound
antileishmanial agent;
antineoplastic agent;
apoptosis inducer;
plant metabolite
00low000000
ascofuranonedihydroxybenzaldehyde;
meroterpenoid;
monochlorobenzenes;
olefinic compound;
resorcinols;
sesquiterpenoid;
tetrahydrofuranone
angiogenesis inhibitor;
antilipemic drug;
antineoplastic agent;
antiprotozoal drug;
fungal metabolite
00low000000
columbianadinalpha,beta-unsaturated carboxylic ester;
furanocoumarin
anti-inflammatory agent;
antineoplastic agent;
apoptosis inducer;
hepatoprotective agent;
plant metabolite;
rat metabolite
00low000000
germacronegermacrane sesquiterpenoid;
olefinic compound
androgen antagonist;
anti-inflammatory agent;
antifeedant;
antifungal agent;
antimicrobial agent;
antineoplastic agent;
antioxidant;
antitussive;
antiviral agent;
apoptosis inducer;
autophagy inducer;
hepatoprotective agent;
insecticide;
neuroprotective agent;
plant metabolite;
volatile oil component
00low000000
rhizoxin1,3-oxazoles;
epoxide;
macrolide antibiotic
antimitotic;
antineoplastic agent;
metabolite
00low000000
sibiromycinaminoglycoside antibiotic;
hemiaminal;
phenols;
pyrrolobenzodiazepine
antineoplastic agent;
bacterial metabolite
00low000000
bryostatin 2bryostatins;
cyclic hemiketal;
enoate ester;
methyl ester;
organic heterotetracyclic compound;
secondary alcohol
antineoplastic agent;
marine metabolite;
protein kinase C agonist
00low000000
manumycinenamide;
epoxide;
organic heterobicyclic compound;
polyketide;
secondary carboxamide;
tertiary alcohol
antiatherosclerotic agent;
antimicrobial agent;
antineoplastic agent;
apoptosis inducer;
bacterial metabolite;
EC 1.8.1.9 (thioredoxin reductase) inhibitor;
EC 2.5.1.58 (protein farnesyltransferase) inhibitor;
marine metabolite
00low000000
thermozymocidinalpha-amino fatty acid;
hydroxy monocarboxylic acid;
non-proteinogenic alpha-amino acid;
sphingoid
antifungal agent;
antimicrobial agent;
antineoplastic agent;
apoptosis inducer;
EC 2.3.1.50 (serine C-palmitoyltransferase) inhibitor;
fungal metabolite;
immunosuppressive agent
00low000000
asukamycinenamide;
epoxide;
organic heterobicyclic compound;
polyketide;
secondary carboxamide;
tertiary alcohol
antibacterial agent;
antifungal agent;
antimicrobial agent;
antineoplastic agent;
bacterial metabolite
00low000000
everolimuscyclic acetal;
cyclic ketone;
ether;
macrolide lactam;
primary alcohol;
secondary alcohol
anticoronaviral agent;
antineoplastic agent;
geroprotector;
immunosuppressive agent;
mTOR inhibitor
201620168.0low000010
13(S)-HODEHODEantineoplastic agent;
human xenobiotic metabolite;
mouse metabolite
00low000000
ixabepilone1,3-thiazoles;
beta-hydroxy ketone;
epoxide;
lactam;
macrocycle
antineoplastic agent;
microtubule-destabilising agent
00low000000
axitinibaryl sulfide;
benzamides;
indazoles;
pyridines
antineoplastic agent;
tyrosine kinase inhibitor;
vascular endothelial growth factor receptor antagonist
00low000000
salvianolic acid B1-benzofurans;
catechols;
dicarboxylic acid;
enoate ester;
polyphenol
anti-inflammatory agent;
antidepressant;
antineoplastic agent;
antioxidant;
apoptosis inducer;
autophagy inhibitor;
cardioprotective agent;
hepatoprotective agent;
hypoglycemic agent;
neuroprotective agent;
osteogenesis regulator;
plant metabolite
00low000000
l 744832benzenes;
ether;
isopropyl ester;
secondary carboxamide;
sulfone;
thiol
antineoplastic agent;
EC 2.5.1.58 (protein farnesyltransferase) inhibitor;
geroprotector
00low000000
sophoraflavanone a(2S)-flavan-4-one;
4'-hydroxyflavanones;
trihydroxyflavanone
antibacterial agent;
antineoplastic agent;
metabolite
00low000000
tanespimycin1,4-benzoquinones;
ansamycin;
carbamate ester;
organic heterobicyclic compound;
secondary amino compound
antineoplastic agent;
apoptosis inducer;
Hsp90 inhibitor
00low000000
manzamine aalkaloid;
beta-carbolines;
isoquinolines
animal metabolite;
anti-HSV-1 agent;
antimalarial;
antineoplastic agent;
EC 2.7.11.26 (tau-protein kinase) inhibitor;
marine metabolite
00low000000
aureothin4-pyranones;
C-nitro compound;
ketene acetal;
olefinic compound;
oxolanes
antibacterial agent;
antifungal agent;
antineoplastic agent;
antiparasitic agent;
bacterial metabolite;
EC 1.6.5.3 [NADH:ubiquinone reductase (H(+)-translocating)] inhibitor
00low000000
fostriecin2-pyranones;
olefinic compound;
phosphate monoester;
polyketide;
primary allylic alcohol;
secondary allylic alcohol;
triol
antineoplastic agent;
apoptosis inhibitor;
bacterial metabolite;
EC 3.1.3.16 (phosphoprotein phosphatase) inhibitor;
topoisomerase II inhibitor
00low000000
artesunateartemisinin derivative;
cyclic acetal;
dicarboxylic acid monoester;
hemisuccinate;
semisynthetic derivative;
sesquiterpenoid
antimalarial;
antineoplastic agent;
ferroptosis inducer
00low000000
ru 5866817beta-hydroxy steroid;
3-hydroxy steroid;
aromatic ether;
organofluorine compound;
sulfone
anti-estrogen;
antineoplastic agent;
estrogen receptor antagonist
00low000000
soblidotintetrapeptideantineoplastic agent;
apoptosis inducer;
microtubule-destabilising agent
00low000000
beta-elemenebeta-elemeneantineoplastic agent00low000000
laulimalidecarboxylic ester;
epoxide;
macrolide;
secondary alcohol;
secondary allylic alcohol
animal metabolite;
antimitotic;
antineoplastic agent;
marine metabolite;
microtubule-stabilising agent
00low000000
jwh-133benzochromene;
dibenzopyran;
organic heterotricyclic compound
analgesic;
anti-inflammatory agent;
antineoplastic agent;
apoptosis inhibitor;
CB2 receptor agonist;
opioid analgesic;
vasodilator agent
00low000000
on 01910N-[2-methoxy-5-({[2-(2,4,6-trimethoxyphenyl)ethenyl]sulfonyl}methyl)phenyl]glycineantineoplastic agent;
apoptosis inducer;
EC 2.7.11.21 (polo kinase) inhibitor;
microtubule-destabilising agent
00low000000
bufalin14beta-hydroxy steroid;
3beta-hydroxy steroid
animal metabolite;
anti-inflammatory agent;
antineoplastic agent;
cardiotonic drug
00low000000
alpha-solanineglycoalkaloid;
organic heterohexacyclic compound;
steroid saponin;
trisaccharide derivative
antineoplastic agent;
apoptosis inducer;
phytotoxin;
plant metabolite
00low000000
rhosinD-tryptophan derivative;
hydrazone;
quinoxaline derivative
antineoplastic agent;
RhoA inhibitor;
RhoC inhibitor
00low000000
s-allylcysteineL-alpha-amino acid zwitterion;
S-hydrocarbyl-L-cysteine
antineoplastic agent;
metabolite
00low000000
2-hydroxy-9-cis-octadecenoic acid2-hydroxy fatty acid;
hydroxy monounsaturated fatty acid;
long-chain fatty acid
antihypertensive agent;
antineoplastic agent;
apoptosis inducer
00low000000
dolastatin 101,3-thiazoles;
tetrapeptide
animal metabolite;
antineoplastic agent;
apoptosis inducer;
marine metabolite;
microtubule-destabilising agent
00low000000
plitidepsindidemninanticoronaviral agent;
antineoplastic agent;
marine metabolite
00low000000
abiraterone acetatepyridines;
sterol ester
antineoplastic agent;
EC 1.14.99.9 (steroid 17alpha-monooxygenase) inhibitor;
prodrug
00low000000
lenvatinibaromatic amide;
aromatic ether;
cyclopropanes;
monocarboxylic acid amide;
monochlorobenzenes;
phenylureas;
quinolines
antineoplastic agent;
EC 2.7.10.1 (receptor protein-tyrosine kinase) inhibitor;
fibroblast growth factor receptor antagonist;
orphan drug;
vascular endothelial growth factor receptor antagonist
00low000000
nsc 716970aromatic amine;
aromatic ether;
indolecarboxamide;
organochlorine compound
antineoplastic agent00low000000
pd 0325901difluorobenzene;
hydroxamic acid ester;
monofluorobenzenes;
organoiodine compound;
propane-1,2-diols;
secondary amino compound
antineoplastic agent;
EC 2.7.12.2 (mitogen-activated protein kinase kinase) inhibitor
00low000000
midostaurinbenzamides;
gamma-lactam;
indolocarbazole;
organic heterooctacyclic compound
antineoplastic agent;
EC 2.7.11.13 (protein kinase C) inhibitor
00low000000
jasplakinolidecyclodepsipeptide;
phenols
actin polymerisation inducer;
animal metabolite;
antifungal agent;
antineoplastic agent;
apoptosis inducer;
marine metabolite;
neuroprotective agent
00low000000
muromonab-cd3alkaloid;
macrocycle;
organic heteropentacyclic compound;
organonitrogen heterocyclic compound;
oxacycle;
tertiary amino compound
antineoplastic agent;
EC 2.7.10.1 (receptor protein-tyrosine kinase) inhibitor;
IP3 receptor antagonist;
marine metabolite
00low000000
ginsenoside m112beta-hydroxy steroid;
3beta-hydroxy-4,4-dimethylsteroid;
3beta-hydroxy steroid;
beta-D-glucoside;
ginsenoside;
tetracyclic triterpenoid
anti-allergic agent;
anti-inflammatory agent;
antineoplastic agent;
hepatoprotective agent;
plant metabolite
00low000000
cabazitaxeltetracyclic diterpenoidantineoplastic agent;
microtubule-stabilising agent
00low000000
elisidepsincyclodepsipeptideantineoplastic agent00low000000
fr 148083aromatic ether;
macrolide;
phenols;
secondary alcohol;
secondary alpha-hydroxy ketone
antibacterial agent;
antineoplastic agent;
metabolite;
NF-kappaB inhibitor
00low000000
tln 4601dibenzodiazepine;
farnesane sesquiterpenoid;
olefinic compound;
secondary amine;
triol
antineoplastic agent;
antioxidant;
cathepsin L (EC 3.4.22.15) inhibitor
00low000000
scio-469aromatic amide;
aromatic ketone;
chloroindole;
dicarboxylic acid diamide;
indolecarboxamide;
monofluorobenzenes;
N-acylpiperazine;
N-alkylpiperazine
antineoplastic agent;
apoptosis inducer;
EC 2.7.11.24 (mitogen-activated protein kinase) inhibitor
00low000000
tmc-95aindoles;
lactam;
macrocycle;
phenols;
secondary alcohol;
tertiary alcohol
antimicrobial agent;
antineoplastic agent;
bacterial metabolite;
fungal metabolite;
proteasome inhibitor
00low000000
cp 7247142-methoxy-N-[3-[4-[3-methyl-4-[(6-methyl-3-pyridinyl)oxy]anilino]-6-quinazolinyl]prop-2-enyl]acetamideantineoplastic agent;
apoptosis inducer;
EC 2.7.10.1 (receptor protein-tyrosine kinase) inhibitor;
hepatotoxic agent
00low000000
9-methoxycanthin-6-onearomatic ether;
indole alkaloid;
organic heterotetracyclic compound
antineoplastic agent;
antiplasmodial drug;
metabolite
00low000000
topopyrone cnaphthochromene;
p-quinones;
phenols
antimicrobial agent;
antineoplastic agent;
antiviral agent;
EC 5.99.1.2 (DNA topoisomerase) inhibitor;
Penicillium metabolite
00low000000
pi103aromatic amine;
morpholines;
organic heterotricyclic compound;
phenols;
tertiary amino compound
antineoplastic agent;
EC 2.7.1.137 (phosphatidylinositol 3-kinase) inhibitor;
mTOR inhibitor
00low000000
5-chloro-6-(1-(2-iminopyrrolidinyl) methyl)uracil hydrochloridehydrochloride;
iminium salt
antineoplastic agent;
EC 2.4.2.4 (thymidine phosphorylase) inhibitor
00low000000
fty 720pmonoalkyl phosphate;
primary alcohol;
primary amino compound
antineoplastic agent;
immunosuppressive agent;
sphingosine-1-phosphate receptor agonist
00low000000
hmr 1275hydrochlorideantineoplastic agent;
antirheumatic drug;
apoptosis inducer;
EC 2.7.11.22 (cyclin-dependent kinase) inhibitor
00low000000
zm 447439aromatic ether;
benzamides;
morpholines;
polyether;
quinazolines;
secondary amino compound;
tertiary amino compound
antineoplastic agent;
apoptosis inducer;
Aurora kinase inhibitor
00low000000
hki 272nitrile;
quinolines
antineoplastic agent;
tyrosine kinase inhibitor
00low000000
ginsenoside f212beta-hydroxy steroid;
beta-D-glucoside;
ginsenoside;
tetracyclic triterpenoid
antineoplastic agent;
apoptosis inducer;
plant metabolite
00low000000
ginsenoside rg3ginsenoside;
glycoside;
tetracyclic triterpenoid
angiogenesis modulating agent;
antineoplastic agent;
apoptosis inducer;
plant metabolite
00low000000
es-285amino alcohol;
sphingoid
antineoplastic agent00low000000
nidulalin amethyl ester;
phenols;
xanthones
antimicrobial agent;
antineoplastic agent;
Penicillium metabolite
00low000000
hypothemycinaromatic ether;
diol;
enone;
epoxide;
macrolide;
phenols;
polyketide;
secondary alpha-hydroxy ketone
antifungal agent;
antineoplastic agent;
EC 2.7.11.24 (mitogen-activated protein kinase) inhibitor;
fungal metabolite
00low000000
rucaparibazepinoindole;
caprolactams;
organofluorine compound;
secondary amino compound
antineoplastic agent;
EC 2.4.2.30 (NAD(+) ADP-ribosyltransferase) inhibitor
00low000000
jte 607hydrochlorideanti-inflammatory agent;
antineoplastic agent;
apoptosis inducer;
cardioprotective agent;
CPSF3 inhibitor;
prodrug
00low000000
pasireotidehomodetic cyclic peptide;
peptide hormone
antineoplastic agent00low000000
npi 23582,5-diketopiperazines;
benzenes;
imidazoles;
olefinic compound
angiogenesis inhibitor;
antineoplastic agent;
apoptosis inducer;
microtubule-destabilising agent
00low000000
rubraxanthonearomatic ether;
polyphenol;
xanthones
antibacterial agent;
antineoplastic agent;
metabolite
00low000000
NNC 55-0396 (free base)benzimidazoles;
cyclopropanecarboxylate ester;
organofluorine compound;
tertiary amino compound;
tetralins
angiogenesis inhibitor;
antineoplastic agent;
apoptosis inducer;
neuroprotective agent;
potassium channel blocker;
T-type calcium channel blocker
00low000000
sr 11302alpha,beta-unsaturated monocarboxylic acid;
retinoid;
toluenes
antineoplastic agent;
AP-1 antagonist
00low000000
sch 51344aromatic amine;
aromatic ether;
primary alcohol;
pyrazoloquinoline;
secondary amino compound
antineoplastic agent00low000000
4alpha-methylergosta-8,24(28)-dien-3,7,11-trione-26-oic acid11-oxo steroid;
3-oxo steroid;
7-oxo steroid;
ergostanoid;
monocarboxylic acid;
steroid acid
anti-inflammatory agent;
antineoplastic agent;
plant metabolite
00low000000
osu 03012antibiotic antifungal drug;
aromatic amide;
glycine derivative;
organofluorine compound;
phenanthrenes;
pyrazoles
antineoplastic agent;
apoptosis inducer;
EC 2.7.11.1 (non-specific serine/threonine protein kinase) inhibitor
00low000000
ly2090314diazepinoindole;
imidazopyridine;
maleimides;
monofluorobenzenes;
piperidinecarboxamide;
ureas
antineoplastic agent;
apoptosis inducer;
EC 2.7.11.26 (tau-protein kinase) inhibitor;
Wnt signalling activator
00low000000
cerberinacetate ester;
cardenolide glycoside;
monosaccharide derivative
antineoplastic agent;
metabolite
00low000000
pateamine a1,3-thiazoles;
macrodiolide;
olefinic compound;
primary amino compound;
tertiary amino compound
antineoplastic agent;
antiviral agent;
eukaryotic initiation factor 4F inhibitor;
marine metabolite
00low000000
6-hydroxytaxoltaxane diterpenoid;
tetracyclic diterpenoid
antineoplastic agent00low000000
masitinib1,3-thiazoles;
benzamides;
N-alkylpiperazine;
pyridines
antineoplastic agent;
antirheumatic drug;
tyrosine kinase inhibitor
00low000000
avenanthramide bamidobenzoic acid;
cinnamamides;
monohydroxybenzoic acid;
monomethoxybenzene;
phenols;
secondary carboxamide
antineoplastic agent;
apoptosis inducer;
phytoalexin
00low000000
ageladine aalkaloid;
aromatic amine;
imidazopyridine;
organobromine compound;
pyrroles
angiogenesis inhibitor;
antineoplastic agent;
matrix metalloproteinase inhibitor;
metabolite
00low000000
ly-2157299aromatic amide;
methylpyridines;
monocarboxylic acid amide;
pyrrolopyrazole;
quinolines
antineoplastic agent;
TGFbeta receptor antagonist
00low000000
pazopanibaminopyrimidine;
indazoles;
sulfonamide
angiogenesis modulating agent;
antineoplastic agent;
tyrosine kinase inhibitor;
vascular endothelial growth factor receptor antagonist
00low000000
azd 6244benzimidazoles;
bromobenzenes;
hydroxamic acid ester;
monochlorobenzenes;
organofluorine compound;
secondary amino compound
anticoronaviral agent;
antineoplastic agent;
EC 2.7.11.24 (mitogen-activated protein kinase) inhibitor
00low000000
azd2858aromatic amine;
N-methylpiperazine;
pyrazines;
pyridines;
secondary carboxamide;
sulfonamide
antineoplastic agent;
bone density conservation agent;
EC 2.7.11.26 (tau-protein kinase) inhibitor;
Wnt signalling activator
00low000000
bibw 2992aromatic ether;
enamide;
furans;
monochlorobenzenes;
organofluorine compound;
quinazolines;
secondary carboxamide;
tertiary amino compound
antineoplastic agent;
tyrosine kinase inhibitor
00low000000
jte 013chloropyridine;
pyrazolopyridine
anti-asthmatic agent;
anti-inflammatory agent;
antineoplastic agent;
osteogenesis regulator;
pro-angiogenic agent;
sphingosine-1-phosphate receptor 2 antagonist
00low000000
holomycinacetamides;
dithiolopyrrolone antibiotic
antibacterial agent;
antineoplastic agent;
bacterial metabolite;
chelator;
EC 2.7.7.6 (RNA polymerase) inhibitor;
marine metabolite
00low000000
binimetinibbenzimidazoles;
bromobenzenes;
hydroxamic acid ester;
monofluorobenzenes;
secondary amino compound
antineoplastic agent;
apoptosis inducer;
EC 2.7.11.24 (mitogen-activated protein kinase) inhibitor
00low000000
aee 7886-{4-[(4-ethylpiperazin-1-yl)methyl]phenyl}-N-(1-phenylethyl)-7H-pyrrolo[2,3-d]pyrimidin-4-amineangiogenesis inhibitor;
antineoplastic agent;
apoptosis inducer;
EC 2.7.10.1 (receptor protein-tyrosine kinase) inhibitor;
epidermal growth factor receptor antagonist;
trypanocidal drug
00low000000
saracatinibaromatic ether;
benzodioxoles;
diether;
N-methylpiperazine;
organochlorine compound;
oxanes;
quinazolines;
secondary amino compound
anticoronaviral agent;
antineoplastic agent;
apoptosis inducer;
autophagy inducer;
EC 2.7.10.2 (non-specific protein-tyrosine kinase) inhibitor;
radiosensitizing agent
00low000000
crenolanibaminopiperidine;
aromatic ether;
benzimidazoles;
oxetanes;
quinolines;
tertiary amino compound
angiogenesis inhibitor;
antineoplastic agent;
apoptosis inducer;
EC 2.7.10.1 (receptor protein-tyrosine kinase) inhibitor
00low000000
trilobacinbutenolide;
polyketide;
triol
antineoplastic agent;
plant metabolite
00low000000
manassantin bbenzodioxoles;
dimethoxybenzene;
lignan;
oxolanes;
secondary alcohol
antineoplastic agent;
metabolite
00low000000
pha 665752dichlorobenzene;
enamide;
indolones;
N-acylpyrrolidine;
pyrrolecarboxamide;
secondary carboxamide;
sulfone;
tertiary carboxamide
antineoplastic agent;
c-Met tyrosine kinase inhibitor
00low000000
PB28aromatic ether;
piperazines;
tetralins
anticoronaviral agent;
antineoplastic agent;
apoptosis inducer;
sigma-2 receptor agonist
00low000000
tmc-95bindoles;
lactam;
macrocycle;
phenols;
secondary alcohol;
tertiary alcohol
antimicrobial agent;
antineoplastic agent;
fungal metabolite;
proteasome inhibitor
00low000000
fr 901464acetate ester;
cyclic hemiketal;
monocarboxylic acid amide;
pyrans;
spiro-epoxide
antimicrobial agent;
antineoplastic agent;
bacterial metabolite
00low000000
vinflunineacetate ester;
methyl ester;
organic heteropentacyclic compound;
organic heterotetracyclic compound;
semisynthetic derivative;
vinca alkaloid
antineoplastic agent00low000000
homocamptothecinepsilon-lactone;
organic heteropentacyclic compound;
organonitrogen heterocyclic compound;
tertiary alcohol
antineoplastic agent;
EC 5.99.1.2 (DNA topoisomerase) inhibitor
00low000000
3,5-dimethoxy-4-hydroxybenzyl alcohol-4-O-beta-D-glucopyranosidearomatic ether;
benzyl alcohols;
beta-D-glucoside;
monosaccharide derivative;
primary alcohol
antineoplastic agent;
metabolite
00low000000
jaspamide bcyclodepsipeptide;
organobromine compound
animal metabolite;
antineoplastic agent;
marine metabolite
00low000000
ossamycincyclic hemiketal;
macrolide antibiotic;
organic heterotetracyclic compound;
secondary alcohol;
spiroketal;
tertiary alcohol
antineoplastic agent;
bacterial metabolite
00low000000
nigranoic aciddicarboxylic acid;
tetracyclic triterpenoid
antineoplastic agent;
HIV-1 reverse transcriptase inhibitor;
metabolite
00low000000
esculeoside aazaspiro compound;
oxaspiro compound;
saponin;
steroid alkaloid;
steroid saponin
antineoplastic agent;
metabolite
00low000000
azadironeacetate ester;
cyclic terpene ketone;
furans;
limonoid;
tetracyclic triterpenoid
antineoplastic agent;
antiplasmodial drug;
plant metabolite
00low000000
iejimalide bether;
formamides;
macrolide
antineoplastic agent;
marine metabolite
00low000000
migrastatinether;
macrolide antibiotic;
piperidones;
secondary alcohol
antineoplastic agent;
metabolite
00low000000
cembra-2,7,11-triene-4,6-diolcembrane diterpenoidantineoplastic agent00low000000
2,3,6,8-tetrahydroxy-1-(3-methylbut-2-enyl)-5-(2-methylbut-3-en-2-yl)-9h-xanthen-9-onepolyphenol;
xanthones
anti-inflammatory agent;
antineoplastic agent;
EC 1.14.99.1 (prostaglandin-endoperoxide synthase) inhibitor;
metabolite
00low000000
regorafenib(trifluoromethyl)benzenes;
aromatic ether;
monochlorobenzenes;
monofluorobenzenes;
phenylureas;
pyridinecarboxamide
antineoplastic agent;
hepatotoxic agent;
tyrosine kinase inhibitor
00low000000
at 7867monochlorobenzenes;
piperidines;
pyrazoles
antineoplastic agent;
EC 2.7.11.1 (non-specific serine/threonine protein kinase) inhibitor
00low000000
ym 155organic bromide saltantineoplastic agent;
apoptosis inducer;
survivin suppressant
00low000000
bielschowskysinacetate ester;
cyclic acetal;
diterpenoid;
gamma-lactone;
organic heterohexacyclic compound
antimalarial;
antineoplastic agent;
metabolite
00low000000
erastinaromatic ether;
diether;
monochlorobenzenes;
N-acylpiperazine;
N-alkylpiperazine;
quinazolines;
tertiary carboxamide
antineoplastic agent;
ferroptosis inducer;
voltage-dependent anion channel inhibitor
00low000000
abt-737aromatic amine;
aryl sulfide;
biphenyls;
C-nitro compound;
monochlorobenzenes;
N-arylpiperazine;
N-sulfonylcarboxamide;
secondary amino compound;
tertiary amino compound
anti-allergic agent;
anti-inflammatory agent;
antineoplastic agent;
apoptosis inducer;
B-cell lymphoma 2 inhibitor
00low000000
brivanibaromatic ether;
diether;
fluoroindole;
pyrrolotriazine;
secondary alcohol
angiogenesis inhibitor;
antineoplastic agent;
apoptosis inducer;
drug metabolite;
EC 2.7.10.1 (receptor protein-tyrosine kinase) inhibitor;
fibroblast growth factor receptor antagonist
00low000000
rx-3117organofluorine compound;
primary allylic alcohol;
triol
antimetabolite;
antineoplastic agent;
apoptosis inducer;
DNA synthesis inhibitor;
prodrug
00low000000
ascochlorincyclohexanones;
dihydroxybenzaldehyde;
meroterpenoid;
monochlorobenzenes;
olefinic compound;
resorcinols;
sesquiterpenoid
angiogenesis inhibitor;
antifungal agent;
antineoplastic agent;
antiprotozoal drug;
fungal metabolite
00low000000
spiculoic acid acarbobicyclic compound;
cyclic ketone;
oxo monocarboxylic acid;
styrenes
antineoplastic agent;
metabolite
00low000000
N(2)-([biphenyl]-4-ylsulfonyl)-N-hydroxy-N(2)-isopropoxy-D-valinamideD-valine derivative;
hydroxamic acid
antineoplastic agent;
autophagy inducer;
EC 3.4.24.24 (gelatinase A) inhibitor;
melanin synthesis inhibitor
00low000000
at 7519dichlorobenzene;
piperidines;
pyrazoles;
secondary carboxamide
antineoplastic agent;
EC 2.7.11.22 (cyclin-dependent kinase) inhibitor
00low000000
ym 2163911,3-oxazoles;
1,3-thiazoles;
azamacrocycle;
benzenes;
heterodetic cyclic peptide
antineoplastic agent;
bacterial metabolite
00low000000
marizomibbeta-lactone;
gamma-lactam;
organic heterobicyclic compound;
organochlorine compound;
salinosporamide
antineoplastic agent;
proteasome inhibitor
00low000000
er-086526cyclic ketal;
cyclic ketone;
macrocycle;
polycyclic ether;
polyether;
primary amino compound
antineoplastic agent;
microtubule-destabilising agent
00low000000
obolactone2-pyranones;
4-pyranones
antineoplastic agent;
plant metabolite
00low000000
episilvestroldioxanes;
ether;
methyl ester;
organic heterotricyclic compound
antineoplastic agent;
metabolite
00low000000
abt 869aromatic amine;
indazoles;
phenylureas
angiogenesis inhibitor;
antineoplastic agent;
EC 2.7.10.1 (receptor protein-tyrosine kinase) inhibitor
00low000000
azd 1152anilide;
monoalkyl phosphate;
monofluorobenzenes;
pyrazoles;
quinazolines;
secondary amino compound;
secondary carboxamide;
tertiary amino compound
antineoplastic agent;
Aurora kinase inhibitor;
prodrug
00low000000
pf 00299804enamide;
monochlorobenzenes;
monofluorobenzenes;
piperidines;
quinazolines;
secondary amino compound;
secondary carboxamide;
tertiary amino compound
antineoplastic agent;
epidermal growth factor receptor antagonist
00low000000
ki11502aromatic ether;
benzamides;
quinolines;
thioureas
antineoplastic agent;
apoptosis inducer;
EC 2.7.10.1 (receptor protein-tyrosine kinase) inhibitor
00low000000
carfilzomibepoxide;
morpholines;
tetrapeptide
antineoplastic agent;
proteasome inhibitor
00low000000
3-[1-(2,6-dichloro-3-fluorophenyl)ethoxy]-5-[1-(piperidin-4-yl)pyrazol-4-yl]pyridin-2-amineaminopyridine;
aromatic ether;
dichlorobenzene;
organofluorine compound;
pyrazolylpiperidine;
racemate
antineoplastic agent;
biomarker;
EC 2.7.10.1 (receptor protein-tyrosine kinase) inhibitor
00low000000
idelalisibaromatic amine;
organofluorine compound;
purines;
quinazolines;
secondary amino compound
antineoplastic agent;
apoptosis inducer;
EC 2.7.1.137 (phosphatidylinositol 3-kinase) inhibitor
00low000000
crizotinib3-[1-(2,6-dichloro-3-fluorophenyl)ethoxy]-5-[1-(piperidin-4-yl)pyrazol-4-yl]pyridin-2-amineantineoplastic agent;
biomarker;
EC 2.7.10.1 (receptor protein-tyrosine kinase) inhibitor
00low000000
zstk474benzimidazoles;
morpholines;
organofluorine compound;
triamino-1,3,5-triazine
antineoplastic agent;
EC 2.7.1.137 (phosphatidylinositol 3-kinase) inhibitor
00low000000
trametinibacetamides;
aromatic amine;
cyclopropanes;
organofluorine compound;
organoiodine compound;
pyridopyrimidine;
ring assembly
anticoronaviral agent;
antineoplastic agent;
EC 2.7.11.24 (mitogen-activated protein kinase) inhibitor;
geroprotector
00low000000
lyoniresinoldimethoxybenzene;
lignan;
polyphenol;
primary alcohol;
tetralins
antineoplastic agent;
metabolite
00low000000
GDC-0879indanes;
ketoxime;
primary alcohol;
pyrazoles;
pyridines
antineoplastic agent;
B-Raf inhibitor
00low000000
physalin benone;
lactone;
organic heteroheptacyclic compound;
physalin
antimalarial;
antimicrobial agent;
antineoplastic agent
00low000000
amrubicinoldiastereoisomeric mixture;
quinone;
secondary alcohol;
tetracenes
antineoplastic agent;
apoptosis inducer;
topoisomerase II inhibitor
00low000000
silvestroldioxanes;
ether;
methyl ester;
organic heterotricyclic compound
antineoplastic agent;
metabolite
00low000000
at 13387benzamides;
isoindoles;
N-alkylpiperazine;
resorcinols;
tertiary carboxamide
antineoplastic agent;
Hsp90 inhibitor
00low000000
cytotrienin acyclopropanecarboxylate ester;
ether;
hydroquinones;
lactam;
macrocycle;
secondary alcohol
antibacterial agent;
antimicrobial agent;
antineoplastic agent;
apoptosis inducer;
metabolite
00low000000
dactolisibimidazoquinoline;
nitrile;
quinolines;
ring assembly;
ureas
antineoplastic agent;
EC 2.7.1.137 (phosphatidylinositol 3-kinase) inhibitor;
mTOR inhibitor
00low000000
bgt226aromatic ether;
imidazoquinoline;
N-arylpiperazine;
organofluorine compound;
pyridines
antineoplastic agent;
EC 2.7.1.137 (phosphatidylinositol 3-kinase) inhibitor;
mTOR inhibitor
00low000000
2'-methoxykurarinone4'-hydroxyflavanones;
dihydroxyflavanone;
dimethoxyflavanone
antineoplastic agent;
metabolite
00low000000
geduninacetate ester;
enone;
epoxide;
furans;
lactone;
limonoid;
organic heteropentacyclic compound;
pentacyclic triterpenoid
antimalarial;
antineoplastic agent;
Hsp90 inhibitor;
plant metabolite
00low000000
monascinalpha,beta-unsaturated ketone;
gamma-lactone;
organic heterotricyclic compound;
polyketide
antilipemic drug;
antineoplastic agent;
fungal metabolite;
PPARgamma agonist
00low000000
monascorubrinazaphilone;
enone;
gamma-lactone;
polyketide;
triketone
anti-inflammatory agent;
antineoplastic agent;
biological pigment;
food colouring;
fungal metabolite;
Hsp90 inhibitor
00low000000
5,7-dihydroxy-2-methyl-8-(4-(3-hydroxy-1-methyl)-piperidinyl)-4h-1-benzopyran-4-onealkaloid;
chromones;
hydroxypiperidine;
resorcinols;
tertiary amino compound
anti-inflammatory agent;
anti-ulcer drug;
anticholesteremic drug;
antileishmanial agent;
antineoplastic agent;
EC 2.7.11.22 (cyclin-dependent kinase) inhibitor;
fungal metabolite;
plant metabolite
00low000000
SYC-435benzenes;
cyclic hydroxamic acid;
pyridone
antineoplastic agent;
EC 1.1.1.42 (isocitrate dehydrogenase) inhibitor
00low000000
ligstrosidebeta-D-glucoside;
diester;
methyl ester;
phenols;
pyrans;
secoiridoid glycoside
antineoplastic agent;
plant metabolite
00low000000
mogrolhydroxy seco-steroid;
tetracyclic triterpenoid
antineoplastic agent00low000000
simalikalactone Dcyclic ether;
delta-lactone;
enone;
organic heteropentacyclic compound;
quassinoid;
secondary alcohol;
secondary alpha-hydroxy ketone;
triol
antimalarial;
antineoplastic agent;
antiviral agent;
metabolite
00low000000
4-methyl-5-pentylbenzene-1,3-diolresorcinolsantineoplastic agent00low000000
mdv 3100(trifluoromethyl)benzenes;
benzamides;
imidazolidinone;
monofluorobenzenes;
nitrile;
thiocarbonyl compound
androgen antagonist;
antineoplastic agent
00low000000
azd 1152-hqpaanilide;
monofluorobenzenes;
primary alcohol;
pyrazoles;
quinazolines;
secondary amino compound;
secondary carboxamide;
tertiary amino compound
antineoplastic agent;
Aurora kinase inhibitor
00low000000
adonixanthincarotenone;
cyclic ketone;
secondary alcohol
algal metabolite;
animal metabolite;
antineoplastic agent;
bacterial metabolite;
marine metabolite;
plant metabolite
00low000000
schweinfurthin gcyclic ether;
organic heterotricyclic compound;
resorcinols;
stilbenoid
antineoplastic agent;
metabolite
00low000000
abarelixpolypeptideantineoplastic agent;
hormone antagonist
00low000000
forapinpeptidyl amide;
polypeptide
animal metabolite;
antineoplastic agent;
apoptosis inducer;
EC 2.7.11.13 (protein kinase C) inhibitor;
hepatoprotective agent;
neuroprotective agent;
venom
00low000000
gastrin 17gastrinantineoplastic agent00low000000
gdc-0973aromatic amine;
difluorobenzene;
N-acylazetidine;
organoiodine compound;
piperidines;
secondary amino compound;
tertiary alcohol
antineoplastic agent;
EC 2.7.11.24 (mitogen-activated protein kinase) inhibitor
00low000000
buparlisibaminopyridine;
aminopyrimidine;
morpholines;
organofluorine compound
antineoplastic agent;
EC 2.7.1.137 (phosphatidylinositol 3-kinase) inhibitor
00low000000
tubocapsanolide a4-hydroxy steroid;
delta-lactone;
enone;
epoxy steroid;
ergostanoid;
secondary alcohol;
withanolide
antineoplastic agent;
NF-kappaB inhibitor
00low000000
ro5126766aryloxypyrimidine;
coumarins;
organofluorine compound;
pyridines;
sulfamides
antineoplastic agent;
EC 2.7.11.24 (mitogen-activated protein kinase) inhibitor
00low000000
pevonedistatcyclopentanols;
indanes;
pyrrolopyrimidine;
secondary amino compound;
sulfamidate
antineoplastic agent;
apoptosis inducer
00low000000
tg101209N-alkylpiperazine;
N-arylpiperazine;
pyrimidines;
secondary amino compound;
sulfonamide
antineoplastic agent;
apoptosis inducer;
EC 2.7.10.2 (non-specific protein-tyrosine kinase) inhibitor
00low000000
gsk6906931,2,5-oxadiazole;
acetylenic compound;
aromatic amine;
aromatic ether;
imidazopyridine;
piperidines;
primary amino compound;
tertiary alcohol
antineoplastic agent;
EC 2.7.11.1 (non-specific serine/threonine protein kinase) inhibitor
00low000000
cnf 20242-aminopurines;
aromatic ether;
organochlorine compound;
pyridines
antineoplastic agent;
Hsp90 inhibitor
00low000000
ku 0063794benzyl alcohols;
monomethoxybenzene;
morpholines;
pyridopyrimidine;
tertiary amino compound
antineoplastic agent;
mTOR inhibitor
00low000000
respirantinbenzamides;
cyclodepsipeptide;
formamides;
phenols
antimicrobial agent;
antineoplastic agent;
metabolite
00low000000
sm 164benzenes;
organic heterobicyclic compound;
secondary carboxamide;
triazoles
antineoplastic agent;
apoptosis inducer;
radiosensitizing agent
00low000000
berkeleydionebeta-diketone;
cyclic terpene ketone;
meroterpenoid;
methyl ester;
organic heterotetracyclic compound;
terpene lactone;
tertiary alcohol;
tertiary alpha-hydroxy ketone
antineoplastic agent;
cysteine protease inhibitor;
Penicillium metabolite
00low000000
lucidenic acid ncyclic terpene ketone;
dioxo monocarboxylic acid;
secondary alcohol;
tetracyclic triterpenoid
antineoplastic agent;
EC 3.1.1.8 (cholinesterase) inhibitor;
metabolite
00low000000
bromophycolide aditerpenoid;
macrolide;
organobromine compound;
phenols;
tertiary alcohol
anti-HIV agent;
antibacterial agent;
antifungal agent;
antimalarial;
antineoplastic agent;
metabolite
00low000000
nnc 55-0396hydrochlorideangiogenesis inhibitor;
antineoplastic agent;
apoptosis inducer;
neuroprotective agent;
potassium channel blocker;
T-type calcium channel blocker
00low000000
meclofenamate sodium anhydroushydrateanalgesic;
anticonvulsant;
antineoplastic agent;
antipyretic;
antirheumatic drug;
EC 1.13.11.34 (arachidonate 5-lipoxygenase) inhibitor;
EC 1.14.99.1 (prostaglandin-endoperoxide synthase) inhibitor;
non-steroidal anti-inflammatory drug
00low000000
brequinar sodiumorganic sodium saltanticoronaviral agent;
antimetabolite;
antineoplastic agent;
antiviral agent;
EC 1.3.5.2 [dihydroorotate dehydrogenase (quinone)] inhibitor;
immunosuppressive agent;
pyrimidine synthesis inhibitor
00low000000
borrelidinaliphatic nitrile;
diol;
macrolide;
monocarboxylic acid;
secondary alcohol
antifungal agent;
antimalarial;
antimicrobial agent;
antineoplastic agent;
apoptosis inducer;
bacterial metabolite
00low000000
olaparibcyclopropanes;
monofluorobenzenes;
N-acylpiperazine;
phthalazines
antineoplastic agent;
apoptosis inducer;
EC 2.4.2.30 (NAD(+) ADP-ribosyltransferase) inhibitor
00low000000
plx 4720aromatic ketone;
difluorobenzene;
organochlorine compound;
pyrrolopyridine;
sulfonamide
antineoplastic agent;
B-Raf inhibitor
00low000000
lcl1611,3-thiazoles;
aromatic ketone;
L-alanine derivative;
monofluorobenzenes;
N-acylpyrrolidine
antineoplastic agent;
apoptosis inducer
00low000000
aspergillide bbridged compound;
cyclic ether;
macrolide;
secondary alcohol
antineoplastic agent;
Aspergillus metabolite
00low000000
tenovin-6monocarboxylic acid amide;
tertiary amino compound;
thioureas
antineoplastic agent;
p53 activator;
Sir2 inhibitor
00low000000
lde225aminopyridine;
aromatic ether;
benzamides;
biphenyls;
morpholines;
organofluorine compound;
tertiary amino compound
antineoplastic agent;
Hedgehog signaling pathway inhibitor;
SMO receptor antagonist
00low000000
gdc 0449benzamides;
monochlorobenzenes;
pyridines;
sulfone
antineoplastic agent;
Hedgehog signaling pathway inhibitor;
SMO receptor antagonist;
teratogenic agent
00low000000
bms 754807pyrazoles;
pyridines;
pyrrolidines;
pyrrolotriazine
antineoplastic agent;
EC 2.7.10.1 (receptor protein-tyrosine kinase) inhibitor
00low000000
marinopyrrole aaromatic ketone;
organochlorine compound;
phenols;
pyrroles
antibacterial agent;
antimicrobial agent;
antineoplastic agent;
bacterial metabolite;
marine metabolite
00low000000
delanzomibC-terminal boronic acid peptide;
phenylpyridine;
secondary alcohol;
threonine derivative
antineoplastic agent;
apoptosis inducer;
proteasome inhibitor
00low000000
grassypeptolidecyclodepsipeptide;
macrocycle
antineoplastic agent;
metabolite
00low000000
pci 32765acrylamides;
aromatic amine;
aromatic ether;
N-acylpiperidine;
pyrazolopyrimidine;
tertiary carboxamide
antineoplastic agent;
EC 2.7.10.2 (non-specific protein-tyrosine kinase) inhibitor
00low000000
ponatinib(trifluoromethyl)benzenes;
acetylenic compound;
benzamides;
imidazopyridazine;
N-methylpiperazine
antineoplastic agent;
tyrosine kinase inhibitor
00low000000
AMG-208aromatic ether;
quinolines;
triazolopyridazine
antineoplastic agent;
c-Met tyrosine kinase inhibitor
00low000000
sch772984biaryl;
indazoles;
N-acylpiperazine;
N-alkylpyrrolidine;
N-arylpiperazine;
pyridines;
pyrimidines;
pyrrolidinecarboxamide;
secondary carboxamide;
tertiary amino compound;
tertiary carboxamide
analgesic;
antineoplastic agent;
apoptosis inducer;
EC 2.7.11.24 (mitogen-activated protein kinase) inhibitor
00low000000
papuamide bcyclodepsipeptide;
olefinic compound;
secondary alcohol;
tertiary alcohol
anti-HIV-1 agent;
antineoplastic agent;
marine metabolite
00low000000
antroquinonol denol ether;
enone;
secondary alcohol
antineoplastic agent;
fungal metabolite
00low000000
quizartinibbenzoimidazothiazole;
isoxazoles;
morpholines;
phenylureas
antineoplastic agent;
EC 2.7.10.1 (receptor protein-tyrosine kinase) inhibitor;
necroptosis inhibitor
00low000000
6-methoxyspirotryprostatin baromatic ether;
azaspiro compound;
indole alkaloid;
indolones
antineoplastic agent;
Aspergillus metabolite
00low000000
PP121aromatic amine;
cyclopentanes;
pyrazolopyrimidine;
pyrrolopyridine
antineoplastic agent;
EC 2.7.1.137 (phosphatidylinositol 3-kinase) inhibitor;
tyrosine kinase inhibitor
00low000000
niraparibbenzenes;
indazoles;
piperidines;
primary carboxamide
antineoplastic agent;
EC 2.4.2.30 (NAD(+) ADP-ribosyltransferase) inhibitor
00low000000
niraparib2-[4-(piperidin-3-yl)phenyl]-2H-indazole-7-carboxamideantineoplastic agent;
apoptosis inducer;
EC 2.4.2.30 (NAD(+) ADP-ribosyltransferase) inhibitor;
radiosensitizing agent
00low000000
navitoclaxaryl sulfide;
monochlorobenzenes;
morpholines;
N-sulfonylcarboxamide;
organofluorine compound;
piperazines;
secondary amino compound;
sulfone;
tertiary amino compound
antineoplastic agent;
apoptosis inducer;
B-cell lymphoma 2 inhibitor
00low000000
lucitanibaromatic ether;
cyclopropanes;
naphthalenecarboxamide;
primary amino compound;
quinolines
antineoplastic agent;
fibroblast growth factor receptor antagonist;
vascular endothelial growth factor receptor antagonist
00low000000
chondramide cchondramide;
indoles;
phenols
antineoplastic agent;
bacterial metabolite
00low000000
n-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamideaminopyrimidine;
benzamides;
morpholines;
nitrile;
secondary amino compound;
tertiary amino compound
anti-anaemic agent;
antineoplastic agent;
apoptosis inducer;
EC 2.7.10.2 (non-specific protein-tyrosine kinase) inhibitor
00low000000
cetrorelixoligopeptideantineoplastic agent;
GnRH antagonist
00low000000
histrelinoligopeptideantineoplastic agent;
gonadotropin releasing hormone agonist
00low000000
cabozantinibaromatic ether;
dicarboxylic acid diamide;
organofluorine compound;
quinolines
antineoplastic agent;
tyrosine kinase inhibitor
00low000000
salvileucalin bbridged compound;
diterpenoid;
furans;
gamma-lactone
antineoplastic agent;
metabolite
00low000000
incb-018424nitrile;
pyrazoles;
pyrrolopyrimidine
antineoplastic agent;
EC 2.7.10.2 (non-specific protein-tyrosine kinase) inhibitor
00low000000
poziotinibacrylamides;
aromatic ether;
dichlorobenzene;
diether;
monofluorobenzenes;
N-acylpiperidine;
quinazolines;
secondary amino compound;
substituted aniline
antineoplastic agent;
apoptosis inducer;
epidermal growth factor receptor antagonist
00low000000
asp3026aromatic amine;
diamino-1,3,5-triazine;
monomethoxybenzene;
N-methylpiperazine;
piperidines;
secondary amino compound;
sulfone
antimalarial;
antineoplastic agent;
apoptosis inducer;
EC 2.7.10.1 (receptor protein-tyrosine kinase) inhibitor;
EC 6.1.1.6 (lysine--tRNA ligase) inhibitor
00low000000
entrectinibbenzamides;
difluorobenzene;
indazoles;
N-methylpiperazine;
oxanes;
secondary amino compound;
secondary carboxamide
antibacterial agent;
antineoplastic agent;
apoptosis inducer;
EC 2.7.10.1 (receptor protein-tyrosine kinase) inhibitor
00low000000
pexidartinibaminopyridine;
organochlorine compound;
organofluorine compound;
pyrrolopyridine;
secondary amino compound
antineoplastic agent;
EC 2.7.10.1 (receptor protein-tyrosine kinase) inhibitor
00low000000
TAK-5801,3-thiazolecarboxamide;
aminopyrimidine;
chloropyridine;
organofluorine compound;
pyrimidinecarboxamide;
secondary carboxamide
antineoplastic agent;
apoptosis inducer;
B-Raf inhibitor
00low000000
glasdegibbenzimidazoles;
nitrile;
phenylureas;
piperidines
antineoplastic agent;
Hedgehog signaling pathway inhibitor;
SMO receptor antagonist
00low000000
gsk 2126458aromatic ether;
difluorobenzene;
pyridazines;
pyridines;
quinolines;
sulfonamide
anticoronaviral agent;
antineoplastic agent;
autophagy inducer;
EC 2.7.1.137 (phosphatidylinositol 3-kinase) inhibitor;
mTOR inhibitor;
radiosensitizing agent
00low000000
ixazomibbenzamides;
boronic acids;
dichlorobenzene;
glycine derivative
antineoplastic agent;
apoptosis inducer;
drug metabolite;
orphan drug;
proteasome inhibitor
00low000000
cx 5461diazepine;
naphthyridine derivative;
organic heterotetracyclic compound;
pyrazines;
secondary carboxamide
antineoplastic agent;
apoptosis inducer;
EC 2.7.7.6 (RNA polymerase) inhibitor
00low000000
(5-(2,4-bis((3s)-3-methylmorpholin-4-yl)pyrido(2,3-d)pyrimidin-7-yl)-2-methoxyphenyl)methanolbenzyl alcohols;
morpholines;
pyridopyrimidine;
tertiary amino compound
antineoplastic agent;
apoptosis inducer;
mTOR inhibitor
00low000000
plx4032aromatic ketone;
difluorobenzene;
monochlorobenzenes;
pyrrolopyridine;
sulfonamide
antineoplastic agent;
B-Raf inhibitor
00low000000
GDC-0623hydroxamic acid ester;
imidazopyridine;
monofluorobenzenes;
organoiodine compound;
primary alcohol;
secondary amino compound;
substituted aniline
antineoplastic agent;
apoptosis inducer;
EC 2.7.12.2 (mitogen-activated protein kinase kinase) inhibitor
00low000000
INDYbenzothiazoles;
enone;
organic hydroxy compound
antineoplastic agent;
drug metabolite;
EC 2.7.12.1 (dual-specificity kinase) inhibitor
00low000000
7,8-dihydroxyflavanonedihydroxyflavanoneantineoplastic agent;
metabolite
00low000000
dabrafenib1,3-thiazoles;
aminopyrimidine;
organofluorine compound;
sulfonamide
anticoronaviral agent;
antineoplastic agent;
B-Raf inhibitor
00low000000
cblc137aromatic ketone;
carbazoles;
methyl ketone;
secondary amino compound;
tertiary amino compound
antineoplastic agent;
apoptosis inducer;
NF-kappaB inhibitor;
p53 activator
00low000000
2,3-dihydro-3beta-O-sulfate withaferin A27-hydroxy steroid;
4-hydroxy steroid;
delta-lactone;
epoxy steroid;
ergostanoid;
primary alcohol;
steroid sulfate;
withanolide
antineoplastic agent;
metabolite;
plant metabolite
00low000000
leachianone a4'-hydroxyflavanones;
monomethoxyflavanone;
trihydroxyflavanone
antimalarial;
antineoplastic agent;
metabolite
00low000000
thiopental sodiumorganochlorine compound;
piperazines;
pyrimidines
antineoplastic agent;
tyrosine kinase inhibitor
00low000000
EG00229benzothiadiazole;
dicarboxylic acid monoamide;
L-arginine derivative;
secondary carboxamide;
sulfonamide;
thiophenes
angiogenesis inhibitor;
antineoplastic agent;
neuropilin receptor antagonist
00low000000
jadomycin bglycoside;
jadomycin;
organic heteropentacyclic compound
antibacterial agent;
antineoplastic agent;
apoptosis inducer;
Aurora kinase inhibitor;
bacterial metabolite
00low000000
tak-632(trifluoromethyl)benzenes;
aromatic ether;
benzothiazoles;
cyclopropylcarboxamide;
monofluorobenzenes;
nitrile;
secondary carboxamide
antineoplastic agent;
apoptosis inducer;
B-Raf inhibitor;
EC 2.7.11.26 (tau-protein kinase) inhibitor;
necroptosis inhibitor
00low000000
chondramide achondramide;
indoles;
phenols
antineoplastic agent;
bacterial metabolite
00low000000
englerin acinnamate ester;
glycolate ester;
guaiane sesquiterpenoid
antineoplastic agent;
metabolite
00low000000
lrrk2-in1aromatic amine;
aromatic ether;
N-acylpiperidine;
N-alkylpiperazine;
pyrimidobenzodiazepine;
secondary amino compound;
tertiary amino compound
antineoplastic agent;
EC 2.7.11.1 (non-specific serine/threonine protein kinase) inhibitor
00low000000
jq1 compoundcarboxylic ester;
organochlorine compound;
tert-butyl ester;
thienotriazolodiazepine
angiogenesis inhibitor;
anti-inflammatory agent;
antineoplastic agent;
apoptosis inducer;
bromodomain-containing protein 4 inhibitor;
cardioprotective agent;
ferroptosis inducer
00low000000
ML-210C-nitro compound;
diarylmethane;
isoxazoles;
monochlorobenzenes;
N-acylpiperazine;
N-alkylpiperazine;
tertiary carboxamide
antineoplastic agent;
EC 1.11.1.9 (glutathione peroxidase) inhibitor;
ferroptosis inducer;
prodrug
00low000000
eurycomanonecyclic ether;
delta-lactone;
enone;
organic heteropentacyclic compound;
pentol;
quassinoid;
secondary alcohol;
secondary alpha-hydroxy ketone;
tertiary alcohol
antimalarial;
antineoplastic agent;
metabolite
00low000000
gilteritinibaromatic amine;
monomethoxybenzene;
N-methylpiperazine;
oxanes;
piperidines;
primary carboxamide;
pyrazines;
secondary amino compound
antineoplastic agent;
apoptosis inducer;
EC 2.7.10.1 (receptor protein-tyrosine kinase) inhibitor
00low000000
alectinibaromatic ketone;
morpholines;
nitrile;
organic heterotetracyclic compound;
piperidines
antineoplastic agent;
EC 2.7.10.1 (receptor protein-tyrosine kinase) inhibitor
00low000000
ML240aromatic amine;
aromatic ether;
benzimidazoles;
primary amino compound;
quinazolines;
secondary amino compound
antineoplastic agent00low000000
torin 1N-acylpiperazine;
N-arylpiperazine;
organofluorine compound;
pyridoquinoline;
quinolines
antineoplastic agent;
mTOR inhibitor
00low000000
abt-199aromatic ether;
C-nitro compound;
monochlorobenzenes;
N-alkylpiperazine;
N-arylpiperazine;
N-sulfonylcarboxamide;
oxanes;
pyrrolopyridine
antineoplastic agent;
apoptosis inducer;
B-cell lymphoma 2 inhibitor
00low000000
physalin fenone;
epoxy steroid;
lactone;
physalin
antileishmanial agent;
antimalarial;
antineoplastic agent;
apoptosis inducer;
immunosuppressive agent
00low000000
xl765aromatic amine;
aromatic ether;
benzamides;
quinoxaline derivative;
sulfonamide
antineoplastic agent;
EC 2.7.1.137 (phosphatidylinositol 3-kinase) inhibitor;
mTOR inhibitor
00low000000
DMH1aromatic ether;
pyrazolopyrimidine;
quinolines
antineoplastic agent;
bone morphogenetic protein receptor antagonist;
protein kinase inhibitor
00low000000
torin 2aminopyridine;
organofluorine compound;
primary amino compound;
pyridoquinoline
antineoplastic agent;
mTOR inhibitor
00low000000
oligomycin aantibiotic antifungal agent;
diketone;
oligomycin;
pentol
antineoplastic agent;
EC 3.6.3.14 (H(+)-transporting two-sector ATPase) inhibitor;
nematicide
00low000000
3-(2,6-dichloro-3,5-dimethoxyphenyl)-1-(6-(4-(4-ethylpiperazin-1-yl)-phenylamino)pyrimidin-4-yl)-1-methylureaaminopyrimidine;
dichlorobenzene;
N-alkylpiperazine;
N-arylpiperazine;
phenylureas
antineoplastic agent;
fibroblast growth factor receptor antagonist
00low000000
3alpha,12alpha-dihydroxy-4alpha-methylergosta-8,24(28)-dien-7,11-dione-26-oic acid11-oxo steroid;
12alpha-hydroxy steroid;
3alpha-hydroxy steroid;
7-oxo steroid;
monocarboxylic acid;
secondary alpha-hydroxy ketone;
steroid acid
antineoplastic agent;
metabolite
00low000000
3alpha-hydroxy-4alpha-methylergosta-8,24(28)-dien-7,11-dione-26-oic acid11-oxo steroid;
3alpha-hydroxy steroid;
7-oxo steroid;
monocarboxylic acid;
steroid acid
antineoplastic agent;
cholinergic antagonist;
metabolite;
serotonergic antagonist
00low000000
chir 98014aminopyrimidine;
C-nitro compound;
diaminopyridine;
dichlorobenzene;
imidazoles;
secondary amino compound
antineoplastic agent;
apoptosis inducer;
EC 2.7.11.26 (tau-protein kinase) inhibitor;
hypoglycemic agent;
tau aggregation inhibitor;
Wnt signalling activator
00low000000
gsk2656157biaryl;
indoles;
methylpyridines;
organofluorine compound;
pyrrolopyrimidine;
tertiary carboxamide
antineoplastic agent;
EC 3.1.3.48 (protein-tyrosine-phosphatase) inhibitor;
PERK inhibitor
00low000000
n-(2-(5-methoxy-2-oxo-2,3-dihydro-1h-indol-3-yl)ethyl)acetamideacetamides;
hydroxyindoles;
tryptamines
antineoplastic agent;
apoptosis inducer;
plant metabolite
00low000000
coumermycinaromatic amide;
coumarins;
glycoside;
heteroarenecarboxylate ester;
pyrroles
antimicrobial agent;
antineoplastic agent;
bacterial metabolite;
DNA synthesis inhibitor;
Hsp90 inhibitor;
topoisomerase IV inhibitor
00low000000
lfm a13aromatic amide;
dibromobenzene;
enamide;
enol;
nitrile;
secondary carboxamide
antineoplastic agent;
apoptosis inducer;
EC 2.7.10.2 (non-specific protein-tyrosine kinase) inhibitor;
EC 2.7.11.21 (polo kinase) inhibitor;
geroprotector;
platelet aggregation inhibitor
00low000000
AZD3463aminopiperidine;
aminopyrimidine;
indoles;
monomethoxybenzene;
organochlorine compound;
secondary amino compound;
tertiary amino compound
antineoplastic agent;
apoptosis inducer;
autophagy inducer;
EC 2.7.10.1 (receptor protein-tyrosine kinase) inhibitor
00low000000
calicheamicin gamma(1)icalicheamicin;
enediyne antibiotic;
organoiodine compound
antineoplastic agent;
metabolite
00low000000
asperfuranone2-benzofurans;
cyclic ketone;
diol;
polyketide;
secondary alcohol;
tertiary alcohol;
tertiary alpha-hydroxy ketone
antineoplastic agent;
fungal metabolite
00low000000
ceritinibaminopyrimidine;
aromatic ether;
organochlorine compound;
piperidines;
secondary amino compound;
sulfone
antineoplastic agent;
EC 2.7.10.1 (receptor protein-tyrosine kinase) inhibitor
00low000000
pelabresibmonochlorobenzenes;
organic heterotricyclic compound;
primary carboxamide
antineoplastic agent;
bromodomain-containing protein 4 inhibitor
00low000000
MK-8353aromatic ether;
dihydropyridine;
indazoles;
methyl sulfide;
N-alkylpyrrolidine;
pyridines;
pyrrolidinecarboxamide;
secondary carboxamide;
tertiary carboxamide;
triazoles
antineoplastic agent;
apoptosis inducer;
EC 2.7.11.24 (mitogen-activated protein kinase) inhibitor
00low000000
gsk2879552benzenes;
benzoic acids;
cyclopropanes;
monocarboxylic acid;
piperidines;
secondary amino compound;
tertiary amino compound
antineoplastic agent;
EC 1.14.99.66 (lysine-specific histone demethylase 1A) inhibitor
00low000000
ssr128129eorganic sodium saltantineoplastic agent;
fibroblast growth factor receptor antagonist
00low000000
aspergillide abridged compound;
cyclic ether;
macrolide;
secondary alcohol
antineoplastic agent;
Aspergillus metabolite
00low000000
capilliposide balpha-L-arabinopyranoside;
bridged compound;
cyclic ether;
diol;
hexacyclic triterpenoid;
hexanoate ester;
lactol;
secondary alcohol;
tetrasaccharide derivative;
triterpenoid saponin
antineoplastic agent;
plant metabolite
00low000000
brasilicardin abenzoate ester;
carbotricyclic compound;
diterpenoid;
N-acetyl-D-glucosaminide;
non-proteinogenic alpha-amino acid;
phenols
antimicrobial agent;
antineoplastic agent;
bacterial metabolite;
immunosuppressive agent
00low000000
surfactin Acyclodepsipeptide;
lipopeptide antibiotic;
macrocyclic lactone
antibacterial agent;
antifungal agent;
antineoplastic agent;
antiviral agent;
metabolite;
surfactant
00low000000
acp-196aromatic amine;
benzamides;
imidazopyrazine;
pyridines;
pyrrolidinecarboxamide;
secondary carboxamide;
tertiary carboxamide;
ynone
antineoplastic agent;
apoptosis inducer;
EC 2.7.10.2 (non-specific protein-tyrosine kinase) inhibitor
00low000000
gsk343aminopyridine;
indazoles;
N-alkylpiperazine;
N-arylpiperazine;
pyridone;
secondary carboxamide
antineoplastic agent;
apoptosis inducer;
EC 2.1.1.43 (enhancer of zeste homolog 2) inhibitor
00low000000
myriaporone 3beta-hydroxy ketone;
epoxide;
lactol;
oxanes;
primary alcohol;
secondary alcohol
antineoplastic agent;
metabolite
00low000000
GSK1059615pyridines;
quinolines;
thiazolidinone
antineoplastic agent;
EC 2.7.1.137 (phosphatidylinositol 3-kinase) inhibitor
00low000000
osimertinibacrylamides;
aminopyrimidine;
biaryl;
indoles;
monomethoxybenzene;
secondary amino compound;
secondary carboxamide;
substituted aniline;
tertiary amino compound
antineoplastic agent;
epidermal growth factor receptor antagonist
00low000000
ivosidenibcyanopyridine;
monochlorobenzenes;
organofluorine compound;
pyrrolidin-2-ones;
secondary carboxamide;
tertiary carboxamide
antineoplastic agent;
EC 1.1.1.42 (isocitrate dehydrogenase) inhibitor
00low000000
phleomycin d1bi-1,3-thiazole;
chelate-forming peptide;
disaccharide derivative;
glycopeptide;
guanidines
antibacterial agent;
antifungal agent;
antimicrobial agent;
antineoplastic agent;
bacterial metabolite
00low000000
ly3009120aminotoluene;
aromatic amine;
biaryl;
monofluorobenzenes;
phenylureas;
pyridopyrimidine;
secondary amino compound
antineoplastic agent;
apoptosis inducer;
autophagy inducer;
B-Raf inhibitor;
necroptosis inhibitor
00low000000
pf-06463922aminopyridine;
aromatic ether;
azamacrocycle;
benzamides;
cyclic ether;
monofluorobenzenes;
nitrile;
organic heterotetracyclic compound;
pyrazoles
antineoplastic agent;
EC 2.7.10.1 (receptor protein-tyrosine kinase) inhibitor
00low000000
as 1842856organofluorine compound;
primary amino compound;
quinolinemonocarboxylic acid;
quinolone;
secondary amino compound;
tertiary amino compound
anti-obesity agent;
antineoplastic agent;
apoptosis inducer;
autophagy inhibitor;
forkhead box protein O1 inhibitor;
hypoglycemic agent
00low000000
physalin d5alpha-hydroxy steroid;
6beta-hydroxy steroid;
cyclic ether;
enone;
lactone;
organic heteroheptacyclic compound;
physalin
antimalarial;
antimycobacterial drug;
antineoplastic agent
00low000000
acarbosechondramide;
indoles;
organochlorine compound;
phenols
antineoplastic agent;
bacterial metabolite
00low000000
sr9243bromobenzenes;
sulfonamide;
sulfone
antineoplastic agent;
apoptosis inducer;
liver X receptor inverse agonist
00low000000
CCT251545azaspiro compound;
chloropyridine;
pyrazoles
antineoplastic agent;
EC 2.7.11.22 (cyclin-dependent kinase) inhibitor;
Wnt signalling inhibitor
00low000000
ldc4297aromatic ether;
piperidines;
pyrazoles;
pyrazolotriazine;
secondary amino compound
antineoplastic agent;
antiviral agent;
apoptosis inducer;
EC 2.7.11.22 (cyclin-dependent kinase) inhibitor
00low000000
hg-9-91-01aminopyrimidine;
dimethoxybenzene;
N-alkylpiperazine;
N-arylpiperazine;
phenylureas;
secondary amino compound
antineoplastic agent;
salt-inducible kinase 2 inhibitor
00low000000
cigb-300heterodetic cyclic peptide;
polypeptide
angiogenesis modulating agent;
antineoplastic agent;
apoptosis inducer;
EC 2.7.11.1 (non-specific serine/threonine protein kinase) inhibitor
00low000000
chondramide dchondramide;
indoles;
phenols
antineoplastic agent;
bacterial metabolite
00low000000
bassianolidecyclodepsipeptide;
cyclooctadepsipeptide
antineoplastic agent;
fungal metabolite;
insecticide
2002201811.2low000180
enasidenib1,3,5-triazines;
aminopyridine;
aromatic amine;
organofluorine compound;
secondary amino compound;
tertiary alcohol
antineoplastic agent;
EC 1.1.1.42 (isocitrate dehydrogenase) inhibitor
00low000000
BDA-366anthraquinone;
epoxide;
secondary alcohol;
secondary amino compound;
tertiary amino compound
antineoplastic agent;
apoptosis inducer
00low000000
ebc-46diester;
diterpenoid;
organic heteropentacyclic compound;
phorbol ester
antineoplastic agent;
plant metabolite;
protein kinase C agonist
00low000000
THZ531aminopyrimidine;
enamide;
indoles;
N-acylpiperidine;
organochlorine compound;
secondary amino compound;
secondary carboxamide
antineoplastic agent;
apoptosis inducer;
EC 2.7.11.22 (cyclin-dependent kinase) inhibitor
00low000000
can 508aromatic amine;
monoazo compound;
phenols;
pyrazoles
angiogenesis inhibitor;
antineoplastic agent;
apoptosis inducer;
EC 2.7.11.22 (cyclin-dependent kinase) inhibitor
00low000000
levoleucovorin5-formyltetrahydrofolic acidantineoplastic agent;
metabolite
1951199252.5low011000
rifampincyclic ketal;
hydrazone;
N-iminopiperazine;
N-methylpiperazine;
rifamycins;
semisynthetic derivative;
zwitterion
angiogenesis inhibitor;
antiamoebic agent;
antineoplastic agent;
antitubercular agent;
DNA synthesis inhibitor;
EC 2.7.7.6 (RNA polymerase) inhibitor;
Escherichia coli metabolite;
geroprotector;
leprostatic drug;
neuroprotective agent;
pregnane X receptor agonist;
protein synthesis inhibitor
1988201518.5low020540
azaguaninenucleobase analogue;
triazolopyrimidines
antimetabolite;
antineoplastic agent;
EC 2.4.2.1 (purine-nucleoside phosphorylase) inhibitor
00low000000
pemetrexedN-acyl-L-glutamic acid;
pyrrolopyrimidine
antimetabolite;
antineoplastic agent;
EC 1.5.1.3 (dihydrofolate reductase) inhibitor;
EC 2.1.1.45 (thymidylate synthase) inhibitor;
EC 2.1.2.2 (phosphoribosylglycinamide formyltransferase) inhibitor
00low000000
tirapazaminearomatic amine;
benzotriazines;
N-oxide
antibacterial agent;
antineoplastic agent;
apoptosis inducer
00low000000
pyrazofurinC-glycosyl compound;
pyrazoles
antimetabolite;
antimicrobial agent;
antineoplastic agent;
EC 4.1.1.23 (orotidine-5'-phosphate decarboxylase) inhibitor
00low000000
MMP-9-IN-1aromatic compound;
organic sulfide;
organofluorine compound;
pyrimidone;
secondary carboxamide
antineoplastic agent;
EC 3.4.24.35 (gelatinase B) inhibitor
00low000000
hydrazinocurcuminaromatic ether;
olefinic compound;
polyphenol;
pyrazoles
angiogenesis modulating agent;
antineoplastic agent;
EC 2.3.1.48 (histone acetyltransferase) inhibitor;
EC 2.7.11.1 (non-specific serine/threonine protein kinase) inhibitor
00low000000
9-arabinofuranosylguaninebeta-D-arabinoside;
purine nucleoside
antineoplastic agent;
DNA synthesis inhibitor
00low000000
cerulomycinaldoxime;
aromatic ether;
bipyridines;
pyridine alkaloid
antineoplastic agent;
bacterial metabolite;
marine metabolite
00low000000
undecylprodigiosinalkaloid;
aromatic ether;
tripyrrole
antibacterial agent;
antineoplastic agent;
apoptosis inducer;
bacterial metabolite;
biological pigment;
immunosuppressive agent;
radiosensitizing agent
00low000000
ver 52296aromatic amide;
isoxazoles;
monocarboxylic acid amide;
morpholines;
resorcinols
angiogenesis inhibitor;
antineoplastic agent;
Hsp90 inhibitor
00low000000
2-hydroxy-3-(5-((morpholin-4-yl)methyl)pyridin-2-yl)-1h-indole-5-carbonitrilehydroxyindoles;
morpholines;
nitrile;
pyridines;
tertiary amino compound
antineoplastic agent;
apoptosis inducer;
EC 2.7.11.26 (tau-protein kinase) inhibitor;
tau aggregation inhibitor
00low000000
XL413benzofuropyrimidine;
organochlorine compound;
pyrrolidines
antineoplastic agent;
EC 2.7.11.1 (non-specific serine/threonine protein kinase) inhibitor
00low000000
pp242aromatic amine;
biaryl;
hydroxyindoles;
phenols;
primary amino compound;
pyrazolopyrimidine
antineoplastic agent;
mTOR inhibitor
00low000000
marineosin aazaspiro compound;
ether;
macrocycle;
oxaspiro compound;
pyrroles
antineoplastic agent;
metabolite
00low000000
marineosin bazaspiro compound;
ether;
macrocycle;
oxaspiro compound;
pyrroles
antineoplastic agent;
metabolite
00low000000
ARS-1620quinazolinesantineoplastic agent;
antiviral agent;
inhibitor
00low000000
sotorasibacrylamides;
methylpyridines;
monofluorobenzenes;
N-acylpiperazine;
phenols;
pyridopyrimidine;
tertiary amino compound;
tertiary carboxamide
antineoplastic agent00low000000
5-methoxytryptaminearomatic ether;
primary amino compound;
tryptamines
5-hydroxytryptamine 2A receptor agonist;
5-hydroxytryptamine 2B receptor agonist;
5-hydroxytryptamine 2C receptor agonist;
antioxidant;
cardioprotective agent;
human metabolite;
mouse metabolite;
neuroprotective agent;
radiation protective agent;
serotonergic agonist
00low000000
dilazepbenzoate ester;
diazepane;
diester;
methoxybenzenes
cardioprotective agent;
platelet aggregation inhibitor;
vasodilator agent
00low000000
nsc 664704indolobenzazepine;
lactam;
organobromine compound
cardioprotective agent;
EC 2.7.11.22 (cyclin-dependent kinase) inhibitor;
EC 2.7.11.26 (tau-protein kinase) inhibitor;
geroprotector
00low000000
molsidomineethyl ester;
morpholines;
oxadiazole;
zwitterion
antioxidant;
apoptosis inhibitor;
cardioprotective agent;
nitric oxide donor;
vasodilator agent
2001202113.5low100341
pioglitazonearomatic ether;
pyridines;
thiazolidinediones
antidepressant;
cardioprotective agent;
EC 2.7.1.33 (pantothenate kinase) inhibitor;
EC 6.2.1.3 (long-chain-fatty-acid--CoA ligase) inhibitor;
ferroptosis inhibitor;
geroprotector;
hypoglycemic agent;
insulin-sensitizing drug;
PPARgamma agonist;
xenobiotic
2002201813.6low000660
methylene blueorganic chloride saltacid-base indicator;
antidepressant;
antimalarial;
antimicrobial agent;
antioxidant;
cardioprotective agent;
EC 1.4.3.4 (monoamine oxidase) inhibitor;
EC 3.1.1.8 (cholinesterase) inhibitor;
EC 4.6.1.2 (guanylate cyclase) inhibitor;
fluorochrome;
histological dye;
neuroprotective agent;
physical tracer
1957202315.3low0224132
mor-14hydroxypiperidine;
piperidine alkaloid;
tertiary amino compound
anti-HIV agent;
cardioprotective agent;
EC 3.2.1.20 (alpha-glucosidase) inhibitor;
plant metabolite
00low000000
zofenoprilaryl sulfide;
L-proline derivative;
N-acyl-L-amino acid;
thioester
anticonvulsant;
apoptosis inhibitor;
cardioprotective agent;
EC 3.4.15.1 (peptidyl-dipeptidase A) inhibitor;
prodrug;
vasodilator agent
00low000000
3-(2,2,2-trimethylhydrazine)propionateammonium betainecardioprotective agent;
EC 1.14.11.1 (gamma-butyrobetaine dioxygenase) inhibitor;
neuroprotective agent
00low000000
ferulic acidferulic acidsanti-inflammatory agent;
antioxidant;
apoptosis inhibitor;
cardioprotective agent;
MALDI matrix material;
plant metabolite
00low000000
rosuvastatindihydroxy monocarboxylic acid;
monofluorobenzenes;
pyrimidines;
statin (synthetic);
sulfonamide
anti-inflammatory agent;
antilipemic drug;
cardioprotective agent;
CETP inhibitor;
environmental contaminant;
xenobiotic
00low000000
zofenoprilatearyl sulfide;
L-proline derivative;
N-acyl-L-amino acid;
thiol
anticonvulsant;
apoptosis inhibitor;
cardioprotective agent;
drug metabolite;
EC 3.4.15.1 (peptidyl-dipeptidase A) inhibitor;
vasodilator agent
00low000000
rosuvastatin calciumN-acyl-15-methylhexadecasphinganine-1-phosphoethanolamine;
organic calcium salt
anti-inflammatory agent;
cardioprotective agent;
CETP inhibitor
00low000000
(E)-2,3,5,4'-tetrahydroxystilbene-2-O-beta-D-glucosidebeta-D-glucoside;
resorcinols;
stilbenoid
anti-inflammatory agent;
antioxidant;
apoptosis inhibitor;
cardioprotective agent;
cyclooxygenase 2 inhibitor;
platelet aggregation inhibitor
00low000000
molsidomineethyl ester;
morpholines;
oxadiazole;
zwitterion
antioxidant;
apoptosis inhibitor;
cardioprotective agent;
nitric oxide donor;
vasodilator agent
00low000000
ramiprilazabicycloalkane;
cyclopentapyrrole;
dicarboxylic acid monoester;
dipeptide;
ethyl ester
bradykinin receptor B2 agonist;
cardioprotective agent;
EC 3.4.15.1 (peptidyl-dipeptidase A) inhibitor;
matrix metalloproteinase inhibitor;
prodrug
1992200626.7low002100
ramiprilatazabicycloalkane;
cyclopentapyrrole;
dicarboxylic acid;
dipeptide
bradykinin receptor B2 agonist;
cardioprotective agent;
drug metabolite;
EC 3.4.15.1 (peptidyl-dipeptidase A) inhibitor;
matrix metalloproteinase inhibitor
00low000000
ursodoxicoltaurinebile acid taurine conjugateanti-inflammatory agent;
apoptosis inhibitor;
bone density conservation agent;
cardioprotective agent;
human metabolite;
neuroprotective agent
00low000000
bay 60-6583aminopyridine;
aromatic ether;
aryl sulfide;
cyanopyridine;
cyclopropanes;
monocarboxylic acid amide
adenosine A2B receptor agonist;
anti-inflammatory agent;
cardioprotective agent
00low000000
ginsenoside rb312beta-hydroxy steroid;
beta-D-glucoside;
disaccharide derivative;
ginsenoside;
tetracyclic triterpenoid
antidepressant;
antioxidant;
cardioprotective agent;
neuroprotective agent;
NMDA receptor antagonist;
plant metabolite
00low000000
ginsenoside rg212beta-hydroxy steroid;
20-hydroxy steroid;
3beta-hydroxy-4,4-dimethylsteroid;
3beta-hydroxy steroid;
beta-D-glucoside;
disaccharide derivative;
ginsenoside;
tetracyclic triterpenoid
anticoagulant;
cardioprotective agent;
plant metabolite
00low000000
angiotensin iangiotensin;
peptide zwitterion
antihypertensive agent;
cardioprotective agent;
human metabolite;
rat metabolite
00low000000
liproxstatin-1azaspiro compound;
monochlorobenzenes;
organic heterotricyclic compound;
secondary amino compound
antioxidant;
cardioprotective agent;
ferroptosis inhibitor;
radical scavenger
00low000000
ethylene dichloridechloroethaneshepatotoxic agent;
mutagen;
non-polar solvent
00low000000
2-nitropropanesecondary nitroalkanecarcinogenic agent;
hepatotoxic agent;
polar aprotic solvent;
xenobiotic
00low000000
acetaminophenacetamides;
phenols
antipyretic;
cyclooxygenase 1 inhibitor;
cyclooxygenase 2 inhibitor;
cyclooxygenase 3 inhibitor;
environmental contaminant;
ferroptosis inducer;
geroprotector;
hepatotoxic agent;
human blood serum metabolite;
non-narcotic analgesic;
non-steroidal anti-inflammatory drug;
xenobiotic
1989202314.9low01813126
methoxyfluraneether;
organochlorine compound;
organofluorine compound
hepatotoxic agent;
inhalation anaesthetic;
nephrotoxic agent;
non-narcotic analgesic
00low000000
diethylnitrosaminenitrosaminecarcinogenic agent;
hepatotoxic agent;
mutagen
00low000000
carbon tetrachloridechlorocarbon;
chloromethanes
hepatotoxic agent;
refrigerant
1982202013.9low0107170
dimethylformamideformamides;
volatile organic compound
geroprotector;
hepatotoxic agent;
polar aprotic solvent
1989198935.0low010000
2-dichlorobenzenedichlorobenzenehepatotoxic agent;
metabolite
00low000000
bromobenzenebromoarene;
bromobenzenes;
volatile organic compound
hepatotoxic agent;
mouse metabolite;
non-polar solvent
00low000000
furanfurans;
mancude organic heteromonocyclic parent;
monocyclic heteroarene
carcinogenic agent;
hepatotoxic agent;
Maillard reaction product
00low000000
2-methylfuranfurans;
volatile organic compound
flavouring agent;
fuel;
hepatotoxic agent;
human urinary metabolite;
plant metabolite
00low000000
ibufenacmonocarboxylic acidEC 1.14.99.1 (prostaglandin-endoperoxide synthase) inhibitor;
hepatotoxic agent;
non-narcotic analgesic;
non-steroidal anti-inflammatory drug
00low000000
cadmium nitratecadmium salt;
inorganic nitrate salt
carcinogenic agent;
genotoxin;
hepatotoxic agent
00low000000
ticrynafenaromatic ether;
aromatic ketone;
dichlorobenzene;
monocarboxylic acid;
thiophenes
antihypertensive agent;
hepatotoxic agent;
loop diuretic
00low000000
benoxaprofen1,3-benzoxazoles;
monocarboxylic acid;
monochlorobenzenes
antipsoriatic;
antipyretic;
EC 1.13.11.34 (arachidonate 5-lipoxygenase) inhibitor;
hepatotoxic agent;
nephrotoxin;
non-narcotic analgesic;
non-steroidal anti-inflammatory drug;
protein kinase C agonist
00low000000
paroxetinearomatic ether;
benzodioxoles;
organofluorine compound;
piperidines
antidepressant;
anxiolytic drug;
hepatotoxic agent;
P450 inhibitor;
serotonin uptake inhibitor
201020229.7low000111
paroxetine hydrochloridehydrochlorideantidepressant;
anxiolytic drug;
hepatotoxic agent;
P450 inhibitor;
serotonin uptake inhibitor
00low000000
droxicamorganic heterotricyclic compound;
pyridines
cyclooxygenase 1 inhibitor;
hepatotoxic agent;
non-narcotic analgesic;
non-steroidal anti-inflammatory drug;
platelet aggregation inhibitor;
prodrug
00low000000
synthalin aguanidineshepatotoxic agent;
hypoglycemic agent;
nephrotoxin
00low000000
flunoxaprofen1,3-benzoxazoles;
monocarboxylic acid;
organofluorine compound
antirheumatic drug;
hepatotoxic agent;
non-steroidal anti-inflammatory drug;
protein kinase C agonist
00low000000
mepanipyrimacetylenic compound;
aminopyrimidine;
anilinopyrimidine fungicide;
secondary amino compound
antifungal agrochemical;
aryl hydrocarbon receptor agonist;
hepatotoxic agent
00low000000
tosufloxacin, 4-toluene sulfonateracemateantiinfective agent;
antimicrobial agent;
DNA synthesis inhibitor;
hepatotoxic agent;
topoisomerase IV inhibitor
00low000000
indospicinecarboxamidine;
non-proteinogenic L-alpha-amino acid
hepatotoxic agent;
plant metabolite
00low000000
genipiniridoid monoterpenoidanti-inflammatory agent;
antioxidant;
apoptosis inhibitor;
cross-linking reagent;
hepatotoxic agent;
uncoupling protein inhibitor
00low000000
polidocanolhydroxypolyetherhepatotoxic agent;
nonionic surfactant;
sclerotherapy agent
1997200922.7low002100
n-methylthioureathioureasdrug metabolite;
hepatotoxic agent;
human xenobiotic metabolite
00low000000
thioacetamidethiocarboxamidehepatotoxic agent2010201710.5low000110
paroxetine maleatemaleate saltantidepressant;
anxiolytic drug;
hepatotoxic agent;
P450 inhibitor;
serotonin uptake inhibitor
00low000000
nitrofurantoinimidazolidine-2,4-dione;
nitrofuran antibiotic;
organonitrogen heterocyclic antibiotic;
organooxygen heterocyclic antibiotic
antibacterial drug;
antiinfective agent;
hepatotoxic agent
00low000000
nifurtoinolhydrazone;
imidazolidine-2,4-dione;
nitrofuran antibiotic;
organonitrogen heterocyclic antibiotic
antibacterial drug;
antiinfective agent;
hepatotoxic agent
00low000000
teriflunomide(trifluoromethyl)benzenes;
aromatic amide;
enamide;
enol;
nitrile;
secondary carboxamide
drug metabolite;
EC 1.3.98.1 [dihydroorotate oxidase (fumarate)] inhibitor;
hepatotoxic agent;
non-steroidal anti-inflammatory drug;
tyrosine kinase inhibitor
00low000000
calmidazoliumimidazolium ionapoptosis inducer;
calmodulin antagonist
00low000000
danthrondihydroxyanthraquinoneapoptosis inducer;
plant metabolite
00low000000
methyl methanesulfonatemethanesulfonate esteralkylating agent;
apoptosis inducer;
carcinogenic agent;
genotoxin;
mutagen
00low000000
niclosamidebenzamides;
C-nitro compound;
monochlorobenzenes;
salicylanilides;
secondary carboxamide
anthelminthic drug;
anticoronaviral agent;
antiparasitic agent;
apoptosis inducer;
molluscicide;
piscicide;
STAT3 inhibitor
00low000000
sb 202190imidazoles;
organofluorine compound;
phenols;
pyridines
apoptosis inducer;
EC 2.7.11.24 (mitogen-activated protein kinase) inhibitor
00low000000
n,n,n',n'-tetrakis(2-pyridylmethyl)ethylenediamineN-substituted diamine;
pyridines;
tertiary amino compound
apoptosis inducer;
chelator;
copper chelator
00low000000
diethyl sulfatealkyl sulfatealkylating agent;
apoptosis inducer;
carcinogenic agent;
mutagen
00low000000
n-nitrosopiperidinenitrosamine;
piperidine
apoptosis inducer;
carcinogenic agent;
environmental contaminant;
mutagen
00low000000
ziramdithiocarbamate salt;
zinc molecular entity
antifungal agrochemical;
apoptosis inducer
00low000000
iberinisothiocyanate;
sulfoxide
apoptosis inducer;
plant metabolite;
quorum sensing inhibitor
00low000000
thallium acetateacetate salt;
thallium molecular entity
apoptosis inducer;
neurotoxin
00low000000
methyl isocyanateisocyanatesallergen;
apoptosis inducer
00low000000
dibromoacetic acid2-bromocarboxylic acid;
monocarboxylic acid
apoptosis inducer;
geroprotector;
marine metabolite
00low000000
antimony trichlorideantimony molecular entity;
inorganic chloride
apoptosis inducer;
colorimetric reagent;
Lewis acid
00low000000
pyoluteorinaromatic ketone;
beta-hydroxy ketone;
diol;
organochlorine compound;
organochlorine pesticide;
polyketide;
pyrroles;
resorcinols
antibacterial agent;
antifungal agent;
apoptosis inducer;
bacterial metabolite;
marine metabolite
00low000000
norsalsolinolisoquinolinolanimal metabolite;
apoptosis inducer;
human metabolite;
marine metabolite
00low000000
1-methyl-4-phenylpyridiniumpyridinium ionapoptosis inducer;
herbicide;
human xenobiotic metabolite;
neurotoxin
2004201315.5low000110
staurosporineindolocarbazole alkaloid;
organic heterooctacyclic compound
apoptosis inducer;
bacterial metabolite;
EC 2.7.11.13 (protein kinase C) inhibitor;
geroprotector
00low000000
mevastatin2-pyranones;
carboxylic ester;
hexahydronaphthalenes;
polyketide;
statin (naturally occurring)
antifungal agent;
apoptosis inducer;
EC 3.4.24.83 (anthrax lethal factor endopeptidase) inhibitor;
fungal metabolite;
Penicillium metabolite
00low000000
tetraiodothyroacetic acid2-halophenol;
aromatic ether;
iodophenol;
monocarboxylic acid
apoptosis inducer;
human metabolite;
thyroid hormone
00low000000
isoalantolactoneeudesmane sesquiterpenoid;
sesquiterpene lactone
antifungal agent;
apoptosis inducer;
plant metabolite
00low000000
ethyl protocatechuatecatechols;
ethyl ester
antibacterial agent;
antioxidant;
apoptosis inducer;
EC 1.14.11.2 (procollagen-proline dioxygenase) inhibitor;
plant metabolite
00low000000
fluazinam(trifluoromethyl)benzenes;
aminopyridine;
C-nitro compound;
chloropyridine;
monochlorobenzenes;
secondary amino compound
allergen;
antifungal agrochemical;
apoptosis inducer;
environmental contaminant;
xenobiotic
00low000000
tabtoxinine beta-lactambeta-lactam antibiotic;
monobactam;
non-proteinogenic L-alpha-amino acid;
tertiary alpha-hydroxy ketone
apoptosis inducer;
bacterial metabolite;
EC 6.3.1.2 (glutamate--ammonia ligase) inhibitor
00low000000
27-hydroxycholesterol26-hydroxycholesterolapoptosis inducer;
human metabolite;
mouse metabolite;
neuroprotective agent
00low000000
cd 437adamantanes;
monocarboxylic acid;
naphthoic acid;
phenols
apoptosis inducer;
retinoic acid receptor gamma agonist
00low000000
sclareollabdane diterpenoidantifungal agent;
antimicrobial agent;
apoptosis inducer;
fragrance;
plant metabolite
00low000000
anacardic acidhydroxy monocarboxylic acid;
hydroxybenzoic acid
anti-inflammatory agent;
antibacterial agent;
anticoronaviral agent;
apoptosis inducer;
EC 2.3.1.48 (histone acetyltransferase) inhibitor;
EC 3.4.22.69 (SARS coronavirus main proteinase) inhibitor;
neuroprotective agent;
plant metabolite
00low000000
nsc 23766aminopyrimidine;
aminoquinoline;
primary amino compound;
secondary amino compound;
tertiary amino compound
antiviral agent;
apoptosis inducer;
EC 3.6.5.2 (small monomeric GTPase) inhibitor;
muscarinic antagonist
00low000000
notoginsenoside r112beta-hydroxy steroid;
3beta-hydroxy-4,4-dimethylsteroid;
3beta-hydroxy steroid;
beta-D-glucoside;
disaccharide derivative;
ginsenoside;
tetracyclic triterpenoid
antioxidant;
apoptosis inducer;
neuroprotective agent;
phytoestrogen;
plant metabolite
00low000000
theasinensin abiflavonoid;
gallate ester;
proanthocyanidin
anti-inflammatory agent;
anticoronaviral agent;
apoptosis inducer;
EC 3.2.1.20 (alpha-glucosidase) inhibitor;
hepatoprotective agent;
hypoglycemic agent;
melanin synthesis inhibitor;
plant metabolite
00low000000
solasodinealkaloid antibiotic;
azaspiro compound;
hemiaminal ether;
oxaspiro compound;
sapogenin;
steroid alkaloid
anticonvulsant;
antifungal agent;
antiinfective agent;
antioxidant;
antipyretic;
antispermatogenic agent;
apoptosis inducer;
cardiotonic drug;
central nervous system depressant;
diuretic;
immunomodulator;
plant metabolite;
teratogenic agent
00low000000
licocoumarone1-benzofurans;
aromatic ether;
resorcinols
antibacterial agent;
apoptosis inducer;
EC 1.4.3.4 (monoamine oxidase) inhibitor;
plant metabolite
00low000000
piperylinebenzodioxoles;
N-acylpyrrolidine;
pyrrolidine alkaloid;
tertiary carboxamide
antifungal agent;
apoptosis inducer;
plant metabolite
00low000000
p-hydroxycinnamaldehydecinnamaldehydesapoptosis inducer;
EC 1.14.13.39 (nitric oxide synthase) inhibitor;
plant metabolite
00low000000
calmidazoliumorganic chloride saltapoptosis inducer;
calmodulin antagonist
00low000000
vx-745aryl sulfide;
dichlorobenzene;
difluorobenzene;
pyrimidopyridazine
anti-inflammatory drug;
apoptosis inducer;
EC 2.7.11.24 (mitogen-activated protein kinase) inhibitor
00low000000
sb 415286C-nitro compound;
maleimides;
monochlorobenzenes;
phenols;
secondary amino compound;
substituted aniline
antioxidant;
apoptosis inducer;
EC 2.7.11.26 (tau-protein kinase) inhibitor;
neuroprotective agent
00low000000
fraxetinaromatic ether;
hydroxycoumarin
anti-inflammatory agent;
antibacterial agent;
antimicrobial agent;
antioxidant;
apoptosis inducer;
apoptosis inhibitor;
Arabidopsis thaliana metabolite;
hepatoprotective agent;
hypoglycemic agent
00low000000
2,4-decadienalpolyunsaturated fatty aldehydeapoptosis inducer;
nematicide
00low000000
natamycinantibiotic antifungal drug;
dicarboxylic acid monoester;
epoxide;
macrolide antibiotic;
monosaccharide derivative;
polyene antibiotic
antifungal agrochemical;
antimicrobial food preservative;
apoptosis inducer;
bacterial metabolite;
ophthalmology drug
00low000000
t-2 toxinacetate ester;
organic heterotetracyclic compound;
trichothecene
apoptosis inducer;
cardiotoxic agent;
DNA synthesis inhibitor;
environmental contaminant;
fungal metabolite;
mycotoxin;
neurotoxin
00low000000
herbimycin1,4-benzoquinones;
lactam;
macrocycle
antimicrobial agent;
apoptosis inducer;
herbicide;
Hsp90 inhibitor;
tyrosine kinase inhibitor
00low000000
ro 41-5253aromatic ether;
benzoic acids;
sulfone;
thiochromane
apoptosis inducer;
retinoic acid receptor alpha antagonist
00low000000
casticindihydroxyflavone;
tetramethoxyflavone
apoptosis inducer;
plant metabolite
00low000000
ag-490catechols;
enamide;
monocarboxylic acid amide;
nitrile;
secondary carboxamide
anti-inflammatory agent;
antioxidant;
apoptosis inducer;
EC 2.7.10.2 (non-specific protein-tyrosine kinase) inhibitor;
geroprotector;
STAT3 inhibitor
00low000000
bay 11-7082nitrile;
sulfone
apoptosis inducer;
EC 2.7.11.10 (IkappaB kinase) inhibitor;
EC 3.1.3.48 (protein-tyrosine-phosphatase) inhibitor;
non-steroidal anti-inflammatory drug;
platelet aggregation inhibitor
00low000000
pipercallosidinealkaloid;
benzodioxoles;
enamide;
secondary carboxamide
apoptosis inducer;
metabolite;
plant metabolite
00low000000
sulindac sulfonemonocarboxylic acid;
organofluorine compound;
sulfone
apoptosis inducer;
cyclooxygenase 2 inhibitor;
EC 1.13.11.34 (arachidonate 5-lipoxygenase) inhibitor
00low000000
bafilomycin a1cyclic hemiketal;
macrolide antibiotic;
oxanes
apoptosis inducer;
autophagy inhibitor;
bacterial metabolite;
EC 3.6.3.10 (H(+)/K(+)-exchanging ATPase) inhibitor;
EC 3.6.3.14 (H(+)-transporting two-sector ATPase) inhibitor;
ferroptosis inhibitor;
fungicide;
potassium ionophore;
toxin
00low000000
HT-2 toxinacetate ester;
organic heterotetracyclic compound;
trichothecene
apoptosis inducer;
fungal metabolite
00low000000
delphinidin 3-sambubiosideanthocyanidin 3-O-beta-D-sambubiosideapoptosis inducer;
metabolite
00low000000
triptohypol Cbenzenediols;
monocarboxylic acid;
pentacyclic triterpenoid
apoptosis inducer;
plant metabolite
00low000000
np 031112benzenes;
naphthalenes;
thiadiazolidine
anti-inflammatory agent;
apoptosis inducer;
EC 2.7.11.26 (tau-protein kinase) inhibitor;
neuroprotective agent
00low000000
laurinterolorganobromine compound;
phenols;
sesquiterpenoid
antibacterial agent;
apoptosis inducer;
EC 3.6.3.9 (Na(+)/K(+)-transporting ATPase) inhibitor;
metabolite
00low000000
MI-63azaspiro compound;
monochlorobenzenes;
monofluorobenzenes;
morpholines;
oxindoles;
pyrrolidines;
secondary carboxamide
apoptosis inducer00low000000
ginsenoside rdbeta-D-glucoside;
ginsenoside;
tetracyclic triterpenoid
anti-inflammatory drug;
apoptosis inducer;
immunosuppressive agent;
neuroprotective agent;
plant metabolite;
vulnerary
00low000000
nsc 23766hydrochlorideantiviral agent;
apoptosis inducer;
EC 3.6.5.2 (small monomeric GTPase) inhibitor;
muscarinic antagonist
00low000000
scalaradialacetate ester;
carbotetracyclic compound;
dialdehyde;
enal;
scalarane sesterterpenoid
animal metabolite;
anti-inflammatory agent;
apoptosis inducer;
EC 3.1.1.4 (phospholipase A2) inhibitor;
marine metabolite;
TRP channel blocker
00low000000
1-palmitoyl-2-(5-oxovaleroyl)-sn-glycero-3-phosphorylcholine1,2-diacyl-sn-glycero-3-phosphocholine;
aldehyde
apoptosis inducer00low000000
duramycinheterodetic cyclic peptide;
macrocycle
antimicrobial agent;
apoptosis inducer;
bacterial metabolite
00low000000
tilimycinphenols;
pyrrolobenzodiazepine
alkylating agent;
apoptosis inducer;
bacterial metabolite;
toxin
00low000000
spermidinepolyazaalkane;
triamine
autophagy inducer;
fundamental metabolite;
geroprotector
1995202114.9low001851
SMER 28organobromine compound;
quinazolines;
secondary amino compound
autophagy inducer00low000000
AZ3451benzimidazoles;
benzodioxoles;
nitrile;
organobromine compound;
secondary carboxamide
anti-inflammatory agent;
autophagy inducer;
PAR2 negative allosteric modulator
00low000000
((5z)5-(1,3-benzodioxol-5-yl)methylene-2-phenylamino-3,5-dihydro-4h-imidazol-4-one)benzodioxoles;
imidazolone;
substituted aniline
autophagy inducer;
EC 2.7.11.22 (cyclin-dependent kinase) inhibitor;
EC 2.7.12.1 (dual-specificity kinase) inhibitor;
neuroprotective agent;
nootropic agent
00low000000
SubstanceStudiesClassesRolesFirst YearLast YearAverage AgeRelationship StrengthTrialspre-19901990's2000's2010'spost-2020
ci 994acetamides;
benzamides;
substituted aniline
antineoplastic agent;
EC 3.5.1.98 (histone deacetylase) inhibitor
00low000000
4-(dimethylamino)-n-(7-(hydroxyamino)-7-oxoheptyl)benzamidebenzamides;
hydroxamic acid;
secondary carboxamide;
tertiary amino compound
antineoplastic agent;
apoptosis inducer;
EC 3.5.1.98 (histone deacetylase) inhibitor
00low000000
entinostatbenzamides;
carbamate ester;
primary amino compound;
pyridines;
substituted aniline
antineoplastic agent;
apoptosis inducer;
EC 3.5.1.98 (histone deacetylase) inhibitor
00low000000
sirtinolaldimine;
benzamides;
naphthols
anti-inflammatory agent;
EC 3.5.1.98 (histone deacetylase) inhibitor;
Sir2 inhibitor
00low000000
panobinostatcinnamamides;
hydroxamic acid;
methylindole;
secondary amino compound
angiogenesis modulating agent;
antineoplastic agent;
EC 3.5.1.98 (histone deacetylase) inhibitor
00low000000
aminoglutethimidedicarboximide;
piperidones;
substituted aniline
adrenergic agent;
anticonvulsant;
antineoplastic agent;
EC 1.14.14.14 (aromatase) inhibitor
2006201514.7low000210
cl 387785bromobenzenes;
quinazolines;
secondary carboxamide;
ynamide
antineoplastic agent;
EC 2.7.10.1 (receptor protein-tyrosine kinase) inhibitor;
epidermal growth factor receptor antagonist
00low000000
meclofenamic acidaminobenzoic acid;
organochlorine compound;
secondary amino compound
analgesic;
anticonvulsant;
antineoplastic agent;
antipyretic;
antirheumatic drug;
EC 1.13.11.34 (arachidonate 5-lipoxygenase) inhibitor;
EC 1.14.99.1 (prostaglandin-endoperoxide synthase) inhibitor;
non-steroidal anti-inflammatory drug
1992199530.5low002000
n(1), n(12)-diethylsperminepolyazaalkane;
secondary amino compound;
substituted spermine;
tetramine
antineoplastic agent00low000000
pd 158780aromatic amine;
bromobenzenes;
diamine;
pyridopyrimidine;
secondary amino compound
antineoplastic agent;
EC 2.7.10.1 (receptor protein-tyrosine kinase) inhibitor
00low000000
pj-34phenanthridines;
secondary carboxamide;
tertiary amino compound
angiogenesis inhibitor;
anti-inflammatory agent;
antiatherosclerotic agent;
antineoplastic agent;
apoptosis inducer;
cardioprotective agent;
EC 2.4.2.30 (NAD(+) ADP-ribosyltransferase) inhibitor;
neuroprotective agent
00low000000
procarbazinebenzamides;
hydrazines
antineoplastic agent1991199332.0low002000
imatinibaromatic amine;
benzamides;
N-methylpiperazine;
pyridines;
pyrimidines
antineoplastic agent;
apoptosis inducer;
tyrosine kinase inhibitor
00low000000
streptonigrinpyridines;
quinolone
antimicrobial agent;
antineoplastic agent
00low000000
suraminnaphthalenesulfonic acid;
phenylureas;
secondary carboxamide
angiogenesis inhibitor;
antinematodal drug;
antineoplastic agent;
apoptosis inhibitor;
EC 2.7.11.13 (protein kinase C) inhibitor;
GABA antagonist;
GABA-gated chloride channel antagonist;
purinergic receptor P2 antagonist;
ryanodine receptor agonist;
trypanocidal drug
1996201916.5low001010
nimustineaminopyrimidine;
N-nitrosoureas;
organochlorine compound
alkylating agent;
antineoplastic agent
00low000000
nelfinaviraryl sulfide;
benzamides;
organic heterobicyclic compound;
phenols;
secondary alcohol;
tertiary amino compound
antineoplastic agent;
HIV protease inhibitor
00low000000
plerixaforazacycloalkane;
azamacrocycle;
benzenes;
crown amine;
secondary amino compound;
tertiary amino compound
anti-HIV agent;
antineoplastic agent;
C-X-C chemokine receptor type 4 antagonist;
immunological adjuvant
00low000000
marimastathydroxamic acid;
secondary carboxamide
antineoplastic agent;
matrix metalloproteinase inhibitor
00low000000
gefitinibaromatic ether;
monochlorobenzenes;
monofluorobenzenes;
morpholines;
quinazolines;
secondary amino compound;
tertiary amino compound
antineoplastic agent;
epidermal growth factor receptor antagonist
00low000000
nsc 2240701,4-benzoquinones;
aziridines;
enamine;
primary alcohol;
secondary amino compound
alkylating agent;
antineoplastic agent
00low000000
abiraterone3beta-hydroxy-Delta(5)-steroid;
3beta-sterol;
pyridines
antineoplastic agent;
EC 1.14.99.9 (steroid 17alpha-monooxygenase) inhibitor
00low000000
vatalanibmonochlorobenzenes;
phthalazines;
pyridines;
secondary amino compound
angiogenesis inhibitor;
antineoplastic agent;
EC 2.7.10.1 (receptor protein-tyrosine kinase) inhibitor;
vascular endothelial growth factor receptor antagonist
00low000000
cyc 682nitrile;
nucleoside analogue;
secondary carboxamide
antimetabolite;
antineoplastic agent;
DNA synthesis inhibitor;
prodrug
00low000000
actinodaphineaporphine alkaloid;
aromatic ether;
organic heteropentacyclic compound;
phenols;
secondary amino compound
antibacterial agent;
antifungal agent;
antineoplastic agent;
apoptosis inducer;
plant metabolite;
platelet aggregation inhibitor;
topoisomerase inhibitor
00low000000
asperphenamatebenzamides;
carboxylic ester;
L-phenylalanine derivative
antineoplastic agent00low000000
erlotinibaromatic ether;
quinazolines;
secondary amino compound;
terminal acetylenic compound
antineoplastic agent;
epidermal growth factor receptor antagonist;
protein kinase inhibitor
00low000000
2-(4-morpholinoanilino)-6-cyclohexylaminopurinemorpholines;
purines;
secondary amino compound;
tertiary amino compound
adenosine A3 receptor antagonist;
antineoplastic agent;
Aurora kinase inhibitor;
cell dedifferentiation agent
00low000000
demecolcinealkaloid;
secondary amino compound
antineoplastic agent;
microtubule-destabilising agent
1990199034.0low001000
gant 61aminal;
dialkylarylamine;
pyridines;
substituted aniline;
tertiary amino compound
antineoplastic agent;
apoptosis inducer;
glioma-associated oncogene inhibitor;
Hedgehog signaling pathway inhibitor
00low000000
prinomastataromatic ether;
hydroxamic acid;
pyridines;
sulfonamide;
thiomorpholines
antineoplastic agent;
EC 3.4.24.35 (gelatinase B) inhibitor;
matrix metalloproteinase inhibitor
00low000000
s 1033(trifluoromethyl)benzenes;
imidazoles;
pyridines;
pyrimidines;
secondary amino compound;
secondary carboxamide
anticoronaviral agent;
antineoplastic agent;
tyrosine kinase inhibitor
00low000000
mcb-613cyclic ketone;
enone;
pyridines
antineoplastic agent;
steroid receptor coactivator stimulator
00low000000
u 0126aryl sulfide;
dinitrile;
enamine;
substituted aniline
antineoplastic agent;
antioxidant;
apoptosis inducer;
EC 2.7.11.24 (mitogen-activated protein kinase) inhibitor;
osteogenesis regulator;
vasoconstrictor agent
00low000000
bms 3870321,3-oxazoles;
1,3-thiazoles;
organic sulfide;
piperidinecarboxamide;
secondary carboxamide
angiogenesis inhibitor;
antineoplastic agent;
apoptosis inducer;
EC 2.7.11.22 (cyclin-dependent kinase) inhibitor
00low000000
dasatinib1,3-thiazoles;
aminopyrimidine;
monocarboxylic acid amide;
N-(2-hydroxyethyl)piperazine;
N-arylpiperazine;
organochlorine compound;
secondary amino compound;
tertiary amino compound
anticoronaviral agent;
antineoplastic agent;
tyrosine kinase inhibitor
201620168.0low000010
tranilastamidobenzoic acid;
cinnamamides;
dimethoxybenzene;
secondary carboxamide
anti-allergic agent;
anti-asthmatic drug;
antineoplastic agent;
aryl hydrocarbon receptor agonist;
calcium channel blocker;
hepatoprotective agent;
nephroprotective agent
00low000000
palbociclibaminopyridine;
aromatic ketone;
cyclopentanes;
piperidines;
pyridopyrimidine;
secondary amino compound;
tertiary amino compound
antineoplastic agent;
EC 2.7.11.22 (cyclin-dependent kinase) inhibitor
00low000000
batimastathydroxamic acid;
L-phenylalanine derivative;
organic sulfide;
secondary carboxamide;
thiophenes;
triamide
angiogenesis inhibitor;
antineoplastic agent;
matrix metalloproteinase inhibitor
00low000000
pederincyclic ketal;
diol;
oxanes;
polyketide;
secondary alcohol;
secondary carboxamide
antimitotic;
antineoplastic agent;
bacterial metabolite;
vesicant
00low000000
3-(3-pyridinyl)-1-(4-pyridinyl)-2-propen-1-oneenone;
pyridines
angiogenesis inhibitor;
antineoplastic agent;
apoptosis inducer;
autophagy inducer;
EC 2.7.1.105 (6-phosphofructo-2-kinase) inhibitor
00low000000
manumycinenamide;
epoxide;
organic heterobicyclic compound;
polyketide;
secondary carboxamide;
tertiary alcohol
antiatherosclerotic agent;
antimicrobial agent;
antineoplastic agent;
apoptosis inducer;
bacterial metabolite;
EC 1.8.1.9 (thioredoxin reductase) inhibitor;
EC 2.5.1.58 (protein farnesyltransferase) inhibitor;
marine metabolite
00low000000
asukamycinenamide;
epoxide;
organic heterobicyclic compound;
polyketide;
secondary carboxamide;
tertiary alcohol
antibacterial agent;
antifungal agent;
antimicrobial agent;
antineoplastic agent;
bacterial metabolite
00low000000
axitinibaryl sulfide;
benzamides;
indazoles;
pyridines
antineoplastic agent;
tyrosine kinase inhibitor;
vascular endothelial growth factor receptor antagonist
00low000000
l 744832benzenes;
ether;
isopropyl ester;
secondary carboxamide;
sulfone;
thiol
antineoplastic agent;
EC 2.5.1.58 (protein farnesyltransferase) inhibitor;
geroprotector
00low000000
tanespimycin1,4-benzoquinones;
ansamycin;
carbamate ester;
organic heterobicyclic compound;
secondary amino compound
antineoplastic agent;
apoptosis inducer;
Hsp90 inhibitor
00low000000
abiraterone acetatepyridines;
sterol ester
antineoplastic agent;
EC 1.14.99.9 (steroid 17alpha-monooxygenase) inhibitor;
prodrug
00low000000
pd 0325901difluorobenzene;
hydroxamic acid ester;
monofluorobenzenes;
organoiodine compound;
propane-1,2-diols;
secondary amino compound
antineoplastic agent;
EC 2.7.12.2 (mitogen-activated protein kinase kinase) inhibitor
00low000000
midostaurinbenzamides;
gamma-lactam;
indolocarbazole;
organic heterooctacyclic compound
antineoplastic agent;
EC 2.7.11.13 (protein kinase C) inhibitor
00low000000
zm 447439aromatic ether;
benzamides;
morpholines;
polyether;
quinazolines;
secondary amino compound;
tertiary amino compound
antineoplastic agent;
apoptosis inducer;
Aurora kinase inhibitor
00low000000
rucaparibazepinoindole;
caprolactams;
organofluorine compound;
secondary amino compound
antineoplastic agent;
EC 2.4.2.30 (NAD(+) ADP-ribosyltransferase) inhibitor
00low000000
sch 51344aromatic amine;
aromatic ether;
primary alcohol;
pyrazoloquinoline;
secondary amino compound
antineoplastic agent00low000000
masitinib1,3-thiazoles;
benzamides;
N-alkylpiperazine;
pyridines
antineoplastic agent;
antirheumatic drug;
tyrosine kinase inhibitor
00low000000
avenanthramide bamidobenzoic acid;
cinnamamides;
monohydroxybenzoic acid;
monomethoxybenzene;
phenols;
secondary carboxamide
antineoplastic agent;
apoptosis inducer;
phytoalexin
00low000000
pazopanibaminopyrimidine;
indazoles;
sulfonamide
angiogenesis modulating agent;
antineoplastic agent;
tyrosine kinase inhibitor;
vascular endothelial growth factor receptor antagonist
00low000000
azd 6244benzimidazoles;
bromobenzenes;
hydroxamic acid ester;
monochlorobenzenes;
organofluorine compound;
secondary amino compound
anticoronaviral agent;
antineoplastic agent;
EC 2.7.11.24 (mitogen-activated protein kinase) inhibitor
00low000000
azd2858aromatic amine;
N-methylpiperazine;
pyrazines;
pyridines;
secondary carboxamide;
sulfonamide
antineoplastic agent;
bone density conservation agent;
EC 2.7.11.26 (tau-protein kinase) inhibitor;
Wnt signalling activator
00low000000
bibw 2992aromatic ether;
enamide;
furans;
monochlorobenzenes;
organofluorine compound;
quinazolines;
secondary carboxamide;
tertiary amino compound
antineoplastic agent;
tyrosine kinase inhibitor
00low000000
binimetinibbenzimidazoles;
bromobenzenes;
hydroxamic acid ester;
monofluorobenzenes;
secondary amino compound
antineoplastic agent;
apoptosis inducer;
EC 2.7.11.24 (mitogen-activated protein kinase) inhibitor
00low000000
saracatinibaromatic ether;
benzodioxoles;
diether;
N-methylpiperazine;
organochlorine compound;
oxanes;
quinazolines;
secondary amino compound
anticoronaviral agent;
antineoplastic agent;
apoptosis inducer;
autophagy inducer;
EC 2.7.10.2 (non-specific protein-tyrosine kinase) inhibitor;
radiosensitizing agent
00low000000
pha 665752dichlorobenzene;
enamide;
indolones;
N-acylpyrrolidine;
pyrrolecarboxamide;
secondary carboxamide;
sulfone;
tertiary carboxamide
antineoplastic agent;
c-Met tyrosine kinase inhibitor
00low000000
abt-737aromatic amine;
aryl sulfide;
biphenyls;
C-nitro compound;
monochlorobenzenes;
N-arylpiperazine;
N-sulfonylcarboxamide;
secondary amino compound;
tertiary amino compound
anti-allergic agent;
anti-inflammatory agent;
antineoplastic agent;
apoptosis inducer;
B-cell lymphoma 2 inhibitor
00low000000
at 7519dichlorobenzene;
piperidines;
pyrazoles;
secondary carboxamide
antineoplastic agent;
EC 2.7.11.22 (cyclin-dependent kinase) inhibitor
00low000000
azd 1152anilide;
monoalkyl phosphate;
monofluorobenzenes;
pyrazoles;
quinazolines;
secondary amino compound;
secondary carboxamide;
tertiary amino compound
antineoplastic agent;
Aurora kinase inhibitor;
prodrug
00low000000
pf 00299804enamide;
monochlorobenzenes;
monofluorobenzenes;
piperidines;
quinazolines;
secondary amino compound;
secondary carboxamide;
tertiary amino compound
antineoplastic agent;
epidermal growth factor receptor antagonist
00low000000
ki11502aromatic ether;
benzamides;
quinolines;
thioureas
antineoplastic agent;
apoptosis inducer;
EC 2.7.10.1 (receptor protein-tyrosine kinase) inhibitor
00low000000
idelalisibaromatic amine;
organofluorine compound;
purines;
quinazolines;
secondary amino compound
antineoplastic agent;
apoptosis inducer;
EC 2.7.1.137 (phosphatidylinositol 3-kinase) inhibitor
00low000000
GDC-0879indanes;
ketoxime;
primary alcohol;
pyrazoles;
pyridines
antineoplastic agent;
B-Raf inhibitor
00low000000
at 13387benzamides;
isoindoles;
N-alkylpiperazine;
resorcinols;
tertiary carboxamide
antineoplastic agent;
Hsp90 inhibitor
00low000000
bgt226aromatic ether;
imidazoquinoline;
N-arylpiperazine;
organofluorine compound;
pyridines
antineoplastic agent;
EC 2.7.1.137 (phosphatidylinositol 3-kinase) inhibitor;
mTOR inhibitor
00low000000
mdv 3100(trifluoromethyl)benzenes;
benzamides;
imidazolidinone;
monofluorobenzenes;
nitrile;
thiocarbonyl compound
androgen antagonist;
antineoplastic agent
00low000000
azd 1152-hqpaanilide;
monofluorobenzenes;
primary alcohol;
pyrazoles;
quinazolines;
secondary amino compound;
secondary carboxamide;
tertiary amino compound
antineoplastic agent;
Aurora kinase inhibitor
00low000000
gdc-0973aromatic amine;
difluorobenzene;
N-acylazetidine;
organoiodine compound;
piperidines;
secondary amino compound;
tertiary alcohol
antineoplastic agent;
EC 2.7.11.24 (mitogen-activated protein kinase) inhibitor
00low000000
buparlisibaminopyridine;
aminopyrimidine;
morpholines;
organofluorine compound
antineoplastic agent;
EC 2.7.1.137 (phosphatidylinositol 3-kinase) inhibitor
00low000000
ro5126766aryloxypyrimidine;
coumarins;
organofluorine compound;
pyridines;
sulfamides
antineoplastic agent;
EC 2.7.11.24 (mitogen-activated protein kinase) inhibitor
00low000000
pevonedistatcyclopentanols;
indanes;
pyrrolopyrimidine;
secondary amino compound;
sulfamidate
antineoplastic agent;
apoptosis inducer
00low000000
tg101209N-alkylpiperazine;
N-arylpiperazine;
pyrimidines;
secondary amino compound;
sulfonamide
antineoplastic agent;
apoptosis inducer;
EC 2.7.10.2 (non-specific protein-tyrosine kinase) inhibitor
00low000000
cnf 20242-aminopurines;
aromatic ether;
organochlorine compound;
pyridines
antineoplastic agent;
Hsp90 inhibitor
00low000000
respirantinbenzamides;
cyclodepsipeptide;
formamides;
phenols
antimicrobial agent;
antineoplastic agent;
metabolite
00low000000
sm 164benzenes;
organic heterobicyclic compound;
secondary carboxamide;
triazoles
antineoplastic agent;
apoptosis inducer;
radiosensitizing agent
00low000000
lde225aminopyridine;
aromatic ether;
benzamides;
biphenyls;
morpholines;
organofluorine compound;
tertiary amino compound
antineoplastic agent;
Hedgehog signaling pathway inhibitor;
SMO receptor antagonist
00low000000
gdc 0449benzamides;
monochlorobenzenes;
pyridines;
sulfone
antineoplastic agent;
Hedgehog signaling pathway inhibitor;
SMO receptor antagonist;
teratogenic agent
00low000000
bms 754807pyrazoles;
pyridines;
pyrrolidines;
pyrrolotriazine
antineoplastic agent;
EC 2.7.10.1 (receptor protein-tyrosine kinase) inhibitor
00low000000
ponatinib(trifluoromethyl)benzenes;
acetylenic compound;
benzamides;
imidazopyridazine;
N-methylpiperazine
antineoplastic agent;
tyrosine kinase inhibitor
00low000000
sch772984biaryl;
indazoles;
N-acylpiperazine;
N-alkylpyrrolidine;
N-arylpiperazine;
pyridines;
pyrimidines;
pyrrolidinecarboxamide;
secondary carboxamide;
tertiary amino compound;
tertiary carboxamide
analgesic;
antineoplastic agent;
apoptosis inducer;
EC 2.7.11.24 (mitogen-activated protein kinase) inhibitor
00low000000
navitoclaxaryl sulfide;
monochlorobenzenes;
morpholines;
N-sulfonylcarboxamide;
organofluorine compound;
piperazines;
secondary amino compound;
sulfone;
tertiary amino compound
antineoplastic agent;
apoptosis inducer;
B-cell lymphoma 2 inhibitor
00low000000
n-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamideaminopyrimidine;
benzamides;
morpholines;
nitrile;
secondary amino compound;
tertiary amino compound
anti-anaemic agent;
antineoplastic agent;
apoptosis inducer;
EC 2.7.10.2 (non-specific protein-tyrosine kinase) inhibitor
00low000000
poziotinibacrylamides;
aromatic ether;
dichlorobenzene;
diether;
monofluorobenzenes;
N-acylpiperidine;
quinazolines;
secondary amino compound;
substituted aniline
antineoplastic agent;
apoptosis inducer;
epidermal growth factor receptor antagonist
00low000000
asp3026aromatic amine;
diamino-1,3,5-triazine;
monomethoxybenzene;
N-methylpiperazine;
piperidines;
secondary amino compound;
sulfone
antimalarial;
antineoplastic agent;
apoptosis inducer;
EC 2.7.10.1 (receptor protein-tyrosine kinase) inhibitor;
EC 6.1.1.6 (lysine--tRNA ligase) inhibitor
00low000000
entrectinibbenzamides;
difluorobenzene;
indazoles;
N-methylpiperazine;
oxanes;
secondary amino compound;
secondary carboxamide
antibacterial agent;
antineoplastic agent;
apoptosis inducer;
EC 2.7.10.1 (receptor protein-tyrosine kinase) inhibitor
00low000000
pexidartinibaminopyridine;
organochlorine compound;
organofluorine compound;
pyrrolopyridine;
secondary amino compound
antineoplastic agent;
EC 2.7.10.1 (receptor protein-tyrosine kinase) inhibitor
00low000000
TAK-5801,3-thiazolecarboxamide;
aminopyrimidine;
chloropyridine;
organofluorine compound;
pyrimidinecarboxamide;
secondary carboxamide
antineoplastic agent;
apoptosis inducer;
B-Raf inhibitor
00low000000
gsk 2126458aromatic ether;
difluorobenzene;
pyridazines;
pyridines;
quinolines;
sulfonamide
anticoronaviral agent;
antineoplastic agent;
autophagy inducer;
EC 2.7.1.137 (phosphatidylinositol 3-kinase) inhibitor;
mTOR inhibitor;
radiosensitizing agent
00low000000
ixazomibbenzamides;
boronic acids;
dichlorobenzene;
glycine derivative
antineoplastic agent;
apoptosis inducer;
drug metabolite;
orphan drug;
proteasome inhibitor
00low000000
cx 5461diazepine;
naphthyridine derivative;
organic heterotetracyclic compound;
pyrazines;
secondary carboxamide
antineoplastic agent;
apoptosis inducer;
EC 2.7.7.6 (RNA polymerase) inhibitor
00low000000
GDC-0623hydroxamic acid ester;
imidazopyridine;
monofluorobenzenes;
organoiodine compound;
primary alcohol;
secondary amino compound;
substituted aniline
antineoplastic agent;
apoptosis inducer;
EC 2.7.12.2 (mitogen-activated protein kinase kinase) inhibitor
00low000000
dabrafenib1,3-thiazoles;
aminopyrimidine;
organofluorine compound;
sulfonamide
anticoronaviral agent;
antineoplastic agent;
B-Raf inhibitor
00low000000
cblc137aromatic ketone;
carbazoles;
methyl ketone;
secondary amino compound;
tertiary amino compound
antineoplastic agent;
apoptosis inducer;
NF-kappaB inhibitor;
p53 activator
00low000000
EG00229benzothiadiazole;
dicarboxylic acid monoamide;
L-arginine derivative;
secondary carboxamide;
sulfonamide;
thiophenes
angiogenesis inhibitor;
antineoplastic agent;
neuropilin receptor antagonist
00low000000
tak-632(trifluoromethyl)benzenes;
aromatic ether;
benzothiazoles;
cyclopropylcarboxamide;
monofluorobenzenes;
nitrile;
secondary carboxamide
antineoplastic agent;
apoptosis inducer;
B-Raf inhibitor;
EC 2.7.11.26 (tau-protein kinase) inhibitor;
necroptosis inhibitor
00low000000
lrrk2-in1aromatic amine;
aromatic ether;
N-acylpiperidine;
N-alkylpiperazine;
pyrimidobenzodiazepine;
secondary amino compound;
tertiary amino compound
antineoplastic agent;
EC 2.7.11.1 (non-specific serine/threonine protein kinase) inhibitor
00low000000
gilteritinibaromatic amine;
monomethoxybenzene;
N-methylpiperazine;
oxanes;
piperidines;
primary carboxamide;
pyrazines;
secondary amino compound
antineoplastic agent;
apoptosis inducer;
EC 2.7.10.1 (receptor protein-tyrosine kinase) inhibitor
00low000000
ML240aromatic amine;
aromatic ether;
benzimidazoles;
primary amino compound;
quinazolines;
secondary amino compound
antineoplastic agent00low000000
xl765aromatic amine;
aromatic ether;
benzamides;
quinoxaline derivative;
sulfonamide
antineoplastic agent;
EC 2.7.1.137 (phosphatidylinositol 3-kinase) inhibitor;
mTOR inhibitor
00low000000
3-(2,6-dichloro-3,5-dimethoxyphenyl)-1-(6-(4-(4-ethylpiperazin-1-yl)-phenylamino)pyrimidin-4-yl)-1-methylureaaminopyrimidine;
dichlorobenzene;
N-alkylpiperazine;
N-arylpiperazine;
phenylureas
antineoplastic agent;
fibroblast growth factor receptor antagonist
00low000000
chir 98014aminopyrimidine;
C-nitro compound;
diaminopyridine;
dichlorobenzene;
imidazoles;
secondary amino compound
antineoplastic agent;
apoptosis inducer;
EC 2.7.11.26 (tau-protein kinase) inhibitor;
hypoglycemic agent;
tau aggregation inhibitor;
Wnt signalling activator
00low000000
lfm a13aromatic amide;
dibromobenzene;
enamide;
enol;
nitrile;
secondary carboxamide
antineoplastic agent;
apoptosis inducer;
EC 2.7.10.2 (non-specific protein-tyrosine kinase) inhibitor;
EC 2.7.11.21 (polo kinase) inhibitor;
geroprotector;
platelet aggregation inhibitor
00low000000
AZD3463aminopiperidine;
aminopyrimidine;
indoles;
monomethoxybenzene;
organochlorine compound;
secondary amino compound;
tertiary amino compound
antineoplastic agent;
apoptosis inducer;
autophagy inducer;
EC 2.7.10.1 (receptor protein-tyrosine kinase) inhibitor
00low000000
ceritinibaminopyrimidine;
aromatic ether;
organochlorine compound;
piperidines;
secondary amino compound;
sulfone
antineoplastic agent;
EC 2.7.10.1 (receptor protein-tyrosine kinase) inhibitor
00low000000
MK-8353aromatic ether;
dihydropyridine;
indazoles;
methyl sulfide;
N-alkylpyrrolidine;
pyridines;
pyrrolidinecarboxamide;
secondary carboxamide;
tertiary carboxamide;
triazoles
antineoplastic agent;
apoptosis inducer;
EC 2.7.11.24 (mitogen-activated protein kinase) inhibitor
00low000000
gsk2879552benzenes;
benzoic acids;
cyclopropanes;
monocarboxylic acid;
piperidines;
secondary amino compound;
tertiary amino compound
antineoplastic agent;
EC 1.14.99.66 (lysine-specific histone demethylase 1A) inhibitor
00low000000
acp-196aromatic amine;
benzamides;
imidazopyrazine;
pyridines;
pyrrolidinecarboxamide;
secondary carboxamide;
tertiary carboxamide;
ynone
antineoplastic agent;
apoptosis inducer;
EC 2.7.10.2 (non-specific protein-tyrosine kinase) inhibitor
00low000000
gsk343aminopyridine;
indazoles;
N-alkylpiperazine;
N-arylpiperazine;
pyridone;
secondary carboxamide
antineoplastic agent;
apoptosis inducer;
EC 2.1.1.43 (enhancer of zeste homolog 2) inhibitor
00low000000
GSK1059615pyridines;
quinolines;
thiazolidinone
antineoplastic agent;
EC 2.7.1.137 (phosphatidylinositol 3-kinase) inhibitor
00low000000
osimertinibacrylamides;
aminopyrimidine;
biaryl;
indoles;
monomethoxybenzene;
secondary amino compound;
secondary carboxamide;
substituted aniline;
tertiary amino compound
antineoplastic agent;
epidermal growth factor receptor antagonist
00low000000
ivosidenibcyanopyridine;
monochlorobenzenes;
organofluorine compound;
pyrrolidin-2-ones;
secondary carboxamide;
tertiary carboxamide
antineoplastic agent;
EC 1.1.1.42 (isocitrate dehydrogenase) inhibitor
00low000000
ly3009120aminotoluene;
aromatic amine;
biaryl;
monofluorobenzenes;
phenylureas;
pyridopyrimidine;
secondary amino compound
antineoplastic agent;
apoptosis inducer;
autophagy inducer;
B-Raf inhibitor;
necroptosis inhibitor
00low000000
pf-06463922aminopyridine;
aromatic ether;
azamacrocycle;
benzamides;
cyclic ether;
monofluorobenzenes;
nitrile;
organic heterotetracyclic compound;
pyrazoles
antineoplastic agent;
EC 2.7.10.1 (receptor protein-tyrosine kinase) inhibitor
00low000000
as 1842856organofluorine compound;
primary amino compound;
quinolinemonocarboxylic acid;
quinolone;
secondary amino compound;
tertiary amino compound
anti-obesity agent;
antineoplastic agent;
apoptosis inducer;
autophagy inhibitor;
forkhead box protein O1 inhibitor;
hypoglycemic agent
00low000000
ldc4297aromatic ether;
piperidines;
pyrazoles;
pyrazolotriazine;
secondary amino compound
antineoplastic agent;
antiviral agent;
apoptosis inducer;
EC 2.7.11.22 (cyclin-dependent kinase) inhibitor
00low000000
hg-9-91-01aminopyrimidine;
dimethoxybenzene;
N-alkylpiperazine;
N-arylpiperazine;
phenylureas;
secondary amino compound
antineoplastic agent;
salt-inducible kinase 2 inhibitor
00low000000
enasidenib1,3,5-triazines;
aminopyridine;
aromatic amine;
organofluorine compound;
secondary amino compound;
tertiary alcohol
antineoplastic agent;
EC 1.1.1.42 (isocitrate dehydrogenase) inhibitor
00low000000
BDA-366anthraquinone;
epoxide;
secondary alcohol;
secondary amino compound;
tertiary amino compound
antineoplastic agent;
apoptosis inducer
00low000000
THZ531aminopyrimidine;
enamide;
indoles;
N-acylpiperidine;
organochlorine compound;
secondary amino compound;
secondary carboxamide
antineoplastic agent;
apoptosis inducer;
EC 2.7.11.22 (cyclin-dependent kinase) inhibitor
00low000000
MMP-9-IN-1aromatic compound;
organic sulfide;
organofluorine compound;
pyrimidone;
secondary carboxamide
antineoplastic agent;
EC 3.4.24.35 (gelatinase B) inhibitor
00low000000
2-hydroxy-3-(5-((morpholin-4-yl)methyl)pyridin-2-yl)-1h-indole-5-carbonitrilehydroxyindoles;
morpholines;
nitrile;
pyridines;
tertiary amino compound
antineoplastic agent;
apoptosis inducer;
EC 2.7.11.26 (tau-protein kinase) inhibitor;
tau aggregation inhibitor
00low000000
pioglitazonearomatic ether;
pyridines;
thiazolidinediones
antidepressant;
cardioprotective agent;
EC 2.7.1.33 (pantothenate kinase) inhibitor;
EC 6.2.1.3 (long-chain-fatty-acid--CoA ligase) inhibitor;
ferroptosis inhibitor;
geroprotector;
hypoglycemic agent;
insulin-sensitizing drug;
PPARgamma agonist;
xenobiotic
2002201813.6low000660
liproxstatin-1azaspiro compound;
monochlorobenzenes;
organic heterotricyclic compound;
secondary amino compound
antioxidant;
cardioprotective agent;
ferroptosis inhibitor;
radical scavenger
00low000000
droxicamorganic heterotricyclic compound;
pyridines
cyclooxygenase 1 inhibitor;
hepatotoxic agent;
non-narcotic analgesic;
non-steroidal anti-inflammatory drug;
platelet aggregation inhibitor;
prodrug
00low000000
mepanipyrimacetylenic compound;
aminopyrimidine;
anilinopyrimidine fungicide;
secondary amino compound
antifungal agrochemical;
aryl hydrocarbon receptor agonist;
hepatotoxic agent
00low000000
teriflunomide(trifluoromethyl)benzenes;
aromatic amide;
enamide;
enol;
nitrile;
secondary carboxamide
drug metabolite;
EC 1.3.98.1 [dihydroorotate oxidase (fumarate)] inhibitor;
hepatotoxic agent;
non-steroidal anti-inflammatory drug;
tyrosine kinase inhibitor
00low000000
niclosamidebenzamides;
C-nitro compound;
monochlorobenzenes;
salicylanilides;
secondary carboxamide
anthelminthic drug;
anticoronaviral agent;
antiparasitic agent;
apoptosis inducer;
molluscicide;
piscicide;
STAT3 inhibitor
00low000000
sb 202190imidazoles;
organofluorine compound;
phenols;
pyridines
apoptosis inducer;
EC 2.7.11.24 (mitogen-activated protein kinase) inhibitor
00low000000
n,n,n',n'-tetrakis(2-pyridylmethyl)ethylenediamineN-substituted diamine;
pyridines;
tertiary amino compound
apoptosis inducer;
chelator;
copper chelator
00low000000
fluazinam(trifluoromethyl)benzenes;
aminopyridine;
C-nitro compound;
chloropyridine;
monochlorobenzenes;
secondary amino compound
allergen;
antifungal agrochemical;
apoptosis inducer;
environmental contaminant;
xenobiotic
00low000000
nsc 23766aminopyrimidine;
aminoquinoline;
primary amino compound;
secondary amino compound;
tertiary amino compound
antiviral agent;
apoptosis inducer;
EC 3.6.5.2 (small monomeric GTPase) inhibitor;
muscarinic antagonist
00low000000
sb 415286C-nitro compound;
maleimides;
monochlorobenzenes;
phenols;
secondary amino compound;
substituted aniline
antioxidant;
apoptosis inducer;
EC 2.7.11.26 (tau-protein kinase) inhibitor;
neuroprotective agent
00low000000
ag-490catechols;
enamide;
monocarboxylic acid amide;
nitrile;
secondary carboxamide
anti-inflammatory agent;
antioxidant;
apoptosis inducer;
EC 2.7.10.2 (non-specific protein-tyrosine kinase) inhibitor;
geroprotector;
STAT3 inhibitor
00low000000
pipercallosidinealkaloid;
benzodioxoles;
enamide;
secondary carboxamide
apoptosis inducer;
metabolite;
plant metabolite
00low000000
MI-63azaspiro compound;
monochlorobenzenes;
monofluorobenzenes;
morpholines;
oxindoles;
pyrrolidines;
secondary carboxamide
apoptosis inducer00low000000
SMER 28organobromine compound;
quinazolines;
secondary amino compound
autophagy inducer00low000000
AZ3451benzimidazoles;
benzodioxoles;
nitrile;
organobromine compound;
secondary carboxamide
anti-inflammatory agent;
autophagy inducer;
PAR2 negative allosteric modulator
00low000000
((5z)5-(1,3-benzodioxol-5-yl)methylene-2-phenylamino-3,5-dihydro-4h-imidazol-4-one)benzodioxoles;
imidazolone;
substituted aniline
autophagy inducer;
EC 2.7.11.22 (cyclin-dependent kinase) inhibitor;
EC 2.7.12.1 (dual-specificity kinase) inhibitor;
neuroprotective agent;
nootropic agent
00low000000
SubstanceStudiesClassesRolesFirst YearLast YearAverage AgeRelationship StrengthTrialspre-19901990's2000's2010'spost-2020
aminolevulinic acid4-oxo monocarboxylic acid;
amino acid zwitterion;
delta-amino acid
antineoplastic agent;
dermatologic drug;
Escherichia coli metabolite;
human metabolite;
mouse metabolite;
photosensitizing agent;
plant metabolite;
prodrug;
Saccharomyces cerevisiae metabolite
202320231.0low000001
coumarincoumarinsfluorescent dye;
human metabolite;
plant metabolite
202320231.0low000001
salicylic acidmonohydroxybenzoic acidalgal metabolite;
antifungal agent;
antiinfective agent;
EC 1.11.1.11 (L-ascorbate peroxidase) inhibitor;
keratolytic drug;
plant hormone;
plant metabolite
202320231.0low000001
thioctic aciddithiolanes;
heterocyclic fatty acid;
thia fatty acid
fundamental metabolite;
geroprotector
202320231.0low000001
picolinic acidpyridinemonocarboxylic acidhuman metabolite;
MALDI matrix material
202320231.0low000001
thiamineprimary alcohol;
vitamin B1
Escherichia coli metabolite;
human metabolite;
mouse metabolite;
Saccharomyces cerevisiae metabolite
202320231.0low000001
pk 11195aromatic amide;
isoquinolines;
monocarboxylic acid amide;
monochlorobenzenes
antineoplastic agent2013201311.0low000010
pd 173074aromatic amine;
biaryl;
dimethoxybenzene;
pyridopyrimidine;
tertiary amino compound;
ureas
antineoplastic agent;
EC 2.7.10.1 (receptor protein-tyrosine kinase) inhibitor;
fibroblast growth factor receptor antagonist
2013201311.0low000010
3-aminobenzamidebenzamides;
substituted aniline
EC 2.4.2.30 (NAD(+) ADP-ribosyltransferase) inhibitor202320231.0low000001
pleconaril202320231.0low000001
4-(2-aminoethyl)benzenesulfonylfluoride202320231.0low000001
phenytoinimidazolidine-2,4-dioneanticonvulsant;
drug allergen;
sodium channel blocker;
teratogenic agent
202320231.0low000001
abt 702bipyridines2013201311.0low000010
acetazolamidemonocarboxylic acid amide;
sulfonamide;
thiadiazoles
anticonvulsant;
diuretic;
EC 4.2.1.1 (carbonic anhydrase) inhibitor
202320231.0low000001
alprenololsecondary alcohol;
secondary amino compound
anti-arrhythmia drug;
antihypertensive agent;
beta-adrenergic antagonist;
sympatholytic agent
202320231.0low000001
amantadineadamantanes;
primary aliphatic amine
analgesic;
antiparkinson drug;
antiviral drug;
dopaminergic agent;
NMDA receptor antagonist;
non-narcotic analgesic
202320231.0low000001
2-aminothiazole1,3-thiazoles;
primary amino compound
202320231.0low000001
amodiaquineaminoquinoline;
organochlorine compound;
phenols;
secondary amino compound;
tertiary amino compound
anticoronaviral agent;
antimalarial;
drug allergen;
EC 2.1.1.8 (histamine N-methyltransferase) inhibitor;
non-steroidal anti-inflammatory drug;
prodrug
202320231.0low000001
aspirinbenzoic acids;
phenyl acetates;
salicylates
anticoagulant;
antipyretic;
cyclooxygenase 1 inhibitor;
cyclooxygenase 2 inhibitor;
drug allergen;
EC 1.1.1.188 (prostaglandin-F synthase) inhibitor;
geroprotector;
non-narcotic analgesic;
non-steroidal anti-inflammatory drug;
plant activator;
platelet aggregation inhibitor;
prostaglandin antagonist;
teratogenic agent
202320231.0low000001
baclofenamino acid zwitterion;
gamma-amino acid;
monocarboxylic acid;
monochlorobenzenes;
primary amino compound
central nervous system depressant;
GABA agonist;
muscle relaxant
202320231.0low000001
benzamidebenzamides202320231.0low000001
bicalutamide(trifluoromethyl)benzenes;
monocarboxylic acid amide;
monofluorobenzenes;
nitrile;
sulfone;
tertiary alcohol
2013201311.0low000010
verapamilaromatic ether;
nitrile;
polyether;
tertiary amino compound
2013201311.0low000010
camostatbenzoate ester;
carboxylic ester;
diester;
guanidines;
tertiary carboxamide
anti-inflammatory agent;
anticoronaviral agent;
antifibrinolytic drug;
antihypertensive agent;
antineoplastic agent;
antiviral agent;
serine protease inhibitor
202320231.0low000001
camphor, (+-)-isomerbornane monoterpenoid;
cyclic monoterpene ketone
plant metabolite202320231.0low000001
candesartanbenzimidazolecarboxylic acid;
biphenylyltetrazole
angiotensin receptor antagonist;
antihypertensive agent;
environmental contaminant;
xenobiotic
202320231.0low000001
celecoxiborganofluorine compound;
pyrazoles;
sulfonamide;
toluenes
cyclooxygenase 2 inhibitor;
geroprotector;
non-narcotic analgesic;
non-steroidal anti-inflammatory drug
2013201311.0low000010
cetylpyridiniumpyridinium ion202320231.0low000001
chelerythrinebenzophenanthridine alkaloid;
organic cation
antibacterial agent;
antineoplastic agent;
EC 2.7.11.13 (protein kinase C) inhibitor
2013201311.0low000010
chloroxylenolmonochlorobenzenes;
phenols
antiseptic drug;
disinfectant;
molluscicide
202320231.0low000001
chlorpromazineorganochlorine compound;
phenothiazines;
tertiary amine
anticoronaviral agent;
antiemetic;
dopaminergic antagonist;
EC 3.4.21.26 (prolyl oligopeptidase) inhibitor;
phenothiazine antipsychotic drug
202320231.0low000001
ci 994acetamides;
benzamides;
substituted aniline
antineoplastic agent;
EC 3.5.1.98 (histone deacetylase) inhibitor
2010201014.0low000100
ciprofibratecyclopropanes;
monocarboxylic acid;
organochlorine compound
antilipemic drug202320231.0low000001
clomipraminedibenzoazepineanticoronaviral agent;
antidepressant;
EC 1.8.1.12 (trypanothione-disulfide reductase) inhibitor;
serotonergic antagonist;
serotonergic drug;
serotonin uptake inhibitor
202320231.0low000001
danthrondihydroxyanthraquinoneapoptosis inducer;
plant metabolite
202320231.0low000001
deferiprone4-pyridonesiron chelator;
protective agent
202320231.0low000001
dipyridamolepiperidines;
pyrimidopyrimidine;
tertiary amino compound;
tetrol
adenosine phosphodiesterase inhibitor;
EC 3.5.4.4 (adenosine deaminase) inhibitor;
platelet aggregation inhibitor;
vasodilator agent
202320231.0low000001
disulfiramorganic disulfide;
organosulfur acaricide
angiogenesis inhibitor;
antineoplastic agent;
apoptosis inducer;
EC 1.2.1.3 [aldehyde dehydrogenase (NAD(+))] inhibitor;
EC 3.1.1.1 (carboxylesterase) inhibitor;
EC 3.1.1.8 (cholinesterase) inhibitor;
EC 5.99.1.2 (DNA topoisomerase) inhibitor;
ferroptosis inducer;
fungicide;
NF-kappaB inhibitor
202320231.0low000001
valproic acidbranched-chain fatty acid;
branched-chain saturated fatty acid
anticonvulsant;
antimanic drug;
EC 3.5.1.98 (histone deacetylase) inhibitor;
GABA agent;
neuroprotective agent;
psychotropic drug;
teratogenic agent
202320231.0low000001
doxazosinaromatic amine;
benzodioxine;
monocarboxylic acid amide;
N-acylpiperazine;
N-arylpiperazine;
quinazolines
alpha-adrenergic antagonist;
antihyperplasia drug;
antihypertensive agent;
antineoplastic agent;
vasodilator agent
202320231.0low000001
ebselenbenzoselenazoleanti-inflammatory drug;
antibacterial agent;
anticoronaviral agent;
antifungal agent;
antineoplastic agent;
antioxidant;
apoptosis inducer;
EC 1.13.11.33 (arachidonate 15-lipoxygenase) inhibitor;
EC 1.13.11.34 (arachidonate 5-lipoxygenase) inhibitor;
EC 1.3.1.8 [acyl-CoA dehydrogenase (NADP(+))] inhibitor;
EC 1.8.1.12 (trypanothione-disulfide reductase) inhibitor;
EC 2.5.1.7 (UDP-N-acetylglucosamine 1-carboxyvinyltransferase) inhibitor;
EC 2.7.10.1 (receptor protein-tyrosine kinase) inhibitor;
EC 3.1.3.25 (inositol-phosphate phosphatase) inhibitor;
EC 3.4.22.69 (SARS coronavirus main proteinase) inhibitor;
EC 3.5.4.1 (cytosine deaminase) inhibitor;
EC 5.1.3.2 (UDP-glucose 4-epimerase) inhibitor;
enzyme mimic;
ferroptosis inhibitor;
genotoxin;
hepatoprotective agent;
neuroprotective agent;
radical scavenger
202320231.0low000001
etidronate1,1-bis(phosphonic acid)antineoplastic agent;
bone density conservation agent;
chelator
202320231.0low000001
2-hexyloxybenzamidearomatic ether;
benzamides
antifungal agent202320231.0low000001
brl 428102-aminopurines;
acetate ester
antiviral drug;
prodrug
202320231.0low000001
fluphenazineN-alkylpiperazine;
organofluorine compound;
phenothiazines
anticoronaviral agent;
dopaminergic antagonist;
phenothiazine antipsychotic drug
202320231.0low000001
fluorouracilnucleobase analogue;
organofluorine compound
antimetabolite;
antineoplastic agent;
environmental contaminant;
immunosuppressive agent;
radiosensitizing agent;
xenobiotic
202320231.0low000001
furosemidechlorobenzoic acid;
furans;
sulfonamide
environmental contaminant;
loop diuretic;
xenobiotic
2013201311.0low000010
gabexatebenzoate ester202320231.0low000001
glutaraldialdehydecross-linking reagent;
disinfectant;
fixative
202320231.0low000001
gossypol2013201311.0low000010
fasudilisoquinolines;
N-sulfonyldiazepane
antihypertensive agent;
calcium channel blocker;
EC 2.7.11.1 (non-specific serine/threonine protein kinase) inhibitor;
geroprotector;
neuroprotective agent;
nootropic agent;
vasodilator agent
201320236.0low000011
haloperidolaromatic ketone;
hydroxypiperidine;
monochlorobenzenes;
organofluorine compound;
tertiary alcohol
antidyskinesia agent;
antiemetic;
dopaminergic antagonist;
first generation antipsychotic;
serotonergic antagonist
202320231.0low000001
miltefosinephosphocholines;
phospholipid
anti-inflammatory agent;
anticoronaviral agent;
antifungal agent;
antineoplastic agent;
antiprotozoal drug;
apoptosis inducer;
immunomodulator;
protein kinase inhibitor
202320231.0low000001
hexylresorcinolresorcinols202320231.0low000001
beta-thujaplicincyclic ketone;
enol;
monoterpenoid
antibacterial agent;
antifungal agent;
antineoplastic agent;
antiplasmodial drug;
plant metabolite
202320231.0low000001
hycanthonethioxanthenesmutagen;
schistosomicide drug
202320231.0low000001
hydrochlorothiazidebenzothiadiazine;
organochlorine compound;
sulfonamide
antihypertensive agent;
diuretic;
environmental contaminant;
xenobiotic
202320231.0low000001
hydroxyureaone-carbon compound;
ureas
antimetabolite;
antimitotic;
antineoplastic agent;
DNA synthesis inhibitor;
EC 1.17.4.1 (ribonucleoside-diphosphate reductase) inhibitor;
genotoxin;
immunomodulator;
radical scavenger;
teratogenic agent
202320231.0low000001
ibuprofenmonocarboxylic acidantipyretic;
cyclooxygenase 1 inhibitor;
cyclooxygenase 2 inhibitor;
drug allergen;
environmental contaminant;
geroprotector;
non-narcotic analgesic;
non-steroidal anti-inflammatory drug;
radical scavenger;
xenobiotic
202320231.0low000001
indirubin-3'-monoxime2013201311.0low000010
indomethacinaromatic ether;
indole-3-acetic acids;
monochlorobenzenes;
N-acylindole
analgesic;
drug metabolite;
EC 1.14.99.1 (prostaglandin-endoperoxide synthase) inhibitor;
environmental contaminant;
gout suppressant;
non-steroidal anti-inflammatory drug;
xenobiotic metabolite;
xenobiotic
202320231.0low000001
avaproazaspiro compound;
biphenylyltetrazole
angiotensin receptor antagonist;
antihypertensive agent;
environmental contaminant;
xenobiotic
202320231.0low000001
itraconazolepiperazines202320231.0low000001
kojic acid4-pyranones;
enol;
primary alcohol
Aspergillus metabolite;
EC 1.10.3.1 (catechol oxidase) inhibitor;
EC 1.10.3.2 (laccase) inhibitor;
EC 1.13.11.24 (quercetin 2,3-dioxygenase) inhibitor;
EC 1.14.18.1 (tyrosinase) inhibitor;
EC 1.4.3.3 (D-amino-acid oxidase) inhibitor;
NF-kappaB inhibitor;
skin lightening agent
202320231.0low000001
lapachol202320231.0low000001
leflunomide(trifluoromethyl)benzenes;
isoxazoles;
monocarboxylic acid amide
antineoplastic agent;
antiparasitic agent;
EC 1.3.98.1 [dihydroorotate oxidase (fumarate)] inhibitor;
EC 3.1.3.16 (phosphoprotein phosphatase) inhibitor;
hepatotoxic agent;
immunosuppressive agent;
non-steroidal anti-inflammatory drug;
prodrug;
pyrimidine synthesis inhibitor;
tyrosine kinase inhibitor
2013201311.0low000010
letrozolenitrile;
triazoles
antineoplastic agent;
EC 1.14.14.14 (aromatase) inhibitor
2013201311.0low000010
lg 1002682013201311.0low000010
loperamidemonocarboxylic acid amide;
monochlorobenzenes;
piperidines;
tertiary alcohol
anticoronaviral agent;
antidiarrhoeal drug;
mu-opioid receptor agonist
202320231.0low000001
loratadinebenzocycloheptapyridine;
ethyl ester;
N-acylpiperidine;
organochlorine compound;
tertiary carboxamide
anti-allergic agent;
cholinergic antagonist;
geroprotector;
H1-receptor antagonist
202320231.0low000001
losartanbiphenylyltetrazole;
imidazoles
angiotensin receptor antagonist;
anti-arrhythmia drug;
antihypertensive agent;
endothelin receptor antagonist
202320231.0low000001
4-(dimethylamino)-n-(7-(hydroxyamino)-7-oxoheptyl)benzamidebenzamides;
hydroxamic acid;
secondary carboxamide;
tertiary amino compound
antineoplastic agent;
apoptosis inducer;
EC 3.5.1.98 (histone deacetylase) inhibitor
201720234.0medium000011
mafenidearomatic amine202320231.0low000001
metforminguanidinesenvironmental contaminant;
geroprotector;
hypoglycemic agent;
xenobiotic
2013201311.0low000010
methazolamidesulfonamide;
thiadiazoles
202320231.0low000001
methocarbamolaromatic ether;
carbamate ester;
secondary alcohol
202320231.0low000001
mitoxantronedihydroxyanthraquinoneanalgesic;
antineoplastic agent
201320236.0low000011
entinostatbenzamides;
carbamate ester;
primary amino compound;
pyridines;
substituted aniline
antineoplastic agent;
apoptosis inducer;
EC 3.5.1.98 (histone deacetylase) inhibitor
2008202310.2low000361
ethylmaleimidemaleimidesanticoronaviral agent;
EC 1.3.1.8 [acyl-CoA dehydrogenase (NADP(+))] inhibitor;
EC 2.1.1.122 [(S)-tetrahydroprotoberberine N-methyltransferase] inhibitor;
EC 2.7.1.1 (hexokinase) inhibitor
202320231.0low000001
nabumetonemethoxynaphthalene;
methyl ketone
cyclooxygenase 2 inhibitor;
non-narcotic analgesic;
non-steroidal anti-inflammatory drug;
prodrug
202320231.0low000001
nafamostatbenzoic acids;
guanidines
202320231.0low000001
nevirapinecyclopropanes;
dipyridodiazepine
antiviral drug;
HIV-1 reverse transcriptase inhibitor
202320231.0low000001
olprinonebipyridines2013201311.0low000010
omeprazolearomatic ether;
benzimidazoles;
pyridines;
sulfoxide
201320236.0low000011
osalmideorganic molecular entity202320231.0low000001
oxethazaineamino acid amide202320231.0low000001
palmidrolendocannabinoid;
N-(long-chain-acyl)ethanolamine;
N-(saturated fatty acyl)ethanolamine
anti-inflammatory drug;
anticonvulsant;
antihypertensive agent;
neuroprotective agent
202320231.0low000001
papaverinebenzylisoquinoline alkaloid;
dimethoxybenzene;
isoquinolines
antispasmodic drug;
vasodilator agent
202320231.0low000001
pentoxifyllineoxopurine202320231.0low000001
perhexilinepiperidinescardiovascular drug202320231.0low000001
phenazopyridinediaminopyridine;
monoazo compound
anticoronaviral agent;
carcinogenic agent;
local anaesthetic;
non-narcotic analgesic
202320231.0low000001
4-phenylbutyric acidmonocarboxylic acidantineoplastic agent;
apoptosis inducer;
EC 3.5.1.98 (histone deacetylase) inhibitor;
prodrug
202320231.0low000001
phenylmethylsulfonyl fluorideacyl fluorideserine proteinase inhibitor202320231.0low000001
pimobendanbenzimidazoles;
pyridazinone
cardiotonic drug;
EC 3.1.4.* (phosphoric diester hydrolase) inhibitor;
vasodilator agent
202320231.0low000001
pioglitazonearomatic ether;
pyridines;
thiazolidinediones
antidepressant;
cardioprotective agent;
EC 2.7.1.33 (pantothenate kinase) inhibitor;
EC 6.2.1.3 (long-chain-fatty-acid--CoA ligase) inhibitor;
ferroptosis inhibitor;
geroprotector;
hypoglycemic agent;
insulin-sensitizing drug;
PPARgamma agonist;
xenobiotic
2013201311.0low000010
pj-34phenanthridines;
secondary carboxamide;
tertiary amino compound
angiogenesis inhibitor;
anti-inflammatory agent;
antiatherosclerotic agent;
antineoplastic agent;
apoptosis inducer;
cardioprotective agent;
EC 2.4.2.30 (NAD(+) ADP-ribosyltransferase) inhibitor;
neuroprotective agent
202320231.0low000001
praziquantelisoquinolines202320231.0low000001
probenecidbenzoic acids;
sulfonamide
uricosuric drug202320231.0low000001
probucoldithioketal;
polyphenol
anti-inflammatory drug;
anticholesteremic drug;
antilipemic drug;
antioxidant;
cardiovascular drug
202320231.0low000001
promazinephenothiazines;
tertiary amine
antiemetic;
dopaminergic antagonist;
EC 3.4.21.26 (prolyl oligopeptidase) inhibitor;
H1-receptor antagonist;
muscarinic antagonist;
phenothiazine antipsychotic drug;
serotonergic antagonist
202320231.0low000001
promethazinephenothiazines;
tertiary amine
anti-allergic agent;
anticoronaviral agent;
antiemetic;
antipruritic drug;
H1-receptor antagonist;
local anaesthetic;
sedative
202320231.0low000001
propranololnaphthalenes;
propanolamine;
secondary amine
anti-arrhythmia drug;
antihypertensive agent;
anxiolytic drug;
beta-adrenergic antagonist;
environmental contaminant;
human blood serum metabolite;
vasodilator agent;
xenobiotic
202320231.0low000001
pyroxamidearomatic amide2010201014.0low000100
3-[(3,5-dibromo-4-hydroxyphenyl)methylidene]-5-iodo-1H-indol-2-oneindoles2013201311.0low000010
riluzolebenzothiazoles2013201311.0low000010
rimantadinealkylamine202320231.0low000001
roliprampyrrolidin-2-onesantidepressant;
EC 3.1.4.* (phosphoric diester hydrolase) inhibitor
202320231.0low000001
sb 206553pyrroloindole2013201311.0low000010
sb 220025aminopyrimidine;
imidazoles;
organofluorine compound;
piperidines
angiogenesis inhibitor;
anti-inflammatory agent;
EC 2.7.11.24 (mitogen-activated protein kinase) inhibitor
2013201311.0low000010
sb 202190imidazoles;
organofluorine compound;
phenols;
pyridines
apoptosis inducer;
EC 2.7.11.24 (mitogen-activated protein kinase) inhibitor
2013201311.0low000010
suberoyl bis-hydroxamic acidhydroxamic acid2010201014.0low000100
scriptaidisoquinolines201020237.3low000111
sebacic acidalpha,omega-dicarboxylic acid;
dicarboxylic fatty acid
human metabolite;
plant metabolite
202320231.0low000001
sk&f 86002imidazoles2013201311.0low000010
fenofibratebenzochromenone;
delta-lactone;
naphtho-alpha-pyrone
platelet aggregation inhibitor;
Sir2 inhibitor
202320231.0low000001
imatinibaromatic amine;
benzamides;
N-methylpiperazine;
pyridines;
pyrimidines
antineoplastic agent;
apoptosis inducer;
tyrosine kinase inhibitor
201320236.0low000011
vorinostatdicarboxylic acid diamide;
hydroxamic acid
antineoplastic agent;
apoptosis inducer;
EC 3.5.1.98 (histone deacetylase) inhibitor
2008202211.1low000581
sulfasalazine2013201311.0low000010
suprofenaromatic ketone;
monocarboxylic acid;
thiophenes
antirheumatic drug;
drug allergen;
EC 1.14.99.1 (prostaglandin-endoperoxide synthase) inhibitor;
non-narcotic analgesic;
non-steroidal anti-inflammatory drug;
peripheral nervous system drug
202320231.0low000001
2-[4-(1,2-diphenylbut-1-enyl)phenoxy]-N,N-dimethylethanaminestilbenoid2013201311.0low000010
thalidomidephthalimides;
piperidones
202320231.0low000001
ticlopidinemonochlorobenzenes;
thienopyridine
anticoagulant;
fibrin modulating drug;
hematologic agent;
P2Y12 receptor antagonist;
platelet aggregation inhibitor
202320231.0low000001
triamterenepteridinesdiuretic;
sodium channel blocker
202320231.0low000001
trifluoperazineN-alkylpiperazine;
N-methylpiperazine;
organofluorine compound;
phenothiazines
antiemetic;
calmodulin antagonist;
dopaminergic antagonist;
EC 1.8.1.12 (trypanothione-disulfide reductase) inhibitor;
EC 5.3.3.5 (cholestenol Delta-isomerase) inhibitor;
phenothiazine antipsychotic drug
202320231.0low000001
triflupromazineorganofluorine compound;
phenothiazines;
tertiary amine
anticoronaviral agent;
antiemetic;
dopaminergic antagonist;
first generation antipsychotic
202320231.0low000001
trigonellinealkaloid;
iminium betaine
food component;
human urinary metabolite;
plant metabolite
202320231.0low000001
trimethobenzamidebenzamides;
tertiary amino compound
antiemetic202320231.0low000001
trimethoprimaminopyrimidine;
methoxybenzenes
antibacterial drug;
diuretic;
drug allergen;
EC 1.5.1.3 (dihydrofolate reductase) inhibitor;
environmental contaminant;
xenobiotic
202320231.0low000001
troglitazonechromanes;
thiazolidinone
anticoagulant;
anticonvulsant;
antineoplastic agent;
antioxidant;
EC 6.2.1.3 (long-chain-fatty-acid--CoA ligase) inhibitor;
ferroptosis inhibitor;
hypoglycemic agent;
platelet aggregation inhibitor;
vasodilator agent
2013201311.0low000010
tyrphostin a9alkylbenzenegeroprotector202320231.0low000001
delavirdineaminopyridine;
indolecarboxamide;
N-acylpiperazine;
sulfonamide
antiviral drug;
HIV-1 reverse transcriptase inhibitor
202320231.0low000001
vesnarinoneorganic molecular entity202320231.0low000001
idoxuridineorganoiodine compound;
pyrimidine 2'-deoxyribonucleoside
antiviral drug;
DNA synthesis inhibitor
202320231.0low000001
chloramphenicolC-nitro compound;
carboxamide;
diol;
organochlorine compound
antibacterial drug;
antimicrobial agent;
Escherichia coli metabolite;
geroprotector;
Mycoplasma genitalium metabolite;
protein synthesis inhibitor
202320231.0low000001
lysineaspartate family amino acid;
L-alpha-amino acid zwitterion;
L-alpha-amino acid;
lysine;
organic molecular entity;
proteinogenic amino acid
algal metabolite;
anticonvulsant;
Escherichia coli metabolite;
human metabolite;
micronutrient;
mouse metabolite;
nutraceutical;
plant metabolite;
Saccharomyces cerevisiae metabolite
202320231.0low000001
phenylethyl alcoholbenzenes;
primary alcohol
Aspergillus metabolite;
fragrance;
plant growth retardant;
plant metabolite;
Saccharomyces cerevisiae metabolite
202320231.0low000001
zoxazolaminebenzoxazole202320231.0low000001
colchicinealkaloid;
colchicine
anti-inflammatory agent;
gout suppressant;
mutagen
201520159.0low000010
cycloheximideantibiotic fungicide;
cyclic ketone;
dicarboximide;
piperidine antibiotic;
piperidones;
secondary alcohol
anticoronaviral agent;
bacterial metabolite;
ferroptosis inhibitor;
neuroprotective agent;
protein synthesis inhibitor
202320231.0low000001
ficusinpsoralensplant metabolite202320231.0low000001
tubercidinantibiotic antifungal agent;
N-glycosylpyrrolopyrimidine;
ribonucleoside
antimetabolite;
antineoplastic agent;
bacterial metabolite
202320231.0low000001
trifluridinenucleoside analogue;
organofluorine compound;
pyrimidine 2'-deoxyribonucleoside
antimetabolite;
antineoplastic agent;
antiviral drug;
EC 2.1.1.45 (thymidylate synthase) inhibitor
202320231.0low000001
9,10-anthraquinoneanthraquinone202320231.0low000001
salicylanilidebenzanilide fungicide;
salicylamides;
salicylanilides
202320231.0low000001
gramineaminoalkylindole;
indole alkaloid;
tertiary amino compound
antibacterial agent;
antiviral agent;
plant metabolite;
serotonergic antagonist
202320231.0low000001
aminacrineaminoacridines;
primary amino compound
acid-base indicator;
antiinfective agent;
antiseptic drug;
fluorescent dye;
MALDI matrix material;
mutagen
202320231.0low000001
methyl gallategallate esteranti-inflammatory agent;
antioxidant;
plant metabolite
202320231.0low000001
monobenzonebenzyl etherallergen;
dermatologic drug;
melanin synthesis inhibitor
202320231.0low000001
ditiocarbdithiocarbamic acidschelator;
copper chelator
202320231.0low000001
catechincatechinantioxidant;
plant metabolite
202320231.0low000001
azacitidineN-glycosyl-1,3,5-triazine;
nucleoside analogue
antineoplastic agent201320236.0low000011
lucanthonethioxanthenesadjuvant;
antineoplastic agent;
EC 5.99.1.2 (DNA topoisomerase) inhibitor;
EC 5.99.1.3 [DNA topoisomerase (ATP-hydrolysing)] inhibitor;
mutagen;
photosensitizing agent;
prodrug;
schistosomicide drug
202320231.0low000001
cepharanthinebisbenzylisoquinoline alkaloid;
isoquinolines
202320231.0low000001
aloe emodinaromatic primary alcohol;
dihydroxyanthraquinone
antineoplastic agent;
plant metabolite
202320231.0low000001
chrysophanic aciddihydroxyanthraquinoneanti-inflammatory agent;
antiviral agent;
plant metabolite
202320231.0low000001
emetineisoquinoline alkaloid;
pyridoisoquinoline
antiamoebic agent;
anticoronaviral agent;
antiinfective agent;
antimalarial;
antineoplastic agent;
antiprotozoal drug;
antiviral agent;
autophagy inhibitor;
emetic;
expectorant;
plant metabolite;
protein synthesis inhibitor
202320231.0low000001
ostholbotanical anti-fungal agent;
coumarins
metabolite202320231.0low000001
flavanoneflavanones202320231.0low000001
phloretic acidhydroxy monocarboxylic acidplant metabolite202320231.0low000001
oleanolic acidhydroxy monocarboxylic acid;
pentacyclic triterpenoid
plant metabolite202320231.0low000001
podophyllotoxinfuronaphthodioxole;
lignan;
organic heterotetracyclic compound
antimitotic;
antineoplastic agent;
keratolytic drug;
microtubule-destabilising agent;
plant metabolite;
tubulin modulator
2013201311.0low000010
angelicinfuranocoumarin202320231.0low000001
diperodoncarbamate ester202320231.0low000001
formestane17-oxo steroid;
3-oxo-Delta(4) steroid;
enol;
hydroxy steroid
antineoplastic agent;
EC 1.14.14.14 (aromatase) inhibitor
2013201311.0low000010
megestrol acetate20-oxo steroid;
3-oxo-Delta(4) steroid;
acetate ester;
steroid ester
antineoplastic agent;
appetite enhancer;
contraceptive drug;
progestin;
synthetic oral contraceptive
202320231.0low000001
acetylcysteineacetylcysteine;
L-cysteine derivative;
N-acetyl-L-amino acid
antidote to paracetamol poisoning;
antiinfective agent;
antioxidant;
antiviral drug;
ferroptosis inhibitor;
geroprotector;
human metabolite;
mucolytic;
radical scavenger;
vulnerary
202320231.0low000001
hydroxychloroquine sulfate201320236.0medium000011
ethambutolethanolamines;
ethylenediamine derivative
antitubercular agent;
environmental contaminant;
xenobiotic
202320231.0low000001
metformin hydrochloridehydrochlorideenvironmental contaminant;
hypoglycemic agent;
xenobiotic
202320231.0low000001
antimycin abenzamides;
formamides;
macrodiolide;
phenols
antifungal agent;
mitochondrial respiratory-chain inhibitor;
piscicide
202320231.0low000001
5,5'-dimethyl-2,2'-bipyridylbipyridines202320231.0medium000001
dichlorobenzyl alcoholbenzyl alcohols;
dichlorobenzene
antiseptic drug202320231.0low000001
amiloride hydrochloride, anhydroushydrochloridediuretic;
sodium channel blocker
2013201311.0low000010
acadesine1-ribosylimidazolecarboxamide;
aminoimidazole;
nucleoside analogue
antineoplastic agent;
platelet aggregation inhibitor
2013201311.0low000010
stavudinedihydrofuran;
nucleoside analogue;
organic molecular entity
antimetabolite;
antiviral agent;
EC 2.7.7.49 (RNA-directed DNA polymerase) inhibitor
202320231.0low000001
dideoxyadenosineadenosines;
purine 2',3'-dideoxyribonucleoside
EC 3.5.4.4 (adenosine deaminase) inhibitor;
EC 4.6.1.1 (adenylate cyclase) inhibitor
202320231.0low000001
cladribineorganochlorine compound;
purine 2'-deoxyribonucleoside
antineoplastic agent;
immunosuppressive agent
2013201311.0low000010
vidarabinebeta-D-arabinoside;
purine nucleoside
antineoplastic agent;
bacterial metabolite;
nucleoside antibiotic
202320231.0low000001
3-deazaadenosine202320231.0low000001
zalcitabinepyrimidine 2',3'-dideoxyribonucleosideantimetabolite;
antiviral drug;
HIV-1 reverse transcriptase inhibitor
202320231.0low000001
ancitabinediol;
organic heterotricyclic compound
antimetabolite;
antineoplastic agent;
prodrug
202320231.0low000001
chloropyramineaminopyridine202320231.0low000001
levamisole6-phenyl-2,3,5,6-tetrahydroimidazo[2,1-b][1,3]thiazoleantinematodal drug;
antirheumatic drug;
EC 3.1.3.1 (alkaline phosphatase) inhibitor;
immunological adjuvant;
immunomodulator
202320231.0low000001
n'-nitrosonornicotinepyridines;
pyrrolidines
202320231.0low000001
daunorubicinaminoglycoside antibiotic;
anthracycline;
p-quinones;
tetracenequinones
antineoplastic agent;
bacterial metabolite
202320231.0low000001
zidovudineazide;
pyrimidine 2',3'-dideoxyribonucleoside
antimetabolite;
antiviral drug;
HIV-1 reverse transcriptase inhibitor
201320236.0low000011
etoposidebeta-D-glucoside;
furonaphthodioxole;
organic heterotetracyclic compound
antineoplastic agent;
DNA synthesis inhibitor
2013201311.0low000010
ribavirin1-ribosyltriazole;
aromatic amide;
monocarboxylic acid amide;
primary carboxamide
anticoronaviral agent;
antiinfective agent;
antimetabolite;
antiviral agent;
EC 2.7.7.49 (RNA-directed DNA polymerase) inhibitor
202320231.0low000001
pyridoxal phosphatepyridinecarbaldehyde202320231.0medium000001
lonidaminedichlorobenzene;
indazoles;
monocarboxylic acid
antineoplastic agent;
antispermatogenic agent;
EC 2.7.1.1 (hexokinase) inhibitor;
geroprotector
2013201311.0low000010
nitazoxanidebenzamides;
carboxylic ester
202320231.0low000001
captoprilalkanethiol;
L-proline derivative;
N-acylpyrrolidine;
pyrrolidinemonocarboxylic acid
antihypertensive agent;
EC 3.4.15.1 (peptidyl-dipeptidase A) inhibitor
202320231.0low000001
oltipraz1,2-dithiole;
pyrazines
angiogenesis modulating agent;
antimutagen;
antineoplastic agent;
antioxidant;
EC 3.1.3.48 (protein-tyrosine-phosphatase) inhibitor;
neurotoxin;
protective agent;
schistosomicide drug
202320231.0low000001
fiacitabine202320231.0low000001
simvastatindelta-lactone;
fatty acid ester;
hexahydronaphthalenes;
statin (semi-synthetic)
EC 1.1.1.34/EC 1.1.1.88 (hydroxymethylglutaryl-CoA reductase) inhibitor;
EC 3.4.24.83 (anthrax lethal factor endopeptidase) inhibitor;
ferroptosis inducer;
geroprotector;
prodrug
2013201311.0low000010
itraconazolearomatic ether;
conazole antifungal drug;
cyclic ketal;
dichlorobenzene;
dioxolane;
N-arylpiperazine;
triazole antifungal drug;
triazoles
EC 3.6.3.44 (xenobiotic-transporting ATPase) inhibitor;
Hedgehog signaling pathway inhibitor;
P450 inhibitor
2013201311.0low000010
pravadoline2013201311.0low000010
ranolazinearomatic amide;
monocarboxylic acid amide;
monomethoxybenzene;
N-alkylpiperazine;
secondary alcohol
202320231.0low000001
brequinarbiphenyls;
monocarboxylic acid;
monofluorobenzenes;
quinolinemonocarboxylic acid
anticoronaviral agent;
antimetabolite;
antineoplastic agent;
antiviral agent;
EC 1.3.5.2 [dihydroorotate dehydrogenase (quinone)] inhibitor;
immunosuppressive agent;
pyrimidine synthesis inhibitor
202320231.0low000001
imiquimodimidazoquinolineantineoplastic agent;
interferon inducer
202320231.0low000001
adefovir6-aminopurines;
ether;
phosphonic acids
antiviral drug;
DNA synthesis inhibitor;
drug metabolite;
HIV-1 reverse transcriptase inhibitor;
nephrotoxic agent
202320231.0low000001
zileuton1-benzothiophenes;
ureas
anti-asthmatic drug;
EC 1.13.11.34 (arachidonate 5-lipoxygenase) inhibitor;
ferroptosis inhibitor;
leukotriene antagonist;
non-steroidal anti-inflammatory drug
2013201311.0low000010
niguldipinediarylmethane2013201311.0low000010
cidofovir anhydrousphosphonic acids;
pyrimidone
anti-HIV agent;
antineoplastic agent;
antiviral drug;
photosensitizing agent
202320231.0low000001
topotecanpyranoindolizinoquinolineantineoplastic agent;
EC 5.99.1.2 (DNA topoisomerase) inhibitor
2013201311.0low000010
eliprodilmonochlorobenzenes;
monofluorobenzenes;
piperidines;
secondary alcohol;
tertiary amino compound
2013201311.0low000010
celgosivir202320231.0low000001
gemcitabineorganofluorine compound;
pyrimidine 2'-deoxyribonucleoside
antimetabolite;
antineoplastic agent;
antiviral drug;
DNA synthesis inhibitor;
EC 1.17.4.1 (ribonucleoside-diphosphate reductase) inhibitor;
environmental contaminant;
immunosuppressive agent;
photosensitizing agent;
prodrug;
radiosensitizing agent;
xenobiotic
201320236.0low000011
lamivudinemonothioacetal;
nucleoside analogue;
oxacycle;
primary alcohol
allergen;
anti-HBV agent;
antiviral drug;
EC 2.7.7.49 (RNA-directed DNA polymerase) inhibitor;
HIV-1 reverse transcriptase inhibitor;
prodrug
202320231.0low000001
valsartanbiphenylyltetrazole;
monocarboxylic acid amide;
monocarboxylic acid
angiotensin receptor antagonist;
antihypertensive agent;
environmental contaminant;
xenobiotic
202320231.0low000001
zanamivirguanidinesantiviral agent;
EC 3.2.1.18 (exo-alpha-sialidase) inhibitor
202320231.0low000001
adefovir dipivoxil6-aminopurines;
carbonate ester;
ether;
organic phosphonate
antiviral drug;
DNA synthesis inhibitor;
HIV-1 reverse transcriptase inhibitor;
nephrotoxic agent;
prodrug
202320231.0low000001
emtricitabinemonothioacetal;
nucleoside analogue;
organofluorine compound;
pyrimidone
antiviral drug;
HIV-1 reverse transcriptase inhibitor
202320231.0low000001
octyl gallategallate esterfood antioxidant;
hypoglycemic agent;
plant metabolite
202320231.0low000001
verapamil hydrochloride2013201311.0low000010
efavirenzacetylenic compound;
benzoxazine;
cyclopropanes;
organochlorine compound;
organofluorine compound
antiviral drug;
HIV-1 reverse transcriptase inhibitor
201320236.0low000011
nelfinaviraryl sulfide;
benzamides;
organic heterobicyclic compound;
phenols;
secondary alcohol;
tertiary amino compound
antineoplastic agent;
HIV protease inhibitor
202320231.0low000001
betulinic acidhydroxy monocarboxylic acid;
pentacyclic triterpenoid
anti-HIV agent;
anti-inflammatory agent;
antimalarial;
antineoplastic agent;
EC 5.99.1.3 [DNA topoisomerase (ATP-hydrolysing)] inhibitor;
plant metabolite
202320231.0low000001
arctigeninlignan202320231.0low000001
baicalindihydroxyflavone;
glucosiduronic acid;
glycosyloxyflavone;
monosaccharide derivative
antiatherosclerotic agent;
antibacterial agent;
anticoronaviral agent;
antineoplastic agent;
antioxidant;
cardioprotective agent;
EC 2.7.7.48 (RNA-directed RNA polymerase) inhibitor;
EC 3.4.21.26 (prolyl oligopeptidase) inhibitor;
ferroptosis inhibitor;
neuroprotective agent;
non-steroidal anti-inflammatory drug;
plant metabolite;
prodrug
202320231.0low000001
plerixaforazacycloalkane;
azamacrocycle;
benzenes;
crown amine;
secondary amino compound;
tertiary amino compound
anti-HIV agent;
antineoplastic agent;
C-X-C chemokine receptor type 4 antagonist;
immunological adjuvant
202320231.0low000001
amprenavircarbamate ester;
sulfonamide;
tetrahydrofuryl ester
antiviral drug;
HIV protease inhibitor
202320231.0low000001
oseltamiviracetamides;
amino acid ester;
cyclohexenecarboxylate ester;
primary amino compound
antiviral drug;
EC 3.2.1.18 (exo-alpha-sialidase) inhibitor;
environmental contaminant;
prodrug;
xenobiotic
202320231.0low000001
epigallocatechin gallateflavans;
gallate ester;
polyphenol
antineoplastic agent;
antioxidant;
apoptosis inducer;
geroprotector;
Hsp90 inhibitor;
neuroprotective agent;
plant metabolite
202320231.0low000001
1,2,3,4,6-pentakis-O-galloyl-beta-D-glucosegallate ester;
galloyl beta-D-glucose
anti-inflammatory agent;
antineoplastic agent;
geroprotector;
hepatoprotective agent;
plant metabolite;
radiation protective agent;
radical scavenger
202320231.0low000001
cephalotaxinebenzazepine alkaloid fundamental parent;
benzazepine alkaloid;
cyclic acetal;
enol ether;
organic heteropentacyclic compound;
secondary alcohol;
tertiary amino compound
202320231.0medium000001
desipramine hydrochloridehydrochloridedrug allergen202320231.0low000001
mefloquine hydrochloridehydrochloride202320231.0low000001
bendamustinebenzimidazoles2013201311.0low000010
aloxistatinepoxide;
ethyl ester;
L-leucine derivative;
monocarboxylic acid amide
anticoronaviral agent;
cathepsin B inhibitor
202320231.0low000001
propazolebenzimidazoles202320231.0low000001
caroverinequinoxaline derivative2013201311.0low000010
cgs 9343bbenzimidazoles2013201311.0low000010
prulifloxacinfluoroquinolone antibiotic;
quinolone antibiotic
202320231.0low000001
telmisartanbenzimidazoles;
biphenyls;
carboxybiphenyl
angiotensin receptor antagonist;
antihypertensive agent;
EC 3.4.15.1 (peptidyl-dipeptidase A) inhibitor;
environmental contaminant;
xenobiotic
201320236.0low000011
bergenintrihydroxybenzoic acidmetabolite202320231.0low000001
2-methoxyestradiol17beta-hydroxy steroid;
3-hydroxy steroid
angiogenesis modulating agent;
antimitotic;
antineoplastic agent;
human metabolite;
metabolite;
mouse metabolite
2013201311.0low000010
zoledronic acid1,1-bis(phosphonic acid);
imidazoles
bone density conservation agent202320231.0low000001
artemisininorganic peroxide;
sesquiterpene lactone
antimalarial;
plant metabolite
202320231.0low000001
brinzolamidesulfonamide;
thienothiazine
antiglaucoma drug;
EC 4.2.1.1 (carbonic anhydrase) inhibitor
202320231.0low000001
dipropylacetamidefatty amidegeroprotector;
metabolite;
teratogenic agent
202320231.0low000001
oxprenolol hydrochloride202320231.0low000001
opipramol hydrochloride202320231.0low000001
moroxydinebiguanides202320231.0low000001
alaceprildipeptide;
thioacetate ester
EC 3.4.15.1 (peptidyl-dipeptidase A) inhibitor2013201311.0low000010
thioxolonebenzoxathioleantiseborrheic202320231.0low000001
ubenimex201320179.0low000020
honokiolbiphenyls202320231.0low000001
nobiletinmethoxyflavoneantineoplastic agent;
plant metabolite
202320231.0low000001
lycorineindolizidine alkaloidanticoronaviral agent;
antimalarial;
plant metabolite;
protein synthesis inhibitor
202320231.0low000001
leupeptinaldehyde;
tripeptide
bacterial metabolite;
calpain inhibitor;
cathepsin B inhibitor;
EC 3.4.21.4 (trypsin) inhibitor;
serine protease inhibitor
202320231.0low000001
tetrandrinebisbenzylisoquinoline alkaloid;
isoquinolines
202320231.0low000001
calpeptinamino acid amide202320231.0low000001
fangchinolinearomatic ether;
bisbenzylisoquinoline alkaloid;
macrocycle
anti-HIV-1 agent;
anti-inflammatory agent;
antineoplastic agent;
antioxidant;
neuroprotective agent;
plant metabolite
202320231.0low000001
maslinic aciddihydroxy monocarboxylic acid;
pentacyclic triterpenoid
anti-inflammatory agent;
antineoplastic agent;
antioxidant;
plant metabolite
202320231.0low000001
atovaquonehydroxy-1,2-naphthoquinone202320231.0low000001
loganinbeta-D-glucoside;
cyclopentapyran;
enoate ester;
iridoid monoterpenoid;
methyl ester;
monosaccharide derivative;
secondary alcohol
anti-inflammatory agent;
EC 3.1.1.7 (acetylcholinesterase) inhibitor;
EC 3.2.1.20 (alpha-glucosidase) inhibitor;
EC 3.4.23.46 (memapsin 2) inhibitor;
neuroprotective agent;
plant metabolite
202320231.0low000001
moexiprilpeptide202320231.0low000001
aucubinorganic molecular entitymetabolite202320231.0low000001
catalpolorganic molecular entitymetabolite202320231.0low000001
lekoptin2-(3,4-dimethoxyphenyl)-5-{[2-(3,4-dimethoxyphenyl)ethyl](methyl)amino}-2-(propan-2-yl)pentanenitrile202320231.0low000001
n-methyladenosinemethyladenosine202320231.0low000001
vinpocetine2013201311.0medium000010
sivelestatN-acylglycine;
pivalate ester
202320231.0low000001
pyronaridineaminoquinoline202320231.0low000001
geniposideterpene glycoside202320231.0low000001
deguelinaromatic ether;
diether;
organic heteropentacyclic compound;
rotenones
angiogenesis inhibitor;
anti-inflammatory agent;
antineoplastic agent;
antiviral agent;
apoptosis inducer;
EC 2.7.11.1 (non-specific serine/threonine protein kinase) inhibitor;
mitochondrial NADH:ubiquinone reductase inhibitor;
plant metabolite
2013201311.0low000010
daidzin7-hydroxyisoflavones 7-O-beta-D-glucoside;
hydroxyisoflavone;
monosaccharide derivative
plant metabolite202320231.0low000001
triptolidediterpenoid;
epoxide;
gamma-lactam;
organic heteroheptacyclic compound
antispermatogenic agent;
plant metabolite
2013201311.0low000010
sophocarpine202320231.0low000001
marimastathydroxamic acid;
secondary carboxamide
antineoplastic agent;
matrix metalloproteinase inhibitor
202320231.0low000001
sr 48692N-acyl-amino acid2013201311.0low000010
elacridar201320236.0low000011
celastrolmonocarboxylic acid;
pentacyclic triterpenoid
anti-inflammatory drug;
antineoplastic agent;
antioxidant;
EC 5.99.1.3 [DNA topoisomerase (ATP-hydrolysing)] inhibitor;
Hsp90 inhibitor;
metabolite
202320231.0low000001
gefitinibaromatic ether;
monochlorobenzenes;
monofluorobenzenes;
morpholines;
quinazolines;
secondary amino compound;
tertiary amino compound
antineoplastic agent;
epidermal growth factor receptor antagonist
2013201311.0low000010
n-(n-(3-carboxyoxirane-2-carbonyl)leucyl)isoamylamineleucine derivative202320231.0low000001
bay x 10052013201311.0low000010
vadimezanmonocarboxylic acid;
xanthones
antineoplastic agent202320231.0low000001
e 64dicarboxylic acid monoamide;
epoxy monocarboxylic acid;
guanidines;
L-leucine derivative;
zwitterion
antimalarial;
antiparasitic agent;
protease inhibitor
202320231.0low000001
gyki 536552013201311.0low000010
umifenovirindolyl carboxylic acid202320231.0low000001
safinamideamino acid amide202320231.0low000001
ilomastathydroxamic acid;
L-tryptophan derivative;
N-acyl-amino acid
anti-inflammatory agent;
antibacterial agent;
antineoplastic agent;
EC 3.4.24.24 (gelatinase A) inhibitor;
neuroprotective agent
202320231.0low000001
ml-30002013201311.0low000010
cd 437adamantanes;
monocarboxylic acid;
naphthoic acid;
phenols
apoptosis inducer;
retinoic acid receptor gamma agonist
2013201311.0low000010
docetaxel anhydroussecondary alpha-hydroxy ketone;
tetracyclic diterpenoid
antimalarial;
antineoplastic agent;
photosensitizing agent
2013201311.0low000010
perifosineammonium betaine;
phospholipid
EC 2.7.1.137 (phosphatidylinositol 3-kinase) inhibitor2013201311.0low000010
atazanavircarbohydrazideantiviral drug;
HIV protease inhibitor
202320231.0low000001
mk 7672013201311.0low000010
vx 497202320231.0low000001
bcx 18123-hydroxy monocarboxylic acid;
acetamides;
cyclopentanols;
guanidines
antiviral drug;
EC 3.2.1.18 (exo-alpha-sialidase) inhibitor
202320231.0low000001
bazedoxifene acetate2013201311.0medium000010
naproxenmethoxynaphthalene;
monocarboxylic acid
antipyretic;
cyclooxygenase 1 inhibitor;
cyclooxygenase 2 inhibitor;
drug allergen;
environmental contaminant;
gout suppressant;
non-narcotic analgesic;
non-steroidal anti-inflammatory drug;
xenobiotic
202320231.0low000001
canertinibmonochlorobenzenes;
morpholines;
organofluorine compound;
quinazolines
antineoplastic agent;
tyrosine kinase inhibitor
2013201311.0low000010
birb 796aromatic ether;
morpholines;
naphthalenes;
pyrazoles;
ureas
EC 2.7.11.24 (mitogen-activated protein kinase) inhibitor;
immunomodulator
2013201311.0low000010
olmesartanbiphenylyltetrazoleangiotensin receptor antagonist;
antihypertensive agent
202320231.0low000001
telbivudinepyrimidine 2'-deoxyribonucleosideantiviral drug;
EC 2.7.7.49 (RNA-directed DNA polymerase) inhibitor
202320231.0low000001
tipifarnibimidazoles;
monochlorobenzenes;
primary amino compound;
quinolone
antineoplastic agent;
apoptosis inducer;
EC 2.5.1.58 (protein farnesyltransferase) inhibitor
2013201311.0low000010
celastrol methyl estercarboxylic ester202320231.0low000001
resiquimodimidazoquinoline202320231.0low000001
cyc 2022,6-diaminopurinesantiviral drug;
EC 2.7.11.22 (cyclin-dependent kinase) inhibitor
2013201311.0low000010
tanshinone ii aabietane diterpenoid202320231.0low000001
anacardic acidhydroxy monocarboxylic acid;
hydroxybenzoic acid
anti-inflammatory agent;
antibacterial agent;
anticoronaviral agent;
apoptosis inducer;
EC 2.3.1.48 (histone acetyltransferase) inhibitor;
EC 3.4.22.69 (SARS coronavirus main proteinase) inhibitor;
neuroprotective agent;
plant metabolite
202320231.0low000001
migalastatpiperidines202320231.0low000001
sb 203580imidazoles;
monofluorobenzenes;
pyridines;
sulfoxide
EC 2.7.11.1 (non-specific serine/threonine protein kinase) inhibitor;
EC 2.7.11.24 (mitogen-activated protein kinase) inhibitor;
geroprotector;
Hsp90 inhibitor;
neuroprotective agent
2013201311.0low000010
enzastaurinindoles;
maleimides
2013201311.0low000010
erlotinibaromatic ether;
quinazolines;
secondary amino compound;
terminal acetylenic compound
antineoplastic agent;
epidermal growth factor receptor antagonist;
protein kinase inhibitor
201320236.0low000011
piboserod2013201311.0low000010
l 1631912013201311.0low000010
limoninepoxide;
furans;
hexacyclic triterpenoid;
lactone;
limonoid;
organic heterohexacyclic compound
inhibitor;
metabolite;
volatile oil component
202320231.0low000001
scutellaringlucosiduronic acid;
glycosyloxyflavone;
monosaccharide derivative;
trihydroxyflavone
antineoplastic agent;
proteasome inhibitor
202320231.0low000001
bd 1047primary amine2013201311.0low000010
etravirineaminopyrimidine;
aromatic ether;
dinitrile;
organobromine compound
antiviral agent;
HIV-1 reverse transcriptase inhibitor
202320231.0low000001
chelidoninealkaloid antibiotic;
alkaloid fundamental parent;
benzophenanthridine alkaloid
202320231.0low000001
4-n-butylresorcinolresorcinols202320231.0low000001
lapatinibfurans;
organochlorine compound;
organofluorine compound;
quinazolines
antineoplastic agent;
tyrosine kinase inhibitor
2013201311.0low000010
darunavircarbamate ester;
furofuran;
sulfonamide
antiviral drug;
HIV protease inhibitor
202320231.0low000001
dapivirine202320231.0low000001
sorafenib(trifluoromethyl)benzenes;
aromatic ether;
monochlorobenzenes;
phenylureas;
pyridinecarboxamide
angiogenesis inhibitor;
anticoronaviral agent;
antineoplastic agent;
EC 2.7.11.1 (non-specific serine/threonine protein kinase) inhibitor;
ferroptosis inducer;
tyrosine kinase inhibitor
2013201311.0low000010
lenalidomidearomatic amine;
dicarboximide;
isoindoles;
piperidones
angiogenesis inhibitor;
antineoplastic agent;
immunomodulator
2013201311.0low000010
N-[4-(3-chloro-4-fluoroanilino)-3-cyano-7-ethoxy-6-quinolinyl]-4-(dimethylamino)-2-butenamideaminoquinoline2013201311.0medium000010
sr 1428062013201311.0low000010
n-hydroxy-2,2-diphenylacetamide2009200915.0medium000100
nsc 74859amidobenzoic acid;
monohydroxybenzoic acid;
tosylate ester
STAT3 inhibitor202320231.0low000001
berbaminebisbenzylisoquinoline alkaloid;
isoquinolines
202320231.0low000001
elesclomolcarbohydrazide;
thiocarbonyl compound
antineoplastic agent;
apoptosis inducer
2013201311.0low000010
u-104202320231.0low000001
7-hydroxy-5-methyl-2-(2-oxopropyl)-8-[3,4,5-trihydroxy-6-(hydroxymethyl)-2-oxanyl]-1-benzopyran-4-oneglycoside202320231.0medium000001
nsc 663284quinolone2013201311.0low000010
bortezomibamino acid amide;
L-phenylalanine derivative;
pyrazines
antineoplastic agent;
antiprotozoal drug;
protease inhibitor;
proteasome inhibitor
201320236.0low000011
ritonavir1,3-thiazoles;
carbamate ester;
carboxamide;
L-valine derivative;
ureas
antiviral drug;
environmental contaminant;
HIV protease inhibitor;
xenobiotic
202320231.0low000001
tizoxanidesalicylamides202320231.0low000001
bardoxolone methylcyclohexenones2013201311.0low000010
nsc 23766aminopyrimidine;
aminoquinoline;
primary amino compound;
secondary amino compound;
tertiary amino compound
antiviral agent;
apoptosis inducer;
EC 3.6.5.2 (small monomeric GTPase) inhibitor;
muscarinic antagonist
2013201311.0low000010
arbutinbeta-D-glucoside;
monosaccharide derivative
Escherichia coli metabolite;
plant metabolite
202320231.0low000001
quinidinecinchona alkaloidalpha-adrenergic antagonist;
anti-arrhythmia drug;
antimalarial;
drug allergen;
EC 1.14.13.181 (13-deoxydaunorubicin hydroxylase) inhibitor;
EC 3.6.3.44 (xenobiotic-transporting ATPase) inhibitor;
muscarinic antagonist;
P450 inhibitor;
potassium channel blocker;
sodium channel blocker
202320231.0low000001
conessinesteroid alkaloid;
tertiary amino compound
antibacterial agent;
antimalarial;
H3-receptor antagonist;
plant metabolite
202320231.0low000001
saquinavirL-asparagine derivative;
quinolines
antiviral drug;
HIV protease inhibitor
202320231.0low000001
abacavir2,6-diaminopurinesantiviral drug;
drug allergen;
HIV-1 reverse transcriptase inhibitor
202320231.0low000001
linezolidacetamides;
morpholines;
organofluorine compound;
oxazolidinone
antibacterial drug;
protein synthesis inhibitor
202320231.0low000001
cephaelinpyridoisoquinoline202320231.0low000001
(-)-usnic acidusnic acidEC 1.13.11.27 (4-hydroxyphenylpyruvate dioxygenase) inhibitor202320231.0medium000001
acetylleucyl-leucyl-norleucinalaldehyde;
tripeptide
cysteine protease inhibitor202320231.0low000001
trichostatin aantibiotic antifungal agent;
hydroxamic acid;
trichostatin
bacterial metabolite;
EC 3.5.1.98 (histone deacetylase) inhibitor;
geroprotector
2008201712.2low000220
resveratrolresveratrolantioxidant;
phytoalexin;
plant metabolite;
quorum sensing inhibitor;
radical scavenger
202320231.0low000001
tacrolimusmacrolide lactambacterial metabolite;
immunosuppressive agent
202320231.0low000001
lycopeneacyclic caroteneantioxidant;
plant metabolite
202320231.0low000001
zithromaxmacrolide antibioticantibacterial drug;
environmental contaminant;
xenobiotic
202320231.0low000001
gw 3965diarylmethane2013201311.0low000010
y 27632aromatic amide2013201311.0low000010
6-bromoindirubin-3'-oxime2013201311.0low000010
purvalanol bpurvalanolprotein kinase inhibitor2013201311.0low000010
y-7002013201311.0low000010
repsoxpyrazolopyridine2013201311.0low000010
roflumilastaromatic ether;
benzamides;
chloropyridine;
cyclopropanes;
organofluorine compound
anti-asthmatic drug;
phosphodiesterase IV inhibitor
202320231.0low000001
L-cycloserine4-amino-1,2-oxazolidin-3-oneanti-HIV agent;
anticonvulsant;
EC 2.3.1.50 (serine C-palmitoyltransferase) inhibitor
202320231.0low000001
h 89N-[2-(4-bromocinnamylamino)ethyl]isoquinoline-5-sulfonamide202320231.0low000001
bevirimatdicarboxylic acid monoester;
monocarboxylic acid;
pentacyclic triterpenoid
HIV-1 maturation inhibitor;
metabolite
202320231.0low000001
benzyloxycarbonylleucyl-leucyl-leucine aldehydeamino aldehyde;
carbamate ester;
tripeptide
proteasome inhibitor202320231.0low000001
tenofovirnucleoside analogue;
phosphonic acids
antiviral drug;
drug metabolite;
HIV-1 reverse transcriptase inhibitor
202320231.0low000001
posaconazolearomatic ether;
conazole antifungal drug;
N-arylpiperazine;
organofluorine compound;
oxolanes;
triazole antifungal drug;
triazoles
trypanocidal drug202320231.0low000001
gw 257406x202320231.0low000001
shikoninhydroxy-1,4-naphthoquinone202320231.0low000001
4,4-difluoro-N-[(1S)-3-[3-(3-methyl-5-propan-2-yl-1,2,4-triazol-4-yl)-8-azabicyclo[3.2.1]octan-8-yl]-1-phenylpropyl]-1-cyclohexanecarboxamidetropane alkaloid201320236.0high000011
cmx 001202320231.0low000001
amd 8664202320231.0medium000001
bay 41-4109202320231.0low000001
bay 57-1293202320231.0low000001
2'-c-methylcytidine202320231.0low000001
isoxanthohumolflavanones202320231.0low000001
4-(4-chloro-2-methylphenoxy)-n-hydroxybutanamidearomatic ether202320231.0low000001
mecarbinate202320231.0low000001
s 1033(trifluoromethyl)benzenes;
imidazoles;
pyridines;
pyrimidines;
secondary amino compound;
secondary carboxamide
anticoronaviral agent;
antineoplastic agent;
tyrosine kinase inhibitor
2013201311.0low000010
acetyl-aspartyl-glutamyl-valyl-aspartaltetrapeptideprotease inhibitor202320231.0low000001
octotropine methylbromide202320231.0low000001
mercaptopurinearyl thiol;
purines;
thiocarbonyl compound
anticoronaviral agent;
antimetabolite;
antineoplastic agent
201320236.0low000011
jrf 12202320231.0low000001
3,4'-dihydroxyflavone202320231.0medium000001
rg108indolyl carboxylic acid2013201311.0low000010
3-(3,4-dimethoxyphenyl)propenoic acidmethoxycinnamic acid202320231.0low000001
stf 0830102013201311.0medium000010
isoferulic acidferulic acidsantioxidant;
biomarker;
metabolite
202320231.0low000001
N-(3-cyano-4,5,6,7-tetrahydro-1-benzothiophen-2-yl)-1-naphthalenecarboxamidenaphthalenecarboxamide2013201311.0low000010
cyclouridine202320231.0medium000001
curcuminaromatic ether;
beta-diketone;
diarylheptanoid;
enone;
polyphenol
anti-inflammatory agent;
antifungal agent;
antineoplastic agent;
biological pigment;
contraceptive drug;
dye;
EC 1.1.1.205 (IMP dehydrogenase) inhibitor;
EC 1.1.1.21 (aldehyde reductase) inhibitor;
EC 1.1.1.25 (shikimate dehydrogenase) inhibitor;
EC 1.6.5.2 [NAD(P)H dehydrogenase (quinone)] inhibitor;
EC 1.8.1.9 (thioredoxin reductase) inhibitor;
EC 2.7.10.2 (non-specific protein-tyrosine kinase) inhibitor;
EC 3.5.1.98 (histone deacetylase) inhibitor;
flavouring agent;
food colouring;
geroprotector;
hepatoprotective agent;
immunomodulator;
iron chelator;
ligand;
lipoxygenase inhibitor;
metabolite;
neuroprotective agent;
nutraceutical;
radical scavenger
202320231.0low000001
cct018159benzodioxine;
pyrazoles;
resorcinols
antineoplastic agent;
apoptosis inducer;
Hsp90 inhibitor
2013201311.0low000010
secinh3triazoles2013201311.0low000010
jk1842013201311.0low000010
zucapsaicinmethoxybenzenes;
phenols
202320231.0low000001
nbd 556202320231.0low000001
thioguanine anhydrous2-aminopurinesanticoronaviral agent;
antimetabolite;
antineoplastic agent
202320231.0low000001
4,5,6,7-tetrachloroindan-1,3-dione202320231.0medium000001
tamoxifen citratecitrate saltangiogenesis inhibitor;
anticoronaviral agent
2013201311.0low000010
hc-0670472013201311.0low000010
bi-78d3aryl sulfide2013201311.0low000010
srpin340202320231.0low000001
gsk 37872013201311.0low000010
pr-619202320231.0medium000001
p5091202320231.0low000001
methyl-thiohydantoin-tryptophanorganonitrogen compound;
organooxygen compound
2013201311.0low000010
2-[2-chloro-6-ethoxy-4-[(3-methyl-5-oxo-1-phenyl-4-pyrazolylidene)methyl]phenoxy]acetic acid methyl estermonocarboxylic acid2013201311.0medium000010
4-(5-(4-methoxyphenyl)-3-phenyl-4,5-dihydro-1h-pyrazol-1-yl)benzenesulfonamidesulfonamide2013201311.0low000010
trovirdine202320231.0low000001
LSM-1318oxa-steroid2013201311.0low000010
fti 277202320231.0medium000001
u 0126aryl sulfide;
dinitrile;
enamine;
substituted aniline
antineoplastic agent;
antioxidant;
apoptosis inducer;
EC 2.7.11.24 (mitogen-activated protein kinase) inhibitor;
osteogenesis regulator;
vasoconstrictor agent
202320231.0low000001
rwj 676572013201311.0low000010
vicriviroc(trifluoromethyl)benzenes202320231.0low000001
telaprevircyclopentapyrrole;
cyclopropanes;
oligopeptide;
pyrazines
antiviral drug;
hepatitis C protease inhibitor;
peptidomimetic
202320231.0low000001
6-methyl-2-(phenylethynyl)pyridineacetylenic compound;
methylpyridines
anxiolytic drug;
metabotropic glutamate receptor antagonist
2013201311.0low000010
bms 3870321,3-oxazoles;
1,3-thiazoles;
organic sulfide;
piperidinecarboxamide;
secondary carboxamide
angiogenesis inhibitor;
antineoplastic agent;
apoptosis inducer;
EC 2.7.11.22 (cyclin-dependent kinase) inhibitor
2013201311.0low000010
orlistatbeta-lactone;
carboxylic ester;
formamides;
L-leucine derivative
anti-obesity agent;
bacterial metabolite;
EC 2.3.1.85 (fatty acid synthase) inhibitor;
EC 3.1.1.3 (triacylglycerol lipase) inhibitor
202320231.0low000001
tandutinibaromatic ether;
N-arylpiperazine;
N-carbamoylpiperazine;
phenylureas;
piperidines;
quinazolines;
tertiary amino compound
antineoplastic agent;
EC 2.7.10.1 (receptor protein-tyrosine kinase) inhibitor
2013201311.0low000010
vx-745aryl sulfide;
dichlorobenzene;
difluorobenzene;
pyrimidopyridazine
anti-inflammatory drug;
apoptosis inducer;
EC 2.7.11.24 (mitogen-activated protein kinase) inhibitor
2013201311.0low000010
corlanorhydrochloridecardiotonic drug2013201311.0medium000010
dasatinib1,3-thiazoles;
aminopyrimidine;
monocarboxylic acid amide;
N-(2-hydroxyethyl)piperazine;
N-arylpiperazine;
organochlorine compound;
secondary amino compound;
tertiary amino compound
anticoronaviral agent;
antineoplastic agent;
tyrosine kinase inhibitor
201320236.0low000011
zd 6474aromatic ether;
organobromine compound;
organofluorine compound;
piperidines;
quinazolines;
secondary amine
antineoplastic agent;
tyrosine kinase inhibitor
2013201311.0low000010
compound 968benzophenanthridineEC 3.5.1.2 (glutaminase) inhibitor2013201311.0low000010
yya-021202320231.0medium000001
sb-2242891,2,4-oxadiazole;
azaspiro compound;
benzamides;
organic heterotetracyclic compound
serotonergic antagonist2013201311.0low000010
gw 7647aryl sulfide;
monocarboxylic acid;
ureas
PPARalpha agonist2013201311.0low000010
l 663536aryl sulfide;
indoles;
monocarboxylic acid;
monochlorobenzenes
antineoplastic agent;
EC 1.13.11.34 (arachidonate 5-lipoxygenase) inhibitor;
leukotriene antagonist
2013201311.0low000010
1-[6-(4-chlorophenyl)-5-imidazo[2,1-b]thiazolyl]-N-[(3,4-dichlorophenyl)methoxy]methanimineimidazoles2013201311.0medium000010
N4-ethyl-N6,1,2-trimethyl-N4-phenylpyrimidin-1-ium-4,6-diaminearomatic amine;
tertiary amino compound
2013201311.0medium000010
2-[[2-[2-(2,3-dihydro-1,4-benzodioxin-6-ylamino)-2-oxoethyl]-1-oxo-5-isoquinolinyl]oxy]propanoic acid ethyl esterisoquinolines2013201311.0low000010
sb 415286C-nitro compound;
maleimides;
monochlorobenzenes;
phenols;
secondary amino compound;
substituted aniline
antioxidant;
apoptosis inducer;
EC 2.7.11.26 (tau-protein kinase) inhibitor;
neuroprotective agent
202320231.0low000001
sch 79797quinazolines2013201311.0low000010
sitagliptintriazolopyrazine;
trifluorobenzene
EC 3.4.14.5 (dipeptidyl-peptidase IV) inhibitor;
environmental contaminant;
hypoglycemic agent;
serine proteinase inhibitor;
xenobiotic
202320231.0low000001
4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1h-imidazol-2-yl)benzamidebenzamides;
benzodioxoles;
imidazoles;
pyridines
EC 2.7.10.1 (receptor protein-tyrosine kinase) inhibitor2013201311.0low000010
1-(4-Fluorophenyl)-3-(3-(4-fluorophenyl)-3-hydroxypropyl)-4-(4-hydroxyphenyl)azetidin-2-onemonobactam2013201311.0medium000010
imd 0354benzamides2013201311.0low000010
ex 527carbazoles;
monocarboxylic acid amide;
organochlorine compound
2013201311.0low000010
tak-220202320231.0medium000001
jtk-303aromatic ether;
monochlorobenzenes;
organofluorine compound;
quinolinemonocarboxylic acid;
quinolone
HIV-1 integrase inhibitor202320231.0low000001
nbd 557202320231.0medium000001
quercetin7-hydroxyflavonol;
pentahydroxyflavone
antibacterial agent;
antineoplastic agent;
antioxidant;
Aurora kinase inhibitor;
chelator;
EC 1.10.99.2 [ribosyldihydronicotinamide dehydrogenase (quinone)] inhibitor;
geroprotector;
phytoestrogen;
plant metabolite;
protein kinase inhibitor;
radical scavenger
2013201311.0low000010
5'-o-caffeoylquinic acidcinnamate ester;
cyclitol carboxylic acid
plant metabolite202320231.0medium000001
luteolin-7-glucosidebeta-D-glucoside;
glycosyloxyflavone;
monosaccharide derivative;
trihydroxyflavone
antioxidant;
plant metabolite
202320231.0low000001
cyclosporine202320231.0low000001
harmineharmala alkaloidanti-HIV agent;
EC 1.4.3.4 (monoamine oxidase) inhibitor;
metabolite
202320231.0low000001
genistein7-hydroxyisoflavonesantineoplastic agent;
EC 5.99.1.3 [DNA topoisomerase (ATP-hydrolysing)] inhibitor;
geroprotector;
human urinary metabolite;
phytoestrogen;
plant metabolite;
tyrosine kinase inhibitor
2013201311.0low000010
eprosartandicarboxylic acid;
imidazoles;
thiophenes
angiotensin receptor antagonist;
antihypertensive agent;
environmental contaminant;
xenobiotic
202320231.0low000001
mycophenolate mofetilcarboxylic ester;
ether;
gamma-lactone;
phenols;
tertiary amino compound
anticoronaviral agent;
EC 1.1.1.205 (IMP dehydrogenase) inhibitor;
immunosuppressive agent;
prodrug
202320231.0low000001
entacapone2-nitrophenols;
catechols;
monocarboxylic acid amide;
nitrile
antidyskinesia agent;
antiparkinson drug;
central nervous system drug;
EC 2.1.1.6 (catechol O-methyltransferase) inhibitor
202320231.0low000001
amentoflavonebiflavonoid;
hydroxyflavone;
ring assembly
angiogenesis inhibitor;
antiviral agent;
cathepsin B inhibitor;
P450 inhibitor;
plant metabolite
202320231.0low000001
baicaleintrihydroxyflavoneangiogenesis inhibitor;
anti-inflammatory agent;
antibacterial agent;
anticoronaviral agent;
antifungal agent;
antineoplastic agent;
antioxidant;
apoptosis inducer;
EC 1.13.11.31 (arachidonate 12-lipoxygenase) inhibitor;
EC 1.13.11.33 (arachidonate 15-lipoxygenase) inhibitor;
EC 3.4.21.26 (prolyl oligopeptidase) inhibitor;
EC 3.4.22.69 (SARS coronavirus main proteinase) inhibitor;
EC 4.1.1.17 (ornithine decarboxylase) inhibitor;
ferroptosis inhibitor;
geroprotector;
hormone antagonist;
plant metabolite;
prostaglandin antagonist;
radical scavenger
202320231.0low000001
genkwanindihydroxyflavone;
monomethoxyflavone
metabolite202320231.0low000001
hyperosidebeta-D-galactoside;
monosaccharide derivative;
quercetin O-glycoside;
tetrahydroxyflavone
hepatoprotective agent;
plant metabolite
202320231.0low000001
mangostinaromatic ether;
phenols;
xanthones
antimicrobial agent;
antineoplastic agent;
antioxidant;
plant metabolite
202320231.0low000001
3-methylquercetin7-hydroxyflavonol;
monomethoxyflavone;
tetrahydroxyflavone
anticoagulant;
EC 1.14.18.1 (tyrosinase) inhibitor;
metabolite
202320231.0low000001
kaempferide7-hydroxyflavonol;
monomethoxyflavone;
trihydroxyflavone
antihypertensive agent;
metabolite
202320231.0low000001
orientin3'-hydroxyflavonoid;
C-glycosyl compound;
tetrahydroxyflavone
antioxidant;
metabolite
202320231.0low000001
scutellareintetrahydroxyflavonemetabolite202320231.0low000001
trans-2,3',4,5'-tetrahydroxystilbenestilbenoid202320231.0low000001
polydatinbeta-D-glucoside;
monosaccharide derivative;
polyphenol;
stilbenoid
anti-arrhythmia drug;
antioxidant;
geroprotector;
hepatoprotective agent;
metabolite;
nephroprotective agent;
potassium channel modulator
202320231.0low000001
chicoric acidorganooxygen compoundgeroprotector;
HIV-1 integrase inhibitor
202320231.0low000001
acteosidecatechols;
cinnamate ester;
disaccharide derivative;
glycoside;
polyphenol
anti-inflammatory agent;
antibacterial agent;
antileishmanial agent;
neuroprotective agent;
plant metabolite
202320231.0low000001
dorzolamidesulfonamide;
thiophenes
antiglaucoma drug;
antihypertensive agent;
EC 4.2.1.1 (carbonic anhydrase) inhibitor
202320231.0low000001
topiramatecyclic ketal;
ketohexose derivative;
sulfamate ester
anticonvulsant;
sodium channel blocker
202320231.0low000001
fenretinidemonocarboxylic acid amide;
retinoid
antineoplastic agent;
antioxidant
2013201311.0low000010
ter 1992013201311.0low000010
arachidonylcyclopropylamide2013201311.0low000010
benzyloxycarbonyl-phe-ala-fluormethylketone202320231.0medium000001
ly 320135benzofurans2013201311.0low000010
n-(n-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl estercarboxylic ester;
difluorobenzene;
dipeptide;
tert-butyl ester
EC 3.4.23.46 (memapsin 2) inhibitor202320231.0low000001
pd 1662852013201311.0low000010
kn 62piperazines2013201311.0low000010
su 66562013201311.0low000010
casticindihydroxyflavone;
tetramethoxyflavone
apoptosis inducer;
plant metabolite
202320231.0low000001
5,7-dihydroxy-6-methoxy-2-phenylchromen-4-onedihydroxyflavone;
monomethoxyflavone
antineoplastic agent;
EC 1.14.13.39 (nitric oxide synthase) inhibitor
202320231.0low000001
(E)-2,3,5,4'-tetrahydroxystilbene-2-O-beta-D-glucosidebeta-D-glucoside;
resorcinols;
stilbenoid
anti-inflammatory agent;
antioxidant;
apoptosis inhibitor;
cardioprotective agent;
cyclooxygenase 2 inhibitor;
platelet aggregation inhibitor
202320231.0low000001
tyrphostin ag 555202320231.0low000001
semaxinibolefinic compound;
oxindoles;
pyrroles
angiogenesis modulating agent;
antineoplastic agent;
EC 2.7.10.1 (receptor protein-tyrosine kinase) inhibitor;
vascular endothelial growth factor receptor antagonist
2013201311.0low000010
su 11248monocarboxylic acid amide;
pyrroles
angiogenesis inhibitor;
antineoplastic agent;
EC 2.7.10.1 (receptor protein-tyrosine kinase) inhibitor;
immunomodulator;
neuroprotective agent;
vascular endothelial growth factor receptor antagonist
2013201311.0low000010
palbociclibaminopyridine;
aromatic ketone;
cyclopentanes;
piperidines;
pyridopyrimidine;
secondary amino compound;
tertiary amino compound
antineoplastic agent;
EC 2.7.11.22 (cyclin-dependent kinase) inhibitor
2013201311.0low000010
jnj-7706621sulfonamide2013201311.0low000010
romidepsincyclodepsipeptide;
heterocyclic antibiotic;
organic disulfide
antineoplastic agent;
EC 3.5.1.98 (histone deacetylase) inhibitor
2010201014.0low000100
pd 151746202320231.0medium000001
lisinoprildipeptideEC 3.4.15.1 (peptidyl-dipeptidase A) inhibitor202320231.0low000001
verteporfin202320231.0low000001
batimastathydroxamic acid;
L-phenylalanine derivative;
organic sulfide;
secondary carboxamide;
thiophenes;
triamide
angiogenesis inhibitor;
antineoplastic agent;
matrix metalloproteinase inhibitor
202320231.0low000001
indinavir sulfatedicarboxylic acid diamide;
N-(2-hydroxyethyl)piperazine;
piperazinecarboxamide
HIV protease inhibitor202320231.0low000001
cisplatindiamminedichloroplatinumantineoplastic agent;
apoptosis inducer;
cross-linking reagent;
ferroptosis inducer;
genotoxin;
mutagen;
nephrotoxin;
photosensitizing agent
2013201311.0low000010
solanesolnonaprenol;
primary alcohol
plant metabolite202320231.0low000001
pepstatinpentapeptide;
secondary carboxamide
bacterial metabolite;
EC 3.4.23.* (aspartic endopeptidase) inhibitor
202320231.0low000001
l 685458carbamate ester;
monocarboxylic acid amide;
peptide;
secondary alcohol
EC 3.4.23.46 (memapsin 2) inhibitor;
peptidomimetic
202320231.0low000001
vx680N-arylpiperazine2013201311.0low000010
bms 806202320231.0low000001
benzyloxycarbonylvalyl-alanyl-aspartyl fluoromethyl ketone202320231.0medium000001
tulobuterol hydrochlorideorganic molecular entity202320231.0low000001
salubrinalaminal;
organochlorine compound;
quinolines;
secondary carboxamide;
thioureas
202320231.0low000001
d 4476imidazoles2013201311.0low000010
cyc 1162013201311.0low000010
bay 19-80042013201311.0low000010
germacronegermacrane sesquiterpenoid;
olefinic compound
androgen antagonist;
anti-inflammatory agent;
antifeedant;
antifungal agent;
antimicrobial agent;
antineoplastic agent;
antioxidant;
antitussive;
antiviral agent;
apoptosis inducer;
autophagy inducer;
hepatoprotective agent;
insecticide;
neuroprotective agent;
plant metabolite;
volatile oil component
202320231.0low000001
(2e,4e,6e,10e)-3,7,11,15-tetramethyl-2,4,6,10,14-hexadecapentaenoic acid202320231.0low000001
lithospermic acid202320231.0medium000001
laq8242008202312.0low000321
ekb 569aminoquinoline;
monocarboxylic acid amide;
monochlorobenzenes;
nitrile
protein kinase inhibitor202320231.0low000001
axitinibaryl sulfide;
benzamides;
indazoles;
pyridines
antineoplastic agent;
tyrosine kinase inhibitor;
vascular endothelial growth factor receptor antagonist
2013201311.0low000010
pai 039indole-3-acetic acids2013201311.0low000010
rilpivirineaminopyrimidine;
nitrile
EC 2.7.7.49 (RNA-directed DNA polymerase) inhibitor;
HIV-1 reverse transcriptase inhibitor
202320231.0low000001
(1Ar,7aS,10aS,10bS)-1a,5-dimethyl-8-methylidene-2,3,6,7,7a,8,10a,10b-octahydrooxireno[9,10]cyclodeca[1,2-b]furan-9(1aH)-onegermacranolide202320231.0medium000001
4,5-di-O-caffeoylquinic acidquinic acid202320231.0low000001
indigo carmine202320231.0low000001
gw2974pyridopyrimidine2013201311.0low000010
pd 404182202020204.0medium000010
tubacin1,3-oxazoles2010201710.5low000110
ispinesibbenzamides2013201311.0low000010
artesunateartemisinin derivative;
cyclic acetal;
dicarboxylic acid monoester;
hemisuccinate;
semisynthetic derivative;
sesquiterpenoid
antimalarial;
antineoplastic agent;
ferroptosis inducer
202320231.0low000001
temsirolimusmacrolide lactam2013201311.0low000010
(3S,6S,9S,12R)-3-[(2S)-Butan-2-yl]-6-[(1-methoxyindol-3-yl)methyl]-9-(6-oxooctyl)-1,4,7,10-tetrazabicyclo[10.4.0]hexadecane-2,5,8,11-tetroneoligopeptide2008202310.3low000201
pd 184352aminobenzoic acid2013201311.0low000010
bibx 1382bssubstituted aniline2013201311.0low000010
vildagliptinamino acid amide202320231.0low000001
belinostathydroxamic acid;
olefinic compound;
sulfonamide
antineoplastic agent;
EC 3.5.1.98 (histone deacetylase) inhibitor
2008202311.4low000331
sk-70412008200816.0medium000100
panobinostatcinnamamides;
hydroxamic acid;
methylindole;
secondary amino compound
angiogenesis modulating agent;
antineoplastic agent;
EC 3.5.1.98 (histone deacetylase) inhibitor
2010201711.0low000120
hdac-42amidobenzoic acid201320236.0medium000011
4-acetamido-N-(2-amino-5-thiophen-2-ylphenyl)benzamidebenzamides2008200816.0low000100
[4-[[4-(1-benzothiophen-2-yl)-2-pyrimidinyl]amino]phenyl]-[4-(1-pyrrolidinyl)-1-piperidinyl]methanonebenzamides;
N-acylpiperidine
2013201311.0low000010
chlorhexidinebiguanides;
monochlorobenzenes
antibacterial agent;
antiinfective agent
202320231.0low000001
gs-73406-aminopurines;
ether;
isopropyl ester;
L-alanine derivative;
phosphoramidate ester
antiviral drug;
HIV-1 reverse transcriptase inhibitor;
prodrug
202320231.0low000001
iniparibcarbonyl compound;
organohalogen compound
201320236.0low000011
n-(2-amino-5-fluorobenzyl)-4-(n-(pyridine-3-acrylyl)aminomethyl)benzamide202320231.0low000001
pri-2205202320231.0low000001
mk 0752201320236.0medium000011
gw 5015161,3-thiazoles;
aromatic ether;
aryl sulfide;
monocarboxylic acid;
organofluorine compound
carcinogenic agent;
PPARbeta/delta agonist
2013201311.0low000010
givinostatcarbamate ester201020236.5low000121
av 4122013201311.0low000010
ag-041r2013201311.0low000010
telatinib2013201311.0low000010
cp 5476322013201311.0low000010
pd 144418202320231.0medium000001
sc 57461201720177.0low000010
spc-8392013201311.0low000010
bicyclol202320231.0low000001
lenvatinibaromatic amide;
aromatic ether;
cyclopropanes;
monocarboxylic acid amide;
monochlorobenzenes;
phenylureas;
quinolines
antineoplastic agent;
EC 2.7.10.1 (receptor protein-tyrosine kinase) inhibitor;
fibroblast growth factor receptor antagonist;
orphan drug;
vascular endothelial growth factor receptor antagonist
2013201311.0low000010
andarineacetamides;
anilide
2013201311.0low000010
gw843682x(trifluoromethyl)benzenes2013201311.0low000010
pd 0325901difluorobenzene;
hydroxamic acid ester;
monofluorobenzenes;
organoiodine compound;
propane-1,2-diols;
secondary amino compound
antineoplastic agent;
EC 2.7.12.2 (mitogen-activated protein kinase kinase) inhibitor
2013201311.0low000010
midostaurinbenzamides;
gamma-lactam;
indolocarbazole;
organic heterooctacyclic compound
antineoplastic agent;
EC 2.7.11.13 (protein kinase C) inhibitor
201320236.0low000011
ag 14361benzimidazoles2013201311.0low000010
sb 2656102013201311.0low000010
ly 450139peptide202320231.0low000001
fr 148083aromatic ether;
macrolide;
phenols;
secondary alcohol;
secondary alpha-hydroxy ketone
antibacterial agent;
antineoplastic agent;
metabolite;
NF-kappaB inhibitor
2013201311.0low000010
osi 930aromatic amide2013201311.0low000010
ki 202272013201311.0low000010
scio-469aromatic amide;
aromatic ketone;
chloroindole;
dicarboxylic acid diamide;
indolecarboxamide;
monofluorobenzenes;
N-acylpiperazine;
N-alkylpiperazine
antineoplastic agent;
apoptosis inducer;
EC 2.7.11.24 (mitogen-activated protein kinase) inhibitor
2013201311.0low000010
ssr 69071pyridopyrimidine2013201311.0low000010
rivaroxabanaromatic amide;
lactam;
monocarboxylic acid amide;
morpholines;
organochlorine compound;
oxazolidinone;
thiophenes
anticoagulant;
EC 3.4.21.6 (coagulation factor Xa) inhibitor
202320231.0low000001
sb 3ct compoundaromatic ether202320231.0low000001
pi103aromatic amine;
morpholines;
organic heterotricyclic compound;
phenols;
tertiary amino compound
antineoplastic agent;
EC 2.7.1.137 (phosphatidylinositol 3-kinase) inhibitor;
mTOR inhibitor
2013201311.0low000010
sb 2103132013201311.0medium000010
gw 4064stilbenoid2013201311.0low000010
ginsenoside rb1ginsenoside;
glycoside;
tetracyclic triterpenoid
anti-inflammatory drug;
anti-obesity agent;
apoptosis inhibitor;
neuroprotective agent;
plant metabolite;
radical scavenger
202320231.0low000001
sa 45032013201311.0low000010
ic 871146-aminopurines;
biaryl;
quinazolines
EC 2.7.1.137 (phosphatidylinositol 3-kinase) inhibitor2013201311.0low000010
zibotentanphenylpyridine2013201311.0low000010
tivozanibaromatic ether2013201311.0low000010
hki 272nitrile;
quinolines
antineoplastic agent;
tyrosine kinase inhibitor
2013201311.0low000010
tofacitinibN-acylpiperidine;
nitrile;
pyrrolopyrimidine;
tertiary amino compound
antirheumatic drug;
EC 2.7.10.2 (non-specific protein-tyrosine kinase) inhibitor
2013201311.0low000010
bibr 15322013201311.0low000010
n-(6-chloro-7-methoxy-9h-beta-carbolin-8-yl)-2-methylnicotinamide2013201311.0low000010
rucaparibazepinoindole;
caprolactams;
organofluorine compound;
secondary amino compound
antineoplastic agent;
EC 2.4.2.30 (NAD(+) ADP-ribosyltransferase) inhibitor
201320236.0low000011
cediranibaromatic ether2013201311.0low000010
gw0742monocarboxylic acid2013201311.0low000010
6h-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepine-6-acetamide, 4-(4-chlorophenyl)-n-(4-hydroxyphenyl)-2,3,9-trimethyl-, (6s)-organonitrogen heterocyclic compound;
organosulfur heterocyclic compound
202320231.0low000001
ps1145beta-carbolines2013201311.0low000010
cetilistatbenzoxazine202320231.0low000001
bay 41-8543pyrazolopyridine2013201311.0low000010
chir 99021aminopyridine;
aminopyrimidine;
cyanopyridine;
diamine;
dichlorobenzene;
imidazoles;
secondary amino compound
EC 2.7.11.26 (tau-protein kinase) inhibitor2013201311.0low000010
ym 201636aromatic amide202320231.0low000001
sb 525334quinoxaline derivative2013201311.0low000010
way-362450indoles2013201311.0low000010
masitinib1,3-thiazoles;
benzamides;
N-alkylpiperazine;
pyridines
antineoplastic agent;
antirheumatic drug;
tyrosine kinase inhibitor
2013201311.0low000010
bx795ureas2013201311.0low000010
linagliptinaminopiperidine;
quinazolines
EC 3.4.14.5 (dipeptidyl-peptidase IV) inhibitor;
hypoglycemic agent
202320231.0low000001
pazopanibaminopyrimidine;
indazoles;
sulfonamide
angiogenesis modulating agent;
antineoplastic agent;
tyrosine kinase inhibitor;
vascular endothelial growth factor receptor antagonist
2013201311.0low000010
sepantroniumorganic cation2013201311.0low000010
azd 6244benzimidazoles;
bromobenzenes;
hydroxamic acid ester;
monochlorobenzenes;
organofluorine compound;
secondary amino compound
anticoronaviral agent;
antineoplastic agent;
EC 2.7.11.24 (mitogen-activated protein kinase) inhibitor
201320236.0low000011
odanacatib202320231.0low000001
1-(2-(1-adamantyl)ethyl)-1-pentyl-3-(3-(4-pyridyl)propyl)urea2013201311.0low000010
apilimod202320231.0low000001
apixabanaromatic ether;
lactam;
piperidones;
pyrazolopyridine
anticoagulant;
EC 3.4.21.6 (coagulation factor Xa) inhibitor
202320231.0low000001
N-(3-cyanophenyl)-2'-methyl-5'-(5-methyl-1,3,4-oxadiazol-2-yl)biphenyl-4-carboxamide1,3,4-oxadiazoles;
benzamides;
biphenyls;
nitrile
EC 2.7.11.24 (mitogen-activated protein kinase) inhibitor2013201311.0medium000010
ar c1558582013201311.0low000010
betrixabanbenzamides;
guanidines;
monochloropyridine;
monomethoxybenzene;
secondary carboxamide
anticoagulant;
EC 3.4.21.6 (coagulation factor Xa) inhibitor
202320231.0low000001
edoxabanchloropyridine;
monocarboxylic acid amide;
tertiary amino compound;
thiazolopyridine
anticoagulant;
EC 3.4.21.6 (coagulation factor Xa) inhibitor;
platelet aggregation inhibitor
202320231.0low000001
aee 7886-{4-[(4-ethylpiperazin-1-yl)methyl]phenyl}-N-(1-phenylethyl)-7H-pyrrolo[2,3-d]pyrimidin-4-amineangiogenesis inhibitor;
antineoplastic agent;
apoptosis inducer;
EC 2.7.10.1 (receptor protein-tyrosine kinase) inhibitor;
epidermal growth factor receptor antagonist;
trypanocidal drug
2013201311.0low000010
saracatinibaromatic ether;
benzodioxoles;
diether;
N-methylpiperazine;
organochlorine compound;
oxanes;
quinazolines;
secondary amino compound
anticoronaviral agent;
antineoplastic agent;
apoptosis inducer;
autophagy inducer;
EC 2.7.10.2 (non-specific protein-tyrosine kinase) inhibitor;
radiosensitizing agent
201320236.0low000011
sd-2082013201311.0low000010
n-(3-amino-1-(cyclobutylmethyl)-2,3-dioxopropyl)-3-(2-((((1,1-dimethylethyl)amino)carbonyl)amino)-3,3-dimethyl-1-oxobutyl)-6,6-dimethyl-3-azabicyclo(3.1.0)hexan-2-carboxamidetripeptide;
ureas
antiviral drug;
hepatitis C protease inhibitor;
peptidomimetic
202320231.0low000001
vx 702phenylpyridine2013201311.0low000010
ly 411575dibenzoazepine;
difluorobenzene;
lactam;
secondary alcohol
EC 3.4.23.46 (memapsin 2) inhibitor202320231.0low000001
galidesivir202320231.0low000001
volasertib2013201311.0low000010
PB28aromatic ether;
piperazines;
tetralins
anticoronaviral agent;
antineoplastic agent;
apoptosis inducer;
sigma-2 receptor agonist
201320236.0low000011
azd 7762aromatic amide;
thiophenes
2013201311.0low000010
krp-2032013201311.0low000010
mk 03542013201311.0low000010
regorafenib(trifluoromethyl)benzenes;
aromatic ether;
monochlorobenzenes;
monofluorobenzenes;
phenylureas;
pyridinecarboxamide
antineoplastic agent;
hepatotoxic agent;
tyrosine kinase inhibitor
2013201311.0low000010
acetic acid 2-[4-methyl-8-(4-morpholinylsulfonyl)-1,3-dioxo-2-pyrrolo[3,4-c]quinolinyl]ethyl esterpyrroloquinoline2013201311.0low000010
6-[[5-fluoro-2-(3,4,5-trimethoxyanilino)-4-pyrimidinyl]amino]-2,2-dimethyl-4H-pyrido[3,2-b][1,4]oxazin-3-onemethoxybenzenes;
substituted aniline
2013201311.0low000010
degrasyn202320231.0low000001
epoxomicinmorpholines;
tripeptide
proteasome inhibitor202320231.0low000001
brivanibaromatic ether;
diether;
fluoroindole;
pyrrolotriazine;
secondary alcohol
angiogenesis inhibitor;
antineoplastic agent;
apoptosis inducer;
drug metabolite;
EC 2.7.10.1 (receptor protein-tyrosine kinase) inhibitor;
fibroblast growth factor receptor antagonist
2013201311.0low000010
icg 001peptide2013201311.0low000010
bms 477118adamantanes;
azabicycloalkane;
monocarboxylic acid amide;
nitrile;
tertiary alcohol
EC 3.4.14.5 (dipeptidyl-peptidase IV) inhibitor;
hypoglycemic agent
202320231.0low000001
pha 680632202320231.0low000001
tmc 353121202320231.0medium000001
amd 070aminoquinoline202320231.0low000001
mp470N-arylpiperazine2013201311.0low000010
danoprevir202320231.0low000001
bms-626529202320231.0low000001
bms-663068202320231.0low000001
nu 7441dibenzothiophenes2013201311.0low000010
at 7519dichlorobenzene;
piperidines;
pyrazoles;
secondary carboxamide
antineoplastic agent;
EC 2.7.11.22 (cyclin-dependent kinase) inhibitor
2013201311.0low000010
bi 25362013201311.0low000010
amenamevir202320231.0low000001
vx 765dipeptide202320231.0low000001
Dihydrotanshinone Iabietane diterpenoidanticoronaviral agent202320231.0low000001
danusertibpiperazines2013201311.0low000010
alogliptinnitrile;
piperidines;
primary amino compound;
pyrimidines
EC 3.4.14.5 (dipeptidyl-peptidase IV) inhibitor;
hypoglycemic agent
202320231.0low000001
N-[4-(2-tert-butylphenyl)sulfonylphenyl]-2,3,4-trihydroxy-5-[(2-propan-2-ylphenyl)methyl]benzamidebenzamides2013201311.0low000010
N-[5-[[5-[(4-acetyl-1-piperazinyl)-oxomethyl]-4-methoxy-2-methylphenyl]thio]-2-thiazolyl]-4-[(3,3-dimethylbutan-2-ylamino)methyl]benzamidebenzamides2013201311.0low000010
abt 869aromatic amine;
indazoles;
phenylureas
angiogenesis inhibitor;
antineoplastic agent;
EC 2.7.10.1 (receptor protein-tyrosine kinase) inhibitor
2013201311.0low000010
fr 180204pyrazoles;
ring assembly
202320231.0low000001
dorsomorphinaromatic ether;
piperidines;
pyrazolopyrimidine;
pyridines
bone morphogenetic protein receptor antagonist;
EC 2.7.11.31 {[hydroxymethylglutaryl-CoA reductase (NADPH)] kinase} inhibitor
2013201311.0low000010
ac 2610662013201311.0low000010
quisinostatindoles201720234.0low000021
carfilzomibepoxide;
morpholines;
tetrapeptide
antineoplastic agent;
proteasome inhibitor
201320236.0low000011
hcv 796202320231.0low000001
gw9508aromatic amine2013201311.0low000010
jnj 268541652013201311.0low000010
resminostat201720234.0medium000011
pf 573228quinolines2013201311.0low000010
gw 25802013201311.0low000010
idelalisibaromatic amine;
organofluorine compound;
purines;
quinazolines;
secondary amino compound
antineoplastic agent;
apoptosis inducer;
EC 2.7.1.137 (phosphatidylinositol 3-kinase) inhibitor
2013201311.0low000010
crizotinib3-[1-(2,6-dichloro-3-fluorophenyl)ethoxy]-5-[1-(piperidin-4-yl)pyrazol-4-yl]pyridin-2-amineantineoplastic agent;
biomarker;
EC 2.7.10.1 (receptor protein-tyrosine kinase) inhibitor
2013201311.0low000010
5-(5,6-dimethoxy-1-benzimidazolyl)-3-[(2-methylsulfonylphenyl)methoxy]-2-thiophenecarbonitrilebenzimidazoles2013201311.0low000010
4-[2-(2-chloro-4-fluoroanilino)-5-methyl-4-pyrimidinyl]-N-[(1S)-1-(3-chlorophenyl)-2-hydroxyethyl]-1H-pyrrole-2-carboxamidearomatic amide;
heteroarene
2013201311.0low000010
osi 906cyclobutanes;
quinolines
2013201311.0low000010
ly21097612013201311.0low000010
chir-265aromatic ether2013201311.0low000010
motesanibpyridinecarboxamide2013201311.0low000010
az-628benzamides2013201311.0low000010
zk 756326aromatic ether202320231.0medium000001
balapiravir202320231.0low000001
trametinibacetamides;
aromatic amine;
cyclopropanes;
organofluorine compound;
organoiodine compound;
pyridopyrimidine;
ring assembly
anticoronaviral agent;
antineoplastic agent;
EC 2.7.11.24 (mitogen-activated protein kinase) inhibitor;
geroprotector
201320236.0low000011
pf-562,271indoles2013201311.0low000010
deoxyarbutin202320231.0low000001
abexinostatbenzofurans201720234.0low000021
silvestroldioxanes;
ether;
methyl ester;
organic heterotricyclic compound
antineoplastic agent;
metabolite
202320231.0low000001
narlaprevirazabicyclohexane;
cyclopropanes;
pyrrolidinecarboxamide;
secondary carboxamide;
sulfone;
tertiary carboxamide;
ureas
anticoronaviral agent;
antiviral drug;
EC 3.4.22.69 (SARS coronavirus main proteinase) inhibitor;
hepatitis C protease inhibitor
202320231.0low000001
teneligliptinamino acid amide202320231.0medium000001
dextrothyroxine202320231.0low000001
veliparibbenzimidazolesEC 2.4.2.30 (NAD(+) ADP-ribosyltransferase) inhibitor201320236.0low000011
ku-0060648dibenzothiophenes2013201311.0low000010
dactolisibimidazoquinoline;
nitrile;
quinolines;
ring assembly;
ureas
antineoplastic agent;
EC 2.7.1.137 (phosphatidylinositol 3-kinase) inhibitor;
mTOR inhibitor
2013201311.0low000010
palomid 5292013201311.0low000010
pf 03491390202320231.0low000001
chidamidebenzamides202020204.0low000010
alloinanthracenes;
C-glycosyl compound;
cyclic ketone;
phenols
laxative;
metabolite
202320231.0medium000001
hc toxin2010201014.0medium000100
tosedostatcarboxylic ester;
hydroxamic acid;
secondary carboxamide
2013201311.0low000010
mdv 3100(trifluoromethyl)benzenes;
benzamides;
imidazolidinone;
monofluorobenzenes;
nitrile;
thiocarbonyl compound
androgen antagonist;
antineoplastic agent
201320236.0low000011
ku 600192013201311.0low000010
gsk 461364(trifluoromethyl)benzenes2013201311.0low000010
n-(3,4-difluoro-2-(2-fluoro-4-iodophenylamino)-6-methoxyphenyl)-1-(2,3-dihydroxypropyl)cyclopropane-1-sulfonamide2013201311.0low000010
nvp-tae684piperidines2013201311.0low000010
bms-650032oligopeptide202320231.0low000001
4-methyl-3-(2-(2-morpholinoethylamino)quinazolin-6-yl)-n-(3-(trifluoromethyl)phenyl)benzamide2013201311.0medium000010
azumamide e2008200816.0medium000100
gsk 269962a2013201311.0low000010
rg 7128202320231.0low000001
oritavancindisaccharide derivative;
glycopeptide;
semisynthetic derivative
antibacterial drug;
antimicrobial agent
202320231.0low000001
a-83-012013201311.0low000010
3-[(1-methyl-3-indolyl)methylidene]-1H-pyrrolo[3,2-b]pyridin-2-oneindoles2013201311.0medium000010
vx-770aromatic amide;
monocarboxylic acid amide;
phenols;
quinolone
CFTR potentiator;
orphan drug
2013201311.0low000010
buparlisibaminopyridine;
aminopyrimidine;
morpholines;
organofluorine compound
antineoplastic agent;
EC 2.7.1.137 (phosphatidylinositol 3-kinase) inhibitor
2013201311.0low000010
azd 14802013201311.0low000010
pevonedistatcyclopentanols;
indanes;
pyrrolopyrimidine;
secondary amino compound;
sulfamidate
antineoplastic agent;
apoptosis inducer
202320231.0low000001
fedratinibsulfonamide2013201311.0low000010
gsk6906931,2,5-oxadiazole;
acetylenic compound;
aromatic amine;
aromatic ether;
imidazopyridine;
piperidines;
primary amino compound;
tertiary alcohol
antineoplastic agent;
EC 2.7.11.1 (non-specific serine/threonine protein kinase) inhibitor
2013201311.0low000010
cnf 20242-aminopurines;
aromatic ether;
organochlorine compound;
pyridines
antineoplastic agent;
Hsp90 inhibitor
2013201311.0low000010
ku 0063794benzyl alcohols;
monomethoxybenzene;
morpholines;
pyridopyrimidine;
tertiary amino compound
antineoplastic agent;
mTOR inhibitor
2013201311.0low000010
uk 453,061aromatic ether202320231.0low000001
azd 7545benzamides;
monochlorobenzenes;
organofluorine compound;
secondary carboxamide;
sulfone;
tertiary alcohol;
tertiary carboxamide
EC 2.7.11.2 - [pyruvate dehydrogenase (acetyl-transferring)] kinase inhibitor;
hypoglycemic agent
2013201311.0low000010
nutlin-3bNutlin;
piperazinone
anticoronaviral agent2013201311.0low000010
valproate sodiumorganic sodium saltgeroprotector201720177.0low000010
N-(2-aminophenyl)-2-pyrazinecarboxamidearomatic amide202320231.0medium000001
pf 04217903quinolines2013201311.0low000010
gdc 0941indazoles;
morpholines;
piperazines;
sulfonamide;
thienopyrimidine
EC 2.7.1.137 (phosphatidylinositol 3-kinase) inhibitor2013201311.0low000010
sm 164benzenes;
organic heterobicyclic compound;
secondary carboxamide;
triazoles
antineoplastic agent;
apoptosis inducer;
radiosensitizing agent
2013201311.0low000010
v 2006202220222.0medium000001
ph 797804aromatic ether;
benzamides;
organobromine compound;
organofluorine compound;
pyridone
anti-inflammatory agent;
EC 2.7.11.24 (mitogen-activated protein kinase) inhibitor
2013201311.0low000010
pha 4082013201311.0low000010
gsk 1016790a1-benzothiophenes;
aromatic primary alcohol;
dichlorobenzene;
N-acylpiperazine;
sulfonamide;
tertiary carboxamide
TRPV4 agonist2013201311.0low000010
tegobuvir202320231.0low000001
pf-429242202320231.0low000001
olaparibcyclopropanes;
monofluorobenzenes;
N-acylpiperazine;
phthalazines
antineoplastic agent;
apoptosis inducer;
EC 2.4.2.30 (NAD(+) ADP-ribosyltransferase) inhibitor
201320236.0low000011
srt17202013201311.0low000010
plx 4720aromatic ketone;
difluorobenzene;
organochlorine compound;
pyrrolopyridine;
sulfonamide
antineoplastic agent;
B-Raf inhibitor
2013201311.0low000010
cx 4945201320236.0low000011
pci 34051indolecarboxamide202020232.5low000011
cudc 101201320179.0low000020
mln 8237benzazepine2013201311.0low000010
lde225aminopyridine;
aromatic ether;
benzamides;
biphenyls;
morpholines;
organofluorine compound;
tertiary amino compound
antineoplastic agent;
Hedgehog signaling pathway inhibitor;
SMO receptor antagonist
2013201311.0low000010
gdc 0449benzamides;
monochlorobenzenes;
pyridines;
sulfone
antineoplastic agent;
Hedgehog signaling pathway inhibitor;
SMO receptor antagonist;
teratogenic agent
2013201311.0low000010
sgx 523aryl sulfide;
biaryl;
pyrazoles;
quinolines;
triazolopyridazine
c-Met tyrosine kinase inhibitor;
nephrotoxic agent
2013201311.0low000010
bms 777607aromatic amide2013201311.0low000010
sgi 1776imidazoles2013201311.0low000010
lomibuvirthiophenecarboxylic acid202320231.0low000001
delanzomibC-terminal boronic acid peptide;
phenylpyridine;
secondary alcohol;
threonine derivative
antineoplastic agent;
apoptosis inducer;
proteasome inhibitor
202320231.0low000001
pci 32765acrylamides;
aromatic amine;
aromatic ether;
N-acylpiperidine;
pyrazolopyrimidine;
tertiary carboxamide
antineoplastic agent;
EC 2.7.10.2 (non-specific protein-tyrosine kinase) inhibitor
2013201311.0low000010
ponatinib(trifluoromethyl)benzenes;
acetylenic compound;
benzamides;
imidazopyridazine;
N-methylpiperazine
antineoplastic agent;
tyrosine kinase inhibitor
2013201311.0low000010
pitavastatin(1-)hydroxy monocarboxylic acid anion202320231.0medium000001
amg 9002013201311.0low000010
mk-1775piperazines2013201311.0low000010
bag9562013201311.0low000010
quizartinibbenzoimidazothiazole;
isoxazoles;
morpholines;
phenylureas
antineoplastic agent;
EC 2.7.10.1 (receptor protein-tyrosine kinase) inhibitor;
necroptosis inhibitor
2013201311.0low000010
GRL-0617benzamides;
naphthalenes;
secondary carboxamide;
substituted aniline
anticoronaviral agent;
protease inhibitor
202320231.0low000001
N-[4-[3-[[[7-(hydroxyamino)-7-oxoheptyl]amino]-oxomethyl]-5-isoxazolyl]phenyl]carbamic acid tert-butyl estercarbamate ester201320236.0low000011
niraparib2-[4-(piperidin-3-yl)phenyl]-2H-indazole-7-carboxamideantineoplastic agent;
apoptosis inducer;
EC 2.4.2.30 (NAD(+) ADP-ribosyltransferase) inhibitor;
radiosensitizing agent
202320231.0low000001
tak 7332013201311.0low000010
mk 2206organic heterotricyclic compoundEC 2.7.1.137 (phosphatidylinositol 3-kinase) inhibitor2013201311.0low000010
navitoclaxaryl sulfide;
monochlorobenzenes;
morpholines;
N-sulfonylcarboxamide;
organofluorine compound;
piperazines;
secondary amino compound;
sulfone;
tertiary amino compound
antineoplastic agent;
apoptosis inducer;
B-cell lymphoma 2 inhibitor
2013201311.0low000010
sns 314ureas2013201311.0low000010
jzl 184benzodioxoles201320236.0low000011
gsk 650394phenylpyridine202320231.0low000001
n-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamideaminopyrimidine;
benzamides;
morpholines;
nitrile;
secondary amino compound;
tertiary amino compound
anti-anaemic agent;
antineoplastic agent;
apoptosis inducer;
EC 2.7.10.2 (non-specific protein-tyrosine kinase) inhibitor
2013201311.0low000010
dcc-2036organofluorine compound;
phenylureas;
pyrazoles;
pyridinecarboxamide;
quinolines
tyrosine kinase inhibitor2013201311.0low000010
oprozomib202320231.0low000001
az 960202320231.0low000001
cabozantinibaromatic ether;
dicarboxylic acid diamide;
organofluorine compound;
quinolines
antineoplastic agent;
tyrosine kinase inhibitor
2013201311.0low000010
golgicide adiastereoisomeric mixturecis-Golgi ArfGEF GBF inhibitor202320231.0low000001
N-(2,6-difluorophenyl)-5-[3-[2-[5-ethyl-2-methoxy-4-[4-(4-methylsulfonyl-1-piperazinyl)-1-piperidinyl]anilino]-4-pyrimidinyl]-2-imidazo[1,2-a]pyridinyl]-2-methoxybenzamidebenzamides2013201311.0low000010
incb-018424nitrile;
pyrazoles;
pyrrolopyrimidine
antineoplastic agent;
EC 2.7.10.2 (non-specific protein-tyrosine kinase) inhibitor
2013201311.0low000010
bix 01294piperidines2013201311.0low000010
cobicistat1,3-thiazoles;
carbamate ester;
monocarboxylic acid amide;
morpholines;
ureas
P450 inhibitor202320231.0low000001
bms-790052biphenyls;
carbamate ester;
carboxamide;
imidazoles;
valine derivative
antiviral drug;
nonstructural protein 5A inhibitor
202320231.0low000001
pf 3845piperidines2013201311.0low000010
gsk 2126458aromatic ether;
difluorobenzene;
pyridazines;
pyridines;
quinolines;
sulfonamide
anticoronaviral agent;
antineoplastic agent;
autophagy inducer;
EC 2.7.1.137 (phosphatidylinositol 3-kinase) inhibitor;
mTOR inhibitor;
radiosensitizing agent
2013201311.0low000010
ixazomibbenzamides;
boronic acids;
dichlorobenzene;
glycine derivative
antineoplastic agent;
apoptosis inducer;
drug metabolite;
orphan drug;
proteasome inhibitor
201320236.0low000011
ldn 193189pyrimidines2013201311.0low000010
ucph 101202320231.0low000001
plx4032aromatic ketone;
difluorobenzene;
monochlorobenzenes;
pyrrolopyridine;
sulfonamide
antineoplastic agent;
B-Raf inhibitor
2013201311.0low000010
(2S)-2-[[2-(2,3-dihydro-1H-inden-5-yloxy)-9-[(4-phenylphenyl)methyl]-6-purinyl]amino]-3-phenyl-1-propanolbiphenyls2013201311.0low000010
gsk 1363089aromatic ether2013201311.0low000010
kin-193pyridopyrimidine2013201311.0low000010
5-(3-methylsulfonylphenyl)-4-[(1-methyl-5-tetrazolyl)thio]thieno[2,3-d]pyrimidinearyl sulfide;
thienopyrimidine
202320231.0low000001
bay 8697662013201311.0low000010
baricitinibazetidines;
nitrile;
pyrazoles;
pyrrolopyrimidine;
sulfonamide
anti-inflammatory agent;
antirheumatic drug;
antiviral agent;
EC 2.7.10.2 (non-specific protein-tyrosine kinase) inhibitor;
immunosuppressive agent
202320231.0low000001
4-[6-[4-(methoxycarbonylamino)phenyl]-4-(4-morpholinyl)-1-pyrazolo[3,4-d]pyrimidinyl]-1-piperidinecarboxylic acid methyl estercarbamate ester2013201311.0low000010
KOM70144acetamides;
benzamides;
naphthalenes;
secondary carboxamide
anticoronaviral agent;
protease inhibitor
202320231.0medium000001
6-[(3-aminophenyl)methyl]-4-methyl-2-methylsulfinyl-5-thieno[3,4]pyrrolo[1,3-d]pyridazinoneorganic heterobicyclic compound;
organonitrogen heterocyclic compound;
organosulfur heterocyclic compound
2013201311.0low000010
e-52862202320231.0low000001
ly2811376202320231.0low000001
anagliptinamino acid amide202320231.0low000001
3-[[4-(2,3-dihydro-1,4-benzodioxin-6-ylsulfonyl)-1,4-diazepan-1-yl]sulfonyl]anilinebenzenes;
sulfonamide
2013201311.0low000010
cp 466722quinazolines2013201311.0low000010
gardiquimod202320231.0low000001
CAY10626ureas2013201311.0medium000010
grazopreviraromatic ether;
azamacrocycle;
carbamate ester;
cyclopropanes;
lactam;
N-sulfonylcarboxamide;
quinoxaline derivative
antiviral drug;
hepatitis C protease inhibitor;
hepatoprotective agent
202320231.0low000001
thiopental sodiumorganochlorine compound;
piperazines;
pyrimidines
antineoplastic agent;
tyrosine kinase inhibitor
2013201311.0low000010
abt-450202320231.0low000001
letermovir202320231.0low000001
sofosbuvirisopropyl ester;
L-alanyl ester;
nucleotide conjugate;
organofluorine compound;
phosphoramidate ester
antiviral drug;
hepatitis C protease inhibitor;
prodrug
202320231.0low000001
5-(4-amino-1-propan-2-yl-3-pyrazolo[3,4-d]pyrimidinyl)-1,3-benzoxazol-2-aminebenzoxazole202320231.0low000001
blz 945202320231.0medium000001
pha 793887piperidinecarboxamide2013201311.0low000010
azd3839202320231.0medium000001
pf 3084014202320231.0low000001
unc 0638quinazolines202320231.0low000001
gs-9620202320231.0low000001
nvp-bsk8052013201311.0low000010
xmd 8-92pyrimidobenzodiazepineprotein kinase inhibitor2013201311.0low000010
n-((5-(methanesulfonyl)pyridin-2-yl)methyl)-6-methyl-5-(1-methyl-1h-pyrazol-5-yl)-2-oxo-1-(3-(trifluoromethyl)phenyl)-1,2-dihydropyridine-3-carboxamide202320231.0low000001
bms 708163oxadiazole;
ring assembly
202320231.0low000001
jq1 compoundcarboxylic ester;
organochlorine compound;
tert-butyl ester;
thienotriazolodiazepine
angiogenesis inhibitor;
anti-inflammatory agent;
antineoplastic agent;
apoptosis inducer;
bromodomain-containing protein 4 inhibitor;
cardioprotective agent;
ferroptosis inducer
201320236.0low000011
jnj38877605quinolines2013201311.0low000010
N-[3-(1,3-benzothiazol-2-yl)-5,6-dihydro-4H-thieno[2,3-c]pyrrol-2-yl]acetamidebenzothiazoles2013201311.0medium000010
1-(5-((2,4-difluorophenyl)thio)-4-nitrothiophen-2-yl)ethanone202320231.0low000001
gsk525762abenzodiazepine202320231.0low000001
ML240aromatic amine;
aromatic ether;
benzimidazoles;
primary amino compound;
quinazolines;
secondary amino compound
antineoplastic agent202320231.0low000001
birinapantdipeptide202320231.0low000001
torin 1N-acylpiperazine;
N-arylpiperazine;
organofluorine compound;
pyridoquinoline;
quinolines
antineoplastic agent;
mTOR inhibitor
2013201311.0low000010
ly2886721202320231.0medium000001
nms-p118202320231.0medium000001
ly29406802013201311.0low000010
tubastatin ahydroxamic acid;
pyridoindole;
tertiary amino compound
EC 3.5.1.98 (histone deacetylase) inhibitor201220235.7low000021
1-[4-fluoro-3-(trifluoromethyl)phenyl]-3-(5-pyridin-4-yl-1,3,4-thiadiazol-2-yl)ureaureas2013201311.0low000010
pracinostatbenzimidazole;
hydroxamic acid;
olefinic compound;
tertiary amino compound
antimalarial;
antineoplastic agent;
apoptosis inducer;
EC 3.5.1.98 (histone deacetylase) inhibitor
201720234.0medium000011
ro 4929097dibenzoazepine;
dicarboxylic acid diamide;
lactam;
organofluorine compound
EC 3.4.23.46 (memapsin 2) inhibitor2013201311.0medium000010
gsk41122013201311.0low000010
spautin-1202320231.0low000001
torin 2aminopyridine;
organofluorine compound;
primary amino compound;
pyridoquinoline
antineoplastic agent;
mTOR inhibitor
2013201311.0low000010
pf-47086712013201311.0low000010
ldn 57444202320231.0low000001
gsk1210151aimidazoquinoline202320231.0low000001
i-bet726202320231.0low000001
acy-1215pyrimidinecarboxylic acid201720234.0low000021
N-[4-(1-benzoyl-4-piperidinyl)butyl]-3-(3-pyridinyl)-2-propenamidebenzamides;
N-acylpiperidine
2013201311.0medium000010
2-methoxy-N-[3-[4-[3-methyl-4-[(6-methyl-3-pyridinyl)oxy]anilino]-6-quinazolinyl]prop-2-enyl]acetamidearomatic ether;
methylpyridines;
olefinic compound;
quinazolines;
secondary amino compound;
secondary carboxamide;
toluenes
2013201311.0medium000010
belinostatolefinic compound2013201311.0medium000010
cudc-907202020232.5low000011
mobic1,3-thiazoles;
benzothiazine;
monocarboxylic acid amide
analgesic;
antirheumatic drug;
cyclooxygenase 2 inhibitor;
non-steroidal anti-inflammatory drug
202320231.0low000001
ethyl 1-benzyl-3-hydroxy-2(5h)-oxopyrrole-4-carboxylatecarboxylic acid;
pyrroline
2013201311.0low000010
tipranavirsulfonamideantiviral drug;
HIV protease inhibitor
202320231.0low000001
tasquinimod202020232.5low000011
a 769662biphenyls2013201311.0low000010
gsk1265744difluorobenzene;
monocarboxylic acid amide;
organic heterotricyclic compound;
secondary carboxamide
HIV-1 integrase inhibitor202320231.0low000001
abt-267aromatic amide;
carbamate ester;
dipeptide;
pyrrolidines
antiviral drug;
hepatitis C virus nonstructural protein 5A inhibitor
202320231.0low000001
abt-333aromatic ether;
naphthalenes;
pyrimidone;
sulfonamide
antiviral drug;
nonnucleoside hepatitis C virus polymerase inhibitor
202320231.0low000001
rgfp966202320231.0low000001
rg2833201720234.0high000011
pi-1840202320231.0medium000001
LimKi 31,3-thiazoles;
dichlorobenzene;
organofluorine compound;
pyrazoles;
secondary carboxamide
LIM kinase inhibitor2013201311.0low000010
1-[4-amino-7-[3-(2-methoxyethylamino)propyl]-5-(4-methylphenyl)-6-pyrrolo[2,3-d]pyrimidinyl]-2-fluoroethanonepyrroles2013201311.0medium000010
2-[5-[(3,5-dimethyl-1H-pyrrol-2-yl)methylidene]-4-methoxy-2-pyrrolylidene]indoledipyrrins2013201311.0medium000010
acy-738202320231.0medium000001
pelabresibmonochlorobenzenes;
organic heterotricyclic compound;
primary carboxamide
antineoplastic agent;
bromodomain-containing protein 4 inhibitor
202320231.0low000001
N-hydroxy-3-[4-[[2-(2-methyl-1H-indol-3-yl)ethylamino]methyl]phenyl]-2-propenamidetryptamines2013201311.0medium000010
3-[(5-tert-butyl-1H-imidazol-4-yl)methylidene]-6-(phenylmethylene)piperazine-2,5-dionepyrazines2013201311.0medium000010
gsk837149a2013201311.0low000010
N-[4-(3-chloro-4-fluoroanilino)-7-[[(3S)-3-oxolanyl]oxy]-6-quinazolinyl]-4-(dimethylamino)-2-butenamidequinazolines2013201311.0medium000010
N-[4-(3-chloro-4-fluoroanilino)-7-methoxy-6-quinazolinyl]-4-(1-piperidinyl)-2-butenamidequinazolines2013201311.0medium000010
wnt-c592013201311.0low000010
5-[1-(2-hydroxyethyl)-3-pyridin-4-yl-4-pyrazolyl]-2,3-dihydroinden-1-one oximeindanes2013201311.0medium000010
gs-5806202320231.0low000001
doravirine202320231.0low000001
gn6958202320231.0medium000001
vx-787202320231.0low000001
ledipasvirazaspiro compound;
benzimidazole;
bridged compound;
carbamate ester;
carboxamide;
fluorenes;
imidazoles;
L-valine derivative;
N-acylpyrrolidine;
organofluorine compound
antiviral drug;
hepatitis C protease inhibitor
202320231.0low000001
gs-5816carbamate ester;
ether;
imidazoles;
L-valine derivative;
N-acylpyrrolidine;
organic heteropentacyclic compound;
ring assembly
antiviral drug;
hepatitis C virus nonstructural protein 5A inhibitor
202320231.0low000001
g007-lk202320231.0low000001
4-((1-butyl-3-phenylureido)methyl)-n-hydroxybenzamide201220236.5low000011
selinexor202320231.0low000001
verdinexor202320231.0low000001
cb-839202320231.0low000001
mk-8742carbamate ester;
imidazoles;
L-valine derivative;
N-acylpyrrolidine;
organic heterotetracyclic compound;
ring assembly
antiviral drug;
hepatitis C virus nonstructural protein 5A inhibitor;
hepatoprotective agent
202320231.0low000001
atglistatin202320231.0low000001
xen445202320231.0medium000001
santacruzamate aorganonitrogen compound;
organooxygen compound
202320231.0medium000001
ldc4297aromatic ether;
piperidines;
pyrazoles;
pyrazolotriazine;
secondary amino compound
antineoplastic agent;
antiviral agent;
apoptosis inducer;
EC 2.7.11.22 (cyclin-dependent kinase) inhibitor
202320231.0medium000001
enasidenib1,3,5-triazines;
aminopyridine;
aromatic amine;
organofluorine compound;
secondary amino compound;
tertiary alcohol
antineoplastic agent;
EC 1.1.1.42 (isocitrate dehydrogenase) inhibitor
202320231.0low000001
s 8932aromatic amine;
C-nucleoside;
carboxylic ester;
nitrile;
phosphoramidate ester;
pyrrolotriazine
anticoronaviral agent;
antiviral drug;
prodrug
202320231.0low000001
entecavir2-aminopurines;
oxopurine;
primary alcohol;
secondary alcohol
antiviral drug;
EC 2.7.7.49 (RNA-directed DNA polymerase) inhibitor
202320231.0low000001
chir 2582013201311.0low000010
acyclovir2-aminopurines;
oxopurine
antimetabolite;
antiviral drug
202320231.0low000001
osi 0272013201311.0low000010
nu 1025phenols;
quinazolines
EC 2.4.2.30 (NAD(+) ADP-ribosyltransferase) inhibitor202320231.0low000001
didanosinepurine 2',3'-dideoxyribonucleosideantimetabolite;
antiviral drug;
EC 2.4.2.1 (purine-nucleoside phosphorylase) inhibitor;
geroprotector;
HIV-1 reverse transcriptase inhibitor
202320231.0low000001
ganciclovir2-aminopurines;
oxopurine
antiinfective agent;
antiviral drug
202320231.0low000001
valacyclovirL-valyl esterantiviral drug202320231.0low000001
penciclovir2-aminopurines;
propane-1,3-diols
antiviral drug202320231.0low000001
hli 3732013201311.0medium000010
4-hydroxyquinazolinequinazolines202320231.0low000001
tegaserodcarboxamidine;
guanidines;
hydrazines;
indoles
gastrointestinal drug;
serotonergic agonist
202320231.0low000001
norclozapinedibenzodiazepine;
organochlorine compound;
piperazines
delta-opioid receptor agonist;
metabolite;
serotonergic antagonist
202320231.0low000001
pemetrexedN-acyl-L-glutamic acid;
pyrrolopyrimidine
antimetabolite;
antineoplastic agent;
EC 1.5.1.3 (dihydrofolate reductase) inhibitor;
EC 2.1.1.45 (thymidylate synthase) inhibitor;
EC 2.1.2.2 (phosphoribosylglycinamide formyltransferase) inhibitor
201320236.0low000011
sildenafil citratecitrate saltEC 3.1.4.35 (3',5'-cyclic-GMP phosphodiesterase) inhibitor;
vasodilator agent
2013201311.0low000010
aprepitant(trifluoromethyl)benzenes;
cyclic acetal;
morpholines;
triazoles
antidepressant;
antiemetic;
neurokinin-1 receptor antagonist;
peripheral nervous system drug;
substance P receptor antagonist
201320236.0low000011
azilsartan1,2,4-oxadiazole;
aromatic ether;
benzimidazolecarboxylic acid
angiotensin receptor antagonist;
antihypertensive agent
202320231.0low000001
xav939(trifluoromethyl)benzenes;
thiopyranopyrimidine
tankyrase inhibitor2013201311.0low000010
2-carboxyarabinitol 1-phosphate2013201311.0low000010
hesperadin202320231.0low000001
nintedanib201320179.0low000020
6-bromoindirubin-3'-acetoxime202320231.0medium000001
n'-(3,4-dihydroxybenzylidene)-3-hydroxy-2-naphthahydrazidecatechols;
hydrazide;
hydrazone;
naphthols
EC 3.6.5.5 (dynamin GTPase) inhibitor202320231.0medium000001
ver 52296aromatic amide;
isoxazoles;
monocarboxylic acid amide;
morpholines;
resorcinols
angiogenesis inhibitor;
antineoplastic agent;
Hsp90 inhibitor
2013201311.0low000010
sb-590885aromatic ether;
imidazoles;
ketoxime;
pyridines;
tertiary amino compound
2013201311.0medium000010
XL413benzofuropyrimidine;
organochlorine compound;
pyrrolidines
antineoplastic agent;
EC 2.7.11.1 (non-specific serine/threonine protein kinase) inhibitor
202320231.0medium000001
pf-4777362013201311.0low000010
me0328202320231.0medium000001
fenobamureas2013201311.0low000010
nvp-tnks656202320231.0medium000001
SubstanceStudiesClassesRolesFirst YearLast YearAverage AgeRelationship StrengthTrialspre-19901990's2000's2010'spost-2020
acetylcarnitineO-acylcarnitinehuman metabolite200920219.0low000101
dinitrochlorobenzeneC-nitro compound;
monochlorobenzenes
allergen;
epitope;
sensitiser
2006201910.5low000260
1,2,4-trichlorobenzenetrichlorobenzene2012201212.0low000010
2,3-dihydroxybenzoic aciddihydroxybenzoic acidhuman xenobiotic metabolite;
plant metabolite
1989199830.5low011000
ethylene chlorohydrinchloroethanolxenobiotic metabolite201820186.0low000010
2,3-diphosphoglyceratebisphosphoglyceric acid;
tetronic acid derivative
human metabolite1999200621.5low001100
protocatechuic acidcatechols;
dihydroxybenzoic acid
antineoplastic agent;
EC 1.1.1.25 (shikimate dehydrogenase) inhibitor;
EC 1.14.11.2 (procollagen-proline dioxygenase) inhibitor;
human xenobiotic metabolite;
plant metabolite
1998202311.0low101041
3-chloroalaninechloroalanine;
non-proteinogenic alpha-amino acid;
organochlorine compound
1997199727.0low001000
3-hydroxyanthranilic acidaminobenzoic acid;
monohydroxybenzoic acid
human metabolite;
mouse metabolite
1992199232.0low001000
acetoacetic acid3-oxo fatty acid;
ketone body
metabolite1981200033.0low012000
phosphoserinenon-proteinogenic alpha-amino acid;
O-phosphoamino acid;
serine derivative
human metabolite201520159.0low000010
cysteine sulfinic acid201520159.0low000010
gamma-aminobutyric acidamino acid zwitterion;
gamma-amino acid;
monocarboxylic acid
human metabolite;
neurotransmitter;
Saccharomyces cerevisiae metabolite;
signalling molecule
2002202111.3low000352
4-hydroxyphenylacetic acidmonocarboxylic acid;
phenols
fungal metabolite;
human metabolite;
mouse metabolite;
plant metabolite
1990200527.4low006300
4-hydroxybenzoic acidmonohydroxybenzoic acidalgal metabolite;
plant metabolite
1995200623.5low001100
aminolevulinic acid4-oxo monocarboxylic acid;
amino acid zwitterion;
delta-amino acid
antineoplastic agent;
dermatologic drug;
Escherichia coli metabolite;
human metabolite;
mouse metabolite;
photosensitizing agent;
plant metabolite;
prodrug;
Saccharomyces cerevisiae metabolite
1987202216.1low011231
5-hydroxytryptophanhydroxytryptophanhuman metabolite;
neurotransmitter
2001200322.0low000200
ethylene glycolethanediol;
glycol
metabolite;
mouse metabolite;
solvent;
toxin
200920238.0low100101
acetic acidmonocarboxylic acidantimicrobial food preservative;
Daphnia magna metabolite;
food acidity regulator;
protic solvent
1984202316.6low033350529
acetaldehydealdehydecarcinogenic agent;
EC 3.5.1.4 (amidase) inhibitor;
electron acceptor;
Escherichia coli metabolite;
human metabolite;
mouse metabolite;
mutagen;
oxidising agent;
Saccharomyces cerevisiae metabolite;
teratogenic agent
1979201329.7low068210
acetoneketone body;
methyl ketone;
propanones;
volatile organic compound
EC 3.5.1.4 (amidase) inhibitor;
human metabolite;
polar aprotic solvent
1986202220.6low013601
adenine6-aminopurines;
purine nucleobase
Daphnia magna metabolite;
Escherichia coli metabolite;
human metabolite;
mouse metabolite;
Saccharomyces cerevisiae metabolite
1946202321.6low143662
agmatineguanidines;
primary amino compound
Escherichia coli metabolite;
mouse metabolite
2007201711.6low000230
allantoinimidazolidine-2,4-dione;
ureas
Escherichia coli metabolite;
human metabolite;
Saccharomyces cerevisiae metabolite;
vulnerary
201120197.8low000060
ammonium hydroxideazane;
gas molecular entity;
mononuclear parent hydride
EC 3.5.1.4 (amidase) inhibitor;
metabolite;
mouse metabolite;
neurotoxin;
NMR chemical shift reference compound;
nucleophilic reagent;
refrigerant
1964202221.7low033342
anthranilic acidaminobenzoic acidhuman metabolite;
mouse metabolite
2012201311.5low000020
arsenic acidarsenic oxoacidEscherichia coli metabolite1949201920.6low010240
quinacrineacridines;
aromatic ether;
organochlorine compound;
tertiary amino compound
antimalarial;
EC 1.8.1.12 (trypanothione-disulfide reductase) inhibitor
1946201733.8low043110
beta-alanineamino acid zwitterion;
beta-amino acid
agonist;
fundamental metabolite;
human metabolite;
inhibitor;
neurotransmitter
1997201519.0low001410
benzenearomatic annulene;
benzenes;
volatile organic compound
carcinogenic agent;
environmental contaminant;
non-polar solvent
1953201826.9low0681040
benzoic acidbenzoic acidsalgal metabolite;
antimicrobial food preservative;
drug allergen;
EC 1.13.11.33 (arachidonate 15-lipoxygenase) inhibitor;
EC 3.1.1.3 (triacylglycerol lipase) inhibitor;
human xenobiotic metabolite;
plant metabolite
1985201523.4low020120
betaineamino-acid betaine;
glycine derivative
fundamental metabolite200420217.7low000262
bromidehalide anion;
monoatomic bromine
1979202223.5low010111281
1-butanolalkyl alcohol;
primary alcohol;
short-chain primary fatty alcohol
human metabolite;
mouse metabolite;
protic solvent
1992202211.3low001222
butyric acidfatty acid 4:0;
straight-chain saturated fatty acid
human urinary metabolite;
Mycoplasma genitalium metabolite
1989201819.3low012250
cadaverinealkane-alpha,omega-diamineDaphnia magna metabolite;
Escherichia coli metabolite;
mouse metabolite;
plant metabolite
1994202118.0low002101
carbamatesamino-acid anion2007202210.5low000341
carbon monoxidecarbon oxide;
gas molecular entity;
one-carbon compound
biomarker;
EC 1.9.3.1 (cytochrome c oxidase) inhibitor;
human metabolite;
ligand;
metabolite;
mitochondrial respiratory-chain inhibitor;
mouse metabolite;
neurotoxin;
neurotransmitter;
P450 inhibitor;
probe;
signalling molecule;
vasodilator agent
1950202119.5low18126181
formic acidmonocarboxylic acidantibacterial agent;
astringent;
metabolite;
protic solvent;
solvent
1998202315.7low003021
aminooxyacetic acidamino acid;
hydroxylamines;
monocarboxylic acid
anticonvulsant;
EC 2.6.1.19 (4-aminobutyrate--2-oxoglutarate transaminase) inhibitor;
EC 4.2.1.22 (cystathionine beta-synthase) inhibitor;
nootropic agent
1981198143.0low010000
carnitineamino-acid betainehuman metabolite;
mouse metabolite
1998202014.6low001430
catecholcatecholsallelochemical;
genotoxin;
plant metabolite
1962201722.5low023250
methanealkane;
gas molecular entity;
mononuclear parent hydride;
one-carbon compound
bacterial metabolite;
fossil fuel;
greenhouse gas
197720239.9low1114503
cholinecholinesallergen;
Daphnia magna metabolite;
Escherichia coli metabolite;
human metabolite;
mouse metabolite;
neurotransmitter;
nutrient;
plant metabolite;
Saccharomyces cerevisiae metabolite
1949202226.9low054761
citric acid, anhydroustricarboxylic acidantimicrobial agent;
chelator;
food acidity regulator;
fundamental metabolite
1964202017.1low1332130
chlorinehalide anion;
monoatomic chlorine
cofactor;
Escherichia coli metabolite;
human metabolite
1952202230.0low1956844184
hydrochloric acidchlorine molecular entity;
gas molecular entity;
hydrogen halide;
mononuclear parent hydride
mouse metabolite1980201818.2low015680
coumarincoumarinsfluorescent dye;
human metabolite;
plant metabolite
2004202010.6low000270
salicylic acidmonohydroxybenzoic acidalgal metabolite;
antifungal agent;
antiinfective agent;
EC 1.11.1.11 (L-ascorbate peroxidase) inhibitor;
keratolytic drug;
plant hormone;
plant metabolite
1989202113.3low01431284
phloroglucinolbenzenetriol;
phenolic donor
algal metabolite1989201218.3low010330
2,3-diaminopropionic acidalanine derivative;
amino acid zwitterion;
beta-amino acid;
diamino acid;
non-proteinogenic alpha-amino acid
Escherichia coli metabolite2001200123.0low000100
gallic acidtrihydroxybenzoic acidantineoplastic agent;
antioxidant;
apoptosis inducer;
astringent;
cyclooxygenase 2 inhibitor;
EC 1.13.11.33 (arachidonate 15-lipoxygenase) inhibitor;
geroprotector;
human xenobiotic metabolite;
plant metabolite
1981202315.3low022694
4-nitrophenylphosphatearyl phosphatemouse metabolite1990199034.0low001000
hydrogen sulfidegas molecular entity;
hydracid;
mononuclear parent hydride;
sulfur hydride
Escherichia coli metabolite;
genotoxin;
metabolite;
signalling molecule;
toxin;
vasodilator agent
1989202311.5low11114294
4-aminophenolaminophenolallergen;
metabolite
2007201413.5low000110
dihydrolipoic acidthio-fatty acidantioxidant;
human metabolite;
neuroprotective agent
1995200324.0low002200
3-hydroxybutyric acid(omega-1)-hydroxy fatty acid;
3-hydroxy monocarboxylic acid;
hydroxybutyric acid
human metabolite1992201420.0low001110
3-chlorobenzoic acidmonochlorobenzoic aciddrug metabolite1993199331.0low001000
caprylic aldehydemedium-chain fatty aldehyde;
n-alkanal;
saturated fatty aldehyde
plant metabolite201720177.0low000010
guaiacolguaiacolsdisinfectant;
EC 1.1.1.25 (shikimate dehydrogenase) inhibitor;
expectorant;
plant metabolite
1975202323.5low015514181
2-keto-4-methylthiobutyric acidomega-(methylthio)-2-oxocarboxylic acid1985200628.7low011100
methylmalonic acidC4-dicarboxylic acidhuman metabolite2011201113.0low000010
n(g),n(g')-dimethyl-l-argininealpha-amino acid2005201811.6low1006110
malic acid2-hydroxydicarboxylic acid;
C4-dicarboxylic acid
food acidity regulator;
fundamental metabolite
2003201910.4low000140
propionaldehydealpha-CH2-containing aldehyde;
propanals
Escherichia coli metabolite1997199727.0low001000
1-aminocyclopropane-1-carboxylic acidamino acid zwitterion;
monocarboxylic acid;
non-proteinogenic alpha-amino acid
ethylene releasers;
plant metabolite
1995201123.6low003110
3,4-dihydroxyphenylacetic acidcatechols;
dihydroxyphenylacetic acid
human metabolite2011201113.0low000010
aminocaproic acidamino acid zwitterion;
epsilon-amino acid;
omega-amino fatty acid
antifibrinolytic drug;
hematologic agent;
metabolite
1964201037.0low010100
creatineglycine derivative;
guanidines;
zwitterion
geroprotector;
human metabolite;
mouse metabolite;
neuroprotective agent;
nutraceutical
1993201518.6low102420
cytosineaminopyrimidine;
pyrimidine nucleobase;
pyrimidone
Escherichia coli metabolite;
human metabolite;
mouse metabolite;
Saccharomyces cerevisiae metabolite
1997202114.2low002112
lactic acid2-hydroxy monocarboxylic acidalgal metabolite;
Daphnia magna metabolite
1951202214.8low52620302
diacetylalpha-diketoneEscherichia coli metabolite;
Saccharomyces cerevisiae metabolite
1989198935.0low010000
dimethyl sulfoxidesulfoxide;
volatile organic compound
alkylating agent;
antidote;
Escherichia coli metabolite;
geroprotector;
MRI contrast agent;
non-narcotic analgesic;
polar aprotic solvent;
radical scavenger
1979202330.3low2199641
formaldehydealdehyde;
one-carbon compound
allergen;
carcinogenic agent;
disinfectant;
EC 3.5.1.4 (amidase) inhibitor;
environmental contaminant;
Escherichia coli metabolite;
mouse metabolite;
Saccharomyces cerevisiae metabolite
1951202117.1low0256151
glutaric acidalpha,omega-dicarboxylic acid;
dicarboxylic fatty acid
Daphnia magna metabolite;
human metabolite
1950195074.0low010000
glycinealpha-amino acid;
amino acid zwitterion;
proteinogenic amino acid;
serine family amino acid
EC 2.1.2.1 (glycine hydroxymethyltransferase) inhibitor;
fundamental metabolite;
hepatoprotective agent;
micronutrient;
neurotransmitter;
NMDA receptor agonist;
nutraceutical
1964202317.4low041424217
glycerolalditol;
triol
algal metabolite;
detergent;
Escherichia coli metabolite;
geroprotector;
human metabolite;
mouse metabolite;
osmolyte;
Saccharomyces cerevisiae metabolite;
solvent
1987202316.6low112142
glycerolalditol;
triol
algal metabolite;
detergent;
Escherichia coli metabolite;
geroprotector;
human metabolite;
mouse metabolite;
osmolyte;
Saccharomyces cerevisiae metabolite;
solvent
1987202315.6low112152
glycolaldehydeglycolaldehydesfundamental metabolite;
human metabolite
1997200523.0low001100
glycocyamineguanidinoacetic acids;
zwitterion
bacterial metabolite;
human metabolite;
mouse metabolite;
nutraceutical;
rat metabolite
1983198341.0low010000
carbonic acidcarbon oxoacid;
chalcocarbonic acid
mouse metabolite2001200123.0low000100
hydrogen cyanidehydracid;
one-carbon compound
Escherichia coli metabolite;
human metabolite;
poison
1950202317.1low020133
hydrogen cyanidehydracid;
one-carbon compound
Escherichia coli metabolite;
human metabolite;
poison
1950200344.7low020100
hydrogen carbonatecarbon oxoanioncofactor;
Escherichia coli metabolite;
human metabolite;
mouse metabolite;
Saccharomyces cerevisiae metabolite
1950202022.8low0131010
dalteparin2001201613.7low100450
histaminearalkylamino compound;
imidazoles
human metabolite;
mouse metabolite;
neurotransmitter
1951202322.3low1093042123
histaminearalkylamino compound;
imidazoles
human metabolite;
mouse metabolite;
neurotransmitter
1951202322.6low1093039123
homogentisic aciddihydroxyphenylacetic acid;
hydroquinones
human metabolite;
plant metabolite
1999199925.0low001000
hydrogenelemental hydrogen;
elemental molecule;
gas molecular entity
antioxidant;
electron donor;
food packaging gas;
fuel;
human metabolite
1946202324.7low1827192
hydroquinonebenzenediol;
hydroquinones
antioxidant;
carcinogenic agent;
cofactor;
Escherichia coli metabolite;
human xenobiotic metabolite;
mouse metabolite;
skin lightening agent
1989202323.2low0213751
hydroxylaminehydroxylaminesalgal metabolite;
bacterial xenobiotic metabolite;
EC 1.1.3.13 (alcohol oxidase) inhibitor;
EC 4.2.1.22 (cystathionine beta-synthase) inhibitor;
EC 4.3.1.10 (serine-sulfate ammonia-lyase) inhibitor;
nitric oxide donor;
nucleophilic reagent
2002201416.4low000320
imidazoleimidazole1988202217.2low012322
indoleindole;
polycyclic heteroarene
Escherichia coli metabolite1955200641.5low020200
indoleacetic acidindole-3-acetic acids;
monocarboxylic acid
auxin;
human metabolite;
mouse metabolite;
plant hormone;
plant metabolite
1955202325.0low01149172
iodinediatomic iodinenutrient1952202036.4low0268520
iodinediatomic iodinenutrient1952202034.9low0268540
dihydroxyphenylalaninehydroxyphenylalanine;
non-proteinogenic alpha-amino acid;
tyrosine derivative
human metabolite1953201836.5low052220
kynureninearomatic ketone;
non-proteinogenic alpha-amino acid;
substituted aniline
human metabolite1950201436.3low031120
thioctic aciddithiolanes;
heterocyclic fatty acid;
thia fatty acid
fundamental metabolite;
geroprotector
1995202013.7low00313140
thioctic aciddithiolanes;
heterocyclic fatty acid;
thia fatty acid
fundamental metabolite;
geroprotector
1995202013.7low00311140
pyruvaldehyde2-oxo aldehyde;
propanals
Escherichia coli metabolite;
human metabolite;
mouse metabolite;
Saccharomyces cerevisiae metabolite
2012201411.3low000030
methanolalkyl alcohol;
one-carbon compound;
primary alcohol;
volatile organic compound
amphiprotic solvent;
Escherichia coli metabolite;
fuel;
human metabolite;
mouse metabolite;
Mycoplasma genitalium metabolite
1963202015.6low0109110
methanolalkyl alcohol;
one-carbon compound;
primary alcohol;
volatile organic compound
amphiprotic solvent;
Escherichia coli metabolite;
fuel;
human metabolite;
mouse metabolite;
Mycoplasma genitalium metabolite
1963202014.8low01117180
phytic acidinositol phosphate1994202116.5low001001
inositolcyclitol;
hexol
200720229.5low000101
melatoninacetamides;
tryptamines
anticonvulsant;
central nervous system depressant;
geroprotector;
hormone;
human metabolite;
immunological adjuvant;
mouse metabolite;
radical scavenger
1997202315.3low101063306
croton oilN-acyl-hexosamine1995202113.3low0016102
naphthalenenaphthalenes;
ortho-fused bicyclic arene
apoptosis inhibitor;
carcinogenic agent;
environmental contaminant;
mouse metabolite;
plant metabolite;
volatile oil component
2005202011.3low000240
nickelmetal allergen;
nickel group element atom
epitope;
micronutrient
1951202312.0low1229296
niacinamidepyridine alkaloid;
pyridinecarboxamide;
vitamin B3
anti-inflammatory agent;
antioxidant;
cofactor;
EC 2.4.2.30 (NAD(+) ADP-ribosyltransferase) inhibitor;
EC 3.5.1.98 (histone deacetylase) inhibitor;
Escherichia coli metabolite;
geroprotector;
human urinary metabolite;
metabolite;
mouse metabolite;
neuroprotective agent;
Saccharomyces cerevisiae metabolite;
Sir2 inhibitor
1995202118.9low004121
niacinpyridine alkaloid;
pyridinemonocarboxylic acid;
vitamin B3
antidote;
antilipemic drug;
EC 3.5.1.19 (nicotinamidase) inhibitor;
Escherichia coli metabolite;
human urinary metabolite;
metabolite;
mouse metabolite;
plant metabolite;
vasodilator agent
1959201527.5low121230
nitratesmonovalent inorganic anion;
nitrogen oxoanion;
reactive nitrogen species
1992202217.9low205786552
nitric acidnitrogen oxoacidprotic solvent;
reagent
201320188.5low000020
nitroxylnitrogen oxoacid2003201315.4low000430
nitritesmonovalent inorganic anion;
nitrogen oxoanion;
reactive nitrogen species
human metabolite1990202317.4low5057127774
nitrous oxidegas molecular entity;
nitrogen oxide
analgesic;
bacterial metabolite;
food packaging gas;
food propellant;
general anaesthetic;
greenhouse gas;
inhalation anaesthetic;
NMDA receptor antagonist;
raising agent;
refrigerant;
vasodilator agent
2006200618.0low000100
1-octanoloctanol;
primary alcohol
antifungal agent;
bacterial metabolite;
fuel additive;
kairomone;
plant metabolite
1992199232.0low001000
hydroxide ionoxygen hydridemouse metabolite1988200826.0low010100
oxaloacetic acidC4-dicarboxylic acid;
oxo dicarboxylic acid
geroprotector;
metabolite
1950195074.0low010000
oxalic acidalpha,omega-dicarboxylic acidalgal metabolite;
human metabolite;
plant metabolite
201720205.7low000060
oxamic aciddicarboxylic acid monoamideEscherichia coli metabolite1988199732.3low012000
4-aminobenzoic acidaminobenzoic acid;
aromatic amino-acid zwitterion
allergen;
Escherichia coli metabolite;
plant metabolite
201220209.2low000080
4-nitrophenol4-nitrophenolshuman xenobiotic metabolite;
mouse metabolite
201120218.7low000061
palmitic acidlong-chain fatty acid;
straight-chain saturated fatty acid
algal metabolite;
Daphnia magna metabolite;
EC 1.1.1.189 (prostaglandin-E2 9-reductase) inhibitor;
plant metabolite
2011201511.0low000040
pentachlorophenolaromatic fungicide;
chlorophenol;
organochlorine pesticide;
pentachlorobenzenes
human xenobiotic metabolite2005201116.3low000210
phenanthreneortho-fused polycyclic arene;
ortho-fused tricyclic hydrocarbon;
phenanthrenes
environmental contaminant;
mouse metabolite
200820209.5low000150
phenolphenolsantiseptic drug;
disinfectant;
human xenobiotic metabolite;
mouse metabolite
1946202320.2low091520163
phenylacetaldehydealpha-CH2-containing aldehyde;
phenylacetaldehydes
Escherichia coli metabolite;
human metabolite;
mouse metabolite;
Saccharomyces cerevisiae metabolite
1987198936.0low020000
phenylacetic acidbenzenes;
monocarboxylic acid;
phenylacetic acids
allergen;
Aspergillus metabolite;
auxin;
EC 6.4.1.1 (pyruvate carboxylase) inhibitor;
Escherichia coli metabolite;
human metabolite;
plant growth retardant;
plant metabolite;
Saccharomyces cerevisiae metabolite;
toxin
2004200420.0low000100
phenethylaminealkaloid;
aralkylamine;
phenylethylamine
Escherichia coli metabolite;
human metabolite;
mouse metabolite
1946194678.0low010000
phosphoenolpyruvatecarboxyalkyl phosphate;
monocarboxylic acid
fundamental metabolite2000200024.0low001000
phosphorylcholinephosphocholinesallergen;
epitope;
hapten;
human metabolite;
mouse metabolite
1991201019.5low101500
phthalic acidbenzenedicarboxylic acidhuman xenobiotic metabolite2009200915.0low000100
diphosphoric acidacyclic phosphorus acid anhydride;
phosphorus oxoacid
Escherichia coli metabolite201820195.3low000030
pqq cofactororthoquinones;
pyrroloquinoline cofactor;
tricarboxylic acid
anti-inflammatory agent;
antioxidant;
cofactor;
water-soluble vitamin (role)
201720177.0low000010
propylene glycolglycol;
propane-1,2-diols
allergen;
human xenobiotic metabolite;
mouse metabolite;
protic solvent
201520159.0low000010
propionic acidsaturated fatty acid;
short-chain fatty acid
antifungal drug1955200633.8low011200
pteridinesazaarene;
mancude organic heterobicyclic parent;
ortho-fused heteroarene;
pteridines
2006200717.5low000200
purinepurine1950200837.7low010200
putrescinealkane-alpha,omega-diamineantioxidant;
fundamental metabolite
2000202114.4low001751
pyrazinamidemonocarboxylic acid amide;
N-acylammonia;
pyrazines
antitubercular agent;
prodrug
1988202119.5low010001
pyrazolepyrazole202020213.5low000011
pyridineazaarene;
mancude organic heteromonocyclic parent;
monocyclic heteroarene;
pyridines
environmental contaminant;
NMR chemical shift reference compound
1950201450.0low030110
pyridoxalhydroxymethylpyridine;
methylpyridines;
monohydroxypyridine;
pyridinecarbaldehyde;
vitamin B6
cofactor;
Escherichia coli metabolite;
human metabolite;
mouse metabolite;
Saccharomyces cerevisiae metabolite
1951199153.0low011000
pyridoxal phosphatemethylpyridines;
monohydroxypyridine;
pyridinecarbaldehyde;
vitamin B6 phosphate
coenzyme;
cofactor;
EC 2.7.7.7 (DNA-directed DNA polymerase) inhibitor;
Escherichia coli metabolite;
human metabolite;
mouse metabolite;
Saccharomyces cerevisiae metabolite
1962201138.3low032110
pyridoxinehydroxymethylpyridine;
methylpyridines;
monohydroxypyridine;
vitamin B6
cofactor;
Escherichia coli metabolite;
human metabolite;
mouse metabolite;
Saccharomyces cerevisiae metabolite
1982202019.3low010020
pyrogallolbenzenetriol;
phenolic donor
plant metabolite1964201726.0low020140
pyruvic acid2-oxo monocarboxylic acidcofactor;
fundamental metabolite
1986202014.2low011470
quinolinic acidpyridinedicarboxylic acidEscherichia coli metabolite;
human metabolite;
mouse metabolite;
NMDA receptor agonist
2013201311.0low000010
dithionitesulfur oxide;
sulfur oxoanion
1980200235.4low031100
sarcosineN-alkylglycine zwitterion;
N-alkylglycine;
N-methyl-amino acid;
N-methylglycines
Escherichia coli metabolite;
glycine receptor agonist;
glycine transporter 1 inhibitor;
human metabolite;
mouse metabolite
1950202221.8low010021
selenic acidselenium oxoacid2010201711.0low000120
selenious acidselenium oxoacid201520168.5low000020
sulfitesdivalent inorganic anion;
sulfur oxide;
sulfur oxoanion
1961202329.3low131131
spermidinepolyazaalkane;
triamine
autophagy inducer;
fundamental metabolite;
geroprotector
1995202114.9low001851
sperminepolyazaalkane;
tetramine
antioxidant;
fundamental metabolite;
immunosuppressive agent
1997202114.8low001632
succinic acidalpha,omega-dicarboxylic acid;
C4-dicarboxylic acid
anti-ulcer drug;
fundamental metabolite;
micronutrient;
nutraceutical;
radiation protective agent
1994201816.2low001120
sulfur dioxidesulfur oxideEscherichia coli metabolite;
food bleaching agent;
refrigerant
2005201714.0low000320
taurineamino sulfonic acid;
zwitterion
antioxidant;
Escherichia coli metabolite;
glycine receptor agonist;
human metabolite;
mouse metabolite;
nutrient;
radical scavenger;
Saccharomyces cerevisiae metabolite
1975202222.0low1132939182
thiamineprimary alcohol;
vitamin B1
Escherichia coli metabolite;
human metabolite;
mouse metabolite;
Saccharomyces cerevisiae metabolite
1963202317.4low021133
thyminepyrimidine nucleobase;
pyrimidone
Escherichia coli metabolite;
human metabolite;
mouse metabolite
1985202222.0low011101
toluenemethylbenzene;
toluenes;
volatile organic compound
cholinergic antagonist;
fuel additive;
neurotoxin;
non-polar solvent
1984201023.5low010300
trimethyloxaminetertiary amine oxideEscherichia coli metabolite;
metabolite;
osmolyte
201420178.3low000030
trimethylaminemethylamines;
tertiary amine
Escherichia coli metabolite;
human xenobiotic metabolite
2001200123.0low000100
tryptamineaminoalkylindole;
aralkylamino compound;
indole alkaloid;
tryptamines
human metabolite;
mouse metabolite;
plant metabolite
201520159.0low000010
uracilpyrimidine nucleobase;
pyrimidone
allergen;
Daphnia magna metabolite;
Escherichia coli metabolite;
human metabolite;
mouse metabolite;
prodrug;
Saccharomyces cerevisiae metabolite
2001202315.4low100401
uric aciduric acidEscherichia coli metabolite;
human metabolite;
mouse metabolite
1964202315.2low4712373514
ureaisourea;
monocarboxylic acid amide;
one-carbon compound
Daphnia magna metabolite;
Escherichia coli metabolite;
fertilizer;
flour treatment agent;
human metabolite;
mouse metabolite;
Saccharomyces cerevisiae metabolite
1948202018.7low03614180
vanillinbenzaldehydes;
monomethoxybenzene;
phenols
anti-inflammatory agent;
anticonvulsant;
antioxidant;
flavouring agent;
plant metabolite
201720215.0low000031
xanthinexanthineSaccharomyces cerevisiae metabolite1949201926.2low036330
4-iodo-2,5-dimethoxyphenylisopropylamineamphetamines;
dimethoxybenzene;
organoiodine compound
2007200717.0low000100
gallopamilbenzenes;
organic amino compound
201620168.0low000010
huperzine aquinolone2013201311.0low000010
mentholp-menthane monoterpenoid;
secondary alcohol
volatile oil component201420197.3low000030
1,10-phenanthrolinephenanthrolineEC 2.7.1.1 (hexokinase) inhibitor;
EC 3.4.19.3 (pyroglutamyl-peptidase I) inhibitor
2002201316.5low000110
1,2-dimethylhydrazinehydrazinesalkylating agent;
carcinogenic agent
1993201818.5low001010
1,3-dipropyl-8-cyclopentylxanthineoxopurineadenosine A1 receptor antagonist;
EC 3.1.4.* (phosphoric diester hydrolase) inhibitor
1997200820.0low001200
s,s'-1,4-phenylene-bis(1,2-ethanediyl)bis-isothiourea2006200717.5low000200
1,5-dihydroxyisoquinolineisoquinolinolEC 2.4.2.30 (NAD(+) ADP-ribosyltransferase) inhibitor2007200717.0low000100
1-(1-naphthyl)piperazineN-arylpiperazine201620168.0low000010
pk 11195aromatic amide;
isoquinolines;
monocarboxylic acid amide;
monochlorobenzenes
antineoplastic agent2005200519.0low000100
1-(3-chlorophenyl)biguanidebiguanides;
monochlorobenzenes
2010201113.5low000110
1-anilino-8-naphthalenesulfonateaminonaphthalene;
naphthalenesulfonic acid
fluorescent probe1993202114.3low20838413
1-methyl-4-phenyl-1,2,3,6-tetrahydropyridinemethylpyridines;
phenylpyridine;
tetrahydropyridine
neurotoxin2005201713.3low000210
1-methylimidazoleimidazoles1989201124.0low010010
n-(3-(aminomethyl)benzyl)acetamidinearalkylamine;
carboxamidine;
primary amino compound
angiogenesis inhibitor;
EC 1.14.13.39 (nitric oxide synthase) inhibitor;
geroprotector
2001201916.5low000740
1h-(1,2,4)oxadiazolo(4,3-a)quinoxalin-1-oneoxadiazoloquinoxalineEC 4.6.1.2 (guanylate cyclase) inhibitor2003200321.0low000100
2,2'-dipyridylbipyridinechelator;
ferroptosis inhibitor
2013201510.0low000020
2,4-dichlorophenoxyacetic acidchlorophenoxyacetic acid;
dichlorobenzene
agrochemical;
defoliant;
EC 1.1.1.25 (shikimate dehydrogenase) inhibitor;
environmental contaminant;
phenoxy herbicide;
synthetic auxin
1994202019.7low004120
2,4-dinitrophenoldinitrophenolallergen;
antiseptic drug;
bacterial xenobiotic metabolite;
geroprotector;
oxidative phosphorylation inhibitor
1994200126.5low002200
2-aminofluorene1990199531.5low002000
mercaptoethanolalkanethiol;
primary alcohol
geroprotector1985199335.0low032000
5,12,20-trihydroxy-6,8,10,14-eicosatetraenoic acid1984199335.5low011000
3,4-methylenedioxyamphetaminebenzodioxoles1996199827.0low002000
amitrolearomatic amine;
triazoles
carotenoid biosynthesis inhibitor;
EC 1.11.1.6 (catalase) inhibitor;
herbicide
1959201535.5low0115310
3-aminobenzamidebenzamides;
substituted aniline
EC 2.4.2.30 (NAD(+) ADP-ribosyltransferase) inhibitor1997201221.2low006810
3-methylcholanthreneortho- and peri-fused polycyclic arenearyl hydrocarbon receptor agonist;
carcinogenic agent
1947194777.0low010000
3-nitropropionic acidC-nitro compoundantimycobacterial drug;
EC 1.3.5.1 [succinate dehydrogenase (quinone)] inhibitor;
mycotoxin;
neurotoxin
201520206.5low000020
ro 5-48642005200618.5low000200
4-(2-aminoethyl)benzenesulfonylfluoride2007200717.0low000100
homovanillic acidguaiacols;
monocarboxylic acid
human metabolite;
mouse metabolite
1991200625.8low003100
4-hydroxybenzoic acid hydrazidecarbohydrazide;
phenols
2000200024.0low001000
5,5-dimethyl-1-pyrroline-1-oxide1-pyrroline nitronesneuroprotective agent;
spin trapping reagent
1980201025.8low037700
phenytoinimidazolidine-2,4-dioneanticonvulsant;
drug allergen;
sodium channel blocker;
teratogenic agent
1984200828.0low010100
5,8,11,14-eicosatetraynoic acidlong-chain fatty acid1994199430.0low001000
5-hydroxydecanoatemedium-chain fatty acid1997201420.3low002010
hydroxyindoleacetic acidindole-3-acetic acidsdrug metabolite;
human metabolite;
mouse metabolite
201420169.0low000020
phenanthridonelactam;
phenanthridines
EC 2.4.2.30 (NAD(+) ADP-ribosyltransferase) inhibitor;
immunosuppressive agent;
mutagen
2002200222.0low000100
7-nitroindazole1996201219.8low001410
8-phenyltheophylline1994199430.0low001000
oxyquinolinemonohydroxyquinolineantibacterial agent;
antifungal agrochemical;
antiseptic drug;
iron chelator
202320231.0low100001
aa 8611,4-benzoquinones;
acetylenic compound;
primary alcohol
EC 1.13.11.34 (arachidonate 5-lipoxygenase) inhibitor;
ferroptosis inhibitor
1991199729.3low003000
2,2'-azobis(2-amidinopropane)monoazo compound1992201423.0low002110
acetaminophenacetamides;
phenols
antipyretic;
cyclooxygenase 1 inhibitor;
cyclooxygenase 2 inhibitor;
cyclooxygenase 3 inhibitor;
environmental contaminant;
ferroptosis inducer;
geroprotector;
hepatotoxic agent;
human blood serum metabolite;
non-narcotic analgesic;
non-steroidal anti-inflammatory drug;
xenobiotic
1989202314.9low01813126
n-acetyltryptophanN-acetyl-amino acid;
tryptophan derivative
metabolite1988198836.0low010000
ag 127nitrophenol2004200420.0low000100
5-aminoisoquinolinoneisoquinolines2004200719.0medium000400
albendazolearyl sulfide;
benzimidazoles;
benzimidazolylcarbamate fungicide;
carbamate ester
anthelminthic drug;
microtubule-destabilising agent;
tubulin modulator
2013201510.0low000020
albuterolphenols;
phenylethanolamines;
secondary amino compound
beta-adrenergic agonist;
bronchodilator agent;
environmental contaminant;
xenobiotic
1995201219.6low101310
alendronate1,1-bis(phosphonic acid);
primary amino compound
bone density conservation agent;
EC 2.5.1.1 (dimethylallyltranstransferase) inhibitor
2004201914.4low000540
alprenololsecondary alcohol;
secondary amino compound
anti-arrhythmia drug;
antihypertensive agent;
beta-adrenergic antagonist;
sympatholytic agent
1992199232.0low001000
amantadineadamantanes;
primary aliphatic amine
analgesic;
antiparkinson drug;
antiviral drug;
dopaminergic agent;
NMDA receptor antagonist;
non-narcotic analgesic
1998199826.0low001000
ambroxolaromatic amine2003201515.0low000110
ametantrone2005200519.0low000100
diatrizoic acidacetamides;
benzoic acids;
organoiodine compound
environmental contaminant;
radioopaque medium;
xenobiotic
2000200024.0low001000
amifostine anhydrousdiamine;
organic thiophosphate
antioxidant;
prodrug;
radiation protective agent
2008201610.2low000130
aminoglutethimidedicarboximide;
piperidones;
substituted aniline
adrenergic agent;
anticonvulsant;
antineoplastic agent;
EC 1.14.14.14 (aromatase) inhibitor
2006201514.7low000210
pimagedineguanidines;
one-carbon compound
EC 1.14.13.39 (nitric oxide synthase) inhibitor;
EC 1.4.3.4 (monoamine oxidase) inhibitor
1994201819.8low00122280
p-aminohippuric acidN-acylglycineDaphnia magna metabolite202020204.0low000010
ampyroneprimary amino compound;
pyrazolone
antipyretic;
antirheumatic drug;
drug metabolite;
EC 1.14.99.1 (prostaglandin-endoperoxide synthase) inhibitor;
marine xenobiotic metabolite;
non-narcotic analgesic;
non-steroidal anti-inflammatory drug;
peripheral nervous system drug
1986202321.4low033431
theophyllinedimethylxanthineadenosine receptor antagonist;
anti-asthmatic drug;
anti-inflammatory agent;
bronchodilator agent;
drug metabolite;
EC 3.1.4.* (phosphoric diester hydrolase) inhibitor;
fungal metabolite;
human blood serum metabolite;
immunomodulator;
muscle relaxant;
vasodilator agent
1985201724.5low113110
2-aminothiazole1,3-thiazoles;
primary amino compound
2003200321.0low000100
amiodarone1-benzofurans;
aromatic ketone;
organoiodine compound;
tertiary amino compound
cardiovascular drug2003200718.3low000300
amitriptylinecarbotricyclic compound;
tertiary amine
adrenergic uptake inhibitor;
antidepressant;
environmental contaminant;
tropomyosin-related kinase B receptor agonist;
xenobiotic
2011201511.0low000020
amlodipinedihydropyridine;
ethyl ester;
methyl ester;
monochlorobenzenes;
primary amino compound
antihypertensive agent;
calcium channel blocker;
vasodilator agent
201520168.5low100020
amodiaquineaminoquinoline;
organochlorine compound;
phenols;
secondary amino compound;
tertiary amino compound
anticoronaviral agent;
antimalarial;
drug allergen;
EC 2.1.1.8 (histamine N-methyltransferase) inhibitor;
non-steroidal anti-inflammatory drug;
prodrug
1991201916.0low001120
amsacrineacridines;
aromatic ether;
sulfonamide
antineoplastic agent;
EC 5.99.1.3 [DNA topoisomerase (ATP-hydrolysing)] inhibitor
1992199232.0low001000
anethole trithionemethoxybenzenes2014201410.0low000010
anthralinanthracenesantipsoriatic1957195767.0low010000
antipyrinepyrazoloneantipyretic;
cyclooxygenase 3 inhibitor;
environmental contaminant;
non-narcotic analgesic;
non-steroidal anti-inflammatory drug;
xenobiotic
1986201815.1low010770
acetovanilloneacetophenones;
aromatic ketone;
methyl ketone
antirheumatic drug;
EC 1.6.3.1. [NAD(P)H oxidase (H2O2-forming)] inhibitor;
non-narcotic analgesic;
non-steroidal anti-inflammatory drug;
peripheral nervous system drug;
plant metabolite
1994202113.6low0017101
apraclonidinedichlorobenzene;
guanidines;
imidazolines
alpha-adrenergic agonist;
antiglaucoma drug;
beta-adrenergic agonist;
diagnostic agent;
ophthalmology drug
1997199727.0low001000
arecolineenoate ester;
methyl ester;
pyridine alkaloid;
tetrahydropyridine
metabolite;
muscarinic agonist
2007200717.0low000100
aspirinbenzoic acids;
phenyl acetates;
salicylates
anticoagulant;
antipyretic;
cyclooxygenase 1 inhibitor;
cyclooxygenase 2 inhibitor;
drug allergen;
EC 1.1.1.188 (prostaglandin-F synthase) inhibitor;
geroprotector;
non-narcotic analgesic;
non-steroidal anti-inflammatory drug;
plant activator;
platelet aggregation inhibitor;
prostaglandin antagonist;
teratogenic agent
1985202317.5low111320211
astemizolebenzimidazoles;
piperidines
anti-allergic agent;
anticoronaviral agent;
H1-receptor antagonist
1993199331.0low001000
atenololethanolamines;
monocarboxylic acid amide;
propanolamine
anti-arrhythmia drug;
antihypertensive agent;
beta-adrenergic antagonist;
environmental contaminant;
sympatholytic agent;
xenobiotic
1994201220.7low001110
atrazinechloro-1,3,5-triazine;
diamino-1,3,5-triazine
environmental contaminant;
herbicide;
xenobiotic
1996201916.0low003450
aurintricarboxylic acidmonohydroxybenzoic acid;
quinomethanes;
tricarboxylic acid
fluorochrome;
histological dye;
insulin-like growth factor receptor 1 antagonist
2003200321.0low000100
azathioprinearyl sulfide;
C-nitro compound;
imidazoles;
thiopurine
antimetabolite;
antineoplastic agent;
carcinogenic agent;
DNA synthesis inhibitor;
hepatotoxic agent;
immunosuppressive agent;
prodrug
1988202115.2low313681
azelaic acidalpha,omega-dicarboxylic acid;
dicarboxylic fatty acid
antibacterial agent;
antineoplastic agent;
dermatologic drug;
plant metabolite
2005200519.0low000100
azelastinemonochlorobenzenes;
phthalazines;
tertiary amino compound
anti-allergic agent;
anti-asthmatic drug;
bronchodilator agent;
EC 1.13.11.34 (arachidonate 5-lipoxygenase) inhibitor;
H1-receptor antagonist;
platelet aggregation inhibitor
1991199630.5low102000
azobenzeneazobenzenes1990199034.0low001000
aztreonam1998199826.0low001000
baclofenamino acid zwitterion;
gamma-amino acid;
monocarboxylic acid;
monochlorobenzenes;
primary amino compound
central nervous system depressant;
GABA agonist;
muscle relaxant
202220222.0low000001
2,2-bis(4-glycidyloxyphenyl)propanediarylmethane2003201117.7low000210
bendroflumethiazidebenzothiadiazine;
sulfonamide
antihypertensive agent;
diuretic
1993199331.0low001000
benzamidebenzamides2010201014.0low000100
benzo(a)pyreneortho- and peri-fused polycyclic arenecarcinogenic agent;
mouse metabolite
1995201720.7low005220
benzothiazidebenzothiadiazine;
sulfonamide
antihypertensive agent;
diuretic
2011201212.5low000020
butylbenzyl phthalatebenzyl ester2012201212.0low000010
bepridilpyrrolidines;
tertiary amine
anti-arrhythmia drug;
antihypertensive agent;
calcium channel blocker;
vasodilator agent
2002200222.0low000100
berberinealkaloid antibiotic;
berberine alkaloid;
botanical anti-fungal agent;
organic heteropentacyclic compound
antilipemic drug;
antineoplastic agent;
antioxidant;
EC 1.1.1.141 [15-hydroxyprostaglandin dehydrogenase (NAD(+))] inhibitor;
EC 1.1.1.21 (aldehyde reductase) inhibitor;
EC 1.13.11.52 (indoleamine 2,3-dioxygenase) inhibitor;
EC 1.21.3.3 (reticuline oxidase) inhibitor;
EC 2.1.1.116 [3'-hydroxy-N-methyl-(S)-coclaurine 4'-O-methyltransferase] inhibitor;
EC 2.1.1.122 [(S)-tetrahydroprotoberberine N-methyltransferase] inhibitor;
EC 2.7.11.10 (IkappaB kinase) inhibitor;
EC 3.1.1.4 (phospholipase A2) inhibitor;
EC 3.1.1.7 (acetylcholinesterase) inhibitor;
EC 3.1.1.8 (cholinesterase) inhibitor;
EC 3.1.3.48 (protein-tyrosine-phosphatase) inhibitor;
EC 3.4.14.5 (dipeptidyl-peptidase IV) inhibitor;
EC 3.4.21.26 (prolyl oligopeptidase) inhibitor;
geroprotector;
hypoglycemic agent;
metabolite;
potassium channel blocker
1993202112.0low0021101
diminazenecarboxamidine;
triazene derivative
antiparasitic agent;
trypanocidal drug
201920204.5low000020
beta-naphthoflavoneextended flavonoid;
naphtho-gamma-pyrone;
organic heterotricyclic compound
aryl hydrocarbon receptor agonist1997199727.0low001000
bethanecholcarbamate ester;
quaternary ammonium ion
muscarinic agonist2007200816.5low000200
bicalutamide(trifluoromethyl)benzenes;
monocarboxylic acid amide;
monofluorobenzenes;
nitrile;
sulfone;
tertiary alcohol
201520159.0low000010
bisbenzimidazolebibenzimidazole;
N-methylpiperazine
anthelminthic drug;
fluorochrome
2000200024.0low001000
bisindolylmaleimide i1993199927.3low003000
bisoprololsecondary alcohol;
secondary amine
anti-arrhythmia drug;
antihypertensive agent;
beta-adrenergic antagonist;
sympatholytic agent
2000202113.5low001001
bromhexineorganobromine compound;
substituted aniline;
tertiary amino compound
mucolytic2003200321.0low000100
seratrodastorganic molecular entity2013201311.0low000010
bupivacainearomatic amide;
piperidinecarboxamide;
tertiary amino compound
2011201113.0low000010
buspironeazaspiro compound;
N-alkylpiperazine;
N-arylpiperazine;
organic heteropolycyclic compound;
piperidones;
pyrimidines
anxiolytic drug;
EC 3.4.21.26 (prolyl oligopeptidase) inhibitor;
sedative;
serotonergic agonist
2014201410.0low000010
busulfanmethanesulfonate esteralkylating agent;
antineoplastic agent;
carcinogenic agent;
insect sterilant;
teratogenic agent
201420226.0low000011
cacodylic acidorganoarsenic compoundxenobiotic metabolite2009200915.0low000100
cadralazineorganic molecular entity1991199133.0low001000
caffeinepurine alkaloid;
trimethylxanthine
adenosine A2A receptor antagonist;
adenosine receptor antagonist;
adjuvant;
central nervous system stimulant;
diuretic;
EC 2.7.11.1 (non-specific serine/threonine protein kinase) inhibitor;
EC 3.1.4.* (phosphoric diester hydrolase) inhibitor;
environmental contaminant;
food additive;
fungal metabolite;
geroprotector;
human blood serum metabolite;
mouse metabolite;
mutagen;
plant metabolite;
psychotropic drug;
ryanodine receptor agonist;
xenobiotic
1995201814.4low002140
verapamilaromatic ether;
nitrile;
polyether;
tertiary amino compound
1989200428.0low015300
camphor, (+-)-isomerbornane monoterpenoid;
cyclic monoterpene ketone
plant metabolite2005200718.0low000200
candesartanbenzimidazolecarboxylic acid;
biphenylyltetrazole
angiotensin receptor antagonist;
antihypertensive agent;
environmental contaminant;
xenobiotic
2003201017.2low000600
carbamazepinedibenzoazepine;
ureas
analgesic;
anticonvulsant;
antimanic drug;
drug allergen;
EC 3.5.1.98 (histone deacetylase) inhibitor;
environmental contaminant;
glutamate transporter activator;
mitogen;
non-narcotic analgesic;
sodium channel blocker;
xenobiotic
1993201615.8low001120
carbofuran1-benzofurans;
carbamate ester
acaricide;
agrochemical;
avicide;
carbamate insecticide;
EC 3.1.1.7 (acetylcholinesterase) inhibitor;
EC 3.1.1.8 (cholinesterase) inhibitor;
nematicide
1985201922.0low010010
carmustineN-nitrosoureas;
organochlorine compound
alkylating agent;
antineoplastic agent
1983199237.0low021000
carvedilolcarbazoles;
secondary alcohol;
secondary amino compound
alpha-adrenergic antagonist;
antihypertensive agent;
beta-adrenergic antagonist;
cardiovascular drug;
vasodilator agent
1992202119.0low007631
celecoxiborganofluorine compound;
pyrazoles;
sulfonamide;
toluenes
cyclooxygenase 2 inhibitor;
geroprotector;
non-narcotic analgesic;
non-steroidal anti-inflammatory drug
2000201416.9low1021060
cetirizineether;
monocarboxylic acid;
monochlorobenzenes;
piperazines
anti-allergic agent;
environmental contaminant;
H1-receptor antagonist;
xenobiotic
1997199727.0low101000
cetyltrimethylammonium ionquaternary ammonium ion1981202324.1low041221
chelerythrinebenzophenanthridine alkaloid;
organic cation
antibacterial agent;
antineoplastic agent;
EC 2.7.11.13 (protein kinase C) inhibitor
2000201417.0low001010
chloroquineaminoquinoline;
organochlorine compound;
secondary amino compound;
tertiary amino compound
anticoronaviral agent;
antimalarial;
antirheumatic drug;
autophagy inhibitor;
dermatologic drug
1986202223.1low032111
chlorpheniraminemonochlorobenzenes;
pyridines;
tertiary amino compound
anti-allergic agent;
antidepressant;
antipruritic drug;
H1-receptor antagonist;
histamine antagonist;
serotonin uptake inhibitor
2003200520.0low000200
chlorpromazineorganochlorine compound;
phenothiazines;
tertiary amine
anticoronaviral agent;
antiemetic;
dopaminergic antagonist;
EC 3.4.21.26 (prolyl oligopeptidase) inhibitor;
phenothiazine antipsychotic drug
1957200837.5low036200
chlorpyrifoschloropyridine;
organic thiophosphate
acaricide;
agrochemical;
EC 3.1.1.7 (acetylcholinesterase) inhibitor;
EC 3.1.1.8 (cholinesterase) inhibitor;
environmental contaminant;
insecticide;
xenobiotic
200920179.6low000160
ciglitazonearomatic ether;
thiazolidinone
antineoplastic agent;
insulin-sensitizing drug
2007201015.5low000400
cilostazollactam;
tetrazoles
anticoagulant;
bronchodilator agent;
EC 3.1.4.17 (3',5'-cyclic-nucleotide phosphodiesterase) inhibitor;
fibrin modulating drug;
neuroprotective agent;
platelet aggregation inhibitor;
vasodilator agent
2006201414.4low000430
cimaterolbenzenes;
nitrile
1992199232.0low001000
cimetidinealiphatic sulfide;
guanidines;
imidazoles;
nitrile
adjuvant;
analgesic;
anti-ulcer drug;
H2-receptor antagonist;
P450 inhibitor
1992201023.5low005500
eucalyptol2004201612.4low000250
ciprofloxacinaminoquinoline;
cyclopropanes;
fluoroquinolone antibiotic;
N-arylpiperazine;
quinolinemonocarboxylic acid;
quinolone antibiotic;
quinolone;
zwitterion
antibacterial drug;
antiinfective agent;
antimicrobial agent;
DNA synthesis inhibitor;
EC 5.99.1.3 [DNA topoisomerase (ATP-hydrolysing)] inhibitor;
environmental contaminant;
topoisomerase IV inhibitor;
xenobiotic
1998202212.3low002031
citalopram2-benzofurans;
cyclic ether;
nitrile;
organofluorine compound;
tertiary amino compound
201920195.0low000010
clenbuterolamino alcohol;
dichlorobenzene;
ethanolamines;
primary arylamine;
secondary amino compound;
substituted aniline
beta-adrenergic agonist;
bronchodilator agent;
sympathomimetic agent
201920223.5low000011
clofaziminemonochlorobenzenes;
phenazines
dye;
leprostatic drug;
non-steroidal anti-inflammatory drug
1987199333.7low012000
clonidineclonidine;
imidazoline
1983201623.0low012020
clotrimazoleconazole antifungal drug;
imidazole antifungal drug;
imidazoles;
monochlorobenzenes
antiinfective agent;
environmental contaminant;
xenobiotic
1974201322.0low010220
4-cresolcresolEscherichia coli metabolite;
human metabolite;
uremic toxin
2003200321.0low000200
cypermethrinaromatic ether;
cyclopropanecarboxylate ester;
nitrile;
organochlorine compound
agrochemical;
molluscicide;
pyrethroid ester acaricide;
pyrethroid ester insecticide
2014201410.0low000010
cytochalasin c2003200321.0low000100
dapiindolesfluorochrome200920209.8low000130
dapsonesubstituted aniline;
sulfone
anti-inflammatory drug;
antiinfective agent;
antimalarial;
leprostatic drug
1978202227.7low079521
2,3-dimethoxy-5-methyl-6-decyl-1,4-benzoquinone1,4-benzoquinonescofactor1989198935.0low010000
deferoxamineacyclic desferrioxaminebacterial metabolite;
ferroptosis inhibitor;
iron chelator;
siderophore
1984202327.0low0615341
desipraminedibenzoazepine;
secondary amino compound
adrenergic uptake inhibitor;
alpha-adrenergic antagonist;
antidepressant;
cholinergic antagonist;
drug allergen;
EC 3.1.4.12 (sphingomyelin phosphodiesterase) inhibitor;
EC 3.4.21.26 (prolyl oligopeptidase) inhibitor;
H1-receptor antagonist;
serotonin uptake inhibitor
2008200816.0low000100
eflornithinealpha-amino acid;
fluoroamino acid
trypanocidal drug1991200822.0low002400
r 59022diarylmethane2011201113.0low000010
diazinonorganic thiophosphate;
pyrimidines
acaricide;
agrochemical;
EC 3.1.1.7 (acetylcholinesterase) inhibitor;
EC 3.1.1.8 (cholinesterase) inhibitor;
environmental contaminant;
nematicide;
xenobiotic
202320231.0low000001
diazoxidebenzothiadiazine;
organochlorine compound;
sulfone
antihypertensive agent;
beta-adrenergic agonist;
bronchodilator agent;
cardiotonic drug;
diuretic;
K-ATP channel agonist;
sodium channel blocker;
sympathomimetic agent;
vasodilator agent
1999201415.1low001240
dibenzothiophenedibenzothiophenes;
mancude organic heterotricyclic parent
keratolytic drug202120213.0low000001
dibutyl phthalatediester;
phthalate ester
EC 3.2.1.20 (alpha-glucosidase) inhibitor;
environmental contaminant;
metabolite;
plasticiser;
teratogenic agent
201420188.0low000020
diclofenacamino acid;
aromatic amine;
dichlorobenzene;
monocarboxylic acid;
secondary amino compound
antipyretic;
drug allergen;
EC 1.14.99.1 (prostaglandin-endoperoxide synthase) inhibitor;
environmental contaminant;
non-narcotic analgesic;
non-steroidal anti-inflammatory drug;
xenobiotic
1990202315.9low0051192
ddtbenzenoid aromatic compound;
chlorophenylethane;
monochlorobenzenes;
organochlorine insecticide
bridged diphenyl acaricide;
carcinogenic agent;
endocrine disruptor;
persistent organic pollutant
1963201535.0low010010
dichlorvosalkenyl phosphate;
dialkyl phosphate;
organochlorine acaricide;
organophosphate insecticide
anthelminthic drug;
antibacterial agent;
antifungal agent;
EC 3.1.1.7 (acetylcholinesterase) inhibitor;
EC 3.1.1.8 (cholinesterase) inhibitor
201920195.0low000010
diethyl pyrocarbonateacyclic carboxylic anhydride1991200227.5low001100
diethylcarbamazineN-carbamoylpiperazine;
N-methylpiperazine
1996199628.0low001000
pentetic acidpentacarboxylic acidcopper chelator1999201220.5low002310
dihydrocytochalasin b1987198737.0low010000
3,3'-diindolylmethaneindolesantineoplastic agent;
P450 inhibitor
2000200919.5low001100
dimapritimidothiocarbamic ester202220222.0low000001
dimethoatemonocarboxylic acid amide;
organic thiophosphate
acaricide;
agrochemical;
EC 3.1.1.7 (acetylcholinesterase) inhibitor;
EC 3.1.1.8 (cholinesterase) inhibitor;
environmental contaminant;
insecticide;
xenobiotic
2011201710.0low000020
diphenyleneiodoniumorganic cation2001201914.5low000740
dipyridamolepiperidines;
pyrimidopyrimidine;
tertiary amino compound;
tetrol
adenosine phosphodiesterase inhibitor;
EC 3.5.4.4 (adenosine deaminase) inhibitor;
platelet aggregation inhibitor;
vasodilator agent
1988201227.8low021010
dipyrithionepyridinium ion2011201113.0low000010
disulfiramorganic disulfide;
organosulfur acaricide
angiogenesis inhibitor;
antineoplastic agent;
apoptosis inducer;
EC 1.2.1.3 [aldehyde dehydrogenase (NAD(+))] inhibitor;
EC 3.1.1.1 (carboxylesterase) inhibitor;
EC 3.1.1.8 (cholinesterase) inhibitor;
EC 5.99.1.2 (DNA topoisomerase) inhibitor;
ferroptosis inducer;
fungicide;
NF-kappaB inhibitor
1950201036.7low010200
diuron3-(3,4-substituted-phenyl)-1,1-dimethylurea;
dichlorobenzene
environmental contaminant;
mitochondrial respiratory-chain inhibitor;
photosystem-II inhibitor;
urea herbicide;
xenobiotic
2001200123.0low000100
valproic acidbranched-chain fatty acid;
branched-chain saturated fatty acid
anticonvulsant;
antimanic drug;
EC 3.5.1.98 (histone deacetylase) inhibitor;
GABA agent;
neuroprotective agent;
psychotropic drug;
teratogenic agent
201220208.5low0000150
valproic acidbranched-chain fatty acid;
branched-chain saturated fatty acid
anticonvulsant;
antimanic drug;
EC 3.5.1.98 (histone deacetylase) inhibitor;
GABA agent;
neuroprotective agent;
psychotropic drug;
teratogenic agent
201220208.5low0000140
2,3-dimethoxy-1,4-naphthoquinone1,4-naphthoquinones201520159.0low000010
donepezilaromatic ether;
indanones;
piperidines;
racemate
EC 3.1.1.7 (acetylcholinesterase) inhibitor;
EC 3.1.1.8 (cholinesterase) inhibitor;
nootropic agent
201820186.0low000010
droperidolaromatic ketone;
benzimidazoles;
organofluorine compound
anaesthesia adjuvant;
antiemetic;
dopaminergic antagonist;
first generation antipsychotic
1993199331.0low001000
dup 697thiophenes2004200420.0low000100
ebselenbenzoselenazoleanti-inflammatory drug;
antibacterial agent;
anticoronaviral agent;
antifungal agent;
antineoplastic agent;
antioxidant;
apoptosis inducer;
EC 1.13.11.33 (arachidonate 15-lipoxygenase) inhibitor;
EC 1.13.11.34 (arachidonate 5-lipoxygenase) inhibitor;
EC 1.3.1.8 [acyl-CoA dehydrogenase (NADP(+))] inhibitor;
EC 1.8.1.12 (trypanothione-disulfide reductase) inhibitor;
EC 2.5.1.7 (UDP-N-acetylglucosamine 1-carboxyvinyltransferase) inhibitor;
EC 2.7.10.1 (receptor protein-tyrosine kinase) inhibitor;
EC 3.1.3.25 (inositol-phosphate phosphatase) inhibitor;
EC 3.4.22.69 (SARS coronavirus main proteinase) inhibitor;
EC 3.5.4.1 (cytosine deaminase) inhibitor;
EC 5.1.3.2 (UDP-glucose 4-epimerase) inhibitor;
enzyme mimic;
ferroptosis inhibitor;
genotoxin;
hepatoprotective agent;
neuroprotective agent;
radical scavenger
1994200522.2low001400
9-(2-hydroxy-3-nonyl)adenine2007201512.0low000120
eicosa-11,14-dienoic acidlong-chain fatty acid1996199628.0low001000
ellipticineindole alkaloid;
organic heterotetracyclic compound;
organonitrogen heterocyclic compound;
polycyclic heteroarene
antineoplastic agent;
plant metabolite
2009202010.7low000120
embelindihydroxy-1,4-benzoquinonesantimicrobial agent;
antineoplastic agent;
hepatitis C protease inhibitor;
plant metabolite
1991201516.0low001030
emodintrihydroxyanthraquinoneantineoplastic agent;
laxative;
plant metabolite;
tyrosine kinase inhibitor
2007202211.2low000561
endosulfancyclic sulfite ester;
cyclodiene organochlorine insecticide
acaricide;
agrochemical;
GABA-gated chloride channel antagonist;
persistent organic pollutant
2003200918.0low000200
epirizolearomatic ether1998199826.0low001000
erythrosine1984202318.6low13811113
ethacrynic acidaromatic ether;
aromatic ketone;
dichlorobenzene;
monocarboxylic acid
EC 2.5.1.18 (glutathione transferase) inhibitor;
ion transport inhibitor;
loop diuretic
1994199430.0low001000
etherether;
volatile organic compound
inhalation anaesthetic;
non-polar solvent;
refrigerant
2006201811.0low000120
etidronate1,1-bis(phosphonic acid)antineoplastic agent;
bone density conservation agent;
chelator
1993199331.0low001000
famotidine1,3-thiazoles;
guanidines;
sulfonamide
anti-ulcer drug;
H2-receptor antagonist;
P450 inhibitor
1993201719.7low104720
carbonyl cyanide p-trifluoromethoxyphenylhydrazonearomatic ether;
hydrazone;
nitrile;
organofluorine compound
ATP synthase inhibitor;
geroprotector;
ionophore
1986198638.0low010000
fenofibratearomatic ether;
chlorobenzophenone;
isopropyl ester;
monochlorobenzenes
antilipemic drug;
environmental contaminant;
geroprotector;
xenobiotic
2009201014.5low000200
fentanylanilide;
monocarboxylic acid amide;
piperidines
adjuvant;
anaesthesia adjuvant;
anaesthetic;
intravenous anaesthetic;
mu-opioid receptor agonist;
opioid analgesic
1993200027.5low002000
fenthionorganic thiophosphateacaricide;
agrochemical;
avicide;
EC 3.1.1.7 (acetylcholinesterase) inhibitor;
EC 3.1.1.8 (cholinesterase) inhibitor;
insecticide
2011201113.0low000010
fluconazoleconazole antifungal drug;
difluorobenzene;
tertiary alcohol;
triazole antifungal drug
environmental contaminant;
P450 inhibitor;
xenobiotic
1999201916.5low101210
flufenamic acidaromatic amino acid;
organofluorine compound
antipyretic;
EC 1.14.99.1 (prostaglandin-endoperoxide synthase) inhibitor;
non-narcotic analgesic;
non-steroidal anti-inflammatory drug
1979200828.4low020300
flumazenilethyl ester;
imidazobenzodiazepine;
organofluorine compound
antidote to benzodiazepine poisoning;
GABA antagonist
2005200519.0low000100
flunitrazepam1,4-benzodiazepinone;
C-nitro compound;
monofluorobenzenes
anxiolytic drug;
GABAA receptor agonist;
sedative
1993199331.0low001000
fluorouracilnucleobase analogue;
organofluorine compound
antimetabolite;
antineoplastic agent;
environmental contaminant;
immunosuppressive agent;
radiosensitizing agent;
xenobiotic
1992202213.5low10413212
fluoxetine(trifluoromethyl)benzenes;
aromatic ether;
secondary amino compound
2008201910.0low000140
flurbiprofenfluorobiphenyl;
monocarboxylic acid
antipyretic;
EC 1.14.99.1 (prostaglandin-endoperoxide synthase) inhibitor;
non-narcotic analgesic;
non-steroidal anti-inflammatory drug
1998201321.5low003210
flutamide(trifluoromethyl)benzenes;
monocarboxylic acid amide
androgen antagonist;
antineoplastic agent
1983200922.6low011500
furegrelatebenzofurans1989199034.5low011000
furosemidechlorobenzoic acid;
furans;
sulfonamide
environmental contaminant;
loop diuretic;
xenobiotic
2003201714.6low000430
gabapentingamma-amino acidanticonvulsant;
calcium channel blocker;
environmental contaminant;
xenobiotic
200320219.3low000111
gabexatebenzoate ester1993200225.6low003200
gemfibrozilaromatic etherantilipemic drug1995199529.0low001000
gentamicin1993201817.6low103750
2,5-dihydroxybenzoic aciddihydroxybenzoic acidEC 1.13.11.33 (arachidonate 15-lipoxygenase) inhibitor;
fungal metabolite;
human metabolite;
MALDI matrix material;
mouse metabolite
1989199930.0low011000
gliclazideN-sulfonylureahypoglycemic agent;
insulin secretagogue;
radical scavenger
201520206.0low000030
glimepiridesulfonamide2011201113.0low000010
glutaraldialdehydecross-linking reagent;
disinfectant;
fixative
1985201623.3low021220
glutethimidepiperidines2007200717.0low000100
glyburidemonochlorobenzenes;
N-sulfonylurea
anti-arrhythmia drug;
EC 2.7.1.33 (pantothenate kinase) inhibitor;
EC 3.6.3.49 (channel-conductance-controlling ATPase) inhibitor;
hypoglycemic agent
1992201517.4low204370
glyphosateglycine derivative;
phosphonic acid
agrochemical;
EC 2.5.1.19 (3-phosphoshikimate 1-carboxyvinyltransferase) inhibitor;
herbicide
201120235.7low000066
go 6976indolocarbazole;
organic heterohexacyclic compound
EC 2.7.11.13 (protein kinase C) inhibitor2011201113.0low000010
gossypol1990201321.0low001110
guaifenesinmethoxybenzenes201920195.0low000010
guaifenesinmethoxybenzenes1996202114.1low30711183
guanethidineazocanes;
guanidines
adrenergic antagonist;
antihypertensive agent;
sympatholytic agent
2000200024.0low001000
guanidinecarboxamidine;
guanidines;
one-carbon compound
1983201325.2low012410
bis(2-guanidinoethyl)disulfide2001200123.0low000100
1-(5-isoquinolinesulfonyl)-2-methylpiperazineisoquinolines;
N-sulfonylpiperazine
EC 2.7.11.13 (protein kinase C) inhibitor1986201419.6low011030
fasudilisoquinolines;
N-sulfonyldiazepane
antihypertensive agent;
calcium channel blocker;
EC 2.7.11.1 (non-specific serine/threonine protein kinase) inhibitor;
geroprotector;
neuroprotective agent;
nootropic agent;
vasodilator agent
2000201415.0low001030
haloperidolaromatic ketone;
hydroxypiperidine;
monochlorobenzenes;
organofluorine compound;
tertiary alcohol
antidyskinesia agent;
antiemetic;
dopaminergic antagonist;
first generation antipsychotic;
serotonergic antagonist
1992201422.5low003210
harmalineharmala alkaloidoneirogen2002200222.0low000100
hexamethoniumquaternary ammonium salt1999201619.6low001610
ethidiumphenanthridinesfluorochrome;
intercalator
1995200722.3low001200
hydralazineazaarene;
hydrazines;
ortho-fused heteroarene;
phthalazines
antihypertensive agent;
vasodilator agent
1990202123.8low0013141
hydroxychloroquineaminoquinoline;
organochlorine compound;
primary alcohol;
secondary amino compound;
tertiary amino compound
anticoronaviral agent;
antimalarial;
antirheumatic drug;
dermatologic drug
201520159.0low000010
hydroxyureaone-carbon compound;
ureas
antimetabolite;
antimitotic;
antineoplastic agent;
DNA synthesis inhibitor;
EC 1.17.4.1 (ribonucleoside-diphosphate reductase) inhibitor;
genotoxin;
immunomodulator;
radical scavenger;
teratogenic agent
1984201926.7low156410
hypericin1999200721.0low001100
ibuprofenmonocarboxylic acidantipyretic;
cyclooxygenase 1 inhibitor;
cyclooxygenase 2 inhibitor;
drug allergen;
environmental contaminant;
geroprotector;
non-narcotic analgesic;
non-steroidal anti-inflammatory drug;
radical scavenger;
xenobiotic
1991201523.1low009530
lidocainebenzenes;
monocarboxylic acid amide;
tertiary amino compound
anti-arrhythmia drug;
drug allergen;
environmental contaminant;
local anaesthetic;
xenobiotic
1985202022.6low131140
ifosfamideifosfamidesalkylating agent;
antineoplastic agent;
environmental contaminant;
immunosuppressive agent;
xenobiotic
2007200717.0low000100
imipraminedibenzoazepineadrenergic uptake inhibitor;
antidepressant;
EC 3.4.21.26 (prolyl oligopeptidase) inhibitor
2010201014.0low000100
amrinonebipyridinesEC 3.1.4.* (phosphoric diester hydrolase) inhibitor2002200222.0low000200
indole-3-carbinolindolyl alcoholantineoplastic agent;
plant metabolite
2005202310.0low000101
indomethacinaromatic ether;
indole-3-acetic acids;
monochlorobenzenes;
N-acylindole
analgesic;
drug metabolite;
EC 1.14.99.1 (prostaglandin-endoperoxide synthase) inhibitor;
environmental contaminant;
gout suppressant;
non-steroidal anti-inflammatory drug;
xenobiotic metabolite;
xenobiotic
1979202320.6low2107189385
iodoacetamide1981201625.0low0561030
iohexolbenzenedicarboxamide;
organoiodine compound
environmental contaminant;
radioopaque medium;
xenobiotic
2003201314.7low000120
iopromidedicarboxylic acid diamide;
organoiodine compound
environmental contaminant;
nephrotoxic agent;
radioopaque medium;
xenobiotic
2013201311.0low000010
iproniazidcarbohydrazide;
pyridines
1991199133.0low001000
irsogladinedichlorobenzene2004200817.3low000300
1-methyl-3-isobutylxanthine3-isobutyl-1-methylxanthine1984200531.0low030200
isofluraneorganofluorine compoundinhalation anaesthetic1991201713.8low101290
isoniazidcarbohydrazideantitubercular agent;
drug allergen
1957202229.6low014129111
isoniazidcarbohydrazideantitubercular agent;
drug allergen
1957202228.8low0141311121
2-propanolsecondary alcohol;
secondary fatty alcohol
protic solvent1984201228.7low039210
isoproterenolcatechols;
secondary alcohol;
secondary amino compound
beta-adrenergic agonist;
bronchodilator agent;
cardiotonic drug;
sympathomimetic agent
1986202320.8low023641
ketaminecyclohexanones;
monochlorobenzenes;
secondary amino compound
analgesic;
environmental contaminant;
intravenous anaesthetic;
neurotoxin;
NMDA receptor antagonist;
xenobiotic
1983202114.0low011351
ketanserinaromatic ketone;
organofluorine compound;
piperidines;
quinazolines
alpha-adrenergic antagonist;
antihypertensive agent;
cardiovascular drug;
EC 3.4.21.26 (prolyl oligopeptidase) inhibitor;
serotonergic antagonist
2007200717.0low000100
ketoconazoledichlorobenzene;
dioxolane;
ether;
imidazoles;
N-acylpiperazine;
N-arylpiperazine
1983201525.3low111010
ketoprofenbenzophenones;
oxo monocarboxylic acid
antipyretic;
drug allergen;
EC 1.14.99.1 (prostaglandin-endoperoxide synthase) inhibitor;
environmental contaminant;
non-steroidal anti-inflammatory drug;
xenobiotic
2000200024.0low001000
ketorolacamino acid;
aromatic ketone;
monocarboxylic acid;
pyrrolizines;
racemate
analgesic;
cyclooxygenase 1 inhibitor;
cyclooxygenase 2 inhibitor;
non-steroidal anti-inflammatory drug
2009200915.0low000100
ketotifencyclic ketone;
olefinic compound;
organic heterotricyclic compound;
organosulfur heterocyclic compound;
piperidines;
tertiary amino compound
anti-asthmatic drug;
H1-receptor antagonist
1996200722.7low003300
kinetin6-aminopurines;
furans
cytokinin;
geroprotector
1983201621.4low011120
kynurenic acidmonohydroxyquinoline;
quinolinemonocarboxylic acid
G-protein-coupled receptor agonist;
human metabolite;
neuroprotective agent;
nicotinic antagonist;
NMDA receptor antagonist;
Saccharomyces cerevisiae metabolite
2008202211.2low000221
lamotrigine1,2,4-triazines;
dichlorobenzene;
primary arylamine
anticonvulsant;
antidepressant;
antimanic drug;
calcium channel blocker;
EC 3.4.21.26 (prolyl oligopeptidase) inhibitor;
environmental contaminant;
excitatory amino acid antagonist;
geroprotector;
non-narcotic analgesic;
xenobiotic
2007200717.0low000100
lansoprazolebenzimidazoles;
pyridines;
sulfoxide
anti-ulcer drug;
EC 3.6.3.10 (H(+)/K(+)-exchanging ATPase) inhibitor
1997202115.9low101621
lauric acidmedium-chain fatty acid;
straight-chain saturated fatty acid
algal metabolite;
antibacterial agent;
plant metabolite
1988198836.0low010000
leflunomide(trifluoromethyl)benzenes;
isoxazoles;
monocarboxylic acid amide
antineoplastic agent;
antiparasitic agent;
EC 1.3.98.1 [dihydroorotate oxidase (fumarate)] inhibitor;
EC 3.1.3.16 (phosphoprotein phosphatase) inhibitor;
hepatotoxic agent;
immunosuppressive agent;
non-steroidal anti-inflammatory drug;
prodrug;
pyrimidine synthesis inhibitor;
tyrosine kinase inhibitor
1995201516.3low001410
letrozolenitrile;
triazoles
antineoplastic agent;
EC 1.14.14.14 (aromatase) inhibitor
201720177.0low000010
liranaftatetetralins2010201014.0low000100
lomefloxacinfluoroquinolone antibiotic;
N-arylpiperazine;
quinolinemonocarboxylic acid;
quinolone antibiotic;
quinolone
antimicrobial agent;
antitubercular agent;
photosensitizing agent
202220222.0low000001
loratadinebenzocycloheptapyridine;
ethyl ester;
N-acylpiperidine;
organochlorine compound;
tertiary carboxamide
anti-allergic agent;
cholinergic antagonist;
geroprotector;
H1-receptor antagonist
1997200622.5low101100
lorglumidebenzamides;
dicarboxylic acid monoamide;
dichlorobenzene;
glutamic acid derivative
2010201014.0low000100
losartanbiphenylyltetrazole;
imidazoles
angiotensin receptor antagonist;
anti-arrhythmia drug;
antihypertensive agent;
endothelin receptor antagonist
2002201715.9low000630
loxapinedibenzooxazepineantipsychotic agent;
dopaminergic antagonist
1997199727.0low001000
loxoprofencyclopentanones;
monocarboxylic acid
antipyretic;
EC 1.14.99.1 (prostaglandin-endoperoxide synthase) inhibitor;
non-narcotic analgesic;
non-steroidal anti-inflammatory drug;
prodrug
2010201312.0low000120
ly 171883acetophenones;
aromatic ether;
phenols;
tetrazoles
anti-asthmatic drug;
leukotriene antagonist
1994199430.0low001000
2-(4-morpholinyl)-8-phenyl-4h-1-benzopyran-4-onechromones;
morpholines;
organochlorine compound
autophagy inhibitor;
EC 2.7.1.137 (phosphatidylinositol 3-kinase) inhibitor;
geroprotector
1997201714.9low001240
malathiondiester;
ethyl ester;
organic thiophosphate
201420235.3low000042
maprotilineanthracenes2013201311.0low000010
edaravonepyrazoloneantioxidant;
radical scavenger
2003202212.4low000661
mebendazolearomatic ketone;
benzimidazoles;
carbamate ester
antinematodal drug;
microtubule-destabilising agent;
tubulin modulator
201520159.0low000010
mechlorethaminenitrogen mustard;
organochlorine compound
alkylating agent1950201533.7low0410040
meclizinediarylmethane2013201311.0low000010
meclofenamic acidaminobenzoic acid;
organochlorine compound;
secondary amino compound
analgesic;
anticonvulsant;
antineoplastic agent;
antipyretic;
antirheumatic drug;
EC 1.13.11.34 (arachidonate 5-lipoxygenase) inhibitor;
EC 1.14.99.1 (prostaglandin-endoperoxide synthase) inhibitor;
non-steroidal anti-inflammatory drug
1992199530.5low002000
meclofenoxatemonocarboxylic acid2003200321.0low000100
mefenamic acidaminobenzoic acid;
secondary amino compound
analgesic;
antipyretic;
antirheumatic drug;
EC 1.14.99.1 (prostaglandin-endoperoxide synthase) inhibitor;
environmental contaminant;
non-steroidal anti-inflammatory drug;
xenobiotic
201920195.0low000010
memantineadamantanes;
primary aliphatic amine
antidepressant;
antiparkinson drug;
dopaminergic agent;
neuroprotective agent;
NMDA receptor antagonist
1998201812.5low001030
vitamin k 31,4-naphthoquinones;
vitamin K
angiogenesis inhibitor;
antineoplastic agent;
EC 3.4.22.69 (SARS coronavirus main proteinase) inhibitor;
human urinary metabolite;
nutraceutical
200520219.0low000111
meperidineethyl ester;
piperidinecarboxylate ester;
tertiary amino compound
antispasmodic drug;
kappa-opioid receptor agonist;
mu-opioid receptor agonist;
opioid analgesic
1949200845.5low010100
2-mercaptoethylguanidine2000200024.0low003000
mesalamineamino acid;
aromatic amine;
monocarboxylic acid;
monohydroxybenzoic acid;
phenols
non-steroidal anti-inflammatory drug1989202218.3low021512173
metforminguanidinesenvironmental contaminant;
geroprotector;
hypoglycemic agent;
xenobiotic
201020228.0low000182
methacrylic acidalpha,beta-unsaturated monocarboxylic acid2007200717.0low000100
methadonebenzenes;
diarylmethane;
ketone;
tertiary amino compound
1949201439.7low011010
methocarbamolaromatic ether;
carbamate ester;
secondary alcohol
201720177.0low000010
methoxsalenaromatic ether;
psoralens
antineoplastic agent;
cross-linking reagent;
dermatologic drug;
photosensitizing agent;
plant metabolite
201920195.0low000010
methoxychlororganochlorine insecticide2000200024.0low001000
methyl parathionC-nitro compound;
organic thiophosphate;
organothiophosphate insecticide
acaricide;
agrochemical;
antifungal agent;
EC 3.1.1.7 (acetylcholinesterase) inhibitor;
EC 3.1.1.8 (cholinesterase) inhibitor;
environmental contaminant;
genotoxin
2005201016.5low000200
methyl parathionC-nitro compound;
organic thiophosphate;
organothiophosphate insecticide
acaricide;
agrochemical;
antifungal agent;
EC 3.1.1.7 (acetylcholinesterase) inhibitor;
EC 3.1.1.8 (cholinesterase) inhibitor;
environmental contaminant;
genotoxin
2010201014.0low000100
methyl salicylatebenzoate ester;
methyl ester;
salicylates
flavouring agent;
insect attractant;
metabolite
2002202011.0low000120
methyl salicylatebenzoate ester;
methyl ester;
salicylates
flavouring agent;
insect attractant;
metabolite
2003201314.2low000130
methylphenidatebeta-amino acid ester;
methyl ester;
piperidines
2003200321.0low000100
metolachloraromatic amide;
benzenes;
ether;
organochlorine compound
201020199.5low000110
metoprololaromatic ether;
propanolamine;
secondary alcohol;
secondary amino compound
antihypertensive agent;
beta-adrenergic antagonist;
environmental contaminant;
geroprotector;
xenobiotic
1996202217.6low102201
metronidazoleC-nitro compound;
imidazoles;
primary alcohol
antiamoebic agent;
antibacterial drug;
antimicrobial agent;
antiparasitic agent;
antitrichomonal drug;
environmental contaminant;
prodrug;
radiosensitizing agent;
xenobiotic
1993201021.4low003400
metyraponearomatic ketoneantimetabolite;
diagnostic agent;
EC 1.14.15.4 (steroid 11beta-monooxygenase) inhibitor
1995200624.2low003100
mianserindibenzoazepineadrenergic uptake inhibitor;
alpha-adrenergic antagonist;
antidepressant;
EC 3.4.21.26 (prolyl oligopeptidase) inhibitor;
geroprotector;
H1-receptor antagonist;
histamine agonist;
sedative;
serotonergic antagonist
2012201510.7low000030
miconazoledichlorobenzene;
ether;
imidazoles
2010201014.0low000100
midazolamimidazobenzodiazepine;
monofluorobenzenes;
organochlorine compound
anticonvulsant;
antineoplastic agent;
anxiolytic drug;
apoptosis inducer;
central nervous system depressant;
GABAA receptor agonist;
general anaesthetic;
muscle relaxant;
sedative
1995200524.0low001100
mirtazapinebenzazepine;
tetracyclic antidepressant
alpha-adrenergic antagonist;
anxiolytic drug;
H1-receptor antagonist;
histamine antagonist;
oneirogen;
serotonergic antagonist
2012201510.7low000030
mitoxantronedihydroxyanthraquinoneanalgesic;
antineoplastic agent
1992201723.0low003210
ml 7N-sulfonyldiazepane;
organoiodine compound
EC 2.7.11.18 (myosin-light-chain kinase) inhibitor2005201315.0low000110
modafinilmonocarboxylic acid amide;
sulfoxide
202020204.0low000010
molsidomineethyl ester;
morpholines;
oxadiazole;
zwitterion
antioxidant;
apoptosis inhibitor;
cardioprotective agent;
nitric oxide donor;
vasodilator agent
2001202113.5low100341
monodansylcadaverineaminonaphthalene;
primary amino compound;
sulfonamide;
tertiary amino compound
EC 2.3.2.13 (protein-glutamine gamma-glutamyltransferase) inhibitor;
fluorochrome;
protective agent
2000200024.0low001000
entinostatbenzamides;
carbamate ester;
primary amino compound;
pyridines;
substituted aniline
antineoplastic agent;
apoptosis inducer;
EC 3.5.1.98 (histone deacetylase) inhibitor
2008201513.1low000340
n-(6-aminohexyl)-1-naphthalenesulfonamidenaphthalenes;
sulfonic acid derivative
1986198638.0low010000
acecainideacetamides;
benzamides
anti-arrhythmia drug1995200822.5low001100
ethylmaleimidemaleimidesanticoronaviral agent;
EC 1.3.1.8 [acyl-CoA dehydrogenase (NADP(+))] inhibitor;
EC 2.1.1.122 [(S)-tetrahydroprotoberberine N-methyltransferase] inhibitor;
EC 2.7.1.1 (hexokinase) inhibitor
1981201032.3low043200
apneapurine nucleoside2004201415.0low000110
nafamostatbenzoic acids;
guanidines
1997201219.5low105440
nalidixic acid1,8-naphthyridine derivative;
monocarboxylic acid;
quinolone antibiotic
antibacterial drug;
antimicrobial agent;
DNA synthesis inhibitor
202220222.0low000001
activins1992201918.5low001010
neostigminequaternary ammonium ionantidote to curare poisoning;
EC 3.1.1.7 (acetylcholinesterase) inhibitor
2014201410.0low000010
ubiquinone q1ubiquinones201620168.0low000010
nifedipineC-nitro compound;
dihydropyridine;
methyl ester
calcium channel blocker;
human metabolite;
tocolytic agent;
vasodilator agent
1988201526.8low023210
nimesulidearomatic ether;
C-nitro compound;
sulfonamide
cyclooxygenase 2 inhibitor;
non-steroidal anti-inflammatory drug
1990201919.8low007740
nimodipine2-methoxyethyl ester;
C-nitro compound;
dicarboxylic acids and O-substituted derivatives;
diester;
dihydropyridine;
isopropyl ester
antihypertensive agent;
calcium channel blocker;
cardiovascular drug;
vasodilator agent
1999201517.0low001010
nitroglycerinnitroglycerolexplosive;
muscle relaxant;
nitric oxide donor;
prodrug;
tocolytic agent;
vasodilator agent;
xenobiotic
1989201424.4low116210
nomifensineisoquinolinesdopamine uptake inhibitor2006200618.0low000100
norfloxacinfluoroquinolone antibiotic;
N-arylpiperazine;
quinolinemonocarboxylic acid;
quinolone antibiotic;
quinolone
antibacterial drug;
DNA synthesis inhibitor;
environmental contaminant;
xenobiotic
201920214.0low000011
ns 1619(trifluoromethyl)benzenes;
benzimidazoles;
phenols
potassium channel opener2012201212.0low000010
n-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamidearomatic ether;
C-nitro compound;
sulfonamide
antineoplastic agent;
cyclooxygenase 2 inhibitor
1997201618.4low002620
ofloxacin3-oxo monocarboxylic acid;
N-arylpiperazine;
N-methylpiperazine;
organofluorine compound;
oxazinoquinoline
200820228.7low100111
olprinonebipyridines2004200519.5low000200
omeprazolearomatic ether;
benzimidazoles;
pyridines;
sulfoxide
1994202116.6low10515101
ondansetroncarbazoles2011201113.0low000010
oxonic acid1,3,5-triazines;
monocarboxylic acid
2013201311.0low000010
oxatomidebenzimidazoles;
diarylmethane;
N-alkylpiperazine
anti-allergic agent;
anti-inflammatory agent;
geroprotector;
H1-receptor antagonist;
serotonergic antagonist
1993199331.0low001000
oxidopaminebenzenetriol;
catecholamine;
primary amino compound
drug metabolite;
human metabolite;
neurotoxin
1984202219.5low012221
oxybutyninacetylenic compound;
carboxylic ester;
racemate;
tertiary alcohol;
tertiary amino compound
antispasmodic drug;
calcium channel blocker;
local anaesthetic;
muscarinic antagonist;
muscle relaxant;
parasympatholytic
2012201212.0low000010
aminosalicylic acidaminobenzoic acid;
phenols
antitubercular agent1989199432.5low011000
quinone1,4-benzoquinonescofactor;
human xenobiotic metabolite;
mouse metabolite
1986200928.4low047500
fencloninephenylalanine derivative2005200519.0low000100
palmidrolendocannabinoid;
N-(long-chain-acyl)ethanolamine;
N-(saturated fatty acyl)ethanolamine
anti-inflammatory drug;
anticonvulsant;
antihypertensive agent;
neuroprotective agent
200720217.8low000143
pamidronatephosphonoacetic acid1993200923.0low001100
pantoprazolearomatic ether;
benzimidazoles;
organofluorine compound;
pyridines;
sulfoxide
anti-ulcer drug;
EC 3.6.3.10 (H(+)/K(+)-exchanging ATPase) inhibitor;
environmental contaminant;
xenobiotic
2005200618.5low000200
4-chlorophenolmonochlorophenol2008201712.0low000220
4-dichlorobenzenedichlorobenzeneinsecticide2007201214.5low000110
1,7-dimethylxanthinedimethylxanthinecentral nervous system stimulant;
human blood serum metabolite;
human xenobiotic metabolite;
mouse metabolite
2010201014.0low000100
patulinfuropyran;
gamma-lactone;
lactol
antimicrobial agent;
Aspergillus metabolite;
carcinogenic agent;
mutagen;
mycotoxin;
Penicillium metabolite
201820186.0low000010
pd 98059aromatic amine;
monomethoxyflavone
EC 2.7.11.24 (mitogen-activated protein kinase) inhibitor;
geroprotector
2001202017.5low000710
pentamidinearomatic ether;
carboxamidine;
diether
anti-inflammatory agent;
antifungal agent;
calmodulin antagonist;
chemokine receptor 5 antagonist;
EC 2.3.1.48 (histone acetyltransferase) inhibitor;
NMDA receptor antagonist;
S100 calcium-binding protein B inhibitor;
trypanocidal drug;
xenobiotic
1989201225.7low011010
pentobarbitalbarbituratesGABAA receptor agonist1959201729.0low011110
pentoxifyllineoxopurine1992201619.4low00141890
perphenazineN-(2-hydroxyethyl)piperazine;
N-alkylpiperazine;
organochlorine compound;
phenothiazines
antiemetic;
dopaminergic antagonist;
phenothiazine antipsychotic drug
2003200321.0low000100
phenobarbitalbarbituratesanticonvulsant;
drug allergen;
excitatory amino acid antagonist;
sedative
1990201025.7low002100
phenolsulfonphthalein2,1-benzoxathiole;
arenesulfonate ester;
phenols;
sultone
acid-base indicator;
diagnostic agent;
two-colour indicator
1991201919.0low001010
4-phenylbutyric acidmonocarboxylic acidantineoplastic agent;
apoptosis inducer;
EC 3.5.1.98 (histone deacetylase) inhibitor;
prodrug
201520159.0low000010
phenylbutazonepyrazolidinesantirheumatic drug;
EC 1.1.1.184 [carbonyl reductase (NADPH)] inhibitor;
metabolite;
non-narcotic analgesic;
non-steroidal anti-inflammatory drug;
peripheral nervous system drug
1959201830.6low031120
phloretindihydrochalconesantineoplastic agent;
plant metabolite
201620168.0low000010
phosalone1,3-benzoxazoles;
carbamate ester;
organochlorine insecticide;
organothiophosphate insecticide
acaricide;
agrochemical;
EC 3.1.1.7 (acetylcholinesterase) inhibitor;
EC 3.1.1.8 (cholinesterase) inhibitor
201620168.0low000010
pinacidilpyridines1993200425.5low001100
pindololindoles;
secondary amine
antiglaucoma drug;
antihypertensive agent;
beta-adrenergic antagonist;
serotonergic antagonist;
vasodilator agent
1992200227.0low001100
pioglitazonearomatic ether;
pyridines;
thiazolidinediones
antidepressant;
cardioprotective agent;
EC 2.7.1.33 (pantothenate kinase) inhibitor;
EC 6.2.1.3 (long-chain-fatty-acid--CoA ligase) inhibitor;
ferroptosis inhibitor;
geroprotector;
hypoglycemic agent;
insulin-sensitizing drug;
PPARgamma agonist;
xenobiotic
2002201813.6low000660
piracetamorganonitrogen compound;
organooxygen compound
2009201313.0low000110
pirenzepinepyridobenzodiazepineanti-ulcer drug;
antispasmodic drug;
muscarinic antagonist
1997199826.5low002000
potassium chlorideinorganic chloride;
inorganic potassium salt;
potassium salt
fertilizer1984201723.4low02111910
potassium iodidepotassium saltexpectorant;
radical scavenger
1981201728.6low052230
ag 1879aromatic amine;
monochlorobenzenes;
pyrazolopyrimidine
beta-adrenergic antagonist;
EC 2.7.10.2 (non-specific protein-tyrosine kinase) inhibitor;
geroprotector
2004200420.0low000100
pyridoxal phosphate-6-azophenyl-2',4'-disulfonic acidarenesulfonic acid;
azobenzenes;
methylpyridines;
monohydroxypyridine;
organic phosphate;
pyridinecarbaldehyde
purinergic receptor P2X antagonist2010201014.0low000100
ono 1078chromones1991201022.2low002300
praziquantelisoquinolines2008201413.0low000110
prazosinaromatic ether;
furans;
monocarboxylic acid amide;
piperazines;
quinazolines
alpha-adrenergic antagonist;
antihypertensive agent;
EC 3.4.21.26 (prolyl oligopeptidase) inhibitor
1983202122.0low011201
prilocaineamino acid amide;
monocarboxylic acid amide
anticonvulsant;
local anaesthetic
2003200321.0low000100
primaquineaminoquinoline;
aromatic ether;
N-substituted diamine
antimalarial201920195.0low000010
probucoldithioketal;
polyphenol
anti-inflammatory drug;
anticholesteremic drug;
antilipemic drug;
antioxidant;
cardiovascular drug
1988201122.5low115520
procainamidebenzamidesanti-arrhythmia drug;
platelet aggregation inhibitor;
sodium channel blocker
1994200822.8low002200
procainebenzoate ester;
substituted aniline;
tertiary amino compound
central nervous system depressant;
drug allergen;
local anaesthetic;
peripheral nervous system drug
1986201022.7low010200
procarbazinebenzamides;
hydrazines
antineoplastic agent1991199332.0low002000
procaterolquinolines2006200618.0low000100
proglumidebenzamides;
dicarboxylic acid monoamide;
glutamine derivative;
racemate
anti-ulcer drug;
cholecystokinin antagonist;
cholinergic antagonist;
delta-opioid receptor agonist;
drug metabolite;
gastrointestinal drug;
opioid analgesic;
xenobiotic metabolite
2005201016.5low000200
promethazinephenothiazines;
tertiary amine
anti-allergic agent;
anticoronaviral agent;
antiemetic;
antipruritic drug;
H1-receptor antagonist;
local anaesthetic;
sedative
1997200025.5low002000
prometrynediamino-1,3,5-triazine;
methylthio-1,3,5-triazine
environmental contaminant;
herbicide;
xenobiotic
2009200915.0low000100
propanilanilide;
dichlorobenzene
herbicide2006200618.0low000100
propazinechloro-1,3,5-triazine;
diamino-1,3,5-triazine
environmental contaminant;
herbicide;
xenobiotic
201820186.0low000010
propentofyllineoxopurine1997199727.0low001000
propidiumphenanthridines;
quaternary ammonium ion
fluorochrome;
intercalator
2003200420.7low000300
propofolphenolsanticonvulsant;
antiemetic;
intravenous anaesthetic;
radical scavenger;
sedative
1991202215.2low102742
propranololnaphthalenes;
propanolamine;
secondary amine
anti-arrhythmia drug;
antihypertensive agent;
anxiolytic drug;
beta-adrenergic antagonist;
environmental contaminant;
human blood serum metabolite;
vasodilator agent;
xenobiotic
1990200824.9low005600
propyl gallatetrihydroxybenzoic acid1996200623.3low002100
protoporphyrin ix1995201520.5low004020
pseudohypericin2007200717.0low000100
pyrilaminearomatic ether;
ethylenediamine derivative
H1-receptor antagonist1998200720.3low001200
pyrimethamineaminopyrimidine;
monochlorobenzenes
antimalarial;
antiprotozoal drug;
EC 1.5.1.3 (dihydrofolate reductase) inhibitor
201920195.0low000010
rabeprazolebenzimidazoles;
pyridines;
sulfoxide
anti-ulcer drug;
EC 3.6.3.10 (H(+)/K(+)-exchanging ATPase) inhibitor
2002200222.0low100100
opc 12759secondary carboxamide1995200524.1low109500
resorcinolbenzenediol;
phenolic donor;
resorcinols
erythropoietin inhibitor;
sensitiser
1963201530.2low011110
pf 5901quinolines1992199232.0low003000
riluzolebenzothiazoles2008200816.0low000100
risperidone1,2-benzoxazoles;
heteroarylpiperidine;
organofluorine compound;
pyridopyrimidine
alpha-adrenergic antagonist;
dopaminergic antagonist;
EC 3.4.21.26 (prolyl oligopeptidase) inhibitor;
H1-receptor antagonist;
psychotropic drug;
second generation antipsychotic;
serotonergic antagonist
2014201410.0low000010
4-(3-butoxy-4-methoxybenzyl)-2-imidazolidinonemethoxybenzenes2004200420.0low000100
rofecoxibbutenolide;
sulfone
analgesic;
cyclooxygenase 2 inhibitor;
non-steroidal anti-inflammatory drug
2002200918.1low0001100
roliprampyrrolidin-2-onesantidepressant;
EC 3.1.4.* (phosphoric diester hydrolase) inhibitor
1992201021.2low0051100
etiron1996199628.0low001000
s-methylisothiopseudouronium2001200322.3low000300
saccharin1,2-benzisothiazole;
N-sulfonylcarboxamide
environmental contaminant;
sweetening agent;
xenobiotic
201920195.0low000010
safrolebenzodioxolesflavouring agent;
insecticide;
metabolite;
plant metabolite
2009200915.0low000100
sanguinarinealkaloid antibiotic;
benzophenanthridine alkaloid;
botanical anti-fungal agent
2014201410.0low000010
sb 239063imidazoles2002200222.0low000100
carbamylhydrazinecarbohydrazide;
monocarboxylic acid amide;
one-carbon compound;
ureas
2011201113.0low000010
sevofluraneether;
organofluorine compound
central nervous system depressant;
inhalation anaesthetic;
platelet aggregation inhibitor
2004202011.7low1004110
sulfadiazinepyrimidines;
substituted aniline;
sulfonamide antibiotic;
sulfonamide
antiinfective agent;
antimicrobial agent;
antiprotozoal drug;
coccidiostat;
drug allergen;
EC 1.1.1.153 [sepiapterin reductase (L-erythro-7,8-dihydrobiopterin forming)] inhibitor;
EC 2.5.1.15 (dihydropteroate synthase) inhibitor;
environmental contaminant;
xenobiotic
201720234.0low100011
simazinechloro-1,3,5-triazine;
diamino-1,3,5-triazine
environmental contaminant;
herbicide;
xenobiotic
1996199727.5low002000
linsidominemorpholines2001201516.8low000220
sk&f 86002imidazoles1996199628.0low001000
sodium fluoridefluoride saltmutagen1980202121.0low123231
sodium fluoridefluoride saltmutagen1980202121.7low123131
sodium iodideinorganic sodium salt;
iodide salt
1980200434.3low041200
iodoacetic acidhaloacetic acid;
organoiodine compound
alkylating agent1988198836.0low010000
sotalolethanolamines;
secondary alcohol;
secondary amino compound;
sulfonamide
anti-arrhythmia drug;
beta-adrenergic antagonist;
environmental contaminant;
xenobiotic
201920195.0low000010
stearic acidlong-chain fatty acid;
saturated fatty acid;
straight-chain saturated fatty acid
algal metabolite;
Daphnia magna metabolite;
human metabolite;
plant metabolite
2000201516.5low001010
vorinostatdicarboxylic acid diamide;
hydroxamic acid
antineoplastic agent;
apoptosis inducer;
EC 3.5.1.98 (histone deacetylase) inhibitor
2008201513.3low000960
vorinostatdicarboxylic acid diamide;
hydroxamic acid
antineoplastic agent;
apoptosis inducer;
EC 3.5.1.98 (histone deacetylase) inhibitor
2009201412.5low000220
succinylacetonebeta-diketone;
dioxo monocarboxylic acid
human metabolite1992200628.0low003100
sulfadimethoxinearomatic ether;
pyrimidines;
substituted aniline;
sulfonamide antibiotic;
sulfonamide
antiinfective agent;
antimicrobial agent;
drug allergen;
environmental contaminant;
xenobiotic
201720196.3low000030
sulfamethazinepyrimidines;
sulfonamide antibiotic;
sulfonamide
antibacterial drug;
antiinfective agent;
antimicrobial agent;
carcinogenic agent;
drug allergen;
EC 2.5.1.15 (dihydropteroate synthase) inhibitor;
environmental contaminant;
ligand;
xenobiotic
2008201413.0low000110
sulfamethoxazoleisoxazoles;
substituted aniline;
sulfonamide antibiotic;
sulfonamide
antibacterial agent;
antiinfective agent;
antimicrobial agent;
drug allergen;
EC 1.1.1.153 [sepiapterin reductase (L-erythro-7,8-dihydrobiopterin forming)] inhibitor;
EC 2.5.1.15 (dihydropteroate synthase) inhibitor;
environmental contaminant;
epitope;
P450 inhibitor;
xenobiotic
1990201916.4low001220
sulfamethoxypyridazinepyridazines;
sulfonamide antibiotic;
sulfonamide
antiinfective agent;
drug allergen;
EC 2.5.1.15 (dihydropteroate synthase) inhibitor
2010201014.0low000100
sulfapyridinepyridines;
substituted aniline;
sulfonamide antibiotic;
sulfonamide
antiinfective agent;
dermatologic drug;
drug allergen;
environmental contaminant;
xenobiotic
1979200834.2low030100
sulfasalazine1979202217.8low121215181
sulfinpyrazonepyrazolidines;
sulfoxide
uricosuric drug1989198935.0low010000
sulfisoxazoleisoxazoles;
sulfonamide antibiotic;
sulfonamide
antibacterial drug;
drug allergen
2006200618.0low000100
sulfobromophthalein2-benzofurans;
organobromine compound;
organosulfonic acid;
phenols
dye2005200519.0low000100
sulforaphaneisothiocyanate;
sulfoxide
antineoplastic agent;
antioxidant;
EC 3.5.1.98 (histone deacetylase) inhibitor;
plant metabolite
200720238.0low000121
sulpiridebenzamides;
N-alkylpyrrolidine;
sulfonamide
antidepressant;
antiemetic;
antipsychotic agent;
dopaminergic antagonist
201920195.0low000010
suraminnaphthalenesulfonic acid;
phenylureas;
secondary carboxamide
angiogenesis inhibitor;
antinematodal drug;
antineoplastic agent;
apoptosis inhibitor;
EC 2.7.11.13 (protein kinase C) inhibitor;
GABA antagonist;
GABA-gated chloride channel antagonist;
purinergic receptor P2 antagonist;
ryanodine receptor agonist;
trypanocidal drug
1996201916.5low001010
terazosinfurans;
piperazines;
primary amino compound;
quinazolines
alpha-adrenergic antagonist;
antihypertensive agent;
antineoplastic agent
202120213.0low000001
terbutalinephenylethanolamines;
resorcinols
anti-asthmatic drug;
beta-adrenergic agonist;
bronchodilator agent;
EC 3.1.1.7 (acetylcholinesterase) inhibitor;
hypoglycemic agent;
sympathomimetic agent;
tocolytic agent
2006200618.0low000100
terfenadinediarylmethane1998200224.7low002100
tetraethylammoniumquaternary ammonium ion201620168.0low000010
thalidomidephthalimides;
piperidones
2004202012.7low00010110
thalidomidephthalimides;
piperidones
2004202012.8low00010100
theobrominedimethylxanthineadenosine receptor antagonist;
bronchodilator agent;
food component;
human blood serum metabolite;
mouse metabolite;
plant metabolite;
vasodilator agent
1996199628.0low001000
thiabendazole1,3-thiazoles;
benzimidazole fungicide;
benzimidazoles
antifungal agrochemical;
antinematodal drug
2011201113.0low000010
thioridazinephenothiazines;
piperidines
alpha-adrenergic antagonist;
dopaminergic antagonist;
EC 1.8.1.12 (trypanothione-disulfide reductase) inhibitor;
EC 3.4.21.26 (prolyl oligopeptidase) inhibitor;
first generation antipsychotic;
H1-receptor antagonist;
serotonergic antagonist
202020204.0low000010
thiramorganic disulfideantibacterial drug;
antifungal agrochemical;
antiseptic drug
201920195.0low000010
ticlopidinemonochlorobenzenes;
thienopyridine
anticoagulant;
fibrin modulating drug;
hematologic agent;
P2Y12 receptor antagonist;
platelet aggregation inhibitor
2010201411.9low100260
tioproninN-acyl-amino acid1985198539.0low010000
8-(n,n-diethylamino)octyl-3,4,5-trimethoxybenzoatetrihydroxybenzoic acid1984198440.0low010000
tolmetinaromatic ketone;
monocarboxylic acid;
pyrroles
EC 1.14.99.1 (prostaglandin-endoperoxide synthase) inhibitor;
non-steroidal anti-inflammatory drug
1981200232.5low010100
tranexamic acidamino acid201620187.0low000020
trapidiltriazolopyrimidines2005200718.0low000300
triclosanaromatic ether;
dichlorobenzene;
monochlorobenzenes;
phenols
antibacterial agent;
antimalarial;
drug allergen;
EC 1.3.1.9 [enoyl-[acyl-carrier-protein] reductase (NADH)] inhibitor;
EC 1.5.1.3 (dihydrofolate reductase) inhibitor;
fungicide;
persistent organic pollutant;
xenobiotic
200720238.3low100111
trifluoperazineN-alkylpiperazine;
N-methylpiperazine;
organofluorine compound;
phenothiazines
antiemetic;
calmodulin antagonist;
dopaminergic antagonist;
EC 1.8.1.12 (trypanothione-disulfide reductase) inhibitor;
EC 5.3.3.5 (cholestenol Delta-isomerase) inhibitor;
phenothiazine antipsychotic drug
1984199037.0low011000
trigonellinealkaloid;
iminium betaine
food component;
human urinary metabolite;
plant metabolite
201920195.0low000010
trimethoprimaminopyrimidine;
methoxybenzenes
antibacterial drug;
diuretic;
drug allergen;
EC 1.5.1.3 (dihydrofolate reductase) inhibitor;
environmental contaminant;
xenobiotic
1999199925.0low001000
troglitazonechromanes;
thiazolidinone
anticoagulant;
anticonvulsant;
antineoplastic agent;
antioxidant;
EC 6.2.1.3 (long-chain-fatty-acid--CoA ligase) inhibitor;
ferroptosis inhibitor;
hypoglycemic agent;
platelet aggregation inhibitor;
vasodilator agent
2004200519.5low000200
tulobuterolorganochlorine compound2006200618.0low000100
tyraminemonoamine molecular messenger;
primary amino compound;
tyramines
EC 3.1.1.8 (cholinesterase) inhibitor;
Escherichia coli metabolite;
human metabolite;
mouse metabolite;
neurotransmitter
1959202118.7low126281
urethanecarbamate esterfungal metabolite;
mutagen
1950200635.8low011200
usnic acidbenzofurans2006201414.0low000110
vesnarinoneorganic molecular entity1994199728.5low002000
w 71986201523.5low010010
pirinixic acidaryl sulfide;
organochlorine compound;
pyrimidines
2004201317.0low000410
xylazine1,3-thiazine;
methylbenzene;
secondary amino compound
alpha-adrenergic agonist;
analgesic;
emetic;
muscle relaxant;
sedative
1996201021.0low001100
3-(5'-hydroxymethyl-2'-furyl)-1-benzylindazolearomatic primary alcohol;
furans;
indazoles
antineoplastic agent;
apoptosis inducer;
platelet aggregation inhibitor;
soluble guanylate cyclase activator;
vasodilator agent
201220179.5low000020
ici 204,219carbamate ester;
indoles;
N-sulfonylcarboxamide
anti-asthmatic agent;
leukotriene antagonist
2001201219.3low000510
zinc chlorideinorganic chloride;
zinc molecular entity
astringent;
disinfectant;
EC 5.3.3.5 (cholestenol Delta-isomerase) inhibitor;
Lewis acid
2006200618.0low000100
hydrocortisone acetatecortisol ester;
tertiary alpha-hydroxy ketone
1983198341.0low010000
mitomycinmitomycinalkylating agent;
antineoplastic agent
1995202319.2low102301
corticosterone11beta-hydroxy steroid;
20-oxo steroid;
21-hydroxy steroid;
3-oxo-Delta(4) steroid;
C21-steroid;
glucocorticoid;
primary alpha-hydroxy ketone
human metabolite;
mouse metabolite
1991201718.9low0091960
prednisolone11beta-hydroxy steroid;
17alpha-hydroxy steroid;
20-oxo steroid;
21-hydroxy steroid;
3-oxo-Delta(1),Delta(4)-steroid;
C21-steroid;
glucocorticoid;
primary alpha-hydroxy ketone;
tertiary alpha-hydroxy ketone
adrenergic agent;
anti-inflammatory drug;
antineoplastic agent;
drug metabolite;
environmental contaminant;
immunosuppressive agent;
xenobiotic
1959202218.5low652949353
estriol16alpha-hydroxy steroid;
17beta-hydroxy steroid;
3-hydroxy steroid
estrogen;
human metabolite;
human xenobiotic metabolite;
mouse metabolite
1980201531.8low030010
reserpinealkaloid ester;
methyl ester;
yohimban alkaloid
adrenergic uptake inhibitor;
antihypertensive agent;
EC 3.4.21.26 (prolyl oligopeptidase) inhibitor;
environmental contaminant;
first generation antipsychotic;
plant metabolite;
xenobiotic
1959201544.2low030110
phentolamineimidazoles;
phenols;
substituted aniline;
tertiary amino compound
alpha-adrenergic antagonist;
vasodilator agent
1983201523.8low011210
sorbitolglucitolcathartic;
Escherichia coli metabolite;
food humectant;
human metabolite;
laxative;
metabolite;
mouse metabolite;
Saccharomyces cerevisiae metabolite;
sweetening agent
1986201323.0low011020
alloxanpyrimidonehyperglycemic agent;
metabolite
1958201622.4low010040
thymidinepyrimidine 2'-deoxyribonucleosideEscherichia coli metabolite;
human metabolite;
metabolite;
mouse metabolite
1981200032.9low027000
piperonyl butoxidebenzodioxolespesticide synergist1996199628.0low001000
2-aminophenolaminophenolbacterial metabolite2008200816.0low000100
bromouracilnucleobase analogue;
pyrimidines
mutagen2001200322.0low000200
hydroxyproline4-hydroxyproline;
L-alpha-amino acid zwitterion
human metabolite;
mouse metabolite;
plant metabolite
1990202216.9low00825172
thyroxine2-halophenol;
iodophenol;
L-phenylalanine derivative;
non-proteinogenic L-alpha-amino acid;
thyroxine zwitterion;
thyroxine
antithyroid drug;
human metabolite;
mouse metabolite;
thyroid hormone
1959202229.8low1128861
carbacholammonium salt;
carbamate ester
cardiotonic drug;
miotic;
muscarinic agonist;
nicotinic acetylcholine receptor agonist;
non-narcotic analgesic
1984201722.1low05132850
carbacholammonium salt;
carbamate ester
cardiotonic drug;
miotic;
muscarinic agonist;
nicotinic acetylcholine receptor agonist;
non-narcotic analgesic
1984201722.5low05132550
norethindrone acetate3-oxo-Delta(4) steroid;
acetate ester;
terminal acetylenic compound
progestin;
synthetic oral contraceptive
2005200519.0low000100
spironolactone3-oxo-Delta(4) steroid;
oxaspiro compound;
steroid lactone;
thioester
aldosterone antagonist;
antihypertensive agent;
diuretic;
environmental contaminant;
xenobiotic
201320227.3low000021
aldosterone11beta-hydroxy steroid;
18-oxo steroid;
20-oxo steroid;
21-hydroxy steroid;
3-oxo-Delta(4) steroid;
C21-steroid hormone;
mineralocorticoid;
primary alpha-hydroxy ketone;
steroid aldehyde
human metabolite;
mouse metabolite
200520209.7low100250
penicillaminenon-proteinogenic alpha-amino acid;
penicillamine
antirheumatic drug;
chelator;
copper chelator;
drug allergen
1983202226.9low0416401
trichlorfonorganic phosphonate;
organochlorine compound;
phosphonic ester
agrochemical;
anthelminthic drug;
EC 3.1.1.7 (acetylcholinesterase) inhibitor;
EC 3.1.1.8 (cholinesterase) inhibitor;
insecticide
202320231.0low000001
prednisone11-oxo steroid;
17alpha-hydroxy steroid;
20-oxo steroid;
21-hydroxy steroid;
3-oxo-Delta(1),Delta(4)-steroid;
C21-steroid;
glucocorticoid;
primary alpha-hydroxy ketone;
tertiary alpha-hydroxy ketone
adrenergic agent;
anti-inflammatory drug;
antineoplastic agent;
immunosuppressive agent;
prodrug
1956202220.5low254673
estrone17-oxo steroid;
3-hydroxy steroid;
phenolic steroid;
phenols
antineoplastic agent;
bone density conservation agent;
estrogen;
human metabolite;
mouse metabolite
1961198952.0low050000
oxandrolone17beta-hydroxy steroid;
3-oxo steroid;
anabolic androgenic steroid;
oxa-steroid
anabolic agent;
androgen
201920195.0low000010
androsterone17-oxo steroid;
3alpha-hydroxy steroid;
androstanoid;
C19-steroid
androgen;
anticonvulsant;
human blood serum metabolite;
human metabolite;
human urinary metabolite;
mouse metabolite;
pheromone
2012201212.0low000010
etiocholanolone17-oxo steroid;
3alpha-hydroxy steroid;
androstanoid
human metabolite;
mouse metabolite
1975197549.0low010000
dehydroepiandrosterone17-oxo steroid;
3beta-hydroxy-Delta(5)-steroid;
androstanoid
androgen;
human metabolite;
mouse metabolite
2006202010.8low000220
adrenochromeindoles2001200123.0low000100
penicillin gpenicillin allergen;
penicillin
antibacterial drug;
drug allergen;
epitope
2009200915.0low000100
pilocarpinepilocarpineantiglaucoma drug1963202018.6low010340
dimethylphenylpiperazinium iodideN-arylpiperazine;
organic iodide salt;
piperazinium salt;
quaternary ammonium salt
nicotinic acetylcholine receptor agonist2001200123.0low000100
pentylenetetrazoleorganic heterobicyclic compound;
organonitrogen heterocyclic compound
2005202211.3low000321
triiodothyronine2-halophenol;
amino acid zwitterion;
iodophenol;
iodothyronine
human metabolite;
mouse metabolite;
thyroid hormone
1963202221.2low134352
isoflurophatedialkyl phosphate2000200024.0low001000
biguanidesguanidines2010201113.5low000110
carbon tetrachloridechlorocarbon;
chloromethanes
hepatotoxic agent;
refrigerant
1982202013.9low0107170
alaninealanine zwitterion;
alanine;
L-alpha-amino acid;
proteinogenic amino acid;
pyruvate family amino acid
EC 4.3.1.15 (diaminopropionate ammonia-lyase) inhibitor;
fundamental metabolite
1975202225.1low1810861
alaninealanine zwitterion;
alanine;
L-alpha-amino acid;
proteinogenic amino acid;
pyruvate family amino acid
EC 4.3.1.15 (diaminopropionate ammonia-lyase) inhibitor;
fundamental metabolite
1975202225.6low1810851
serineL-alpha-amino acid;
proteinogenic amino acid;
serine family amino acid;
serine zwitterion;
serine
algal metabolite;
Escherichia coli metabolite;
human metabolite;
mouse metabolite;
Saccharomyces cerevisiae metabolite
1997202017.4low004750
desoxycorticosterone acetatecorticosteroid hormone1956195668.0low010000
chloramphenicolC-nitro compound;
carboxamide;
diol;
organochlorine compound
antibacterial drug;
antimicrobial agent;
Escherichia coli metabolite;
geroprotector;
Mycoplasma genitalium metabolite;
protein synthesis inhibitor
1963202218.2low010021
aspartic acidaspartate family amino acid;
aspartic acid;
L-alpha-amino acid;
proteinogenic amino acid
Escherichia coli metabolite;
mouse metabolite;
neurotransmitter
1975202218.6low021622
glutamineamino acid zwitterion;
glutamine family amino acid;
glutamine;
L-alpha-amino acid;
polar amino acid zwitterion;
proteinogenic amino acid
EC 1.14.13.39 (nitric oxide synthase) inhibitor;
Escherichia coli metabolite;
human metabolite;
metabolite;
micronutrient;
mouse metabolite;
nutraceutical;
Saccharomyces cerevisiae metabolite
1988202216.5low01413111
lysineaspartate family amino acid;
L-alpha-amino acid zwitterion;
L-alpha-amino acid;
lysine;
organic molecular entity;
proteinogenic amino acid
algal metabolite;
anticonvulsant;
Escherichia coli metabolite;
human metabolite;
micronutrient;
mouse metabolite;
nutraceutical;
plant metabolite;
Saccharomyces cerevisiae metabolite
1986202218.1low111622132
lysineaspartate family amino acid;
L-alpha-amino acid zwitterion;
L-alpha-amino acid;
lysine;
organic molecular entity;
proteinogenic amino acid
algal metabolite;
anticonvulsant;
Escherichia coli metabolite;
human metabolite;
micronutrient;
mouse metabolite;
nutraceutical;
plant metabolite;
Saccharomyces cerevisiae metabolite
1986202118.4low111622131
allyl isothiocyanatealkenyl isothiocyanate;
isothiocyanate
antimicrobial agent;
antineoplastic agent;
apoptosis inducer;
lachrymator;
metabolite
201520168.5low000020
cyanidespseudohalide anionEC 1.9.3.1 (cytochrome c oxidase) inhibitor1948201934.2low029101340
physostigminecarbamate ester;
indole alkaloid
antidote to curare poisoning;
EC 3.1.1.8 (cholinesterase) inhibitor;
miotic
1998201418.0low001010
sucroseglycosyl glycosidealgal metabolite;
Escherichia coli metabolite;
human metabolite;
mouse metabolite;
osmolyte;
Saccharomyces cerevisiae metabolite;
sweetening agent
1986202312.0low0127154
sucroseglycosyl glycosidealgal metabolite;
Escherichia coli metabolite;
human metabolite;
mouse metabolite;
osmolyte;
Saccharomyces cerevisiae metabolite;
sweetening agent
1986202311.1low0127215
ethinyl estradiol17-hydroxy steroid;
3-hydroxy steroid;
terminal acetylenic compound
xenoestrogen1985202118.0low010211
9,10-dimethyl-1,2-benzanthraceneortho-fused polycyclic arene;
tetraphenes
carcinogenic agent1981202025.6low027220
apomorphineaporphine alkaloidalpha-adrenergic drug;
antidyskinesia agent;
antiparkinson drug;
dopamine agonist;
emetic;
serotonergic drug
2004200420.0low000100
aminopyrinepyrazolone;
tertiary amino compound
antipyretic;
environmental contaminant;
non-narcotic analgesic;
non-steroidal anti-inflammatory drug;
xenobiotic
1989201028.4low015100
adenosine diphosphateadenosine 5'-phosphate;
purine ribonucleoside 5'-diphosphate
fundamental metabolite;
human metabolite
1981201819.1low120630
2,3,4,6-tetrachlorophenoltetrachlorophenolxenobiotic metabolite1991202314.3low003962
uridineuridinesdrug metabolite;
fundamental metabolite;
human metabolite
201420207.0low000020
kanamycin akanamycinsbacterial metabolite200220238.2low000132
bromodeoxyuridinepyrimidine 2'-deoxyribonucleosideantimetabolite;
antineoplastic agent
1993201421.8low003210
galactoseD-galactose;
galactopyranose
Escherichia coli metabolite;
mouse metabolite
1982202315.8low120232
carbostyrilmonohydroxyquinoline;
quinolone
bacterial xenobiotic metabolite1995202322.2low2012511
phenylephrinephenols;
phenylethanolamines;
secondary amino compound
alpha-adrenergic agonist;
cardiotonic drug;
mydriatic agent;
nasal decongestant;
protective agent;
sympathomimetic agent;
vasoconstrictor agent
1983201924.7low047920
benzoxazolonebenzoxazoleallelochemical;
phytoalexin
2005202014.0low000210
levodopaamino acid zwitterion;
dopa;
L-tyrosine derivative;
non-proteinogenic L-alpha-amino acid
allelochemical;
antidyskinesia agent;
antiparkinson drug;
dopaminergic agent;
hapten;
human metabolite;
mouse metabolite;
neurotoxin;
plant growth retardant;
plant metabolite;
prodrug
1986202315.6low010231
edetic acidethylenediamine derivative;
polyamino carboxylic acid;
tetracarboxylic acid
anticoagulant;
antidote;
chelator;
copper chelator;
geroprotector
1964202224.4low08181081
p-dimethylaminoazobenzeneazobenzenes1991199829.5low002000
phenylethyl alcoholbenzenes;
primary alcohol
Aspergillus metabolite;
fragrance;
plant growth retardant;
plant metabolite;
Saccharomyces cerevisiae metabolite
2002201915.5low0001770
tyrosineamino acid zwitterion;
erythrose 4-phosphate/phosphoenolpyruvate family amino acid;
L-alpha-amino acid;
proteinogenic amino acid;
tyrosine
EC 1.3.1.43 (arogenate dehydrogenase) inhibitor;
fundamental metabolite;
micronutrient;
nutraceutical
1951202219.4low41394201887
cysteamineamine;
thiol
geroprotector;
human metabolite;
mouse metabolite;
radiation protective agent
1988201725.0low038340
monomethylhydrazine1993199331.0low001000
methoxamineamphetaminesalpha-adrenergic agonist;
antihypotensive agent
1994200325.5low001100
adenosine monophosphateadenosine 5'-phosphate;
purine ribonucleoside 5'-monophosphate
adenosine A1 receptor agonist;
cofactor;
EC 3.1.3.1 (alkaline phosphatase) inhibitor;
EC 3.1.3.11 (fructose-bisphosphatase) inhibitor;
fundamental metabolite;
micronutrient;
nutraceutical
2001200521.0low100200
methicillinpenicillin allergen;
penicillin
antibacterial drug2011201113.0low000010
n,n-dimethyltryptaminetryptamine alkaloid;
tryptamines
2014201410.0low000010
methylene blueorganic chloride saltacid-base indicator;
antidepressant;
antimalarial;
antimicrobial agent;
antioxidant;
cardioprotective agent;
EC 1.4.3.4 (monoamine oxidase) inhibitor;
EC 3.1.1.8 (cholinesterase) inhibitor;
EC 4.6.1.2 (guanylate cyclase) inhibitor;
fluorochrome;
histological dye;
neuroprotective agent;
physical tracer
1957202315.3low0224132
bretylium tosylateorganosulfonate salt;
quaternary ammonium salt
adrenergic antagonist;
anti-arrhythmia drug;
antihypertensive agent
2006200618.0low000100
zoxazolaminebenzoxazole1993199331.0low001000
leucineamino acid zwitterion;
L-alpha-amino acid;
leucine;
proteinogenic amino acid;
pyruvate family amino acid
algal metabolite;
Escherichia coli metabolite;
human metabolite;
mouse metabolite;
plant metabolite;
Saccharomyces cerevisiae metabolite
1976201526.3low0491020
leucineamino acid zwitterion;
L-alpha-amino acid;
leucine;
proteinogenic amino acid;
pyruvate family amino acid
algal metabolite;
Escherichia coli metabolite;
human metabolite;
mouse metabolite;
plant metabolite;
Saccharomyces cerevisiae metabolite
1976201227.0low0491010
ethyl methanesulfonatemethanesulfonate esteralkylating agent;
antineoplastic agent;
carcinogenic agent;
genotoxin;
mutagen;
teratogenic agent
1990200127.0low002100
methacholine chloridequaternary ammonium salt1987201125.1low128810
anilineanilines;
primary arylamine
1950201335.0low010110
androstenedione17-oxo steroid;
3-oxo-Delta(4) steroid;
androstanoid
androgen;
Daphnia magna metabolite;
human metabolite;
mouse metabolite
1981201227.5low010010
carbarylcarbamate ester;
naphthalenes
acaricide;
agrochemical;
carbamate insecticide;
EC 3.1.1.7 (acetylcholinesterase) inhibitor;
EC 3.1.1.8 (cholinesterase) inhibitor;
plant growth retardant
202220222.0low000001
lactoselactose2000201614.8low101120
methionineaspartate family amino acid;
L-alpha-amino acid;
methionine zwitterion;
methionine;
proteinogenic amino acid
antidote to paracetamol poisoning;
human metabolite;
micronutrient;
mouse metabolite;
nutraceutical
1962202223.1low0221723214
1,2-dipalmitoylphosphatidylcholine1997201418.5low001010
phenylalanineamino acid zwitterion;
erythrose 4-phosphate/phosphoenolpyruvate family amino acid;
L-alpha-amino acid;
phenylalanine;
proteinogenic amino acid
algal metabolite;
EC 3.1.3.1 (alkaline phosphatase) inhibitor;
Escherichia coli metabolite;
human xenobiotic metabolite;
micronutrient;
mouse metabolite;
nutraceutical;
plant metabolite;
Saccharomyces cerevisiae metabolite
1958202321.0low05813103
desoxycorticosterone20-oxo steroid;
21-hydroxy steroid;
3-oxo-Delta(4) steroid;
mineralocorticoid;
primary alpha-hydroxy ketone
human metabolite;
mouse metabolite
1950200545.2low020200
colchicinealkaloid;
colchicine
anti-inflammatory agent;
gout suppressant;
mutagen
1977202226.2low035121
cytidinecytidinesEscherichia coli metabolite;
human metabolite;
mouse metabolite;
Saccharomyces cerevisiae metabolite
201120217.4low000041
cycloheximideantibiotic fungicide;
cyclic ketone;
dicarboximide;
piperidine antibiotic;
piperidones;
secondary alcohol
anticoronaviral agent;
bacterial metabolite;
ferroptosis inhibitor;
neuroprotective agent;
protein synthesis inhibitor
1981201230.3low065210
ficusinpsoralensplant metabolite1981198143.0low010000
egtazic aciddiether;
tertiary amino compound;
tetracarboxylic acid
chelator1981200531.5low052400
chloroformchloromethanes;
one-carbon compound
carcinogenic agent;
central nervous system drug;
inhalation anaesthetic;
non-polar solvent;
refrigerant
1999201811.5low001030
dimethyl sulfonesulfone2011201312.0low000020
fluocinolone acetonide11beta-hydroxy steroid;
20-oxo steroid;
21-hydroxy steroid;
3-oxo-Delta(1),Delta(4)-steroid;
cyclic ketal;
fluorinated steroid;
glucocorticoid;
organic heteropentacyclic compound;
primary alpha-hydroxy ketone
anti-inflammatory drug;
antipruritic drug
1992199232.0low001000
gliotoxindipeptide;
organic disulfide;
organic heterotetracyclic compound;
pyrazinoindole
antifungal agent;
EC 2.5.1.58 (protein farnesyltransferase) inhibitor;
immunosuppressive agent;
mycotoxin;
proteasome inhibitor
2006200717.3low000300
sodium citrate, anhydrousorganic sodium saltanticoagulant;
flavouring agent
2000201713.3low101020
dimethylformamideformamides;
volatile organic compound
geroprotector;
hepatotoxic agent;
polar aprotic solvent
1989198935.0low010000
norethindrone17beta-hydroxy steroid;
3-oxo-Delta(4) steroid;
terminal acetylenic compound;
tertiary alcohol
progestin;
synthetic oral contraceptive
2005200519.0low000100
cycloserine4-amino-1,2-oxazolidin-3-one;
organonitrogen heterocyclic antibiotic;
organooxygen heterocyclic antibiotic;
zwitterion
antiinfective agent;
antimetabolite;
antitubercular agent;
metabolite;
NMDA receptor agonist
1959195965.0low020000
17-alpha-hydroxyprogesterone17alpha-hydroxy-C21-steroid;
17alpha-hydroxy steroid;
tertiary alpha-hydroxy ketone
human metabolite;
metabolite;
mouse metabolite;
progestin
2012201212.0low000010
chlorisondamineisoindoles2007200717.0low000100
tubercidinantibiotic antifungal agent;
N-glycosylpyrrolopyrimidine;
ribonucleoside
antimetabolite;
antineoplastic agent;
bacterial metabolite
1986198638.0low010000
ampicillinbeta-lactam antibiotic;
penicillin allergen;
penicillin
antibacterial drug1983201122.4low113320
mannitolmannitolallergen;
antiglaucoma drug;
compatible osmolytes;
Escherichia coli metabolite;
food anticaking agent;
food bulking agent;
food humectant;
food stabiliser;
food thickening agent;
hapten;
metabolite;
osmotic diuretic;
sweetening agent
1979202221.1low265682
cytarabinebeta-D-arabinoside;
monosaccharide derivative;
pyrimidine nucleoside
antimetabolite;
antineoplastic agent;
antiviral agent;
immunosuppressive agent
1986201924.5low139830
dithionitrobenzoic acidnitrobenzoic acid;
organic disulfide
indicator1992200228.3low002100
trifluridinenucleoside analogue;
organofluorine compound;
pyrimidine 2'-deoxyribonucleoside
antimetabolite;
antineoplastic agent;
antiviral drug;
EC 2.1.1.45 (thymidylate synthase) inhibitor
202320231.0low100001
ornithinenon-proteinogenic L-alpha-amino acid;
ornithine
algal metabolite;
hepatoprotective agent;
mouse metabolite
1992202016.5low003540
dinitrofluorobenzeneC-nitro compound;
organofluorine compound
agrochemical;
allergen;
chromatographic reagent;
EC 2.7.3.2 (creatine kinase) inhibitor;
protein-sequencing agent;
spectrophotometric reagent
1999202115.2low0031381
asparagineamino acid zwitterion;
asparagine;
aspartate family amino acid;
L-alpha-amino acid;
proteinogenic amino acid
Escherichia coli metabolite;
human metabolite;
micronutrient;
mouse metabolite;
nutraceutical;
plant metabolite;
Saccharomyces cerevisiae metabolite
1981202121.1low012321
histidineamino acid zwitterion;
histidine;
L-alpha-amino acid;
polar amino acid zwitterion;
proteinogenic amino acid
algal metabolite;
Escherichia coli metabolite;
human metabolite;
micronutrient;
mouse metabolite;
nutraceutical;
Saccharomyces cerevisiae metabolite
1963202318.4low0361697
medroxyprogesterone acetate20-oxo steroid;
3-oxo-Delta(4) steroid;
acetate ester;
corticosteroid;
steroid ester
adjuvant;
androgen;
antineoplastic agent;
antioxidant;
female contraceptive drug;
inhibitor;
progestin;
synthetic oral contraceptive
2005201215.5low000110
valineL-alpha-amino acid zwitterion;
L-alpha-amino acid;
proteinogenic amino acid;
pyruvate family amino acid;
valine
algal metabolite;
Escherichia coli metabolite;
human metabolite;
micronutrient;
mouse metabolite;
nutraceutical;
Saccharomyces cerevisiae metabolite
1999202216.9low001411
threonineamino acid zwitterion;
aspartate family amino acid;
L-alpha-amino acid;
proteinogenic amino acid;
threonine
algal metabolite;
Escherichia coli metabolite;
human metabolite;
micronutrient;
mouse metabolite;
nutraceutical;
plant metabolite;
Saccharomyces cerevisiae metabolite
1987201322.6low012410
mestranol17beta-hydroxy steroid;
aromatic ether;
terminal acetylenic compound
prodrug;
xenoestrogen
1985198539.0low010000
alizarindihydroxyanthraquinonechromophore;
dye;
plant metabolite
2011201113.0low000010
chlorquinaldolmonohydroxyquinoline;
organochlorine compound
antibacterial drug;
antiprotozoal drug;
antiseptic drug
202320231.0low100001
cordycepin3'-deoxyribonucleoside;
adenosines
antimetabolite;
nucleoside antibiotic
2002200222.0low000100
tryptophanerythrose 4-phosphate/phosphoenolpyruvate family amino acid;
L-alpha-amino acid zwitterion;
L-alpha-amino acid;
proteinogenic amino acid;
tryptophan zwitterion;
tryptophan
antidepressant;
Escherichia coli metabolite;
human metabolite;
micronutrient;
mouse metabolite;
nutraceutical;
plant metabolite;
Saccharomyces cerevisiae metabolite
1950202335.4low0371327124
isoleucineaspartate family amino acid;
isoleucine;
L-alpha-amino acid zwitterion;
L-alpha-amino acid;
proteinogenic amino acid
algal metabolite;
Escherichia coli metabolite;
human metabolite;
mouse metabolite;
plant metabolite;
Saccharomyces cerevisiae metabolite
2004201514.0low000120
isoleucineaspartate family amino acid;
isoleucine;
L-alpha-amino acid zwitterion;
L-alpha-amino acid;
proteinogenic amino acid
algal metabolite;
Escherichia coli metabolite;
human metabolite;
mouse metabolite;
plant metabolite;
Saccharomyces cerevisiae metabolite
2004201116.5low000110
argininearginine;
glutamine family amino acid;
L-alpha-amino acid;
proteinogenic amino acid
biomarker;
Escherichia coli metabolite;
micronutrient;
mouse metabolite;
nutraceutical
1977202218.5low324344454
ethylenealkene;
gas molecular entity
plant hormone;
refrigerant
1995202015.3low0039110
methyl chloridechloromethanes;
methyl halides
marine metabolite;
mutagen;
refrigerant
2011201113.0low000010
methylaminemethylamines;
one-carbon compound;
primary aliphatic amine
mouse metabolite1947201841.5low010010
acetonitrilealiphatic nitrile;
volatile organic compound
EC 3.5.1.4 (amidase) inhibitor;
NMR chemical shift reference compound;
polar aprotic solvent
2006200618.0low000200
methylene chloridechloromethanes;
volatile organic compound
carcinogenic agent;
polar aprotic solvent;
refrigerant
2009201312.8low000230
isocyanic acidhydracid;
one-carbon compound
201920195.0low000010
cyclopropanecycloalkane;
cyclopropanes
inhalation anaesthetic201720177.0low000010
phosgeneacyl chloride2010201213.0low000110
tert-butyl alcoholtertiary alcoholhuman xenobiotic metabolite200820229.0low000101
tert-butylhydroperoxidealkyl hydroperoxideantibacterial agent;
oxidising agent
1991201720.7low003420
trichloroacetic acidmonocarboxylic acid;
organochlorine compound
carcinogenic agent;
metabolite;
mouse metabolite
1980201322.2low010210
gibberellic acidC19-gibberellin;
gibberellin monocarboxylic acid;
lactone;
organic heteropentacyclic compound
mouse metabolite;
plant metabolite
1983202013.9low010250
phencyclidinebenzenes;
piperidines
anaesthetic;
neurotoxin;
NMDA receptor antagonist;
psychotropic drug
1990201621.2low005520
divinyl sulfonesulfonecross-linking reagent2007200717.0low000100
tromethamineprimary amino compound;
triol
buffer1988201024.7low011100
quinic acid2002200222.0low000100
tetraethoxysilane201820186.0low000010
linaloolmonoterpenoid;
tertiary alcohol
antimicrobial agent;
fragrance;
plant metabolite;
volatile oil component
201520168.5low000020
isoprenealkadiene;
hemiterpene;
volatile organic compound
plant metabolite2003201415.5low000110
isobutyraldehyde2-methyl-branched fatty aldehyde;
propanals
Saccharomyces cerevisiae metabolite1986199533.5low011000
trichloroethylenechloroethenesinhalation anaesthetic;
mouse metabolite
2012201212.0low000010
acrylamideacrylamides;
N-acylammonia;
primary carboxamide
alkylating agent;
carcinogenic agent;
Maillard reaction product;
mutagen;
neurotoxin
2000201714.2low001120
acrylic acidalpha,beta-unsaturated monocarboxylic acidmetabolite201520206.5low000020
peracetic acida peroxy aciddisinfectant;
oxidising agent
1989201323.0low010010
isobutyric acidbranched-chain saturated fatty acid;
fatty acid 4:0;
methyl-branched fatty acid
Daphnia magna metabolite;
plant metabolite;
volatile oil component
201920195.0low000010
dichloroacetic acidmonocarboxylic acid;
organochlorine compound
astringent;
marine metabolite
2011201710.3low000030
pantothenic acidpantothenic acid;
vitamin B5
antidote to curare poisoning;
geroprotector;
human blood serum metabolite
1991201816.7low001020
tetrabromobisphenol abrominated flame retardant;
bromobisphenol
200820209.0low000120
bisphenol abisphenolendocrine disruptor;
environmental contaminant;
xenobiotic;
xenoestrogen
1998202013.8low003360
cumene hydroperoxideperoxolenvironmental contaminant;
Mycoplasma genitalium metabolite;
oxidising agent
1986201721.4low011210
alpha-pinenepineneplant metabolite201220226.3low000021
dehydrocholic acid12-oxo steroid;
3-oxo-5beta-steroid;
7-oxo steroid;
oxo-5beta-cholanic acid
gastrointestinal drug202020204.0low000010
taurocholic acidamino sulfonic acid;
bile acid taurine conjugate
human metabolite1998202012.9low00322340
rhodamine borganic chloride salt;
xanthene dye
fluorescent probe;
fluorochrome;
histological dye
2006202210.5low000121
methylprednisolone6-methylprednisolone;
primary alpha-hydroxy ketone;
tertiary alpha-hydroxy ketone
adrenergic agent;
anti-inflammatory drug;
antiemetic;
environmental contaminant;
neuroprotective agent;
xenobiotic
1992202315.8low101542263
rotenoneorganic heteropentacyclic compound;
rotenones
antineoplastic agent;
metabolite;
mitochondrial NADH:ubiquinone reductase inhibitor;
phytogenic insecticide;
piscicide;
toxin
1988201916.1low010340
rotenoneorganic heteropentacyclic compound;
rotenones
antineoplastic agent;
metabolite;
mitochondrial NADH:ubiquinone reductase inhibitor;
phytogenic insecticide;
piscicide;
toxin
1988201916.7low010440
skimmianinealkaloid antibiotic;
organic heterotricyclic compound;
organonitrogen heterocyclic compound;
oxacycle
201320217.0low000011
(+-)stylopine2013201311.0low000010
diquatorganic cationdefoliant;
herbicide
2000200024.0low001000
pyocyanineiminium betaine;
phenazines
antibacterial agent;
bacterial metabolite;
biological pigment;
virulence factor
1990201719.9low003040
methyl n-methylanthranilatebenzoate ester;
methyl ester;
secondary amino compound;
substituted aniline
animal metabolite;
fungal metabolite;
plant metabolite
202220222.0low000001
isosorbide dinitrateglucitol derivative;
nitrate ester
nitric oxide donor;
vasodilator agent
1995201420.8low001410
phthalide2-benzofurans;
gamma-lactone
201520159.0low000010
gramineaminoalkylindole;
indole alkaloid;
tertiary amino compound
antibacterial agent;
antiviral agent;
plant metabolite;
serotonergic antagonist
2013201311.0low000010
penicillanic acidpenicillanic acids201620168.0low000010
1,2,3-trichlorobenzenetrichlorobenzene2002200222.0low000100
2,6-dichlorophenoldichlorophenol2006200618.0low000100
xylitol201720177.0low000010
2,4,6-trichlorophenoltrichlorophenolcarcinogenic agent2010201511.0low000120
n-vinyl-2-pyrrolidinonepyrrolidin-2-ones1985202324.3low024012
2,3,5-triiodobenzoic acidbenzoic acids;
organoiodine compound
antiauxins2007200717.0low000100
picryl chlorideC-nitro compound;
monochlorobenzenes
allergen;
epitope;
explosive;
hapten
2006202212.0low000201
picric acidC-nitro compoundantiseptic drug;
explosive;
fixative
1992199232.0low001000
2,4-dinitrobenzenesulfonic acidarenesulfonic acid;
C-nitro compound
1999201519.3medium0041630
pyromellitic dianhydride2014201410.0low000010
thymolmonoterpenoid;
phenols
volatile oil component201220198.0low000050
salicylaldehydehydroxybenzaldehydenematicide;
plant metabolite
202020204.0low000010
1-naphtholnaphtholgenotoxin;
human xenobiotic metabolite
1981201025.7low010200
pyrogallol 1,3-dimethyl etherdimethoxybenzene;
phenols
plant metabolite2011201212.5low000020
quinoxalinesmancude organic heterobicyclic parent;
naphthyridine;
ortho-fused heteroarene
1996201219.1low001520
quinolineazaarene;
mancude organic heterobicyclic parent;
ortho-fused heteroarene;
quinolines
2008201612.0low000110
isatinindoledioneEC 1.4.3.4 (monoamine oxidase) inhibitor;
plant metabolite
2005200519.0low000100
2-naphthylaminenaphthylaminecarcinogenic agent2001201018.5low000200
3,3'-diaminobenzidinebiphenyls;
substituted aniline
histological dye1975202327.4low11011741
3,3'-diaminobenzidinebiphenyls;
substituted aniline
histological dye1975202327.9low11010731
tolonium chloride1999200921.8low002200
pyronineiminium salt;
organic chloride salt
histological dye2010201710.3low000120
phenidone1995199728.0low002000
proflavineaminoacridinesantibacterial agent;
antiseptic drug;
carcinogenic agent;
chromophore;
intercalator
2012201212.0low000010
4-biphenylamineaminobiphenylcarcinogenic agent1997199727.0low001000
4-phenylphenolhydroxybiphenyls2004200420.0low000100
xanthenesxanthene200720219.8low000211
phenothiazinephenothiazineferroptosis inhibitor;
plant metabolite;
radical scavenger
2000200322.5low001100
benzidinebiphenyls;
substituted aniline
carcinogenic agent1951201237.3low061320
4-nitrobiphenylbiphenyls1997199727.0low001000
veratryl alcoholbenzyl alcohols;
dimethoxybenzene;
primary alcohol
fungal metabolite2004202111.4low000221
n,n-diethyl 4-phenylenediamine201920195.0low000010
veratric acidbenzoic acidsallergen;
plant metabolite
2014201410.0low000010
1-phenylpropanolorganic molecular entity201320188.8low000060
benzoic anhydrideacyclic carboxylic anhydride201520159.0low000010
synephrineethanolamines;
phenethylamine alkaloid;
phenols
alpha-adrenergic agonist;
plant metabolite
2014201410.0low000010
propylparabenbenzoate ester;
paraben;
phenols
antifungal agent;
antimicrobial agent
1995200623.5low001100
benzoyl peroxidecarbonyl compound201620196.5low000020
piperonylic acidaromatic carboxylic acid;
benzodioxoles;
monocarboxylic acid
antifungal agent;
EC 1.14.14.91 ( trans-cinnamate 4-monooxygenase) inhibitor;
plant metabolite;
vulnerary
2011201113.0low000010
1,2-diaminobenzenephenylenediaminehydrogen donor1984202214.0low010141
2-chlorophenol2-halophenol;
monochlorophenol
2006201613.0low000110
4-butyrolactonebutan-4-olidemetabolite;
neurotoxin
1997201912.2low001040
2,4-di-tert-butylphenolalkylbenzene;
phenols
antioxidant;
bacterial metabolite;
marine metabolite
201820186.0low000010
furaldehydealdehyde;
furans
Maillard reaction product;
metabolite
2002200918.5low000200
arsanilic acidorganoarsonic acid201820186.0low000010
acetophenoneacetophenonesanimal metabolite;
photosensitizing agent;
xenobiotic
201820186.0low000010
nitrobenzenenitroarene;
nitrobenzenes
1960201238.0low010010
trehalosetrehaloseEscherichia coli metabolite;
geroprotector;
human metabolite;
mouse metabolite;
Saccharomyces cerevisiae metabolite
201220237.0low000021
sym-trinitrobenzenetrinitrobenzeneexplosive1999201316.5low001120
carvonebotanical anti-fungal agent;
carvones
allergen2002201416.0low000110
4-bromophenacyl bromide1993200624.0low001200
4-cymenemonoterpene;
toluenes
human urinary metabolite;
plant metabolite;
volatile oil component
2012201411.0low000020
dimethyl-4-phenylenediaminediamine;
substituted aniline
1958195866.0low010000
terephthalic acidbenzenedicarboxylic acid201820205.0low000030
2-diethylaminoethanolethanolamines;
primary alcohol;
tertiary amino compound
1992199232.0low001000
ethylbenzenealkylbenzene2010201014.0low000100
styrenestyrenes;
vinylarene;
volatile organic compound
mouse metabolite;
mutagen;
plant metabolite
1986200628.0low010100
phenylhydrazinephenylhydrazinesxenobiotic1991201818.8low002020
methylphenylsulfidearyl sulfide;
benzenes
1998200124.5low001100
quinuclidinesquinuclidines;
saturated organic heterobicyclic parent
1999202012.8low0018100
pyridostigmine bromidepyridinium salt2001200322.0low000200
boric acidboric acidsastringent1950202325.2low010111
4-phenylenediaminephenylenediamineallergen;
dye;
hapten;
reagent
2000201017.7low001200
epichlorohydrinepoxide;
organochlorine compound
2006200618.0low000100
glycidyl methacrylateenoate ester;
epoxide
1990201422.0low001010
1,3-butadienebutadienecarcinogenic agent;
mutagen
1992201723.8low003110
acroleinenalherbicide;
human xenobiotic metabolite;
toxin
1997201815.2low001750
acrylonitrilealiphatic nitrile;
volatile organic compound
antifungal agent;
carcinogenic agent;
fungal metabolite;
mutagen;
polar aprotic solvent
1990201223.3low002010
chloroacetonitrilenitrile2004200420.0low000100
glyoxaldialdehydeagrochemical;
allergen;
pesticide;
plant growth regulator
201420197.5low000020
2-methylpentanealkane2003201812.0low000120
maleic anhydridecyclic dicarboxylic anhydride;
furans
allergen2012201510.5low000020
melaminetriamino-1,3,5-triazinexenobiotic metabolite2003202110.6low000131
chlorobenzenemonochlorobenzenessolvent2012201212.0low000010
cyclohexanolcyclohexanols;
secondary alcohol
solvent2004201613.1low000360
thiophenolaryl thiol2012201212.0low000010
pentanealkane;
volatile organic compound
non-polar solvent;
refrigerant
1990199034.0low001000
allyl cyanidealiphatic nitrile;
olefinic compound
antifeedant;
neurotoxin;
plant metabolite
2013201311.0low000010
2-hydroxyethylhydrazinehydrazinesherbicide2005200519.0low000100
vinyl etherether2001200820.3low000300
pyrrolespyrrole;
secondary amine
1991202312.5low50414185
pyrrolespyrrole;
secondary amine
1991202312.5low50412185
tetrahydrofurancyclic ether;
oxolanes;
saturated organic heteromonocyclic parent;
volatile organic compound
polar aprotic solvent2009200915.0low000100
furanfurans;
mancude organic heteromonocyclic parent;
monocyclic heteroarene
carcinogenic agent;
hepatotoxic agent;
Maillard reaction product
2014201410.0low000020
thiophenesmancude organic heteromonocyclic parent;
monocyclic heteroarene;
thiophenes;
volatile organic compound
non-polar solvent1990202117.2low0062292
n-hexanealkane;
volatile organic compound
neurotoxin;
non-polar solvent
201520187.5low000020
diethylenetriaminepolyazaalkane;
triamine
1985202121.0low010001
diethanolamineethanolamineshuman xenobiotic metabolite1984198440.0low010000
methyl palmitatefatty acid methyl estermetabolite2012201212.0low000010
2,2,2-trichloroethanolchloroethanolmouse metabolite201820186.0low000010
diethylhexyl phthalatediester;
phthalate ester
androstane receptor agonist;
apoptosis inhibitor;
plasticiser
201720177.0low000010
hexachlorobenzenearomatic fungicide;
chlorobenzenes
antifungal agrochemical;
carcinogenic agent;
persistent organic pollutant
202220231.5low000002
framycetinaminoglycosideallergen;
antibacterial drug;
Escherichia coli metabolite
1994199828.0low002000
dianisidinebiphenyls1957201927.8low043530
scoparonearomatic ether;
coumarins
anti-allergic agent;
anti-inflammatory agent;
antihypertensive agent;
antilipemic drug;
immunosuppressive agent;
plant metabolite
2014201410.0low000020
anthraceneacene;
anthracenes;
ortho-fused tricyclic hydrocarbon
1957201726.0low010120
2,4-dichlorophenoldichlorophenol1991202314.5low001412
2,4-dinitrotoluenedinitrotoluene2007200717.0low000100
vanillic acidmethoxybenzoic acid;
monohydroxybenzoic acid
plant metabolite2000201816.2low001220
pyrazolanthroneanthrapyrazole;
aromatic ketone;
cyclic ketone
antineoplastic agent;
c-Jun N-terminal kinase inhibitor;
geroprotector
2004201216.2low000310
pamoic aciddicarboxylic acid201720177.0low000010
megluminehexosamine;
secondary amino compound
201820186.0low000010
3-amino-9-ethylcarbazolecarbazoles1965199245.5low011000
alpha-naphthylphthalamic acidcarboxylic acid;
dicarboxylic acid monoamide;
N-(1-naphthyl)carboxamide
herbicide201520159.0low000010
indolebutyric acidindol-3-yl carboxylic acidauxin;
plant hormone;
plant metabolite
2001201814.7low000210
syringaldehydedimethoxybenzene;
hydroxybenzaldehyde
hypoglycemic agent;
plant metabolite
2000200024.0low001000
2-naphtholnaphtholantinematodal drug;
genotoxin;
human urinary metabolite;
human xenobiotic metabolite;
mouse metabolite;
radical scavenger
1980201723.3low053740
neozonenaphthalenes2010201014.0low000100
shikimic acidalpha,beta-unsaturated monocarboxylic acid;
cyclohexenecarboxylic acid;
hydroxy monocarboxylic acid
Escherichia coli metabolite;
plant metabolite;
Saccharomyces cerevisiae metabolite
201220238.2low100041
shikimic acidalpha,beta-unsaturated monocarboxylic acid;
cyclohexenecarboxylic acid;
hydroxy monocarboxylic acid
Escherichia coli metabolite;
plant metabolite;
Saccharomyces cerevisiae metabolite
2012201910.0low000040
4-nitrosodimethylanilinedimethylaniline;
nitroso compound;
tertiary amino compound
1985198539.0low010000
nitrilotriacetic acidNTA;
tricarboxylic acid
carcinogenic agent;
nephrotoxic agent
1998201319.0low001110
4-tert-octylphenolalkylbenzene201720177.0low000010
citronellolmonoterpenoidplant metabolite2006200618.0low000100
ethyl acetateacetate ester;
ethyl ester;
volatile organic compound
EC 3.4.19.3 (pyroglutamyl-peptidase I) inhibitor;
metabolite;
polar aprotic solvent;
Saccharomyces cerevisiae metabolite
2002202410.2low000222
2-hydroxypyridinemonohydroxypyridineplant metabolite202020204.0low000010
n-heptanealkane;
volatile organic compound
non-polar solvent;
plant metabolite
1999199925.0low001000
sodium cyanidecyanide salt;
one-carbon compound;
sodium salt
EC 1.15.1.1 (superoxide dismutase) inhibitor1982201229.0low021110
monomethylarsonic acidarsonic acids;
one-carbon compound;
organoarsonic acid
2009200915.0low000200
pregnenolone20-oxo steroid;
3beta-hydroxy-Delta(5)-steroid;
C21-steroid
human metabolite;
mouse metabolite
2007202110.0low000101
yohimbinemethyl 17-hydroxy-20xi-yohimban-16-carboxylatealpha-adrenergic antagonist;
dopamine receptor D2 antagonist;
serotonergic antagonist
1996200921.5low001100
2-chloroadenosinepurine nucleoside1993199331.0low001000
copper phthalocyanine1953195371.0low010000
diphenhydramine hydrochloridehydrochloride;
organoammonium salt
anti-allergic agent;
antiemetic;
antiparkinson drug;
antipruritic drug;
H1-receptor antagonist;
local anaesthetic;
muscarinic antagonist;
sedative
2012201212.0low000010
pentoxylpyrimidone202120213.0low000001
ditiocarbdithiocarbamic acidschelator;
copper chelator
1990201420.8low002210
mequinolmethoxybenzenes;
phenols
metabolite1987200727.0low010100
potassium cyanidecyanide salt;
one-carbon compound;
potassium salt
EC 1.15.1.1 (superoxide dismutase) inhibitor;
EC 1.9.3.1 (cytochrome c oxidase) inhibitor;
neurotoxin
1953200731.4low066500
methohexitalacetylenic compound;
barbiturates
drug allergen;
intravenous anaesthetic
1993200127.0low101100
catechincatechinantioxidant;
plant metabolite
1998202313.9low10226242
thiamine pyrophosphateorganic chloride salt;
vitamin B1
201220169.3low000030
diazooxonorleucineamino acid zwitterion;
diazo compound;
ketone;
non-proteinogenic L-alpha-amino acid
analgesic;
antibacterial agent;
antimetabolite;
antineoplastic agent;
antiviral agent;
apoptosis inducer;
bacterial metabolite;
EC 2.4.2.14 (amidophosphoribosyltransferase) inhibitor;
EC 3.5.1.2 (glutaminase) inhibitor;
EC 6.3.4.2 [CTP synthase (glutamine hydrolyzing)] inhibitor;
EC 6.3.5.1 [NAD(+) synthase (glutamine-hydrolysing)] inhibitor;
EC 6.3.5.2 [GMP synthase (glutamine-hydrolysing)] inhibitor;
EC 6.3.5.3 (phosphoribosylformylglycinamidine synthase) inhibitor;
EC 6.3.5.4 [asparagine synthase (glutamine-hydrolysing)] inhibitor;
EC 6.3.5.5 [carbamoyl-phosphate synthase (glutamine-hydrolysing)] inhibitor;
glutamine antagonist
2007200816.5low000200
peryleneortho- and peri-fused polycyclic arene;
perylenes
1992201917.2low002120
fluorantheneortho- and peri-fused polycyclic arene201920233.0low000011
phthalazineazaarene;
mancude organic heterobicyclic parent;
ortho-fused heteroarene;
phthalazines
1991199133.0low001000
quinazolinesazaarene;
mancude organic heterobicyclic parent;
ortho-fused heteroarene;
quinazolines
200320218.7low000142
acridinesacridines;
mancude organic heterotricyclic parent;
polycyclic heteroarene
genotoxin1983201227.2low08211320
indazolesindazole1995201717.5low002540
benzoxazoles1,3-benzoxazoles;
mancude organic heterobicyclic parent
2005202014.0low000210
triethylenediaminebridged compound;
diamine;
saturated organic heterobicyclic parent;
tertiary amino compound
antioxidant;
catalyst;
reagent
1995200026.3low003000
adamantaneadamantanes;
polycyclic alkane
1990201913.0low101240
cyclopentanecycloalkane;
cyclopentanes;
volatile organic compound
non-polar solvent1992202113.0low00413213
isoxazolesisoxazoles;
mancude organic heteromonocyclic parent;
monocyclic heteroarene
1959202117.0low011441
oxazoles1,3-oxazoles;
mancude organic heteromonocyclic parent;
monocyclic heteroarene
1990201914.4low002260
oxazoles1,3-oxazoles;
mancude organic heteromonocyclic parent;
monocyclic heteroarene
1990201915.0low002250
thiazoles1,3-thiazoles;
mancude organic heteromonocyclic parent;
monocyclic heteroarene
1993202117.0low00725142
1,2,4-triazole1,2,4-triazole201920195.0low000010
pyrazinesdiazine;
pyrazines
Daphnia magna metabolite1986202018.4low0169100
pyrazinesdiazine;
pyrazines
Daphnia magna metabolite1986202018.6low0168100
nitroblue tetrazoliumorganic cation1976201335.5low03871010
triphenyltetrazoliumorganic cation1989200921.7low011400
methylphenazonium methosulfateazaheterocycle sulfate salt;
phenazines
2000200621.0low001100
calcium gluconatecalcium saltnutraceutical2011201113.0low000010
diiodotyrosinediiodotyrosine;
L-tyrosine derivative;
non-proteinogenic L-alpha-amino acid
human metabolite;
mouse metabolite
1963200540.1low042100
muscarinemonosaccharide2002200222.0low000100
hydrazineazane;
hydrazines
EC 4.3.1.10 (serine-sulfate ammonia-lyase) inhibitor1989202018.4low014970
thiocyanatepseudohalide anion;
sulfur molecular entity
human metabolite1984201720.7low141117120
perfluorodecalinfluorocarbonblood substitute;
solvent
1995199529.0low001000
perfluorooctanefluoroalkane;
fluorocarbon
1995199529.0low001000
dexamethasone 21-phosphate11beta-hydroxy steroid;
17-hydroxy steroid;
3-oxo-Delta(4) steroid;
fluorinated steroid;
steroid phosphate;
tertiary alpha-hydroxy ketone
glucocorticoid receptor agonist2012201212.0low000010
evans blueorganic sodium saltfluorochrome;
histological dye;
sodium channel blocker;
teratogenic agent
1989202316.4low01213102
monocrotalinepyrrolizidine alkaloid2009201412.4low000230
opipramoldibenzoazepine2009200915.0low000100
aminophyllinemixturebronchodilator agent;
cardiotonic drug
1987200727.0low110100
azacitidineN-glycosyl-1,3,5-triazine;
nucleoside analogue
antineoplastic agent201020219.2low000131
azacitidineN-glycosyl-1,3,5-triazine;
nucleoside analogue
antineoplastic agent201720177.0low000010
galantaminebenzazepine alkaloid fundamental parent;
benzazepine alkaloid;
organic heterotetracyclic compound;
tertiary amino compound
antidote to curare poisoning;
cholinergic drug;
EC 3.1.1.7 (acetylcholinesterase) inhibitor;
EC 3.1.1.8 (cholinesterase) inhibitor;
plant metabolite
201620168.0low000010
aminoimidazole carboxamideaminoimidazole;
monocarboxylic acid amide
mouse metabolite1995201516.4low002030
methysergideergoline alkaloid1998199826.0low001000
kynuraminekynurenamines;
primary amino compound
metabolite2003201816.4low000410
n,n,n',n'-tetramethylbenzidine1984198440.0low010000
citrullineamino acid zwitterion;
citrulline
Daphnia magna metabolite;
EC 1.14.13.39 (nitric oxide synthase) inhibitor;
Escherichia coli metabolite;
human metabolite;
micronutrient;
mouse metabolite;
nutraceutical;
plant metabolite;
protective agent;
Saccharomyces cerevisiae metabolite
1994202012.4low1016130
betamethasone11beta-hydroxy steroid;
17alpha-hydroxy steroid;
20-oxo steroid;
21-hydroxy steroid;
3-oxo-Delta(1),Delta(4)-steroid;
fluorinated steroid;
glucocorticoid;
primary alpha-hydroxy ketone;
tertiary alpha-hydroxy ketone
anti-asthmatic agent;
anti-inflammatory drug;
immunosuppressive agent
1991201323.5low007030
cyanamidenitrile;
one-carbon compound
EC 1.2.1.3 [aldehyde dehydrogenase (NAD(+))] inhibitor202220222.0low000001
perflubronhaloalkane;
organobromine compound;
perfluorinated compound
blood substitute;
radioopaque medium
1994200325.7low002100
cyproterone acetate20-oxo steroid;
3-oxo-Delta(4) steroid;
acetate ester;
chlorinated steroid;
steroid ester
androgen antagonist;
geroprotector;
progestin
202020204.0low000010
4-methylcatecholmethylcatecholantioxidant;
carcinogenic agent;
hapten;
human metabolite;
plant metabolite
1999199925.0low001000
cyanogendinitrile;
pseudohalogen
201220236.6low000043
hydantoinsimidazolidine-2,4-dione2000202312.5low001001
fluorobenzenesmonofluorobenzenesNMR chemical shift reference compound2005201116.4low300410
methylguanidineguanidinesEC 1.14.13.39 (nitric oxide synthase) inhibitor;
metabolite;
uremic toxin
2004200917.5low000200
limestonecalcium salt;
carbonate salt;
inorganic calcium salt;
one-carbon compound
antacid;
fertilizer;
food colouring;
food firming agent
2013201410.5low000020
glycocholic acidbile acid glycine conjugatehuman metabolite2001200123.0low000100
fusarium1990202210.8low0016183
cepharanthinebisbenzylisoquinoline alkaloid;
isoquinolines
2014201410.0low000010
chrysophanic aciddihydroxyanthraquinoneanti-inflammatory agent;
antiviral agent;
plant metabolite
201620168.0low000010
imperatorinpsoralensEC 3.1.1.7 (acetylcholinesterase) inhibitor;
metabolite
2011201113.0low000010
cdtaorganooxygen compound2009200915.0low000100
emetineisoquinoline alkaloid;
pyridoisoquinoline
antiamoebic agent;
anticoronaviral agent;
antiinfective agent;
antimalarial;
antineoplastic agent;
antiprotozoal drug;
antiviral agent;
autophagy inhibitor;
emetic;
expectorant;
plant metabolite;
protein synthesis inhibitor
2000200024.0low001000
ostholbotanical anti-fungal agent;
coumarins
metabolite2013201510.0low000040
dihydralazinephthalazines1991199332.0low002000
flavanoneflavanones2002200222.0low000100
kainic aciddicarboxylic acid;
L-proline derivative;
non-proteinogenic L-alpha-amino acid;
pyrrolidinecarboxylic acid
antinematodal drug;
excitatory amino acid agonist
1987200727.0low010100
indole-3-carbaldehydeheteroarenecarbaldehyde;
indole alkaloid;
indoles
bacterial metabolite;
human xenobiotic metabolite;
marine metabolite;
plant metabolite
2005200519.0low000100
thymoquinone1,4-benzoquinonesadjuvant;
anti-inflammatory agent;
antidepressant;
antineoplastic agent;
antioxidant;
cardioprotective agent;
plant metabolite
2003201713.4low000350
melarsoproltriazines2008200816.0low000100
benzohydroxamic acid1992200624.5low004200
sodium carbonatecarbonate salt;
organic sodium salt
2001201317.0low100110
carvacrolbotanical anti-fungal agent;
p-menthane monoterpenoid;
phenols
agrochemical;
antimicrobial agent;
flavouring agent;
TRPA1 channel agonist;
volatile oil component
2009201610.3low000120
indophenolquinone iminedye1965200340.0low010100
4-hydroxyphenylethanolphenolsanti-arrhythmia drug;
antioxidant;
cardiovascular drug;
fungal metabolite;
geroprotector;
plant metabolite;
protective agent
201720177.0low000010
phloretic acidhydroxy monocarboxylic acidplant metabolite1992199530.5low002000
isovaleric acidbranched-chain saturated fatty acid;
methylbutyric acid;
short-chain fatty acid
mammalian metabolite;
plant metabolite
201920195.0low000010
alpha-aminopyridine2005202211.0low000341
alpha-aminopyridine2005202210.7low000331
thiazolidinesthiazolidine2001200123.0low000100
mustard gasethyl sulfide;
organochlorine compound
alkylating agent;
carcinogenic agent;
vesicant
1997202213.6low002261
cyanogen bromide1993200127.0low001100
thioacetic acidthioacetic acid2001200123.0low000100
oleanolic acidhydroxy monocarboxylic acid;
pentacyclic triterpenoid
plant metabolite2001201913.8low000670
tetranitromethaneorganonitrogen compound1998200522.5low001100
myrtenol201620168.0low000010
hematoxylinorganic heterotetracyclic compound;
oxacycle;
polyphenol;
tertiary alcohol
histological dye;
plant metabolite
200120237.6low100214
noramidopyrinepyrazoles;
secondary amino compound
antipyretic;
drug metabolite;
EC 1.14.99.1 (prostaglandin-endoperoxide synthase) inhibitor;
non-narcotic analgesic;
non-steroidal anti-inflammatory drug;
opioid analgesic;
peripheral nervous system drug
201820186.0low000010
hesperidin3'-hydroxyflavanones;
4'-methoxyflavanones;
dihydroxyflavanone;
disaccharide derivative;
flavanone glycoside;
monomethoxyflavanone;
rutinoside
mutagen1990202211.5low0022111
dihydrotestosterone17beta-hydroxy steroid;
17beta-hydroxyandrostan-3-one;
3-oxo-5alpha-steroid
androgen;
Daphnia magna metabolite;
human metabolite;
mouse metabolite
2006200618.0low000100
luminol1978202324.6low1285024265
flavoneflavonesmetabolite;
nematicide
2009201910.0low000110
tryptopholindolyl alcoholauxin;
plant metabolite;
Saccharomyces cerevisiae metabolite
202020204.0low000010
gluconic acidgluconic acidchelator;
Penicillium metabolite
1984200231.0low010100
copper gluconateorganic molecular entity1984201922.3low010110
azomycinC-nitro compound;
imidazoles
antitubercular agent202020204.0low000010
cellobiosecellobioseepitope1991201720.0low001010
syringic acidbenzoic acids;
dimethoxybenzene;
phenols
plant metabolite1981201924.0low010010
hydroxyhydroquinonebenzenetriolmouse metabolite2014201410.0low000010
tropolonealpha-hydroxy ketone;
cyclic ketone;
enol
bacterial metabolite;
fungicide;
toxin
1994199430.0low001000
4,6-dinitro-o-cresoldinitrophenol acaricide;
hydroxytoluene;
nitrotoluene
dinitrophenol insecticide;
fungicide;
herbicide
1957195767.0low010000
methoxyhydroxyphenylglycolmethoxybenzenes;
phenols
201520159.0low000010
3,5-dibromotyrosinemonocarboxylic acid2005200519.0low000100
methamphetamineamphetamines;
secondary amine
central nervous system stimulant;
environmental contaminant;
neurotoxin;
psychotropic drug;
xenobiotic
2006201811.3low000120
4-iodophenoliodophenol1990200427.0low001100
uranyl acetate201520159.0low000010
3-aminobutyric acidamino acid zwitterion;
beta-amino acid;
monocarboxylic acid
metabolite2013201410.5low000020
malondialdehydedialdehydebiomarker1988202412.8low2578749177960
cadmium acetate2004200420.0low000100
n-hexadecanelong-chain alkanenon-polar solvent;
plant metabolite;
volatile oil component
2001201317.0low000110
trinitrobenzenesulfonic acidarenesulfonic acid;
C-nitro compound
epitope;
explosive;
reagent
1988202316.6medium337515714210
eosine yellowish-(ys)organic sodium salt;
organobromine compound
fluorochrome;
histological dye
1959202315.0low110104
violacein2006200618.0low000100
gentian violetorganic chloride saltanthelminthic drug;
antibacterial agent;
antifungal agent;
antiseptic drug;
histological dye
2005200519.0low000100
resazurinphenoxazine2009200915.0low000100
1-naphthylisothiocyanateisothiocyanateinsecticide1999201119.8low002210
trimellitic anhydride2-benzofurans;
cyclic dicarboxylic anhydride;
dioxo monocarboxylic acid
allergen;
epitope;
hapten
1998200522.5low001100
hematoporphyrin1989200129.0low010100
neutral redhydrochlorideacid-base indicator;
dye;
two-colour indicator
1960200039.0low012000
nicotinic acid hydrazide1994199430.0low001000
lithium carbonatecarbonate salt;
lithium salt
antimanic drug1980198044.0low010000
linamarinbeta-D-glucoside1999199925.0low001000
4-chloromercuribenzenesulfonatearenesulfonic acid;
arylmercury compound
1982200431.0low010100
glycylglycinedipeptide zwitterion;
dipeptide
human metabolite2006200618.0low000100
octamethylcyclotetrasiloxanecyclosiloxane;
organosilicon compound
2003200321.0low000100
4-methyl-1-(1-methylethyl)-3-cyclohexen-1-olterpineol;
tertiary alcohol
anti-inflammatory agent;
antibacterial agent;
antineoplastic agent;
antioxidant;
antiparasitic agent;
apoptosis inducer;
plant metabolite;
volatile oil component
2013201311.0low000010
glycerylphosphorylcholineglycerophosphocholine2013201410.5low000020
malachite greenorganic chloride saltantibacterial agent;
antifungal drug;
carcinogenic agent;
environmental contaminant;
fluorochrome;
histological dye;
teratogenic agent
201820186.0low000010
congo redbis(azo) compound1987202311.2low010012
2,6-xylenolhydroxytoluene201920195.0low000010
docusatediester;
organosulfonic acid
1997200921.0low001100
3-hydroxyflavoneflavonols;
monohydroxyflavone
1964202118.1low011831
toluene 2,4-diisocyanatetoluene meta-diisocyanateallergen;
hapten
1996200524.0low002100
diphenylaminearomatic amine;
bridged diphenyl fungicide;
secondary amino compound
antifungal agrochemical;
antioxidant;
carotogenesis inhibitor;
EC 1.3.99.29 [phytoene desaturase (zeta-carotene-forming)] inhibitor;
ferroptosis inhibitor;
radical scavenger
2005200718.0low000200
mercuric cyanidemercury coordination entity2008200816.0low000100
allyl sulfideorganic sulfide2009201014.5low000200
glycopyrrolateorganic bromide salt;
quaternary ammonium salt
2000200024.0low101000
4-chloro-1-naphthol1980201632.0medium030010
alpha-naphthoflavoneextended flavonoid;
naphtho-gamma-pyrone;
organic heterotricyclic compound
aryl hydrocarbon receptor agonist;
aryl hydrocarbon receptor antagonist;
EC 1.14.14.14 (aromatase) inhibitor
1997200622.5low001100
2,6-dinitrotoluenedinitrotoluenegenotoxin2007200717.0low000100
benzoylhydrazinecarbohydrazide2003201415.5low000110
n-methyl-n-nitrosoaniline1992199232.0low001000
acetylcysteineacetylcysteine;
L-cysteine derivative;
N-acetyl-L-amino acid
antidote to paracetamol poisoning;
antiinfective agent;
antioxidant;
antiviral drug;
ferroptosis inhibitor;
geroprotector;
human metabolite;
mucolytic;
radical scavenger;
vulnerary
1987202316.1low731353354
ethyl pyruvateoxo carboxylic acid2006201713.4low000870
ethyl palmitatehexadecanoate ester;
long-chain fatty acid ethyl ester
plant metabolite2012201212.0low000010
heptadecanelong-chain alkaneplant metabolite;
volatile oil component
1985198539.0low010000
c.i. 425101957201822.0low021050
brilliant greenorganic hydrogensulfate saltantibacterial agent;
antiseptic drug;
environmental contaminant;
fluorochrome;
histological dye;
poison
201520159.0low000010
benzydaminearomatic ether;
indazoles;
tertiary amino compound
analgesic;
central nervous system stimulant;
hallucinogen;
local anaesthetic;
non-steroidal anti-inflammatory drug
2010201014.0low100100
erythromycincyclic ketone;
erythromycin
1986201424.5low012210
chromonarcoumarins1992200428.8low007100
1-chloro-2-hydroxy-3-butene1992199232.0medium001000
homoserineamino acid zwitterion;
homoserine
algal metabolite;
Escherichia coli metabolite;
human metabolite;
Saccharomyces cerevisiae metabolite
201720177.0low000010
2-piperidonedelta-lactam;
piperidones
EC 1.2.1.88 (L-glutamate gamma-semialdehyde dehydrogenase) inhibitor201420169.0low000020
dibutyldichlorotin201520159.0low000010
2-chloroethyl ethyl sulfide2009201113.6low000230
2,3,5-trimethylquinolhydroquinones;
methylbenzene
2000200024.0low001000
diphenyliodonium2009200915.0low000100
phosmetorganic thiophosphate;
organothiophosphate insecticide;
phthalimides
acaricide;
agrochemical;
EC 3.1.1.7 (acetylcholinesterase) inhibitor
202320231.0low000001
1,2-cyclohexanedionecyclohexanedione1989198935.0low010000
ethyl gallategallate esterplant metabolite2012201212.0low000010
1-phenylazo-2-naphthol1995200922.0low001100
boldenone17beta-hydroxy steroid;
3-oxo-Delta(1),Delta(4)-steroid;
anabolic androgenic steroid
201720205.5low000020
hydroxyethyl methacrylateenoate esterallergen;
polymerisation monomer
1987198737.0low010000
benzoylarginine nitroanilide2011201113.0low000010
amaranth dye201920195.0low000010
3,4-epoxy-1-butene1992200128.0low003100
n-phenylmaleimide2011201113.0low000010
deoxycytidinepyrimidine 2'-deoxyribonucleosideEscherichia coli metabolite;
human metabolite;
mouse metabolite;
Saccharomyces cerevisiae metabolite
1999202213.0low101241
deoxycytidinepyrimidine 2'-deoxyribonucleosideEscherichia coli metabolite;
human metabolite;
mouse metabolite;
Saccharomyces cerevisiae metabolite
1999202215.6low001211
2'-deoxyadenosinepurine 2'-deoxyribonucleoside;
purines 2'-deoxy-D-ribonucleoside
Escherichia coli metabolite;
human metabolite;
mouse metabolite;
Saccharomyces cerevisiae metabolite
2003200321.0low000100
azure a1959195965.0low010000
canrenonesteroid lactone201520159.0low100010
rhodamine 6g1994199430.0low001000
acetylhydrazinecarbohydrazide;
carbohydrazonic acid
drug metabolite201620168.0low000010
ethambutolethanolamines;
ethylenediamine derivative
antitubercular agent;
environmental contaminant;
xenobiotic
1988198836.0low010000
phenylglyoxalphenylacetaldehydes1989201422.5low010010
4-vinylbenzoic acid2006200618.0low000100
nicotinamide mononucleotidenicotinamide mononucleotideEscherichia coli metabolite;
mouse metabolite
2001200123.0low000100
dimethoxonorganic thiophosphate;
organothiophosphate insecticide
acaricide;
agrochemical;
EC 3.1.1.7 (acetylcholinesterase) inhibitor
2011201113.0low000010
methionylmethylsulfonium chloride202220222.0low000001
tetramethylpyrazinealkaloid;
pyrazines
antineoplastic agent;
apoptosis inhibitor;
bacterial metabolite;
neuroprotective agent;
platelet aggregation inhibitor;
vasodilator agent
2005201614.1low000550
decabromobiphenyl etherpolybromodiphenyl etherneurotoxin201420159.5low000020
ethylenediamine-n,n'-bis(2-hydroxyphenylacetic acid)2009200915.0low000100
4-aminothiophenol201820186.0low000010
carmine202320231.0low100001
gallium arsenide202020204.0low000010
calcium peroxidecalcium oxides200620228.5low000121
durapatite1988202015.1low011140
cadmium sulfidecadmium molecular entity2014201410.0low000020
germanium oxide201620177.5low000020
sodium hydroxidealkali metal hydroxide1984202115.5low010021
manganese dioxidemanganese molecular entity;
metal oxide
2000201910.0low001030
molybdenum trioxidemolybdenum oxide202120213.0low000001
zinc oxidezinc molecular entity201320234.9low100077
vanadium pentoxidevanadium oxide201620168.0low000010
molybdenum disulfidesulfide salt201420235.9low000081
ferrous sulfide2009202010.3low000120
cupric sulfide201220227.5low000051
arsenic trioxide2007201513.0low000120
ammonium hydroxideinorganic hydroxy compoundfood acidity regulator1991200327.0low001100
ferrous oxideiron oxide201320188.5low000020
vancomycinglycopeptideantibacterial drug;
antimicrobial agent;
bacterial metabolite
2009202110.3low000141
glycyrrhizic acidenone;
glucosiduronic acid;
pentacyclic triterpenoid;
tricarboxylic acid;
triterpenoid saponin
EC 3.4.21.5 (thrombin) inhibitor;
plant metabolite
1998202014.1low001860
d-alpha tocopherolalpha-tocopherolalgal metabolite;
antiatherogenic agent;
anticoagulant;
antioxidant;
antiviral agent;
EC 2.7.11.13 (protein kinase C) inhibitor;
immunomodulator;
micronutrient;
nutraceutical;
plant metabolite
1981202120.6low854344272
tocopherols1991201716.3low002540
guanazolearomatic amine;
triazoles
antineoplastic agent;
DNA synthesis inhibitor;
EC 1.17.4.1 (ribonucleoside-diphosphate reductase) inhibitor
1984198440.0low010000
selenomethionineselenoamino acid;
selenomethionines
plant metabolite1991199133.0low001000
9,10-diphenylanthraceneanthracenesfluorochrome;
photosensitizing agent
1992199232.0low001000
2,4-dinitrothiocyanatobenzeneC-nitro compound;
thiocyanates
hapten;
tolerogen
2007200717.0low000100
diphenyldiselenide2012201311.8low000040
digoxigenin12beta-hydroxy steroid;
14beta-hydroxy steroid;
3beta-hydroxy steroid;
3beta-sterol
hapten;
plant metabolite
1992201521.8low003210
decanealkane201520159.0low000010
5-chlorouracilorganochlorine compound2003201017.7low000300
tetrachloroisophthalonitrilearomatic fungicide;
dinitrile;
tetrachlorobenzene
antifungal agrochemical2010201014.0low000100
paraquatorganic cationgeroprotector;
herbicide
1986201915.3low02411200
pristanelong-chain alkane;
norterpene
biomarker;
immunological adjuvant
201520168.5low000020
2-tert-butylhydroquinonehydroquinonesfood antioxidant201820186.0low000010
dronabinolbenzochromene;
diterpenoid;
phytocannabinoid;
polyketide
cannabinoid receptor agonist;
epitope;
hallucinogen;
metabolite;
non-narcotic analgesic
2007201314.0low000210
methionine sulfoximinemethionine derivative;
non-proteinogenic alpha-amino acid;
sulfoximide
1994199430.0low001000
amiloridearomatic amine;
guanidines;
organochlorine compound;
pyrazines
diuretic;
sodium channel blocker
1996200524.3low002100
diallyl trisulfideorganic trisulfideanti-inflammatory agent;
antilipemic drug;
antineoplastic agent;
antioxidant;
antiprotozoal drug;
apoptosis inducer;
estrogen receptor antagonist;
insecticide;
platelet aggregation inhibitor;
vasodilator agent
201520216.0low000021
4-chlorobiphenylmonochlorobiphenyl2010201014.0low000100
pimozidebenzimidazoles;
heteroarylpiperidine;
organofluorine compound
antidyskinesia agent;
dopaminergic antagonist;
first generation antipsychotic;
H1-receptor antagonist;
serotonergic antagonist
1999199925.0low001000
bromophosorganic thiophosphate201520159.0low000010
pyronine biminium salt;
organic chloride salt
histological dye2014201410.0low000010
diallyl disulfideorganic disulfideantifungal agent;
antineoplastic agent;
plant metabolite
201820204.7low000030
fluorescein2-benzofurans;
gamma-lactone;
organic heteropentacyclic compound;
oxaspiro compound;
polyphenol;
xanthene dye
fluorescent dye;
radioopaque medium
1991201618.4low003140
methylprednisolone hemisuccinatecorticosteroid hormone;
hemisuccinate
2010201014.0low000100
thioflavin torganic chloride saltfluorochrome;
geroprotector;
histological dye
200720208.8low000140
2,4,2',4'-tetrachlorobiphenyldichlorobenzene;
tetrachlorobiphenyl
2005200519.0low000100
alpha-terpineolterpineolplant metabolite2011201113.0low000010
fucosefucopyranose;
L-fucose
Escherichia coli metabolite;
mouse metabolite
2001201515.8low100220
butyrylcholineacylcholine1998199826.0low001000
ethamsylateorganosulfur compound;
sulfonic acid derivative
1992201321.5low001010
acadesine1-ribosylimidazolecarboxamide;
aminoimidazole;
nucleoside analogue
antineoplastic agent;
platelet aggregation inhibitor
1995201518.2low002020
glycidyl trimethylammonium chloride2011201113.0low000010
10-camphorsulfonic acidorganosulfonic acid2007200717.0low000100
2,2-bis(bromomethyl)-1,3-propanediolprimary alcohol1953201920.2low012750
fluorescein-5-isothiocyanatefluorescein isothiocyanate1990202022.0low009830
n-acetylbenzidine2000200024.0low002000
sabinenethujeneplant metabolite199920238.8low0013183
mannoseD-aldohexose;
D-mannose;
mannopyranose
metabolite1977201921.6low015720
anabaseinebipyridines2007200717.0low000100
dithiothreitol1,4-dimercaptobutane-2,3-diol;
butanediols;
dithiol;
glycol;
thiol
chelator;
human metabolite;
reducing agent
1981202321.8low1231131
phenoxyacetic acidaromatic ether;
monocarboxylic acid
allergen;
Aspergillus metabolite;
human xenobiotic metabolite;
plant growth retardant
202020204.0low000010
ecdysone14alpha-hydroxy steroid;
22-hydroxy steroid;
25-hydroxy steroid;
2beta-hydroxy steroid;
3beta-sterol;
6-oxo steroid;
ecdysteroid
prohormone2014201410.0low000010
streptomycinantibiotic antifungal drug;
antibiotic fungicide;
streptomycins
antibacterial drug;
antifungal agrochemical;
antimicrobial agent;
antimicrobial drug;
bacterial metabolite;
protein synthesis inhibitor
1948198861.0low050000
carbonatescarbon oxoanion2001201318.0low100310
l 451167201720177.0low000010
dideoxyadenosineadenosines;
purine 2',3'-dideoxyribonucleoside
EC 3.5.4.4 (adenosine deaminase) inhibitor;
EC 4.6.1.1 (adenylate cyclase) inhibitor
2007200717.0low000100
acetylthiocholine1988201920.5low010010
trimetazidinearomatic amine1999200821.8low002400
buthionine sulfoximinediastereoisomeric mixture;
homocysteines;
non-proteinogenic alpha-amino acid;
sulfoximide
EC 6.3.2.2 (glutamate--cysteine ligase) inhibitor;
ferroptosis inducer
1994201319.5low004420
4-aminobenzhydrazide1995202014.8high0036100
dihydrostreptomycin sulfate1951199849.5low011000
aseanostatin p5branched-chain saturated fatty acid;
long-chain fatty acid
1991199531.0low002000
vidarabinebeta-D-arabinoside;
purine nucleoside
antineoplastic agent;
bacterial metabolite;
nucleoside antibiotic
2004200420.0low000100
iodinated glyceroldioxolane1998202313.5low001421
limonenecycloalkene;
p-menthadiene
human metabolite2002202010.5low000130
olsalazineazobenzenes;
dicarboxylic acid
non-steroidal anti-inflammatory drug;
prodrug
1994201119.0low001110
n-methylaspartateamino dicarboxylic acid;
D-alpha-amino acid;
D-aspartic acid derivative;
secondary amino compound
neurotransmitter agent1996201615.2low001230
1-(2-methoxy-5-nitrophenylazo)-2-hydroxy-3-(3-nitrophenylcarbamoyl)naphthalene201920195.0low000010
3-deazaadenosine1986198638.0low010000
sodium metasilicateinorganic sodium salt202020204.0low000010
tert-nitrosobutane2007200717.0low000100
coralyneisoquinolines2013201311.0low000010
dysprosiumf-block element atom;
lanthanoid atom
2005200519.0low000100
iridiumcobalt group element atom;
platinum group metal atom
200920235.2low100122
lanthanumf-block element atom;
lanthanoid atom;
scandium group element atom
1994201616.2low002470
manganeseelemental manganese;
manganese group element atom
Escherichia coli metabolite;
micronutrient
1953202317.1low078262710
mercuryelemental mercury;
zinc group element atom
neurotoxin1950202318.1low0348134
molybdenumchromium group element atommicronutrient1951202310.2low02031411
neodymiumf-block element atom;
lanthanoid atom
2013201311.0low000010
osmiumiron group element atom;
platinum group metal atom
2007200717.0low000100
palladiummetal allergen;
nickel group element atom;
platinum group metal atom
201220236.5low0000266
platinumelemental platinum;
nickel group element atom;
platinum group metal atom
201020236.1low00014016
rutheniumiron group element atom;
platinum group metal atom
200820218.7low000222
samariumf-block element atom;
lanthanoid atom
202320231.0low000001
silvercopper group element atom;
elemental silver
Escherichia coli metabolite198820238.7low11343311
terbiumf-block element atom;
lanthanoid atom
2008202011.8low000220
thoriumactinoid atom;
f-block element atom
201920195.0low000010
titaniumtitanium group element atom1990202210.3low0022205
tungstenchromium group element atommicronutrient1991202016.0low003150
cadmiumcadmium molecular entity;
zinc group element atom
2000202411.2low101471005
ceriumf-block element atom;
lanthanoid atom
200920236.9low0001155
chromiumchromium group element atom;
metal allergen
micronutrient1983202312.9low0118153
europiumf-block element atom;
lanthanoid atom
2008202310.8low100211
gadoliniumf-block element atom;
lanthanoid atom
1999201916.4low0021360
goldcopper group element atom;
elemental gold
198120238.7low1810412154
heliummonoatomic helium;
noble gas atom;
s-block element atom
food packaging gas2005201514.0low000210
uraniumactinoid atom;
f-block element atom;
monoatomic uranium
201020227.8low000131
vanadiumelemental vanadium;
vanadium group element atom
micronutrient1999202210.7low001242
xenonmonoatomic xenon;
noble gas atom;
p-block element atom
2008200816.0low000100
yttriumd-block element atom;
rare earth metal atom;
scandium group element atom
2012201212.0low000010
zirconiumtitanium group element atom200220238.7low000132
aluminum chloridealuminium coordination entityLewis acid201520207.0low000030
magnesium sulfatemagnesium salt;
metal sulfate;
organic magnesium salt
anaesthetic;
analgesic;
anti-arrhythmia drug;
anticonvulsant;
calcium channel blocker;
cardiovascular drug;
fertilizer;
tocolytic agent
2007201214.0low000120
mercuric chloridemercury coordination entitysensitiser1992201325.9low0011120
acetylglucosamineN-acetyl-D-glucosamineepitope1989201320.0low012220
galactosamineD-galactosamine;
primary amino compound
toxin1990202212.3low0036161
sodium nitrateinorganic nitrate salt;
inorganic sodium salt
fertilizer;
NMR chemical shift reference compound
201920233.0low000011
cesium chlorideinorganic caesium salt;
inorganic chloride
phase-transfer catalyst;
vasoconstrictor agent
2005200519.0low000100
2-nitrobenzenesulfenyl chloride2001200123.0low000100
hypochlorous acidchlorine oxoacid;
reactive oxygen species
EC 2.5.1.18 (glutathione transferase) inhibitor;
EC 3.1.1.7 (acetylcholinesterase) inhibitor;
human metabolite
1952202320.0medium04913013412628
camptothecindelta-lactone;
pyranoindolizinoquinoline;
quinoline alkaloid;
tertiary alcohol
antineoplastic agent;
EC 5.99.1.2 (DNA topoisomerase) inhibitor;
genotoxin;
plant metabolite
200820208.6low000170
ferric chlorideiron coordination entityastringent;
Lewis acid
1996201319.5low001010
nickel chloridenickel coordination entitycalcium channel blocker;
hapten
201620168.0low000010
ferrous sulfateiron molecular entity;
metal sulfate
reducing agent1989201920.0low010010
phosphinemononuclear parent hydride;
phosphanes;
phosphine
carcinogenic agent;
fumigant insecticide
1990201418.3low001020
brominediatomic bromine1990202019.8low003630
potassium persulfate201720177.0low000010
barium sulfatebarium salt;
inorganic barium salt;
metal sulfate
radioopaque medium1994199529.5low002000
s-methylcysteineS-alkyl-L-cysteine zwitterion;
S-alkyl-L-cysteine
human urinary metabolite;
plant metabolite
201620168.0low000010
zinc sulfatemetal sulfate;
zinc molecular entity
fertilizer1998201617.4low002320
potassium nitrateinorganic nitrate salt;
potassium salt
fertilizer2003200619.5low000200
sodium sulfateinorganic sodium salt199920228.2low001022
sodium sulfiteinorganic sodium salt;
sulfite salt
food preservative;
reducing agent
201620168.0low000010
tricalcium phosphatecalcium phosphate1985201623.5low010010
lead chlorideinorganic chloride;
lead coordination entity
201820186.0low000010
chromateschromium oxoanion;
divalent inorganic anion
oxidising agent1992199232.0low001000
copper sulfatemetal sulfateemetic;
fertilizer;
sensitiser
1964202022.6low013230
tungstatedivalent inorganic anion;
tungsten oxoanion
1951195173.0low010000
silver nitrateinorganic nitrate salt;
silver salt
astringent201520159.0low000010
sodium chromate(vi)inorganic sodium saltcarcinogenic agent;
diagnostic agent;
oxidising agent;
poison
1992199232.0low001000
potassium sulfateinorganic potassium salt;
potassium salt
202120213.0low000001
deuteriumdihydrogen1977202335.0low041001
fluorinediatomic fluorine;
gas molecular entity
NMR chemical shift reference compound2013201311.0low000020
chlorinediatomic chlorine;
gas molecular entity
bleaching agent1982202123.4low08172732
nitrous acidnitrogen oxoacid1993199729.0low002000
deuterium oxidedeuterated compound;
water
NMR solvent1982199535.0low012000
fluorosulfonic acidsulfur oxoacidNMR solvent2012201212.0low000010
molybdate iondivalent inorganic anion;
molybdenum oxoanion
Escherichia coli metabolite1951195173.0low010000
calcium pyrophosphatecalcium phosphate2004200420.0low000100
chlorosulfonic acid2006200618.0low000100
sulfur trioxidesulfur oxide2013201311.0low000010
galactose1997200622.3low001200
poloxaleneepoxide1994199430.0low001000
vasotocin2001200123.0low000100
ozoneelemental molecule;
gas molecular entity;
reactive oxygen species;
triatomic oxygen
antiseptic drug;
disinfectant;
electrophilic reagent;
greenhouse gas;
mutagen;
oxidising agent;
tracer
1989201917.4low82919170
radonmonoatomic radon;
noble gas atom;
p-block element atom
201220189.0low000020
ferric phosphateinorganic phosphate salt;
inorganic phosphate;
iron molecular entity
2012201411.0low000020
lead nitrateinorganic nitrate salt;
lead coordination entity
2008202010.7low000120
sodium seleniteinorganic sodium salt;
selenite salt
nutraceutical1999201812.4low101350
cadmium chloridecadmium coordination entity2000202114.9low0011051
cobalt sulfatemetal sulfate202020204.0low000010
trolamine salicylate1989202016.4low01811110
stanozolol17beta-hydroxy steroid;
anabolic androgenic steroid;
organic heteropentacyclic compound;
tertiary alcohol
anabolic agent;
androgen
201720205.5low000020
rhamnoseL-rhamnose2012201212.0low000010
clodronic acid1,1-bis(phosphonic acid);
one-carbon compound;
organochlorine compound
antineoplastic agent;
bone density conservation agent
1990201225.0low003110
chloraminehalide1991202120.6low009831
carbendazimbenzimidazole fungicide;
benzimidazoles;
benzimidazolylcarbamate fungicide;
carbamate ester
antifungal agrochemical;
antinematodal drug;
metabolite;
microtubule-destabilising agent
2010201710.5low000110
chrysotile1990199034.0low001000
ammonium chlorideammonium salt;
inorganic chloride
ferroptosis inhibitor1986201527.8low042210
ethionineS-ethylhomocysteineantimetabolite;
carcinogenic agent
1952200732.7low023200
procion blue mx-r201820186.0low000010
benzo(a)pyrene 7,8-dihydrodiolpyrenes1985200032.9low026000
titanium dioxidetitanium oxidesfood colouring199020239.8low0011153
sodium tungstate(vi)inorganic sodium saltreagent2009200915.0low000100
apazonebenzotriazinesnon-steroidal anti-inflammatory drug;
uricosuric drug
1990199133.7low003000
tetrathionic acidsulfur oxoacid2005200519.0low000100
tiletamine hydrochloride1980201430.6low094410
levamisole6-phenyl-2,3,5,6-tetrahydroimidazo[2,1-b][1,3]thiazoleantinematodal drug;
antirheumatic drug;
EC 3.1.3.1 (alkaline phosphatase) inhibitor;
immunological adjuvant;
immunomodulator
1981201532.4low050020
devrinolaromatic ether;
monocarboxylic acid amide;
naphthalenes
2010201014.0low000100
thiamphenicolmonocarboxylic acid amide;
sulfone
antimicrobial agent;
immunosuppressive agent
202320231.0low000001
cephalexinbeta-lactam antibiotic allergen;
cephalosporin;
semisynthetic derivative
antibacterial drug2006200618.0low000200
ammonium nickel sulfateammonium salt;
metal sulfate;
nickel coordination entity
1951195173.0medium010000
cromolyn sodiumorganic sodium saltanti-asthmatic drug;
drug allergen
1998201613.3low001140
tetradecanoylphorbol acetateacetate ester;
diester;
phorbol ester;
tertiary alpha-hydroxy ketone;
tetradecanoate ester
antineoplastic agent;
apoptosis inducer;
carcinogenic agent;
mitogen;
plant metabolite;
protein kinase C agonist;
reactive oxygen species generator
1980202225.9low18312971574
ethephonphosphonic acidsplant growth regulator1998201619.0low003020
sodium bisulfide2008201611.6low000270
fluoroboric acidboron fluoride201620168.0low000010
fluorideshalide anion;
monoatomic fluorine
1951202128.5low064531
stannic oxidetin oxide202120213.0low000001
chromiumchromium cation;
monoatomic hexacation
200920217.9low000152
mecysteineL-cysteinyl ester;
primary amino compound;
thiol
mucolytic1988198836.0low010000
keracyaninanthocyanin chlorides2012201610.0low000020
1-deoxynojirimycin2-(hydroxymethyl)piperidine-3,4,5-triol;
piperidine alkaloid
anti-HIV agent;
anti-obesity agent;
bacterial metabolite;
EC 3.2.1.20 (alpha-glucosidase) inhibitor;
hepatoprotective agent;
hypoglycemic agent;
plant metabolite
2004200420.0low000100
taurolidinethiadiazinane2002200222.0low000100
iodinehalide anion;
monoatomic iodine
human metabolite1952201735.9low14117740
osmium tetroxideosmium coordination entityfixative;
histological dye;
oxidising agent;
poison
1979197945.0low010000
daunorubicinaminoglycoside antibiotic;
anthracycline;
p-quinones;
tetracenequinones
antineoplastic agent;
bacterial metabolite
1986201024.5low113700
aluminum phosphide202220222.0low000001
cephapirincephalosporinantibacterial drug1998199826.0low001000
phosphotyrosineL-tyrosine derivative;
non-proteinogenic L-alpha-amino acid;
O(4)-phosphotyrosine
Escherichia coli metabolite;
immunogen
1997201620.2low001310
carbimazole1,3-dihydroimidazole-2-thiones;
carbamate ester
antithyroid drug;
prodrug
2008200816.0low000100
bromocriptineindole alkaloidantidyskinesia agent;
antiparkinson drug;
dopamine agonist;
hormone antagonist
2008200816.0low000100
cetalkonium chloride1993199331.0low001000
zingeronemethyl ketone;
monomethoxybenzene;
phenols
anti-inflammatory agent;
antiemetic;
antioxidant;
flavouring agent;
fragrance;
plant metabolite;
radiation protective agent
201420207.0low000020
phenyl acetatebenzenes;
phenyl acetates
1963202218.6low172030314
cetylpyridinium chloride anhydrouschloride salt;
organic chloride salt
antiseptic drug;
surfactant
200720239.0low000121
acetylacetonebeta-diketone1991199133.0low001000
1,4-dioxanedioxane;
volatile organic compound
carcinogenic agent;
metabolite;
NMR chemical shift reference compound;
non-polar solvent
2005200917.0low000200
dimedone2001200123.0low000100
n-chlorosuccinimidedicarboximide;
pyrrolidinone
1986200827.0low010100
ursodeoxycholic acidbile acid;
C24-steroid;
dihydroxy-5beta-cholanic acid
human metabolite;
mouse metabolite
1997201814.6low002140
pyreneortho- and peri-fused polycyclic arenefluorescent probe;
persistent organic pollutant
2007200816.5low000400
isothiuronium1996200323.8low001300
benzonidazoleC-nitro compound;
imidazoles;
monocarboxylic acid amide
antiprotozoal drug202020204.0low000010
butachloraromatic amide;
organochlorine compound;
tertiary carboxamide
environmental contaminant;
herbicide;
xenobiotic
2001200222.5low000200
4-methoxyamphetamine1999201519.8low002110
8-bromo cyclic adenosine monophosphate3',5'-cyclic purine nucleotide;
adenyl ribonucleotide;
organobromine compound
antidepressant;
protein kinase agonist
1984201030.2low022100
triazophosorganic thiophosphate;
organothiophosphate insecticide
acaricide;
agrochemical;
EC 3.1.1.7 (acetylcholinesterase) inhibitor;
nematicide
2007200717.0low000100
transferrin1978201727.2low175150
alkenes1986202118.1low012031
calcium oxalateorganic calcium salt2007200717.0low000100
glutamic acidglutamic acid;
glutamine family amino acid;
L-alpha-amino acid;
proteinogenic amino acid
Escherichia coli metabolite;
ferroptosis inducer;
micronutrient;
mouse metabolite;
neurotransmitter;
nutraceutical
1992202016.0low0041270
glucaric acidglucaric acidantineoplastic agent2012201212.0low000010
azoxymethane2009201710.8low000150
cefazolinbeta-lactam antibiotic allergen;
cephalosporin;
tetrazoles;
thiadiazoles
antibacterial drug2002202013.0low000110
sodium azideinorganic sodium saltantibacterial agent;
explosive;
mitochondrial respiratory-chain inhibitor;
mutagen
1981201429.2low017151030
azidespseudohalide anionmitochondrial respiratory-chain inhibitor1948202337.0low04926301
adenosine diphosphate riboseADP-sugarEscherichia coli metabolite;
mouse metabolite
1996200523.3low001200
amoxicillinpenicillin allergen;
penicillin
antibacterial drug1997200125.0low001100
timololtimololanti-arrhythmia drug;
antiglaucoma drug;
antihypertensive agent;
beta-adrenergic antagonist
1994199430.0low001000
norflurazone(trifluoromethyl)benzenes;
organochlorine compound;
pyridazinone;
secondary amino compound
agrochemical;
carotenoid biosynthesis inhibitor;
herbicide
2004200420.0low000100
ferrozine2013201311.0low000010
nigericinpolycyclic etherantibacterial agent;
antimicrobial agent;
bacterial metabolite;
potassium ionophore
2006200618.0low000100
enterobactincatechols;
crown compound;
macrotriolide;
polyphenol
bacterial metabolite;
siderophore
201520187.5low000020
dimethyl suberimidate1977197747.0low010000
zidovudineazide;
pyrimidine 2',3'-dideoxyribonucleoside
antimetabolite;
antiviral drug;
HIV-1 reverse transcriptase inhibitor
2009200915.0low000100
acetylgalactosamineN-acetyl-D-hexosamine;
N-acetylgalactosamine
Escherichia coli metabolite;
human metabolite;
mouse metabolite
1996199628.0low001000
5,7-dihydroxytryptamine1992199232.0low001000
flubendazolearomatic ketone;
benzimidazoles;
carbamate ester;
organofluorine compound
antinematodal drug;
teratogenic agent
201520159.0low000010
amdinocillinpenicillinantibacterial drug;
antiinfective agent
1998199826.0low001000
tobramycinamino cyclitol glycosideantibacterial agent;
antimicrobial agent;
toxin
1993199331.0low001000
paclitaxeltaxane diterpenoid;
tetracyclic diterpenoid
antineoplastic agent;
human metabolite;
metabolite;
microtubule-stabilising agent
2007201214.5low100110
paclitaxeltaxane diterpenoid;
tetracyclic diterpenoid
antineoplastic agent;
human metabolite;
metabolite;
microtubule-stabilising agent
2004201216.3low100210
amitrazformamidines;
tertiary amino compound
acaricide;
environmental contaminant;
insecticide;
xenobiotic
2000200422.0low001100
etoposidebeta-D-glucoside;
furonaphthodioxole;
organic heterotetracyclic compound
antineoplastic agent;
DNA synthesis inhibitor
1994201718.2low102830
substance ppeptideneurokinin-1 receptor agonist;
neurotransmitter;
vasodilator agent
1986201920.4low01163050
isoproturon3-(3,4-substituted-phenyl)-1,1-dimethylureaagrochemical;
environmental contaminant;
herbicide;
xenobiotic
2008200816.0low000100
dobutaminecatecholamine;
secondary amine
beta-adrenergic agonist;
cardiotonic drug;
sympathomimetic agent
2004201713.5low000110
tertatololthiochromane1992199232.0low001000
ticarcillinpenicillin allergen;
penicillin
antibacterial drug1993199331.0low001000
2,4'-dichlorobiphenyldichlorobiphenyl;
monochlorobenzenes
1998199826.0low001000
halofantrinephenanthrenes2008200816.0low000100
ribavirin1-ribosyltriazole;
aromatic amide;
monocarboxylic acid amide;
primary carboxamide
anticoronaviral agent;
antiinfective agent;
antimetabolite;
antiviral agent;
EC 2.7.7.49 (RNA-directed DNA polymerase) inhibitor
2009201213.5low100110
amikacinalpha-D-glucoside;
amino cyclitol glycoside;
aminoglycoside;
carboxamide
antibacterial drug;
antimicrobial agent;
nephrotoxin
2012201212.0low000010
thiocholine201920195.0low000010
2,3,4,2',3',4'-hexachlorobiphenyl1998199826.0low001000
1,2,3,7,8-pentachlorodibenzo-p-dioxinpolychlorinated dibenzodioxine1990199034.0low001000
pendimethalinC-nitro compound;
secondary amino compound;
substituted aniline
agrochemical;
environmental contaminant;
herbicide
202220222.0low000001
profenofosmonochlorobenzenes;
organic thiophosphate;
organochlorine insecticide;
organophosphate insecticide
acaricide;
agrochemical;
EC 3.1.1.7 (acetylcholinesterase) inhibitor
2010201014.0low000100
tricyclazoletriazolobenzothiazoleantifungal agrochemical;
melanin synthesis inhibitor
201620168.0low000010
diltiazem5-[2-(dimethylamino)ethyl]-2-(4-methoxyphenyl)-4-oxo-2,3,4,5-tetrahydro-1,5-benzothiazepin-3-yl acetateantihypertensive agent;
calcium channel blocker;
vasodilator agent
2004201614.0low000110
oxyfluorofenaromatic etherEC 1.3.3.4 (protoporphyrinogen oxidase) inhibitor;
herbicide
2005200519.0low000100
triadimefonaromatic ether;
hemiaminal ether;
ketone;
monochlorobenzenes;
triazoles
2002200819.0low000200
1-methyl-4-phenylpyridiniumpyridinium ionapoptosis inducer;
herbicide;
human xenobiotic metabolite;
neurotoxin
2004201315.5low000110
ng-nitroarginine methyl esteralpha-amino acid ester;
L-arginine derivative;
methyl ester;
N-nitro compound
EC 1.14.13.39 (nitric oxide synthase) inhibitor1992202320.5low004251162
benoxaprofen1,3-benzoxazoles;
monocarboxylic acid;
monochlorobenzenes
antipsoriatic;
antipyretic;
EC 1.13.11.34 (arachidonate 5-lipoxygenase) inhibitor;
hepatotoxic agent;
nephrotoxin;
non-narcotic analgesic;
non-steroidal anti-inflammatory drug;
protein kinase C agonist
1983198440.5low020000
deoxynivalenolcyclic ketone;
enone;
primary alcohol;
secondary alpha-hydroxy ketone;
trichothecene;
triol
mycotoxin201420178.5low000020
thidiazuronureas2005201016.5low000200
doxantrazole1998200920.7low001200
decamethrinaromatic ether;
cyclopropanecarboxylate ester;
nitrile;
organobromine compound
agrochemical;
antifeedant;
calcium channel agonist;
EC 3.1.3.16 (phosphoprotein phosphatase) inhibitor;
pyrethroid ester insecticide
202220222.0low000001
pirfenidonepyridoneantipyretic;
non-narcotic analgesic;
non-steroidal anti-inflammatory drug
1995201915.2low001120
6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acidchromanol;
monocarboxylic acid;
phenols
antioxidant;
ferroptosis inhibitor;
neuroprotective agent;
radical scavenger;
Wnt signalling inhibitor
1991201522.3low105410
lodoxamide ethyl1990199730.5low002000
3,3',5,5'-tetramethylbenzidine1979202310.5medium031087715
7,8-dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxideepoxideintercalator1992200726.0low002200
torsemideaminopyridine;
N-sulfonylurea;
secondary amino compound
antihypertensive agent;
loop diuretic
202220222.0low000001
desfluraneorganofluorine compoundinhalation anaesthetic201620168.0low000010
2,3,4,7,8-pentachlorodibenzofuranpolychlorinated dibenzofuran1990199034.0low001000
closantelaromatic amide;
monocarboxylic acid amide;
monochlorobenzenes;
nitrile;
organoiodine compound;
phenols
201920195.0low000010
metalaxylalanine derivative;
aromatic amide;
carboxamide;
ether;
methyl ester
2014201410.0low000010
elliptiniumcarbazoles1985198539.0low010000
enkephalin, methionine1982200732.0low033100
idarubicinanthracycline antibiotic;
deoxy hexoside;
monosaccharide derivative
1999201219.0low002220
fluridonephenylpyridinecarotenoid biosynthesis inhibitor2000200024.0low001000
propiconazoleconazole fungicide;
cyclic ketal;
dichlorobenzene;
triazole fungicide;
triazoles
antifungal agrochemical;
EC 1.14.13.70 (sterol 14alpha-demethylase) inhibitor;
environmental contaminant;
xenobiotic
1992202018.0low001010
3-pyridyl pinacidil1993199331.0medium001000
nitrosobis(2-oxopropyl)amineketone;
nitrosamine
carcinogenic agent1990200029.0low002000
piperacillinpenicillin allergen;
penicillin
antibacterial drug201620168.0low000010
paroxetinearomatic ether;
benzodioxoles;
organofluorine compound;
piperidines
antidepressant;
anxiolytic drug;
hepatotoxic agent;
P450 inhibitor;
serotonin uptake inhibitor
201020229.7low000111
captoprilalkanethiol;
L-proline derivative;
N-acylpyrrolidine;
pyrrolidinemonocarboxylic acid
antihypertensive agent;
EC 3.4.15.1 (peptidyl-dipeptidase A) inhibitor
1994201819.3low105820
oltipraz1,2-dithiole;
pyrazines
angiogenesis modulating agent;
antimutagen;
antineoplastic agent;
antioxidant;
EC 3.1.3.48 (protein-tyrosine-phosphatase) inhibitor;
neurotoxin;
protective agent;
schistosomicide drug
2007200717.0low000100
nicorandilnitrate ester;
pyridinecarboxamide
potassium channel opener;
vasodilator agent
1995201717.1low202230
bw-755c1993199331.0low002000
colforsinacetate ester;
cyclic ketone;
labdane diterpenoid;
organic heterotricyclic compound;
tertiary alpha-hydroxy ketone;
triol
adenylate cyclase agonist;
anti-HIV agent;
antihypertensive agent;
plant metabolite;
platelet aggregation inhibitor;
protein kinase A agonist
1984201821.3low026440
fluperlapinebenzazepine1997200025.5low002000
nedocromildicarboxylic acid;
organic heterotricyclic compound
anti-allergic agent;
anti-asthmatic drug;
non-steroidal anti-inflammatory drug
2010201014.0low000100
4,5-amino-3,5-dichloro-6-fluoro-2-pyridinyloxyacetic acidaminopyridine;
aromatic ether;
monocarboxylic acid;
organochlorine compound;
organofluorine compound
environmental contaminant;
herbicide;
xenobiotic
2010201014.0low000100
fluazifop-butylaromatic ether;
carboxylic ester;
organofluorine compound;
pyridines
201720177.0low000010
cefaclor anhydrouscephalosporinantibacterial drug;
drug allergen
1983202022.5low110010
daurisolineisoquinolines2004200420.0low000100
alfentanilmonocarboxylic acid amide;
piperidines
central nervous system depressant;
intravenous anaesthetic;
mu-opioid receptor agonist;
opioid analgesic;
peripheral nervous system drug
1993199331.0low001000
fomesafenaromatic ether;
C-nitro compound;
monochlorobenzenes;
N-sulfonylcarboxamide;
organofluorine compound;
phenols
agrochemical;
EC 1.3.3.4 (protoporphyrinogen oxidase) inhibitor;
herbicide
2013201311.0low000010
fomesafenaromatic ether;
C-nitro compound;
monochlorobenzenes;
N-sulfonylcarboxamide;
organofluorine compound;
phenols
agrochemical;
EC 1.3.3.4 (protoporphyrinogen oxidase) inhibitor;
herbicide
1996201419.5low003210
fenoxycarbaromatic ether;
carbamate ester
environmental contaminant;
insecticide;
juvenile hormone mimic;
xenobiotic
201520159.0low000010
metsulfuron methyl1,3,5-triazines;
benzoate ester;
N-sulfonylurea
environmental contaminant;
herbicide;
xenobiotic
2006201315.0low000210
2-amino-3-methylimidazo(4,5-f)quinolineimidazoquinolinecarcinogenic agent1984198440.0low010000
quizalofop-ethylaromatic ether;
ethyl ester;
organochlorine compound;
quinoxaline derivative
2012201212.0low000010
dazmegrel1990199034.0low001000
bm 135051989199034.5low011000
simvastatindelta-lactone;
fatty acid ester;
hexahydronaphthalenes;
statin (semi-synthetic)
EC 1.1.1.34/EC 1.1.1.88 (hydroxymethylglutaryl-CoA reductase) inhibitor;
EC 3.4.24.83 (anthrax lethal factor endopeptidase) inhibitor;
ferroptosis inducer;
geroprotector;
prodrug
2003201813.5low20010120
balsalazide2009200915.0low000100
pravastatin3-hydroxy carboxylic acid;
carbobicyclic compound;
carboxylic ester;
hydroxy monocarboxylic acid;
secondary alcohol;
statin (semi-synthetic)
anticholesteremic drug;
environmental contaminant;
metabolite;
xenobiotic
2001201018.2low100500
imazethapyraromatic carboxylic acid;
pyridines
2009200915.0low000100
quinaprildicarboxylic acid monoester;
ethyl ester;
isoquinolines;
tertiary carboxamide
antihypertensive agent;
EC 3.4.15.1 (peptidyl-dipeptidase A) inhibitor;
prodrug
1999199925.0low001000
raloxifene hydrochloridehydrochloridebone density conservation agent;
estrogen antagonist;
estrogen receptor modulator
1996201318.6low001220
methyl bensulfuronaromatic ether;
methyl ester;
N-sulfonylurea;
pyrimidines
agrochemical;
EC 2.2.1.6 (acetolactate synthase) inhibitor;
herbicide
2012201212.0low000010
mifepristone3-oxo-Delta(4) steroid;
acetylenic compound;
tertiary amino compound
abortifacient;
contraceptive drug;
hormone antagonist;
synthetic oral contraceptive
2004201615.8low000510
gusperimusN-acyl-amino acid2008200816.0low000100
dopexaminecatecholamine2001200123.0low100100
chlorimuron ethylaromatic ether;
ethyl ester;
N-sulfonylurea;
organochlorine pesticide;
pyrimidines;
sulfamoylbenzoate
agrochemical;
EC 2.2.1.6 (acetolactate synthase) inhibitor;
proherbicide
2006200618.0low000100
salmeterol xinafoatenaphthoic acid2003200619.5low100200
fura-21994201120.2low001210
delmopinolmorpholines1995199529.0low001000
imiquimodimidazoquinolineantineoplastic agent;
interferon inducer
201220217.6low000041
esmololaromatic ether;
ethanolamines;
methyl ester;
secondary alcohol;
secondary amino compound
202320231.0low100001
prinomideanilide1997199727.0medium001000
zileuton1-benzothiophenes;
ureas
anti-asthmatic drug;
EC 1.13.11.34 (arachidonate 5-lipoxygenase) inhibitor;
ferroptosis inhibitor;
leukotriene antagonist;
non-steroidal anti-inflammatory drug
1993201024.0low003200
clopidogrelmethyl ester;
monochlorobenzenes;
thienopyridine
anticoagulant;
P2Y12 receptor antagonist;
platelet aggregation inhibitor
2010202110.4low100271
mibefradiltetralinsT-type calcium channel blocker1993199331.0low001000
bimakalim1995199529.0low001000
topotecanpyranoindolizinoquinolineantineoplastic agent;
EC 5.99.1.2 (DNA topoisomerase) inhibitor
201720186.5low000020
tenidap1991199133.0low001000
gemcitabineorganofluorine compound;
pyrimidine 2'-deoxyribonucleoside
antimetabolite;
antineoplastic agent;
antiviral drug;
DNA synthesis inhibitor;
EC 1.17.4.1 (ribonucleoside-diphosphate reductase) inhibitor;
environmental contaminant;
immunosuppressive agent;
photosensitizing agent;
prodrug;
radiosensitizing agent;
xenobiotic
201120227.0low100031
gemcitabineorganofluorine compound;
pyrimidine 2'-deoxyribonucleoside
antimetabolite;
antineoplastic agent;
antiviral drug;
DNA synthesis inhibitor;
EC 1.17.4.1 (ribonucleoside-diphosphate reductase) inhibitor;
environmental contaminant;
immunosuppressive agent;
photosensitizing agent;
prodrug;
radiosensitizing agent;
xenobiotic
202220222.0low000001
ro 24-47361996199628.0low001000
remifentanilalpha-amino acid ester;
anilide;
monocarboxylic acid amide;
piperidinecarboxylate ester
intravenous anaesthetic;
mu-opioid receptor agonist;
opioid analgesic;
sedative
2010201511.0low000120
atorvastatinaromatic amide;
dihydroxy monocarboxylic acid;
monofluorobenzenes;
pyrroles;
statin (synthetic)
environmental contaminant;
xenobiotic
2005202210.2low2006141
duloxetine hydrochlorideduloxetine hydrochlorideantidepressant201920195.0low000010
irinotecancarbamate ester;
delta-lactone;
N-acylpiperidine;
pyranoindolizinoquinoline;
ring assembly;
tertiary alcohol;
tertiary amino compound
antineoplastic agent;
apoptosis inducer;
EC 5.99.1.2 (DNA topoisomerase) inhibitor;
prodrug
200820218.5low000161
pobilukast1989198935.0low010000
valsartanbiphenylyltetrazole;
monocarboxylic acid amide;
monocarboxylic acid
angiotensin receptor antagonist;
antihypertensive agent;
environmental contaminant;
xenobiotic
201720177.0low000010
simendan2008201512.5low000110
tirofibanL-tyrosine derivative;
piperidines;
sulfonamide
anticoagulant;
fibrin modulating drug;
platelet glycoprotein-IIb/IIIa receptor antagonist
201520159.0low000010
capecitabinecarbamate ester;
cytidines;
organofluorine compound
antimetabolite;
antineoplastic agent;
prodrug
202320231.0low000001
adenosineadenosines;
purines D-ribonucleoside
analgesic;
anti-arrhythmia drug;
fundamental metabolite;
human metabolite;
vasodilator agent
1991202220.0low102720111
sudan black bazobenzenes;
bis(azo) compound;
perimidines
histological dye1982201329.0low077510
3-n-butylphthalidebenzofurans2000200024.0low001000
coomassie brilliant blue r201520159.0low000010
terbium chloride2009200915.0low000100
gadolinium chloridegadolinium coordination entityTRP channel blocker1999201718.5low002920
potassium superoxide1990201515.2low001030
vanadatestrivalent inorganic anion;
vanadium oxoanion
EC 3.1.3.1 (alkaline phosphatase) inhibitor;
EC 3.1.3.16 (phosphoprotein phosphatase) inhibitor;
EC 3.1.3.41 (4-nitrophenylphosphatase) inhibitor;
EC 3.1.3.48 (protein-tyrosine-phosphatase) inhibitor
1951201541.0low010010
dimethylhydrazines1993199331.0low001000
2-amino-3,8-dimethylimidazo(4,5-f)quinoxalinearomatic amine;
imidazoquinoxaline
carcinogenic agent;
genotoxin;
Maillard reaction product;
mutagen
2005200519.0low000100
acridine orangeaminoacridines;
aromatic amine;
tertiary amino compound
fluorochrome;
histological dye
1986201523.8low012210
vanillyl alcoholbenzyl alcohols;
guaiacols
plant metabolite201720177.0low000010
benzylaminopurine6-aminopurinescytokinin;
plant metabolite
200520209.5low000130
ethyl hydroperoxide1984199136.5low011000
isothiocyanic acidhydracid;
one-carbon compound
201320179.0low000020
ammonium peroxydisulfate2000200024.0low001000
potassium phosphateinorganic phosphate salt;
inorganic potassium salt
1999199925.0low001000
caloreen201520159.0low000010
octyl glucosidebeta-D-glucosideplant metabolite1999199925.0low001000
halofuginonequinazolines201020189.8low000130
venlafaxine hydrochloridehydrochloride201620168.0low000010
trazodone hydrochloridehydrochlorideadrenergic antagonist;
antidepressant;
H1-receptor antagonist;
sedative;
serotonin uptake inhibitor
1961202314.9low07453674
trovafloxacin2008200816.0low000100
promethazine sulfoxidephenothiazines1997199727.0medium001000
3,4,5,3',4'-pentachlorobiphenylpentachlorobiphenyl;
trichlorobenzene
1998199826.0low001000
efavirenzacetylenic compound;
benzoxazine;
cyclopropanes;
organochlorine compound;
organofluorine compound
antiviral drug;
HIV-1 reverse transcriptase inhibitor
201620168.0low000010
3-(2'-spiroadamantane)-4-methoxy-4-(3''-phosphoryloxy)phenyl-1,2-dioxetane1990199034.0low001000
methionine methyl ester202220222.0low000001
glucose, (beta-d)-isomerD-glucopyranoseepitope;
mouse metabolite
1964202323.9low0476345554
glucose, (beta-d)-isomerD-glucopyranoseepitope;
mouse metabolite
1964202324.1low0476343524
lanthanum chloride2008200816.0low000100
2',7'-dichlorofluorescein2-benzofuransfluorochrome1986200428.5low012100
ursolic acidhydroxy monocarboxylic acid;
pentacyclic triterpenoid
geroprotector;
plant metabolite
2007201612.8low000220
meglumine antimoniate201820186.0low000010
1,5-anhydroglucitolanhydro sugarhuman metabolite201820186.0low000010
norharmanbeta-carbolines;
mancude organic heterotricyclic parent
fungal metabolite;
marine metabolite
2014201410.0low000010
thiazolyl blueorganic bromide saltcolorimetric reagent;
dye
2001202112.9low000431
18-hydroxydeoxycorticosterone18-hydroxy steroid;
20-oxo steroid;
21-hydroxy steroid;
3-oxo-Delta(4) steroid
2004200420.0low000100
betulinic acidhydroxy monocarboxylic acid;
pentacyclic triterpenoid
anti-HIV agent;
anti-inflammatory agent;
antimalarial;
antineoplastic agent;
EC 5.99.1.3 [DNA topoisomerase (ATP-hydrolysing)] inhibitor;
plant metabolite
201020218.2low000122
arctigeninlignan2008201512.0low000120
baicalindihydroxyflavone;
glucosiduronic acid;
glycosyloxyflavone;
monosaccharide derivative
antiatherosclerotic agent;
antibacterial agent;
anticoronaviral agent;
antineoplastic agent;
antioxidant;
cardioprotective agent;
EC 2.7.7.48 (RNA-directed RNA polymerase) inhibitor;
EC 3.4.21.26 (prolyl oligopeptidase) inhibitor;
ferroptosis inhibitor;
neuroprotective agent;
non-steroidal anti-inflammatory drug;
plant metabolite;
prodrug
2003201911.6low000480
prostratin1992199232.0low001000
plerixaforazacycloalkane;
azamacrocycle;
benzenes;
crown amine;
secondary amino compound;
tertiary amino compound
anti-HIV agent;
antineoplastic agent;
C-X-C chemokine receptor type 4 antagonist;
immunological adjuvant
2010201014.0low000100
allicinbotanical anti-fungal agent;
sulfoxide
antibacterial agent201520207.3low000060
5-methylcytosinemethylcytosine;
pyrimidines
human metabolite202120213.0low000002
thionine201720205.5low000020
epigallocatechin gallateflavans;
gallate ester;
polyphenol
antineoplastic agent;
antioxidant;
apoptosis inducer;
geroprotector;
Hsp90 inhibitor;
neuroprotective agent;
plant metabolite
2005202212.1low000881
alpha-terthienylterthiophene2000200024.0low001000
deoxyuridine triphosphatedeoxyuridine phosphate;
pyrimidine 2'-deoxyribonucleoside 5'-triphosphate
Arabidopsis thaliana metabolite;
Escherichia coli metabolite;
human metabolite;
mouse metabolite
1995199529.0low001000
homocitrullineamino acid zwitterion;
L-lysine derivative;
non-proteinogenic L-alpha-amino acid;
ureas
human metabolite;
mouse metabolite
2007201812.0low000230
cholesteryl sulfatesteroid sulfatehuman metabolite2004200420.0low000100
fluorexonxanthene dyefluorochrome2004201813.0low000110
25-hydroxycholesterol25-hydroxy steroid;
oxysterol
human metabolite201920195.0low000010
3-hydroxynorvalinenon-proteinogenic alpha-amino acid;
non-proteinogenic amino acid derivative
1987198737.0low010000
10,10'-dimethyl-9,9'-biacridinium1983201227.4low08211220
phenylalanylphenylalanine201520159.0low000010
chlorin1984199633.3low012000
aica ribonucleotide1-(phosphoribosyl)imidazolecarboxamide;
aminoimidazole
cardiovascular drug;
Escherichia coli metabolite;
human metabolite;
mouse metabolite;
plant metabolite;
Saccharomyces cerevisiae metabolite
201520159.0low000010
4-nitrophenylgalactosidebeta-D-galactoside;
monosaccharide derivative
affinity label202220222.0low000001
2',5'-dideoxyadenosinedeoxyribonucleoside2007200717.0low000100
nile redaromatic amine;
cyclic ketone;
organic heterotetracyclic compound;
tertiary amino compound
fluorochrome;
histological dye
2008201114.5low000110
metaperiodateiodine oxoacid1947202319.7low011531
neocuproinephenanthrolineschelator;
copper chelator
2002200222.0low000100
1,2,3,4,6-pentakis-O-galloyl-beta-D-glucosegallate ester;
galloyl beta-D-glucose
anti-inflammatory agent;
antineoplastic agent;
geroprotector;
hepatoprotective agent;
plant metabolite;
radiation protective agent;
radical scavenger
2010201014.0low000100
fluorophosphatefluorine molecular entity;
phosphoric acid derivative
1951199544.0low012000
pyrrolidine dithiocarbamatedithiocarbamic acids;
pyrrolidines
anticonvulsant;
antineoplastic agent;
geroprotector;
neuroprotective agent;
NF-kappaB inhibitor;
radical scavenger
1999202118.2low003811
peroxynitric acidnitrogen oxoacid1993200125.2low0031500
glutathione disulfideglutathione derivative;
organic disulfide
Escherichia coli metabolite;
mouse metabolite
1994202214.2low00414122
4-amino-4'-hydroxylaminodiphenylsulfonesulfonic acid derivative2007200717.0low000100
4-nitrobenzylthioinosinepurine nucleoside1994199430.0low001000
n-acetyl-5-aminosalicylic acidaminobenzoic acid1989198935.0low010000
7-hydroxydehydroepiandrosterone17-oxo steroid;
3beta-hydroxy-Delta(5)-steroid;
7alpha-hydroxy steroid;
androstanoid
anti-inflammatory agent;
antioxidant;
estrogen;
human xenobiotic metabolite;
rat metabolite
2006200618.0low000100
n-acetylpenicillamineN-acetyl-D-amino acid1996199628.0low001000
cephalosporin ccephalosporinfungal metabolite1990202123.4low108201
tomatidine3beta-hydroxy steroid;
azaspiro compound;
oxaspiro compound
202120213.0low000001
erdosteineN-acyl-amino acid2003201017.7low0001000
st 679N-acyl-amino acid2002200321.5low000200
milnacipranacetamides202020204.0low000010
lercanidipinediarylmethane2014201410.0low100010
leminoprazole1996199628.0low001000
web 2086organonitrogen heterocyclic compound;
organosulfur heterocyclic compound
1990200228.2low005100
mizolastinebenzimidazoles1998199826.0low001000
bepafant1991200724.5low004200
rp 592271998199826.0low001000
raxofelast1994200325.0high003200
telmisartanbenzimidazoles;
biphenyls;
carboxybiphenyl
angiotensin receptor antagonist;
antihypertensive agent;
EC 3.4.15.1 (peptidyl-dipeptidase A) inhibitor;
environmental contaminant;
xenobiotic
2010201910.0low000120
n-phenylglycinenon-proteinogenic alpha-amino acidallergen202120222.5low000002
tetramethylputrescine201820186.0medium000010
boron nitridenitride201620215.5low000011
cetiedilazepanes1983198341.0low010000
perylenediimidedicarboximide;
organic heteropolycyclic compound
fluorochrome201920195.0low000010
salicylhydroxamic acidhydroxamic acid;
phenols
antibacterial drug;
EC 1.11.2.2 (myeloperoxidase) inhibitor;
EC 3.5.1.5 (urease) inhibitor;
trypanocidal drug
1989201526.1low025210
thiochrome1999200820.5low001100
3-(dimethylamino)benzoic acid2009200915.0medium000100
protoanemoninbutenolide1948194876.0low010000
bromosuccinimidedicarboximide;
organobromine compound;
pyrrolidinone
reagent2005200519.0low000100
3-hydroxy-4'-nitro-2-naphthanilide chloroacetate2009200915.0medium000100
phenoxazinephenoxazineferroptosis inhibitor;
radical scavenger
2000200919.5low001100
1,7-phenanthrolinephenanthroline1996201320.3low001110
anthranil2,1-benzoxazoles;
mancude organic heterobicyclic parent
1959195965.0low010000
benzo-1,2,3-thiadiazole2013201311.0low000010
triazoles1,2,3-triazole1963202321.2low131310101
triazoles1,2,3-triazole1963202321.6low13131091
5-fluoroindolefluoroindole2014201410.0medium000010
pinocembrin(2S)-flavan-4-one;
dihydroxyflavanone
antineoplastic agent;
antioxidant;
metabolite;
neuroprotective agent;
vasodilator agent
2003200321.0low000100
isocoumarinsisocoumarins2003200321.0low000100
gold cyanide1996199827.0low002000
delphinidinanthocyanidin chloride1985200133.2low021100
2-aminobenzaldehyde201520159.0low000010
sesamolbenzodioxoles2011201411.5low000020
1,2-dithiol-3-thione1,2-dithiole1994199430.0low001000
fluorodeoxyglucose f182-deoxy-2-((18)F)fluoro-D-glucose;
2-deoxy-2-fluoro-aldehydo-D-glucose
2002201416.9low100520
sertralinedichlorobenzene;
secondary amino compound;
tetralins
antidepressant;
serotonin uptake inhibitor
201920195.0low000010
delta sleep-inducing peptide2001200123.0low000100
artemisininorganic peroxide;
sesquiterpene lactone
antimalarial;
plant metabolite
200620209.8low000230
cinitapridearomatic ether;
C-nitro compound
1998199826.0low001000
cloricromencoumarins1992200428.8medium007100
2,3-dimethylhydroquinone2000200024.0medium001000
1,3,5-trimethoxybenzenemethoxybenzenesbiomarker;
human xenobiotic metabolite
1989198935.0low010000
resorufinphenoxazine2005200519.0low000100
n,n-dimethyl-4-anisidine1986198638.0low010000
cyclopropylamineprimary aliphatic aminemouse metabolite2008200816.0low000100
2-(aminomethyl)phenol202020204.0low000010
3-chloroperbenzoic acidmonochlorobenzenes;
peroxy acid
1989200127.3low011100
dansylglycine201720177.0low000010
5-hydroxymethylcytosineaminopyrimidine;
aromatic primary alcohol;
nucleobase analogue;
pyrimidone
human metabolite;
mouse metabolite
202120213.0low000001
acamprosateacetamides;
organosulfonic acid
environmental contaminant;
neurotransmitter agent;
xenobiotic
2000200024.0low001000
enrofloxacincyclopropanes;
N-alkylpiperazine;
N-arylpiperazine;
organofluorine compound;
quinolinemonocarboxylic acid;
quinolone
antibacterial agent;
antimicrobial agent;
antineoplastic agent
1997201717.0low001010
cromakalim1999201417.5low001010
atipamezole2011201113.0low000010
bindarit2008200816.0low000100
tyloxapol201620168.0low000010
masoprocolnordihydroguaiaretic acidantineoplastic agent;
hypoglycemic agent;
lipoxygenase inhibitor;
metabolite
1987201328.0low016110
a 787731998199826.0low001000
trichlorosucrosedisaccharide derivative;
organochlorine compound
environmental contaminant;
sweetening agent;
xenobiotic
201820195.1low000080
enocitabineorganic molecular entity2002200222.0low100100
protizinic acidorganic molecular entity1982198242.0medium010000
ubenimex1994199430.0low001000
avarol2008200816.0low000100
hesperetin3'-hydroxyflavanones;
4'-methoxyflavanones;
monomethoxyflavanone;
trihydroxyflavanone
antineoplastic agent;
antioxidant;
plant metabolite
1990202212.8low001021
phorbol-12,13-diacetate2013201311.0low000010
magnololbiphenyls1992201816.2low001230
honokiolbiphenyls201420197.5low000020
sesaminbenzodioxoles;
furofuran;
lignan
antineoplastic agent;
neuroprotective agent;
plant metabolite
201620168.0low000010
betulindiol;
pentacyclic triterpenoid
analgesic;
anti-inflammatory agent;
antineoplastic agent;
antiviral agent;
metabolite
201520187.5low000020
nobiletinmethoxyflavoneantineoplastic agent;
plant metabolite
201620177.5low000020
uroporphyrin i1989198935.0low010000
berberrubine201820186.0low000010
methanesulfonamide2003200321.0low000100
xylenol orange2013201311.0low000010
tetrandrinebisbenzylisoquinoline alkaloid;
isoquinolines
2008201413.8low000310
beta-amyrinpentacyclic triterpenoid;
secondary alcohol
Aspergillus metabolite;
plant metabolite
2008201313.4low000230
nicosulfuronN-sulfonylurea;
pyridines;
pyrimidines
environmental contaminant;
herbicide;
xenobiotic
201620196.5low000020
dauricinearomatic ether;
bisbenzylisoquinoline alkaloid;
isoquinolines;
phenols;
tertiary amino compound
plant metabolite2004200718.5low000200
monotropeinbeta-D-glucoside;
cyclopentapyran;
iridoid monoterpenoid;
monocarboxylic acid;
monosaccharide derivative
anti-inflammatory agent;
metabolite
2013201311.0low000010
1-methyl-1,2,3,4-tetrahydro-beta-carboline-3-carboxylic acidharmala alkaloid2014201410.0low000010
tryptanthrinealkaloid antibiotic;
organic heterotetracyclic compound;
organonitrogen heterocyclic compound
2014201410.0low000010
corilaginellagitannin;
gallate ester
antihypertensive agent;
antioxidant;
EC 3.4.15.1 (peptidyl-dipeptidase A) inhibitor;
non-steroidal anti-inflammatory drug
201320179.7low000030
glycyl-histidyl-lysinetripeptidechelator;
hepatoprotective agent;
metabolite;
vulnerary
201620168.0low000010
indicinecarboxylic ester;
pyrrolizines
2006200618.0low000100
arjunolic acidhydroxy monocarboxylic acid;
pentacyclic triterpenoid
antibacterial agent;
antifungal agent;
antioxidant;
metabolite
2001200123.0low000100
tetracyanoquinodimethanealicyclic compound;
nitrile;
quinodimethane
1997199727.0low001000
oxazolidin-2-onecarbamate ester;
oxazolidinone
metabolite2009201910.8low000130
ceric oxidecerium molecular entity;
metal oxide
201120236.6low000083
perfluorooctane sulfonic acidperfluoroalkanesulfonic acidantilipemic drug;
persistent organic pollutant
201320198.0low000020
ethylene diurea2008200915.5low000200
c.i. direct red 80organic sodium saltfluorochrome;
histological dye
2014201410.0low000010
cobalt phthalocyanine2014201410.0low000010
1-pyrenebutyrate201520159.0low000010
sofosbuviraminopyrimidine;
aromatic carboxylic acid;
nucleobase analogue;
pyrimidone
metabolite202120213.0low000001
2',7'-dichlorodihydrofluorescein diacetate2004200420.0low000100
rivastigminecarbamate ester;
tertiary amino compound
cholinergic drug;
EC 3.1.1.8 (cholinesterase) inhibitor;
neuroprotective agent
2013201311.0low000010
rosiglitazoneaminopyridine;
thiazolidinediones
EC 6.2.1.3 (long-chain-fatty-acid--CoA ligase) inhibitor;
ferroptosis inhibitor;
insulin-sensitizing drug
2001201815.3low1002090
5-hydroxymethyluracilprimary alcohol;
pyrimidone
human metabolite202120213.0low000001
fc 75alkyltetrahydrofuran;
organofluorine compound
2006200817.0low000200
hydroxyguanidineguanidines;
one-carbon compound
antineoplastic agent;
antiviral agent
1998199826.0low001000
carvacryl acetatemonoterpenoid2014201410.0low000010
3,7-dimethyl-7-octen-1-ol2006200817.0low000200
2,3-dioxo-5-indolinesulfonic acid2005200519.0medium000100
3,4-dihydroxyphenylethanolcatechols;
primary alcohol
antineoplastic agent;
antioxidant;
metabolite
201920195.0low000010
iridium oxide200920209.5low000110
platinum oxide202120213.0low000001
vanadium dioxidevanadium oxide202320231.0low000001
propagermaniumorganogermanium compound201720177.0low000010
eriocitrin3'-hydroxyflavanones;
4'-hydroxyflavanones;
disaccharide derivative;
flavanone glycoside;
rutinoside;
trihydroxyflavanone
antioxidant201920195.0low000010
hypobromous acidbromine oxoacid2002202013.1medium0009110
3-(trimethoxysilyl)propylamine2006200618.0low000100
biocytinazabicycloalkane;
L-alpha-amino acid zwitterion;
L-lysine derivative;
monocarboxylic acid amide;
non-proteinogenic L-alpha-amino acid;
thiabicycloalkane;
ureas
mouse metabolite1998200721.5low001100
clarithromycinmacrolide antibioticantibacterial drug;
environmental contaminant;
protein synthesis inhibitor;
xenobiotic
1999201814.4low101240
asperulosideacetate ester;
beta-D-glucoside;
gamma-lactone;
iridoid monoterpenoid;
monosaccharide derivative
metabolite201620168.0low000010
bromatesbromine oxoanion;
monovalent inorganic anion
2002202012.9low0009120
procion brilliant blue hgranthraquinonedye200920189.5high000130
cholest-5-ene-3,4-diol201920195.0low000010
coenzyme aadenosine 3',5'-bisphosphatecoenzyme;
Escherichia coli metabolite;
mouse metabolite
201920195.0low000010
2,4-bis(4-methoxyphenyl)-1,3,2,4-dithiadiphosphetane-2,4-disulfide2013201311.0low000010
5,7-dimethoxyflavonedimethoxyflavoneplant metabolite2008200816.0low000100
n-acetyltyrosine, (dl)-isomerN-acetyl-amino acid;
phenols;
tyrosine derivative
human urinary metabolite2001200123.0low000200
nicotine3-(1-methylpyrrolidin-2-yl)pyridineanxiolytic drug;
biomarker;
immunomodulator;
mitogen;
neurotoxin;
nicotinic acetylcholine receptor agonist;
peripheral nervous system drug;
phytogenic insecticide;
plant metabolite;
psychotropic drug;
teratogenic agent;
xenobiotic
1984201717.8low01516120
3',5'-dimethylacetaminophen1996199628.0medium001000
fibrinogeniditolfungal metabolite1983202316.8low331117184
hecogenintriterpenoid201620168.0low000010
aucubinorganic molecular entitymetabolite201720177.0low000010
equolhydroxyisoflavans201620168.0low000010
friedelincyclic terpene ketone;
pentacyclic triterpenoid
anti-inflammatory drug;
antipyretic;
non-narcotic analgesic;
plant metabolite
201420159.5low000020
7-ketocholesterol3beta-hydroxy-Delta(5)-steroid;
3beta-sterol;
7-oxo steroid;
cholestanoid
neuroprotective agent2006200618.0low000100
6-phosphogluconic acidgluconic acid phosphatefundamental metabolite1984198440.0low010000
galaxolideisochromenes;
organic heterotricyclic compound
fragrance2011201511.3low000030
cadmium telluride2011201610.5low000020
goethite202120213.0low000001
3,4-dihydroxyphenylglycolcatechols;
tetrol
metabolite;
mouse metabolite
201520159.0low000010
homocysteineamino acid zwitterion;
homocysteine;
serine family amino acid
fundamental metabolite;
mouse metabolite
1986202314.5low010732
alpha,beta-methyleneadenosine 5'-triphosphatenucleoside triphosphate analogue2010201014.0low000100
salsolinol1-methyl-1,2,3,4-tetrahydroisoquinoline-6,7-diolhuman urinary metabolite1991199133.0low001000
methionyl-leucyl-phenylalanineoligopeptide1988198935.5low020000
coronatineN-acyl-amino acid2000200024.0low001000
anilofosanilide2013201311.0low000010
triflumizol201920195.0low000010
quincloracmonocarboxylic acid;
organochlorine compound;
quinolinemonocarboxylic acid
agrochemical;
herbicide;
synthetic auxin
201620168.0low000010
chlorfenapyrhemiaminal ether;
monochlorobenzenes;
nitrile;
organochlorine acaricide;
organochlorine insecticide;
organofluorine acaricide;
organofluorine insecticide;
pyrroles
proacaricide;
proinsecticide
2006200618.0low000100
sarsasapogeninsapogenin201520159.0low000010
iodosobenzene2004200420.0low000100
elemololefinic compound;
sesquiterpenoid;
tertiary alcohol
fragrance;
plant metabolite
2011201113.0low000010
melanotan-iiorganic molecular entity2004200420.0low000100
mci 9038peptide2000200024.0low101000
gamma-tocopheroltocopherol;
vitamin E
algal metabolite;
food antioxidant;
plant metabolite
2004201116.5low000110
n-epsilon-acetyllysineacetyl-L-lysine;
amino acid zwitterion;
N(6)-acyl-L-lysine
human metabolite1997199826.5low002000
firefly luciferin1,3-thiazolemonocarboxylic acid;
benzothiazoles;
imidothioate
luciferin1987202024.4low015120
firefly luciferin1,3-thiazolemonocarboxylic acid;
benzothiazoles;
imidothioate
luciferin1987202026.1low015110
glycidyl nitrate1993201618.7low001110
n-(9h-(fluoren-9-ylmethoxy)carbonyl)glycine1993199331.0medium001000
glycylsarcosinedipeptide zwitterion;
dipeptide
2011201113.0low000010
6-paradolketone;
monomethoxybenzene;
phenols
2001200123.0low000100
alpha-tocopherol phosphate2014201410.0low000010
glucuronic acidD-glucuronic acidalgal metabolite1987202113.1low0115101
2,6-dichloroisonicotinic acidmonocarboxylic acid;
organochlorine compound;
pyridines
EC 1.11.1.11 (L-ascorbate peroxidase) inhibitor2013201311.0low000010
diffractaic acidcarbonyl compound2012201212.0low000010
n-phenethylbenzamide201520159.0medium000010
2,2',4,4'-tetrabromodiphenyl etheraromatic ether;
organobromine compound
201420188.0low000020
8-bromoadenosinepurine nucleoside1993199331.0low001000
canthin-6-oneenone;
indole alkaloid;
organic heterotetracyclic compound
antimycobacterial drug;
metabolite
2011201113.0low000010
1,3,4-oxadiazole201520206.5low000020
hexylglutathioneS-substituted glutathione2006200618.0low000100
n-acetylphenylalanine beta-naphthyl esteralpha-amino acid ester;
phenylalanine derivative
1983198341.0low010000
1,2,3,4-tetrahydro-beta-carboline-3-carboxylic acidalpha-amino acid;
aromatic amino acid;
beta-carboline alkaloid
human urinary metabolite;
human xenobiotic metabolite;
plant metabolite;
rat metabolite
2014201410.0low000010
tetrathiafulvalenefulvalenes;
organosulfur heterocyclic compound
1997199727.0low001000
diosgenin3beta-sterol;
hexacyclic triterpenoid;
sapogenin;
spiroketal
antineoplastic agent;
antiviral agent;
apoptosis inducer;
metabolite
201420187.2low000040
2,2,5,7,8-pentamethyl-1-hydroxychroman2000200322.5low001100
isobrucein btriterpenoid201520159.0medium000010
3,7-dimethyl-1-propargylxanthine1996199628.0low001000
phorbolol myristate acetate2012201212.0low000010
thaliporphine2005200519.0low000100
enkephalinamide-met, ala(2)-1989199034.5low011000
arctiinglycoside;
lignan
2013201311.0low000020
saframycin a2012201212.0low000010
n-succinimidyl 3-(2-pyridyldithio)propionate1981198143.0low010000
3-chloro-6-hydrazino-pyridazine1995199529.0medium001000
5-chloro-2'-deoxycytidine1999201616.5medium001010
cholesteryl octanoate2006200618.0low000100
n-methyladenosinemethyladenosine202320231.0low100001
4-nitrophenyl-2-acetamido-2-deoxy-beta-d-glucopyranosideC-nitro compound;
N-acetyl-beta-D-glucosaminide
chromogenic compound2013201311.0low000010
2,3-bis(4-hydroxyphenyl)-propionitrilenitrile;
phenols
estrogen receptor agonist201420178.5low000020
cobaltcobalt group element atom;
metal allergen
micronutrient199820236.5low00202813
p-methoxy-n-methylphenethylaminearomatic ether;
secondary amino compound
metabolite1996201419.1low003820
fulvestrant17beta-hydroxy steroid;
3-hydroxy steroid;
organofluorine compound;
sulfoxide
antineoplastic agent;
estrogen antagonist;
estrogen receptor antagonist
1996201418.4low001610
hydrogen sulfitesulfur oxoanionhuman metabolite;
mouse metabolite;
Saccharomyces cerevisiae metabolite
1992201321.5low001010
1,2-bis(2-aminophenoxy)ethane-n,n,n',n'-tetraacetic acidpolyamino carboxylic acid;
tetracarboxylic acid
chelator1991200526.0low001100
mizoribineimidazolesanticoronaviral agent1997202212.8low102151
enkephalin, d-penicillamine (2,5)-heterodetic cyclic peptidedelta-opioid receptor agonist202120213.0low000001
arginyl-glycyl-aspartic acidoligopeptide1994201218.6low001220
calcium phosphate, dibasic, dihydratecalcium salt;
hydrate
1985198539.0low010000
vitamin b 6201820224.0low000011
imipenem, anhydrousbeta-lactam antibiotic allergen;
carbapenems;
zwitterion
antibacterial drug1998201218.4low002210
quin21989199134.0low011000
sr141716amidopiperidine;
carbohydrazide;
dichlorobenzene;
monochlorobenzenes;
pyrazoles
anti-obesity agent;
appetite depressant;
CB1 receptor antagonist
2007201513.0low000110
s-nitrosoglutathioneglutathione derivative;
nitrosothio compound
bronchodilator agent;
nitric oxide donor;
platelet aggregation inhibitor;
signalling molecule
2000201217.3low001110
bosentan anhydrousprimary alcohol;
pyrimidines;
sulfonamide
antihypertensive agent;
endothelin receptor antagonist
2001201516.2low000320
u 74006fcorticosteroid hormone1996199827.0low004000
ecgonine methyl estermethyl ester;
tertiary amino compound;
tropane alkaloid
analgesic;
central nervous system depressant;
metabolite;
mouse metabolite;
opioid analgesic;
peripheral nervous system drug
1999199925.0low001000
diacetyldichlorofluorescein1995201719.0low002310
u 74389f1993199828.8low3011000
cp 963452003200718.8low000400
ly 1170181-benzothiophenes;
aromatic ketone;
N-alkylpyrrolidine;
phenols
bone density conservation agent;
estrogen receptor antagonist;
estrogen receptor modulator
1996199628.0low001000
1-(2-(3-(4-methoxyphenyl)propoxy)-4-methoxyphenylethyl)-1h-imidazoleether;
imidazoles;
monomethoxybenzene
TRP channel blocker2005200519.0low000100
sr 489681997200125.0low001100
prolinedithiocarbamate2005200718.0low000200
artesunic acid201920195.0low000010
dihydrorhodamine 1231996202017.5low002420
cyanates1996201918.1low003230
bradykinin, des-arg(9)-oligopeptidebradykinin receptor B2 agonist2009200915.0low000100
beta-n-methylamino-l-alaninediamino acid;
L-alanine derivative;
non-proteinogenic L-alpha-amino acid;
secondary amino compound
bacterial metabolite;
neurotoxin
2011201113.0low000010
fura-2-am2011201113.0low000010
methyllycaconitine201420159.5low000020
s-ethyl glutathioneoligopeptide201520159.0low000010
sivelestatN-acylglycine;
pivalate ester
1996201419.0low0061060
propionylcarnitineO-acylcarnitineanalgesic;
antirheumatic drug;
cardiotonic drug;
human metabolite;
peripheral nervous system drug
1998199826.0low001000
cv 62091993199530.0low003000
arginyl-glycyl-aspartyl-serine1992201421.0low001010
1,1-dimethylheptyl-11-hydroxytetrahydrocannabinol2013201311.0low000010
saikosaponin d201920195.0low000010
6-hydroxydopanon-proteinogenic alpha-amino acid1990199034.0low001000
hypotaurineaminosulfinic acid;
zwitterion
human metabolite;
metabolite;
mouse metabolite
1985201524.0low010010
geniposideterpene glycoside201220179.5low000020
phorbol-12-myristate2000201019.0low001100
procyanidinproanthocyanidin1999202214.2low001741
pisatin201620168.0low000010
dityrosinebiphenyls;
non-proteinogenic alpha-amino acid;
tyrosine derivative
biomarker1991202022.0medium0021970
epicatechin gallatecatechin;
gallate ester;
polyphenol
EC 3.2.1.1 (alpha-amylase) inhibitor;
EC 3.2.1.20 (alpha-glucosidase) inhibitor;
metabolite
2004200420.0low000100
phosphitesphosphite ion;
trivalent inorganic anion
201520159.0low000010
asulacrineacridines1992199232.0low001000
u 74500a1997199727.0low001000
fingolimod hydrochloridehydrochlorideimmunosuppressive agent;
prodrug;
sphingosine-1-phosphate receptor agonist
1999202017.0low001620
n(g)-iminoethylornithineL-alpha-amino acid1992200726.3low002100
triptolidediterpenoid;
epoxide;
gamma-lactam;
organic heteroheptacyclic compound
antispermatogenic agent;
plant metabolite
2011201810.0low000040
cobaltiprotoporphyrin2007200717.0low000100
n-chlorotaurine1989202020.0low017850
sri 63-4411992199431.0low002000
asiaticoside2004201315.5low000110
proanthocyanidin1999201516.2low001120
parthenolidegermacranolide2010201213.0low000110
benzamilguanidines;
pyrazines
1998199826.0low001000
kt 5823gamma-lactam;
hemiaminal;
indolocarbazole;
methyl ester;
organic heterooctacyclic compound
EC 2.7.11.12 (cGMP-dependent protein kinase) inhibitor2014201410.0low000010
1-hexadecyl-2-acetyl-glycero-3-phosphocholine2-acetyl-1-alkyl-sn-glycero-3-phosphocholineantihypertensive agent;
beta-adrenergic antagonist;
bronchoconstrictor agent;
hematologic agent;
vasodilator agent
1986201626.1low04612260
sr 1403331999201517.6low001510
deoxyglucose1984202120.6low013131
5-hydroxythiabendazolebenzimidazoles2011201113.0low000010
tadalafilbenzodioxoles;
pyrazinopyridoindole
EC 3.1.4.35 (3',5'-cyclic-GMP phosphodiesterase) inhibitor;
vasodilator agent
2012201610.0low000030
glycofurol2008200816.0low000100
3-chloro-L-tyrosinechloroamino acid;
L-alpha-amino acid zwitterion;
L-tyrosine derivative;
monochlorobenzenes;
non-proteinogenic L-alpha-amino acid
biomarker;
human metabolite
1996202217.7high0081981
anserinebeta-alanine derivative;
dipeptide;
zwitterion
animal metabolite;
mouse metabolite
1995199529.0low002000
5,6-dihydroxyindoledihydroxyindolemouse metabolite1991200727.5low003100
7-o-(2,6-dideoxy-2-fluoro-alpha-talopyranosyl)adriamycinone- 14-beta-alaniate hydrochloride2001200123.0low000100
homoorientinflavone C-glycoside;
tetrahydroxyflavone
antineoplastic agent;
radical scavenger
202220222.0low000001
sulfamethoxazole hydroxylamineisoxazoles;
sulfonamide
allergen;
metabolite
1990200725.5low001100
phenoxazinone1992199232.0low001000
3-deoxyglucosonedeoxyglucose;
deoxyketohexose
2014201410.0low000010
higenaminenorcoclaurine2012201510.5low000020
thromboxanes1989201227.4low113010
tanshinoneabietane diterpenoidanticoronaviral agent2008202110.9low100241
cinnabarinic acidphenoxazine1992199232.0low001000
zinc coproporphyrin iii1989198935.0low010000
sc 419301989199532.6high038000
bn 507391992200028.0low002000
gastrodinglycoside201720225.0low000021
trypanothioneorganic disulfide2001200123.0low000100
way 100135piperazines2013201410.5low000020
fe(ii)-edtairon coordination entity1995199529.0low001000
brassinolide22-hydroxy steroid;
23-hydroxy steroid;
2alpha-hydroxy steroid;
3alpha-hydroxy steroid;
brassinosteroid
plant growth stimulator;
plant hormone
2002202110.4low0003141
3'-o-(4-benzoyl)benzoyladenosine 5'-triphosphatepurine ribonucleoside triphosphate2011201113.0low000010
3,5-dibromo-4-nitrosobenzenesulfonate2000201516.5low001010
ici 1986151995199529.0low001000
sc 58125organofluorine compound;
pyrazoles;
sulfone
antineoplastic agent;
cyclooxygenase 2 inhibitor
1999199925.0low001000
taraxasterolpentacyclic triterpenoid;
secondary alcohol
anti-inflammatory agent;
metabolite
201420226.0low000011
sophocarpine2011201113.0low000010
3-chloro-4-hydroxyphenylacetic acidhydroxy monocarboxylic acid;
monochlorobenzenes;
phenols
mammalian metabolite2001200123.0low000100
marimastathydroxamic acid;
secondary carboxamide
antineoplastic agent;
matrix metalloproteinase inhibitor
1999199925.0low001000
nitroaspirincarbonyl compound1999200423.0low002200
asiatic acidmonocarboxylic acid;
pentacyclic triterpenoid;
triol
angiogenesis modulating agent;
metabolite
201320169.5low000020
taurohyodeoxycholic acidbile acid taurine conjugate2011201113.0low000010
4-(2-chlorophenyl)-2-(2-(4-isobutylphenyl)ethyl)-6,9-dimethyl-6h-thieno(3,2-f)(1,2,4)triazolo(4,3-a)(1,4)diazepine1996199628.0low001000
lithospermate b2013201410.5low000020
2,2'-dihydroxy-3,3'-di-tert-butyl-5,5'-dimethoxydiphenyl1991199133.0medium001000
dioscinhexacyclic triterpenoid;
spiroketal;
spirostanyl glycoside;
trisaccharide derivative
anti-inflammatory agent;
antifungal agent;
antineoplastic agent;
antiviral agent;
apoptosis inducer;
EC 1.14.18.1 (tyrosinase) inhibitor;
hepatoprotective agent;
metabolite
201820186.0low000010
astilbin3'-hydroxyflavanones;
4'-hydroxyflavanones;
alpha-L-rhamnoside;
flavanone glycoside;
monosaccharide derivative;
tetrahydroxyflavanone
anti-inflammatory agent;
plant metabolite;
radical scavenger
2010201014.0low000100
bw 245cimidazolidine-2,4-dione;
monocarboxylic acid;
secondary alcohol
2000200024.0low001000
n-(9h-(2,7-dimethylfluoren-9-ylmethoxy)carbonyl)leucine1993199829.6medium005000
nitroflurbiprofenbiphenyls;
carboxylic ester;
nitrate ester;
organofluorine compound
cyclooxygenase 1 inhibitor;
cyclooxygenase 2 inhibitor;
EC 1.14.13.39 (nitric oxide synthase) inhibitor;
geroprotector;
non-steroidal anti-inflammatory drug;
vasodilator agent
1998200523.3low002100
dopachromeorthoquinones1982198242.0low010000
5,6-dihydroxy-2-indolylcarboxylic aciddihydroxyindolemouse metabolite1991199631.0low003000
n-formylnorleucyl-leucyl-4-phenylalanine1985199433.4medium014000
pentosidineimidazopyridine;
non-proteinogenic L-alpha-amino acid
biomarker;
cross-linking reagent
2003201714.0low100110
parecoxibisoxazoles;
N-sulfonylcarboxamide
cyclooxygenase 2 inhibitor;
non-narcotic analgesic;
non-steroidal anti-inflammatory drug;
prodrug
202120213.0low000001
quinovic acid201520159.0low000010
brl 444082012201212.0low000010
alliinalpha-amino acid201720177.0low000010
l 6587581990201024.9high005200
dl 111-it2004200420.0low000100
ly 255283aromatic ketone1991200029.3low003000
ici 2003551998199826.0low001000
1,2-dioxetane2000200024.0low001000
s-nitroso-n-acetylcysteine1996199628.0low001000
formylmethionyl-leucyl-phenylalanine methyl esterpeptide2003200321.0low000100
desethylamodiaquine1991199133.0low001000
cyclo(7-aminoheptanoylphenylalanyl-tryptophyl-lysyl-benzylthreonyl)2007200717.0low000100
5-s-cysteinyldopamineS-conjugate201620168.0low000010
rc 30952009201014.5low000200
dx 9065a2000200621.0low001100
gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate2004200619.0low000200
l 6599891994199927.5low002000
luzindoleacetamides;
indoles
melatonin receptor antagonist2010201014.0low000100
l 6513921989198935.0low010000
tyrosyl-arginyl-phenylalanyl-lysinamide2003200321.0low000100
chlorodimedone1980201032.1high084300
a 689302-benzopyran201620168.0low100010
astragaloside a201520178.2low000040
celastrolmonocarboxylic acid;
pentacyclic triterpenoid
anti-inflammatory drug;
antineoplastic agent;
antioxidant;
EC 5.99.1.3 [DNA topoisomerase (ATP-hydrolysing)] inhibitor;
Hsp90 inhibitor;
metabolite
201420188.3low000030
trichloromethyl free radicalorganic radical2013201311.0low000010
phenoxy radicalorganic radical1995200822.5low006600
carbenecarbene;
methanediyl
1999199925.0low001000
bromamine1995201518.2medium001210
peroxynitrous acidnitrogen oxoacid2001202316.1low00054221
fullerene c60fullerenegeroprotector2011201610.2low000050
imatinib mesylatemethanesulfonate saltanticoronaviral agent;
antineoplastic agent;
apoptosis inducer;
tyrosine kinase inhibitor
201520159.0low000010
mk 0663bipyridines;
organochlorine compound;
sulfone
cyclooxygenase 2 inhibitor;
non-steroidal anti-inflammatory drug
201420217.7low000021
tazobactampenicillanic acids;
triazoles
antiinfective agent;
antimicrobial agent;
EC 3.5.2.6 (beta-lactamase) inhibitor
201620168.0low000010
n-(n-(3-carboxyoxirane-2-carbonyl)leucyl)isoamylamineleucine derivative1998199826.0low001000
n(6)-(3-iodobenzyl)-5'-n-methylcarboxamidoadenosineadenosines;
monocarboxylic acid amide;
organoiodine compound
adenosine A3 receptor agonist2003201017.5low000200
bay x 10051996200523.7low102100
n(6)-carboxymethyllysineL-lysine derivative;
non-proteinogenic L-alpha-amino acid
antigen1999201718.8low002110
angiotensin ii, des-phe(8)-amino acid zwitterion;
angiotensin
vasodilator agent201920214.0low000021
2-chloro-n(6)cyclopentyladenosine2007200816.5low000200
heliox2005200519.0low000100
citrate phosphate dextrose1999199925.0low001000
n,n-dimethylargininedimethylarginine;
guanidines;
L-arginine derivative;
non-proteinogenic L-alpha-amino acid
EC 1.14.13.39 (nitric oxide synthase) inhibitor2005201811.6low1006110
antibiotic g 4182001200123.0low000100
3-(2,2,2-trimethylhydrazine)propionateammonium betainecardioprotective agent;
EC 1.14.11.1 (gamma-butyrobetaine dioxygenase) inhibitor;
neuroprotective agent
202320231.0low000001
interleukin-1beta (163-171)2004201315.5low000110
f-chemotactic peptide1983201826.0low011010
ramatrobanorganic molecular entity1993199430.5low002000
tak 0441999199925.0low001000
bradykinin, leu(8)-des-arg(9)-2013201311.0low000010
1-((3,5-dichloro)-2,6-dihydroxy-4-methoxyphenyl)-1-hexanonedichlorobenzene;
differentiation-inducing factor;
monomethoxybenzene;
resorcinols
eukaryotic metabolite;
signalling molecule
202120213.0low000001
n(omega)-hydroxyarginineamino acid zwitterion;
N(5)-[(E)-amino(hydroxyimino)methyl]ornithine;
N(5)-[(hydroxyamino)(imino)methyl]ornithine;
N(5)-[(Z)-amino(hydroxyimino)methyl]ornithine;
N(5)-[amino(hydroxyimino)methyl]-L-ornithine;
N(5)-[amino(hydroxyimino)methyl]ornithine;
N(omega)-hydroxy-L-arginine
2013201311.0low000010
phosphohistidine2012201212.0low000010
alanylglutaminedipeptide zwitterion;
dipeptide
metabolite2002201416.0low000420
gamma-glutamylcysteinegamma-glutamylcysteineEscherichia coli metabolite;
human metabolite;
mouse metabolite;
Saccharomyces cerevisiae metabolite
2007200816.5low000200
e 64dicarboxylic acid monoamide;
epoxy monocarboxylic acid;
guanidines;
L-leucine derivative;
zwitterion
antimalarial;
antiparasitic agent;
protease inhibitor
2012201212.0low000010
glabridinhydroxyisoflavansantiplasmodial drug2003201814.3low000210
nitrosylprotoheme2007200717.0low000100
glucogallin201920195.0low000010
n,n-dimethyl-1-methyldodecylamine oxide2003200321.0low000100
2-methyl-2-(4-methylpent-3-enyl)-2h-chromen-6-ol1995199529.0medium001000
hypothiocyanite ion1984201627.9medium3310220
hypothiocyanite ionone-carbon compound;
sulfur oxoacid
antibacterial agent;
antifungal agent;
antiviral agent;
human metabolite;
oxidising agent;
rat metabolite
200920239.2high0002202
glycerophosphoinositol 4,5-bisphosphate2007200717.0low000100
idb 10311995199529.0medium001000
4-methoxy-2,2,6,6-tetramethylpiperidinyl-1-oxy201720177.0medium000010
butyloxycarbonyl-phenylalanyl-leucyl-phenylalanyl-leucyl-phenylalanine2001201317.0low000110
glycyl-glycyl-tyrosyl-arginine1996199628.0medium001000
ectoine1,4,5,6-tetrahydropyrimidines;
carboxamidine;
monocarboxylic acid;
zwitterion
osmolyte201520159.0low000010
pre 084morpholines2008200816.0low000100
lestaurtinibindolocarbazole2012201212.0low000010
l 0122013201510.0low000020
methotrexatedicarboxylic acid;
monocarboxylic acid amide;
pteridines
abortifacient;
antimetabolite;
antineoplastic agent;
antirheumatic drug;
dermatologic drug;
DNA synthesis inhibitor;
EC 1.5.1.3 (dihydrofolate reductase) inhibitor;
immunosuppressive agent
1992202115.1low101017232
2,3-bis-(palmitoyloxy)-2-propyl-n-palmitoyl-cysteinylserine2008200816.0low000100
sb 2114751998200025.3high003000
mar 991997199727.0medium001000
n-hydroxysuccinimide s-acetylthioacetate1951195173.0low010000
ro 32-04322005200519.0low000100
l 6562241987198737.0medium010000
salvinorin aorganic heterotricyclic compound;
organooxygen compound
metabolite;
oneirogen
2012201212.0low000010
dihydroethidium2003201616.0low100420
cyanidin5-hydroxyanthocyanidinantioxidant;
metabolite;
neuroprotective agent
2012201212.0low000010
pyrroxamycinbenzodioxine1991199133.0medium001000
planininlignan201820186.0low000010
isf 24051991199133.0medium001000
antiprimod1998199826.0low001000
4-(3,4-dibutoxybenzyl)-2-imidazolidinone2007200717.0low000100
ovothiol aaryl thiol;
L-alpha-amino acid zwitterion;
L-histidine derivative;
non-proteinogenic L-alpha-amino acid
antioxidant;
marine metabolite;
radical scavenger
2001200123.0low000100
sulbactampenicillanic acids1993199331.0low001000
diphenyl-1-pyrenylphosphine2003200321.0low000100
7-ethoxy-4-trifluoromethylcoumarin2006200618.0low000100
olmesartan medoxomilbiphenyls202220231.5low000002
tryptamine-4,5-dione2009201213.5medium000110
dexpanthenolamino alcohol;
monocarboxylic acid amide
cholinergic drug;
provitamin
201320226.3low000021
mdl 734041991199133.0low001000
cornuside2009200915.0low000100
eth 6151993199331.0medium001000
4-benzyl-3-crotonyl-2-oxazolidinone201920195.0low000010
c 13112003200321.0low000100
l 7036062010201312.5low000110
l 368899201920195.0low000010
omega-n-methylarginineamino acid zwitterion;
arginine derivative;
guanidines;
L-arginine derivative;
non-proteinogenic L-alpha-amino acid
1991200925.6low0012400
allotrap2005200519.0low000100
zm 2304871998199826.0medium002000
rupatadinebenzocycloheptapyridine202220222.0low000001
n-formyl-methionyl-leucyl-phenylalanyl-phenylalanine2001200123.0medium000100
castasterone22-hydroxy steroid;
23-hydroxy steroid;
2alpha-hydroxy steroid;
3alpha-hydroxy steroid;
6-oxo steroid;
brassinosteroid
plant growth stimulator201720177.0low000010
febuxostat1,3-thiazolemonocarboxylic acid;
aromatic ether;
nitrile
EC 1.17.3.2 (xanthine oxidase) inhibitor201320206.7low000030
isodityrosine1993199331.0medium001000
butoxamine1996200424.0low001100
triiodothyroninetetrahydrothiophenes;
thiolactone
human metabolite1986201722.5low010010
aspartamecarboxylic acid;
dipeptide zwitterion;
dipeptide;
methyl ester
apoptosis inhibitor;
EC 3.1.3.1 (alkaline phosphatase) inhibitor;
environmental contaminant;
micronutrient;
nutraceutical;
sweetening agent;
xenobiotic
201820186.0low000010
xyloseD-xylose2011201113.0low000010
valerylsalicylatebenzoic acids;
salicylates;
valerate ester
cyclooxygenase 1 inhibitor2007200717.0low000100
ompi1981198143.0medium010000
quinone methidequinomethane1998199826.0low001000
m 82182008202010.6low000250
phytol2014201410.0low000010
prolineamino acid zwitterion;
glutamine family amino acid;
L-alpha-amino acid;
proline;
proteinogenic amino acid
algal metabolite;
compatible osmolytes;
Escherichia coli metabolite;
micronutrient;
mouse metabolite;
nutraceutical;
Saccharomyces cerevisiae metabolite
1951202310.9low012337211
cucurbitaceae2000201815.5low001230
dipfluzine2005200519.0low000100
sodium dithionate201520159.0low000010
2-(1-octynyl)adenosine2000200024.0low001000
ci 9221987198836.5high020000
docetaxel anhydroussecondary alpha-hydroxy ketone;
tetracyclic diterpenoid
antimalarial;
antineoplastic agent;
photosensitizing agent
201820186.0low000010
3-bromotyrosinemonocarboxylic acid2000201020.3medium001200
levofloxacin9-fluoro-3-methyl-10-(4-methylpiperazin-1-yl)-7-oxo-2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylic acid;
fluoroquinolone antibiotic;
quinolone antibiotic
antibacterial drug;
DNA synthesis inhibitor;
EC 5.99.1.3 [DNA topoisomerase (ATP-hydrolysing)] inhibitor;
topoisomerase IV inhibitor
200820229.0low100101
ezetimibeazetidines;
beta-lactam;
organofluorine compound
anticholesteremic drug;
antilipemic drug;
antimetabolite
2012201212.0low000010
1-methyl-4-phenyl-2,3-dihydropyridinium2004200420.0low000100
3-methyleneoxindoleoxindoles1961196163.0medium010000
1-methylcyclopropenecycloalkene;
cyclopropenes
agrochemical;
plant growth regulator
2005201513.5low000130
cox 189amino acid;
monocarboxylic acid;
organochlorine compound;
organofluorine compound;
secondary amino compound
cyclooxygenase 2 inhibitor;
non-steroidal anti-inflammatory drug
2008200816.0low000100
cilomilastmethoxybenzenes2008200816.0low000100
cariporide2002200918.5low000200
tezosentan2004200917.3low000300
evodiaminebeta-carbolines201520159.0low000010
3,17-diacetoxyestra-1,3,5(10)-trien-2-carboxylic acid2009200915.0low000100
2,4,6-tribromo-3-hydroxybenzoic acid1988198836.0medium010000
pentacyanoferrate (ii)2013201311.0low000010
3-mercapto-2-methylpropionic acid202320231.0medium000001
moxifloxacinaromatic ether;
cyclopropanes;
fluoroquinolone antibiotic;
pyrrolidinopiperidine;
quinolinemonocarboxylic acid;
quinolone antibiotic;
quinolone
antibacterial drug2008202210.7low100201
mn(iii) 5,10,15,20-tetrakis(n-methylpyridinium-2-yl)porphyrin201620168.0low000010
as 3201201620168.0low000010
ruboxistaurin2005200519.0low000100
centchroman1991200625.5low001100
centchroman1991199133.0low001000
is 7412000200322.5medium001100
phorbolsditerpene;
terpenoid fundamental parent
1980202226.0low030002
kolaviron4'-methoxyflavanones;
biflavonoid;
dihydroflavonols;
ring assembly;
secondary alpha-hydroxy ketone
hepatoprotective agent;
plant metabolite
201320226.5low000011
schizandrin a202020204.0low000010
cyanopindololindoles1992200227.0low001100
b 6691993199331.0low001000
naproxenmethoxynaphthalene;
monocarboxylic acid
antipyretic;
cyclooxygenase 1 inhibitor;
cyclooxygenase 2 inhibitor;
drug allergen;
environmental contaminant;
gout suppressant;
non-narcotic analgesic;
non-steroidal anti-inflammatory drug;
xenobiotic
1979201523.6low127450
cinacalcet(trifluoromethyl)benzenes;
naphthalenes;
secondary amino compound
calcimimetic;
P450 inhibitor
2013201311.0low000010
hydroxyl radicaloxygen hydride;
oxygen radical;
reactive oxygen species
1977202323.9low1212924126
atazanavir sulfateorganic sulfate salt201620168.0low000010
olmesartanbiphenylyltetrazoleangiotensin receptor antagonist;
antihypertensive agent
201320169.2low100040
rhodiolosideglycoside201320179.3low000030
ci 9491991199133.0medium001000
methyl-3-tyrosineamino acid zwitterion;
L-tyrosine derivative;
non-proteinogenic L-alpha-amino acid
2012201212.0medium000010
cerium phosphate2012201212.0low000010
singlet oxygenchalcogen;
monoatomic oxygen;
nonmetal atom
macronutrient1984201825.7low069530
manganese protoporphyrin1997200622.5low001100
peroxymonosulfatesulfur oxide;
sulfur oxoanion
2013201311.0low000010
2-methyl-3-(4-phenylpiperidino)propionohydroxamic acid hydrochloride1997199727.0medium001000
ukrain201720177.0low000010
aloesinchromones2011201113.0low000010
naphthol as-d chloroacetate1990200725.5medium001100
fenton's reagent1995201816.6low002120
2-(phenylmethyl)-1-naphthol1989199034.5high011000
cyc 2022,6-diaminopurinesantiviral drug;
EC 2.7.11.22 (cyclin-dependent kinase) inhibitor
2003200321.0low000100
carbodiimidescarbodiimide2008200816.0low000100
sulochrinbenzophenones;
carboxylic ester;
phenols
metabolite1997199727.0low001000
oxypeucadaninpsoralens202220222.0low000001
victoria blue 4riminium salt;
organic chloride salt
fluorochrome;
histological dye
1957195767.0medium010000
methylselenic acidone-carbon compound;
organoselenium compound
antineoplastic agent;
EC 3.5.1.98 (histone deacetylase) inhibitor;
human xenobiotic metabolite
2002200222.0low000100
syringopicroside2011201113.0low000010
8-o-acetyl shanzhiside methyl ester2014201410.0low000010
malabaricone b2009200915.0low000100
schizandrer a2014201410.0low000010
1-(2,6-dimethylphenoxy)-2-(3,4-dimethoxyphenylethylamino)propane2009200915.0low000100
antiflammin p12009200915.0low000100
diazoluminolmelanin1993199331.0medium001000
methylinositol2007200717.0low000100
trityrosine1996199628.0medium001000
dihydrocorynantheol2013201311.0medium000010
cysteinesulfenic acidL-cysteine derivative;
non-proteinogenic L-alpha-amino acid
2005200519.0low000100
4'-galactooligosaccharide202120213.0low000001
technetium tc 99m pentetate2013201311.0low000010
metaperiodateiodine oxoanion;
monovalent inorganic anion
1947201722.1low011330
thiophosphoric acidphosphorothioic acid202120213.0low000001
amplex red2003201813.5low000440
8-gingerolbeta-hydroxy ketone;
monomethoxybenzene;
phenols
201720177.0low000010
symmetric dimethylarginineamino acid zwitterion;
dimethylarginine;
guanidines;
L-arginine derivative;
non-proteinogenic L-alpha-amino acid
EC 1.14.13.39 (nitric oxide synthase) inhibitor2011201113.0low000010
aminopterindicarboxylic acidEC 1.5.1.3 (dihydrofolate reductase) inhibitor;
mutagen
1950195074.0low010000
cinnamophilin2009200915.0low000100
bathocuproine disulfonatearenesulfonic acid;
phenanthrolines
chelator1996199628.0low001000
s(8)202220222.0medium000001
n-(1-methyldodecyl)-n,n,n-trimethylammonium bromide2003200321.0medium000100
n-acetyl-n-formyl-5-methoxykynurenaminearomatic ketone2003200819.0low000400
n,n'-bis(salicylideneamino)ethane-manganese(ii)2002200222.0low000100
biotinbiotins;
vitamin B7
coenzyme;
cofactor;
Escherichia coli metabolite;
fundamental metabolite;
human metabolite;
mouse metabolite;
nutraceutical;
prosthetic group;
Saccharomyces cerevisiae metabolite
1983201923.8low1121918110
angiotensin iiamino acid zwitterion;
angiotensin II
human metabolite2000202013.8low10115110
angiotensin iiamino acid zwitterion;
angiotensin II
human metabolite2000202014.0low10115100
n-formylmethionyl-methionyl-phenylalanine2012201212.0medium000010
n-hydroxytyrosineL-tyrosine derivative;
N-hydroxy-alpha-amino-acid
2001200123.0medium000100
1-methyl-3-ethylimidazolium1-alkyl-3-methylimidazolium2010201014.0low000100
atropine1995201222.3low004210
galactosucrose201520159.0low000010
lignin1981202412.0low0210466829
ropivacainepiperidinecarboxamide;
ropivacaine
local anaesthetic1999201417.5low001010
sb 203580imidazoles;
monofluorobenzenes;
pyridines;
sulfoxide
EC 2.7.11.1 (non-specific serine/threonine protein kinase) inhibitor;
EC 2.7.11.24 (mitogen-activated protein kinase) inhibitor;
geroprotector;
Hsp90 inhibitor;
neuroprotective agent
2002201912.5low000580
nbi 27914dialkylarylamine;
tertiary amino compound
2010201014.0low000100
sb 216763indoles;
maleimides
201420159.5low000020
cardioplegin1986198638.0medium010000
zm 241385diamino-1,3,5-triazine2000201216.2low001210
erlotinib hydrochloridehydrochloride;
terminal acetylenic compound
antineoplastic agent;
protein kinase inhibitor
202320231.0low100001
adelmidrol201620168.0low000010
dihydrodaidzeinhydroxyisoflavanonemetabolite201620168.0low000010
corynolinebenzophenanthridine alkaloid;
cyclic acetal;
isoquinolines;
organic heterohexacyclic compound;
secondary alcohol
antineoplastic agent;
EC 3.1.1.7 (acetylcholinesterase) inhibitor;
hepatoprotective agent;
metabolite
201720177.0low000010
lu 1352522001200123.0low000100
organophosphonatesdivalent inorganic anion;
phosphite ion
2009201113.7low000120
ly 293111aromatic ether2002200222.0low000100
nickel monoxide201520225.7low000021
lunularinstilbenoid2000200024.0low001000
sodium percarbonate2009200915.0low000100
aceglutamideN-acetyl-L-amino acid;
N(2)-acetylglutamine;
N(2)-acyl-L-glutamine
human metabolite2007200717.0low000100
l 1588092010201014.0low000100
tak 7792002200222.0low000100
melagatranazetidines;
carboxamidine;
dicarboxylic acid monoamide;
non-proteinogenic alpha-amino acid;
secondary amino compound
anticoagulant;
EC 3.4.21.5 (thrombin) inhibitor;
serine protease inhibitor
2011201113.0low000010
propargylglycine1997201416.5low001430
aflatoxin b1aflatoxin;
aromatic ether;
aromatic ketone
carcinogenic agent;
human metabolite
200520227.7low000172
esculentin steroid2007200717.0low000100
isospaglumic aciddipeptidehuman metabolite1998199826.0low101000
dehydromethionine2009200915.0high000200
solidagenone202120213.0low000001
deflazacortcorticosteroid hormone2009200915.0low000100
cavidine201520168.5medium000020
5'-o-(9-phenylxanthen-9-yl)-2'-deoxynebularine202220222.0medium000001
cucurbit(6)uril202120213.0low000001
oxodihydrothiochrome2008200816.0medium000100
6-(n-(4-aminobutyl)-n-ethyl)amino-2,3-dihydrophthalazine-1,4-dionephthalazines1993199331.0low001000
7-(3-(2-(cyclopropylmethyl)-3-methoxy-4-((methylamino)carbonyl)phenoxy)propoxy)-3,4-dihydro-8-propyl-2h-1-benzopyran-2-propanoic acid1993199529.4high005000
chloritechlorine oxoanion;
monovalent inorganic anion
1952201435.3low011010
fe(iii)-edtairon coordination entity1986200928.0low011100
n-acetylchitohexaose2003200321.0low000100
maropitant201820186.0low000010
anabasineanabasine2007200717.0low000100
firocoxibbutenolide;
cyclopropanes;
enol ether;
sulfone
antineoplastic agent;
cyclooxygenase 2 inhibitor;
non-narcotic analgesic;
non-steroidal anti-inflammatory drug
201820186.0low000010
prizescarboxamidine;
monochloropyridine;
nitrile
environmental contaminant;
neonicotinoid insectide;
xenobiotic
201520159.0low000010
sorafenib(trifluoromethyl)benzenes;
aromatic ether;
monochlorobenzenes;
phenylureas;
pyridinecarboxamide
angiogenesis inhibitor;
anticoronaviral agent;
antineoplastic agent;
EC 2.7.11.1 (non-specific serine/threonine protein kinase) inhibitor;
ferroptosis inducer;
tyrosine kinase inhibitor
202120213.0low000001
ono 68182004200420.0low000100
succinobucolbenzoate ester;
phenols
2008200816.0low100100
lenalidomidearomatic amine;
dicarboximide;
isoindoles;
piperidones
angiogenesis inhibitor;
antineoplastic agent;
immunomodulator
201520178.0low000020
lenalidomidearomatic amine;
dicarboximide;
isoindoles;
piperidones
angiogenesis inhibitor;
antineoplastic agent;
immunomodulator
201720177.0low000010
4-chloro-alpha-cyanocinnamic acid2009200915.0low000100
pimaric acidditerpenoid201620168.0low000010
demecolcinealkaloid;
secondary amino compound
antineoplastic agent;
microtubule-destabilising agent
1990199034.0low001000
cholic acid12alpha-hydroxy steroid;
3alpha-hydroxy steroid;
7alpha-hydroxy steroid;
bile acid;
C24-steroid;
trihydroxy-5beta-cholanic acid
human metabolite;
mouse metabolite
1996199827.0low002000
deoxycholic acidbile acid;
C24-steroid;
dihydroxy-5beta-cholanic acid
human blood serum metabolite2014201410.0low000010
estradiol 3-benzoate17beta-hydroxy steroid;
benzoate ester
estrogen receptor agonist;
xenoestrogen
1999200721.0low001100
cortisone11-oxo steroid;
17alpha-hydroxy steroid;
20-oxo steroid;
21-hydroxy steroid;
3-oxo-Delta(4) steroid;
C21-steroid;
glucocorticoid;
primary alpha-hydroxy ketone;
tertiary alpha-hydroxy ketone
human metabolite;
mouse metabolite
1951201359.9low060010
cholesterol alpha-oxide3beta-hydroxy steroid;
epoxy steroid;
oxysterol
1993199331.0low001000
2-methylthioadenosine2012201212.0low000010
3-nitrotyrosine2-nitrophenols;
C-nitro compound;
nitrotyrosine;
non-proteinogenic alpha-amino acid
1996202317.6low4029126461
epinastinecorticosteroid hormone1999201117.7low001110
5-hydroxymethylfurfuralarenecarbaldehyde;
furans;
primary alcohol
indicator;
Maillard reaction product
2002200918.5low000200
sodium sulfide1993199331.0low001000
2,3-dihydro-1h-imidazo(1,2-b)pyrazole1984198440.0low010000
lanosterol14alpha-methyl steroid;
3beta-sterol;
tetracyclic triterpenoid
bacterial metabolite;
human metabolite;
mouse metabolite;
plant metabolite;
Saccharomyces cerevisiae metabolite
201020209.3low000120
2-hydroxyestradiol17beta-hydroxy steroid;
2-hydroxy steroid
carcinogenic agent;
human metabolite;
metabolite;
mouse metabolite;
prodrug
1986199135.5low011000
benzofurans1978202221.1low0310572
sodium bromidebromide salt;
inorganic sodium salt
1986198638.0low010000
lupeolpentacyclic triterpenoid;
secondary alcohol
anti-inflammatory drug;
plant metabolite
2001202111.7low000111
nas1951195173.0low010000
tricainemethanesulfonate saltgeneral anaesthetic2005200519.0low000100
solanine2010201014.0low000100
noscapinearomatic ether;
benzylisoquinoline alkaloid;
cyclic acetal;
isobenzofuranone;
organic heterobicyclic compound;
organic heterotricyclic compound;
tertiary amino compound
antineoplastic agent;
antitussive;
apoptosis inducer;
plant metabolite
202120232.0low000002
allylpyrocatechol2009200915.0low000100
wortmanninacetate ester;
cyclic ketone;
delta-lactone;
organic heteropentacyclic compound
anticoronaviral agent;
antineoplastic agent;
autophagy inhibitor;
EC 2.7.1.137 (phosphatidylinositol 3-kinase) inhibitor;
geroprotector;
Penicillium metabolite;
radiosensitizing agent
1997202114.5low0011081
3-methoxyphthalic acid2005200519.0medium000100
trimethoprim, sulfamethoxazole drug combination2008200816.0low000100
taurochenodeoxycholic acidbile acid taurine conjugatehuman metabolite;
mouse metabolite
1997201620.3low002010
bortezomibamino acid amide;
L-phenylalanine derivative;
pyrazines
antineoplastic agent;
antiprotozoal drug;
protease inhibitor;
proteasome inhibitor
2010201113.5low000110
bortezomibamino acid amide;
L-phenylalanine derivative;
pyrazines
antineoplastic agent;
antiprotozoal drug;
protease inhibitor;
proteasome inhibitor
2011201113.0low000010
n-acetyl-5-methoxy kynurenaminekynurenamines2004200420.0low000100
bardoxolone methylcyclohexenones201520159.0low000010
dihydropyridines1995201420.0low102220
leupeptins2007200916.2low000400
carboplatin2000201317.5low001010
anatoxin atropane alkaloid2004201315.5low000110
lithium chlorideinorganic chloride;
lithium salt
antimanic drug;
geroprotector
1993201323.3low002010
biotinyl n-hydroxysuccinimide ester1995199529.0low001000
s-adenosylhomocysteineadenosines;
amino acid zwitterion;
homocysteine derivative;
homocysteines;
organic sulfide
cofactor;
EC 2.1.1.72 [site-specific DNA-methyltransferase (adenine-specific)] inhibitor;
EC 2.1.1.79 (cyclopropane-fatty-acyl-phospholipid synthase) inhibitor;
epitope;
fundamental metabolite
2011201113.0low000010
glycogen1953202032.0low02273100
arabinoseL-arabinoseEscherichia coli metabolite;
mouse metabolite
1980200233.0low010100
n-acetylneuraminic acidN-acetylneuraminic acidsantioxidant;
bacterial metabolite;
EC 3.2.1.18 (exo-alpha-sialidase) inhibitor;
human metabolite;
mouse metabolite
1979201920.6low026370
mannose-6-phosphateD-mannopyranose 6-phosphate1998201619.7low002010
fibrinpeptide1999202214.1low001541
bradykininoligopeptidehuman blood serum metabolite;
vasodilator agent
1986202316.1low0221382
hexacyanoferrate iii1985199036.5low011000
glucosamineD-glucosamineEscherichia coli metabolite;
geroprotector;
mouse metabolite
1980202216.4low011231
elastinoligopeptide1982201927.5low052120
carnosineamino acid zwitterion;
dipeptide
anticonvulsant;
antineoplastic agent;
antioxidant;
Daphnia magna metabolite;
geroprotector;
human metabolite;
mouse metabolite;
neuroprotective agent
1990201723.6low004210
mevalonic acid3,5-dihydroxy-3-methylpentanoic acid2005202310.0low100101
raffinoseraffinose family oligosaccharide;
trisaccharide
mouse metabolite;
plant metabolite;
Saccharomyces cerevisiae metabolite
1992202319.5low003401
naringenin(2S)-flavan-4-one;
naringenin
expectorant;
plant metabolite
2005201612.0low000140
epiglucan1985202215.7low11213101
oxytocinheterodetic cyclic peptide;
peptide hormone
oxytocic;
vasodilator agent
2001201916.1low000820
laminaran1985200626.0low012200
dopaquinone1,2-benzoquinones;
amino acid zwitterion;
L-phenylalanine derivative
human metabolite;
mouse metabolite
1992199232.0low001000
theanineamino acid zwitterion;
N(5)-alkyl-L-glutamine
geroprotector;
neuroprotective agent;
plant metabolite
201920195.0low000010
3,4-dihydroxyphenyllactic acid2-hydroxy monocarboxylic acid;
catechols
201020209.0low000110
cysteinylglycinedipeptide zwitterion;
dipeptide
Escherichia coli metabolite;
human metabolite;
Saccharomyces cerevisiae metabolite
201620168.0low000010
ouabain11alpha-hydroxy steroid;
14beta-hydroxy steroid;
5beta-hydroxy steroid;
alpha-L-rhamnoside;
cardenolide glycoside;
steroid hormone
anti-arrhythmia drug;
cardiotonic drug;
EC 2.3.3.1 [citrate (Si)-synthase] inhibitor;
EC 3.1.3.41 (4-nitrophenylphosphatase) inhibitor;
EC 3.6.3.10 (H(+)/K(+)-exchanging ATPase) inhibitor;
EC 3.6.3.9 (Na(+)/K(+)-transporting ATPase) inhibitor;
ion transport inhibitor;
plant metabolite
1975197549.0low010000
salicinaromatic primary alcohol;
aryl beta-D-glucoside;
benzyl alcohols
antipyretic;
EC 1.14.99.1 (prostaglandin-endoperoxide synthase) inhibitor;
metabolite;
non-narcotic analgesic;
non-steroidal anti-inflammatory drug;
prodrug
2014201410.0low000010
alloseallopyranose;
D-allose
antioxidant201320208.7low000030
casein hydrolysate2004200420.0low000100
puromycinpuromycinsantiinfective agent;
antimicrobial agent;
antineoplastic agent;
EC 3.4.11.14 (cytosol alanyl aminopeptidase) inhibitor;
EC 3.4.14.2 (dipeptidyl-peptidase II) inhibitor;
nucleoside antibiotic;
protein synthesis inhibitor
1978197846.0low010000
taxifolintaxifolinmetabolite1990200924.5low001100
mannuronic acidD-mannonic acid201920195.0low000010
tartaric acidtartaric acidEscherichia coli metabolite201520159.0low000010
pentostatincoformycinsantimetabolite;
antineoplastic agent;
Aspergillus metabolite;
bacterial metabolite;
EC 3.5.4.4 (adenosine deaminase) inhibitor
1994199430.0low001000
monoiodotyrosineamino acid zwitterion;
L-tyrosine derivative;
monoiodotyrosine;
non-proteinogenic L-alpha-amino acid
EC 1.14.16.2 (tyrosine 3-monooxygenase) inhibitor;
human metabolite;
mouse metabolite
1962199843.8low032000
n-formylmethionineL-methionine derivative;
N-formyl amino acid;
proteinogenic amino acid
metabolite1980198342.0low0120000
taurolithocholic acidbile acid taurine conjugate;
monocarboxylic acid amide
human metabolite2014201410.0low000010
3,5-dichlorotyrosinechloroamino acid;
dichlorobenzene;
dihalogenated L-tyrosine;
non-proteinogenic L-alpha-amino acid
2005200519.0medium000100
nitroarginineguanidines;
L-arginine derivative;
N-nitro compound;
non-proteinogenic L-alpha-amino acid
1992200826.8low005100
4-hydroxyphenylacetaldehydealpha-CH2-containing aldehyde;
phenylacetaldehydes
Escherichia coli metabolite;
human metabolite;
mouse metabolite
1996200125.2high005100
adenosine 5'-o-(3-thiotriphosphate)nucleoside triphosphate analogue1996200822.0low001100
homoglutathionegamma-glutamylcysteine2001201615.5low000110
dehydroascorbic aciddehydroascorbic acid;
vitamin C
coenzyme;
mouse metabolite
1996201616.6low001220
eriodictyol3'-hydroxyflavanones;
tetrahydroxyflavanone
1990201621.0low001010
fructans2004201116.5low000110
cellulasecellotriose2000202213.9low001742
strychninemonoterpenoid indole alkaloid;
organic heteroheptacyclic compound
avicide;
cholinergic antagonist;
glycine receptor antagonist;
neurotransmitter agent;
rodenticide
2013201311.0low000010
quinidinecinchona alkaloidalpha-adrenergic antagonist;
anti-arrhythmia drug;
antimalarial;
drug allergen;
EC 1.14.13.181 (13-deoxydaunorubicin hydroxylase) inhibitor;
EC 3.6.3.44 (xenobiotic-transporting ATPase) inhibitor;
muscarinic antagonist;
P450 inhibitor;
potassium channel blocker;
sodium channel blocker
1994199430.0low001000
monensincyclic hemiketal;
monocarboxylic acid;
polyether antibiotic;
spiroketal
antifungal agent;
coccidiostat;
ionophore
1986199434.8low053000
mycothiol202220222.0low000001
cefoxitinbeta-lactam antibiotic allergen;
cephalosporin;
cephamycin;
semisynthetic derivative
antibacterial drug1998199826.0low001000
hyperforin2007200717.0low000100
abacavir2,6-diaminopurinesantiviral drug;
drug allergen;
HIV-1 reverse transcriptase inhibitor
2009200915.0low000100
mometasone furoate11beta-hydroxy steroid;
2-furoate ester;
20-oxo steroid;
3-oxo-Delta(1),Delta(4)-steroid;
organochlorine compound;
steroid ester
anti-allergic agent;
anti-inflammatory drug
2011201113.0low100010
linezolidacetamides;
morpholines;
organofluorine compound;
oxazolidinone
antibacterial drug;
protein synthesis inhibitor
2009201412.7low000120
phalloidinehomodetic cyclic peptide1991199133.0low001000
indicanbeta-D-glucoside;
exopolysaccharide;
indolyl carbohydrate
2014201410.0low000010
eupholtriterpenoid2014201410.0low000010
furostanol ibeta-D-glucoside;
cyclic hemiketal;
pentacyclic triterpenoid;
steroid saponin;
trisaccharide derivative
metabolite201720177.0low000010
ruscogenintriterpenoid2012201212.0low000010
ginsenoside rg112beta-hydroxy steroid;
3beta-hydroxy-4,4-dimethylsteroid;
beta-D-glucoside;
ginsenoside;
tetracyclic triterpenoid
neuroprotective agent;
pro-angiogenic agent
202120213.0low100001
notoginsenoside r112beta-hydroxy steroid;
3beta-hydroxy-4,4-dimethylsteroid;
3beta-hydroxy steroid;
beta-D-glucoside;
disaccharide derivative;
ginsenoside;
tetracyclic triterpenoid
antioxidant;
apoptosis inducer;
neuroprotective agent;
phytoestrogen;
plant metabolite
2010201511.0low000120
carnosolditerpenoid2009201313.3low000210
steviosidebeta-D-glucoside;
bridged compound;
diterpene glycoside;
ent-kaurane diterpenoid;
tetracyclic diterpenoid
anti-inflammatory agent;
antineoplastic agent;
antioxidant;
hypoglycemic agent;
plant metabolite;
sweetening agent
2013201311.0low000010
lenticinamino-acid betaine;
indole alkaloid;
L-tryptophan derivative
fungal metabolite;
plant metabolite;
xenobiotic
2001200123.0low000100
absynthinorganic heteroheptacyclic compound;
sesquiterpene lactone;
triterpenoid
anti-inflammatory agent;
plant metabolite
201520159.0low000010
patchouli alcohol201520168.5low000020
farrerolorganic molecular entitymetabolite201820186.0low000010
genipiniridoid monoterpenoidanti-inflammatory agent;
antioxidant;
apoptosis inhibitor;
cross-linking reagent;
hepatotoxic agent;
uncoupling protein inhibitor
2011201610.5low000020
naringin(2S)-flavan-4-one;
4'-hydroxyflavanones;
dihydroxyflavanone;
disaccharide derivative;
neohesperidoside
anti-inflammatory agent;
antineoplastic agent;
metabolite
2011201810.3low000030
ochratoxin aisochromanes;
monocarboxylic acid amide;
N-acyl-L-phenylalanine;
organochlorine compound;
phenylalanine derivative
Aspergillus metabolite;
calcium channel blocker;
carcinogenic agent;
mycotoxin;
nephrotoxin;
Penicillium metabolite;
teratogenic agent
200020239.5low001122
gingerolbeta-hydroxy ketone;
guaiacols
antineoplastic agent;
plant metabolite
201720196.0low000030
4-hydroxy-3-(3-methyl-2-butenyl)acetophenone2003200321.0low000100
alpha-chaconineglycoalkaloid;
steroid saponin
2010201014.0low000100
lignans1992202012.3low0016140
bq 485peptide1996200422.5low001300
bq 123cyclic peptide2006201415.0low100210
n-formylmethionine leucyl-phenylalaninetripeptide1981202327.7low2559256132
sodium arsenitearsenic molecular entity;
inorganic sodium salt
antibacterial agent;
antifungal agent;
antineoplastic agent;
carcinogenic agent;
herbicide;
insecticide;
rodenticide
1999202113.5low001111
valnemulincarbotricyclic compound;
carboxylic ester;
cyclic ketone
2010201014.0low000100
mepirodipinedihydropyridine201520159.0low000010
vinpocetinealkaloidgeroprotector201520159.0low000010
betadexcyclodextrin2005201613.8low000320
e-z cinnamic acidcinnamic acidplant metabolite201520159.0low000010
ergosterol3beta-hydroxy-Delta(5)-steroid;
3beta-sterol;
ergostanoid;
phytosterols
fungal metabolite;
Saccharomyces cerevisiae metabolite
201720177.0low000010
trichostatin aantibiotic antifungal agent;
hydroxamic acid;
trichostatin
bacterial metabolite;
EC 3.5.1.98 (histone deacetylase) inhibitor;
geroprotector
201420169.0low000050
tretinoinretinoic acid;
vitamin A
anti-inflammatory agent;
antineoplastic agent;
antioxidant;
AP-1 antagonist;
human metabolite;
keratolytic drug;
retinoic acid receptor agonist;
retinoid X receptor agonist;
signalling molecule
1984202324.4low0416641
equilenin17-oxo steroid;
3-hydroxy steroid
antioxidant;
mammalian metabolite
1991199133.0low001000
arachidonic acidicosa-5,8,11,14-tetraenoic acid;
long-chain fatty acid;
omega-6 fatty acid
Daphnia galeata metabolite;
EC 3.1.1.1 (carboxylesterase) inhibitor;
human metabolite;
mouse metabolite
1982201825.5low013341990
prostaglandin h2olefinic compound;
oxylipin;
prostaglandins H;
secondary alcohol
mouse metabolite1997201317.0low001310
farnesolfarnesolplant metabolite2011201113.0low000010
phosphoramidondeoxyaldohexose phosphate;
dipeptide
bacterial metabolite;
EC 3.4.24.11 (neprilysin) inhibitor;
EC 3.4.24.71 (endothelin-converting enzyme 1) inhibitor
1990199034.0low001000
resveratrolresveratrolantioxidant;
phytoalexin;
plant metabolite;
quorum sensing inhibitor;
radical scavenger
1998202213.2low00130282
retinolretinol;
vitamin A
human metabolite;
mouse metabolite;
plant metabolite
1950202024.1low132930
cyanoginosin lrmicrocystinbacterial metabolite;
EC 3.1.3.16 (phosphoprotein phosphatase) inhibitor;
environmental contaminant;
xenobiotic
2001201913.5low000240
oleic acidoctadec-9-enoic acidantioxidant;
Daphnia galeata metabolite;
EC 3.1.1.1 (carboxylesterase) inhibitor;
Escherichia coli metabolite;
mouse metabolite;
plant metabolite;
solvent
1990202019.7low0061250
tacrolimusmacrolide lactambacterial metabolite;
immunosuppressive agent
1991201919.2low00141680
ferric hydroxide201920195.0low000010
ferulic acidferulic acidsanti-inflammatory agent;
antioxidant;
apoptosis inhibitor;
cardioprotective agent;
MALDI matrix material;
plant metabolite
1997202316.3low0031791
pectinsD-galactopyranuronic acid1996202114.6low1031192
cerivastatindihydroxy monocarboxylic acid;
pyridines;
statin (synthetic)
2004200420.0low000100
cocainebenzoate ester;
methyl ester;
tertiary amino compound;
tropane alkaloid
adrenergic uptake inhibitor;
central nervous system stimulant;
dopamine uptake inhibitor;
environmental contaminant;
local anaesthetic;
mouse metabolite;
plant metabolite;
serotonin uptake inhibitor;
sodium channel blocker;
sympathomimetic agent;
vasoconstrictor agent;
xenobiotic
1999201912.1low001060
eicosapentaenoic acidicosapentaenoic acid;
omega-3 fatty acid
anticholesteremic drug;
antidepressant;
antineoplastic agent;
Daphnia galeata metabolite;
fungal metabolite;
micronutrient;
mouse metabolite;
nutraceutical
1993201816.7low203440
thapsigarginbutyrate ester;
organic heterotricyclic compound;
sesquiterpene lactone
calcium channel blocker;
EC 3.6.3.8 (Ca(2+)-transporting ATPase) inhibitor
1994200722.7low001200
mycophenolic acid2-benzofurans;
gamma-lactone;
monocarboxylic acid;
phenols
anticoronaviral agent;
antimicrobial agent;
antineoplastic agent;
EC 1.1.1.205 (IMP dehydrogenase) inhibitor;
environmental contaminant;
immunosuppressive agent;
mycotoxin;
Penicillium metabolite;
xenobiotic
2005202211.3low100662
clindamycin1992202020.7low002010
keratan sulfate2005201414.5low000110
gw 6471201620168.0low000010
lycopeneacyclic caroteneantioxidant;
plant metabolite
1998202113.8low002371
zithromaxmacrolide antibioticantibacterial drug;
environmental contaminant;
xenobiotic
2000202215.2low301421
geranylgeranyl pyrophosphategeranylgeranyl diphosphatemouse metabolite201820186.0low000010
2-butenalenal1992199232.0low001000
t09013172006201712.4low000230
y 27632aromatic amide2003201813.3low000360
adenosine-5'-(n-ethylcarboxamide)adenosines;
monocarboxylic acid amide
adenosine A1 receptor agonist;
adenosine A2A receptor agonist;
antineoplastic agent;
EC 3.1.4.* (phosphoric diester hydrolase) inhibitor;
vasodilator agent
1996201020.7low001200
benzoylecgoninebenzoate ester;
tropane alkaloid
epitope;
human xenobiotic metabolite;
marine xenobiotic metabolite;
plant metabolite
1999199925.0low001000
mln 4760dichlorobenzene;
L-histidine derivative;
L-leucine derivative
anti-inflammatory agent;
EC 3.4.17.23 (angiotensin-converting enzyme 2) inhibitor
2009200915.0low000100
violaxanthinviolaxanthinfood colouring2005200519.0low000100
prostaglandin d2prostaglandins Dhuman metabolite;
mouse metabolite
1992201920.3low0051210
diethylstilbestrololefinic compound;
polyphenol
antifungal agent;
antineoplastic agent;
autophagy inducer;
calcium channel blocker;
carcinogenic agent;
EC 1.1.1.146 (11beta-hydroxysteroid dehydrogenase) inhibitor;
EC 3.6.3.10 (H(+)/K(+)-exchanging ATPase) inhibitor;
endocrine disruptor;
xenoestrogen
1955202132.0low043401
n-acetylmethionineL-methionine derivative;
N-acetyl-L-amino acid;
N-acetylmethionine
nutraceutical1988198836.0low010000
eptifibatidehomodetic cyclic peptide;
macrocycle;
organic disulfide
anticoagulant;
platelet aggregation inhibitor
1994201818.0low201210
roflumilastaromatic ether;
benzamides;
chloropyridine;
cyclopropanes;
organofluorine compound
anti-asthmatic drug;
phosphodiesterase IV inhibitor
2005202213.2low000301
h 89N-[2-(4-bromocinnamylamino)ethyl]isoquinoline-5-sulfonamide2012201212.0low000010
afimoxifenephenols;
tertiary amino compound
antineoplastic agent;
estrogen receptor antagonist;
metabolite
1999199925.0low001000
imidazolidinesazacycloalkane;
imidazolidines;
saturated organic heteromonocyclic parent
1981198143.0low010000
decitabine2'-deoxyribonucleoside2010201511.5low000110
iridoids201120209.2low0000120
kt 5720carboxylic ester;
gamma-lactam;
hemiaminal;
indolocarbazole;
organic heterooctacyclic compound;
semisynthetic derivative;
tertiary alcohol
EC 2.7.11.11 (cAMP-dependent protein kinase) inhibitor1992200724.5low001100
laminaran2007201314.0low000110
dactinomycinactinomycinmutagen1981200432.4low053100
gamma-sitosterol3beta-hydroxy-Delta(5)-steroid;
3beta-sterol;
phytosterols
marine metabolite;
plant metabolite
1999201713.2low001040
melphalanL-phenylalanine derivative;
nitrogen mustard;
non-proteinogenic L-alpha-amino acid;
organochlorine compound
alkylating agent;
antineoplastic agent;
carcinogenic agent;
drug allergen;
immunosuppressive agent
1986201821.7low010110
enkephalin, leucinepentapeptide;
peptide zwitterion
analgesic;
delta-opioid receptor agonist;
human metabolite;
mu-opioid receptor agonist;
neurotransmitter;
rat metabolite
1982201426.0low021210
benzyloxycarbonylleucyl-leucyl-leucine aldehydeamino aldehyde;
carbamate ester;
tripeptide
proteasome inhibitor2007200916.2low000400
tenofovirnucleoside analogue;
phosphonic acids
antiviral drug;
drug metabolite;
HIV-1 reverse transcriptase inhibitor
201920195.0low000010
shikoninhydroxy-1,4-naphthoquinone201320189.3low000030
riboflavinflavin;
vitamin B2
anti-inflammatory agent;
antioxidant;
cofactor;
Escherichia coli metabolite;
food colouring;
fundamental metabolite;
human urinary metabolite;
mouse metabolite;
photosensitizing agent;
plant metabolite
1950201923.4low010220
n,n'-ethylenediamine disuccinic acid202320231.0low000001
lisofylline1-(5-hydroxyhexyl)-3,7-dimethyl-3,7-dihydro-1H-purine-2,6-dioneanti-inflammatory agent;
immunomodulator
2002200222.0low000100
likviritonbeta-D-glucoside;
flavanone glycoside;
monohydroxyflavanone;
monosaccharide derivative
anti-inflammatory agent;
anticoronaviral agent;
plant metabolite
2012201212.0low000010
m404012001200421.5medium000200
bx 4712007200717.0low000100
sodium thiocyanateorganic sodium salt1992201923.5low003010
potassium thiocyanatepotassium salt2013201311.0low000010
sodium bicarbonateone-carbon compound;
organic sodium salt
antacid;
food anticaking agent
1964201721.8low010220
sodium benzoateorganic sodium saltalgal metabolite;
antimicrobial food preservative;
drug allergen;
EC 1.13.11.33 (arachidonate 15-lipoxygenase) inhibitor;
EC 3.1.1.3 (triacylglycerol lipase) inhibitor;
human xenobiotic metabolite;
plant metabolite
2007201911.0low000110
ammonium acetateacetate salt;
ammonium salt
buffer;
food acidity regulator
1996199628.0low001000
3-carbamoyl-2,2,5,5-tetramethyl-1-pyrrolidinyl-n-oxylaminoxyls;
pyrrolidinecarboxamide
2004200420.0low000100
dipyroneorganic sodium saltanti-inflammatory agent;
antipyretic;
antirheumatic drug;
cyclooxygenase 3 inhibitor;
non-narcotic analgesic;
peripheral nervous system drug;
prodrug
2002201815.2low000320
oxazolidineoxazolidine201920195.0low000010
bromochloroacetic acid2-bromocarboxylic acid;
monocarboxylic acid;
organochlorine compound
1983201922.0low023330
isopropyl n-methylanthranilate202220222.0medium000001
carbenoxolone sodiumtriterpenoid2008200816.0low000100
cinnamaldehyde3-phenylprop-2-enal;
cinnamaldehydes
antifungal agent;
EC 4.3.1.24 (phenylalanine ammonia-lyase) inhibitor;
flavouring agent;
hypoglycemic agent;
plant metabolite;
sensitiser;
vasodilator agent
2006201811.8low000230
trans-4-coumaric acid4-coumaric acidfood component;
mouse metabolite;
plant metabolite
1998202119.0low002301
anetholeanetholeflavouring agent2013201311.0low000020
geraniol3,7-dimethylocta-2,6-dien-1-ol;
monoterpenoid;
primary alcohol
allergen;
fragrance;
plant metabolite;
volatile oil component
2008201413.0low000110
dimethyl fumaratediester;
enoate ester;
methyl ester
antipsoriatic;
immunomodulator
201520159.0low000010
glycosides1964202113.6low0128133
chalconechalconeEC 3.2.1.1 (alpha-amylase) inhibitor1998202112.0low001141
sinapinic acidsinapic acidMALDI matrix material;
plant metabolite
2006200717.5low000200
isomethyleugenolisomethyleugenol1990202320.8low2010451
citralenal;
monoterpenoid;
polyprenal
plant metabolite;
volatile oil component
1999201615.0low001120
beta-iononeiononeantioxidant;
fragrance
2003200321.0low000100
retinaldehyderetinal;
vitamin A
gap junctional intercellular communication inhibitor;
human metabolite;
mouse metabolite
1999200820.5low001100
piperinebenzodioxoles;
N-acylpiperidine;
piperidine alkaloid;
tertiary carboxamide
food component;
human blood serum metabolite;
NF-kappaB inhibitor;
plant metabolite
201220209.2low000050
retinol acetateacetate ester2002200222.0low000100
stilbenesstilbene1990202214.2low00436332
isoliquiritigeninchalconesantineoplastic agent;
biological pigment;
EC 1.14.18.1 (tyrosinase) inhibitor;
GABA modulator;
geroprotector;
metabolite;
NMDA receptor antagonist
201620168.0low000010
phenyl-n-tert-butylnitrone1993200820.8low001300
p-hydroxycinnamaldehydecinnamaldehydesapoptosis inducer;
EC 1.14.13.39 (nitric oxide synthase) inhibitor;
plant metabolite
2000200024.0low001000
cardamoninchalcones201720177.0low000010
sorbic acidalpha,beta-unsaturated monocarboxylic acid;
sorbic acid
2004200519.5low000200
ricinoleic acid(9Z)-12-hydroxyoctadec-9-enoic acid2014201410.0low000010
flavin-adenine dinucleotideflavin adenine dinucleotide;
vitamin B2
cofactor;
Escherichia coli metabolite;
human metabolite;
mouse metabolite;
prosthetic group
1946198557.8low040000
cocaethylenebenzoate ester1999199925.0low001000
cannabidiololefinic compound;
phytocannabinoid;
resorcinols
antimicrobial agent;
plant metabolite
2007202012.3low000460
buprenorphinemorphinane alkaloiddelta-opioid receptor antagonist;
kappa-opioid receptor antagonist;
mu-opioid receptor agonist;
opioid analgesic
202020204.0low000010
arginine vasopressinvasopressincardiovascular drug;
hematologic agent;
mitogen
1997201317.0low001020
pyrophosphatediphosphate ion201820224.2low000032
gw9662benzamides2005201613.2low000330
acetyl-aspartyl-glutamyl-valyl-aspartaltetrapeptideprotease inhibitor2004200420.0low000100
omapatrilatdipeptide2009200915.0low000100
polidocanolhydroxypolyetherhepatotoxic agent;
nonionic surfactant;
sclerotherapy agent
1997200922.7low002100
tropisetronindolyl carboxylic acid2002201712.6low000140
benidipine2001200123.0low000100
sodium metabisulfiteinorganic sodium saltfood antioxidant202320231.0low100001
fludarabinepurine nucleoside2004200420.0low000100
propylthiouracilpyrimidinethioneantidote to paracetamol poisoning;
antimetabolite;
antioxidant;
antithyroid drug;
carcinogenic agent;
EC 1.14.13.39 (nitric oxide synthase) inhibitor;
hormone antagonist
1984202320.4low052129141
nsc 43472002201417.8low000410
n(6)-cyclopentyladenosine2004201315.0low000210
sesquiterpenes2002202311.9low00013181
etomidateethyl ester;
imidazoles
intravenous anaesthetic;
sedative
1995201320.0low001010
mercaptopurinearyl thiol;
purines;
thiocarbonyl compound
anticoronaviral agent;
antimetabolite;
antineoplastic agent
1993200226.5low101100
sb 3667912006200717.5low000200
3,3',4,5'-tetrahydroxystilbenecatechols;
polyphenol;
resorcinols;
stilbenol
antineoplastic agent;
apoptosis inducer;
geroprotector;
hypoglycemic agent;
plant metabolite;
protein kinase inhibitor;
tyrosine kinase inhibitor
2004201115.0low000230
thioinosine1994199430.0low001000
phenylthioureathioureasEC 1.14.18.1 (tyrosinase) inhibitor2003200321.0low000100
benzylthiouracilpyrimidone2003200916.8medium000400
caffeic acidcaffeic acidgeroprotector;
mouse metabolite
1998202112.4low001462
captaxaryl thiol;
benzothiazoles
carcinogenic agent;
metabolite
2010201014.0low000100
alpha-naphthyl thioureanaphthalenes1947200249.5low010100
ethyl ferulate2008200816.0low000100
purine-nucleoside phosphorylase1995199529.0low001000
isoeugenolisoeugenolplant metabolite201920195.0low000010
cotinineN-alkylpyrrolidine;
pyridines;
pyrrolidin-2-ones;
pyrrolidine alkaloid
antidepressant;
biomarker;
human xenobiotic metabolite;
plant metabolite
2009201411.8low100130
flunarizinediarylmethane2011201113.0low000010
dieldrinepoxide;
organochlorine compound;
organochlorine insecticide
carcinogenic agent;
xenobiotic
1997199727.0low001000
curcuminaromatic ether;
beta-diketone;
diarylheptanoid;
enone;
polyphenol
anti-inflammatory agent;
antifungal agent;
antineoplastic agent;
biological pigment;
contraceptive drug;
dye;
EC 1.1.1.205 (IMP dehydrogenase) inhibitor;
EC 1.1.1.21 (aldehyde reductase) inhibitor;
EC 1.1.1.25 (shikimate dehydrogenase) inhibitor;
EC 1.6.5.2 [NAD(P)H dehydrogenase (quinone)] inhibitor;
EC 1.8.1.9 (thioredoxin reductase) inhibitor;
EC 2.7.10.2 (non-specific protein-tyrosine kinase) inhibitor;
EC 3.5.1.98 (histone deacetylase) inhibitor;
flavouring agent;
food colouring;
geroprotector;
hepatoprotective agent;
immunomodulator;
iron chelator;
ligand;
lipoxygenase inhibitor;
metabolite;
neuroprotective agent;
nutraceutical;
radical scavenger
2003202311.0low10021374
curcuminaromatic ether;
beta-diketone;
diarylheptanoid;
enone;
polyphenol
anti-inflammatory agent;
antifungal agent;
antineoplastic agent;
biological pigment;
contraceptive drug;
dye;
EC 1.1.1.205 (IMP dehydrogenase) inhibitor;
EC 1.1.1.21 (aldehyde reductase) inhibitor;
EC 1.1.1.25 (shikimate dehydrogenase) inhibitor;
EC 1.6.5.2 [NAD(P)H dehydrogenase (quinone)] inhibitor;
EC 1.8.1.9 (thioredoxin reductase) inhibitor;
EC 2.7.10.2 (non-specific protein-tyrosine kinase) inhibitor;
EC 3.5.1.98 (histone deacetylase) inhibitor;
flavouring agent;
food colouring;
geroprotector;
hepatoprotective agent;
immunomodulator;
iron chelator;
ligand;
lipoxygenase inhibitor;
metabolite;
neuroprotective agent;
nutraceutical;
radical scavenger
2003202311.1low10024434
hc 0300312013201311.0low000010
nootkatonecarbobicyclic compound;
enone;
sesquiterpenoid
fragrance;
insect repellent;
plant metabolite
201820205.0low000020
2-thioxanthene201220197.7high000030
thiouracilnucleobase analogue;
thiocarbonyl compound
antithyroid drug;
metabolite
1946201627.6low020420
n-methylcytisine201820186.0low000010
methimazole1,3-dihydroimidazole-2-thionesantithyroid drug1988201423.8low02111230
methimazole1,3-dihydroimidazole-2-thionesantithyroid drug1988201423.5low0291230
urb 597biphenyls201720177.0low000010
snap 378892011201113.0low000010
cinnarizinediarylmethane;
N-alkylpiperazine;
olefinic compound
anti-allergic agent;
antiemetic;
calcium channel blocker;
geroprotector;
H1-receptor antagonist;
histamine antagonist;
muscarinic antagonist
2005200519.0low000100
sulindacmonocarboxylic acid;
organofluorine compound;
sulfoxide
analgesic;
antineoplastic agent;
antipyretic;
apoptosis inducer;
EC 1.14.99.1 (prostaglandin-endoperoxide synthase) inhibitor;
non-narcotic analgesic;
non-steroidal anti-inflammatory drug;
prodrug;
tocolytic agent
2014201410.0low000010
capsaicincapsaicinoidnon-narcotic analgesic;
TRPV1 agonist;
voltage-gated sodium channel blocker
1990201919.1low0093080
enclomiphene1991202118.0low001001
coniferyl alcoholguaiacols;
phenylpropanoid
animal metabolite;
monolignol;
mouse metabolite;
pheromone;
plant metabolite;
volatile oil component
2003202310.3low000142
n-(fluorenyl-9-methoxycarbonyl)leucine1993199331.0low001000
oxazolone1989202018.6low014650
oxazolone1989202018.7low014550
chlorogenic acidcinnamate ester;
tannin
food component;
plant metabolite
2002202210.3low000563
2,2,5,7,8-pentamethylchroman1999199925.0medium001000
thioguanine anhydrous2-aminopurinesanticoronaviral agent;
antimetabolite;
antineoplastic agent
1986200330.0low011100
thiobarbituric acidbarbituratesallergen;
reagent
1982201524.7low013030
1,3-dimethylthiourea1989201723.8low012020
s-phenyl-n-acetylcysteinearyl sulfide;
S-substituted N-acetyl-L-cysteine
biomarker;
human urinary metabolite
2005200519.0low000100
thioureaone-carbon compound;
thioureas;
ureas
antioxidant;
chromophore
1946202129.6low053451
indigo carmine1962202323.0low110111
D-fructopyranosecyclic hemiketal;
D-fructose;
fructopyranose
sweetening agent2000202114.8low001851
potassium oxonateorganic molecular entity2013201311.0low000010
thioacetamidethiocarboxamidehepatotoxic agent2010201710.5low000110
tempoaminoxyls;
piperidines
catalyst;
ferroptosis inhibitor;
radical scavenger
1995201718.7low001110
ferric ferrocyanide200020235.7low00101110
tungsten carbide2014201410.0low000010
succimerdicarboxylic acid;
dithiol;
sulfur-containing carboxylic acid
chelator2011201113.0low000010
digoxincardenolide glycoside;
steroid saponin
anti-arrhythmia drug;
cardiotonic drug;
EC 3.6.3.9 (Na(+)/K(+)-transporting ATPase) inhibitor;
epitope
1996200523.5low001100
capsazepinebenzazepine;
catechols;
monochlorobenzenes;
thioureas
capsaicin receptor antagonist2001201517.5low0001230
fumonisin b1diester;
fumonisin;
primary amino compound;
triol
carcinogenic agent;
metabolite
2009200915.0low000100
1,3-dihydroxy-4,4,5,5-tetramethyl-2-(4-carboxyphenyl)tetrahydroimidazolebenzoic acid;
imidazolines;
organic radical
apoptosis inhibitor;
radical scavenger
201520187.5low000020
2-phenyl-4,4,5,5-tetramethylimidazoline-1-oxyl-3-oxide2005200718.0low000200
tamoxifenstilbenoid;
tertiary amino compound
angiogenesis inhibitor;
antineoplastic agent;
bone density conservation agent;
EC 1.2.3.1 (aldehyde oxidase) inhibitor;
EC 2.7.11.13 (protein kinase C) inhibitor;
estrogen antagonist;
estrogen receptor antagonist;
estrogen receptor modulator
1989201919.8low111310
sodium taurodeoxycholatebile acid taurine conjugatehuman metabolite2002201117.4low000410
1-butyl-3-methylimidazolium chloride201520159.0low000010
1-butyl-2,3-dimethylimidazolium201620168.0low000010
1-butyl-3-methylimidazolium hexafluorophosphate2011201610.7low000030
1-butyl-3-methylimidazolium tetrafluoroborate2009200915.0low000100
buclizine1-alkyl-3-methylimidazolium201520187.5low000020
1-dodecyl-3-methylimidazolium1-alkyl-3-methylimidazolium201520159.0low000010
1-octyl-3-methylimidazolium hexafluorophosphate201620187.0low000020
nadp1963202326.6low017912102
1,1-diphenyl-2-picrylhydrazyl2002202012.2low00011180
t 0070907carbonyl compound;
organohalogen compound
2007200717.0low000100
sirtinolaldimine;
benzamides;
naphthols
anti-inflammatory agent;
EC 3.5.1.98 (histone deacetylase) inhibitor;
Sir2 inhibitor
2008201513.3low000210
zeranolmacrolide2000200024.0low001000
lincomycincarbohydrate-containing antibiotic;
L-proline derivative;
monocarboxylic acid amide;
pyrrolidinecarboxamide;
S-glycosyl compound
antimicrobial agent;
bacterial metabolite
1998199826.0low001000
thiopentalbarbituratesanticonvulsant;
drug allergen;
environmental contaminant;
intravenous anaesthetic;
sedative;
xenobiotic
1995199529.0low001000
ranitidineC-nitro compound;
furans;
organic sulfide;
tertiary amino compound
anti-ulcer drug;
drug allergen;
environmental contaminant;
H2-receptor antagonist;
xenobiotic
1993201719.6low104910
thiamine disulfideaminopyrimidine;
formamides;
homoallylic alcohol;
organic disulfide
2008200816.0low000100
maraviroctropane alkaloid2013201311.0low000010
u 0126aryl sulfide;
dinitrile;
enamine;
substituted aniline
antineoplastic agent;
antioxidant;
apoptosis inducer;
EC 2.7.11.24 (mitogen-activated protein kinase) inhibitor;
osteogenesis regulator;
vasoconstrictor agent
2007201314.8low000310
laccase1947202413.6low01627346
n-bromotaurine2004200420.0low000100
tetomilast1997200324.0medium001100
lithiumalkali metal atom1980201234.8low041010
cobaltous chloridecobalt salt;
inorganic chloride
allergen;
calcium channel blocker;
sensitiser;
two-colour indicator
2013201311.0low000010
nitrogen dioxidenitrogen oxide1995202319.3low2071222
nitromifene1981198143.0low010000
maneb2008200816.0low000100
thiouridinenucleoside analogue;
thiouridine
affinity label;
antimetabolite
1999202114.0low001001
dermatan sulfateamino disaccharide;
glycosylgalactose derivative;
iduronic acids;
oligosaccharide sulfate
2009200915.0low000100
nizatidine1993199331.0low001000
droloxifenestilbenoid1999199925.0low001000
quininecinchona alkaloidantimalarial;
muscle relaxant;
non-narcotic analgesic
1946201939.0low011010
kaurenoic acid2002202112.5low000101
azoxystrobinaryloxypyrimidine;
enoate ester;
enol ether;
methoxyacrylate strobilurin antifungal agent;
methyl ester;
nitrile
antifungal agrochemical;
environmental contaminant;
mitochondrial cytochrome-bc1 complex inhibitor;
quinone outside inhibitor;
xenobiotic
201320198.6low000050
1,2-bis(2-aminophenoxy)ethane n,n,n',n'-tetraacetic acid acetoxymethyl ester2002200421.0low000200
glycodeoxycholic acidbile acid glycine conjugatehuman metabolite1999201616.5low002530
thymidine glycolpyrimidine 2'-deoxyribonucleoside1993199331.0low001000
2,2-dimethyl-5-hydroxy-1-pyrrolidinyloxy1999200622.7low002100
rtki cpd2003200321.0low000100
e 61232001200123.0low000100
2,4-dinitrofluorobenzene sulfonic acid1999202115.1medium003871
tryptophan tryptophylquinone2014201410.0low000010
2-chloro-n(6)-(3-iodobenzyl)adenosine-5'-n-methyluronamide201420159.5low000020
thioperamideprimary aliphatic amine2007200717.0low000100
cystine1963201725.8low021120
u-50488dichlorobenzene;
monocarboxylic acid amide;
N-alkylpyrrolidine
analgesic;
antitussive;
calcium channel blocker;
diuretic;
kappa-opioid receptor agonist
2011201113.0low000020
dimemorfanmorphinane alkaloid2008200816.0low000100
lamifibanN-acylglycine2002200222.0low000100
modipafant1998200423.0low001100
safingolamino alcohol1987198737.0low010000
dasatinib1,3-thiazoles;
aminopyrimidine;
monocarboxylic acid amide;
N-(2-hydroxyethyl)piperazine;
N-arylpiperazine;
organochlorine compound;
secondary amino compound;
tertiary amino compound
anticoronaviral agent;
antineoplastic agent;
tyrosine kinase inhibitor
201620168.0low000010
5-nitroso-salicylatehydroxybenzoic acid1991199133.0medium001000
pelargonidin-3-glucosideanthocyanin chlorides201820186.0low000010
clinitest1964196460.0low010000
sr 144528bridged compound;
monochlorobenzenes;
pyrazoles;
secondary carboxamide
CB2 receptor antagonist;
EC 2.3.1.26 (sterol O-acyltransferase) inhibitor
201420169.0low000020
nitinol201720177.0low000010
mycobactin1996199628.0low001000
5-chlorocytosine1999201517.0medium001010
amanitins1999199925.0low001000
cytellin1999201713.2low001040
wogonosidebeta-D-glucosiduronic acid;
glycosyloxyflavone;
monohydroxyflavone;
monomethoxyflavone;
monosaccharide derivative
201820186.0low000010
ginsenosides2005202210.8low100472
bacillomycin d201920195.0low000010
2-(4-(2-carboxyethyl)phenethylamino)-5'-n-ethylcarboxamidoadenosineadenosines;
dicarboxylic acid monoamide;
monocarboxylic acid
adenosine A2A receptor agonist;
anti-inflammatory agent
1996201917.8low004530
ovalbumin1985202216.8low11622191
ovalbumin1985202216.8low11621191
3-nitrobenzhydrazide1995199529.0medium001000
anthraquinone sulfonate2013201311.0low000010
epoxiconazoleepoxide;
monochlorobenzenes;
monofluorobenzenes;
triazoles
201520159.0low000010
sodium dodecyl sulfateorganic sodium saltdetergent;
protein denaturant
1984201820.4low026260
crocin201720177.0low000010
2-amino-4-nitrophenol4-nitrophenols2001200123.0low000100
mtt formazan2004200420.0low000100
chloramine-torganic sodium saltallergen;
antifouling biocide;
disinfectant
1991199631.0low003000
l 663536aryl sulfide;
indoles;
monocarboxylic acid;
monochlorobenzenes
antineoplastic agent;
EC 1.13.11.34 (arachidonate 5-lipoxygenase) inhibitor;
leukotriene antagonist
1992201321.9low004030
flavan-3-olhydroxyflavonoid2004201414.8low000220
6-cyano-7-nitroquinoxaline-2,3-dionequinoxaline derivative1996199628.0low001000
2,4-dinitrophenylhydrazineC-nitro compound;
phenylhydrazines
reagent1996199926.0low003000
zinc protoporphyrin ix2005201613.2low000660
sb 225002nitrophenol2010202310.5low000211
alpha-chymotrypsin1976202031.9low082220
alpinetinether;
flavonoids
201320198.0low000030
sew2871oxadiazole;
ring assembly
2006201512.3low000120
4-benzyl-2-methyl-1,2,4-thiadiazolidine-3,5-dionebenzenes;
thiadiazolidine
anti-inflammatory agent;
antineoplastic agent;
apoptosis inducer;
EC 2.7.11.26 (tau-protein kinase) inhibitor;
neuroprotective agent
2006201814.5low000310
clopidogrel carboxylic acidmonocarboxylic acid;
monochlorobenzenes;
tertiary amino compound;
thienopyridine
drug metabolite;
marine xenobiotic metabolite
2012201212.0low000010
sb 415286C-nitro compound;
maleimides;
monochlorobenzenes;
phenols;
secondary amino compound;
substituted aniline
antioxidant;
apoptosis inducer;
EC 2.7.11.26 (tau-protein kinase) inhibitor;
neuroprotective agent
2006200618.0low000100
naphthoquinones2001202111.8low000251
d 6092006200618.0low000100
jhw 015indolecarboxamide2008200816.0low000100
am 630N-acylindole201720177.0low000010
sc 560aromatic ether;
monochlorobenzenes;
organofluorine compound;
pyrazoles
angiogenesis modulating agent;
antineoplastic agent;
apoptosis inducer;
cyclooxygenase 1 inhibitor;
non-steroidal anti-inflammatory drug
2004201017.0low000700
sodium borohydrideinorganic sodium salt;
metal tetrahydridoborate
1985200532.3low020100
3-nitro-o-phenylenediamine202320231.0low000001
alpha-carotenecarotenoid beta-end derivative;
cyclic carotene
plant metabolite;
provitamin A
1997199727.0low001000
osteoprotegerinlong-chain fatty acid200920238.9low000142
cathepsin g1980202124.8low18321691
3-(2-hydroxy-4-(1,1-dimethylheptyl)phenyl)-4-(3-hydroxypropyl)cyclohexanolalkylbenzene;
ring assembly
2006201115.5low000110
rhodamine 123organic cation;
xanthene dye
fluorochrome2003200321.0low000100
tolcapone2-nitrophenols;
benzophenones;
catechols
antiparkinson drug;
EC 2.1.1.6 (catechol O-methyltransferase) inhibitor
2003200321.0low000100
myelin basic protein2006201413.8low000230
jnj 77771202005201414.5low000110
diethyl maleateethyl ester;
maleate ester
glutathione depleting agent1994199430.0low001000
fraxinaromatic ether;
beta-D-glucoside;
hydroxycoumarin
anti-inflammatory agent;
hepatoprotective agent;
plant metabolite
201920204.5low000020
fraxetinaromatic ether;
hydroxycoumarin
anti-inflammatory agent;
antibacterial agent;
antimicrobial agent;
antioxidant;
apoptosis inducer;
apoptosis inhibitor;
Arabidopsis thaliana metabolite;
hepatoprotective agent;
hypoglycemic agent
201420216.5low000011
quercetin 3-o-glucuronidebeta-D-glucosiduronic acid;
quercetin O-glycoside
antidepressant;
antioxidant;
metabolite
2011201212.5low000020
sphingosinesphing-4-eninehuman metabolite;
mouse metabolite
1987201819.0low0131030
quercetin7-hydroxyflavonol;
pentahydroxyflavone
antibacterial agent;
antineoplastic agent;
antioxidant;
Aurora kinase inhibitor;
chelator;
EC 1.10.99.2 [ribosyldihydronicotinamide dehydrogenase (quinone)] inhibitor;
geroprotector;
phytoestrogen;
plant metabolite;
protein kinase inhibitor;
radical scavenger
1988202314.2low12327276
bilirubinbiladienes;
dicarboxylic acid
antioxidant;
human metabolite;
mouse metabolite
1981202218.9low07713133
dinoprostoneprostaglandins Ehuman metabolite;
mouse metabolite;
oxytocic
1987202118.3low325790662
dinoprostmonocarboxylic acid;
prostaglandins Falpha
human metabolite;
mouse metabolite
1999201815.5low3048100
biochanin a4'-methoxyisoflavones;
7-hydroxyisoflavones
antineoplastic agent;
EC 3.5.1.99 (fatty acid amide hydrolase) inhibitor;
phytoestrogen;
plant metabolite;
tyrosine kinase inhibitor
2004200420.0low000100
formononetin4'-methoxyisoflavones;
7-hydroxyisoflavones
phytoestrogen;
plant metabolite
2013201311.0low000010
leukotriene a4epoxy fatty acid;
leukotriene;
long-chain fatty acid;
oxylipin;
polyunsaturated fatty acid
human metabolite;
mouse metabolite;
plant metabolite
1994199430.0low002000
arachidonyltrifluoromethanefatty acid derivative;
ketone;
olefinic compound;
organofluorine compound
EC 3.1.1.4 (phospholipase A2) inhibitor2003200321.0low000100
acacetindihydroxyflavone;
monomethoxyflavone
anticonvulsant;
plant metabolite
201820205.0low000020
apigenintrihydroxyflavoneantineoplastic agent;
metabolite
200720219.2low000261
luteolin3'-hydroxyflavonoid;
tetrahydroxyflavone
angiogenesis inhibitor;
anti-inflammatory agent;
antineoplastic agent;
apoptosis inducer;
c-Jun N-terminal kinase inhibitor;
EC 2.3.1.85 (fatty acid synthase) inhibitor;
immunomodulator;
nephroprotective agent;
plant metabolite;
radical scavenger;
vascular endothelial growth factor receptor antagonist
1990202217.0low001101
7,3'-dihydroxy-4'-methoxyisoflavone4'-methoxyisoflavones;
7-hydroxyisoflavones
antioxidant;
metabolite
201520159.0low000010
linoleic acidoctadecadienoic acid;
omega-6 fatty acid
algal metabolite;
Daphnia galeata metabolite;
plant metabolite
1948201723.9low026640
calcitriolD3 vitamins;
hydroxycalciol;
triol
antineoplastic agent;
antipsoriatic;
bone density conservation agent;
calcium channel agonist;
calcium channel modulator;
hormone;
human metabolite;
immunomodulator;
metabolite;
mouse metabolite;
nutraceutical
1987202117.9low011221
pinosylvinpinosylvin2010201014.0low000100
quercitrinalpha-L-rhamnoside;
monosaccharide derivative;
quercetin O-glycoside;
tetrahydroxyflavone
antileishmanial agent;
antioxidant;
EC 1.1.1.184 [carbonyl reductase (NADPH)] inhibitor;
EC 1.1.1.21 (aldehyde reductase) inhibitor;
EC 1.14.18.1 (tyrosinase) inhibitor;
plant metabolite
2002201815.3low000210
scopoletinhydroxycoumarinplant growth regulator;
plant metabolite
1984201823.4low020210
vitamin k semiquinone radical1950200742.3low020100
beta carotenecarotenoid beta-end derivative;
cyclic carotene
antioxidant;
biological pigment;
cofactor;
ferroptosis inhibitor;
human metabolite;
mouse metabolite;
plant metabolite;
provitamin A
1989201718.5low1121230
leukotriene b4dihydroxy monocarboxylic acid;
hydroxy polyunsaturated fatty acid;
leukotriene;
long-chain fatty acid
human metabolite;
mouse metabolite;
plant metabolite;
vasoconstrictor agent
1983202125.1low9168745201
leukotriene c4leukotrienebronchoconstrictor agent;
human metabolite;
mouse metabolite
1993201821.5low008240
thromboxane a2epoxy monocarboxylic acid;
thromboxanes A
mouse metabolite1989202327.2low018101
sinapyl alcoholsinapyl alcoholmonolignol2006202310.6medium000232
retinol palmitateall-trans-retinyl ester;
retinyl palmitate
antioxidant;
Escherichia coli metabolite;
human xenobiotic metabolite
1996199628.0low001000
2-hexadecenalhexadecenal;
n-alk-2-enal;
trans-2,3-unsaturated fatty aldehyde
2007200717.0low000100
hymecromonehydroxycoumarinantineoplastic agent;
hyaluronic acid synthesis inhibitor
1986199732.5low011000
daphnetinhydroxycoumarin2014201410.0low000020
8,11,14-eicosatrienoic acidfatty acid 20:3;
long-chain fatty acid
fungal metabolite;
human metabolite;
nutraceutical
2001201416.5low000110
alprostadilprostaglandins Eanticoagulant;
human metabolite;
platelet aggregation inhibitor;
vasodilator agent
1988201428.0low1213110
5-hydroxy-6,8,11,14-eicosatetraenoic acidHETEhuman metabolite;
mouse metabolite
201820205.0low100020
vitamin d 2hydroxy seco-steroid;
seco-ergostane;
vitamin D
bone density conservation agent;
nutraceutical;
plant metabolite;
rodenticide
201720177.0low100010
stigmasterol3beta-hydroxy-Delta(5)-steroid;
3beta-sterol;
phytosterols;
stigmastane sterol
plant metabolite1999201614.7low001020
cholecalciferolD3 vitamins;
hydroxy seco-steroid;
seco-cholestane;
secondary alcohol;
steroid hormone
geroprotector;
human metabolite
1991200926.3low002100
rutindisaccharide derivative;
quercetin O-glucoside;
rutinoside;
tetrahydroxyflavone
antioxidant;
metabolite
1961202220.9low043792
3-methylkaempferolmonomethoxyflavone;
trihydroxyflavone
plant metabolite2009200915.0low000100
kaempferol7-hydroxyflavonol;
flavonols;
tetrahydroxyflavone
antibacterial agent;
geroprotector;
human blood serum metabolite;
human urinary metabolite;
human xenobiotic metabolite;
plant metabolite
201020219.4low000161
leukotriene d4dipeptide;
leukotriene;
organic sulfide
bronchoconstrictor agent;
human metabolite;
mouse metabolite
1995201122.2low002210
leukotriene e4amino dicarboxylic acid;
L-cysteine thioether;
leukotriene;
non-proteinogenic L-alpha-amino acid;
secondary alcohol
1983200526.2low112200
prostaglandin g2prostaglandins Ghuman metabolite;
mouse metabolite
1987200227.8low012100
9-deoxy-delta-9-prostaglandin d2prostaglandins Jhuman metabolite2010201014.0low000100
6-ketoprostaglandin f1 alphaprostaglandins Falphahuman metabolite;
mouse metabolite
1987201724.0low03111110
arachidonic acid omega-9 hydroperoxideHPETEmouse metabolite2004200420.0low000100
zeaxanthincarotenolantioxidant;
bacterial metabolite;
cofactor
2012201212.0low100010
lipoxin a4hydroxy polyunsaturated fatty acid;
lipoxin;
long-chain fatty acid
human metabolite;
metabolite
2004202111.0low000391
gamma-linolenic acidlinolenic acid;
omega-6 fatty acid
human metabolite;
mouse metabolite;
plant metabolite
1997202017.0low001110
alpha-linolenic acidlinolenic acid;
omega-3 fatty acid
micronutrient;
mouse metabolite;
nutraceutical
2003200321.0low000100
prostaglandin f1prostaglandins Falphahuman metabolite1997201221.6low003110
harmineharmala alkaloidanti-HIV agent;
EC 1.4.3.4 (monoamine oxidase) inhibitor;
metabolite
2014201410.0low000010
genistein7-hydroxyisoflavonesantineoplastic agent;
EC 5.99.1.3 [DNA topoisomerase (ATP-hydrolysing)] inhibitor;
geroprotector;
human urinary metabolite;
phytoestrogen;
plant metabolite;
tyrosine kinase inhibitor
1998201618.5low002720
amphotericin bantibiotic antifungal drug;
macrolide antibiotic;
polyene antibiotic
antiamoebic agent;
antiprotozoal drug;
bacterial metabolite
2003200321.0low000100
pulmicort11beta-hydroxy steroid;
20-oxo steroid;
21-hydroxy steroid;
3-oxo-Delta(1),Delta(4)-steroid;
cyclic acetal;
glucocorticoid;
primary alpha-hydroxy ketone
anti-inflammatory drug;
bronchodilator agent;
drug allergen
1994202220.9low60111051
cefzil202120213.0low100001
pyrantel pamoateorganic molecular entity2010201014.0low000100
montelukastaliphatic sulfide;
monocarboxylic acid;
quinolines
anti-arrhythmia drug;
anti-asthmatic drug;
leukotriene antagonist
2003201714.3low10013100
oxantel pamoatenaphthoic acid2010201014.0low000100
paricalcitolhydroxy seco-steroid;
seco-cholestane
antiparathyroid drug201720177.0low100010
jasmonic acidoxo monocarboxylic acidjasmonates;
plant metabolite
2004202310.9low000784
buteinchalcones;
polyphenol
antineoplastic agent;
antioxidant;
EC 1.1.1.21 (aldehyde reductase) inhibitor;
geroprotector;
hypoglycemic agent;
plant metabolite;
radiosensitizing agent;
tyrosine kinase inhibitor
201320188.5low000020
astaxanthinecarotenol;
carotenone
animal metabolite;
anticoagulant;
antioxidant;
food colouring;
plant metabolite
2003201811.2low000140
cryptoxanthinscarotenolantioxidant;
biomarker;
plant metabolite;
provitamin A
2012201212.0low100010
luteincarotenolfood colouring;
plant metabolite
1948201922.6low010130
norbixinditerpenoid202120213.0low000001
azadirachtinacetate ester;
azadirachtin;
cyclic hemiketal;
enoate ester;
epoxide;
methyl ester;
organic heterotetracyclic compound;
secondary alcohol;
tertiary alcohol
hepatoprotective agent2010201014.0low000100
mezereinditerpenoid1992201023.0low001100
ophiobolin acyclic ketone;
enal;
oxaspiro compound;
sesterterpenoid;
tertiary alcohol
201720177.0low000010
calophyllolidneoflavonoid201720177.0medium000010
harmanharmala alkaloid;
indole alkaloid fundamental parent;
indole alkaloid
anti-HIV agent;
EC 1.4.3.4 (monoamine oxidase) inhibitor;
plant metabolite
2014201410.0low000010
esculetinhydroxycoumarinantioxidant;
plant metabolite;
ultraviolet filter
2010201014.0low000100
esculinbeta-D-glucoside;
hydroxycoumarin
antioxidant;
metabolite
201420178.5low000020
alpha-farnesenealpha-farnesene2005200519.0low000100
humulenealpha-humulene2007200717.0low000100
humulenealpha-humulene200220239.7low000111
oleuropeinbeta-D-glucoside;
catechols;
diester;
methyl ester;
pyrans;
secoiridoid glycoside
anti-inflammatory agent;
antihypertensive agent;
antineoplastic agent;
antioxidant;
apoptosis inducer;
NF-kappaB inhibitor;
nutraceutical;
plant metabolite;
radical scavenger
2011201910.3low000030
zearalenonemacrolide;
resorcinols
fungal metabolite;
mycoestrogen
201820224.0low100011
amentoflavonebiflavonoid;
hydroxyflavone;
ring assembly
angiogenesis inhibitor;
antiviral agent;
cathepsin B inhibitor;
P450 inhibitor;
plant metabolite
2013201311.0low000010
baicaleintrihydroxyflavoneangiogenesis inhibitor;
anti-inflammatory agent;
antibacterial agent;
anticoronaviral agent;
antifungal agent;
antineoplastic agent;
antioxidant;
apoptosis inducer;
EC 1.13.11.31 (arachidonate 12-lipoxygenase) inhibitor;
EC 1.13.11.33 (arachidonate 15-lipoxygenase) inhibitor;
EC 3.4.21.26 (prolyl oligopeptidase) inhibitor;
EC 3.4.22.69 (SARS coronavirus main proteinase) inhibitor;
EC 4.1.1.17 (ornithine decarboxylase) inhibitor;
ferroptosis inhibitor;
geroprotector;
hormone antagonist;
plant metabolite;
prostaglandin antagonist;
radical scavenger
1999202213.5low101441
chrysin7-hydroxyflavonol;
dihydroxyflavone
anti-inflammatory agent;
antineoplastic agent;
antioxidant;
EC 2.7.11.18 (myosin-light-chain kinase) inhibitor;
hepatoprotective agent;
plant metabolite
2007202110.6low000241
diosmindihydroxyflavanone;
disaccharide derivative;
glycosyloxyflavone;
monomethoxyflavone;
rutinoside
anti-inflammatory agent;
antioxidant
1993201819.1low002320
fisetin3'-hydroxyflavonoid;
7-hydroxyflavonol;
tetrahydroxyflavone
anti-inflammatory agent;
antioxidant;
EC 5.99.1.3 [DNA topoisomerase (ATP-hydrolysing)] inhibitor;
geroprotector;
metabolite;
plant metabolite
2009201413.0low000210
galangin7-hydroxyflavonol;
trihydroxyflavone
antimicrobial agent;
EC 3.1.1.3 (triacylglycerol lipase) inhibitor;
plant metabolite
201420216.5low000011
hyperosidebeta-D-galactoside;
monosaccharide derivative;
quercetin O-glycoside;
tetrahydroxyflavone
hepatoprotective agent;
plant metabolite
201920195.0low000010
mangiferinC-glycosyl compound;
xanthones
anti-inflammatory agent;
antioxidant;
hypoglycemic agent;
plant metabolite
2004202110.0low000111
mangostinaromatic ether;
phenols;
xanthones
antimicrobial agent;
antineoplastic agent;
antioxidant;
plant metabolite
2014201410.0low000010
3-methylquercetin7-hydroxyflavonol;
monomethoxyflavone;
tetrahydroxyflavone
anticoagulant;
EC 1.14.18.1 (tyrosinase) inhibitor;
metabolite
201620168.0low000010
morin7-hydroxyflavonol;
pentahydroxyflavone
angiogenesis modulating agent;
anti-inflammatory agent;
antibacterial agent;
antihypertensive agent;
antineoplastic agent;
antioxidant;
EC 5.99.1.2 (DNA topoisomerase) inhibitor;
hepatoprotective agent;
metabolite;
neuroprotective agent
2001201912.5low000220
myricetin7-hydroxyflavonol;
hexahydroxyflavone
antineoplastic agent;
antioxidant;
cyclooxygenase 1 inhibitor;
food component;
geroprotector;
hypoglycemic agent;
plant metabolite
201320218.2low000031
myricitrinalpha-L-rhamnoside;
glycosyloxyflavone;
monosaccharide derivative;
pentahydroxyflavone
anti-allergic agent;
EC 1.14.13.39 (nitric oxide synthase) inhibitor;
EC 2.7.11.13 (protein kinase C) inhibitor;
plant metabolite
2008200816.0low000100
tricetinpentahydroxyflavoneantineoplastic agent;
metabolite
2009200915.0low000100
7-hydroxy-6,4'-dimethoxyisoflavone4'-methoxyisoflavones;
7-hydroxyisoflavones
plant metabolite2013201311.0low000010
daidzein7-hydroxyisoflavonesantineoplastic agent;
EC 2.7.7.7 (DNA-directed DNA polymerase) inhibitor;
EC 3.2.1.20 (alpha-glucosidase) inhibitor;
phytoestrogen;
plant metabolite
2003201910.4low000140
pterostilbenediether;
methoxybenzenes;
stilbenol
anti-inflammatory agent;
antineoplastic agent;
antioxidant;
apoptosis inducer;
hypoglycemic agent;
neuroprotective agent;
neurotransmitter;
plant metabolite;
radical scavenger
2010201113.5low000110
diferulic acid2011201511.3medium000030
echinacosideoligosaccharide2007201612.5low000110
irisolidone4'-methoxyisoflavones201720177.0low000010
caffeic acid phenethyl esteralkyl caffeate esteranti-inflammatory agent;
antibacterial agent;
antineoplastic agent;
antioxidant;
antiviral agent;
immunomodulator;
metabolite;
neuroprotective agent
2002201616.4low0001750
plantamajosidehydroxycinnamic acid201620168.0low000010
rosmarinic acidrosmarinic acidgeroprotector;
plant metabolite
199420229.4low001073
salvianolic acid astilbenoid201820186.0low000010
acteosidecatechols;
cinnamate ester;
disaccharide derivative;
glycoside;
polyphenol
anti-inflammatory agent;
antibacterial agent;
antileishmanial agent;
neuroprotective agent;
plant metabolite
2007200916.0low000200
tectorigenin7-hydroxyisoflavones;
methoxyisoflavone
anti-inflammatory agent;
plant metabolite
2014201410.0low000010
wedelolactonearomatic ether;
coumestans;
delta-lactone;
polyphenol
antineoplastic agent;
apoptosis inducer;
EC 5.99.1.3 [DNA topoisomerase (ATP-hydrolysing)] inhibitor;
hepatoprotective agent;
metabolite
201920195.0low000010
ellagic acidcatechols;
cyclic ketone;
lactone;
organic heterotetracyclic compound;
polyphenol
antioxidant;
EC 1.14.18.1 (tyrosinase) inhibitor;
EC 2.3.1.5 (arylamine N-acetyltransferase) inhibitor;
EC 2.4.1.1 (glycogen phosphorylase) inhibitor;
EC 2.5.1.18 (glutathione transferase) inhibitor;
EC 2.7.1.127 (inositol-trisphosphate 3-kinase) inhibitor;
EC 2.7.1.151 (inositol-polyphosphate multikinase) inhibitor;
EC 2.7.4.6 (nucleoside-diphosphate kinase) inhibitor;
EC 2.7.7.7 (DNA-directed DNA polymerase) inhibitor;
EC 5.99.1.2 (DNA topoisomerase) inhibitor;
EC 5.99.1.3 [DNA topoisomerase (ATP-hydrolysing)] inhibitor;
food additive;
fungal metabolite;
geroprotector;
plant metabolite;
skin lightening agent
2002202311.5low000371
coenzyme q10ubiquinonesantioxidant;
ferroptosis inhibitor;
human metabolite
2007201910.3low200370
anandamideendocannabinoid;
N-acylethanolamine 20:4
human blood serum metabolite;
neurotransmitter;
vasodilator agent
2006200717.5low000200
ceruleninepoxide;
monocarboxylic acid amide
antifungal agent;
antiinfective agent;
antilipemic drug;
antimetabolite;
antimicrobial agent;
fatty acid synthesis inhibitor
2004200420.0low000100
l 683590ether;
lactol;
macrolide;
secondary alcohol
antifungal agent;
bacterial metabolite;
immunosuppressive agent
1993199331.0low001000
astragalinbeta-D-glucoside;
kaempferol O-glucoside;
monosaccharide derivative;
trihydroxyflavone
plant metabolite;
trypanocidal drug
202020204.0low000010
lafutidineorganic molecular entity2000201716.4low101310
gefarnateorganic molecular entity2005200519.0low000100
ethyl linoleatelong-chain fatty acid ethyl esteranti-inflammatory agent;
plant metabolite
201620168.0low000010
plaunotolditerpenoid;
primary alcohol
anti-ulcer drug;
antibacterial agent;
antineoplastic agent;
apoptosis inducer;
nephroprotective agent;
plant metabolite;
vulnerary
2005200519.0low000100
geranylgeranylacetone1998200720.8low002600
tranilastamidobenzoic acid;
cinnamamides;
dimethoxybenzene;
secondary carboxamide
anti-allergic agent;
anti-asthmatic drug;
antineoplastic agent;
aryl hydrocarbon receptor agonist;
calcium channel blocker;
hepatoprotective agent;
nephroprotective agent
201720186.5low000020
4-acetamido-4'-isothiocyanatostilbene-2,2'-disulfonic acidstilbenoid1992199232.0low001000
8-epi-prostaglandin f2alphaF2-isoprostanebiomarker;
bronchoconstrictor agent;
vasoconstrictor agent
2000201814.2low3027100
glyceryl 2-arachidonate2-acylglycerol 20:4;
endocannabinoid
human metabolite2006202113.0low000311
isotretinoinretinoic acidantineoplastic agent;
keratolytic drug;
teratogenic agent
2013201311.0low000010
misoprostol1992200528.4low006100
ozagrelcinnamic acids1988199532.5low011000
fondaparinuxamino sugar;
oligosaccharide sulfate;
pentasaccharide derivative
anticoagulant2005200519.0low000100
hydrocortisone valeratecortisol ester;
glucocorticoid;
primary alpha-hydroxy ketone;
valerate ester
1992199232.0low001000
13-hydroxy-9,11-octadecadienoic acidoctadecadienoic acid2006201414.0low000110
13-oxo-9,11-octadecadienoic acid13-oxo-9,11-octadecadienoic acid;
oxo fatty acid
metabolite2006200618.0low000100
16,16-dimethylprostaglandin e2cyclopentanones;
monocarboxylic acid;
prostanoid;
secondary allylic alcohol
anti-ulcer drug;
gastrointestinal drug;
radiation protective agent
1989201026.2low014300
leukotriene b5dihydroxy monocarboxylic acid;
hydroxy polyunsaturated fatty acid;
leukotriene;
long-chain fatty acid
anti-inflammatory agent;
human xenobiotic metabolite;
rat metabolite
201820186.0low100010
thromboxane b2thromboxanes Bhuman metabolite;
mouse metabolite
1984202024.3low14211350
20-hydroxy-5,8,11,14-eicosatetraenoic acidHETE;
hydroxy monocarboxylic acid
human metabolite;
mouse metabolite
202220222.0low000001
arachidonic acid 5-hydroperoxideHPETEhuman xenobiotic metabolite1988198836.0low010000
4-hydroxy-2-nonenal4-hydroxynon-2-enal;
4-hydroxynonenal
1997202213.1low102491
n-oleoylethanolamineendocannabinoid;
N-(long-chain-acyl)ethanolamine;
N-acylethanolamine 18:1
EC 3.5.1.23 (ceramidase) inhibitor;
geroprotector;
PPARalpha agonist
201520159.0low000010
menaquinone 62010201014.0low000100
sphingosine 1-phosphatesphingoid 1-phosphatemouse metabolite;
signalling molecule;
sphingosine-1-phosphate receptor agonist;
T-cell proliferation inhibitor;
vasodilator agent
2004201813.7low000420
cholesteryl oleateCE(18:1);
cholesteryl octadec-9-enoate
mouse metabolite1988198836.0low010000
codeinemorphinane alkaloid;
organic heteropentacyclic compound
antitussive;
drug allergen;
environmental contaminant;
opioid analgesic;
opioid receptor agonist;
prodrug;
xenobiotic
1949200149.0low010100
indolidan1993199331.0low001000
methyl linoleatefatty acid methyl esterplant metabolite201520159.0low000010
phenylephrine hydrochloridehydrochloride2000201615.7low101110
rutin sulfate1988199731.5low011000
3-amino-1-methyl-5h-pyrido(4,3-b)indolepyridoindole1980198044.0low010000
diminazene aceturateN-acetylglycinate saltantiparasitic agent;
trypanocidal drug
201920204.5low000020
granisetronaromatic amide;
indazoles
2001201714.7low000210
levetiracetampyrrolidin-2-onesanticonvulsant;
environmental contaminant;
xenobiotic
2009201313.0low000110
naloxonemorphinane alkaloid;
organic heteropentacyclic compound;
tertiary alcohol
antidote to opioid poisoning;
central nervous system depressant;
mu-opioid receptor antagonist
1989202116.5low010621
sirolimusantibiotic antifungal drug;
cyclic acetal;
cyclic ketone;
ether;
macrolide lactam;
organic heterotricyclic compound;
secondary alcohol
antibacterial drug;
anticoronaviral agent;
antineoplastic agent;
bacterial metabolite;
geroprotector;
immunosuppressive agent;
mTOR inhibitor
1992201817.6low002230
4-hydroxystilbenestilben-4-ol1990199034.0low001000
brefeldin amacrolide antibioticPenicillium metabolite1992199431.0low002000
alvocidibdihydroxyflavone;
hydroxypiperidine;
monochlorobenzenes;
tertiary amino compound
antineoplastic agent;
antirheumatic drug;
apoptosis inducer;
EC 2.7.11.22 (cyclin-dependent kinase) inhibitor
2014201410.0low000010
topiroxostat202020204.0low000010
morphinemorphinane alkaloid;
organic heteropentacyclic compound;
tertiary amino compound
anaesthetic;
drug allergen;
environmental contaminant;
geroprotector;
mu-opioid receptor agonist;
opioid analgesic;
plant metabolite;
vasodilator agent;
xenobiotic
1949202018.8low0101050
morphinemorphinane alkaloid;
organic heteropentacyclic compound;
tertiary amino compound
anaesthetic;
drug allergen;
environmental contaminant;
geroprotector;
mu-opioid receptor agonist;
opioid analgesic;
plant metabolite;
vasodilator agent;
xenobiotic
1949202317.7low0121271
4-oxoretinolcyclic ketone;
enone;
primary allylic alcohol;
retinoid
antineoplastic agent2008200816.0low000100
pyoverdin201720177.0low000010
as 605240quinoxaline derivative;
thiazolidinediones
anti-inflammatory agent;
antirheumatic drug;
EC 2.7.1.137 (phosphatidylinositol 3-kinase) inhibitor
2012201212.0low000010
atosibanoligopeptide2001200123.0low000100
bay u9773benzoic acids;
dicarboxylic acid;
organic sulfide;
polyunsaturated fatty acid;
secondary alcohol
leukotriene antagonist2011201113.0low000010
clobetasol11beta-hydroxy steroid;
17alpha-hydroxy steroid;
20-oxo steroid;
3-oxo-Delta(1),Delta(4)-steroid;
chlorinated steroid;
fluorinated steroid;
glucocorticoid;
tertiary alpha-hydroxy ketone
anti-inflammatory drug;
SMO receptor agonist
1995199529.0low001000
deamino arginine vasopressinheterodetic cyclic peptidediagnostic agent;
renal agent;
vasopressin receptor agonist
2009200915.0low000100
dexmedetomidinemedetomidinealpha-adrenergic agonist;
analgesic;
non-narcotic analgesic;
sedative
200920208.8low2001160
fluticasone11beta-hydroxy steroid;
17alpha-hydroxy steroid;
3-oxo-Delta(4) steroid;
corticosteroid;
fluorinated steroid;
thioester
anti-allergic agent;
anti-asthmatic drug
1996201620.8low403110
kallidinpeptide2008200816.0low000100
iloprostcarbobicyclic compound;
monocarboxylic acid;
secondary alcohol
platelet aggregation inhibitor;
vasodilator agent
1987201924.5low026510
15-deoxy-delta(12,14)-prostaglandin j2prostaglandins Jelectrophilic reagent;
insulin-sensitizing drug;
metabolite
2003200719.0low000500
enisoprost1995199529.0low001000
ono-ae1-3292002200222.0low000100
taprostenebenzoic acids1990199034.0low001000
lysophosphatidylcholines1-O-acyl-sn-glycero-3-phosphocholine1985202320.7low011711
magnesium trisilicate201520168.5low000020
mdl 1009072007200717.0low000100
cytochalasin bcytochalasin;
lactam;
lactone;
organic heterotricyclic compound
actin polymerisation inhibitor;
metabolite;
mycotoxin;
platelet aggregation inhibitor
1975202331.7low02021811
neurokinin a1995199529.0low001000
pd 123319imidazopyridineangiotensin receptor antagonist;
endothelin receptor antagonist;
vasoconstrictor agent
2010201412.0low000110
r 7152006200618.0low000100
rioprostilaliphatic alcohol1989198935.0low010000
sq 295481989198935.0low010000
silodosinindolecarboxamide201620168.0low000010
s 145monoterpenoid1996199628.0low001000
1,2-oleoylphosphatidylcholinephosphatidylcholine(1+)2006201811.8low000240
casticindihydroxyflavone;
tetramethoxyflavone
apoptosis inducer;
plant metabolite
201620168.0low000010
biliverdine1989201816.4low010220
cannabigerolphytocannabinoid;
resorcinols
anti-inflammatory agent;
antibacterial agent;
antioxidant;
appetite enhancer;
cannabinoid receptor agonist;
neuroprotective agent;
plant metabolite
2013201311.0low000010
syringinbeta-D-glucoside;
dimethoxybenzene;
monosaccharide derivative;
primary alcohol
hepatoprotective agent;
plant metabolite
201720177.0low000010
ailanthoidol2006200618.0medium000100
andrographolidecarbobicyclic compound;
gamma-lactone;
labdane diterpenoid;
primary alcohol;
secondary alcohol
anti-HIV agent;
anti-inflammatory drug;
antineoplastic agent;
metabolite
201220218.5low100091
isorhapontigeninstilbenoid2014201410.0low000010
juglaninflavonoids;
glycoside
202020204.0low000010
icariinflavonols;
glycosyloxyflavone
antioxidant;
bone density conservation agent;
EC 3.1.4.35 (3',5'-cyclic-GMP phosphodiesterase) inhibitor;
phytoestrogen
2010201014.0low000100
licochalcone achalcones201820186.0low000010
4-methylesculetinhydroxycoumarinanti-inflammatory agent;
antioxidant;
hyaluronan synthesis inhibitor
201220207.3medium000030
methyl linolenatefatty acid methyl esterinsect attractant;
plant metabolite
201620168.0low000010
nerolidolnerolidol201120208.5low000020
nigakinonebeta-carbolines2009200915.0low000100
5,7-dihydroxy-6-methoxy-2-phenylchromen-4-onedihydroxyflavone;
monomethoxyflavone
antineoplastic agent;
EC 1.14.13.39 (nitric oxide synthase) inhibitor
201520159.0low000010
tilirosidecinnamate ester;
glycosyloxyflavone;
monosaccharide derivative;
trihydroxyflavone
plant metabolite2003200321.0low000100
atractylenolide i202320231.0low000001
atractylodinfurans201820186.0low000010
caryophyllene2007202213.2low000301
malealdehydebut-2-enedial2010201412.6low000320
fluvoxamine(trifluoromethyl)benzenes;
5-methoxyvalerophenone O-(2-aminoethyl)oxime
antidepressant;
anxiolytic drug;
serotonin uptake inhibitor
200920208.2low000130
casein kinase ii2014201410.0low000010
ag 5562000200720.5medium001300
ag-490catechols;
enamide;
monocarboxylic acid amide;
nitrile;
secondary carboxamide
anti-inflammatory agent;
antioxidant;
apoptosis inducer;
EC 2.7.10.2 (non-specific protein-tyrosine kinase) inhibitor;
geroprotector;
STAT3 inhibitor
1998201716.0low001110
ag 1272000200720.3low001200
fosbretabulin2000201417.0low001010
ergothioneine1,3-dihydroimidazole-2-thiones;
amino-acid betaine;
L-histidine derivative;
sulfur-containing amino acid
antioxidant;
chelator;
fungal metabolite;
plant metabolite;
xenobiotic metabolite
1962201641.4low030110
leadcarbon group element atom;
elemental lead;
metal atom
neurotoxin1979202311.0low11019495
12-hydroxy-5,8,10,14-eicosatetraenoic acid1989199532.0low011000
13-hydroperoxy-9,11-octadecadienoic acidhydroperoxy polyunsaturated fatty acid;
octadecadienoic acid
2006201413.0low000120
15-hydroxy-5,8,11,13-eicosatetraenoic acid1993199331.0low001000
5-oxo-6,8,11,14-eicosatetraenoic acid2008200816.0low000100
bay 11-7082nitrile;
sulfone
apoptosis inducer;
EC 2.7.11.10 (IkappaB kinase) inhibitor;
EC 3.1.3.48 (protein-tyrosine-phosphatase) inhibitor;
non-steroidal anti-inflammatory drug;
platelet aggregation inhibitor
2013201311.0low000010
bay 11-7085benzenes;
nitrile;
sulfone
anti-inflammatory agent;
antibacterial agent;
antineoplastic agent;
apoptosis inducer;
autophagy inducer;
EC 2.7.11.10 (IkappaB kinase) inhibitor;
ferroptosis inducer;
NF-kappaB inhibitor
2003200321.0low000200
8-hydroxy-11,12-epoxyeicosa-5,9,14-trienoic acid2014201410.0low000010
15-hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic acid1989200328.2low012100
antimonymetalloid atom;
pnictogen
201420236.0low000031
cesiumalkali metal atom2005201613.5low000110
bariumalkaline earth metal atom;
elemental barium
201020218.5low000101
8-oxo-7,8-dihydrodeoxyguanine1995199529.0low001000
muconic acidmuconic acidbiomarker;
human xenobiotic metabolite
2004200519.5low000200
aluminumboron group element atom;
elemental aluminium;
metal atom
2000202111.9low00112152
ethylmorphinemorphinane alkaloid1993199331.0low001000
strontiumalkaline earth metal atom202220222.0low000001
bismuthmetal atom;
pnictogen
201220236.4low000061
thalliumboron group element atom202020204.0low000010
arsenicmetalloid atom;
pnictogen
micronutrient1949202212.3low0106173
naltrexonecyclopropanes;
morphinane-like compound;
organic heteropentacyclic compound
antidote to opioid poisoning;
central nervous system depressant;
environmental contaminant;
mu-opioid receptor antagonist;
xenobiotic
2001201216.5low000220
galliumboron group element atom201520207.3low000030
butorphanolmorphinane alkaloidantitussive;
kappa-opioid receptor agonist;
mu-opioid receptor agonist;
opioid analgesic
2014201410.0low000010
cefodizime1,3-thiazoles;
cephalosporin;
oxime O-ether
antibacterial drug;
EC 1.14.18.1 (tyrosinase) inhibitor
1986198638.0low010000
lisinoprildipeptideEC 3.4.15.1 (peptidyl-dipeptidase A) inhibitor1994201319.5low201610
ramiprilazabicycloalkane;
cyclopentapyrrole;
dicarboxylic acid monoester;
dipeptide;
ethyl ester
bradykinin receptor B2 agonist;
cardioprotective agent;
EC 3.4.15.1 (peptidyl-dipeptidase A) inhibitor;
matrix metalloproteinase inhibitor;
prodrug
1992200626.7low002100
ridogrel(trifluoromethyl)benzenes1999199925.0low001000
batimastathydroxamic acid;
L-phenylalanine derivative;
organic sulfide;
secondary carboxamide;
thiophenes;
triamide
angiogenesis inhibitor;
antineoplastic agent;
matrix metalloproteinase inhibitor
2001200920.6low000500
sulfurchalcogen;
nonmetal atom
macronutrient1945202215.5low0208113
geldanamycin2007200717.0low000100
zimeldinestyrenes1995199529.0low002000
muskmacrolide2010201014.0low000100
costunolide200920208.3low000120
plastoquinoneplastoquinone201320169.5low000020
jaceosidindimethoxyflavone;
trihydroxyflavone
anti-allergic agent;
anti-inflammatory agent;
antineoplastic agent;
apoptosis inducer;
metabolite
201920195.0low000010
puerarinC-glycosyl compound;
isoflavonoid
201520188.0low000030
eleostearic acidoctadecatrienoic acid201920195.0low000010
enalaprildicarboxylic acid monoester;
dipeptide
antihypertensive agent;
EC 3.4.15.1 (peptidyl-dipeptidase A) inhibitor;
geroprotector;
prodrug
2006201413.0low100120
nitrofurazone1951195173.0low010000
catharanthinealkaloid ester;
bridged compound;
methyl ester;
monoterpenoid indole alkaloid;
organic heteropentacyclic compound;
tertiary amino compound
2012201212.0low000010
cytochalasin acytochalasin2006200618.0low000100
sinomeninemorphinane alkaloid2007200717.0low000100
deoxyribosedeoxypentosehuman metabolite;
mouse metabolite;
Saccharomyces cerevisiae metabolite
1982200831.7low020100
fumaratesbutenedioate;
C4-dicarboxylate
human metabolite;
metabolite;
Saccharomyces cerevisiae metabolite
1963201539.0low031020
seleninic acidselenium oxoacid202020204.0low000010
tyrosinealpha-amino-acid radical2002201318.8medium000410
cysteinecysteiniumfundamental metabolite1964202314.6low1913274022
thyroninesthyronine1958198949.5low040000
siliconcarbon group element atom;
metalloid atom;
nonmetal atom
2003202210.0low0006142
phosphorusmonoatomic phosphorus;
nonmetal atom;
pnictogen
macronutrient1946202223.6low0725162
boronboron group element atom;
metalloid atom;
nonmetal atom
micronutrient200920238.3low000253
heroinmorphinane alkaloidmu-opioid receptor agonist;
opioid analgesic;
prodrug
2014201410.0low000010
enalaprilat anhydrousdicarboxylic acid;
dipeptide
antihypertensive agent;
EC 3.4.15.1 (peptidyl-dipeptidase A) inhibitor
1994200723.5low001100
quinaldine bluecyanine dye;
organic iodide salt
fluorochrome2008200816.0low000100
2,2'-azino-di-(3-ethylbenzothiazoline)-6-sulfonic acid1984202314.4low01813244
ramiprilatazabicycloalkane;
cyclopentapyrrole;
dicarboxylic acid;
dipeptide
bradykinin receptor B2 agonist;
cardioprotective agent;
drug metabolite;
EC 3.4.15.1 (peptidyl-dipeptidase A) inhibitor;
matrix metalloproteinase inhibitor
1992199431.0low002000
nitecaponehydroxycinnamic acid1999199925.0low102000
bakuchiol1996199628.0low001000
zerumbonecyclic ketone;
sesquiterpenoid
anti-inflammatory agent;
glioma-associated oncogene inhibitor;
plant metabolite
201720196.0low000020
artepillin c202020204.0low000010
paepalantine2003200321.0medium000100
cefepimecephalosporin;
oxime O-ether
antibacterial drug202320231.0low100001
norbinaltorphimineisoquinolines2012201212.0low000010
monodehydroascorbateorganic radicalmouse metabolite1996199628.0low001000
ici 118551aromatic ether;
indanes;
secondary alcohol;
secondary amino compound
beta-adrenergic antagonist2014201410.0low000010
enkephalin, ala(2)-mephe(4)-gly(5)-2003202112.0low000101
3,3'-dipropyl-2,2'-thiadicarbocyanine1981198143.0low010000
methoxysuccinyl-alanyl-alanyl-prolyl-valine chloromethyl ketonealpha-chloroketone;
methyl ester;
tripeptide
EC 3.4.21.37 (leukocyte elastase) inhibitor1990199034.0low001000
troxerutin1988202119.5low010001
pregabalingamma-amino acidanticonvulsant;
calcium channel blocker
2002201116.0low000120
tiotropium bromide2007200717.0low100200
n-nitratopivaloyl-s-(n'-acetylalanyl)-cysteine ethyl ester1993199530.3medium003000
3,8-dihydroxy-6h-dibenzo(b,d)pyran-6-onecoumarinsgeroprotector201620168.0low000010
uroguanylin2013201311.0low000010
antiarrhythmic peptide2007200717.0low000100
aliskirenmonocarboxylic acid amide;
monomethoxybenzene
antihypertensive agent2014201410.0low000010
n-acetylsphingosineN-acylsphingosine2003200321.0low000100
trioleintriglycerideCaenorhabditis elegans metabolite;
plant metabolite
2000200422.0low001100
geduninlimonoid202220222.0low000001
epicinchoninecinchona alkaloid1990199034.0low001000
resiniferatoxincarboxylic ester;
diterpenoid;
enone;
monomethoxybenzene;
organic heteropentacyclic compound;
ortho ester;
phenols;
tertiary alpha-hydroxy ketone
analgesic;
neurotoxin;
plant metabolite;
TRPV1 agonist
2004201513.8low000220
abscisic acid2-trans-abscisic acid1985202311.6low0128255
carbocyaninescyanine dye;
organic iodide salt
fluorochrome1981202016.0low010130
salubrinalaminal;
organochlorine compound;
quinolines;
secondary carboxamide;
thioureas
2014201410.0low000010
cefotaxime1,3-thiazoles;
cephalosporin;
oxime O-ether
antibacterial drug;
drug allergen
1986198638.0low010000
semapimod1998201219.0low001010
cinidon-ethylethyl ester;
isoindoles;
monochlorobenzenes
herbicide200520208.8low000140
zearalenol2000202213.0low101001
flumethrin202120213.0low000001
indicaxanthinnon-proteinogenic alpha-amino acid2005200519.0low000100
ammonium sulfateammonium salt;
inorganic sulfate salt
fertilizer1951202220.9low033731
bisabolol2011201113.0low000010
kresoxim-methylaromatic ether;
methoxyiminoacetate strobilurin antifungal agent;
methyl ester;
oxime O-ether
antifungal agrochemical;
environmental contaminant;
mitochondrial cytochrome-bc1 complex inhibitor;
xenobiotic
201320188.5low000020
4,4'-diisothiocyanostilbene-2,2'-disulfonic acid1992200923.5low001100
12-o-retinoylphorbol-13-acetate1994199430.0low001000
ma-1carboxamidine;
organochlorine compound;
pyrimidone;
pyrrolidines
antineoplastic agent;
EC 2.4.2.4 (thymidine phosphorylase) inhibitor
202320231.0low100001
monordencyclic ketone;
enone;
epoxide;
macrolide antibiotic;
monochlorobenzenes;
phenols
antifungal agent;
metabolite;
tyrosine kinase inhibitor
2007200717.0low000100
coomassie brilliant blue1984201519.7low010020
rifamycin svacetate ester;
cyclic ketal;
lactam;
macrocycle;
organic heterotetracyclic compound;
polyphenol;
rifamycins
antimicrobial agent;
antitubercular agent;
bacterial metabolite
1989198935.0low010000
mastoparanmastoparans;
peptidyl amide
antimicrobial agent2011201113.0low000010
tetrodotoxinazatetracycloalkane;
oxatetracycloalkane;
quinazoline alkaloid
animal metabolite;
bacterial metabolite;
marine metabolite;
neurotoxin;
voltage-gated sodium channel blocker
2001201617.5low000310
germaniumcarbon group element atom;
metalloid atom;
nonmetal atom
201620177.5low000020
seleniumchalcogen;
nonmetal atom
micronutrient1981202314.5low23515283
selenocysteine1998201317.5low001120
telluriumchalcogen;
metalloid atom
201120199.4low000050
selenourea2011201113.0low000010
fosetyl-al1995199529.0low001000
oxalates2003200321.0low000100
1,1-diethyl-2-hydroxy-2-nitrosohydrazineorganic anion2002200222.0low000100
(3S,5S,6E)-7-[3-(4-fluorophenyl)-1-(propan-2-yl)-1H-indol-2-yl]-3,5-dihydroxyhept-6-enoic acid(6E)-7-[3-(4-fluorophenyl)-1-(propan-2-yl)-1H-indol-2-yl]-3,5-dihydroxyhept-6-enoic acid2003201117.2low000310
fk 4092007200916.0low000200
dizocilpine maleatemaleate salt;
tetracyclic antidepressant
anaesthetic;
anticonvulsant;
neuroprotective agent;
nicotinic antagonist;
NMDA receptor antagonist
2005200519.0low000100
antimycin aamidobenzoic acid2000200620.3low001200
pyrachlostrobinaromatic ether;
carbamate ester;
carbanilate fungicide;
methoxycarbanilate strobilurin antifungal agent;
monochlorobenzenes;
pyrazoles
antifungal agrochemical;
environmental contaminant;
mitochondrial cytochrome-bc1 complex inhibitor;
xenobiotic
201520187.5low000020
guaiacylglycerol-beta-guaiacyl etherglycerol ether201920195.0low000010
cobalt oxide202120222.5low000004
cholestanolcholestanoid2011201113.0low000010
cilastatincarboxamide;
L-cysteine derivative;
non-proteinogenic L-alpha-amino acid;
organic sulfide
EC 3.4.13.19 (membrane dipeptidase) inhibitor;
environmental contaminant;
protease inhibitor;
xenobiotic
1995199529.0low001000
1-palmitoyl-2-oleoylphosphatidylcholine1994200621.6low001400
dithiadenedithiadene1999200621.5medium001100
bafilomycin a1cyclic hemiketal;
macrolide antibiotic;
oxanes
apoptosis inducer;
autophagy inhibitor;
bacterial metabolite;
EC 3.6.3.10 (H(+)/K(+)-exchanging ATPase) inhibitor;
EC 3.6.3.14 (H(+)-transporting two-sector ATPase) inhibitor;
ferroptosis inhibitor;
fungicide;
potassium ionophore;
toxin
201520159.0low000010
1-oleoyl-2-acetylglycerol1,2-diglyceride2000200024.0low001000
involucrin201620168.0low000010
15-hydroperoxy-5,8,11,13-eicosatetraenoic acidHPETEhuman xenobiotic metabolite1993201422.4low003110
myxothiazol2005200519.0low000100
piriprost1986198638.0low010000
ly 538571991199133.0low001000
lumefantrinefluorenes;
monochlorobenzenes;
secondary alcohol;
tertiary amine
antimalarial202120213.0low000001
sphingosine phosphorylcholine2007200816.5low000200
microcystin rrmicrocystin;
organic molecular entity
bacterial metabolite;
environmental contaminant;
xenobiotic
2006200618.0low000100
ono 40571991200926.0low003100
1-palmitoyl-2-linoleoylphosphatidylcholine1994200126.5low001100
limaprostlong-chain fatty acid1999199925.0low001000
n-acetyl-s-farnesylcysteinesesquiterpenoid2008200816.0low000100
5-phenylpent-4-enyl-1-hydroperoxide1992199232.0low001000
1,2-dioleoylphosphatidylserinephosphatidylserine(18:1/18:1)mouse metabolite2007200717.0low000100
ditaurobilirubin1992199232.0low001000
tussilagone201820186.0low000010
rooperol1993199331.0low001000
tmk 6882010201014.0low000100
n,n,n-trimethylsphingosine1996199827.0medium002000
wild 201993199331.0medium001000
microcystin ly2012201212.0medium000010
goniothalamin201620168.0low000010
microcystin ll2001200123.0medium000100
curdionegermacrane sesquiterpenoid202320231.0low000001
1-stearoyl-2-arachidonylphosphatidylcholine1994200225.0medium001200
diacetylcurcumin201520159.0low000020
bilirubin ditaurine1989198935.0low010000
everolimuscyclic acetal;
cyclic ketone;
ether;
macrolide lactam;
primary alcohol;
secondary alcohol
anticoronaviral agent;
antineoplastic agent;
geroprotector;
immunosuppressive agent;
mTOR inhibitor
201620168.0low000010
jl 13 compound1997199727.0medium001000
hydroxysafflor yellow a2010201213.0low000110
laq8242008200816.0low000100
chlorophyll201620205.7low000030
b 1287organic sodium salt2014201410.0low000010
beta-apo-10'-carotenalapo carotenoid;
enal
2003200321.0low000100
salvianolic acid B1-benzofurans;
catechols;
dicarboxylic acid;
enoate ester;
polyphenol
anti-inflammatory agent;
antidepressant;
antineoplastic agent;
antioxidant;
apoptosis inducer;
autophagy inhibitor;
cardioprotective agent;
hepatoprotective agent;
hypoglycemic agent;
neuroprotective agent;
osteogenesis regulator;
plant metabolite
201320179.0low000020
i(3)so3-galactosylceramidegalactosylceramide sulfate;
N-acyl-beta-D-galactosylsphingosine
1998200025.0low002000
netupitantaminopyridine;
monocarboxylic acid amide;
N-alkylpiperazine;
N-arylpiperazine;
organofluorine compound;
toluenes
antiemetic;
neurokinin-1 receptor antagonist
2014201410.0low000010
engeletin201820186.0low000010
(melle-4)cyclosporin2008200816.0low000100
beta-escintriterpenoid saponin2003201118.0low000210
cholesteryl arachidonatecholesteryl icosatetraenoateantibacterial agent;
mouse metabolite
2004200420.0low000100
tanespimycin1,4-benzoquinones;
ansamycin;
carbamate ester;
organic heterobicyclic compound;
secondary amino compound
antineoplastic agent;
apoptosis inducer;
Hsp90 inhibitor
2007200717.0low000100
fm1 43organic bromide salt;
pyridinium salt;
quaternary ammonium salt;
tertiary amine
fluorochrome2007200717.0low000100
verlukast1996199628.0low001000
beta-escin1985202213.3low0124111
l-165041aromatic ketone2005200519.0low000100
s-nitroso-n-acetylpenicillaminenitroso compound;
nitrosothio compound
nitric oxide donor;
vasodilator agent
1992200823.7low004300
lactacystinlactam;
S-substituted L-cysteine
2000200720.5low001100
4-methyl-5-amino-1-formylisoquinoline thiosemicarbazone1984198440.0low010000
gadolinium dtpagadolinium coordination entityMRI contrast agent2006202210.5low000562
morphinansisoquinoline alkaloid fundamental parent;
morphinane alkaloid
2007200816.5low000200
ergolinediamine;
ergoline alkaloid;
indole alkaloid fundamental parent;
indole alkaloid;
organic heterotetracyclic compound
1991199133.0low001000
corrole2001200123.0low000100
adenosine-3',5'-cyclic phosphorothioatenucleoside 3',5'-cyclic phosphorothioate1993199331.0low001000
sq-23377cyclic ether;
enol;
polyunsaturated fatty acid;
very long-chain fatty acid
calcium ionophore;
metabolite
1989201224.2low023130
eritoranlipid As2011201113.0low000010
fk 866benzamides;
N-acylpiperidine
2012201212.0low000010
ici 2008801997199727.0medium001000
biib 5132000200024.0low001000
bn 809332003200321.0medium000100
neomangiferin201620168.0low000010
ucb 35625202020204.0low000010
jwh-133benzochromene;
dibenzopyran;
organic heterotricyclic compound
analgesic;
anti-inflammatory agent;
antineoplastic agent;
apoptosis inhibitor;
CB2 receptor agonist;
opioid analgesic;
vasodilator agent
201320169.7low000030
vildagliptinamino acid amide201720186.5low100020
dalcetrapibanilide2013201311.0low100010
belinostathydroxamic acid;
olefinic compound;
sulfonamide
antineoplastic agent;
EC 3.5.1.98 (histone deacetylase) inhibitor
2008200915.5low000200
panobinostatcinnamamides;
hydroxamic acid;
methylindole;
secondary amino compound
angiogenesis modulating agent;
antineoplastic agent;
EC 3.5.1.98 (histone deacetylase) inhibitor
2008201114.6low000410
rebaudioside abeta-D-glucoside;
rebaudioside;
tetracyclic diterpenoid
sweetening agent2014201410.0low000010
bornyl acetateacetate ester;
monoterpenoid
2000201417.0low001010
isoborneolborneol201320179.0low000020
staurosporineammonium ion derivative1992200724.2low002200
chloralose2006200618.0low000100
dioleoylphosphatidic acid1,2-bis(octadec-9-enoyl)phosphatidic acid2007200717.0low000100
hypericumpenicillanic acids2003201515.7low000420
phosphocreatinephosphagen;
phosphoamino acid
human metabolite;
mouse metabolite
2000200024.0low002000
chlorhexidinebiguanides;
monochlorobenzenes
antibacterial agent;
antiinfective agent
2002201713.6low100320
formazans1992200424.8low002200
s 1743magnesium saltanti-ulcer drug;
EC 3.6.3.10 (H(+)/K(+)-exchanging ATPase) inhibitor
2005201116.0low000110
ferrihydrite201920224.0low000031
s-allylcysteineL-alpha-amino acid zwitterion;
S-hydrocarbyl-L-cysteine
antineoplastic agent;
metabolite
201520159.0low000010
win 517082009200915.0low000100
lexipafant2001200521.5low000400
atl 146e2001200620.0medium000600
bay 58-2667aromatic ether;
benzoic acids;
dicarboxylic acid;
tertiary amino compound
antihypertensive agent;
soluble guanylate cyclase activator;
vasodilator agent
201620168.0low000010
amoxicillin-potassium clavulanate combination2008201015.0low000200
sr 1428012001200123.0low000100
jbp 4852011201312.0low000020
acanthoic acid2010201511.5low000110
bicyclol2011201113.0low000010
bms 1910952005200519.0low000100
ro 32-35552014201410.0low000010
a-3174912009200915.0low000100
abt 2991996199628.0medium001000
seryl-leucyl-isoleucyl-glycyl--arginyl-leucinamide2014201410.0low000010
ezetimibe, simvastatin drug combination2010201014.0low000100
sincalideoligopeptide2003201516.9low000610
3,5-dimethyl-2-(3-pyridyl)thiazolidin-4-one2001200123.0low000100
reparixinmonoterpenoid2004201315.7low000210
n(6)-cyclohexyladenosine2006200618.0low000100
brl 37344monocarboxylic acid1992200227.0low001100
ursodoxicoltaurinebile acid taurine conjugateanti-inflammatory agent;
apoptosis inhibitor;
bone density conservation agent;
cardioprotective agent;
human metabolite;
neuroprotective agent
1998201617.0low001010
(S)-nadifloxacinnadifloxacin202020204.0low000010
valencenecarbobicyclic compound;
polycyclic olefin;
sesquiterpene
201820186.0low000010
ferrous phosphate201820186.0low000010
ibuprofen arginine2009200915.0low000100
sc 2362000200024.0low001000
alloindiastereoisomeric mixtureEC 1.14.18.1 (tyrosinase) inhibitor;
laxative
201120199.0low000020
cp 1056962000200024.0low001000
sabiporide2013201311.0low000010
ticagreloraryl sulfide;
hydroxyether;
organofluorine compound;
secondary amino compound;
triazolopyrimidines
P2Y12 receptor antagonist;
platelet aggregation inhibitor
201020208.0low100120
rivaroxabanaromatic amide;
lactam;
monocarboxylic acid amide;
morpholines;
organochlorine compound;
oxazolidinone;
thiophenes
anticoagulant;
EC 3.4.21.6 (coagulation factor Xa) inhibitor
202020204.0low000010
men 114202000200024.0low001000
antileukinate2007200717.0low000100
lipid adodecanoate ester;
lipid A;
tetradecanoate ester
Escherichia coli metabolite1993201521.7low007240
gpi 61502002200222.0medium000200
dehydroxymethylepoxyquinomicin2014201410.0low000010
n-acetylcysteine lysinate2005200718.0low000200
naproxen-n-butyl nitratecarboxylic ester;
methoxynaphthalene;
nitrate ester
EC 1.14.99.1 (prostaglandin-endoperoxide synthase) inhibitor;
nitric oxide donor;
non-narcotic analgesic;
non-steroidal anti-inflammatory drug;
prodrug
1999200621.5low001100
3,5-bis(2-fluorobenzylidene)piperidin-4-one2014201410.0low000010
dapagliflozinaromatic ether;
C-glycosyl compound;
monochlorobenzenes
hypoglycemic agent;
sodium-glucose transport protein subtype 2 inhibitor
202220222.0low000001
sm 197122009200915.0medium000100
am 362006200618.0low000100
er 341221998199826.0medium001000
n-formylmethionyl-leucyl-phenylalanyl-lysine1999200124.0low001100
pd 1562522000200024.0medium001000
shu 91192004200420.0low000100
ginsenoside rb1ginsenoside;
glycoside;
tetracyclic triterpenoid
anti-inflammatory drug;
anti-obesity agent;
apoptosis inhibitor;
neuroprotective agent;
plant metabolite;
radical scavenger
2008201413.0low000220
psd 5022003200321.0low000100
secoisolariciresinol diglucoside201320216.7low000021
antiflammin p21995199529.0low001000
sorbitan monooleatefatty acid ester1997199727.0low001000
ammonium trichloro(dioxoethylene-o,o'-)tellurate2002200222.0low000100
tofacitinibN-acylpiperidine;
nitrile;
pyrrolopyrimidine;
tertiary amino compound
antirheumatic drug;
EC 2.7.10.2 (non-specific protein-tyrosine kinase) inhibitor
201920223.5low000011
gw0742monocarboxylic acid2006201214.8low000320
jte 607hydrochlorideanti-inflammatory agent;
antineoplastic agent;
apoptosis inducer;
cardioprotective agent;
CPSF3 inhibitor;
prodrug
2003200420.5medium000200
darapladib2012201212.0low100010
s 56821993199331.0low001000
bpc 1571995200822.5low001100
zeolites201820232.8low100013
3,4-dihydro-5-(4-(1-piperidinyl)butoxy)-1(2h)-isoquinolinone2013201311.0low000010
ubiquinolpolyprenylhydroquinone;
ubiquinol
biomarker;
metabolite
1997199727.0low001000
g(m1) gangliosidealpha-N-acetylneuraminosyl-(2->3)-[beta-D-galactosyl-(1->3)-N-acetyl-beta-D-galactosaminyl-(1->4)]-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-N-acylsphingosine;
sialotetraosylceramide
2003200321.0low000100
medigoxin201520159.0low000010
diaminorhodamine-4m2012201212.0low000010
aluminum oxide2003201913.0low000110
arachidonoylserotoninN-acylserotonin;
phenols
anti-inflammatory agent;
anticonvulsant;
antioxidant;
capsaicin receptor antagonist;
EC 3.5.1.99 (fatty acid amide hydrolase) inhibitor;
human metabolite;
signalling molecule
2006200618.0low000100
methionine sulfoxideamino acid zwitterion;
L-methionine S-oxide
Escherichia coli metabolite1981201823.6low031320
phosphoramidite2008200816.0low000100
ly-2157299aromatic amide;
methylpyridines;
monocarboxylic acid amide;
pyrrolopyrazole;
quinolines
antineoplastic agent;
TGFbeta receptor antagonist
201620168.0low000010
delta-viniferin1-benzofurans;
polyphenol;
stilbenoid
202220222.0low000001
sepantroniumorganic cation202120213.0low000001
prasugrel hydrochloride2013201311.0low000010
heptakis(2,6-o-dimethyl)beta-cyclodextrin2006200618.0low000100
n-acetylcysteinamide2009200915.0low000100
m 404032001200521.6low000500
vitamin umethyl-L-methionine;
sulfonium betaine
202220222.0low000002
artenimol201520159.0low000010
homocarnosinedipeptide zwitterion;
dipeptide;
homocarnosine;
L-histidine derivative;
N-acyl-L-alpha-amino acid anion;
N-acyl-L-alpha-amino acid
human metabolite1995199529.0low001000
trans-sodium crocetinate1995202015.0low001020
sotrastaurinindoles;
maleimides;
N-alkylpiperazine;
N-arylpiperazine;
quinazolines
anticoronaviral agent;
EC 2.7.11.13 (protein kinase C) inhibitor;
immunosuppressive agent
201620168.0low000010
alpha-synuclein2004202010.0low000140
8-nitroxanthine2003200321.0medium000100
strictosamidebeta-carbolines202120213.0low000001
kukoamine bamine2014201410.0low000010
myrsinoic acid b1-benzofurans;
monocarboxylic acid
anti-inflammatory agent;
EC 4.4.1.11 (methionine gamma-lyase) inhibitor;
metabolite
2012201212.0medium000010
le 135dibenzodiazepine2010201014.0low000100
jnj 10191584benzimidazoles2005200519.0low000100
5s,12r,18r-trihydroxy-6z,8e,10e,14z,16e-eicosapentaenoic acidhydroxy polyunsaturated fatty acid;
long-chain fatty acid;
nonclassic icosanoid;
resolvin;
triol
anti-inflammatory agent;
human xenobiotic metabolite
2005200917.0low000200
sb 6569332011201113.0medium100010
oxadiazoles1995202015.1low001550
4,5-diaminofluorescein2006201215.0low000110
ucn 1028 c2005200519.0low000100
riboseD-ribose;
ribopyranose
2009201014.7low000300
urb602202020204.0low000010
5-formylcytosineaminopyrimidine;
heteroarenecarbaldehyde;
nucleobase analogue;
pyrimidone
metabolite202120213.0low000001
acebutololalpha-D-glucosyl-(1->4)-D-mannopyranose2002202311.5low100101
lactulose2003202212.5low000321
2-chlorohexadecanoic acid2010201810.0high000110
regorafenib(trifluoromethyl)benzenes;
aromatic ether;
monochlorobenzenes;
monofluorobenzenes;
phenylureas;
pyridinecarboxamide
antineoplastic agent;
hepatotoxic agent;
tyrosine kinase inhibitor
202320231.0low100001
acetyl-11-ketoboswellic acidtriterpenoid2007200717.0low000100
lodoxamide tromethamine1988198836.0low010000
calpain inhibitor iii201720177.0low000010
2-amino-4-(3,4-(methylenedioxy)benzylamino)-6-(3-methoxyphenyl)pyrimidinepyrimidines201520159.0low000010
brimonidine tartrate1996200224.3low001200
pnu-2829872011201113.0low000010
cardanolphenols2003200321.0low000100
cvt-6883201920195.0low000010
picoxystrobinaromatic ether;
enoate ester;
enol ether;
methoxyacrylate strobilurin antifungal agent;
organofluorine compound;
pyridines
antifungal agrochemical;
mitochondrial cytochrome-bc1 complex inhibitor
201820186.0low000010
nystatin a1nystatins1998200423.0low101100
linoleic acid hydroperoxide1999200024.5low002000
resolvin d2hydroxy polyunsaturated fatty acid;
resolvin;
secondary allylic alcohol;
triol
anti-inflammatory agent;
anti-obesity agent;
estrogen receptor agonist;
human xenobiotic metabolite;
rat metabolite
201520159.0low000010
inno-406biaryl2013201311.0low000010
bimosiamose disodium1997200823.0medium003200
dorsomorphinaromatic ether;
piperidines;
pyrazolopyrimidine;
pyridines
bone morphogenetic protein receptor antagonist;
EC 2.7.11.31 {[hydroxymethylglutaryl-CoA reductase (NADPH)] kinase} inhibitor
2011201113.0low000010
azd3241201520188.0high000030
quisinostatindoles2009200915.0low000100
hu 308aromatic ether;
bridged compound;
carbobicyclic compound;
primary allylic alcohol;
synthetic cannabinoid
anti-inflammatory agent;
antihypertensive agent;
apoptosis inhibitor;
bone density conservation agent;
CB2 receptor agonist
2006201016.3low000300
carfilzomibepoxide;
morpholines;
tetrapeptide
antineoplastic agent;
proteasome inhibitor
201920195.0low000010
apremilastaromatic ether;
N-acetylarylamine;
phthalimides;
sulfone
non-steroidal anti-inflammatory drug;
phosphodiesterase IV inhibitor
201920195.0low000010
niranthin2006200618.0medium000100
sitagliptin phosphate2011201113.0low000010
chlorophyll bchlorophyllcofactor200620209.8low0001120
veratridine2007200717.0low000100
atl 3132008201015.0medium000400
2',4',6'-tris(methoxymethoxy) chalcone2011201113.0medium000010
2,4,3',5'-tetrahydroxystilbene202420240.0low000001
cefdinir1994199430.0low001000
ginsenoside rdbeta-D-glucoside;
ginsenoside;
tetracyclic triterpenoid
anti-inflammatory drug;
apoptosis inducer;
immunosuppressive agent;
neuroprotective agent;
plant metabolite;
vulnerary
2012201212.0low000020
n,n'-dibenzhydrylethane-1,2-diamine dihydrochloridehydrochloridegeroprotector;
metabotropic glutamate receptor agonist;
neuroprotective agent
201920195.0low000010
bay 60-6583aminopyridine;
aromatic ether;
aryl sulfide;
cyanopyridine;
cyclopropanes;
monocarboxylic acid amide
adenosine A2B receptor agonist;
anti-inflammatory agent;
cardioprotective agent
201220208.0low000020
physalin benone;
lactone;
organic heteroheptacyclic compound;
physalin
antimalarial;
antimicrobial agent;
antineoplastic agent
2005200519.0low000100
losartan potassium1998201915.7low1011570
3',4'-anhydrovinblastine2003200321.0medium000100
alpha-Neup5Ac-(2->3)-beta-D-Galp-(1->4)-[alpha-L-Fucp-(1->3)]-D-GlcpNAcamino tetrasaccharide;
glucosamine oligosaccharide
epitope1994200426.7low009200
2-((2,6-dichlorophenyl)amino)benzeneacetic acid 4-(3h-1,2-dithiol-3-thione-5-yl)phenyl ester2007200717.0medium000100
technetium tc 99m exametazime2001200521.0low000200
calcimycinbenzoxazole1977202228.3low11034641
dextrothyroxine199620238.2low001003
veliparibbenzimidazolesEC 2.4.2.30 (NAD(+) ADP-ribosyltransferase) inhibitor202020204.0low000010
sepharose1983202320.5low016341
indocyanine green1,1-diunsubstituted alkanesulfonate;
benzoindole;
cyanine dye
2003200321.0low000100
vindoline2012201212.0low000010
pituitrin2007200717.0low000100
pyrostatin a1,4,5,6-tetrahydropyrimidines;
carboxamidine;
iminium betaine;
monocarboxylic acid;
secondary alcohol
201520159.0low000010
n-monoacetylcystine1988198836.0low010000
phytosterols1999201616.8low101120
oleanonic acid2001200123.0low000100
rifamycins1989201619.0low010120
tenuigenin12alpha-hydroxy steroid201620168.0low000010
clove202020242.0low000011
acid phosphatase1959202332.6low3894218173
mefloquine2008200816.0low000100
homobrassinolide2008201413.0low000120
ants2009201910.0low000110
bleomycetin201520159.0low000010
cosmomycin d202220222.0medium000001
hypoxoside2009201014.5medium000200
maltoheptaosemaltoheptaose heptasaccharide201520159.0low000010
ci 9591990199034.0low001000
2',7'-dichlorodihydrofluorescein2003200619.2low000400
oroxylin a-7-o-glucuronidebeta-D-glucosiduronic acid;
glycosyloxyflavone;
monohydroxyflavone;
monomethoxyflavone;
monosaccharide derivative
plant metabolite201620168.0low000010
physalaemin1987198737.0low010000
icatibant2001201613.2low000240
hmr 10982005200519.0low000100
jujubogenin2009200915.0low000100
oxaziclomefonealkylbenzene2005200519.0medium000100
cyanidin-3-o-beta-glucopyranoside2002201417.7low000210
nadorganophosphate oxoanioncofactor;
human metabolite;
hydrogen acceptor;
Saccharomyces cerevisiae metabolite
1949202329.2low021131776
tin mesoporphyrin2001200123.0low000100
protectin d1dihydroxydocosahexaenoic acid;
protectin;
secondary allylic alcohol
anti-inflammatory agent;
apoptosis inhibitor;
hepatoprotective agent;
human xenobiotic metabolite;
neuroprotective agent;
PPARgamma agonist;
specialised pro-resolving mediator
2014201410.0low000020
cytochrome c-t1947202214.3low05029544
myxolxanthophyll202120213.0low000001
3,6-anhydrogalactosealdehyde;
anhydrohexose
2014201410.0low000010
cosyntropin2008200816.0low000100
melitten2011201113.0low000010
cholecystokinin2002201717.3low000610
ceruletideoligopeptidediagnostic agent;
gastrointestinal drug
1995202015.8low001162420
motilin2010201014.0low000100
dynorphins2014201410.0low000010
bivalirudinpolypeptideanticoagulant;
EC 3.4.21.5 (thrombin) inhibitor
2007200816.5low200200
atrial natriuretic factorpolypeptide2001201914.0low000520
tanninstannin202320231.0low000001
dermaseptin s1998199826.0low001000
adrenocorticotropin zinc2008200816.0low000100
thrombin receptor peptide (42-55)2004200718.5low000200
m 352010201014.0low000100
nociceptinorganic molecular entity;
polypeptide
human metabolite;
rat metabolite
2009200915.0low000100
galantide2010201014.0low000200
fibrinopeptide b2000200024.0low001000
gastrins1996202216.8low001401
glucagonpeptide hormone1989199332.7low012000
beta-endorphin2001201417.0low000320
thymosin beta(4)201320179.0low000020
neuropeptide y2008201114.3low000210
angiotensinogen2008200816.0low000100
astressinhomodetic cyclic peptide;
polypeptide
corticotropin-releasing factor receptor antagonist;
neuroprotective agent
1999201019.5low001100
m402010201014.0low000100
tannins1958202216.5low010361
oligonucleotides1989202215.2low012791
liraglutidelipopeptide;
polypeptide
glucagon-like peptide-1 receptor agonist;
neuroprotective agent
201820214.5low000011
glucagon-like peptide 1201020198.0low000120
vivit peptide2013201311.0low000010
c-peptide2011201113.0low000010
ceruletide diethylamineorganoammonium saltdiagnostic agent;
gastrointestinal drug
2005200519.0medium000100
gastrin 17gastrinantineoplastic agent202220222.0low000001
exendin (9-39)2012201212.0low000010
pr 392001201715.0low000110
celluloseglycoside1963202219.8low235763
perovskite202120213.0low000001
endothelin-11996201816.9low10816130
phosphatidylcholines1,2-diacyl-sn-glycero-3-phosphocholine1985202218.4low111225141
cufe2o4202020204.0low000010
atractyloside2008200816.0low000100
(9R)-9-chloro-11,17-dihydroxy-17-(2-hydroxy-1-oxoethyl)-10,13,16-trimethyl-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-3-one21-hydroxy steroid1998201519.7low102010
amikacin202120213.0low000001
chlorophyll achlorophyll;
methyl ester
cofactor1983202311.1low1239317814
vendexorganotin acaricide2001200123.0low000100
thimerosalalkylmercury compoundantifungal drug;
antiseptic drug;
disinfectant;
drug allergen
2003200321.0low000100
nsc 23766hydrochlorideantiviral agent;
apoptosis inducer;
EC 3.6.5.2 (small monomeric GTPase) inhibitor;
muscarinic antagonist
2011201610.5low000020
adenosine kinase1996201518.5low001010
boc-d-fmk2004200420.0low000100
hoe 333422005201016.5low000200
jsh 23diamine;
substituted aniline
NF-kappaB inhibitor201620168.0low000010
sodium salicylateorganic molecular entity2007200717.0low000100
sphingosine kinase201020199.2low000130
ubiquinone1986201916.9low231580
sm 164benzenes;
organic heterobicyclic compound;
secondary carboxamide;
triazoles
antineoplastic agent;
apoptosis inducer;
radiosensitizing agent
202320231.0low000001
3,4-dihydroxyphenylethanol-elenolic acid dialdehydealcohol;
phenols
202420240.0low000001
calpain1993202216.3low002751
calpain1993202216.7low002741
sodium cyanoborohydride201720177.0low000010
sapogenins201620168.0low000010
hydroxyoctadecadienoic acid2010201014.0low000100
antamanide1991199133.0low001000
scalaradialacetate ester;
carbotetracyclic compound;
dialdehyde;
enal;
scalarane sesterterpenoid
animal metabolite;
anti-inflammatory agent;
apoptosis inducer;
EC 3.1.1.4 (phospholipase A2) inhibitor;
marine metabolite;
TRP channel blocker
1994200725.0low002100
biotinyltyramide2000201917.7low102010
chitosan199920239.2low001144110
s-propargylcysteine2012201212.0low000010
15-deoxyprostaglandin j22004200718.7low000300
s-nitro-n-acetylpenicillamine1999200621.8low001300
mesnaorganosulfonic acid2003201714.8low000530
azuletil sodiumorganic sodium salt;
organosulfonate salt
anti-ulcer drug;
thromboxane A2 antagonist
2013201311.0low000010
bucladesine3',5'-cyclic purine nucleotide1993199430.3low003000
rs 51861990199034.0low001000
osteumorganic molecular entity1990199034.0low001000
sodium hypochloriteinorganic sodium saltbleaching agent;
disinfectant
1980202325.7low035311
sodium nitriteinorganic sodium salt;
nitrite salt
antidote to cyanide poisoning;
antihypertensive agent;
antimicrobial food preservative;
food antioxidant;
poison
1989201324.5low019330
potassium bromatebromate salt;
potassium salt
flour treatment agent201520159.0low000010
methyl orange201420169.0low000020
holothurin a2013201311.0low000010
sodium glutamatemonosodium glutamateflavouring agent1985201822.5low010010
merocyanine dye1992199232.0low001000
ro13-9904201520206.5low000020
cortisol succinate, sodium saltorganic molecular entity1989201522.0low010010
chiniofon1987200329.0low110100
bof 42721998199826.0low001000
olaparibcyclopropanes;
monofluorobenzenes;
N-acylpiperazine;
phthalazines
antineoplastic agent;
apoptosis inducer;
EC 2.4.2.30 (NAD(+) ADP-ribosyltransferase) inhibitor
201820186.0low000010
forsythoside b2010201213.0low000110
methyl jasmonate1998202311.7low0026132
liriodendrin201720177.0low000010
phosphatidylcholines1-acyl-2-oleoyl-sn-glycero-3-phosphocholine betaine;
1-octadecanoyl-2-octadecenoyl-sn-glycero-3-phosphocholine
2001200222.5low000200
atheronal-asesquiterpenoid2009200915.0medium000100
picrotoxin2014201410.0low000010
2',3'-o-(2,4,6-trinitrophenyl)adenosine 5'-triphosphateC-nitro compound;
spiroketal
antagonist2009201014.5low000200
pci 32765acrylamides;
aromatic amine;
aromatic ether;
N-acylpiperidine;
pyrazolopyrimidine;
tertiary carboxamide
antineoplastic agent;
EC 2.7.10.2 (non-specific protein-tyrosine kinase) inhibitor
202020204.0low000010
ponatinib(trifluoromethyl)benzenes;
acetylenic compound;
benzamides;
imidazopyridazine;
N-methylpiperazine
antineoplastic agent;
tyrosine kinase inhibitor
202120213.0low000001
ethyl celluloseglycoside2011201511.0low100020
oxymatrine2012201212.0low000030
N-[4-[3-[[[7-(hydroxyamino)-7-oxoheptyl]amino]-oxomethyl]-5-isoxazolyl]phenyl]carbamic acid tert-butyl estercarbamate ester201720177.0low000010
egg white1988202317.3low010101
telotristatphenylalanine derivative201520159.0low000010
quetiapine fumaratefumarate salt201220179.5low000020
cardiovascular agents1987201522.0low024320
neurotensinpeptide hormonehuman metabolite;
mitogen;
neurotransmitter;
vulnerary
2008200816.0low000100
fibrinopeptide a2000200024.0low001000
apelin-13 peptideoligopeptideantihypertensive agent;
autophagy inhibitor;
biomarker;
human metabolite;
neuroprotective agent
201520206.7low000030
systemin2007200717.0low000100
osteogenic growth peptide2004200420.0low000100
compstatin201420178.5low000020
incb-018424nitrile;
pyrazoles;
pyrrolopyrimidine
antineoplastic agent;
EC 2.7.10.2 (non-specific protein-tyrosine kinase) inhibitor
201420227.3low000021
mannans1981202020.5low161390
pf 3845piperidines201520159.0low000010
3,4-oxoisopropylideneshikimic acid2012201311.5high000020
nitrogenase2012201510.5low000020
s-ethylcysteineS-alkyl-L-cysteine zwitterion;
S-alkyl-L-cysteine
antitubercular agent201620168.0low000010
phosphinothricinorganic anion200820199.7low000120
peptones2004200420.0low000100
2-chlorohexadecanal2001202015.2high000530
4-hydroxy-5-nitrophenyl acetic acidmonocarboxylic acid anion1996200125.5low001100
bacillithiolglycoside;
monosaccharide derivative;
thiol
antioxidant;
bacterial metabolite;
cofactor
201420225.3low000021
a 9670792013201311.0low000010
urushiol2004200420.0low000100
glycolipids1984202221.6low032321
elafin2006201911.5low000110
magnesium protoporphyrin2014201410.0low000010
piperidines1996202213.6low10521222
piperidines1996202213.7low10521212
resolvin d1hydroxy polyunsaturated fatty acid;
resolvin;
triol
anti-inflammatory agent201120188.6low000090
bryostatin 11993201818.5low001010
thymosin2003201712.5low000130
5-hydroxymethyl-2'-deoxyuridine1995199529.0low001000
galactocerebroside1992199232.0low001000
interleukin-81983202317.4low473791331029
kakkalide201720177.0low000010
gnaphalin1999200323.0high001100
phillyrin2013201311.0low000010
punicalagintannin201520159.0low000010
myrtucommulone aaromatic ketone2009200915.0low000100
ningnanmycin201120199.0low000030
gx 15-0702010201014.0low000200
colistin201620168.0low000010
tilmicosin2005200519.0low100100
tylosin2005200519.0low100200
fosinopril2006200618.0low000100
exenatide2011201212.5low000020
aplysiatoxinaplysiatoxins;
bromophenol;
cyclic hemiketal;
ether;
organic heterotricyclic compound;
secondary alcohol;
spiroketal
algal metabolite;
carcinogenic agent;
cyanotoxin;
marine metabolite;
protein kinase C agonist
1994199430.0low001000
gsk0660sulfonamide2010201014.0low000100
n-((5-(methanesulfonyl)pyridin-2-yl)methyl)-6-methyl-5-(1-methyl-1h-pyrazol-5-yl)-2-oxo-1-(3-(trifluoromethyl)phenyl)-1,2-dihydropyridine-3-carboxamide201620168.0low000010
chymostatin2001200123.0low000100
fructose-1,6-diphosphate1995200824.7low002100
gyy 4137organic molecular entity202320231.0low000001
glpg0634201920195.0low000010
physalin fenone;
epoxy steroid;
lactone;
physalin
antileishmanial agent;
antimalarial;
antineoplastic agent;
apoptosis inducer;
immunosuppressive agent
2005200519.0low000100
methylcellulose2011201710.0low100020
jujuboside atriterpenoid2009200915.0low000100
isoquercitrin2012201212.0low000010
nirtetralin2006200618.0medium000100
vasoactive intestinal peptide1988201519.7low026870
natriuretic peptide, brainpolypeptide2001202112.5low70032292
heme1959202318.2low02743819126
leukotoxin1986200825.2low012200
anemarsaponin b2007200717.0medium000100
7-methyl-5-(1-((3-(trifluoromethyl)phenyl)acetyl)-2,3-dihydro-1h-indol-5-yl)-7h-pyrrolo(2,3-d)pyrimidin-4-amine201820186.0low000010
heparitin sulfate1993201517.2low002430
tuftsinpeptide1975199240.5low011000
trifloxystrobin201320188.5low000020
ascorbic acidascorbic acid;
vitamin C
coenzyme;
cofactor;
flour treatment agent;
food antioxidant;
food colour retention agent;
geroprotector;
plant metabolite;
skin lightening agent
1945202318.3low629389510215
ascorbic acidascorbic acid;
vitamin C
coenzyme;
cofactor;
flour treatment agent;
food antioxidant;
food colour retention agent;
geroprotector;
plant metabolite;
skin lightening agent
1945202318.3low629389410215
tetracycline1990202217.2low002011
chlortetracycline1984202317.5low010111
oxytetracycline, anhydrous1995201617.2low002020
minocycline1996201814.4low002360
salicylatesmonohydroxybenzoateplant metabolite1985202020.4low025550
dicumarolhydroxycoumarinanticoagulant;
EC 1.6.5.2 [NAD(P)H dehydrogenase (quinone)] inhibitor;
Hsp90 inhibitor;
vitamin K antagonist
1994199430.0low001000
piroxicambenzothiazine;
monocarboxylic acid amide;
pyridines
analgesic;
antirheumatic drug;
cyclooxygenase 1 inhibitor;
EC 1.14.99.1 (prostaglandin-endoperoxide synthase) inhibitor;
non-steroidal anti-inflammatory drug
1985202322.3low015511
roquinimexaromatic amide2003200321.0low000100
mobic1,3-thiazoles;
benzothiazine;
monocarboxylic acid amide
analgesic;
antirheumatic drug;
cyclooxygenase 2 inhibitor;
non-steroidal anti-inflammatory drug
2000201118.5low001810
mobiflexheteroaryl hydroxy compound;
monocarboxylic acid amide;
pyridines;
thienothiazine
antipyretic;
EC 1.14.99.1 (prostaglandin-endoperoxide synthase) inhibitor;
non-narcotic analgesic;
non-steroidal anti-inflammatory drug
1985198539.0low010000
warfarinbenzenes;
hydroxycoumarin;
methyl ketone
1988202210.5low0106252
dihydroxyfumarate2-hydroxydicarboxylic acid;
C4-dicarboxylic acid
1963199051.3low021000
metastat2006200618.0low000100
antimycin2006200618.0low000100
4-hydroxycoumarinhydroxycoumarin2008200816.0low000100
s 01392001200123.0low000100
lornoxicamheteroaryl hydroxy compound;
monocarboxylic acid amide;
organochlorine compound;
pyridines;
thienothiazine
antipyretic;
non-narcotic analgesic;
non-steroidal anti-inflammatory drug
2008200816.0low000100
pogostonearomatic ketone201620168.0low000010
lfm a13201920195.0low000010
potassium ascorbyl tocopheryl phosphate1996199628.0low001000
nickel nitrilotriacetic acid1998199826.0low001000
betalains2001201317.0low000110
epidermal growth factor1986201622.3low01101150
d-4f peptide2005200519.0low000200
microcystinpeptide2004202113.8low000501
gastrin-releasing peptide2009200915.0low000100
calca protein, human2012201311.5low000020
kaolinitealuminosilicate mineral;
mixture
antidiarrhoeal drug;
excipient
2011201511.0low000040
clay2009202010.3low000150
plasmalyte a201720177.0low000010
charybdotoxin2002200222.0low000100
bismuth oxybromide201420207.0low000020
transforming growth factor beta1993202313.8low10523303
phytoestrogens2008201512.0low000120
3-hydroxy-5-oxo-5,6-secocholestan-6-al2011201113.0low000010
staphyloxanthinapo carotenoid triterpenoid;
D-aldohexose derivative;
fatty acid ester;
triol;
xanthophyll
antioxidant;
biological pigment;
metabolite;
virulence factor
201420188.0low000020
astressin-2b2010201014.0low000100
okadaic acidketal2000200024.0low001000
tcv 3091994199928.0low004000
sybr green ibenzothiazolium ion;
cyanine dye;
quinolines;
tertiary amine
fluorescent dye2004200619.0low000200
4-(((r)-1-(benzo(b)thiophene-3-carbonyl)-2-methyl-azetidine-2-carbonyl)-(3-chloro-benzyl)-amino)-butyric acid202120213.0medium000001
pyrethrins200620228.2low000112
globotriaosylceramide2006200618.0low000100
benzalazine1994199430.0low001000
carboxyethyl-hydroxychroman2013201311.0low100010
siroheme1984198440.0low010000
deltibant1994199629.0medium002000
timosaponin aiii201520159.0low000010
araldite1994199430.0low001000
fti 2772014201410.0low000010
trp-lys-tyr-met-val-met202020204.0low000010
spiroiminodihydantoinazaspiro compoundmutagen2001201318.7low000210
platonin2012201212.0low000010
eupalinolide a2012201212.0medium000010
necrox-5201420207.0medium000020
pf-06282999201520197.0high000040
agar2014201410.0low000010
3-(4-chlorophenyl)-adamantane-1-carboxylic acid (pyridin-4-ylmethyl)amide2010201014.0low000100
5-(1-(3-fluorophenyl)-1h-pyrazol-4-yl)-2h-tetrazole201720177.0medium000010
epiisopiloturine201320198.0medium000020
hirudin2004202113.6low200311
reactive blue 212011201113.0low000010
cyclin d12003201315.4low000320
petrosaspongiolide m2004200420.0low000100
alcohol oxidase1997202214.3low002131
lysophosphatidylethanolamine2009200915.0low000100
caseins1978202019.3low033680
limbrel200920229.7low000111
thearubigin2003201415.5low000110
a-8894252013201311.0medium000010
scorpion toxin i, androctonus201620168.0low000010
asbestos, crocidolite2002200222.0low000100
benzyloxycarbonylvalyl-alanyl-aspartyl fluoromethyl ketone1999201319.4low001310
azulenyl nitrone2002200222.0medium000100
nitrophenols1990202115.7low002461
bassianolidecyclodepsipeptide;
cyclooctadepsipeptide
antineoplastic agent;
fungal metabolite;
insecticide
2002201811.2low000180
hydroxytyrosyl acetate201520159.0low000010
lewis x antigen1994202020.0low005630
1 alpha,24-dihydroxyvitamin d32004200420.0low000100
glucagon-like peptide 22007202310.1low000241
kaliotoxin201520159.0low000010
angiotensin iangiotensin;
peptide zwitterion
human metabolite;
neurotransmitter agent
200820219.0low000141
ferric oxide, saccharated2012201212.0low000010
hyaluronoglucosaminidase200520247.8low000112
adrenomedullin2000202015.0low001440
mica2005201315.0low000110
epoetin alfa201720177.0low000010
ginkgolide b1995201620.8low003120
ginkgolide c202120213.0low000001
ganoderic acid a202020204.0low000010
gibberellins1983202014.7low010360
t-2 toxin2012201212.0low000010
copper bis(3,5-diisopropylsalicylate)1985198539.0low010000
peoniflorin2009201413.5low000310
vitamin b 121979201433.2low051110
aconitine201420159.5low000020
refludan2004200420.0low000100
transforming growth factor alpha2002201911.6low000230
glutamyl-valyl-glycinepeptide2013201311.0low000010
maxadilan protein, insect2014201410.0low000010
cyclosporine1991202318.6low00121182
flavin mononucleotide1964196460.0low010000
silybin201520178.0low000040
cytochalasin d1984201526.7low013110
apicidin2008200816.0low000100
peptide yy2007201115.0low000110
lactoferrin1975202327.8low268712852344
factor f4302001200123.0low000100
digitonin1975199139.3low021000
catalpol2014201410.0low000010
oxysophocarpine2012201212.0low000010
isonicotinyl-nad201620168.0medium000010
tomatine202120213.0low000001
reactive blue 15202320231.0low000001
glutathione sulfonamide2006201712.6high000230
asbestos, amosite1985198539.0low010000
orabase200220229.2low000251
apyrase1996202113.7low001321
thromboplastin1986202314.4low011692
muramidase1975202227.2low1510977575210
kutkin2000200024.0low001000
chromomycins1986198638.0low010000
rhamnogalacturonan i2000200024.0low001000
amyloid beta-peptides2011201510.7low000030
chondroitin sulfates1979201520.5low012530
iminoquinone1999199925.0low001000
angiogenin202020204.0low000010
entecavir2-aminopurines;
oxopurine;
primary alcohol;
secondary alcohol
antiviral drug;
EC 2.7.7.49 (RNA-directed DNA polymerase) inhibitor
201920195.0low000010
levoleucovorin5-formyltetrahydrofolic acidantineoplastic agent;
metabolite
1951199252.5low011000
cyclic gmp3',5'-cyclic purine nucleotide;
guanyl ribonucleotide
Escherichia coli metabolite;
human metabolite;
mouse metabolite;
plant metabolite;
Saccharomyces cerevisiae metabolite
1977201823.1low04241480
deoxyguanosinepurine 2'-deoxyribonucleoside;
purines 2'-deoxy-D-ribonucleoside
Escherichia coli metabolite;
human metabolite;
mouse metabolite;
Saccharomyces cerevisiae metabolite
1993201915.5low20918250
2'-deoxyguanosine 5'-phosphatedeoxyguanosine phosphate;
guanyl deoxyribonucleotide;
purine 2'-deoxyribonucleoside 5'-monophosphate
Escherichia coli metabolite;
mouse metabolite
2000200024.0low001000
7,8-dihydroneopterindihydropterin;
neopterins
Escherichia coli metabolite;
human metabolite;
metabolite;
mouse metabolite;
Saccharomyces cerevisiae metabolite
2009200915.0low000100
guanosine diphosphateguanosine 5'-phosphate;
purine ribonucleoside 5'-diphosphate
Escherichia coli metabolite;
mouse metabolite;
uncoupling protein inhibitor
1990201622.0low002010
guanosine monophosphateguanosine 5'-phosphate;
purine ribonucleoside 5'-monophosphate
biomarker;
Escherichia coli metabolite;
metabolite;
mouse metabolite
1995199529.0low001000
guanosine triphosphateguanosine 5'-phosphate;
purine ribonucleoside 5'-triphosphate
Escherichia coli metabolite;
mouse metabolite;
uncoupling protein inhibitor
201620168.0low000010
guanine2-aminopurines;
oxopurine;
purine nucleobase
algal metabolite;
Escherichia coli metabolite;
human metabolite;
mouse metabolite;
Saccharomyces cerevisiae metabolite
1995201916.9low003740
guanosineguanosines;
purines D-ribonucleoside
fundamental metabolite1995202117.6low002331
hypoxanthinenucleobase analogue;
oxopurine;
purine nucleobase
fundamental metabolite1985201728.2low129110
inosinic acidinosine phosphate;
purine ribonucleoside 5'-monophosphate
Escherichia coli metabolite;
human metabolite;
mouse metabolite
2007200717.0low000100
inosineinosines;
purines D-ribonucleoside
Escherichia coli metabolite;
human metabolite;
mouse metabolite;
Saccharomyces cerevisiae metabolite
1994200923.1low002600
sapropterin5,6,7,8-tetrahydrobiopterincoenzyme;
cofactor;
diagnostic agent;
human metabolite
2001200123.0low000100
folic acidfolic acids;
N-acyl-amino acid
human metabolite;
mouse metabolite;
nutrient
1949201831.6low051260
guanosine 5'-o-(3-thiotriphosphate)nucleoside triphosphate analogue1994200027.0low003000
pheophytin a1997202310.1low0018304
neopterin200420229.0low3006173
rifampincyclic ketal;
hydrazone;
N-iminopiperazine;
N-methylpiperazine;
rifamycins;
semisynthetic derivative;
zwitterion
angiogenesis inhibitor;
antiamoebic agent;
antineoplastic agent;
antitubercular agent;
DNA synthesis inhibitor;
EC 2.7.7.6 (RNA polymerase) inhibitor;
Escherichia coli metabolite;
geroprotector;
leprostatic drug;
neuroprotective agent;
pregnane X receptor agonist;
protein synthesis inhibitor
1988201518.5low020540
clozapinebenzodiazepine;
N-arylpiperazine;
N-methylpiperazine;
organochlorine compound
adrenergic antagonist;
dopaminergic antagonist;
EC 3.4.21.26 (prolyl oligopeptidase) inhibitor;
environmental contaminant;
GABA antagonist;
histamine antagonist;
muscarinic antagonist;
second generation antipsychotic;
serotonergic antagonist;
xenobiotic
1991202322.6low2013131
ganciclovir2-aminopurines;
oxopurine
antiinfective agent;
antiviral drug
1998200124.5low001100
olanzapinebenzodiazepine;
N-arylpiperazine;
N-methylpiperazine
antiemetic;
dopaminergic antagonist;
histamine antagonist;
muscarinic antagonist;
second generation antipsychotic;
serotonergic antagonist;
serotonin uptake inhibitor
1997199826.5low002000
oxypurinolpyrazolopyrimidinedrug metabolite;
EC 1.17.3.2 (xanthine oxidase) inhibitor
1987200428.7low023200
zaprinasttriazolopyrimidines201720177.0low000010
2-methyl-6-(4-methoxyphenyl)-3,7-dihydroimidazo(1,2-alpha)pyrazin-3-one1991201824.4low003110
syringaldazine1990201418.0low001130
allopurinolnucleobase analogue;
organic heterobicyclic compound
antimetabolite;
EC 1.17.3.2 (xanthine oxidase) inhibitor;
gout suppressant;
radical scavenger
1945202325.3low8448180368
celestine blue201520159.0medium000010
rifapentineN-alkylpiperazine;
N-iminopiperazine;
rifamycins
antitubercular agent;
leprostatic drug
1989198935.0low010000
diazeniumdiolate202120213.0low000001
2,4-diaminohypoxanthinehydroxypyrimidine1996199628.0low001000
tegaserodcarboxamidine;
guanidines;
hydrazines;
indoles
gastrointestinal drug;
serotonergic agonist
2004200718.5low000200
norclozapinedibenzodiazepine;
organochlorine compound;
piperazines
delta-opioid receptor agonist;
metabolite;
serotonergic antagonist
1999199925.0low101000
1-hydroxyphenazinephenazines1990199930.8low004000
sildenafil citratecitrate saltEC 3.1.4.35 (3',5'-cyclic-GMP phosphodiesterase) inhibitor;
vasodilator agent
2006201513.2low100670
aprepitant(trifluoromethyl)benzenes;
cyclic acetal;
morpholines;
triazoles
antidepressant;
antiemetic;
neurokinin-1 receptor antagonist;
peripheral nervous system drug;
substance P receptor antagonist
202120213.0low000001
vicineglycoside1997199727.0low001000
azilsartan1,2,4-oxadiazole;
aromatic ether;
benzimidazolecarboxylic acid
angiotensin receptor antagonist;
antihypertensive agent
201520159.0low000010
dimethylglyoxime2013201311.0low000010
8-bromocyclic gmp3',5'-cyclic purine nucleotide;
organobromine compound
muscle relaxant;
protein kinase G agonist
1984201326.3low014110
8-hydroxyguanineoxopurine2000201317.5low001010
trypan blue1979200535.5low021100
nintedanib201620168.0low000010
8-bromo-2'-deoxyguanosineguanosines;
organobromine compound
201520168.5medium000020
bis(3',5')-cyclic diguanylic acidcyclic purine dinucleotide;
guanyl ribonucleotide
immunomodulator;
signalling molecule
2012201610.0low000020
8-hydroxy-2'-deoxyguanosineguanosinesbiomarker1993202313.7low20614243
2-naphthol orange2005201612.0low000230
alizarine yellow g201920195.0low000010
remazol black b201620168.0low000010
dehydrocoelenterazine202020204.0medium000010
guanylyl-(3'-5')-guanosinenucleoside analogue;
purines
2014201410.0low000010
echinochrome a2001200123.0low000100
8-nitroguanineoxopurine1999200024.5low002000
fr 1676532001200123.0low000100
ur 127462003200321.0medium000100
cytidylyl-3'-5'-guanosine(3'->5')-dinucleotide1997199727.0low001000
imidaclopridimidacloprid;
imidazolidines;
monochloropyridine
environmental contaminant;
genotoxin;
neonicotinoid insectide;
nicotinic acetylcholine receptor agonist;
xenobiotic
201120218.7low000021
alpha-(4-pyridyl-1-oxide)-n-tert-butylnitrone1992200228.3low002100
porphyrin a201620168.0medium000010
bay 73-6691201620168.0low000010
carthaminehydroxycinnamic acid202120213.0low000001
carthaminehydroxycinnamic acid2012201311.5low000020
defibrotide1991200625.5low001100
8-nitro-2'-deoxyguanosine1999199925.0medium001000
alcian blue1995200723.0low001100
lipoteichoic acid1978200728.3low010200
eye1989202121.1low013121
fructooligosaccharideoligosaccharide2003201913.2low100330
maltodextrin2012201212.0low000010
mitotempo201620168.0low000010
acetylcellulose1963196361.0low010000
carbidopa201820186.0low000010
picroside ii201920195.0low000010
ganoderic acid b202020204.0low000010
concanavalin a1979202226.8low0107551
trypsinogen1999202014.3low001480
metallothionein1997202114.5low002771
antimony sodium gluconate2010201014.0low000100
vermiculite2007200717.0low000100
vescalagin201520159.0low000010
dinitrobenzenes1992200722.4low001400
phosphorus radioisotopes1997199727.0low001000
thrombin aptamer201720177.0low000020
n-succinyl-chitosan2011201113.0low000010
recombinant soluble cd4201620168.0low000010
leptin2002202213.5low2001792
pyrimidinones1992201912.7low0021100
araban2000201317.5low001010
n-acetylheparin1999201417.5medium001010
tetrafluoroaluminate2003200321.0low000100
phenanthrenes2002202013.5low0001090
ConditionIndicatedStudiesFirst YearLast YearAverage AgeRelationship StrengthTrialspre-19901990's2000's2010'spost-2020
2019 Novel Coronavirus Disease0202020232.3low2000434
47,XX,+2101975201531.4low061220
A-V Dissociation02004200619.0low000200
Abdominal Abscess02006200618.0low000100
Abdominal Aortic Aneurysm01995202014.6low2038110
Abdominal Compartment Syndrome02013201510.0low000020
Abdominal Cramps01997201617.0low001110
Abdominal Injuries02007200717.0low000100
Abdominal Obesity02011201312.0low100020
Abdominal Pain02003201715.0low000430
Aberrant Crypt Foci0201320188.5low000020
Abnormalities, Autosome01977201627.3low1714930
Abnormalities, Cardiovascular01957195767.0low010000
Abnormalities, Congenital01955195569.0low010000
Abnormalities, Drug-Induced02007201314.0low000110
Abnormalities, Multiple01983198341.0low010000
Abnormalities, Skin01991202118.0low001001
Abnormality, Heart02000201816.7low201110
Abnormality, Torsion02001201317.0low000110
Abortion, Habitual01999202313.0low001001
Abortion, Recurrent01999202313.0low001001
Abortion, Spontaneous02004202012.0low000110
Abortion, Tubal02004202012.0low000110
Abscess01963202029.4low060130
Abscess, Abdominal02006200618.0low000100
Abscess, Amebic0201620196.5low000020
Abscess, Amebic, Hepatic0200820208.8low000130
Abscess, Hepatic01977201135.0low020010
Abscess, Intracranial, Subdural0201820186.0low000010
Abscess, Peritonsillar02002200222.0low000100
Abscess, Pulmonary02014201410.0low000010
Absence of Brain, Congenital01987198737.0low010000
Absence Seizure01950202118.8low010041
Absence Status01997201020.5low001100
Acanthamoeba Keratitis02001200123.0low000100
Acanthamoeba Meningoencephalitis0201920195.0low000010
Acariasis0201420178.5low000020
Acatalasemia01976199041.2low031000
Acetonemia02000200024.0low001000
Ache01998202311.4low30117308
Achondroplasia01998199826.0low001000
Achondroplasia, Severe, With Developmental Delay And Acanthosis Nigricans01998199826.0low001000
Acid Aspiration Syndrome01993201421.1low008530
Acid beta-Glucosidase Deficiency01976197648.0low010000
Acid-Base Imbalance01999201218.5low001010
Acidosis01999201618.2low002120
Acidosis, Diabetic0201620168.0low000010
Acidosis, Respiratory02009200915.0low000100
Acinetobacter Infections02006201414.0low000110
Acne01996202113.8low001111
Acne Inversa0202120213.0low000002
Acne Vulgaris01996202113.8low001111
Acquired Autoimmune Hemolytic Anemia02000200820.0low001100
Acquired Immune Deficiency Syndrome01987200928.8low022200
Acquired Immunodeficiency Syndrome01987200928.8low022200
Acquired Laryngeal Stenosis0201620196.5low000020
Acquired Storage Pool Disease02007200717.0low000100
Acquired-Immune Deficiency Syndrome Dementia Complex02010201014.0low000100
Acrania01987201722.0low010010
Acromegaly02010201014.0low000100
Actinobacillus Infections02005201714.9low100610
Actinomycetales Infections02012201212.0low000010
Active Hyperemia01988201721.9low011320
Acute Autoimmune Neuropathy02000200024.0low001000
Acute Bacterial Prostatitis01999200722.0low002200
Acute Biphenotypic Leukemia01990201815.4low002250
Acute Brain Injuries01992202216.1low101215182
Acute Confusional Senile Dementia01996202313.0low20315175
Acute Coronary Syndrome02005202311.9low90025471
Acute Disease01976202320.0low6361272181168
Acute Edematous Pancreatitis01987202315.4low02301251037
Acute Febrile Neutrophilic Dermatosis01998202012.6low001240
Acute Hemolytic Transfusion Reaction01997201222.0low002010
Acute Hepatic Failure02003202210.2low000281
Acute Hypercapnic Respiratory Failure01989201918.9low212830
Acute Ischemic Stroke0202320231.0low000003
Acute Kidney Failure01988202313.2low011130646
Acute Kidney Injury01988202313.2low011130646
Acute Kidney Tubular Necrosis02004201615.3low000210
Acute Liver Injury, Drug-Induced01990202211.6low00521586
Acute Lung Injury0200320239.7low1005633720
Acute Lymphoid Leukemia01988202124.6low14411662
Acute Mesenteric Arterial Embolus0201120227.4low000041
Acute Myelogenous Leukemia01975202329.2low11075541274
Acute Necrotizing Pancreatitis01999201615.1low00242230
Acute Onset Vascular Dementia0201620168.0low000010
Acute Pain0201220188.7low100030
Acute Post-operative Pain02007201513.0low000110
Acute Post-Traumatic Stress Disorder0201520159.0low000010
Acute Promyelocytic Leukemia01988202325.5low01032574
Acute Respiratory Distress Syndrome01983202219.9low294688293
Acute Rheumatic Fever0202020204.0low000010
Acute Yellow Atrophy02004200420.0low000100
Acute-On-Chronic Liver Failure0202120213.0low000001
Acute-On-Chronic Liver Failure (ACLF)0202120213.0low000001
Acute-Phase Reaction01990202019.8low1031410
Adamantiades-Behcet Disease01980202325.7low032211
ADDH02014201410.0low000010
Addiction, Opioid02001200123.0low000100
Addison's Anemia01962199043.3low012000
Adenitis01985198539.0low010000
Adenitis, Salivary Gland01992200824.0low001100
Adenocarcinoma01984202316.9low1321393
Adenocarcinoma, Basal Cell01984202316.9low1321393
Adenofibroma01984198838.0low020000
Adenohypophyseal Diseases02013201311.0low000010
Adenoma01981201720.3low012240
Adenoma, Basal Cell01981201720.3low012240
Adenoma, Prostatic01999201814.3low001020
Adenomatous Polyposis Coli02005201514.0low000110
Adenomatous Polyposis Coli, Familial02005201514.0low000110
Adenomatous Polyps01999199925.0low001000
Adenosis of Breast01984198838.0low020000
Adenoviridae Infections0200720228.7low000111
Adenovirus Infections0200720228.7low000111
Adhesions, Tissue01995202016.9low002320
Adipocere01988201821.8low020120
Adjuvant Arthritis01997202312.1low00216244
Adnexitis01994201022.0low101100
Adolescent Gynecomastia02003200321.0low000100
Adolescent Obesity0201320188.0low100040
ADPKD02013201311.0low000010
Adrenal Cancer01988201522.5low010010
Adrenal Gland Hypofunction02007201314.7low000210
Adrenal Insufficiency02007201314.7low000210
Adult Fanconi Syndrome02007200717.0low000100
Adult Periodontitis02008201911.3low5006140
Adult-Onset Dystonias0202020204.0low000010
Adult-Onset Still Disease0201320198.0low000020
Adverse Drug Event01950201924.2low110220
Aerobic Glycolysis, Oncologic0202120213.0low000001
Affective Disorders02004201614.0low000110
Affective Psychosis, Bipolar0201520168.5low000020
Afibrinogenemia02006200618.0low000100
Afibrinogenemia, Congenital02006200618.0low000100
African Lymphoma01983202323.4low228211
African Sleeping Sickness01953201241.5low010010
African Tick-Bite Fever0202020204.0low000010
Agammaglobulinemia01976200933.4low022100
Age-Related Memory Disorders0200920218.6low000161
Age-Related Osteoporosis02011201113.0low000010
Agenesis of Hemidiaphragm02001200123.0low000100
Aggressive Periodontitis01987201522.1low014130
Aging01959202219.6low471532203
Agnogenic Myeloid Metaplasia01977201630.0low061030
Agranulocytosis01975201431.6low11111420
Agricultural Worker Disease02008200816.0low000100
AIDS Dementia Complex02010201014.0low000100
AIDS-Related Complex01991199332.0low002000
AIDS-Related Opportunistic Infections01993199331.0low001000
AIDS, Simian0201820186.0low000010
Air Embolism02010201213.0low000110
Airflow Obstruction, Chronic02001202312.7low110032353
Airway Hyper-Responsiveness01994201617.9low004350
Airway Obstruction01989202118.2low112221
Airway Remodeling02011201610.5low000040
Akinetic-Rigid Variant of Huntington Disease0200520209.0low000120
Albers-Schoenberg Disease01982198242.0low010000
Albinism01964196460.0low010000
Albuminuria02004202311.8low000211
Alcaptonuria01999199925.0low001000
Alcohol Abuse01986201919.5low022150
Alcohol Drinking01991202315.8low104341
Alcohol-Induced Disorders0201620168.0low000010
Alcohol-Induced Peripheral Neuropathy02012201212.0low000010
Alcoholic Cirrhosis01980201622.2low020120
Alcoholic Fatty Liver02008201711.5low000110
Alcoholic Hepatitis01988198836.0low010000
Alcoholic Intoxication01989201418.2low011430
Alcoholic Liver Diseases02001201217.5low000110
Alcoholic Pancreatitis02000201217.8low001410
Alcoholism01986201919.5low022150
Aldrich Syndrome01995201121.0low001010
Algodystrophic Syndrome01998201617.0low001010
Alkalosis02009200915.0low000100
Alkaptonuria01999199925.0low001000
Allergic Alveolitis, Extrinsic01992199929.7low003000
Allergic Angiitis01990202314.1low0016253217
Allergic Bronchopulmonary Aspergilloses01997199727.0low002000
Allergic Conjunctivitis02000201218.7low001110
Allergic Contact Dermatitis02004202211.3low000231
Allergic Cutaneous Angiitis01990201322.0low00111130
Allergic Encephalomyelitis02001201911.7low000590
Allergic Reaction01954201721.0low018690
Allergic Rhinitis0201320199.0low100030
Allergy, Drug01990200825.0low003200
Allergy, Food01999202016.7low001620
Allergy, Milk02007201015.2low100400
Allergy, Peanut02004200420.0low000100
Allergy, Wheat02010202110.3low000201
Allodynia01998202211.2low00218473
Alloxan Diabetes01958202213.7low04217395
Alopecia Areata0202120213.0low000001
Alopecia Circumscripta0202120213.0low000001
Alpers Diffuse Degeneration of Cerebral Gray Matter with Hepatic Cirrhosis02000200024.0low001000
alpha 1-Antitrypsin Deficiency01992202019.3low204440
alpha-Galactosidase A Deficiency01976200633.0low010100
alpha-Lipoprotein Deficiency Disease, Familial02014201410.0low000010
Alport Syndrome01977197747.0low010000
ALS - Amyotrophic Lateral Sclerosis02002202312.5low100211
Altered Level of Consciousness02014201410.0low000010
Altidudinal Hemianopia02012201212.0low000010
Altitude Hypoxia0201120199.0low000020
Altitude Sickness0201120199.0low000020
Alveolar Bone Atrophy02005202311.3low00012271
Alveolar Echinococcosis, Hepatic01987200130.0low010100
Alveolitis, Extrinsic Allergic01992199929.7low003000
Alveolitis, Fibrosing01978202218.1low171126291
Alzheimer Disease01996202313.0low20315175
Amaurosis01997201518.0low001010
Ambulation Disorders, Neurologic0201720177.0low000010
Amebiasis0201620196.5low000020
Amebiasis, Intestinal02008200816.0low000100
Amentia0201320189.0low000040
American Trypanosomiasis01983202216.1low120122
Amnionitis0200820199.9low100190
Amyloid Deposits01999200422.5low001100
Amyloid Neuropathies, Familial02014201410.0low000010
Amyloid Neuropathy Type 102014201410.0low000010
Amyloidosis01976202026.0low020210
Amyotonia Congenita01978200035.0low011000
Amyotrophic Lateral Sclerosis02002202312.5low100211
Anaphylactic Reaction01954201725.6low013310
Anaphylaxis01954201725.6low013310
Anaplasma Infection0201720177.0low000010
Anaplastic Large-Cell Lymphoma01996201819.0low001110
Anasarca01988202415.4low136610717712
Anastomotic Leak02012201212.0low000010
ANCA-Associated Vasculitides0200920236.2medium110016267139
Ancylostomiasis02011201113.0low000010
Androgen-Independent Prostatic Cancer0202120213.0low000001
Anemia01952201934.1low171260
Anemia, Aplastic01953200438.9low042100
Anemia, Fanconi01998200622.0low001100
Anemia, Hemolytic01998201816.2low001120
Anemia, Hemolytic, Acquired01998201816.2low001120
Anemia, Hemolytic, Autoimmune02000200820.0low001100
Anemia, Hypochromic01962199440.5low093000
Anemia, Hypoplastic01953200438.9low042100
Anemia, Iron-Deficiency0201120218.0low000021
Anemia, Macrocytic01977199040.5low011000
Anemia, Megaloblastic01977200433.5low012100
Anemia, Refractory01988201127.3low011010
Anemia, Refractory, with Excess of Blasts01988200230.8low012100
Anemia, Sickle Cell01976202216.8low214471
Anemia, Sideroblastic01988200229.0low010100
Anemia, Splenic01982199336.5low011000
Anemias, Iron-Deficiency0201120218.0low000021
Anesthesia01990201718.9low104640
Aneuploid02002200222.0low000100
Aneurysm0200920219.0low000101
Aneurysm, Anterior Cerebral Artery0200320238.9low100253
Aneurysm, Arteriovenous02007201412.7low000120
Aneurysm, Bacterial02013201311.0low000010
Aneurysm, Ruptured02000202110.4low101031
Aneurysm, Thoracic Aortic02003202014.0low100210
Angiitis01985202321.2low41148196419
Angiitis, Central Nervous System01998202214.9low001321
Angina at Rest01996201417.5low3021550
Angina Pectoris01995201515.3low20111100
Angina Pectoris with Normal Coronary Arteriogram02009200915.0low100100
Angina Pectoris, Stable0201320178.8low200060
Angina Pectoris, Variant01996199628.0low001000
Angina, Stable0201320178.8low200060
Angina, Unstable01996201417.5low3021550
Angioedema02008200816.0low000100
Angioedema, Hereditary0202120213.0low000001
Angioedemas, Hereditary0202120213.0low000001
Angiofollicular Lymph Hyperplasia01998199826.0low001000
Angiogenesis, Pathologic02003202311.3low1009253
Angiogranuloma02013201311.0low000010
Angioma01999199925.0low001000
Angiomyxoma02005200519.0low000100
Angioneurotic Edema02008200816.0low000100
Angiospasm, Intracranial02000201216.7low001110
Angiostrongylus Infections01997200822.2low003300
Angle's Classification02014201410.0low000020
Angor Pectoris01995201515.3low20111100
Anguilluliasis02008201811.7low000120
Animal Mammary Carcinoma0200020219.0low001021
Anisakiasis02006201115.5low000110
Ankylosing Spondylarthritis01991202114.8low102222
Anochlesia0201320188.5low000020
Anorectal Diseases02003200918.0low000200
Anorexia01996199628.0low001000
Anosmia0202120213.0low000001
Anovulation01986198638.0low010000
Anoxemia01981202217.2low311419242
Anoxia-Ischemia, Brain02002201515.8low000630
Anoxia, Brain0201820186.0low000010
Anterior Cerebral Circulation Infarction02001201714.5low00012100
Anterior Cervical Pain0201520159.0low000010
Anterior Choroidal Artery Infarction01991202317.3low00920102
Anterior Circulation Transient Ischemic Attack01991202321.4low00151831
Anterior Fascicular Block02004200420.0low000100
Anterior Ischemic Optic Neuropathy02010201014.0low000100
Anthrax0201720177.0low000010
Anti-GBM Disease01990202319.4low00151164
Anti-Glomerular Basement Membrane Disease01990202319.4low00151164
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis0200920236.2medium110016267139
Antibiotic-Associated Colitis01984201424.1low016320
Antibody Deficiency Syndrome01976201730.6low0410020
Anus Prolapse0201820186.0low000010
Anxiety02006201911.0low000280
Anxiety Disorders02004201513.0low000220
Anxiety Neuroses02004201513.0low000220
Aortic Aneurysm, Abdominal01995202014.6low2038110
Aortic Aneurysm, Ruptured01995201818.6low002320
Aortic Aneurysm, Thoracic02003202014.0low100210
Aortic Arteritis, Giant Cell0200020239.4low001214
Aortic Coarctation02007200717.0low000100
Aortic Diseases01994202116.8low102621
Aortic Dissection0202020204.0low100010
Aortic Incompetence0202120213.0low000001
Aortic Stenosis0201320225.2low000022
Aortic Valve Disease 102014201410.0low000010
Aortic Valve Insufficiency0202120213.0low000001
Aortic Valve Stenosis0201320225.2low000022
Aortitis02000200720.5low001100
Aortitis Syndrome0202020204.0low000010
Aphthae01987201421.0low110110
Aplasia Pure Red Cell02004200420.0low000100
Apnea02004201415.0low000110
Apnea, Obstructive Sleep0200720238.3low200192
Apnea, Sleep02012201212.0low000010
Apolipoprotein B-100, Familial Defective02008202011.0low100120
Apoplexy0200120239.5low10013339
Appendicitis01984202015.5low010030
Arachnidism02012201212.0low000010
Arachnoid Membrane Inflammation0201720177.0low000010
Arachnoidal Cerebellar Sarcoma, Circumscribed01989198935.0low010000
ARC01991199332.0low002000
Arrhythmia01994201918.9low006940
Arrhythmias, Cardiac01994201918.9low006940
ARSA Deficiency01976197648.0low010000
Arsenic Encephalopathy02003201017.5low000200
Arterial Diseases, Carotid02000201813.1low201980
Arterial Diseases, Cerebral0201620168.0low000010
Arterial Inflammation01988202324.2low1113312
Arterial Obstructive Diseases01991202021.9low0014940
Arterial Occlusive Diseases01991202021.9low0014940
Arteriosclerosis01981200824.0low13343800
Arteriosclerosis Obliterans02013201311.0low000010
Arteriosclerosis, Coronary01996202212.7low80353654
Arteriovenous Malformations, Cerebral02004200818.0low000300
Arthralgia0201720205.5low000020
Arthritides, Bacterial01992202115.8low001111
Arthritis01989202016.4low01811110
Arthritis, Degenerative01985202315.5low213171
Arthritis, Gouty0201320224.8low000022
Arthritis, Juvenile01979202119.5low012221
Arthritis, Juvenile Chronic01979202119.5low012221
Arthritis, Post-Infectious01983199933.0low011000
Arthritis, Psoriatic01996202211.2low002013
Arthritis, Reactive01983199933.0low011000
Arthritis, Rheumatoid01975202320.5low1124220309
Arthropathies01984201320.2low011130
Arthus Phenomenon01986201624.5low016120
Asbestosis02002200720.2low000400
Ascites01999201519.1low0031020
Ascorbic Acid Deficiency01977200035.5low011000
Aseptic Meningitis02007200717.0low000100
Asialia02008201812.3low000210
Aspergillosis01983202314.5low022454
Aspergillosis, Allergic Bronchopulmonary01997199727.0low002000
Aspergillus Infection01983202314.5low022454
Asphyxia0201320198.0low000020
Asphyxia Neonatorum02007201910.7low000120
Aspiration, Meconium02005200718.3low000300
Aspiration, Respiratory02008200915.5low000200
Asthenia02011201113.0low000010
Asthma01978202320.5low984849344
Asthma, Bronchial01978202320.5low984849344
Asthma, Exercise-Induced01997202314.0low101001
Asthma, Occupational0201520159.0low000010
Asthmatic Crisis01999199925.0low001000
Astrocytoma, Grade IV01994202216.0low001001
Astrocytosis02007202010.9low000250
Asymptomatic Colonization0201820205.0low000020
Asymptomatic Conditions0201220217.0low000021
Asystole02000202315.5low101421
Ataxia Telangiectasia01995199529.0low001000
Ataxia Telangiectasia Syndrome01995199529.0low001000
Ataxias, Hereditary0201920195.0low000010
Atelectasis02004200718.3low000300
Atheroembolism02002200620.3low000300
Atherogenesis02005202311.2low300648413
Atheroma0201020238.2low2002344
Atherosclerosis02005202311.2low300648413
Atherosclerotic Parkinsonism02010201014.0low000100
Athlete's Foot01986198638.0low020000
ATLL01989200426.4low015200
Atopic Hypersensitivity01983200924.4low115800
Atresia, Biliary01987199334.0low011000
Atrial Fibrillation0200520237.9low2003126
Atrial Remodeling0201620206.0low000020
Atrial Septal Defect01993199331.0low001000
Atrioventricular Block0202120213.0low000001
Atrioventricular Conduction Block0202120213.0low000001
Atrioventricular Nodal Re-Entrant Tachycardia02002200222.0low000100
Atrophic Muscular Disorders02008200816.0low000100
Atrophy0200420239.3low100444
Atrophy, Muscle02006200816.5low000400
Attachment Loss, Periodontal01996201716.7low202940
Attention Deficit Disorder with Hyperactivity02014201410.0low000010
Atypical Chronic Myeloid Leukemia02007201612.5low000110
Atypical Ductal Hyperplasia01984198440.0low010000
Atypical Endometrial Hyperplasia01982198242.0low010000
Atypical Mycobacterial Infection, Disseminated0201820233.5low000011
Auditory Vertigo01998199826.0low001000
Aura0200720227.8low000121
Auricular Fibrillation0200520237.9low2003126
Autism Spectrum Disorder0202120213.0low000001
Autoimmune Chronic Hepatitis01998202015.9low002330
Autoimmune Diabetes01988202116.3low033493
Autoimmune Disease01982202320.1low163941274
Autoimmune Diseases01982202320.1low163941274
Autoimmune Thrombocytopenia0201620225.0low000011
Autoimmune Thyroiditis01988201522.5low0471050
Autolysis01995199529.0low001000
Autonomic Dysfunction, Paraneoplastic0201620168.0low000010
Autosomal Chromosome Disorders01982201631.5low032010
Autosomal Dominant Juvenile Parkinson Disease0200520228.8low000141
Autosomal Recessive Chronic Granulomatous Disease01975202036.5low07022840
Avian Flu0201520159.0low000010
Avian Sarcoma01947194777.0low010000
Azoospermia0202320231.0low100001
B cepacia Infection02001201216.7low000210
B Virus Infection01995201420.7low001110
B-Cell Chronic Lymphocytic Leukemia01988202218.4low111411
B-Cell Leukemia02004202110.0low000111
B-Cell Lymphoma01991200526.2low004200
B. burgdorferi Infection02014201410.0low000010
B16 Melanoma01990202116.6low002021
Bacillaceae Infections02006200618.0low000100
Bacillus anthracis Infection0201720177.0low000010
Bacteremia01992202320.5low1013362
Bacterial Conjunctivitides02000201118.5low001010
Bacterial Disease01976202324.2low5272120138
Bacterial Endocarditides02010201014.0low000100
Bacterial Endocarditides, Subacute02001200123.0low000100
Bacterial Eye Infections01995202018.2low0041450
Bacterial Infections01976202324.2low5272120138
Bacterial Infections, Gram-Negative01997202210.9low2015202
Bacterial Infections, Gram-Positive02007201911.1low000340
Bacterial Meningitides02000201917.3low003120
Bacterial Pneumonia01996202215.7low20520132
Bacterial Skin Diseases02014201410.0low000010
Bacterial Vaginitides02011201113.0low000020
Bacteriuria01995202016.5low001010
Bacteroidaceae Infections02000201316.7low101110
Bancroftian Elephantiasis01996199628.0low001000
Bang Disease02004200420.0low000100
Barrett Epithelium01995201418.8low001320
Barrett Esophagus01995201418.8low001320
Basedow Disease01989201821.4low01142060
Basophilic Leukemia, Acute02001200322.0low000200
Becker Muscular Dystrophy0200020239.2low101021
Bed Sores02000201916.2low001210
Behavior Disorders02011201113.0low000010
Behcet Syndrome01980202325.7low032211
Bends02002201314.5low000130
Benign Cerebellar Neoplasms01989200527.3low011100
Benign Meningeal Neoplasms02007200717.0low000100
Benign Monoclonal Gammopathies02002202013.0low000110
Benign Mucosal Pemphigoid02014201410.0low000010
Benign Neoplasms01947202316.0low41610304724
Benign Neoplasms, Brain01997201914.4low001240
Benign Paroxysmal Peritonitis01983202124.0low011001
Benign Psychomotor Epilepsy, Childhood0202020204.0low000010
Berger Disease01992202216.9low005661
Beriberi01964196460.0low010000
Besnier-Boeck Disease01980202224.0low040112
Besnoitiasis01984201617.0low010030
Bewilderment02004200420.0low000100
Bicuspid Aortic Valve Disease02014201410.0low000010
Bilateral Deafness01997201120.0low001210
Bilateral Headache0200320238.7low000333
Bilateral Nasal Obstruction01998200822.0low002100
Bile Duct Cancer0200620237.7low100111
Bile Duct Neoplasms0200620237.7low100111
Bile Duct Obstruction01980202119.0low0261561
Bile Duct Obstruction, Extrahepatic01996201617.0low001210
Bile Duct Obstruction, Intrahepatic02003201414.0low000220
Bilharziasis01981199635.5low011000
Biliary Atresia01987199334.0low011000
Biliary Cirrhosis01998200720.3low001500
Biliary Tract Cancer02000201516.5low001010
Biliary Tract Diseases01993202117.0low001001
Biliary Tract Neoplasms02000201516.5low001010
Bilirubin Encephalopathy02009200915.0low000100
Binge Alcohol Consumption0201820186.0low000010
Biological Clock Disturbances02008200816.0low000100
Bipolar Disorder0201520168.5low000020
Birth Weight01995202210.2low001061
Bisphosphonate Osteonecrosis02014201410.0low000010
Black Death01987201622.5low010010
Black Fever01982201122.6low010310
Bladder Cancer01992201421.8low004410
Bladder Diseases02007200717.0low000100
Bladder Neck Obstruction02013201311.0low000010
Blast Crisis01987201725.0low0212520
Blast Injuries01996201813.4low001260
Blast Phase01987201725.0low0212520
Blastomyces brasiliensis Infection02008201015.0low000300
Bleb01985201420.3low013140
Bleeding01945202118.2low123153471
Blepharitis01999199925.0low001000
Blepharoptosis01996199628.0low001000
Blindness01997201518.0low001010
Blood Clot01983202310.9low2218197
Blood Coagulation Disorders01982201420.8low010120
Blood Diseases01975201333.8low098030
Blood Loss, Postoperative02005200519.0low100100
Blood Loss, Surgical01994200525.5low202200
Blood Platelet Disorders02004200420.0low000100
Blood Poisoning01983202313.1low65188914419
Blood Pressure, High01990202213.9low20715253
Blood Pressure, Low01993201921.4low007420
Bloom Syndrome01995199529.0low001000
Blue-Eared Pig Disease0201520159.0low000010
Blunt Injuries01994202018.5low005240
Body Weight01959202315.8low4232113888
Body Weight, Fetal0201320188.3low000030
Boils01963196361.0low010000
Bone Cancer01998202310.4low101112
Bone Fractures02013201311.0low000010
Bone Loss, Osteoclastic01989202115.2low010221
Bone Marrow Diseases01982201332.2low030010
Bone Marrow Failure Syndromes, Congenital0201820186.0low000010
Bone Marrow Neoplasms02012201212.0low000010
Bone Neoplasms01998202310.4low101112
Bone Tuberculosis01956195668.0low020000
Bonnevie-Ullrich Syndrome01982198242.0low010000
BOOP01995202116.0low001001
Bordetella Infections02002200222.0low000100
Bordetella pertussis Infection, Respiratory01950195173.5low020000
Bouillaud Disease02007200717.0low100100
Bovine Diseases01981202117.1low032481
Bovine Leukemia02013201311.0low000010
Bovine Virus Diarrhea Mucosal Disease01981198143.0low010000
Bowel Diseases, Inflammatory01988202315.4low513662709
Brachial Paresis02012201212.0low000010
Brain Abscess0201820186.0low000010
Brain Concussion0202020204.0low000010
Brain Damage, Chronic01997199727.0low002000
Brain Dead01996201714.5low001230
Brain Diseases01964202115.6low010161
Brain Disorders01964202115.6low010161
Brain Edema01994201916.3low10721150
Brain Emboli02001200322.0low000200
Brain Embolism and Thrombosis01992199928.0low103000
Brain Hemorrhage02012201411.0low000020
Brain Hemorrhage, Cerebral01996202116.7low0041471
Brain Infarction02001201714.5low00012100
Brain Inflammation02000202012.5low10111160
Brain Injuries01992202216.1low101215182
Brain Injuries, Penetrating0201520159.0low000010
Brain Injuries, Traumatic0201720205.3low000030
Brain Ischemia01982202315.3low211538443
Brain Neoplasms01997201914.4low001240
Brain Swelling01994201916.3low10721150
Brain Thrombosis02005201911.3low000120
Brain Vascular Disorders01981202219.0low012221
Branch Retinal Artery Occlusion02003200321.0low000100
Branch Vein Occlusion0202120213.0low000001
Break-Bone Fever0201020199.5low000110
Breast Cancer01983202217.3low26919193
Breast Neoplasms01983202217.3low26919193
Breathing Sounds01995202313.9low202231
Breathlessness02000201713.3low101570
Bright Disease01977202317.9low2613111011934
Brill-Symmers Disease02003201714.0low100110
Broad Beta Disease01999199925.0low001000
Bronchial Diseases0201920195.0low000010
Bronchial Hyperreactivity01994201621.6low30121060
Bronchial Pneumonia01963200332.8low022200
Bronchiectasis01995202216.6low107352
Bronchiolitis01989201723.1low013210
Bronchiolitis Obliterans01999202016.2low003230
Bronchiolitis, Exudative01999202016.2low003230
Bronchiolitis, Viral0201520178.0low000020
Bronchitis01988201622.2low61121640
Bronchitis, Chronic01999201517.3low001320
Bronchopulmonary Dysplasia01996201516.9low303340
Bronchopulmonary Sequestration01996200922.8low002400
Bronchospasm, Exercise-Induced01997202314.0low101001
Bronze Diabetes02005201116.0low000110
Brown Tendon Sheath Syndrome02012201212.0low000010
Brucella Infection01963202325.0low011111
Brucellosis01963202325.0low011111
Bruise02000201216.1low001520
Buckley Syndrome01975197648.3low030000
Buerger Disease01998199826.0low002000
Bulimia Nervosa02012201212.0low000010
Bullous Dermatoses0202220231.5low000002
Burkholderia pseudomallei Infection02008200816.0low000100
Burkitt Lymphoma01983202323.4low228211
Burning Mouth Syndrome02010201014.0low000100
Burns01975202217.8low212365342
Burns, Chemical01984201917.1low011240
Burns, Electric02011201113.0low000010
Burns, Inhalation02008200816.0low000100
C gattii Infection01996200623.3low002100
CACH Syndrome02012201212.0low000010
Cachexia02008200816.0low100200
Cadaver02014201410.0low000010
Cadmium Poisoning0202120213.0low000001
Calcification, Pathologic02009201313.7low000210
Calcinosis02009201313.7low000210
Calcinosis-Raynaud Phenomenon-Sclerodactyly-Telangiectasia02000200521.7low001200
Calcium Pyrophosphate Deposition Disease01976197648.0low010000
Caliciviridae Infections02003201714.0low000110
Campylobacter Infection0202320231.0low200002
Cancer of Cecum02004200420.0low000100
Cancer of Cervix01980201820.9low033450
Cancer of Colon01983202315.7low2156122
Cancer of Digestive System01982198242.0low010000
Cancer of Endocrine Gland02000200024.0low001000
Cancer of Endometrium02001201814.6low000320
Cancer of Esophagus01992202316.1low102651
Cancer of Gallbladder02007200717.0low000100
Cancer of Gastrointestinal Tract0202320231.0low100001
Cancer of Head01982202116.0low012051
Cancer of Intestines02007201115.0low000110
Cancer of Kidney01984200129.7low111100
Cancer of Larynx01979200430.2low023100
Cancer of Lip02008201811.0low000110
Cancer of Liver01946202316.2low322786
Cancer of Lung01983202316.9low25933235
Cancer of Mouth01986201718.5low011330
Cancer of Muscle02010201014.0low000100
Cancer of Nasopharynx0201620234.5low000011
Cancer of Oropharnyx02004200420.0low000100
Cancer of Ovary01995202314.1low002661
Cancer of Pancreas0200820236.3low600469
Cancer of Paranasal Sinus02005200519.0low000100
Cancer of Parotid01991200924.0low001100
Cancer of Pharynx01986200031.0low011000
Cancer of Pituitary01995199529.0low001000
Cancer of Prostate01994202211.5low0023172
Cancer of Rectum0201220234.7low200012
Cancer of Skin01947202321.0low231614112
Cancer of Spleen01999199925.0low001000
Cancer of Stomach01981202121.5low071961
Cancer of Testis02003202012.5low000110
Cancer of the Thyroid01965202325.4low132221
Cancer of the Tongue02013201311.0low000010
Cancer of the Tonsil02002200222.0low000100
Cancer of the Ureter01999199925.0low001000
Cancer of the Urinary Tract0201920195.0low100010
Cancer of the Uterus01980201728.9low041110
Cancer of the Vulva02005200519.0low000100
Cancer, Radiation-Induced0201620168.0low000010
Cancer, Second Primary01999201318.0low001310
Candida Infection01979202026.8low11161530
Candidiasis01979202026.8low11161530
Candidiasis, Chronic Mucocutaneous01982199138.0low032000
Candidiasis, Cutaneous01988199731.5low011000
Candidiasis, Genital02008201811.4low000140
Candidiasis, Oral01974201324.3low113030
Candidiasis, Vulvovaginal02008201811.4low000140
Cane-Cutter Fever01983198341.0low010000
Canine Diseases01975202319.1low045383
Capillary Leak Syndrome01999201416.1low001430
Caprine Diseases02011201610.3low000030
Carbohydrate Metabolism, Inborn Error01977197747.0low010000
Carbon Monoxide Poisoning01993201619.6low002120
Carbon Tetrachloride Poisoning02004201514.3low000210
Carcinogenesis01965202311.7low110081
Carcinoma01981202221.3low032331
Carcinoma 256, Walker01955201638.5low010010
Carcinoma, Anaplastic01981202221.3low032331
Carcinoma, Basal Cell0201520159.0low000010
Carcinoma, Basal Cell, Pigmented0201520159.0low000010
Carcinoma, Bronchial01986198638.0low010000
Carcinoma, Bronchogenic01986198638.0low010000
Carcinoma, Ductal, Breast01996199727.7low003000
Carcinoma, Ductal, Pancreatic0200820235.5low100112
Carcinoma, Ehrlich Tumor02004200917.3low000300
Carcinoma, Epidermoid01983202318.6low134981
Carcinoma, Hepatocellular01946202317.9low122564
Carcinoma, Intraductal, Noninfiltrating01984198440.0low010000
Carcinoma, Lobular01996199628.0low001000
Carcinoma, Non-Small Cell Lung01995202313.0low101412
Carcinoma, Non-Small-Cell Lung11995202313.0low101412
Carcinoma, Oat Cell01995201022.2low002300
Carcinoma, Ovarian Epithelial0201820234.0low000021
Carcinoma, Pancreatic Ductal0200820235.5low100112
Carcinoma, Papillary01986201722.2low011020
Carcinoma, Small Cell01995201022.2low002300
Carcinoma, Small Cell Lung02010201213.0low000110
Carcinoma, Squamous Cell01983202318.6low134981
Carcinoma, Squamous Cell of Head and Neck0201820186.0low000010
Carcinoma, Thymic01995199529.0low001000
Carcinoma, Transitional Cell01999201915.0low101010
Cardiac Arrest, Sudden02004201912.3low000120
Cardiac Cancer02005201215.5low000110
Cardiac Conduction Defect0201920195.0low000010
Cardiac Death01999201519.8low002110
Cardiac Diseases01957202316.3low2149121
Cardiac Failure0200320239.6low700223014
Cardiac Free Wall Rupture0201120189.7low000030
Cardiac Hypertrophy0201320218.3low000021
Cardiac Output, Low02006200618.0low000200
Cardiac Remodeling, Ventricular02003202111.6low1009122
Cardiac Rupture, Post-Infarction02003201117.0low000110
Cardiac Rupture, Traumatic02005201712.0low000230
Cardiac Toxicity0201520224.7low000051
Cardio-Renal Syndrome0201520196.7low000030
Cardiomegaly0201320218.3low000021
Cardiometabolic Syndrome0200820229.1low6006162
Cardiomyopathies01986202318.1low133262
Cardiomyopathies, Primary01986202318.1low133262
Cardiomyopathy, Chagas0200720218.7low000111
Cardiomyopathy, Congestive0201320217.0low000011
Cardiomyopathy, Dilated0201320217.0low000011
Cardiomyopathy, Hypertrophic0202220222.0low000001
Cardiomyopathy, Hypertrophic Obstructive0202220222.0low000001
Cardiomyopathy, Restrictive0202120213.0low000001
Cardiotoxicity0201520224.7low000051
Cardiovascular Abnormalities01957195767.0low010000
Cardiovascular Diseases01991202311.6low804486812
Cardiovascular Pregnancy Complications02004200420.0low000100
Cardiovascular Stroke01981202319.0low101277111813
Cardiovirus Infections01998199826.0low001000
Carditis01990201917.4low003960
Caries, Dental01965202127.4low121011
Carotid Arteriopathies, Traumatic0201520159.0low000010
Carotid Artery Diseases02000201813.1low201980
Carotid Artery Narrowing02006202011.8low100240
Carotid Artery Thrombosis02014201410.0low000010
Carotid Stenosis02006202011.8low100240
Castleman Disease01998199826.0low001000
Cat Diseases02005201016.5low000400
Cataract01959201133.2low012110
Cataract, Membranous01959201133.2low012110
Catarrh01999200223.5low101100
Cecal Diseases01996201123.0low003010
Celiac Disease01989202018.6low011610
Celiac Sprue01989202018.6low011610
Cell Transformation, Neoplastic01976201825.5low089770
Cell Transformation, Viral01984198937.5low020000
Cells, Neoplasm Circulating0201720177.0low000010
Cellulitis01963198251.5low020000
Central Diabetes Insipidus02001200123.0low000100
Central Hypothyroidism01993201718.3low0041150
Central Nervous System Disease02001201318.8low000310
Central Nervous System Diseases02001201318.8low000310
Central Nervous System Neoplasm0201520159.0low000010
Central Nervous System Neoplasms0201520159.0low000010
Central Nervous System Toxoplasmosis0201620168.0low000010
Central Nervous System Tuberculosis0201720177.0low000010
Centriacinar Emphysema01979201925.3low265640
Cerebral Arterial Diseases0201620168.0low000010
Cerebral Concussion0202020204.0low000010
Cerebral Cryptococcosis02002200620.0low000200
Cerebral Hemorrhage01996202116.7low0041471
Cerebral Infarction01991202317.3low00920102
Cerebral Infarction, Middle Cerebral Artery02000202115.4low00339241
Cerebral Ischemia01982202315.3low211538443
Cerebral Malaria0201620196.0low000030
Cerebral Microangiopathies0201920223.5low000011
Cerebral Palsy01960200733.7low010200
Cerebral Palsy, Athetoid01960200733.7low010200
Cerebral Pseudosclerosis01976200732.5low010100
Cerebral Small Vessel Diseases0201920223.5low000011
Cerebro-Oculo-Renal Syndrome0201920195.0low000010
Cerebromeningitis01998201617.0low001010
Cerebrovascular Disorders01981202219.0low012221
Cerebrovascular Moyamoya Disease02007201214.5low000110
Cervical Tuberculous Lymphadenitis0202120213.0low000001
Cervicitis02010201810.0low000110
Cervix Dysplasia01994201617.0low001020
Chagas Cardiomyopathy0200720218.7low000111
Chagas Disease01983202216.1low120122
Chediak-Higashi Syndrome01975201138.4low0256110
Chemical and Drug Induced Liver Injury01990202211.6low00521586
Chemical and Drug Induced Liver Injury, Chronic0201320236.0low100011
Chemical Dependence02001202013.7low000210
Chest Injuries02000202015.2low001120
Chest Pain02003201814.0low10011120
Chicken Pox01984200032.0low011000
Chickenpox01984200032.0low011000
Child Development Deviations02006200618.0low000100
Child Malnutrition0201820186.0low000010
Chlamydia Infections01995201422.0low002210
Chlamydia pneumoniae Infections02007200717.0low000100
Chlamydial Pneumonia0201620168.0low000010
Chloroma01959202217.7low0202481
Cholangiitis, Sclerosing01992199829.0low003000
Cholangiocarcinoma0202020232.5low100011
Cholangiocellular Carcinoma0202020232.5low100011
Cholangitis01987198737.0low010000
Cholangitis, Sclerosing01992199829.0low003000
Cholecystitis01987199929.0low016000
Cholelithiasis01989201125.5low114010
Cholera02002202312.0low100221
Cholera Infantum01988202315.3low113783
Cholestasis01980202119.0low0261561
Cholestasis, Intrahepatic02003201414.0low000220
Choline Deficiency01999201818.3low002010
Chondrocalcinosis01976197648.0low010000
Chondrodystrophic Myotonia01998201915.5low001010
Chondromalacia of Trachea and Bronchi0201920195.0low000010
Chorioamnionitis0200820199.9low100190
Choriocarcinoma0202320231.0low000001
Choroid Neoplasms01994199430.0low001000
Chromosomal Breakage02009200915.0low000100
Chromosomal Fragility01991199133.0low001000
Chromosomal Translocation01987201424.9low05171510
Chromosomal Triplication01976200232.0low011100
Chromosome Deletion01985200031.2low024000
Chromosome Inversion02002200222.0low000200
Chromosome-Defective Micronuclei02003200818.5low000200
Chronic Bronchitis01999201517.3low001320
Chronic Disease01978202318.9low91842734913
Chronic Hepatitis02002200222.0low000100
Chronic Hepatitis B0201120237.0low000011
Chronic Hepatitis C01999201416.5low202540
Chronic Illness01978202318.9low91842734913
Chronic Insomnia02012201212.0low000010
Chronic Kidney Diseases0200720227.4low3002175
Chronic Kidney Failure01982202313.7low546283114
Chronic Lung Injury01990202214.3low402276935
Chronic Lymphocytic Thyroiditis02005201711.8low000260
Chronic Pain0201620187.0low000020
Chronic Pancreatitis02005202110.5low000251
Chronic Primary Open Angle Glaucoma02005200519.0low000200
Chronic Progressive Multiple Sclerosis0201820186.0low000010
Churg-Strauss Syndrome01990202314.1low0016253217
Chylopericardium02005202310.7low000111
Cicatrix01989201714.4low010160
Cicatrization01989201714.4low010160
Ciliophora Infections02011201810.3low000030
Circoviridae Infections0201720177.0low000010
Circulatory Collapse01945200926.5low01221200
Cirrhoses, Experimental Liver02003200818.2low000500
Cirrhosis01995202312.1low00224256
Cirrhosis, Liver01975202314.6low11410164
Classic Galactosemia02012201212.0low000010
Classic Globoid Cell Leukodystrophy01976197648.0low010000
Clinical Deterioration0202120213.0low000001
Clinically Isolated CNS Demyelinating Syndrome02012201212.0low000010
Clostridioides difficile Infection01984201828.7low020010
Clostridium Infections01984201828.7low020010
Co-infection0201220236.0low100053
Coagulation Disorders, Blood01982201420.8low010120
Coagulation, Disseminated Intravascular01983200330.5low023100
Coarctation of Aorta02007200717.0low000100
Cocaine Abuse02007201513.5low000330
Cocaine-Related Disorders02007201513.5low000330
Cocarcinogenesis01997200422.0low001300
Cochlear Hearing Loss01996201319.4low002530
Cognition Disorders02006202110.0low000251
Cognitive Decline0201820233.5low200022
Cognitive Dysfunction0201820233.5low200022
Coin Lesion, Pulmonary02010201014.0low000100
Cold Fingers, Hereditary01991199729.7low003000
Cold Panniculitis0201720215.0low000011
Colicky Pain02003201715.0low000430
Colitis01984202315.8low4714632434134
Colitis Gravis01976202314.5low45438013525
Colitis, Collagenous02006201116.3low200210
Colitis, Granulomatous01976202217.1low141410274
Colitis, Ischemic01994200425.0low102100
Colitis, Mucous02003201914.3low100740
Colitis, Ulcerative01976202314.5low45438013525
Collagen Diseases01993200028.0low003000
Collagenous Colitis02006201116.3low200210
Colon Cancer, Familial Nonpolyposis02008200816.0low000100
Colonic Diseases01991201420.2low0041210
Colonic Diseases, Functional01975197549.0low010000
Colonic Neoplasms01983202315.7low2156122
Colonic Pseudo-Obstruction02008200816.0low000100
Colorectal Cancer01989202310.3low1115215
Colorectal Neoplasms01989202310.3low1115215
Colorectal Neoplasms, Hereditary Nonpolyposis02008200816.0low000100
Common Bile Duct Diseases01996199628.0low001000
Common Bile Duct Neoplasms02010201014.0low000100
Common Cold01999200223.5low101100
Communicable Diseases01963202318.5low011022
Community Acquired Infection02004201016.0low000300
Compartment Syndromes02003201117.2low000510
Complication, Intraoperative01996200824.5low303100
Complication, Postoperative01984202317.0low721430186
Complications of Diabetes Mellitus01977201518.3low020670
Complications, Hematologic Pregnancy01980200925.3low010200
Complications, Infectious Pregnancy01985201429.3low020010
Complications, Pregnancy01987201914.4low0107100
Concussive Convulsion0202020204.0low000010
Condition, Preneoplastic01985201220.0low010510
Congenital Myotonic Dystrophy01986198638.0low010000
Congenital Thrombotic Thrombocytopenic Purpura02005201016.5low000200
Congenital Zika Syndrome0202020232.5low000011
Congo Virus Infection0201320179.0low000020
Conjunctival Diseases02014201410.0low000010
Conjunctivitis02000200024.0low001000
Conjunctivitis, Allergic02000201218.7low001110
Conjunctivitis, Bacterial02000201118.5low001010
Connective Tissue Disease, Mixed01994201818.0low004140
Connective Tissue Diseases01994202317.0low104203
Constitutional Liver Dysfunction0201520159.0low000010
Constriction, Pathologic01999201615.9low002240
Constriction, Pathological01999201615.9low002240
Constrictive Pericarditis01996199628.0low001000
Contact Dermatitis01988202117.9low01911121
Contusions02000201216.1low001520
Conus Medullaris Syndrome01996201719.1low0041010
Convalescence01986200032.8low022000
Convulsions, Grand Mal02007200717.0low000100
Cornea Injuries01984201815.8low010130
Corneal Angiogenesis02008201015.0low000200
Corneal Diseases0201620168.0low000010
Corneal Edema02010201014.0low000100
Corneal Injuries01984201815.8low010130
Corneal Neovascularization02008201015.0low000200
Corneal Opacity02011201511.0low000020
Corneal Ulcer01996202314.0low002441
Coronary Artery Disease01996202212.7low80353654
Coronary Artery Stenosis02002201613.8low100580
Coronary Disease01985201823.2low4111924140
Coronary Heart Disease01985201823.2low4111924140
Coronary Occlusion02011201610.0low000030
Coronary Restenosis0200820209.7low000120
Coronary Stenosis02002201613.8low100580
Coronary Thrombosis01995201717.3low002520
Coronavirus Infections0202020204.0low000030
Cortical Lewy Body Disease0202020204.0low000010
Corynebacterium diphtheriae Infection01948199154.5low011000
Cough01950202119.9low111441
Coxarthrosis0200820219.5low000101
Coxsackie Virus Infections02008200816.0low000100
Cranial Nerve Diseases0201020219.8low000131
Cranial Nerve I Injury02011201113.0low000010
Cranial Nerve III Diseases02013201311.0low000010
Craniofacial Pain02005201215.5low000110
Critical Illness01999202311.4low101132
Crohn Disease01976202217.1low141410274
Cronobacter Infections02006201612.7low000460
Cross Infection02006200618.0low000100
Crush Syndrome0201120199.8low000050
Cruveilhier-Baumgarten Syndrome01996202320.9low004301
Cryoglobulinemia01998201914.4low001330
Cryptococcosis01996200623.3low002100
Cryptogenic Fibrosing Alveolitis0201320216.1low0000113
Cryptosporidiosis02006201712.5low000110
Cryptosporidium Infection02006201712.5low000110
Curling Ulcer01988201420.5low113520
Cyst, Pulmonary Hydatid02001200123.0low000100
Cystadenoma, Mucinous02008200816.0low000100
Cystic Echinococcosis02001200123.0low000100
Cystic Fibrosis01975202219.0low941924182
Cystic Fibrosis of Pancreas01975202219.0low941924182
Cystine Diathesis01976197648.0low010000
Cystinosis01976197648.0low010000
Cystitis02009202210.2low000391
Cytokine Release Syndrome0202120222.8low100004
Cytomegalic Inclusion Disease01997201019.0low001400
Cytomegalovirus01991200724.0low001200
Cytomegalovirus Infections01997201019.0low001400
Dacryoadenitis02007200717.0low000100
Day Blindness02012201212.0low000010
DDD MPGNII01993202317.6low003312
DDPAC0202320231.0low100001
Deafness, Transitory0201020237.3low000111
Death, Sudden02000200024.0low001000
Death, Sudden, Cardiac02004201912.3low000120
Debility0202120213.0low100001
Deep Vein Thrombosis01998202010.2low001040
Deficiency Diseases01976200437.3low020100
Deficiency of Glucose-6-Phosphate Dehydrogenase01975199544.3low0111000
Deficiency Syndrome, Leukocyte-Adhesion01995200723.5low002200
Deficiency, Ascorbic Acid01977200035.5low011000
Deficiency, Folic Acid01990199034.0low001000
Deficiency, Magnesium02009200915.0low000100
Deficiency, Protein01986201620.7low010110
Deficiency, Pyridoxine02011201113.0low000010
Deficiency, Thiamine01995200026.5low002000
Deficiency, Vitamin A01996201022.0low002100
Deficiency, Vitamin B0202120213.0low000001
Deficiency, Vitamin B 1201977201131.3low011010
Deficiency, Vitamin E01995200026.5low002000
Degenerative Diseases, Central Nervous System0200620238.1low1003102
Degos Disease0202220222.0low000001
Dehiscence, Surgical Wound01991201020.7low001200
Dehydration01986202210.9low1109113
Delayed Effects, Prenatal Exposure0200820238.7low100151
Delayed Graft Function0202120213.0low000001
Delayed Hypersensitivity01981200928.4low055500
Delirium0201120227.5low000011
Delirium of Mixed Origin0201120227.5low000011
Dementia0201320189.0low000040
Dementia Praecox02000201912.2low101250
Dementia, Vascular0201620168.0low000010
Demyelinating Diseases02012201212.0low000010
Demyelinative Myelitis02010201014.0low000100
Dengue0201020199.5low000110
Dental Caries01965202127.4low121011
Dental Deposit01999199925.0low001000
Dental Fistula01991199133.0low001000
Dental Fluoroses0201320179.0low000020
Dental Plaque01977202126.1low164521
Dental Pulp Exposure02013201311.0low000010
Depression01994201911.5low0011100
Depression, Endogenous02012201510.0low000040
Depression, Involutional02004202211.5low000341
Depressive Disorder02012201510.0low000040
Depressive Disorder, Major02004202211.5low000341
Dermatitis01982202120.7low0581082
Dermatitis Herpetiformis01978200236.0low020100
Dermatitis Medicamentosa01994201819.2low004220
Dermatitis, Allergic Contact02004202211.3low000231
Dermatitis, Atopic01983201925.5low045040
Dermatitis, Contact01988202117.9low01911121
Dermatitis, Contact, Phototoxic02006202011.0low000120
Dermatitis, Eczematous01997201720.0low002010
Dermatitis, Irritant02005201216.0low000210
Dermatitis, Poison Ivy01951195173.0low010000
Dermatitis, Radiation-Induced0201820186.0low000010
Dermatomycoses01987199433.5low011000
Dermatomyositis01999202213.0low002031
Dermatomyositis, Adult Type01999202213.0low002031
Dermatophytoses01963201037.5low010100
Dermatosclerosis02002202213.3low000201
Dermatoses01979202116.9low0276131
Developmental Disabilities02006200618.0low000100
Devic Disease02009202210.5low000211
Dextro-Looped Transposition of the Great Arteries0201820186.0low000010
Di Guglielmo Disease01976200530.9low026200
Diabetes Insipidus0201620168.0low000010
Diabetes Insipidus, Neurogenic02001200123.0low000100
Diabetes Mellitus01976202320.4low0103595
Diabetes Mellitus, Adult-Onset01988202211.8low91419355
Diabetes Mellitus, Gestational02010201014.0low000100
Diabetes Mellitus, Type 101988202116.3low033493
Diabetes Mellitus, Type 201988202211.8low91419355
Diabetes, Gestational02010201014.0low000100
Diabetic Angiopathies02004201713.4low100660
Diabetic Cardiomyopathies0201520216.0low000011
Diabetic Feet0201920195.0low000010
Diabetic Foot0201920195.0low000010
Diabetic Glomerulosclerosis01998201516.9low001740
Diabetic Ketoacidosis0201620168.0low000010
Diabetic Nephropathies01998201516.9low001740
Diabetic Retinopathy01993201716.6low002030
Diaphragmatic Hernia02001200123.0low000100
Diarrhea01995202314.4low10620173
Diarrhea, Infantile0201620177.5low000020
Diastolic Heart Failure0201820214.5low000011
Diathesis01975202118.0low051422202
Diffuse Cutaneous Systemic Sclerosis02007201812.0low000230
Diffuse Large B-Cell Lymphoma01984202120.6low113131
Diffuse Lymphocytic Lymphoma, Poorly-Differentiated02003200420.5low000200
Diffuse Mixed Small and Large Cell Lymphoma01975202323.2low140521
Diffuse Myofascial Pain Syndrome0201720186.5low000020
Diffuse Parenchymal Lung Disease01996202312.2low008101112
Digestive System Neoplasms01982198242.0low010000
Dilatation, Pathologic01997202013.8low001220
Diphtheria01948199154.5low011000
Disbacteriosis0201420206.0low0000180
Disease01999201815.5low001010
Disease Exacerbation01995202214.0low601289955
Disease Models, Animal01984202314.1low1792258011,02272
Disease Resistance0201120237.5low3000537
Disease, Pulmonary01980202320.1low357698476
Diseases in Twins01987201326.0low011010
Diseases of Immune System01954201519.0low011280
Diseases of Nasopharynx01950195074.0low010000
Diseases, Metabolic01958201923.5low022040
Diseases, Occupational01990201621.7low0010630
Diseases, Peripheral Vascular02008201015.4low100500
Disseminated Fusariosis0201220189.0low000020
Disseminated Intravascular Coagulation01983200330.5low023100
Distorted Hearing0201820186.0low000010
Down Syndrome01975201531.4low061220
Drowning02009201611.5low000110
Drug Hypersensitivity01990200825.0low003200
Drug Overdose0201720177.0low000010
Drug Refractory Epilepsy0202120213.0low000001
Drug-Induced Stevens Johnson Syndrome02010201412.0low000120
Drug-Related Side Effects and Adverse Reactions01950201924.2low110220
Dry Eye01995201319.0low001110
Dry Eye Syndromes01995201319.0low001110
Ductus Arteriosus, Patent01995200225.5low001100
Duhring Disease01978200236.0low020100
Duncan Disease01982201331.8low031010
Duodenal Ulcer01988201420.5low113520
Duodenitis01990202317.5low001001
Dwarfism, Growth Hormone Deficiency01985198539.0low010000
Dwarfism, Pituitary01985198539.0low010000
Dysarthosis0201920195.0low000010
Dysentery, Bacillary02000200720.3low001200
Dysentery, Shiga bacillus02000200720.3low001200
Dysesthesia0201620168.0low000010
Dyskinesia Syndromes02005201215.0low000210
Dyslipidemia0200920229.4low000271
Dyslipidemias0200920229.4low000271
Dysmyelopoietic Syndromes01985202222.2low2716447
Dyspepsia01988201919.5low110210
Dysplastic Nevus Syndrome, Hereditary0202220222.0low100001
Dyspnea02000201713.3low101570
Dystonic Disorders0202020204.0low000010
E chaffeensis Infection01999201616.5low001010
E coli Infections01987202019.6low03117130
Ear Diseases01995200524.0low001100
Ear Infection01998201020.0low001100
EBV Infections02005202111.0low000101
Eccentro-Osteochondrodysplasia0201520159.0low000010
Eclampsia02006200618.0low000100
Eczema01997201720.0low002010
Eczema, Atopic01983201925.5low045040
Eczema, Dyshidrotic0201520159.0low000010
Edema01988202415.4low136610717712
Edema-Proteinuria-Hypertension Gestosis01992202213.8low0027101
Edema, Pulmonary01987202115.6low013037742
Egyptian Ophthalmia01982198242.0low010000
EHS Tumor01965200040.3low021000
Electrolytes01995202115.2low004862
Electron Transport Chain Deficiencies, Mitochondrial02012201212.0low000010
Elephantiasis, Filarial01996199628.0low001000
Elevated Cholesterol02001202015.0low1001430
Elliptocytosis, Hereditary01990199034.0low001000
Embolism, Cholesterol02002200620.3low000300
Embolism, Fat02000200820.0low001100
Embolism, Pulmonary01992202313.9low102732
Embryopathies02012201311.5low000020
Emergencies02005200817.5low000200
Emesis02012201212.0low000020
Emphysema01991202018.6low002120
Empyema, Gall Bladder01987199929.0low016000
Encephalitis02000202012.5low10111160
Encephalitis Infection0201620168.0low000010
Encephalitis, Japanese01999199925.0low001000
Encephalitis, Japanese B01999199925.0low001000
Encephalitis, JC Polyomavirus01996202016.0low001010
Encephalitis, Saint Louis0201720177.0low000010
Encephalitis, Viral0201620168.0low000010
Encephalopathy, Toxic02012201510.3low000030
Encephalopathy, Traumatic0201720205.3low000030
Endemic Goiter01996199628.0low101000
Endocarditis0202220222.0low000001
Endocarditis, Bacterial02010201014.0low000100
Endocarditis, Loeffler01994199430.0low002000
Endocrine Gland Neoplasms02000200024.0low001000
Endolymphatic Hydrops01998199826.0low001000
Endometrial Diseases02013201510.0low100020
Endometrial Hyperplasia01982198242.0low010000
Endometrial Neoplasms02001201814.6low000320
Endometrioma01985201816.7low112260
Endometriosis01985201816.7low112260
Endometritis0200620229.3low000391
Endomyometritis0200620229.3low000391
Endophthalmitis01984201318.9low010330
Endotoxemia01996202117.4low202353312
Endotoxin Shock01986202317.3low111321221
Enlarged Liver02005200519.0low000100
Enlarged Spleen01984201624.8low012110
ENT Diseases0200920207.7low000150
Entamoeba histolytica Infection02001200819.5low000200
Enteric Fever01963198644.2low050000
Enteritis01984202120.5low01182661
Enterobacteriaceae Infections02006201612.7low000460
Enterocolitis01996201420.4low003020
Enterocolitis, Necrotizing0200520219.6low000161
Enterocolitis, Pseudomembranous01984201424.1low016320
Enteropathy, Exudative0202120213.0low000001
Envenomation, Scorpion02012201212.0low000010
Envenomation, Snakebite02010201511.8low000130
Eosinophilia01977202222.0low05114121
Eosinophilia, Pulmonary02011201113.0low100010
Eosinophilia, Tropical01977202222.0low05114121
Eosinophilic Granuloma02003200321.0low000100
Epididymitis02006202011.0low000110
Epidural Neoplasm, Malignant01996199628.0low001000
Epilepsy0200720227.8low000121
Epilepsy, Temporal Lobe0202020204.0low000010
Epilepsy, Tonic-Clonic02007200717.0low000100
Epiphora0200920219.0low000101
Episcleritis01996202015.7low002130
Epistaxis0202020232.5low000011
Epithelial Neoplasms0201820186.0low000010
Epithelial Ovarian Cancer0201820234.0low000021
Epstein-Barr Virus Infections02005202111.0low000101
Epulides01958201822.5low010030
Epulides, Giant Cell0201520159.0low000010
Equine Diseases01991202117.1low401011131
ER-Negative PR-Negative HER2-Negative Breast Cancer0201820186.0low000010
Erectile Dysfunction02005202113.1low000531
Erosive Duodenitis01990202317.5low001001
Erysipelas01985198738.0low020000
Erythema01982202117.3low010411
Erythremia01986200029.7low012000
Erythrocytosis01998199826.0low001000
Erythrophagocytic Lymphohistiocytosis, Familial02011201113.0low000010
Escherichia coli Infections01987202019.6low03117130
Escherichia coli Meningitis0201720177.0low000010
Esophageal Dysmotility02001200123.0low000100
Esophageal Neoplasms01992202316.1low102651
Esophageal Reflux02002201815.3low000850
Esophageal Squamous Cell Carcinoma0201520187.5low000020
Esophageal Stenosis02006201414.0low000110
Esophageal Stricture02006201414.0low000110
Esophagitis01995201118.4low001310
Esophagitis, Peptic02001202315.2low100621
Esophagitis, Reflux02001202315.2low100621
Essential Hypertension02013201510.0low000020
Essential Polyarteritis01988202022.6low01211980
Ewing Sarcoma02010201014.0low000100
Exanthem02002202310.5low100202
Exanthema02002202310.5low100202
Exertional Heat Illness02003202211.5low100211
Exfoliation Glaucoma02005200519.0low000100
Exfoliation Syndrome02005200519.0low000100
Exocrine Pancreatic Insufficiency02008200816.0low000100
Exophthalmos02005201315.0low000110
Experimental Hepatoma01982199935.0low031000
Experimental Leukemia01976199240.3low074000
Experimental Lung Inflammation01963202214.8low7520761086
Experimental Mammary Neoplasms01980201925.8low043040
Experimental Neoplasms01957202227.7low077241
Experimental Pneumococcal Meningitis01975201427.8low021020
Experimental Radiation Injuries01987202118.1low0141361
Experimental Spinal Cord Ischemia02004202310.1low000673
Exposure, Dental Pulp02013201311.0low000010
External Ear Inflammation01993199331.0low001000
Extramembranous Glomerulopathy01997202114.5low0037102
Extrasystole, Ventricular01999200721.0low001100
Extravasation of Contrast Media01999201416.1low001420
Extravascular Hemolysis01980202021.1low0576100
Eye Burns01984201922.5low010010
Eye Diseases01993202111.4low001141
Eye Disorders01993202111.4low001141
Eye Infections, Fungal0201920233.0low000012
Eye Infections, Viral02007200717.0low000100
Eye Injuries02010201611.3low000120
Fabry Disease01976200633.0low010100
Facial Dermatoses01998200522.5low001100
Facial Pain02005201215.5low000110
Facial Palsy01998202111.8low001121
Fallot's Tetralogy0201820186.0low000010
Familial Combined Hyperlipidemia0201820186.0low000010
Familial Mediterranean Fever01983202124.0low011001
Familial Nonmedullary Thyroid Cancer0201320179.0low000020
Familial Primary Pulmonary Hypertension0202020204.0low000010
Familial Spastic Paraparesis, Htlv-1-Associated02000200024.0low001000
Fanconi Anemia01998200622.0low001100
Far East Scarlet-like Fever01989198935.0low010000
Fasciitis, Necrotizing0201820186.0low000010
Fasciola Infection0201920195.0low000010
Fascioliasis0201920195.0low000010
Fasciolopsiasis01993199331.0low001000
Fasting Hypoglycemia02012201212.0low000010
Fat Necrosis02013201311.0low000010
Fatigue01963201919.5low010230
Fatty Liver01951201913.4low0104190
Fatty Liver, Nonalcoholic0201120236.8low1000135
Female Genital Diseases01994201822.0low002010
Female Genital Neoplasms02003202313.3low100201
Female Genitourinary Diseases0201520178.0low000020
Femoral Fractures01999201516.4low001430
Fetal Death01997201319.0low002020
Fetal Growth Restriction02003201812.0low000150
Fetal Growth Retardation02003201812.0low000150
Fetal Membranes, Premature Rupture01985201328.3low020010
Fever01996202014.2low002760
Fever of Unknown Origin02000202114.3low001221
Fibrocystic Breast Disease01984198838.0low020000
Fibroid01980201725.5low020110
Fibroma, Shope01990201024.3low002100
Fibromyalgia0201720186.5low000020
Fibrosarcoma01991200723.2low001300
Fibrosis01995202312.1low00224256
Fibrosis, Inflammatory Perianeurysmal0202020204.0low000010
Fibrosis, Radiation02011201113.0low000010
Fish Diseases01998202210.5low3018305
Fistula02000200024.0low001000
Fluorosis, Dental0201320179.0low000020
FMR1-Related Primary Ovarian Insufficiency0201520159.0low000010
Focal Infection01986201026.0low010100
Focal Segmental Glomerulosclerosis01992201518.3low001230
Folic Acid Deficiency01990199034.0low001000
Food Hypersensitivity01999202016.7low001620
Food Poisoning, Salmonella0201820186.0low000010
Foot and Mouth Disease02009200915.0low000100
Foot Dermatoses01978198740.3low030000
Foot Diseases02001200818.5low000400
Foot Injuries02006200618.0low000100
Foreign Bodies02003200321.0low000100
Foreign-Body Granuloma02007201513.0low000110
Foreign-Body Reaction02010201412.0low000110
Forestier-Certonciny Syndrome02008200816.0low000100
Fractures, Bone02013201311.0low000010
Fractures, Ununited0201620168.0low000010
Francisella tularensis Infection0202020204.0low000010
Frontal Sinusitis01998199826.0low001000
Frontotemporal Dementia0202320231.0low100001
Fungal Diseases01984202116.6low011231
Fungal Lung Diseases01996201221.3low003210
Fungal Meningitis01993199331.0low001000
Furcation Defects02001200123.0low100100
Fusariosis0201220189.0low000020
Fusiform Aneurysm0200920219.0low000101
Galactosemias02012201212.0low000010
Gall Bladder Diseases02010201014.0low000100
Gallbladder Neoplasms02007200717.0low000100
Gallstone Disease01989201125.5low114010
Gammapathy, Monoclonal01986202023.3low011010
Ganglioside Storage Diseases01976197648.0low010000
Gangliosidoses01976197648.0low010000
Gangrene01991199133.0low001000
Gasser Syndrome02006200618.0low000100
Gastric Diseases01979202118.9low015841
Gastric Stasis02007200717.0low000100
Gastric Ulcer01988202116.4low224167716
Gastritis01991201918.2low10925110
Gastritis, Atrophic02002201616.0low000310
Gastroduodenal Ulcer01991201618.8low0051330
Gastroenteritis01993202316.3low102211
Gastroesophageal Reflux02002201815.3low000850
Gastrointestinal Hemorrhage01990202119.7low0081241
Gastroparesis02007200717.0low000100
Gaucher Disease01976197648.0low010000
Genetic Diseases0202220222.0low000001
Genetic Diseases, Inborn0202220222.0low000001
Genetic Diseases, X-Chromosome Linked0202020204.0low000010
Genetic Predisposition01999202314.0low20577717
Genetic Skin Diseases0202120213.0low000001
Genital Diseases, Female01994201822.0low002010
Genital Diseases, Male02003201812.0low000120
Genital Neoplasms, Female02003202313.3low100201
Germinoblastoma01975202224.6low1710761
Gestational Hypertension0201620177.5low000020
Giant Cell Arteritis0200020239.4low001214
Gigantism01953195669.5low040000
Gingival Diseases01958201822.5low010030
Gingival Hemorrhage01990201618.1low203730
Gingival Hypertrophy0201520159.0low000010
Gingival Overgrowth02010201014.0low000100
Gingival Pocket01990199034.0low001000
Gingivitis01977201921.7low410810140
Glaucoma02011201610.5low000020
Glaucoma, Open-Angle02005200519.0low000200
Glial Cell Tumors01997201911.5low001140
Glioblastoma01994202216.0low001001
Glioma01997201911.5low001140
Glomerular Necrosis02012201212.0low000010
Glomerulonephritis01977202317.9low2613111011934
Glomerulonephritis, IGA01992202216.9low005661
Glomerulonephritis, Lupus01988202114.9low013791
Glomerulonephritis, Membranoproliferative01993202317.6low003312
Glomerulonephritis, Membranous01997202114.5low0037102
Glomerulonephritis, Minimal Change02003201017.5low000200
Glomerulosclerosis, Focal Segmental01992201518.3low001230
Glucose Intolerance0201620215.5low000011
Glucosephosphate Dehydrogenase Deficiency01975199544.3low0111000
Glycosuria01957201936.0low030030
Goiter01961199441.7low012000
Goiter, Nodular01990201720.5low001010
Goldblatt Syndrome01998201913.5low001120
Gonorrhea01985199534.0low011000
Gout01976202311.2low110133
Gouty Arthritis0201320224.8low000022
Graft Occlusion, Vascular02012201510.5low100020
Graft vs Host Disease02013201410.5low000020
Graft-Versus-Host Disease02013201410.5low000020
Gram-Negative Bacterial Infections01997202210.9low2015202
Gram-Positive Bacterial Infections02007201911.1low000340
Granulocytic Leukemia01963201632.3low148601750
Granulocytic Leukemia, Chronic01989201327.4low0416610
Granuloma01984202321.5low0351131
Granuloma, Giant Cell0201520159.0low000010
Granuloma, Hodgkin01962201428.4low141240
Granuloma, Respiratory Tract02007200717.0low000100
Granulomas01984202321.5low0351131
Granulomatosis with Polyangiitis01988202316.8low2180546836
Granulomatosis, Orofacial0202120213.0low000001
Granulomatosis, Wegener's01988202316.8low2180546836
Granulomatous Disease, Chronic01975202036.5low07022840
Graves Disease01989201821.4low01142060
Gray Platelet Syndrome0201820186.0low000010
Grippe01963202312.8low0103102
Group A Strep Infection01975202221.0low265463
Growth Disorders0200120218.8low000252
Guillain-Barre Syndrome02000200024.0low001000
Gynecomastia02003200321.0low000100
Haemonchiasis01999201913.0low001020
Haemophilus Infections02004200420.0low000100
Haim-Monk Syndrome01996202213.3low001011
Hand Dermatoses01978201527.5low010010
Hand Dermatosis01978201527.5low010010
Hand Foot and Mouth Disease0201520159.0low100010
Hand-Schu00FCller-Christian Disease01962201432.8low020110
Hand, Foot and Mouth Disease0201520159.0low100010
Hangman Fracture02011201113.0low000010
Hansen Disease01981201823.0low013310
Hashimoto Disease02005201711.8low000260
Hay Fever01987201321.1low8161120
HbS Disease01976202216.8low214471
Head and Neck Neoplasms01982202116.0low012051
Headache0200320238.7low000333
Health Care Associated Infection02006200618.0low000100
Hearing Loss0201020237.3low000111
Hearing Loss, Sensorineural01996201319.4low002530
Heart Arrest02000202315.5low101421
Heart Defects, Congenital02000201816.7low201110
Heart Disease, Ischemic01993202220.8low604543193
Heart Diseases01957202316.3low2149121
Heart Failure0200320239.6low700223014
Heart Failure, Diastolic0201820214.5low000011
Heart Failure, Systolic0202120213.0low000001
Heart Septal Defects, Ventricular0201820186.0low000010
Heart Valve Diseases0201020219.0low000111
Heartwater Disease01996199628.0low001000
Heat Stroke01999201913.5low001120
Heatstroke01999201913.5low001120
Heavy Menstrual Bleeding02007200717.0low000100
Helicobacter Infections01995201619.7low2093960
HELLP Syndrome02013201311.0low100010
Hemangioma01999199925.0low001000
Hematochezia01990202119.7low0081241
Hematologic Diseases01975201333.8low098030
Hematologic Malignancies01999201616.3low101420
Hematologic Neoplasms01999201616.3low101420
Hematoma0201120219.3low000021
Hematuria01995202311.9low001663
Hemochromatosis02005201116.0low000110
Hemoglobinuria, Paroxysmal01980198044.0low010000
Hemolysis01980202021.1low0576100
Hemolysis, Elevated Liver Enzymes, Lowered Platelets02013201311.0low100010
Hemolytic-Uremic Syndrome02006200618.0low000100
Hemoptysis01997202213.7low103552
Hemorrhage01945202118.2low123153471
Hemorrhage, Gingival01990201618.1low203730
Hemorrhage, Peptic Ulcer02002200919.0low000400
Hemorrhage, Subarachnoid01978202115.4low011451
Hemorrhage, Uterine01981198143.0low010000
Hemorrhagic Diathesis02014201410.0low000010
Hemorrhagic Disorders02014201410.0low000010
Hemorrhagic Fever with Renal Syndrome0201820224.0low000011
Hemorrhagic Fever, Epidemic0201820224.0low000011
Hemorrhagic Proctocolitis01999200024.5low002000
Hemorrhagic Shock01986202315.4low212251583
Hemorrhagic Thrombocythemia01979200037.9low072000
Hemorrhoids0201320169.5low000020
Hemosiderosis01998202011.0low001030
Hemostatic Disorders0202220222.0low000001
Hepatic Failure02003200420.5low000200
Hepatic Veno Occlusive Disease02009201114.0low000110
Hepatic Veno-Occlusive Disease02009201114.0low000110
Hepatitis01993202012.6low1024110
Hepatitis B01982199635.0low011000
Hepatitis B Virus Infection01982199635.0low011000
Hepatitis B, Chronic0201120237.0low000011
Hepatitis C01994202315.7low102121
Hepatitis C, Chronic01999201416.5low202540
Hepatitis, Alcoholic01988198836.0low010000
Hepatitis, Animal01996200324.5low001100
Hepatitis, Autoimmune01998202015.9low002330
Hepatitis, Chronic02002200222.0low000100
Hepatitis, Viral, Human01982198242.0low010000
Hepatitis, Viral, Non-A, Non-B, Parenterally-Transmitted01994202315.7low102121
Hepato-Pulmonary Syndrome01999201416.3low001110
Hepatoblastoma02003200321.0low000100
Hepatocellular Carcinoma01946202317.9low122564
Hepatolenticular Degeneration01976200732.5low010100
Hepatopulmonary Syndrome01999201416.3low001110
Hereditary Autoinflammation Diseases0201720177.0low000010
Heritable Pulmonary Arterial Hypertension0202020204.0low000010
Hermanski-Pudlak Syndrome0202320231.0low000001
Hernias, Diaphragmatic, Congenital02001200123.0low000100
Heroin Abuse02014201410.0low000010
Heroin Dependence02014201410.0low000010
Herpes Simplex01991201026.3low002100
Herpes Simplex Keratitis01998199826.0low001000
Herpes Simplex Virus Infection01991201026.3low002100
Herpes Zoster01963200041.7low021000
Hibernation, Myocardial01997201319.7low001110
Hiccough02010201014.0low000100
Hidradenitis Suppurativa0202120213.0low000002
Histiocytic Necrotising Lymphadenitis02001202115.2low000621
Histiocytosis, Langerhans-Cell01962201432.8low020110
Histomoniasis01986198936.5low020000
HIV01987202020.8low012020
HIV Coinfection01991202117.7low107561
HIV Infections01991202117.7low107561
Hives02008200816.0low000100
Hoarseness0202320231.0low100001
Hodgkin Disease11962201428.4low141240
Hormone-Dependent Neoplasms02002200222.0low000100
Hospital-Acquired Condition01999199925.0low001000
HPV Infection01994201619.5low002110
Human Trichinellosis01975200927.6low0218700
Huntington Disease0200520209.0low000120
Hyaline Membrane Disease02000200024.0low101000
Hydronephrosis02001200919.0low000200
Hymenolepiasis02001200720.0low000200
Hyperandrogenism02013201311.0low000010
Hypercalcemia01985201131.0low030010
Hypercapnia01997201517.4low002410
Hypercholesterolemia02001202015.0low1001430
Hypercoagulability02004202011.0low000120
Hyperemia01988201721.9low011320
Hypereosinophilic Syndrome01994199430.0low002000
Hypergammaglobulinemia01980201332.6low031010
Hyperglycemia02000202311.3low0014101
Hyperglycemia, Postprandial02000202311.3low0014101
Hypergonadotropic Hypogonadism0202020204.0low000010
Hyperhomocysteinemia02014201410.0low000010
Hyperlipemia01976201918.8low022570
Hyperlipidemia, Familial Combined0201820186.0low000010
Hyperlipidemias01976201918.8low022570
Hyperlipoproteinemia Type II02008202011.0low100120
Hyperlipoproteinemia Type III01999199925.0low001000
Hypermelanosis02002200520.5low000200
Hypernutrition0201920195.0low000010
Hyperoxia01945202015.9low01316190
Hyperphagia02010201511.5low000110
Hyperpigmentation02002200520.5low000200
Hyperplasia01950202222.0low02111061
Hyperplasia, Reactive Lymphoid02000200024.0low001000
Hypersensitivity01954201721.0low018690
Hypersensitivity, Type III01984201527.2low0313130
Hypertension01990202213.9low20715253
Hypertension, Essential02013201510.0low000020
Hypertension, Portal01996202320.9low004301
Hypertension, Pregnancy-Induced0201620177.5low000020
Hypertension, Pulmonary01993201816.6low004470
Hypertension, Renovascular01998201913.5low001120
Hyperthyroid01980201322.0low016920
Hyperthyroidism01980201322.0low016920
Hypertrophy01995202310.4low0024135
Hypertrophy, Left Ventricular0200220229.7low000111
Hypertrophy, Right Ventricular02010201014.0low000100
Hyperuricemia02008202010.8low100140
Hypesthesia0201920195.0low000010
Hypoalbuminemia0201620168.0low000010
Hypogalactia01990199133.5low002000
Hypogammaglobulinemia01976200933.4low022100
Hypoglycemia02012201212.0low000010
Hypogonadism0202020204.0low000010
Hypomenorrhea0201720177.0low000010
Hypoparathyroidism01996199628.0low001000
Hypopharyngeal Cancer01998199826.0low001000
Hypopharyngeal Neoplasms01998199826.0low001000
Hypoplastic Left Heart Syndrome0201820186.0low000010
Hypotension01993201921.4low007420
Hypothermia02001201415.3low000120
Hypothermia, Accidental02001201415.3low000120
Hypothyroidism01993201718.3low0041150
Hypovolemia02009200915.0low000100
Hypovolemic02009200915.0low000100
Hypoxia01981202217.2low311419242
Hypoxia-Ischemia, Brain02002201515.8low000630
Ichthyosis01980198442.0low020000
Icterus01980201029.0low010100
Icterus Gravis Neonatorum01981202121.3low010101
Idiopathic Hypoparathyroidism01996199628.0low001000
Idiopathic Inflammatory Myopathies01991202214.0low101431
Idiopathic Interstitial Pneumonia0201820233.5low000011
Idiopathic Parkinson Disease0200420239.9low0005102
Idiopathic Pulmonary Fibrosis0201320216.1low0000113
IgA Vasculitis01991202216.2low103623
IgG4 Related Systemic Disease0201920233.0low000014
Ileal Diseases01990201616.6low002840
Ileitis01989202119.2low011314111
Ileus02004202113.9low000741
Immune System Diseases01954201519.0low011280
Immunoglobulin G4-Related Disease0201920233.0low000014
Immunologic Deficiency Syndromes01976201730.6low0410020
Impaired Glucose Tolerance0201620215.5low000011
Impairment, Light Touch Sensation0202020204.0low000010
Impetigo02014201410.0low000010
Impetigo Contagiosa02014201410.0low000010
Impotence02005202113.1low000531
Impotence, Arteriogenic02007200717.0low000100
Inadequate Sleep02008201114.2low000220
Inappropriate GH Secretion Syndrome (Acromegaly)02010201014.0low000100
Inborn Errors of Metabolism01975202023.6low0891130
Inclusion Body Myopathy, Sporadic0202020204.0low000010
Incompetence, Pulmonary Valve02002200222.0low000100
Indigestion01988201919.5low110210
Infant, Newborn, Diseases01975201431.5low121010
Infant, Premature, Diseases01994201421.2low102210
Infant, Small for Gestational Age01976197648.0low010000
Infantile Diarrhea0201620177.5low000020
Infantile Respiratory Distress Syndrome01995201817.4low002230
Infarct01997201717.5low002420
Infarct, Lacunar02011201113.0low000010
Infarction, Middle Cerebral Artery02000202115.4low00339241
Infection01963202026.5low01361080
Infection, Mycobacterium avium-intracellulare02000200024.0low001000
Infection, Postoperative Wound01997200721.0low001200
Infection, Wound01995202310.9low001141
Infections01963202026.5low01361080
Infections, Chlamydia01995201422.0low002210
Infections, Coronavirus0202020204.0low000030
Infections, Helicobacter01995201619.7low2093960
Infections, Klebsiella01991201817.5low0031160
Infections, Legionella pneumophila02001200222.5low000200
Infections, Listeria01984201824.0low012220
Infections, Meningococcal0201820186.0low000010
Infections, Mycobacterium02002201416.5low000310
Infections, Nematode01999201220.3low002010
Infections, Orthomyxoviridae02001202312.3low0006102
Infections, Paramyxoviridae01984201718.3low010020
Infections, Parvoviridae02005200519.0low000100
Infections, Pasteurella02014201410.0low000010
Infections, Picornaviridae02000201714.0low001020
Infections, Plasmodium01987202311.6low111024
Infections, Pneumococcal01976202117.4low011632
Infections, Prosthesis-Related02002202013.0low000110
Infections, Proteus01992199232.0low001000
Infections, Pseudomonas01986202317.4low111819193
Infections, Respiratory01986202219.7low316931
Infections, Respiratory Syncytial Virus01994202116.1low003231
Infections, Retroviridae02010201014.0low000100
Infections, Rhabdoviridae02008200816.0low000100
Infections, RNA Virus02008200816.0low000100
Infections, Salmonella01975201818.6low010130
Infections, Staphylococcal01975202218.5low012517255
Infections, Taenia01987199433.5low011000
Infections, Trichomonas0201320198.0low000020
Infections, Ureaplasma02003200321.0low000100
Infections, Vibrio01996201614.4low001130
Infections, Yersinia01989199233.0low013000
Infectious Bovine Rhinotracheitis02009200915.0low000100
Infectious Diseases01963202318.5low011022
Infectious Endophthalmitis01984201318.9low010330
Infectious Keratoconjunctivitis01988198836.0low010000
Infectious Myelitis01998201515.4low001220
Infectious Skin Diseases01982198839.0low020000
Infective Endocarditis0202220222.0low000001
Inferior Dislocation02005200519.0low000100
Infertility02004200420.0low000100
Infertility, Female01984202121.3low012021
Infertility, Male01992202116.8low004441
Inflammation01948202313.8low4142139502739119
Inflammation, Endodontic02006201314.5low000110
Inflammatory Bowel Diseases01988202315.4low513662709
Inflammatory Response Syndrome, Systemic01995202215.3low10320172
Influenza in Birds0201520159.0low000010
Influenza, Human01963202312.8low0103102
Inhalation Injury, Smoke01994201616.8low0039100
Injuries01975202119.0low14527112
Injuries, Eye02010201611.3low000120
Injuries, Leg02001201413.0low000140
Injuries, Multiple01991202313.5low103171
Injuries, Radiation02001201713.8low000240
Injuries, Soft Tissue02008201313.5low000110
Injuries, Spinal Cord01990202215.6low101550391
Injuries, Tendon02008200816.0low000100
Injury, Ischemia-Reperfusion01989202317.6low16124746631420
Injury, Myocardial Reperfusion01988202222.0low2811286401
Innate Inflammatory Response01948202313.8low4142139502739119
Inner Ear Disease0201520159.0low000010
Insulin Resistance0200320239.7low3004211
Insulin Sensitivity0200320239.7low3004211
Intermittent Claudication02004200818.0low000200
Interstitial Nephritis01992202316.1low003541
Intestinal Diseases01985202214.4low01923353
Intestinal Diseases, Parasitic01984200228.6low016100
Intestinal Neoplasms02007201115.0low000110
Intestinal Obstruction01990201621.9low005610
Intestinal Perforation01992201022.0low002500
Intracranial Aneurysm0200320238.9low100253
Intracranial Arteriovenous Malformations02004200818.0low000300
Intracranial Hemorrhages02012201411.0low000020
Intradural-Extramedullary Spinal Cord Neoplasms02005200519.0low000100
Intraventricular Septal Defects0201820186.0low000010
Invasiveness, Neoplasm01986201621.8low011110
Iritis01984199733.5low011000
Iron Overload02001201813.7low000120
Irritable Bowel Syndrome02003201914.3low100740
Ischemia01986202321.7low98104683811
Ischemic Attack, Transient01991202321.4low00151831
Ischemic Stroke0202320231.0low000003
Itching01982201023.3low010200
Jaundice01980201029.0low010100
Jaundice, Cholestatic02005201413.9low000520
Jaundice, Neonatal01981202121.3low010101
Jaundice, Obstructive02005201413.9low000520
Jaw Diseases01983198341.0low010000
Jejunal Diseases01995201221.3low005410
Job Syndrome01975197648.3low030000
Joint Diseases01984201320.2low011130
Joint Pain0201720205.5low000020
Kahler Disease01986202318.0low123361
Kawasaki Disease01999202214.0low001221
Keratitis01995202314.8low0041464
Keratitis, Acanthamoeba02001200123.0low000100
Keratitis, Herpetic01998199826.0low001000
Keratitis, Ulcerative01996202314.0low002441
Keratoconjunctivitis01990200029.0low002000
Keratoconjunctivitis Sicca01995199529.0low001000
Keratoderma Blennorrhagicum01996200324.5low001100
Keratosis01996200324.5low001100
Kernicterus02009200915.0low000100
Kidney Calculi02007200717.0low000100
Kidney Diseases01985202314.8low1122475710
Kidney Failure01993201918.5low0041340
Kidney Failure, Chronic01982202313.7low546283114
Kidney Neoplasms01984200129.7low111100
Kidney Stones02007200717.0low000100
Kidney Tubular Necrosis, Acute02004201615.3low000210
Klebsiella Infections01991201817.5low0031160
Koch's Disease01956202132.3low082252
Koehler Disease02011201113.0low000020
Kwashiorkor01976197648.0low010000
Labor Pain01951195173.0low010000
Labor, Premature01998200423.3low102100
Labyrinth Diseases0201520159.0low000010
Lacrimal Apparatus Diseases0200920219.0low000101
Laryngeal Neoplasms01979200430.2low023100
Laryngitis02013201410.5low000020
Laryngopharyngeal Reflux02009201412.5low000110
Lassitude01963201919.5low010230
Latent Tuberculosis0201820214.5low000011
Lead Poisoning01979197945.0low010000
Leanness02009201213.3low000120
Left Heart Hypoplasia Syndrome0201820186.0low000010
Left Ventricular Dysfunction01995202015.5low202960
Left Ventricular Hypertrophy0200220229.7low000111
Leiomyoma01980201725.5low020110
Leiomyosarcoma1201720177.0low000010
Leiomyosarcoma, Epithelioid0201720177.0low000010
Leishmania Infection02001201615.5low000110
Leishmaniasis02001201615.5low000110
Leishmaniasis, American02010201810.2low000130
Leishmaniasis, Cutaneous02010201810.2low000130
Leishmaniasis, Mucocutaneous02010201014.0low000100
Leishmaniasis, Visceral01982201122.6low010310
Leprosy01981201823.0low013310
Leptospirosis01983198341.0low010000
Lesion of Sciatic Nerve02007201813.2low000320
Leucocythaemia01958202330.3low249422376
Leukemia11958202330.3low249422376
Leukemia L 121001984200430.0low010100
Leukemia-Lymphoma, Adult T-Cell01989200426.4low015200
Leukemia, Acute Monocytic01976201534.8low096110
Leukemia, Basophilic, Acute02001200322.0low000200
Leukemia, Biphenotypic, Acute01990201815.4low002250
Leukemia, Erythroblastic, Acute01976200530.9low026200
Leukemia, Lymphoblastic, Acute, T Cell0201220208.5low000040
Leukemia, Lymphocytic01975200339.1low0264200
Leukemia, Lymphocytic, Chronic, B-Cell11988202218.4low111411
Leukemia, Lymphocytic, T Cell02002200421.0low000200
Leukemia, Lymphoid01975200339.1low0264200
Leukemia, Megakaryoblastic, Acute01987201626.6low068340
Leukemia, Megakaryocytic01987201626.6low068340
Leukemia, Monocytic, Acute01976201534.8low096110
Leukemia, Myelogenous, Chronic, BCR-ABL Positive01989201327.4low0416610
Leukemia, Myeloid01963201632.3low148601750
Leukemia, Myeloid, Acute11975202329.2low11075541274
Leukemia, Myeloid, Acute, M401989202124.4low019421
Leukemia, Myelomonocytic, Acute01989202124.4low019421
Leukemia, Myelomonocytic, Chronic01991201922.4low005030
Leukemia, Neutrophilic, Chronic01994199430.0low002000
Leukemia, Pre-B-Cell01991201921.5low002110
Leukemia, Promyelocytic, Acute01988202325.5low01032574
Leukemia, Radiation-Induced01993199331.0low001000
Leukemia, Smoldering01988200230.8low012100
Leukemia, T-Cell02002200421.0low000200
Leukemic Infiltration01997202316.8low003631
Leukocyte Disorders01997202213.7low003291
Leukocyte-Adhesion Deficiency Syndrome01995200723.5low002200
Leukocytopenia01982202323.8low1422461
Leukocytosis01994201718.7low104530
Leukodystrophy, Globoid Cell01976197648.0low010000
Leukodystrophy, Metachromatic01976197648.0low010000
Leukoencephalopathy, Progressive Multifocal01996202016.0low001010
Leukokeratosis01985198539.0low010000
Leukoma02011201511.0low000020
Leukopenia01982202323.8low1422461
Leukoplakia01985198539.0low010000
Lewy Body Disease0202020204.0low000010
Libman-Sacks Disease01990202221.3low003613132
Lichen Planus, Oral0201520159.0low000010
Lichen Simplex Chronicus01985198539.0low010000
Limited Scleroderma02014201410.0low000010
Lipidoses01975197848.0low030000
Lipodystrophy01976201717.8low010030
Livedo Reticularis0202020204.0low000010
Liver Abscess01977201135.0low020010
Liver Abscess, Pyogenic0201720177.0low000010
Liver Cirrhosis01975202314.6low11410164
Liver Cirrhosis, Alcoholic01980201622.2low020120
Liver Cirrhosis, Biliary01998200720.3low001500
Liver Diseases01990202115.9low001646332
Liver Diseases, Alcoholic02001201217.5low000110
Liver Dysfunction01990202115.9low001646332
Liver Failure02003200420.5low000200
Liver Failure, Acute02003202210.2low000281
Liver Neoplasms01946202316.2low322786
Liver Steatosis01951201913.4low0104190
Local Neoplasm Recurrence0200820235.8low200153
Long Sleeper Syndrome0201320198.0low000020
Lower Urinary Tract Symptom02013201510.0low000020
Lung Abscess02014201410.0low000010
Lung Diseases01980202320.1low357698476
Lung Diseases, Interstitial01996202312.2low008101112
Lung Diseases, Obstructive01982201428.5low3413310
Lung Diseases, Parasitic02004200420.0low000100
Lung Injury, Acute0200320239.7low1005633720
Lung Injury, Ventilator-Induced0200520228.8low0002152
Lung Neoplasms11983202316.9low25933235
Lupus Erythematosus Panniculitis01998199826.0low001000
Lupus Erythematosus, Systemic01990202221.3low003613132
Lupus Nephritis01988202114.9low013791
Lupus Vulgaris01991199133.0low001000
Lyme Disease02014201410.0low000010
Lymph Node Metastasis01986202118.2low022141
Lymphatic Diseases01950201334.0low030210
Lymphocytopenia01985200728.0low010100
Lymphocytosis01992199232.0low001000
Lymphogranuloma Inguinale01982198242.0low010000
Lymphohistiocytosis, Hemophagocytic02011201113.0low000010
Lymphoma11975202224.6low1710761
Lymphoma, B-Cell01991200526.2low004200
Lymphoma, Follicular12003201714.0low100110
Lymphoma, Large B-Cell, Diffuse01984202120.6low113131
Lymphoma, Large-Cell, Anaplastic01996201819.0low001110
Lymphoma, Mantle-Cell02003200420.5low000200
Lymphoma, Non-Hodgkin01975202323.2low140521
Lymphoma, T-Cell01997201018.7low001200
Lymphopenia01985200728.0low010100
Lymphoproliferative Disorders01982201331.8low031010
Maculopapular Cutaneous Mastocytosis01984198440.0low010000
Maggot Infestations02011201113.0low000010
Magnesium Deficiency02009200915.0low000100
Malabsorption Syndromes0201920195.0low100010
Malaria01987202311.6low111024
Malaria, Falciparum02003202311.0low000101
Male Genitourinary Diseases02000201715.5low001010
Malignant Melanoma01982202315.1low112124
Malnourishment0200620237.8low100152
Malnutrition0200620237.8low100152
Malocclusion02014201410.0low000020
Mandibular Diseases02001201415.3low100120
Mandibular Neoplasms02010201014.0low000100
Manganese Poisoning02012201212.0low000010
Mange, Sarcoptic02014201410.0low000010
Marasmus01977201724.7low021210
Marchiafava-Micheli Syndrome01980198044.0low010000
Mast Cell Activation Disease01996199628.0low001000
Mastitis0199720219.0low1013242
Mastitis, Bovine01989202019.8low115440
Mastocytosis01996199628.0low001000
Maxillary Diseases02008200816.0low000100
Maxillary Neoplasms02010201014.0low000100
Maxillary Sinusitis02008200816.0low100100
Measles01984198440.0low010000
Meconium Aspiration Syndrome02005200718.3low000300
Mediastinitis02009200915.0low000100
Medulloblastoma01989198935.0low010000
Melanoma11982202315.1low112124
Melena02010201014.0low000100
Memory Disorders0200920218.6low000161
Meniere Disease01998199826.0low001000
Meningeal Neoplasms02007200717.0low000100
Meningitis01976202311.5low0217178
Meningitis, Aseptic02007200717.0low000100
Meningitis, Bacterial02000201917.3low003120
Meningitis, Cryptococcal02002200620.0low000200
Meningitis, Meningococcal01992200028.0low002000
Meningitis, Meningococcal, Serogroup A01992200028.0low002000
Meningitis, Pneumococcal01975201427.8low021020
Meningococcal Infections0201820186.0low000010
Menopause01984201916.8low112170
Menorrhagia02007200717.0low000100
Mental Disorders02011201113.0low000010
Mesenteric Lymphadenitis02014201410.0low000010
Mesenteric Vascular Occlusion01991201521.6low1011850
Metabolic Acidosis01999201618.2low002120
Metabolic Diseases01958201923.5low022040
Metabolic Syndrome0200820229.1low6006162
Metabolism, Inborn Errors01975202023.6low0891130
Metaplasia02001202314.6low100311
Metastase01977201913.5low011090
Microbial Superinvasion02004200420.0low000100
Microglossia02013201311.0low000010
Microscopic Polyangiitis0200820237.8medium300118427
Middle Ear Effusion01996201920.3low103210
Middle Ear Inflammation01985202313.6low0152143
Milk Hypersensitivity02007201015.2low100400
Milk-Alkali Syndrome01985201131.0low030010
Minimal Disease, Residual01998202119.0low002101
Minimally Conscious State02007200717.0low000100
Mitochondrial Diseases02012201212.0low000010
Mitral Incompetence0201720215.0low000011
Mitral Valve Insufficiency0201720215.0low000011
MODS01990202217.5low301735193
Monieziasis0201520159.0low000010
Moniliasis, Oral01974201324.3low113030
Monkey Diseases01981198143.0low010000
Mononeuritis0201120215.8low000022
Mononeuropathies0201120215.8low000022
Monosomy01985200228.7low011100
Mood Disorders02004201614.0low000110
Morbid Obesity02009202011.6low200440
Morphine Abuse02010201014.0low000100
Morphine Dependence02010201014.0low000100
Mosquito Borne Diseases0202220222.0low000001
Motor Disorders0201920223.5low000011
Mouth Diseases02013201311.0low000010
Mouth Neoplasms01986201718.5low011330
Mouth Ulcer02005201315.0low000110
Mouth, Edentulous0201420169.0low000020
Movement Disorders02005201215.0low000210
MPTP Neurotoxicity Syndrome02013201311.0low000010
MS (Multiple Sclerosis)01981202317.2low1161381
Mucocutaneous Lymph Node Syndrome01999202214.0low001221
Mucopolysaccharidoses01976197648.0low010000
Mucopolysaccharidosis01976197648.0low010000
Mucopolysaccharidosis IV0201520159.0low000010
Mucositis02008202210.7low0007221
Mucositis, Oral02005201812.0low1006120
Multiple Myeloma01986202318.0low123361
Multiple Organ Failure01990202217.5low301735193
Multiple Primary Neoplasms01999200820.5low001100
Multiple Pulmonary Nodules0200920228.5low000202
Multiple Sclerosis01981202317.2low1161381
Multiple Sclerosis, Chronic Progressive0201820186.0low000010
Multiple System Atrophy0201220207.8low000040
Multiple System Atrophy Syndrome0201220207.8low000040
Mumps01984199037.0low011000
Muscle Contraction01989201918.9low111746140
Muscle Disorders01990201625.8low004010
Muscle Pain0201420237.2low000031
Muscle Relaxation01996201522.3low004110
Muscle Weakness0201820205.0low000030
Muscular Atrophy02006200816.5low000400
Muscular Atrophy, Postpoliomyelitis02010201014.0low000100
Muscular Diseases01990201625.8low004010
Muscular Dystrophies01956200950.3low020100
Muscular Dystrophy01956200950.3low020100
Muscular Dystrophy, Animal01997199727.0low001000
Muscular Dystrophy, Duchenne0200020239.2low101021
Muscular Weakness0201820205.0low000030
Musculoskeletal Pain02014201410.0low000010
Myalgia0201420237.2low000031
Mycobacterium avium-intracellulare Infection02000200024.0low001000
Mycobacterium Infections02002201416.5low000310
Mycoplasma dispar Infection01992201819.0low002020
Mycoses01984202116.6low011231
Myelodysplastic Syndromes11985202222.2low2716447
Myelomonocytic Leukemia, Chronic01991201922.4low005030
Myelopathy02007200717.0low000100
Myeloproliferative Disorders01982202227.0low161311
Myocardial Infarction01981202319.0low101277111813
Myocardial Ischemia01993202220.8low604543193
Myocarditis01990201917.4low003960
Myoglobinuria01995201220.5low001010
Myoma02000200024.0low001000
Myositis01991202214.0low101431
Myositis, Inclusion Body0202020204.0low000010
Myositis, Multiple02000202010.7low001020
Myotonic Dystrophy01986198638.0low010000
Nail Fungus01986198638.0low010000
Nasal Bleeding0202020232.5low000011
Nasal Catarrh01992202314.2low103644
Nasal Obstruction01998200822.0low002100
Nasal Polyps02005202310.5low100332
Nasal Septal Perforation0201620168.0low000010
Nasopharyngeal Neoplasms0201620234.5low000011
Neck Pain0201520159.0low000010
Necrosis01980202320.0low226547434
Necrotizing Enterocolitis0200520219.6low000161
Necrotizing Pyelonephritis01963202026.5low050330
Neisseria gonorrhoeae Infection01985199534.0low011000
Neointima0201520197.3low000030
Neoplasm Metastasis01977201913.5low011090
Neoplasm Metastasis, Unknown Primary0201520159.0low000010
Neoplasms11947202316.0low41610304724
Neoplasms, Bone Marrow02012201212.0low000010
Neoplasms, Plasma Cell02012201212.0low000010
Neoplasms, Pleural01998199826.0low001000
Neoplasms, Squamous Cell02002200222.0low000100
Neoplasms, Vascular02001201118.0low000110
Neovascularization, Optic Disc0202320231.0low000001
Nephritis01993202317.0low008844
Nephritis, Hereditary01977197747.0low010000
Nephritis, Interstitial01992202316.1low003541
Nephrocalcinosis0201520159.0low000010
Nephrosclerosis02002200719.5low000200
Nephrosis, Lipoid02003201017.5low000200
Nephrotic Syndrome02003202110.7low000141
Nerve Degeneration01995201715.5low002750
Nerve Pain02006202010.9low0002160
Nerve Root Avulsion0201920195.0low000010
Nervous System Diseases01990201915.0low003390
Nervous System Disorders01990201915.0low003390
Neural Tube Defects01987201722.0low010010
Neuralgia02006202010.9low0002160
Neuralgia, Sciatic02003202112.0low000101
Neuritis01998201418.0low001010
Neuroblastoma01987200528.0low012100
Neurodegenerative Diseases0200620238.1low1003102
Neurodermatitis01985198539.0low010000
Neurogenic Inflammation02001201914.0low000210
Neuromuscular Diseases01978200035.0low011000
Neuromyelitis Optica02009202210.5low000211
Neuroretinitis01994200326.7low002100
Neutropenia01975202325.4low111242261
Neutrophilic Leukemia, Chronic01994199430.0low002000
Newcastle Disease01989201223.5low010010
Niemann-Pick Disease01976197648.0low010000
Niemann-Pick Diseases01976197648.0low010000
No-Reflow Phenomenon0201320178.7low100030
Nociceptive Pain0201220217.8low000051
Nodular Goiter01990201720.5low001010
Non-alcoholic Fatty Liver Disease0201120236.8low1000135
Non-ST Elevated Myocardial Infarction0201620168.0low000010
Non-ST-Elevation Myocardial Infarction0201620168.0low000010
Nutrition Disorders01982199533.7low012000
Nutritional Disorders01982199533.7low012000
Obesity0200020239.5low3018386
Obesity, Morbid02009202011.6low200440
Obstructive Lung Diseases01982201428.5low3413310
Onchocerciasis01996199926.5low002000
Onychomycosis01986198638.0low010000
Oophoritis02012201311.5low000020
Opioid-Related Disorders02001200123.0low000100
Opisthorchiasis0202020204.0low000010
Opisthorchis felineus Infection0202020204.0low000010
Opportunistic Infections01993200822.2low002300
Optic Neuropathy, Ischemic02010201014.0low000100
Oral Ulcer02005201315.0low000110
Orbital Diseases02000201417.0low001010
Orbital Neoplasms02005201612.2low000130
Orchitis0202020204.0low000010
Organophosphate Poisoning01988198836.0low010000
Organophosphorus Poisoning01988198836.0low010000
Ornithosis02012201212.0low000010
Oropharyngeal Neoplasms02004200420.0low000100
Orphan Diseases0202020204.0low000010
Orthomyxoviridae Infections02001202312.3low0006102
Osteoarthritis01985202315.5low213171
Osteoarthritis of Knee02007202011.8low100220
Osteoarthritis, Hip0200820219.5low000101
Osteoarthritis, Knee02007202011.8low100220
Osteochondritis Dissecans02013201311.0low000010
Osteogenic Sarcoma02004202312.7low100201
Osteolysis02014201410.0low000010
Osteomyelitis01983202022.7low030030
Osteopetrosis01982198242.0low010000
Osteoporosis02011201113.0low000010
Osteosarcoma02004202312.7low100201
Otitis Externa01993199331.0low001000
Otitis Media01985202313.6low0152143
Otitis Media with Effusion01996201920.3low103210
Otitis Media, Purulent01985201126.7low011010
Otitis Media, Suppurative01985201126.7low011010
Ovarian Diseases0201620168.0low000010
Ovarian Neoplasms01995202314.1low002661
Overweight0200720189.6low300260
Ovine Diseases0201320197.4low000050
Ovoid Neutrophil Nuclei, Developmental Delay, Epilepsy and Skeletal Abnormalities01987198737.0low010000
P carinii Pneumonia0202020232.5low000011
Pachymeningitis01976202311.5low0217178
Pain01998202311.4low30117308
Pain, Chronic0201620187.0low000020
Pain, Intractable0201720177.0low000010
Pain, Postoperative02007201513.0low000110
Palmoplantaris Pustulosis01976202318.9low11334147
Palsy02008201612.8low000220
Pancreatic Diseases02003202113.0low100311
Pancreatic Fistula0202020204.0low000010
Pancreatic Insufficiency02008200816.0low000100
Pancreatic Neoplasms0200820236.3low600469
Pancreatitis01987202315.4low02301251037
Pancreatitis, Chronic02005202110.5low000251
Pancytopenia01985200330.3low011100
Panuveitis0202020204.0low000010
Papilloma01985201224.8low011110
Papilloma, Squamous Cell01985201224.8low011110
Papillomavirus Infections01994201619.5low002110
Paralysis02008201612.8low000220
Paralysis, Legs0201020229.8low000211
Paramyxoviridae Infections01984201718.3low010020
Paranasal Sinus Diseases02008200816.0low000100
Paranasal Sinus Neoplasms02005200519.0low000100
Paraparesis02007200717.0low000100
Paraparesis, Tropical Spastic02000200024.0low001000
Paraplegia0201020229.8low000211
Paraproteinemias01986202023.3low011010
Parasite Infections01997202112.0low101011
Parasitemia0200820209.0low000120
Parkinson Disease0200420239.9low0005102
Parkinson Disease, Secondary02010201014.0low000100
Parkinsonian Disorders0200520228.8low000141
Parodontosis01954202125.8low055541
Parotid Neoplasms01991200924.0low001100
Parotiditis01978201621.5low010210
Pasteurellosis, Pneumonic02005200917.0low000200
Patency of the Ductus Arteriosus01995200225.5low001100
Peanut Hypersensitivity02004200420.0low000100
Pelvic Inflammatory Disease01994201022.0low101100
Pelvic Pain02003200321.0low000100
Pemphigoid01993200026.2low006000
Pemphigoid, Benign Mucous Membrane02014201410.0low000010
Pemphigoid, Bullous01993200026.2low006000
Pemphigus01993199331.0low001000
Pemphigus Foliaceus01993199331.0low001000
Peptic Ulcer01991201618.8low0051330
Perforated Appendicitis01984202015.5low010030
Peri-Implantitis0201420169.0low000020
Pericardial Effusion02005202310.7low000111
Pericarditis01998201119.5low001210
Pericarditis, Tuberculous02000200024.0low001000
Pericementitis01977202316.5low471229383
Periimplantitis0201420169.0low000020
Periodontal Diseases01954202125.8low055541
Periodontal Pocket01980202116.3low21312101
Periodontitis01977202316.5low471229383
Periostitis01983198341.0low010000
Peripheral Arterial Disease02009202110.2low000131
Peripheral Arterial Diseases02009202110.2low000131
Peripheral Nerve Diseases0199320219.8low002163
Peripheral Nerve Injuries0200920209.0low000130
Peripheral Nerve Injury0200920209.0low000130
Peripheral Nervous System Diseases0199320219.8low002163
Peripheral Vascular Diseases02008201015.4low100500
Peritoneal Carcinomatosis02002200222.0low000100
Peritoneal Diseases01995202014.6low001220
Peritoneal Neoplasms02002200222.0low000100
Peritonitis01977202217.1low232039393
Petechiae0200720229.5low000101
Ph 1 Chromosome01991200028.3low006000
Phagocyte Bactericidal Dysfunction01975199240.5low0101000
Pharyngeal Neoplasms01986200031.0low011000
Pheochromocytoma01988198836.0low010000
Pheochromocytoma, Extra-Adrenal01988198836.0low010000
Phlegmasia Alba Dolens02002201515.5low000110
Phlegmon01963198251.5low020000
Pink Eye02000200024.0low001000
Pituitary Diseases02013201311.0low000010
Pituitary Neoplasms01995199529.0low001000
Placenta, Retained02014201410.0low000010
Plague01987201622.5low010010
Plasmodium falciparum Malaria02003202311.0low000101
Pleural Diseases0201620168.0low000010
Pleural Effusion01998201818.0low001610
Pleurisy01988202315.6low011127272
Pleurisy, Tuberculous0201820186.0low000010
Pleuropericarditis01998201119.5low001210
Pleuropneumonia02004201813.0low000110
Plica Syndrome01996201713.4low001240
Pneumococcal Infections01976202117.4low011632
Pneumonia01963202214.8low7520761086
Pneumonia, Aspiration01993201421.1low008530
Pneumonia, Bacterial01996202215.7low20520132
Pneumonia, Pneumococcal01978202019.2low012630
Pneumonia, Pneumocystis0202020232.5low000011
Pneumonia, Staphylococcal02011201412.0low000030
Pneumonia, Ventilator-Associated0201820186.0low100020
Pneumonia, Viral0200720219.2low000341
Pocket, Periodontal01980202116.3low21312101
Poisoning01954195470.0low010000
Poisoning, Lead01979197945.0low010000
Polyarthritis01989202016.4low01811110
Polycystic Kidney, Autosomal Dominant02013201311.0low000010
Polycystic Ovarian Syndrome0201220217.4low000072
Polycystic Ovary Syndrome0201220217.4low000072
Polycythemia Vera01986200029.7low012000
Polymyalgia Rheumatica02008200816.0low000100
Polymyositis02000202010.7low001020
Polyneuropathies02000202111.0low001011
Polyneuropathy, Acquired02000202111.0low001011
Polyploid01998201017.2low001300
Postoperative Complications01984202317.0low721430186
Postpoliomyelitis Syndrome02010201014.0low000100
Potassium Deficiency01964196460.0low010000
Pouch Ileitis01998201717.2low002210
Pouchitis01998201717.2low002210
Poultry Diseases02001201812.3low000120
Pre-Eclampsia01992202213.8low0027101
Precancerous Conditions01985201220.0low010510
Precordial Catch02003201814.0low10011120
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma01991201921.5low002110
Precursor Cell Lymphoblastic Leukemia-Lymphoma01988202124.6low14411662
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma0201220208.5low000040
Prediabetes0201120207.7low000030
Prediabetic State0201120207.7low000030
Pregnancy01948202318.9low82825497214
Preleukemia01976198343.4low080000
Premature Birth02012201410.8low000040
Premature Rupture of Fetal Membranes01985201328.3low020010
Pressure Ulcer02000201916.2low001210
Preterm Birth02012201410.8low000040
Priapism02003200321.0low000100
Primary Graft Dysfunction02011201113.0low000010
Primary Myelofibrosis01977201630.0low061030
Primary Ovarian Insufficiency0201520159.0low000010
Primary Peritonitis01977202217.1low232039393
Prinzmetal Angina01996199628.0low001000
Proctitis01995200323.8low001300
Proctocolitis01999200024.5low002000
Proliferative Vitreoretinopathy01994199529.5low002000
Prostatic Hyperplasia01999201814.3low001020
Prostatic Neoplasms01994202211.5low0023172
Prostatic Neoplasms, Castration-Resistant0202120213.0low000001
Prostatitis01999200722.0low002200
Prosthesis Durability0201820186.0low000010
Protein Aggregation, Pathological0201520159.0low000010
Protein Folding Diseases02010201014.0low000200
Protein-Energy Malnutrition01977201724.7low021210
Protein-Losing Enteropathies0202120213.0low000001
Proteinuria01987202314.7low0268153
Protozoan Infections, Animal01989200723.3low010200
Prurigo0202020204.0low000010
Pruritus01982201023.3low010200
Pseudomonas Infections01986202317.4low111819193
Psittacosis02012201212.0low000010
Psoriasis01976202318.9low11334147
Psoriasis Arthropathica01996202211.2low002013
Ptosis, Eyelid01996199628.0low001000
Puerperal Disorders02006200618.0low000100
Pulmonary Arterial Remodeling0201520188.0low000030
Pulmonary Consumption01961202122.1low022541
Pulmonary Disease, Chronic Obstructive02001202312.7low110032353
Pulmonary Edema01987202115.6low013037742
Pulmonary Embolism01992202313.9low102732
Pulmonary Eosinophilia02011201113.0low100010
Pulmonary Fibrosis01978202218.1low171126291
Pulmonary Hypertension01993201816.6low004470
Pulmonary Sarcoidosis02007202210.0low000111
Pulpitis02006201314.5low000110
Purpura0200720229.5low000101
Purpura, Thrombocytopenic02000200024.0low001000
Purpura, Thrombocytopenic, Idiopathic0201620225.0low000011
Purpura, Thrombopenic02000200024.0low001000
Purpura, Thrombotic Thrombocytopenic02005201016.5low000200
Pus01954201835.1low062110
Pyelonephritis01963202026.5low050330
Pyoderma01963202331.7low011001
Pyoderma Gangrenosum0201020218.5low000101
Pyrexia01996202014.2low002760
Pythiosis0201520159.0low000010
Radiation Pneumonitis02011201113.0low000010
Radiculopathy0201920195.0low000010
Radiodermatitis0201820186.0low000010
Raynaud Disease01991199729.7low003000
Recrudescence01978202315.8low81119395313
Rectal Diseases02003200918.0low000200
Rectal Neoplasms0201220234.7low200012
Red-Cell Aplasia, Pure02004200420.0low000100
Reflex Sympathetic Dystrophy01998201617.0low001010
Refractory Anemia01988201127.3low011010
Regurgitation, Gastric02009201412.5low000110
Remission, Spontaneous01977201622.4low011210
Renal Artery Obstruction02002200222.0low000100
Renal Artery Stenosis02002200222.0low000100
Renal Insufficiency01993201918.5low0041340
Renal Insufficiency, Chronic0200720227.4low3002175
Reperfusion Injury01989202317.6low16124746631420
Reproductive Sterility02004200420.0low000100
Respiration Disorders01983200228.7low010200
Respiratory Distress Syndrome01983202219.9low294688293
Respiratory Distress Syndrome, Newborn01995201817.4low002230
Respiratory Insufficiency01989201918.9low212830
Respiratory Sounds01995202313.9low202231
Respiratory Syncytial Virus Infections01994202116.1low003231
Respiratory Tract Diseases01985201722.8low116510
Respiratory Tract Infections01986202219.7low316931
Retinal Artery Occlusion02003200321.0low000100
Retinal Degeneration01992201719.5low001010
Retinal Diseases01993202319.1low003211
Retinal Neovascularization0202320231.0low000001
Retinal Vein Occlusion0202120213.0low000001
Retinitis01994200326.7low002100
Retinopathy of Prematurity01988202318.5low010001
Retrolental Fibroplasia01988202318.5low010001
Retroperitoneal Fibrosis0202020204.0low000010
Retroviridae Infections02010201014.0low000100
Rhabdomyolysis02006201912.0low000140
Rhabdomyosarcoma 202007200717.0low000100
Rhabdomyosarcoma, Alveolar02007200717.0low000100
Rheumatic Diseases01983200130.4low013100
Rheumatic Heart Disease02007200717.0low100100
Rheumatism01983200130.4low013100
Rheumatoid Arthritis01975202320.5low1124220309
Rheumatoid Nodule01995199529.0low001000
Rhinitis01992202314.2low103644
Rhinitis, Allergic0201320199.0low100030
Rhinitis, Allergic, Nonseasonal01992201319.4low104430
Rhinitis, Allergic, Perennial01992201319.4low104430
Rhinitis, Allergic, Seasonal01987201321.1low8161120
Rhinosporidiosis0201920195.0low000010
Right Ventricular Dysfunction02007201015.5low000400
Rodent Diseases01984199136.5low011000
Root Resorption02014201410.0low000010
Rubeola01984198440.0low010000
Rupture02012201311.5low000020
Rupture, Spontaneous01993201619.2low002310
Salivary Gland Diseases0202120213.0low000001
Salmonella Food Poisoning0201820186.0low000010
Salmonella Infections, Animal01990201620.8low005230
Sarcoidosis01980202224.0low040112
Sarcoidosis, Pulmonary02007202210.0low000111
Sarcoma02000201516.5low001010
Sarcoma, Epithelioid02000201516.5low001010
Sarcoma, Ewing02010201014.0low000100
Sarcoma, Myeloid01959202217.7low0202481
Sarcopenia0202220231.5low100002
Scabies02014201410.0low000010
Scalp Dermatoses0201520159.0low000010
Schistosoma haematobia Infection01999199925.0low001000
Schistosoma mansoni Infection02001201417.7low000510
Schistosomiasis01981199635.5low011000
Schistosomiasis haematobia01999199925.0low001000
Schistosomiasis mansoni02001201417.7low000510
Schizophrenia02000201912.2low101250
Schwartzman Phenomenon01997199727.0low001000
Sciatica02003202112.0low000101
Scleritis01996202015.7low002130
Scleroderma, Diffuse02007201812.0low000230
Scleroderma, Limited02014201410.0low000010
Scleroderma, Localized02002202213.3low000201
Scleroderma, Systemic01975202321.9low01141032
Sclerosis, Systemic01975202321.9low01141032
Seizures01950202118.8low010041
Sensation Disorders02005200519.0low000100
Sensitivity and Specificity01989202318.3low13268126677
Sepsis01983202313.1low65188914419
Sepsis Associated Delirium0202220222.0low000001
Serum Sickness01993199331.0low001000
Severe Acute Malnutrition0201920195.0low100010
Sexually Transmitted Disease, Viral01991199133.0low001000
Sexually Transmitted Diseases02000200322.5low001100
Shingles01963200041.7low021000
Shock01945200926.5low01221200
Shock, Cardiogenic02003200818.5low000200
Shock, Septic01986202317.3low111321221
Shock, Traumatic01994202321.8low1010321
Sicca Syndrome01999202114.0low101881
Sick Building Syndrome01999199925.0low001000
Sickle Cell Trait01992199331.5low002000
Silicosis01961201327.4low022410
Sinus Infections01997202310.6low001593
Sinusitis01997202310.6low001593
Sinusitis, Maxillary02008200816.0low100100
Sjogren's Syndrome01999202114.0low101881
Skin Abnormalities01991202118.0low001001
Skin Diseases01979202116.9low0276131
Skin Diseases, Bacterial02014201410.0low000010
Skin Diseases, Infectious01982198839.0low020000
Skin Diseases, Vascular01996202018.0low001310
Skin Neoplasms01947202321.0low231614112
Skin Ulcer02011201113.0low000010
Sleep Apnea Syndromes02012201212.0low000010
Sleep Apnea, Obstructive0200720238.3low200192
Sleep Initiation and Maintenance Disorders02012201212.0low000010
Sleep Wake Disorders0201320198.0low000020
Small Cell Lung Carcinoma02010201213.0low000110
Small Fiber Neuropathy0202320231.0low000001
Smoking Cessation02006201315.8low200310
Sneezing01998199826.0low001000
Snoring02007201711.0low000130
Soft Tissue Neoplasms02008200816.0low000100
Spasmophilia02001200123.0low000100
Spermatic Cord Torsion02002202211.8low300743
Spinal Cord Diseases02007200717.0low000100
Spinal Cord Injuries01990202215.6low101550391
Spinal Cord Neoplasms02005200519.0low000100
Spinal Fractures02011201113.0low000010
Spondylitis, Ankylosing01991202114.8low102222
Sporothrix brasiliensis Infection01986198638.0low010000
Sporotrichosis01986198638.0low010000
Spotted Fever Group Rickettsiosis0202020204.0low000010
Squamous Cell Carcinoma of Head and Neck1201820186.0low000010
ST Elevated Myocardial Infarction0201620216.0low2000121
ST Elevation Myocardial Infarction0201620216.0low2000121
Staphylococcal Infections01975202218.5low012517255
Staphylococcal Pneumonia02011201412.0low000030
Starvation02008200816.0low000100
Status Asthmaticus01999199925.0low001000
Status Epilepticus01997201020.5low001100
Steatitis02002200222.0low000100
Sterility, Female01984202121.3low012021
Sterility, Male01992202116.8low004441
Stevens-Johnson Syndrome02010201412.0low000120
Still's Disease, Adult-Onset0201320198.0low000020
Stomach Neoplasms01981202121.5low071961
Stomach Ulcer01988202116.4low224167716
Stomatitis02005201812.0low1006120
Stomatitis, Aphthous01987201421.0low110110
Stomatitis, Denture01999201218.5low001010
Streptococcal Infections01975202221.0low265463
Stress Disorders, Post-Traumatic0201520159.0low000010
Stroke0200120239.5low10013339
Strongyloidiasis02008201811.7low000120
Stunted Growth0200120218.8low000252
Subarachnoid Hemorrhage01978202115.4low011451
Submandibular Gland Diseases02008200816.0low000100
Substance-Related Disorders02001202013.7low000210
Suffocation0201320198.0low000020
Sunburn02000201812.3low001020
Surgical Incision0201620168.0low000010
Swine Diseases01983202315.4low110231
Symptom Cluster01976202121.3low13101571
Syndrome01976202121.3low13101571
Synovitis01996201713.4low001240
Systemic Inflammatory Response Syndrome01995202215.3low10320172
Systemic Vasculitis0201020189.3low000160
Systolic Heart Failure0202120213.0low000001
T-Cell Lymphoma01997201018.7low001200
Tachycardia, Ventricular02002200222.0low000100
Tachypnea0201520159.0low000010
Taeniasis01987199433.5low011000
Takayasu Arteritis0202020204.0low000010
Tauopathies0202020204.0low000010
Teeth, Impacted0201920195.0low000010
Temporomandibular Disorders02005201812.3low000340
Temporomandibular Joint Disorders02005201812.3low000340
Testicular Diseases02001201912.7low000340
Testicular Neoplasms02003202012.5low000110
Tetralogy of Fallot0201820186.0low000010
Thiamine Deficiency01995200026.5low002000
Thrombocythemia, Essential01979200037.9low072000
Thrombocytopathy02004200420.0low000100
Thrombocytopenia01985202216.5low011441
Thromboembolism01994202216.0low001001
Thromboembolism, Venous0201420216.0low000031
Thrombopenia01985202216.5low011441
Thrombophilia02004202011.0low000120
Thrombophlebitis02002201515.5low000110
Thrombosis01983202310.9low2218197
Thrombotic Microangiopathies02012201212.0low000020
Thymoma01995199529.0low001000
Thyroid Diseases01981202321.0low032622
Thyroid Neoplasms01965202325.4low132221
Thyrotoxicosis02014201410.0low000020
Tinea01963201037.5low010100
Tinea Pedis01986198638.0low020000
Tongue Neoplasms02013201311.0low000010
Tonsillar Neoplasms02002200222.0low000100
Tonsillitis01996202015.2low001220
Tooth Erosion02012201212.0low000010
Tooth Mobility0201720177.0low000010
Toxemia01994199430.0low001000
Toxocariasis01992199232.0low001000
Toxoplasmosis, Animal0201720186.5low000020
Toxoplasmosis, Cerebral0201620168.0low000010
Tracheal Diseases02008200816.0low000100
Tracheal Stenosis0201920195.0low000010
Tracheitis01990200527.2low002200
Transfusion Reaction01997201222.0low002010
Transposition of Great Vessels0201820186.0low000010
Trichinellosis01975200927.6low0218700
Trichocephaliasis02010201511.5low000110
Trichomonas Infections0201320198.0low000020
Trichomonas Vaginitis02008200816.0low000100
Trichomoniasis, Human02008200816.0low000100
Trichuriasis02010201511.5low000110
Triple Negative Breast Neoplasms0201820186.0low000010
Trypanosomiasis01953202130.0low010101
Trypanosomiasis, African01953201241.5low010010
Tuberculosis01956202132.3low082252
Tuberculosis, Bovine02013201311.0low000010
Tuberculosis, Drug-Resistant02010201213.0low000110
Tuberculosis, Miliary02002200222.0low000100
Tuberculosis, Multidrug-Resistant02010201213.0low000110
Tuberculosis, Oral02013201311.0low000010
Tuberculosis, Pulmonary01961202122.1low022541
Tuberculosis, Renal02003200321.0low000100
Tularemia0202020204.0low000010
Turner Syndrome01982198242.0low010000
Typhoid Fever01963198644.2low050000
Ulcer01991201618.7low0071450
Uremia01980201623.5low032520
Ureteral Diseases0202220222.0low000001
Ureteral Neoplasms01999199925.0low001000
Ureteral Obstruction02007201911.0low000110
Urethral Diseases01990199034.0low001000
Urethritis01990199531.5low002000
Urinary Bladder Neoplasms11992201421.8low004410
Urinary Retention02006200618.0low000100
Urinary Tract Diseases01995199529.0low001000
Urinary Tract Infections01997201916.2low003460
Urination Disorders02006200618.0low000100
Urticaria02008200816.0low000100
Uterine Cervical Dysplasia01994201617.0low001020
Uterine Cervical Neoplasms01980201820.9low033450
Uterine Cervicitis02010201810.0low000110
Uterine Diseases02013201510.0low100020
Uterine Hemorrhage01981198143.0low010000
Uterine Neoplasms01980201728.9low041110
Uveitis01984202323.4low0311612
Uveitis, Anterior01992201723.0low003020
Uveitis, Posterior01992201721.3low002010
Vaginosis, Bacterial02011201113.0low000020
Varices01992200227.0low001100
Varicocele01999200024.5low002000
Varicose Veins01992200227.0low001100
Vascular Diseases01989202213.5low012263
Vascular Injuries0201420197.5low000020
Vasculitis01985202321.2low41148196419
Vasospasm, Intracranial02000201216.7low001110
Venous Insufficiency01998201321.8low003110
Venous Thromboembolism0201420216.0low000031
Venous Thrombosis01998202010.2low001040
Ventilator-Associated Pneumonia0201820186.0low100020
Ventricular Dysfunction, Left01995202015.5low202960
Ventricular Fibrillation01988201324.8low016510
Verruca01989198935.0low010000
Vestibular Diseases01996199628.0low001000
Vibrio cholerae Infection02002202312.0low100221
Viral Diseases01978202127.6low024201
Viral Hepatitis, Human01982198242.0low010000
Viremia01994199430.0low001000
Virus Diseases01978202127.6low024201
Visceral Pain0201320197.8low000050
Vitamin A Deficiency01996201022.0low002100
Vitamin B 12 Deficiency01977201131.3low011010
Vitamin B Deficiency0202120213.0low000001
Vitiligo02006200618.0low000100
Vitreoretinopathy, Proliferative01994199529.5low002000
Vomiting02012201212.0low000020
Vulvar Neoplasms02005200519.0low000100
Wallerian Degeneration02008202010.0low000110
Warts01989198935.0low010000
Weight Gain01994202115.7low0066102
Weight Loss01994202312.9low30320321
Weight Reduction01994202312.9low30320321
Whooping Cough01950195173.5low020000
Wiskott-Aldrich Syndrome01995201121.0low001010
Wounds and Injuries01975202119.0low14527112
Wounds, Gunshot02009200915.0low000100
Wounds, Penetrating01998201619.2low002110
Wounds, Stab02006201216.0low000210
Xeroderma01980198442.0low020000
Xerophthalmia02002200222.0low000100
Xerostomia02008201812.3low000210
Zika Virus Infection0202020232.5low000011

Safety/Toxicity (268)

ArticleYear
Galectin-3 and Myeloperoxidase May Monitor Cancer-Therapy-Related Cardiotoxicity? A Systematic Review and Meta-Analysis.
Biomolecules, , 11-30, Volume: 12, Issue:12
2022
Quercetin Protected from Aluminum Phosphide-induced Acute and Subacute Cardio- and Hepatotoxicity in Rats.
Current pharmaceutical design, , Volume: 28, Issue:43
2022
Asparagus racemosus improves immune-related parameters in Nile tilapia (Oreochromis niloticus) and mitigates deltamethrin-induced toxicity.
Fish & shellfish immunology, , Volume: 130
2022
Phellinus linteus polysaccharides mediates acetaminophen-induced hepatotoxicity via activating AMPK/Nrf2 signaling pathways.
Aging, , Sep-01, Volume: 14, Issue:17
2022
Zinc oxide nanoparticles (ZnO-NPs) exhibit immune toxicity to crucian carp (Carassius carassius) by neutrophil extracellular traps (NETs) release and oxidative stress.
Fish & shellfish immunology, , Volume: 129
2022
The efficacy and safety of mizoribine for maintenance therapy in patients with myeloperoxidase anti-neutrophil cytoplasmic antibody (MPO-ANCA)-associated vasculitis: the usefulness of serum mizoribine monitoring.
Clinical and experimental nephrology, , Volume: 26, Issue:11
2022
Amelioration of lead toxicity by ascorbic acid in sugarcane (Saccharum officinarum L.) under in vitro condition.
Environmental science and pollution research international, , Volume: 29, Issue:56
2022
Evaluation of the toxicity effects of microplastics and cadmium on earthworms.
The Science of the total environment, , Aug-25, Volume: 836
2022
Glutamine Is a Superior Protector Against Lead-Induced Hepatotoxicity in Rats via Antioxidant, Anti-inflammatory, and Chelating Properties.
Biological trace element research, , Volume: 200, Issue:11
2022
Quercetin inhibits neutrophil extracellular traps release and their cytotoxic effects on A549 cells, as well the release and enzymatic activity of elastase and myeloperoxidase.
Brazilian journal of biology = Revista brasleira de biologia, , Volume: 84
2022
Toxicity and tissue accumulation characteristics of the herbicide pendimethalin under silicon application in ginger (Zingiber officinale Roscoe).
Environmental science and pollution research international, , Volume: 29, Issue:17
2022
Chrysin attenuates sodium arsenite-induced nephrotoxicity in rats by suppressing oxidative stress and inflammation.
Tissue & cell, , Volume: 73
2021
Regulation of Keap-1/Nrf2/AKT and iNOS/NF-κB/TLR4 signals by apocynin abrogated methotrexate-induced testicular toxicity: Mechanistic insights and computational pharmacological analysis.
Life sciences, , Nov-01, Volume: 284
2021
Diethylenetriamine/NONOate-doped alginate hydrogel with sustained nitric oxide release and minimal toxicity to accelerate healing of MRSA-infected wounds.
Carbohydrate polymers, , Oct-15, Volume: 270
2021
Inhibition of Sp1-mediated survivin and MCL1 expression cooperates with SLC35F2 and myeloperoxidase to modulate YM155 cytotoxicity to human leukemia cells.
Biochemical pharmacology, , Volume: 188
2021
ZnO nanoparticle-based seed priming modulates early growth and enhances physio-biochemical and metabolic profiles of fragrant rice against cadmium toxicity.
Journal of nanobiotechnology, , Mar-17, Volume: 19, Issue:1
2021
Sulfur supply reduces barium toxicity in Tanzania guinea grass (Panicum maximum) by inducing antioxidant enzymes and proline metabolism.
Ecotoxicology and environmental safety, , Jan-15, Volume: 208
2021
Treatment-related damage in elderly-onset ANCA-associated vasculitis: safety outcome analysis of two nationwide prospective cohort studies.
Arthritis research & therapy, , 10-12, Volume: 22, Issue:1
2020
5-aminolevulinic acid regulates Krebs cycle, antioxidative system and gene expression in Brassica juncea L. to confer tolerance against lead toxicity.
Journal of biotechnology, , Nov-10, Volume: 323
2020
Biochemical adaptation of wild and cultivated soybean against toxicity of lead salts.
Environmental toxicology and pharmacology, , Volume: 79
2020
Comparative ecotoxicity of single and binary mixtures exposures of cadmium and zinc on growth and biomarkers of Lemna gibba.
Ecotoxicology (London, England), , Volume: 29, Issue:5
2020
Gonadoprotective ability of Vincetoxicum arnottianum extract against bisphenol A-induced testicular toxicity and hormonal imbalance in male Sprague Dawley rats.
Andrologia, , Volume: 52, Issue:6
2020
The possible neurobehavioral protective effects of natural antioxidant against phototoxicity attenuation of antimicrobial quinolone group in rats.
Journal of biochemical and molecular toxicology, , Volume: 34, Issue:7
2020
Phytotoxicity assay to assess sewage sludge phytoremediation rate using guaiacol peroxidase activity (GPX): A comparison of four growth substrates.
Journal of environmental management, , Jun-01, Volume: 263
2020
[Сurrent views on predictors and biomarkers of early diagnosis of anthracycline-mediated cardiotoxicity in patients with breast cancer (review of literature).]
Klinicheskaia laboratornaia diagnostika, , Volume: 65, Issue:3
2020
Phytotoxicity, Bioaccumulation, and Degradation of Nonylphenol in Different Microalgal Species without Bacterial Influences.
International journal of molecular sciences, , Feb-17, Volume: 21, Issue:4
2020
Spermine ameliorates prolonged fluoride toxicity in soil-grown rice seedlings by activating the antioxidant machinery and glyoxalase system.
Ecotoxicology and environmental safety, , Volume: 189
2020
Melatonin ameliorates sodium valproate-induced hepatotoxicity in rats.
Molecular biology reports, , Volume: 47, Issue:1
2020
A case of anti-neutrophil cytoplasmic antibody-associated vasculitis with anti-glomerular basement membrane antibodies that was successfully treated with mizoribine as a safe and effective remission maintenance therapy with prednisolone and plasma exchang
CEN case reports, , Volume: 9, Issue:1
2020
Combined toxic effects of microcystin-LR and phenanthrene on growth and antioxidant system of duckweed (Lemna gibba L.).
Ecotoxicology and environmental safety, , Dec-15, Volume: 185
2019
Protective Responses Induced by Chiral 3-Dichloroacetyl Oxazolidine Safeners in Maize (
Molecules (Basel, Switzerland), , Aug-22, Volume: 24, Issue:17
2019
Increased whitening efficacy and reduced cytotoxicity are achieved by the chemical activation of a highly concentrated hydrogen peroxide bleaching gel.
Journal of applied oral science : revista FOB, , Aug-12, Volume: 27
2019
Calcium amendment improved the performance of fragrant rice and reduced metal uptake under cadmium toxicity.
Environmental science and pollution research international, , Volume: 26, Issue:24
2019
Phytotoxicity and oxidative stress of perfluorooctanesulfonate to two riparian plants: Acorus calamus and Phragmites communis.
Ecotoxicology and environmental safety, , Sep-30, Volume: 180
2019
Increased antioxidative capacity and decreased cadmium uptake contribute to hemin-induced alleviation of cadmium toxicity in Chinese cabbage seedlings.
Ecotoxicology and environmental safety, , Aug-15, Volume: 177
2019
Comparative Cardiac Safety of Selective Serotonin Reuptake Inhibitors among Individuals Receiving Maintenance Hemodialysis.
Journal of the American Society of Nephrology : JASN, , Volume: 30, Issue:4
2019
Safety, tolerability, pharmacokinetics and effect on serum uric acid of the myeloperoxidase inhibitor AZD4831 in a randomized, placebo-controlled, phase I study in healthy volunteers.
British journal of clinical pharmacology, , Volume: 85, Issue:4
2019
Salicylic acid alleviates thiram toxicity by modulating antioxidant enzyme capacity and pesticide detoxification systems in the tomato (Solanum lycopersicum Mill.).
Plant physiology and biochemistry : PPB, , Volume: 135
2019
Assessing the Safety and Efficacy of Lactobacillus plantarum MTCC 5690 and Lactobacillus fermentum MTCC 5689 in Colitis Mouse Model.
Probiotics and antimicrobial proteins, , Volume: 11, Issue:3
2019
Acute toxicity of the fungicide azoxystrobin on the diatom Phaeodactylum tricornutum.
Ecotoxicology and environmental safety, , Jan-30, Volume: 168
2019
Usefulness of myeloperoxidase as a biomarker for the ranking of pulmonary toxicity of nanomaterials.
Particle and fibre toxicology, , 10-23, Volume: 15, Issue:1
2018
Exogenous foliar application of fulvic acid alleviate cadmium toxicity in lettuce (Lactuca sativa L.).
Ecotoxicology and environmental safety, , Jan-15, Volume: 167
2019
Adsorption of Plasma Proteins on Single-Walled Carbon Nanotubes Reduced Cytotoxicity and Modulated Neutrophil Activation.
Chemical research in toxicology, , 10-15, Volume: 31, Issue:10
2018
Boron inhibits aluminum-induced toxicity to citrus by stimulating antioxidant enzyme activity.
Journal of environmental science and health. Part C, Environmental carcinogenesis & ecotoxicology reviews, , Volume: 36, Issue:3
2018
Reno-protective effects of ursodeoxycholic acid against gentamicin-induced nephrotoxicity through modulation of NF-κB, eNOS and caspase-3 expressions.
Cell and tissue research, , Volume: 374, Issue:2
2018
Aluminium toxicity and phosphate deficiency activates antioxidant systems and up-regulates expression of phosphate transporters gene in ryegrass (Lolium perenne L.) plants.
Plant physiology and biochemistry : PPB, , Volume: 130
2018
Fibrinogen binding-dependent cytotoxicity and degradation of single-walled carbon nanotubes.
Journal of materials science. Materials in medicine, , Jul-17, Volume: 29, Issue:8
2018
Reduced phytotoxicity of propazine on wheat, maize and rapeseed by salicylic acid.
Ecotoxicology and environmental safety, , Oct-30, Volume: 162
2018
[Protection of Herba Scutellariae Barbatae against hepatotoxicity induced by Rhizoma Dioscoreae Bulbiferae and its mechanism].
Yao xue xue bao = Acta pharmaceutica Sinica, , Volume: 51, Issue:3
2016
Acute toxicity and associated mechanisms of four strobilurins in algae.
Environmental toxicology and pharmacology, , Volume: 60
2018
Alleviation of iron toxicity in Schinus terebinthifolius Raddi (Anacardiaceae) by humic substances.
Environmental science and pollution research international, , Volume: 25, Issue:10
2018
Hepatotoxicity of bisphenol A under conditions of differential supplementation with retinoids.
Ukrainian biochemical journal, , Volume: 88, Issue:3
Toxic effects and mechanism of 2,2',4,4'-tetrabromodiphenyl ether (BDE-47) on Lemna minor.
Chemosphere, , Volume: 193
2018
Evaluation of heme oxygenase 1 (HO 1) in Cd and Ni induced cytotoxicity and crosstalk with ROS quenching enzymes in two to four leaf stage seedlings of Vigna radiata.
Protoplasma, , Volume: 255, Issue:2
2018
Oxidative Damage and Genetic Toxicity Induced by DBP in Earthworms (Eisenia fetida).
Archives of environmental contamination and toxicology, , Volume: 74, Issue:4
2018
Protective effect of ferulic acid on cisplatin induced nephrotoxicity in rats.
Environmental toxicology and pharmacology, , Volume: 54
2017
Alterations in growth, oxidative damage, and metal uptake of five aromatic rice cultivars under lead toxicity.
Plant physiology and biochemistry : PPB, , Volume: 115
2017
Toxicity of diesel water accommodated fraction toward microalgae, Pseudokirchneriella subcapitata and Chlorella sp. MM3.
Ecotoxicology and environmental safety, , Volume: 142
2017
Antioxidant and antiapoptotic effects of sea cucumber and valsartan against doxorubicin-induced cardiotoxicity in rats: The role of low dose gamma irradiation.
Journal of photochemistry and photobiology. B, Biology, , Volume: 170
2017
Toxicity effects of di-(2-ethylhexyl) phthalate to Eisenia fetida at enzyme, cellular and genetic levels.
PloS one, , Volume: 12, Issue:3
2017
Physiological highlights of manganese toxicity symptoms in soybean plants: Mn toxicity responses.
Plant physiology and biochemistry : PPB, , Volume: 113
2017
Potential roles of myeloperoxidase and hypochlorous acid in metabolism and toxicity of alkene hydrocarbons and drug molecules containing olefinic moieties.
Expert opinion on drug metabolism & toxicology, , Volume: 13, Issue:5
2017
Atorvastatin protected from paraquat-induced cytotoxicity in alveolar macrophages via down-regulation of TLR-4.
Environmental toxicology and pharmacology, , Volume: 49
2017
Co-application of 6-ketone type brassinosteroid and metal chelator alleviates cadmium toxicity in B. juncea L.
Environmental science and pollution research international, , Volume: 24, Issue:1
2017
Remediation of cadmium toxicity in field peas (Pisum sativum L.) through exogenous silicon.
Ecotoxicology and environmental safety, , Volume: 135
2017
Zinc oxide nanoparticles (ZnONPs) alleviate heavy metal-induced toxicity in Leucaena leucocephala seedlings: A physiochemical analysis.
Plant physiology and biochemistry : PPB, , Volume: 110
2017
Biochemical Profile, Biological Activities, and Toxic Effects of Proteins in the Rhinella schneideri Parotoid Gland Secretion.
Journal of experimental zoology. Part A, Ecological genetics and physiology, , Volume: 325, Issue:8
2016
Methotrexate Locally Released from Poly(e-Caprolactone) Implants: Inhibition of the Inflammatory Angiogenesis Response in a Murine Sponge Model and the Absence of Systemic Toxicity.
Journal of pharmaceutical sciences, , Volume: 104, Issue:11
2015
Recombinant Thrombomodulin (Solulin) Ameliorates Early Intestinal Radiation Toxicity in a Preclinical Rat Model.
Radiation research, , Volume: 186, Issue:2
2016
Potential of morin and hesperidin in the prevention of cisplatin-induced nephrotoxicity.
Renal failure, , Volume: 38, Issue:8
2016
Transcriptomic and physiological analysis of common duckweed Lemna minor responses to NH4(+) toxicity.
BMC plant biology, , Apr-18, Volume: 16
2016
Toxicity of OTC to Ipomoea aquatica Forsk. and to microorganisms in a long-term sewage-irrigated farmland soil.
Environmental science and pollution research international, , Volume: 23, Issue:15
2016
Reduction of chlorpyrifos-induced toxicity in human lymphocytes by selected phosphodiesterase inhibitors.
Pesticide biochemistry and physiology, , Volume: 128
2016
Dietary protocatechuic acid ameliorates dextran sulphate sodium-induced ulcerative colitis and hepatotoxicity in rats.
Food & function, , Volume: 7, Issue:2
2016
The interaction of salicylic acid and Ca(2+) alleviates aluminum toxicity in soybean (Glycine max L.).
Plant physiology and biochemistry : PPB, , Volume: 98
2016
Agmatine improves renal function in gentamicin-induced nephrotoxicity in rats.
Canadian journal of physiology and pharmacology, , Volume: 94, Issue:3
2016
Quaternary ammonium salts with tetrafluoroborate anion: Phytotoxicity and oxidative stress in terrestrial plants.
Journal of hazardous materials, , Mar-05, Volume: 304
2016
Terminalia arjuna bark extract alleviates nickel toxicity by suppressing its uptake and modulating antioxidative defence in rice seedlings.
Protoplasma, , Volume: 253, Issue:6
2016
Protective Effects of Molsidomine Against Cisplatin-Induced Nephrotoxicity.
Advances in clinical and experimental medicine : official organ Wroclaw Medical University, , Volume: 24, Issue:4
Biochemical and Histological Effects of Thiamine Pyrophosphate against Acetaminophen-Induced Hepatotoxicity.
Basic & clinical pharmacology & toxicology, , Volume: 118, Issue:1
2016
Evaluation of the safety, gastroprotective activity and mechanism of action of standardised leaves infusion extract of Copaifera malmei Harms.
Journal of ethnopharmacology, , Dec-04, Volume: 175
2015
Protective effect of allicin against gentamicin-induced nephrotoxicity in rats.
International immunopharmacology, , Volume: 29, Issue:2
2015
Prophylactic efficacy of S-2(2-aminoethylamino)ethyl phenyl sulfide (DRDE-07) against sulfur mustard induced lung toxicity in mice.
Drug and chemical toxicology, , Volume: 39, Issue:2
2016
Toxicological effects, mechanisms, and implied toxicity thresholds in the roots of Vicia faba L. seedlings grown in copper-contaminated soil.
Environmental science and pollution research international, , Volume: 22, Issue:18
2015
Nitric oxide ameliorates zinc oxide nanoparticles-induced phytotoxicity in rice seedlings.
Journal of hazardous materials, , Oct-30, Volume: 297
2015
The reduced bioavailability of copper by nano-TiO₂ attenuates the toxicity to Microcystis aeruginosa.
Environmental science and pollution research international, , Volume: 22, Issue:16
2015
Effects of edaravone on cardiac damage in valproic acid induced toxicity.
Annals of clinical and laboratory science, ,Spring, Volume: 45, Issue:2
2015
Adverse events and infectious burden, microbes and temporal outline from immunosuppressive therapy in antineutrophil cytoplasmic antibody-associated vasculitis with native renal function.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, , Volume: 30 Suppl 1
2015
24-epibrassinolide mitigates the adverse effects of manganese induced toxicity through improved antioxidant system and photosynthetic attributes in Brassica juncea.
Environmental science and pollution research international, , Volume: 22, Issue:15
2015
Flavanone silibinin treatment attenuates nitrogen mustard-induced toxic effects in mouse skin.
Toxicology and applied pharmacology, , May-15, Volume: 285, Issue:1
2015
Treatment With Dimethyl Fumarate Attenuates Calcineurin Inhibitor-induced Nephrotoxicity.
Transplantation, , Volume: 99, Issue:6
2015
Selenium alleviates chromium toxicity by preventing oxidative stress in cabbage (Brassica campestris L. ssp. Pekinensis) leaves.
Ecotoxicology and environmental safety, , Volume: 114
2015
A novel strategy for antimicrobial agent: role of exogenous carbon monoxide on suppressing Escherichia coli vitality and toxicity.
Pakistan journal of pharmaceutical sciences, , Volume: 28, Issue:1 Suppl
2015
Endoplasmic reticulum stress-activated glycogen synthase kinase 3β aggravates liver inflammation and hepatotoxicity in mice with acute liver failure.
Inflammation, , Volume: 38, Issue:3
2015
Evaluation of arsenic trioxide genotoxicity in wheat seedlings using oxidative system and RAPD assays.
Environmental science and pollution research international, , Volume: 22, Issue:9
2015
The genotoxic and cytotoxic effects of 1-butyl-3-methylimidazolium chloride in soil on Vicia faba seedlings.
Journal of hazardous materials, , Mar-21, Volume: 285
2015
Edaravone ameliorates the adverse effects of valproic acid toxicity in small intestine.
Human & experimental toxicology, , Volume: 34, Issue:6
2015
Protective effects of resveratrol on hepatotoxicity induced by isoniazid and rifampicin via SIRT1 modulation.
Journal of natural products, , Oct-24, Volume: 77, Issue:10
2014
Ameliorative effect of fisetin on cisplatin-induced nephrotoxicity in rats via modulation of NF-κB activation and antioxidant defence.
PloS one, , Volume: 9, Issue:9
2014
Formaldehyde induces bone marrow toxicity in mice by inhibiting peroxiredoxin 2 expression.
Molecular medicine reports, , Volume: 10, Issue:4
2014

Long-term Use (28)

ArticleYear
Intravitreal thalidomide ameliorates inflammation in a model of experimental uveitis induced by BCG.
International immunopharmacology, , Volume: 81
2020
Calcineurin inhibitor Tacrolimus impairs host immune response against urinary tract infection.
Scientific reports, , 01-14, Volume: 9, Issue:1
2019
Gastroprotective Effects of PMK-S005 against Ethanol-Induced Acute Gastric Damage in Rats.
Gut and liver, , May-23, Volume: 10, Issue:3
2016
Long-term administration of simvastatin reduces ventilator-induced lung injury and upregulates heme oxygenase 1 expression in a rat model.
The Journal of surgical research, , Volume: 199, Issue:2
2015
Investigation of the protective effects of proanthocyanidin and vitamin E against the toxic effect caused by formaldehyde on the liver tissue.
Environmental toxicology, , Volume: 30, Issue:12
2015
Catechins suppress muscle inflammation and hasten performance recovery after exercise.
Medicine and science in sports and exercise, , Volume: 45, Issue:9
2013
Exenatide-induced chronic damage of pancreatic tissue in rats.
Pancreas, , Volume: 41, Issue:8
2012
Dietary polydextrose prevents inflammatory bowel disease in trinitrobenzenesulfonic acid model of rat colitis.
Journal of medicinal food, , Volume: 13, Issue:6
2010
ApoA-1 mimetic peptide reverses uremia-induced upregulation of pro-atherogenic pathways in the aorta.
American journal of nephrology, , Volume: 32, Issue:3
2010
Effect of acute and chronic administration of progesterone, estrogen, FSH and LH on oxidant and antioxidant parameters in rat gastric tissue.
Chemico-biological interactions, , Nov-10, Volume: 182, Issue:1
2009
Effects of phosphodiesterase inhibitors on the inflammatory response of endothelial cells stimulated by myeloperoxidase-modified low-density lipoprotein or tumor necrosis factor alpha.
European urology, , Volume: 57, Issue:3
2010
Chronic morphine administration enhances nociceptive sensitivity and local cytokine production after incision.
Molecular pain, , Feb-22, Volume: 4
2008
Pomegranate peel extract prevents liver fibrosis in biliary-obstructed rats.
The Journal of pharmacy and pharmacology, , Volume: 59, Issue:9
2007
Influence of thyroid hormone on thyroid hormone receptor beta-1 expression and lacrimal gland and ocular surface morphology.
Investigative ophthalmology & visual science, , Volume: 48, Issue:7
2007
Pravastatin inhibits arrhythmias induced by coronary artery ischemia in anesthetized rats.
Journal of pharmacological sciences, , Volume: 103, Issue:3
2007
Chronic administration of galanin attenuates the TNBS-induced colitis in rats.
Regulatory peptides, , Jun-07, Volume: 141, Issue:1-3
2007
Effect of rofecoxib, a cyclo-oxygenase-2 inhibitor, on various biochemical parameters of brain associated with pentylenetetrazol-induced chemical kindling in mice.
Fundamental & clinical pharmacology, , Volume: 20, Issue:3
2006
Effect of naproxen, a non-selective cyclo-oxygenase inhibitor, on pentylenetetrazol-induced kindling in mice.
Clinical and experimental pharmacology & physiology, , Volume: 32, Issue:7
2005
Long-term administration of aqueous garlic extract (AGE) alleviates liver fibrosis and oxidative damage induced by biliary obstruction in rats.
Life sciences, , Apr-15, Volume: 76, Issue:22
2005
Crescentic glomerulonephritis associated with myeloperoxidase-antineutrophil-cytoplasmic antibodies: first report on the efficacy of primary anti-TNF-alpha treatment.
International journal of tissue reactions, , Volume: 26, Issue:3-4
2004
Aggravation of inflammatory bowel disease by cyclooxygenase-2 inhibitors in rats.
Pharmacology, , Volume: 72, Issue:2
2004
Comparison of the effects of rebamipide with those of cimetidine on chronic gastritis associated with Helicobacter pylori in Mongolian gerbils.
Alimentary pharmacology & therapeutics, , Volume: 18 Suppl 1
2003
The protective effect of N-acetylcysteine on apoptotic lung injury in cecal ligation and puncture-induced sepsis model.
Shock (Augusta, Ga.), , Volume: 19, Issue:4
2003
Preventive efficacy of butyrate enemas and oral administration of Clostridium butyricum M588 in dextran sodium sulfate-induced colitis in rats.
Journal of gastroenterology, , Volume: 35, Issue:5
2000
Changes in colonic inflammation induced by dextran sulfate sodium (DSS) during short- and long-term administration of rebamipide.
Digestive diseases and sciences, , Volume: 43, Issue:9 Suppl
1998
Long-term probucol treatment reverses the severity of myocardial injury in watanabe heritable hyperlipidemic rabbits.
Arteriosclerosis, thrombosis, and vascular biology, , Volume: 17, Issue:11
1997
Central interleukin-1 receptors contribute to suppression of feeding after acute colitis in the rat.
The American journal of physiology, , Volume: 266, Issue:5 Pt 2
1994
Ischemia/reperfusion-induced feline intestinal dysfunction: importance of granulocyte recruitment.
Gastroenterology, , Volume: 103, Issue:3
1992

Pharmacokinetics (53)

ArticleYear
Identifying long-range synaptic inputs using genetically encoded labels and volume electron microscopy.
Scientific reports, , 06-17, Volume: 12, Issue:1
2022
Clinical efficacy of biomarkers for evaluation of volume status in dialysis patients.
Medicine, , Jul-31, Volume: 99, Issue:31
2020
Non-Linear Rituximab Pharmacokinetics and Complex Relationship between Rituximab Concentrations and Anti-Neutrophil Cytoplasmic Antibodies (ANCA) in ANCA-Associated Vasculitis: The RAVE Trial Revisited.
Clinical pharmacokinetics, , Volume: 59, Issue:4
2020
Safety, tolerability, pharmacokinetics and effect on serum uric acid of the myeloperoxidase inhibitor AZD4831 in a randomized, placebo-controlled, phase I study in healthy volunteers.
British journal of clinical pharmacology, , Volume: 85, Issue:4
2019
Myeloperoxidase and Prostate volume: A preliminary study.
Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie, , Volume: 28, Issue:10
2018
Population Pharmacokinetic Modeling With Enterohepatic Circulation for AZD3241 in Healthy Subjects and Patients With Multiple System Atrophy.
Journal of clinical pharmacology, , Volume: 58, Issue:11
2018
NADPH oxidase activation regulates apoptotic neutrophil clearance by murine macrophages.
Blood, , 05-24, Volume: 131, Issue:21
2018
The chlorinated lipidome originating from myeloperoxidase-derived HOCl targeting plasmalogens: Metabolism, clearance, and biological properties.
Archives of biochemistry and biophysics, , 03-01, Volume: 641
2018
Lung Protective Effects of Low-Volume Resuscitation and Pharmacologic Treatment of Swine Subjected to Polytrauma and Hemorrhagic Shock.
Inflammation, , Volume: 40, Issue:4
2017
The critical role of myeloperoxidase in Streptococcus pneumoniae clearance and tissue damage during mouse acute otitis media.
Innate immunity, , Volume: 23, Issue:3
2017
Myeloperoxidase Attenuates Pathogen Clearance during Plasmodium yoelii Nonlethal Infection.
Infection and immunity, , Volume: 85, Issue:1
2017
Early Therapeutic Intervention for Crush Syndrome: Characterization of Intramuscular Administration of Dexamethasone by Pharmacokinetic and Biochemical Parameters in Rats.
Biological & pharmaceutical bulletin, , Volume: 39, Issue:9
2016
Development of an Improved Inhalable Powder Formulation of Pirfenidone by Spray-Drying: In Vitro Characterization and Pharmacokinetic Profiling.
Pharmaceutical research, , Volume: 33, Issue:6
2016
PHARMACODYNAMICAL EVALUATION OF MATRIX TYPE TRANSDERMAL THERAPEUTIC SYSTEMS CONTAINING CAPTOPRIL.
Acta poloniae pharmaceutica, , Volume: 72, Issue:4
Pharmacokinetics and Disposition of the Thiouracil Derivative PF-06282999, an Orally Bioavailable, Irreversible Inactivator of Myeloperoxidase Enzyme, Across Animals and Humans.
Drug metabolism and disposition: the biological fate of chemicals, , Volume: 44, Issue:2
2016
A patient with diffuse cutaneous systemic sclerosis complicated by antineutrophil-cytoplasmic antibody-associated vasculitis exhibiting honeycomb lung without volume loss.
Internal medicine (Tokyo, Japan), , Volume: 53, Issue:7
2014
Liquid chromatography mass spectrometry determination of mocetinostat (MGCD0103) in rat plasma and its application to a pharmacokinetic study.
Xenobiotica; the fate of foreign compounds in biological systems, , Volume: 44, Issue:9
2014
Relationships between pharmacokinetics and efficacy of Xie-xin decoction in rats with experimental ulcerative colitis.
Journal of ethnopharmacology, , Jun-21, Volume: 148, Issue:1
2013
Dose- and time-dependent effects of lipopolysaccharide on technetium-99-m-labeled diethylene-triamine pentaacetatic acid clearance, respiratory system mechanics and pulmonary inflammation.
Experimental biology and medicine (Maywood, N.J.), , Volume: 238, Issue:2
2013
Increased resistance to Staphylococcus aureus endophthalmitis in BALB/c mice: Fas ligand is required for resolution of inflammation but not for bacterial clearance.
Infection and immunity, , Volume: 81, Issue:6
2013
Lipoxin A(4) activates alveolar epithelial sodium channel, Na,K-ATPase, and increases alveolar fluid clearance.
American journal of respiratory cell and molecular biology, , Volume: 48, Issue:5
2013
Genotype-dependent impairment of hemoglobin clearance increases oxidative and inflammatory response in human diabetic atherosclerosis.
Arteriosclerosis, thrombosis, and vascular biology, , Volume: 32, Issue:11
2012
Impaired clearance and enhanced pulmonary inflammatory/fibrotic response to carbon nanotubes in myeloperoxidase-deficient mice.
PloS one, , Volume: 7, Issue:3
2012
Regulation of ENaC-mediated alveolar fluid clearance by insulin via PI3K/Akt pathway in LPS-induced acute lung injury.
Respiratory research, , Mar-30, Volume: 13
2012
Gut flora enhance bacterial clearance in lung through toll-like receptors 4.
Journal of biomedical science, , Sep-10, Volume: 18
2011
Eicosapentaenoic acid ablates valproate-induced liver oxidative stress and cellular derangement without altering its clearance rate: dynamic synergy and therapeutic utility.
Biochimica et biophysica acta, , Volume: 1811, Issue:7-8
Pharmacologic modulation of alveolar liquid clearance in transplanted lungs by phentolamine and FK506.
The Annals of thoracic surgery, , Volume: 88, Issue:3
2009
Validation of low-volume 1536-well assay-ready compound plates.
Journal of biomolecular screening, , Volume: 14, Issue:5
2009
Method for co-purification of equine neutrophil elastase and myeloperoxidase from a limited blood volume.
Research in veterinary science, , Volume: 87, Issue:3
2009
[Effects of conventional mechanical ventilation with low tidal volume on the expression of growth factors and inflammatory mediators in developing porcine lungs].
Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics, , Volume: 10, Issue:4
2008
Evaluation of the pharmacodynamic effects of MGCD0103 from preclinical models to human using a novel HDAC enzyme assay.
Clinical cancer research : an official journal of the American Association for Cancer Research, , Jun-01, Volume: 14, Issue:11
2008
The effect of pentoxifylline on the pulmonary response to high tidal volume ventilation in rats.
Pulmonary pharmacology & therapeutics, , Volume: 21, Issue:1
2008
Decreased bacterial clearance from the lungs of mice following primary respiratory syncytial virus infection.
Journal of medical virology, , Volume: 78, Issue:6
2006
Hyperoxia and tidal volume: Independent and combined effects on neonatal pulmonary inflammation.
Biology of the neonate, , Volume: 90, Issue:2
2006
Platelet-activating factor receptor-deficient mice show an unaltered clearance of nontypeable Haemophilus influenzae from their respiratory tract.
Shock (Augusta, Ga.), , Volume: 22, Issue:6
2004
Vaccinia virus complement control protein increases early bacterial clearance during experimental peritonitis.
Surgical infections, ,Winter, Volume: 4, Issue:4
2003
Protective effect of pentoxifylline on volume-induced lung injury in newborn piglets.
Biology of the neonate, , Volume: 86, Issue:1
2004
Deficiency of myeloperoxidase increases infarct volume and nitrotyrosine formation in mouse brain.
Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism, , Volume: 22, Issue:1
2002
Seasonal differences of peak expiratory flow rate variability and mediators of allergic inflammation in non-atopic adolescents.
Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology, , Volume: 12, Issue:5
2001
Surfactant protein D enhances clearance of influenza A virus from the lung in vivo.
Journal of immunology (Baltimore, Md. : 1950), , Nov-15, Volume: 167, Issue:10
2001
Effects of antivenom on Buthus occitanus tunetanus (Bot) scorpion venom pharmacokinetics: towards an optimization of antivenom immunotherapy in a rabbit model.
Toxicon : official journal of the International Society on Toxinology, , Volume: 39, Issue:9
2001
The use of platelet density and volume measurements to estimate the severity of pre-eclampsia.
European journal of clinical investigation, , Volume: 30, Issue:12
2000
Lung recruitment and lung volume maintenance: a strategy for improving oxygenation and preventing lung injury during both conventional mechanical ventilation and high-frequency oscillation.
Intensive care medicine, , Volume: 26, Issue:6
2000
Innate lung defenses and compromised Pseudomonas aeruginosa clearance in the malnourished mouse model of respiratory infections in cystic fibrosis.
Infection and immunity, , Volume: 68, Issue:4
2000
P-selectin antibody reduces hemorrhage and infarct volume resulting from MCA occlusion in the rat.
Journal of the neurological sciences, , Nov-26, Volume: 161, Issue:1
1998
High-volume continuous hemofiltration during cardiopulmonary bypass attenuates pulmonary dysfunction in neonatal lambs after deep hypothermic circulatory arrest.
Circulation, , Nov-10, Volume: 98, Issue:19 Suppl
1998
Synthetic peptide derived from the Bordetella pertussis bacterium reduces infarct volume after transient middle cerebral artery occlusion in the rat.
Neurology, , Volume: 46, Issue:5
1996
Neutralization of macrophage inflammatory protein-2 attenuates neutrophil recruitment and bacterial clearance in murine Klebsiella pneumonia.
The Journal of infectious diseases, , Volume: 173, Issue:1
1996
Tidal flow volume loops and inflammatory indicators in small children.
International archives of allergy and immunology, , Volume: 107, Issue:1-3
Eosinophil cationic protein and tidal flow volume loops in children 0-2 years of age.
The European respiratory journal, , Volume: 8, Issue:7
1995
Flow cytometric analysis of macrophage heterogeneity and differentiation: utilization of electronic cell volume and fluorescent substrates corresponding to common macrophage markers.
Journal of the Reticuloendothelial Society, , Volume: 32, Issue:4
1982
Identification of proteins in small tear volumes with and without size exclusion HPLC fractionation.
Current eye research, , Volume: 7, Issue:2
1988
Age-dependent pulmonary clearance of Pseudomonas aeruginosa in a mouse model: diminished migration of polymorphonuclear leukocytes to N-formyl-methionyl-leucyl-phenylalanine.
Infection and immunity, , Volume: 60, Issue:4
1992

Bioavailability (97)

ArticleYear
GYY4137, a hydrogen sulfide donor, protects against endothelial dysfunction in porcine coronary arteries exposed to myeloperoxidase and hypochlorous acid.
Vascular pharmacology, , Volume: 152
2023
A novel nano-formulation of olmesartan medoxomil with improved delivery and efficacy in the treatment of indomethacin-induced duodenitis in rats.
Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas, , Volume: 56
2023
Chronic intermittent hypoxia promotes early intrahepatic endothelial impairment in rats with nonalcoholic fatty liver disease.
American journal of physiology. Gastrointestinal and liver physiology, , Oct-01, Volume: 323, Issue:4
2022
Melatonin interferes with COVID-19 at several distinct ROS-related steps.
Journal of inorganic biochemistry, , Volume: 223
2021
Magnetoresponsive nanozyme: magnetic stimulation on the nanozyme activity of iron oxide nanoparticles.
Science China. Life sciences, , Volume: 65, Issue:1
2022
Anti-Inflammatory Effects of Rosmarinic Acid-Loaded Nanovesicles in Acute Colitis through Modulation of NLRP3 Inflammasome.
Biomolecules, , 01-26, Volume: 11, Issue:2
2021
Anti-inflammatory and Antioxidant Activity of Nanoencapsulated Curcuminoids Extracted from Curcuma longa L. in a Model of Cutaneous Inflammation.
Inflammation, , Volume: 44, Issue:2
2021
Discovery of a novel indole pharmacophore for the irreversible inhibition of myeloperoxidase (MPO).
Bioorganic & medicinal chemistry, , 06-15, Volume: 28, Issue:12
2020
Antagonism or synergism? Responses of Hydrocharis dubia (Bl.) Backer to linear alkylbenzene sulfonate, naphthalene and their joint exposure.
Ecotoxicology and environmental safety, , Sep-01, Volume: 200
2020
Dielectric barrier atmospheric cold plasma applied on camu-camu juice processing: Effect of the excitation frequency.
Food research international (Ottawa, Ont.), , Volume: 131
2020
Emerging perspectives on cytoglobin, beyond NO dioxygenase and peroxidase.
Redox biology, , Volume: 32
2020
A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein.
Molecular pharmacology, , Volume: 96, Issue:5
2019
A three-pronged formulation approach to improve oral bioavailability and therapeutic efficacy of two lipophilic drugs with gastric lability.
Drug delivery and translational research, , Volume: 9, Issue:4
2019
Nanocurcumin ameliorates Staphylococcus aureus-induced mastitis in mouse by suppressing NF‑κB signaling and inflammation.
International immunopharmacology, , Volume: 65
2018
EDTA and organic acids assisted phytoextraction of Cd and Zn from a smelter contaminated soil by potherb mustard (Brassica juncea, Coss) and evaluation of its bioindicators.
Ecotoxicology and environmental safety, , Jan-15, Volume: 167
2019
In vitro and in vivo anti-inflammatory properties of imine resveratrol analogues.
Bioorganic & medicinal chemistry, , 09-15, Volume: 26, Issue:17
2018
Discovery of 1-((6-Aminopyridin-3-yl)Methyl)-3-(4-Bromophenyl)Urea as a Potent, Irreversible Myeloperoxidase Inhibitor.
The Journal of pharmacology and experimental therapeutics, , Volume: 367, Issue:1
2018
Population Pharmacokinetic Modeling With Enterohepatic Circulation for AZD3241 in Healthy Subjects and Patients With Multiple System Atrophy.
Journal of clinical pharmacology, , Volume: 58, Issue:11
2018
Myeloperoxidase in Hypertensive Disorders of Pregnancy and Its Relation With Nitric Oxide.
Hypertension (Dallas, Tex. : 1979), , Volume: 69, Issue:6
2017
Protective effects of tranilast on experimental colitis in rats.
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, , Volume: 90
2017
Regulation of the nitric oxide oxidase activity of myeloperoxidase by pharmacological agents.
Biochemical pharmacology, , 07-01, Volume: 135
2017
Altered systemic bioavailability and organ distribution of azathioprine in methotrexate-induced intestinal mucositis in rats.
Indian journal of pharmacology, , Volume: 48, Issue:3
Relative Inhibitions of 5-Lipoxygenase and Myeloperoxidase and Free-Radical Scavenging Activities of Daidzein, Dihydrodaidzein, and Equol.
Journal of medicinal food, , Volume: 19, Issue:6
2016
Diclofenac acid nanocrystals as an effective strategy to reduce in vivo skin inflammation by improving dermal drug bioavailability.
Colloids and surfaces. B, Biointerfaces, , Jul-01, Volume: 143
2016
Development and performance evaluation of novel nanoparticles of a grafted copolymer loaded with curcumin.
International journal of biological macromolecules, , Volume: 86
2016
Small bowel protection against NSAID-injury in rats: Effect of rifaximin, a poorly absorbed, GI targeted, antibiotic.
Pharmacological research, , Volume: 104
2016
The DyP-type peroxidase DtpA is a Tat-substrate required for GlxA maturation and morphogenesis in Streptomyces.
Open biology, , Volume: 6, Issue:1
2016
Pharmacokinetics and Disposition of the Thiouracil Derivative PF-06282999, an Orally Bioavailable, Irreversible Inactivator of Myeloperoxidase Enzyme, Across Animals and Humans.
Drug metabolism and disposition: the biological fate of chemicals, , Volume: 44, Issue:2
2016
The Effect of a Selective Inhibitor of Phosphodiesterase-9 on Oxidative Stress, Inflammation and Cytotoxicity in Neutrophils from Patients with Sickle Cell Anaemia.
Basic & clinical pharmacology & toxicology, , Volume: 118, Issue:4
2016
The reduced bioavailability of copper by nano-TiO₂ attenuates the toxicity to Microcystis aeruginosa.
Environmental science and pollution research international, , Volume: 22, Issue:16
2015
Levosimendan displays anti-inflammatory effects and decreases MPO bioavailability in patients with severe heart failure.
Scientific reports, , Apr-13, Volume: 5
2015
Colorimetric peroxidase mimetic assay for uranyl detection in sea water.
ACS applied materials & interfaces, , Mar-04, Volume: 7, Issue:8
2015
Quercetin bioavailability is associated with inadequate plasma vitamin C status and greater plasma endotoxin in adults.
Nutrition (Burbank, Los Angeles County, Calif.), , Volume: 30, Issue:11-12
Micronized/ultramicronized palmitoylethanolamide displays superior oral efficacy compared to nonmicronized palmitoylethanolamide in a rat model of inflammatory pain.
Journal of neuroinflammation, , Aug-28, Volume: 11
2014
Decrease of a specific biomarker of collagen degradation in osteoarthritis, Coll2-1, by treatment with highly bioavailable curcumin during an exploratory clinical trial.
BMC complementary and alternative medicine, , May-17, Volume: 14
2014
Inducible nitric oxide synthase inhibition reverses pulmonary arterial dysfunction in lung transplantation.
Inflammation research : official journal of the European Histamine Research Society ... [et al.], , Volume: 63, Issue:8
2014
Mechanism and regulation of peroxidase-catalyzed nitric oxide consumption in physiological fluids: critical protective actions of ascorbate and thiocyanate.
Free radical biology & medicine, , Volume: 72
2014
Liquid chromatography mass spectrometry determination of mocetinostat (MGCD0103) in rat plasma and its application to a pharmacokinetic study.
Xenobiotica; the fate of foreign compounds in biological systems, , Volume: 44, Issue:9
2014
Myeloperoxidase upregulates endothelin receptor type B expression.
Journal of molecular and cellular cardiology, , Volume: 69
2014
The smoking-associated oxidant hypothiocyanous acid induces endothelial nitric oxide synthase dysfunction.
The Biochemical journal, , Jan-01, Volume: 457, Issue:1
2014
Speciation and bioavailability of dissolved copper in different freshwaters: comparison of modelling, biological and chemical responses in aquatic mosses and gammarids.
The Science of the total environment, , May-01, Volume: 452-453
2013
Bioavailability and oxidative stress of cadmium to Corbicula fluminea.
Environmental science. Processes & impacts, , Volume: 15, Issue:4
2013
Design, synthesis and bioevalution of novel benzamides derivatives as HDAC inhibitors.
Bioorganic & medicinal chemistry letters, , Jan-01, Volume: 23, Issue:1
2013
6b,11b-Dihydroxy-6b,11b-dihydro-7H-indeno[1,2-b]naphtho[2,1-d]furan-7-one (DHFO), a small molecule targeting NF-κB, demonstrates therapeutic potential in immunopathogenic chronic inflammatory conditions.
International immunopharmacology, , Volume: 15, Issue:1
2013
Accumulation of heavy metals and antioxidant responses in Vicia faba plants grown on monometallic contaminated soil.
Environmental science and pollution research international, , Volume: 20, Issue:2
2013
Nitrite reduces ischemia/reperfusion-induced muscle damage and improves survival rates in rat crush injury model.
The journal of trauma and acute care surgery, , Volume: 72, Issue:6
2012
Activation of peroxisome proliferator-activated receptor-β/-δ (PPARβ/δ) prevents endothelial dysfunction in type 1 diabetic rats.
Free radical biology & medicine, , Aug-15, Volume: 53, Issue:4
2012
Nitro-oxidative stress biomarkers in active and inactive men.
International journal of sports medicine, , Volume: 33, Issue:4
2012
Green tea polyphenol epigallocatechin-3-gallate shows therapeutic antioxidative effects in a murine model of colitis.
Journal of Crohn's & colitis, , Volume: 6, Issue:2
2012
The use of nano-quercetin to arrest mitochondrial damage and MMP-9 upregulation during prevention of gastric inflammation induced by ethanol in rat.
Biomaterials, , Volume: 33, Issue:10
2012
Pathogenic cycle between the endogenous nitric oxide synthase inhibitor asymmetrical dimethylarginine and the leukocyte-derived hemoprotein myeloperoxidase.
Circulation, , Dec-13, Volume: 124, Issue:24
2011
Myeloperoxidase deficiency preserves vasomotor function in humans.
European heart journal, , Volume: 33, Issue:13
2012
Systemic inflammation is linked to low arginine and high ADMA plasma levels resulting in an unfavourable NOS substrate-to-inhibitor ratio: the Hoorn Study.
Clinical science (London, England : 1979), , Volume: 121, Issue:2
2011
Amelioration of experimental colitis by a novel nanoselenium-silymarin mixture.
Toxicology mechanisms and methods, , Volume: 21, Issue:3
2011
Discovery of (2-fluoro-benzyl)-(2-methyl-2-phenethyl-2H-chromen-6-yl)-amine (KRH-102140) as an orally active 5-lipoxygenase inhibitor with activity in murine inflammation models.
Pharmacology, , Volume: 87, Issue:1-2
2011
Mobile phone radiation-induced free radical damage in the liver is inhibited by the antioxidants N-acetyl cysteine and epigallocatechin-gallate.
International journal of radiation biology, , Volume: 86, Issue:11
2010
The role of erythropoietin in the protection of gastric mucosa from indometacin-induced gastric injury and its relationship with oxidant and antioxidant parameters in rats.
The Journal of pharmacy and pharmacology, , Volume: 62, Issue:1
2010
A case of infection-associated antiproteinase-3-negative cytoplasmic antineutrophil cytoplasmic antibody pauci-immune focal necrotizing glomerulonephritis.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, , Volume: 25, Issue:9
2010
Regular exercise training prevents aortic valve disease in low-density lipoprotein-receptor-deficient mice.
Circulation, , Feb-16, Volume: 121, Issue:6
2010
Myeloperoxidase-dependent oxidative metabolism of nitric oxide in the cystic fibrosis airway.
Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society, , Volume: 9, Issue:2
2010
Vascular endothelial function is related to white blood cell count and myeloperoxidase among healthy middle-aged and older adults.
Hypertension (Dallas, Tex. : 1979), , Volume: 55, Issue:2
2010
[Research advances in plant lead tolerance and detoxification mechanism].
Ying yong sheng tai xue bao = The journal of applied ecology, , Volume: 20, Issue:3
2009
Myeloperoxidase: a useful biomarker for cardiovascular disease risk stratification?
Clinical chemistry, , Volume: 55, Issue:8
2009
Ibuprofen-arginine generates nitric oxide and has enhanced anti-inflammatory effects.
Pharmacological research, , Volume: 60, Issue:4
2009
Role of oxidative and nitrosative stress biomarkers in chronic heart failure.
Frontiers in bioscience (Landmark edition), , 01-01, Volume: 14, Issue:6
2009
Copper toxicity influence on antioxidant enzymes activity in tomato plants and role of arbuscular mycorrhizal fungus Glomus etunicatum in the tolerance of toxicity.
Pakistan journal of biological sciences : PJBS, , Jun-15, Volume: 10, Issue:12
2007
Liberation of vessel adherent myeloperoxidase by enoxaparin improves endothelial function.
International journal of cardiology, , Apr-01, Volume: 140, Issue:1
2010
New coumarin-based anti-inflammatory drug: putative antagonist of the integrins alphaLbeta2 and alphaMbeta2.
The Journal of pharmacy and pharmacology, , Volume: 60, Issue:11
2008
Bivalirudin decreases NO bioavailability by vascular immobilization of myeloperoxidase.
The Journal of pharmacology and experimental therapeutics, , Volume: 327, Issue:2
2008
Discovery of N-(2-aminophenyl)-4-[(4-pyridin-3-ylpyrimidin-2-ylamino)methyl]benzamide (MGCD0103), an orally active histone deacetylase inhibitor.
Journal of medicinal chemistry, , Jul-24, Volume: 51, Issue:14
2008
The interaction between coronary endothelial dysfunction, local oxidative stress, and endogenous nitric oxide in humans.
Hypertension (Dallas, Tex. : 1979), , Volume: 51, Issue:1
2008
Colon-specific delivery of 5-aminosalicylic acid from chitosan-Ca-alginate microparticles.
International journal of pharmaceutics, , Sep-05, Volume: 342, Issue:1-2
2007
Betanin inhibits the myeloperoxidase/nitrite-induced oxidation of human low-density lipoproteins.
Free radical research, , Volume: 41, Issue:3
2007
Coronary plaque injury triggers neutrophil activation in patients with coronary artery disease.
Free radical biology & medicine, , Feb-15, Volume: 42, Issue:4
2007
Inhaled nitric oxide attenuates reperfusion inflammatory responses in humans.
Anesthesiology, , Volume: 106, Issue:2
2007
Myeloperoxidase-mediated LDL oxidation and endothelial cell toxicity of oxidized LDL: attenuation by (-)-epicatechin.
Free radical research, , Volume: 40, Issue:10
2006
Heparins increase endothelial nitric oxide bioavailability by liberating vessel-immobilized myeloperoxidase.
Circulation, , Apr-18, Volume: 113, Issue:15
2006
Endurance training reduces circulating asymmetric dimethylarginine and myeloperoxidase levels in persons at risk of coronary events.
Thrombosis and haemostasis, , Volume: 94, Issue:6
2005
Antioxidant defense system during endometrial receptivity in the guinea pig: effect of ormeloxifene, a selective estrogen receptor modulator.
The Journal of endocrinology, , Volume: 188, Issue:1
2006
Toxicity assessment of two soils from Jales mine (Portugal) using plants: growth and biochemical parameters.
Archives of environmental contamination and toxicology, , Volume: 50, Issue:2
2006
Pharmacological profile of CR3465, a new leukotriene CysLT1 receptor antagonist with broad anti-inflammatory activity.
European journal of pharmacology, , Nov-19, Volume: 504, Issue:3
2004
Leukocyte-derived myeloperoxidase amplifies high-glucose--induced endothelial dysfunction through interaction with high-glucose--stimulated, vascular non--leukocyte-derived reactive oxygen species.
Diabetes, , Volume: 53, Issue:11
2004
Membrane permeability and antipyrine absorption in a rat model of ischemic colitis.
International journal of pharmaceutics, , Nov-22, Volume: 286, Issue:1-2
2004
Serum myeloperoxidase levels independently predict endothelial dysfunction in humans.
Circulation, , Aug-31, Volume: 110, Issue:9
2004
Myeloperoxidase enhances nitric oxide catabolism during myocardial ischemia and reperfusion.
Free radical biology & medicine, , Sep-15, Volume: 37, Issue:6
2004
Albumin mediates the transcytosis of myeloperoxidase by means of caveolae in endothelial cells.
Proceedings of the National Academy of Sciences of the United States of America, , May-18, Volume: 101, Issue:20
2004
The role of oxidative stress-altered lipoprotein structure and function and microinflammation on cardiovascular risk in patients with minor renal dysfunction.
Journal of the American Society of Nephrology : JASN, , Volume: 15, Issue:3
2004
Myeloperoxidase up-regulates the catalytic activity of inducible nitric oxide synthase by preventing nitric oxide feedback inhibition.
Proceedings of the National Academy of Sciences of the United States of America, , Dec-09, Volume: 100, Issue:25
2003
Myeloperoxidase, a leukocyte-derived vascular NO oxidase.
Science (New York, N.Y.), , Jun-28, Volume: 296, Issue:5577
2002
Leaf biochemical parameters in Avicennia marina (Forsk.) Vierh as potential biomarkers of heavy metal stress in estuarine ecosystems.
Marine pollution bulletin, , Volume: 44, Issue:3
2002
Effects of antivenom on Buthus occitanus tunetanus (Bot) scorpion venom pharmacokinetics: towards an optimization of antivenom immunotherapy in a rabbit model.
Toxicon : official journal of the International Society on Toxinology, , Volume: 39, Issue:9
2001
Sulfinamide formation following peroxidatic metabolism of N-acetylbenzidine.
Chemical research in toxicology, , Volume: 13, Issue:2
2000
The effect of an inhibitor of matrix metalloproteinases on colonic inflammation in a trinitrobenzenesulphonic acid rat model of inflammatory bowel disease.
Alimentary pharmacology & therapeutics, , Volume: 13, Issue:11
1999
Neutral endopeptidase (EC 3.4.24.11) terminates colitis by degrading substance P.
Proceedings of the National Academy of Sciences of the United States of America, , Sep-28, Volume: 96, Issue:20
1999
Beneficial effect of raxofelast, an hydrophilic vitamin E analogue, in the rat heart after ischemia and reperfusion injury.
Journal of molecular and cellular cardiology, , Volume: 30, Issue:8
1998
Regulation of intracellular polymorphonuclear leukocyte Fc receptors by lipopolysaccharide.
Cellular immunology, , Volume: 157, Issue:2
1994
Topical anticolitic efficacy and selectivity of the glucocorticoid budesonide in a new model of acetic acid-induced acute colitis in the rat.
Alimentary pharmacology & therapeutics, , Volume: 8, Issue:4
1994

Dosage (242)

ArticleYear
RLS-0071 Moderated Elevated Myeloperoxidase Level and Activity in an Asymptomatic Subject in Clinical Trial RLS-0071-101.
The American journal of case reports, , May-26, Volume: 24
2023
Cerium and samarium blocked antioxidant enzymes in wheat plants.
Scientific reports, , 05-22, Volume: 13, Issue:1
2023
Equine Muscle Derived Mesenchymal Stem Cells Loaded with Water-Soluble Curcumin: Modulation of Neutrophil Activation and Enhanced Protection against Intracellular Oxidative Attack.
International journal of molecular sciences, , Jan-05, Volume: 24, Issue:2
2023
Plasma exchange and glucocorticoids to delay death or end-stage renal disease in anti-neutrophil cytoplasm antibody-associated vasculitis: PEXIVAS non-inferiority factorial RCT.
Health technology assessment (Winchester, England), , Volume: 26, Issue:38
2022
Moderate intestinal immunopathology after acute oral infection with Toxoplasma gondii oocysts is associated with expressive levels of serotonin.
Life sciences, , Nov-15, Volume: 309
2022
Peroxidase-Mimetic Copper-Doped Carbon-Dots for Oxidative Stress-Mediated Broad-Spectrum and Efficient Antibacterial Activity.
Chemistry (Weinheim an der Bergstrasse, Germany), , Mar-07, Volume: 28, Issue:14
2022
Plasma creatinine below limit of quantification in a patient with acute kidney injury.
Clinica chimica acta; international journal of clinical chemistry, , Jan-01, Volume: 524
2022
Toxicity and tissue accumulation characteristics of the herbicide pendimethalin under silicon application in ginger (Zingiber officinale Roscoe).
Environmental science and pollution research international, , Volume: 29, Issue:17
2022
Chlorogenic acid reduces inflammation in murine model of acute pancreatitis.
Pharmacological reports : PR, , Volume: 73, Issue:5
2021
Vitamin C, Hydrocortisone, and the Combination Thereof Significantly Inhibited Two of Nine Inflammatory Markers Induced by Escherichia Coli But Not by Staphylococcus Aureus - When Incubated in Human Whole Blood.
Shock (Augusta, Ga.), , 01-01, Volume: 57, Issue:1
2022
Highly Efficient Activatable MRI Probe to Sense Myeloperoxidase Activity.
Journal of medicinal chemistry, , 05-13, Volume: 64, Issue:9
2021
Gegen Qinlian decoction relieved DSS-induced ulcerative colitis in mice by modulating Th17/Treg cell homeostasis via suppressing IL-6/JAK2/STAT3 signaling.
Phytomedicine : international journal of phytotherapy and phytopharmacology, , Volume: 84
2021
Polyphenol oxidase dominates the conversions of flavonol glycosides in tea leaves.
Food chemistry, , Mar-01, Volume: 339
2021
Early Clinical Experience With AZD4831, A Novel Myeloperoxidase Inhibitor, Developed for Patients With Heart Failure With Preserved Ejection Fraction.
Clinical and translational science, , Volume: 14, Issue:3
2021
Association of Cigarette Smoking With Antineutrophil Cytoplasmic Antibody-Associated Vasculitis.
JAMA internal medicine, , 06-01, Volume: 180, Issue:6
2020
Rationale of concomitant cyclophosphamide for remission-induction in patients with antineutrophil cytoplasmic antibody-associated vasculitis: A propensity score-matched analysis of two nationwide prospective cohort studies.
Modern rheumatology, , Volume: 31, Issue:1
2021
Clinical Effect of Alpha-1 Antitrypsin Deficiency in Antineutrophil Cytoplasmic Antibody-associated Vasculitis: Results from a French Retrospective Monocentric Cohort.
The Journal of rheumatology, , Volume: 46, Issue:11
2019
Effect of selective versus nonselective cyclooxygenase inhibitors on gastric ulceration scores and intestinal inflammation in horses.
Veterinary surgery : VS, , Volume: 47, Issue:6
2018
Detoxification of mercury in soil by selenite and related mechanisms.
Ecotoxicology and environmental safety, , Sep-15, Volume: 159
2018
Tocoyena sellowiana extract decreases bone loss in an experimental model of periodontitis in rats: Putative role for cyclooxygenase-2 and IL-1? inhibition.
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, , Volume: 98
2018
Berberrubine attenuates mucosal lesions and inflammation in dextran sodium sulfate-induced colitis in mice.
PloS one, , Volume: 13, Issue:3
2018
Chitosan nanoparticles having higher degree of acetylation induce resistance against pearl millet downy mildew through nitric oxide generation.
Scientific reports, , 02-06, Volume: 8, Issue:1
2018
Remote myocardial injury: the protective role of fluoxetine.
Canadian journal of physiology and pharmacology, , Volume: 96, Issue:4
2018
Prophylactic and therapeutic effect of Punica granatum in trinitrobenzene sulfonic acid induced inflammation in rats.
Pakistan journal of pharmaceutical sciences, , Volume: 30, Issue:1
2017
5-ASA-loaded SiO2 nanoparticles-a novel drug delivery system targeting therapy on ulcerative colitis in mice.
Molecular medicine reports, , Volume: 15, Issue:3
2017
Differential Effectiveness of Clinically-Relevant Analgesics in a Rat Model of Chemotherapy-Induced Mucositis.
PloS one, , Volume: 11, Issue:7
2016
Phosalone-induced inflammation and oxidative stress in the colon: Evaluation and treatment.
World journal of gastroenterology, , Jun-07, Volume: 22, Issue:21
2016
Ginkgolide B functions as a determinant constituent of Ginkgolides in alleviating lipopolysaccharide-induced lung injury.
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, , Volume: 81
2016
Recombinant human brain natriuretic peptide attenuates trauma-/haemorrhagic shock-induced acute lung injury through inhibiting oxidative stress and the NF-κB-dependent inflammatory/MMP-9 pathway.
International journal of experimental pathology, , Volume: 96, Issue:6
2015
A new animal model of intestinal mucositis induced by the combination of irinotecan and 5-fluorouracil in mice.
Cancer chemotherapy and pharmacology, , Volume: 77, Issue:2
2016
Neutrophil-derived myeloperoxidase promotes atherogenesis and neointima formation in mice.
International journal of cardiology, , Feb-01, Volume: 204
2016
Metabolic changes in rats after intragastric administration of MGCD0103 (Mocetinostat), a HDAC class I inhibitor.
International journal of clinical and experimental pathology, , Volume: 8, Issue:8
2015
Effects of arachidonic acid intake on inflammatory reactions in dextran sodium sulphate-induced colitis in rats.
The British journal of nutrition, , Sep-14, Volume: 114, Issue:5
2015
Toxicological effects, mechanisms, and implied toxicity thresholds in the roots of Vicia faba L. seedlings grown in copper-contaminated soil.
Environmental science and pollution research international, , Volume: 22, Issue:18
2015
A modified "double-hit" induced acute lung injury model in rats and protective effects of tetramethylpyrazine on the injury via Rho/ROCK pathway.
International journal of clinical and experimental pathology, , Volume: 8, Issue:5
2015
Molecular, Biochemical and Ultrastructural Changes Induced by Pb Toxicity in Seedlings of Theobroma cacao L.
PloS one, , Volume: 10, Issue:7
2015
Effects of fenugreek (Trigonella foenum graecum) on gilthead seabream (Sparus aurata L.) immune status and growth performance.
Fish & shellfish immunology, , Volume: 45, Issue:2
2015
Natural antioxidant betanin protects rats from paraquat-induced acute lung injury interstitial pneumonia.
BioMed research international, , Volume: 2015
2015
Changes in soil microbial functional diversity and biochemical characteristics of tree peony with amendment of sewage sludge compost.
Environmental science and pollution research international, , Volume: 22, Issue:15
2015
Development of rapid multistep carbon-11 radiosynthesis of the myeloperoxidase inhibitor AZD3241 to assess brain exposure by PET microdosing.
Nuclear medicine and biology, , Volume: 42, Issue:6
2015
Oxidative status imbalance in patients with metabolic syndrome: role of the myeloperoxidase/hydrogen peroxide axis.
Oxidative medicine and cellular longevity, , Volume: 2014
2014
Intricacies of redoxome function demonstrated with a simple in vitro chemiluminescence method, with special reference to vitamin B12 as antioxidant.
Scandinavian journal of immunology, , Volume: 80, Issue:6
2014
Rutin has intestinal antiinflammatory effects in the CD4+ CD62L+ T cell transfer model of colitis.
Pharmacological research, , Volume: 90
2014
A novel zebrafish model to provide mechanistic insights into the inflammatory events in carrageenan-induced abdominal edema.
PloS one, , Volume: 9, Issue:8
2014
Chemotherapy-associated steatohepatitis induced by irinotecan: a novel animal model.
Cancer chemotherapy and pharmacology, , Volume: 74, Issue:4
2014
The effect of etoricoxib on kidney ischemia-reperfusion injury in rats: a biochemical and immunohistochemical assessment.
International immunopharmacology, , Volume: 23, Issue:1
2014
Repeated daily dosing with sildenafil provides sustained protection from endothelial dysfunction caused by ischemia and reperfusion: a human in vivo study.
American journal of physiology. Heart and circulatory physiology, , Sep-15, Volume: 307, Issue:6
2014
Effects of enoxaparin on myeloperoxidase release during hemodialysis.
Hemodialysis international. International Symposium on Home Hemodialysis, , Volume: 18, Issue:4
2014
Sulfated caffeic acid dehydropolymer attenuates elastase and cigarette smoke extract-induced emphysema in rats: sustained activity and a need of pulmonary delivery.
Lung, , Volume: 192, Issue:4
2014
Evaluation of the pharmacological properties of salicylic acid-derivative organoselenium: 2-hydroxy-5-selenocyanatobenzoic acid as an anti-inflammatory and antinociceptive compound.
Pharmacology, biochemistry, and behavior, , Volume: 118
2014
Soybean peroxidase-mediated degradation of an azo dye- a detailed mechanistic study.
BMC biochemistry, , Dec-05, Volume: 14
2013
Peroxidase-like activity of Fe3O4@carbon nanoparticles enhances ascorbic acid-induced oxidative stress and selective damage to PC-3 prostate cancer cells.
ACS applied materials & interfaces, , Dec-26, Volume: 5, Issue:24
2013
[Therapeutic effects of muscovite on ulcerative colitis in rats].
Zhonghua yi xue za zhi, , Jul-23, Volume: 93, Issue:28
2013
Pentoxifylline protects the small intestine after severe ischemia and reperfusion.
Experimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation, , Volume: 11, Issue:3
2013
Protective effect of sevoflurane on hepatic ischaemia/reperfusion injury in the rat: A dose-response study.
European journal of anaesthesiology, , Volume: 30, Issue:10
2013
Investigation of neurotoxic and immunotoxic effects of some plant growth regulators at subacute and subchronic applications on rats.
Toxicology and industrial health, , Volume: 31, Issue:12
2015
5-Aminolevulinic acid ameliorates cadmium-induced morphological, biochemical, and ultrastructural changes in seedlings of oilseed rape.
Environmental science and pollution research international, , Volume: 20, Issue:10
2013
Relationships between pharmacokinetics and efficacy of Xie-xin decoction in rats with experimental ulcerative colitis.
Journal of ethnopharmacology, , Jun-21, Volume: 148, Issue:1
2013
Therapeutic effect of liposomal-N-acetylcysteine against acetaminophen-induced hepatotoxicity.
Journal of drug targeting, , Volume: 21, Issue:5
2013
Systems pharmacology modeling of drug-induced modulation of thyroid hormones in dogs and translation to human.
Pharmaceutical research, , Volume: 30, Issue:6
2013
Maintenance of α(1)-antitrypsin activity by means of co-application of hypochlorous acid-scavengers in vitro and in the supernatant of polymorphonuclear leukocytes: as a basis for a new drug delivery approach.
Biomatter, , Volume: 2, Issue:1
5-Aminolevolinic acid mitigates the cadmium-induced changes in Brassica napus as revealed by the biochemical and ultra-structural evaluation of roots.
Ecotoxicology and environmental safety, , Volume: 92
2013
Bioavailability and oxidative stress of cadmium to Corbicula fluminea.
Environmental science. Processes & impacts, , Volume: 15, Issue:4
2013
High-dose chlorogenic acid induces inflammation reactions and oxidative stress injury in rats without implication of mast cell degranulation.
Journal of ethnopharmacology, , May-02, Volume: 147, Issue:1
2013
Efficiency of biodegradable EDDS, NTA and APAM on enhancing the phytoextraction of cadmium by Siegesbeckia orientalis L. grown in Cd-contaminated soils.
Chemosphere, , Volume: 91, Issue:9
2013
A comparative study of pentoxifylline effects in adult and aged rats submitted to lung dysfunction by thermal injury.
Acta cirurgica brasileira, , Volume: 28, Issue:2
2013
The comparision of Coprinus cinereus peroxidase enzyme and TiO2 catalyst for phenol removal.
Journal of environmental science and health. Part A, Toxic/hazardous substances & environmental engineering, , Volume: 48, Issue:3
2013
The novel orally active guanylhydrazone CPSI-2364 prevents postoperative ileus in mice independently of anti-inflammatory vagus nerve signaling.
Langenbeck's archives of surgery, , Volume: 397, Issue:7
2012
Potential role of a quetiapine metabolite in quetiapine-induced neutropenia and agranulocytosis.
Chemical research in toxicology, , May-21, Volume: 25, Issue:5
2012
Hepatoprotective effect of Filipendula hexapetala Gilib. (Rosaceae) in carbon tetrachloride-induced hepatotoxicity in rats.
Phytotherapy research : PTR, , Volume: 26, Issue:7
2012
Protection of ultra-filtration extract from Danggui Buxue Decoction on oxidative damage in cardiomyocytes of neonatal rats and its mechanism.
Chinese journal of integrative medicine, , Volume: 17, Issue:11
2011
Suppression of NF-κB pathway by crocetin contributes to attenuation of lipopolysaccharide-induced acute lung injury in mice.
European journal of pharmacology, , Jan-15, Volume: 674, Issue:2-3
2012
Oxidative biomarkers in leaf tissue of barley seedlings in response to aluminum stress.
Ecotoxicology and environmental safety, , Volume: 75, Issue:1
2012
Protective effect of ellagic acid, a natural polyphenolic compound, in a murine model of Crohn's disease.
Biochemical pharmacology, , Oct-01, Volume: 82, Issue:7
2011
Toxicity profile of solvents by aspiration approach for topical agent delivery to respiratory tract epithelium.
International journal of toxicology, , Volume: 30, Issue:3
2011
Magnesium sulfate mitigates lung injury induced by bilateral lower limb ischemia-reperfusion in rats.
The Journal of surgical research, , Volume: 171, Issue:1
2011
Myeloperoxidase-mediated bioactivation of 5-hydroxythiabendazole: a possible mechanism of thiabendazole toxicity.
Toxicology in vitro : an international journal published in association with BIBRA, , Volume: 25, Issue:5
2011
SB-656933, a novel CXCR2 selective antagonist, inhibits ex vivo neutrophil activation and ozone-induced airway inflammation in humans.
British journal of clinical pharmacology, , Volume: 72, Issue:2
2011
Degradation of pentachlorophenol by a novel peroxidase-catalyzed process in the presence of reduced nicotinamide adenine dinucleotide.
Chemosphere, , Volume: 83, Issue:2
2011
Evaluation of anti-inflammatory and antinociceptive effects of D-002 (beeswax alcohols).
Journal of natural medicines, , Volume: 65, Issue:2
2011
Neurotoxic and immunotoxic effects of fenthion and omethoate on frogs at acute exposure.
Toxicology and industrial health, , Volume: 27, Issue:4
2011
Evaluation of neurotoxic and immunotoxic effects of trichloroacetic acid on rats.
Toxicology and industrial health, , Volume: 26, Issue:10
2010
The effects of Delta-tetrahydrocannabinol and cannabidiol alone and in combination on damage, inflammation and in vitro motility disturbances in rat colitis.
British journal of pharmacology, , Volume: 160, Issue:3
2010
Pentoxifylline inhibits intercellular adhesion molecule-1 (ICAM-1) and lung injury in experimental phosgene-exposure rats.
Inhalation toxicology, , Volume: 22, Issue:11
2010
Adaptation of rat gastric tissue against indomethacin toxicity.
Chemico-biological interactions, , Jun-07, Volume: 186, Issue:1
2010
Mycophenolate mofetil for induction and maintenance of remission in microscopic polyangiitis with mild to moderate renal involvement--a prospective, open-label pilot trial.
Clinical journal of the American Society of Nephrology : CJASN, , Volume: 5, Issue:3
2010
Improvement of rapidly progressive lupus nephritis associated MPO-ANCA with tacrolimus.
Modern rheumatology, , Volume: 20, Issue:3
2010
Action of a Novel PDE4 inhibitor ZL-n-91 on lipopolysaccharide-induced acute lung injury.
International immunopharmacology, , Volume: 10, Issue:4
2010
[Case of microscopic polyangiitis presenting initially as prostatic vasculitis].
Nihon Jinzo Gakkai shi, , Volume: 51, Issue:8
2009
Acetaminophen (paracetamol) inhibits myeloperoxidase-catalyzed oxidant production and biological damage at therapeutically achievable concentrations.
Biochemical pharmacology, , Apr-15, Volume: 79, Issue:8
2010
Lung inflammation is associated with reduced pulmonary nucleotide excision repair in vivo.
Mutagenesis, , Volume: 25, Issue:1
2010
Zl-n-91, a selective phosphodiesterase 4 inhibitor, suppresses inflammatory response in a COPD-like rat model.
International immunopharmacology, , Volume: 10, Issue:2
2010
A long-term follow-up of serum myeloperoxidase antineutrophil cytoplasmic antibodies (MPO-ANCA) in patients with Graves disease treated with propylthiouracil.
Endocrine journal, , Volume: 57, Issue:1
2010
Non-alcoholic steatohepatitis induces non-fibrosis-related portal hypertension associated with splanchnic vasodilation and signs of a hyperdynamic circulation in vitro and in vivo in a rat model.
Liver international : official journal of the International Association for the Study of the Liver, , Volume: 30, Issue:3
2010
Heavy metal uptake and its effect on macronutrients, chlorophyll, protein, and peroxidase activity of Paspalum distichum grown on sludge-dosed soils. Heavy metal uptake and its effect on P. distichum.
Environmental monitoring and assessment, , Volume: 169, Issue:1-4
2010
Neuroprotective effect of melatonin on experimental peripheral nerve injury: an electron microscopic and biochemical study.
Central European neurosurgery, , Volume: 70, Issue:3
2009
Sono-enhanced degradation of dye pollutants with the use of H2O2 activated by Fe3O4 magnetic nanoparticles as peroxidase mimetic.
Ultrasonics sonochemistry, , Volume: 17, Issue:1
2010
Human umbilical cord blood-derived mesenchymal stem cells attenuate hyperoxia-induced lung injury in neonatal rats.
Cell transplantation, , Volume: 18, Issue:8
2009
Neurotoxic and immunotoxic effects of Indole-3-butyric acid on rats at subacute and subchronic exposure.
Neurotoxicology, , Volume: 30, Issue:3
2009
Diallyl sulfide enhances antioxidants and inhibits inflammation through the activation of Nrf2 against gentamicin-induced nephrotoxicity in Wistar rats.
European journal of pharmacology, , Mar-15, Volume: 606, Issue:1-3
2009

Interactions (29)

ArticleYear
The value of serum Lp-PLA2 combined with MPO in the diagnosis of cerebral infarction caused by large artery atherosclerosis.
Clinical neurology and neurosurgery, , Volume: 232
2023
Antieosinophil Antibodies Alone or in Combination with Antineutrophil Cytoplasmic Antibodies (ANCA) Detected in Different Autoimmune Conditions.
Journal of immunology research, , Volume: 2023
2023
Clinical Evaluation of High-Resolution MRI Combined With DWI in Identifying Vulnerable Carotid Plaque.
The neurologist, , Jan-01, Volume: 28, Issue:1
2023
Immunomodulatory dose of clindamycin in combination with ceftriaxone improves survival and prevents organ damage in murine polymicrobial sepsis.
Naunyn-Schmiedeberg's archives of pharmacology, , Volume: 393, Issue:9
2020
Effects of mesalazine combined with bifid triple viable on intestinal flora, immunoglobulin and levels of cal, MMP-9, and MPO in feces of patients with ulcerative colitis.
European review for medical and pharmacological sciences, , Volume: 24, Issue:2
2020
Phase I/II study of mocetinostat in combination with gemcitabine for patients with advanced pancreatic cancer and other advanced solid tumors.
Cancer chemotherapy and pharmacology, , Volume: 81, Issue:2
2018
Mocetinostat combined with gemcitabine for the treatment of leiomyosarcoma: Preclinical correlates.
PloS one, , Volume: 12, Issue:11
2017
Neutrophil extracellular traps induce IL-1β production by macrophages in combination with lipopolysaccharide.
International journal of molecular medicine, , Volume: 39, Issue:3
2017
Effect of coenzyme Q10 alone and its combination with metformin on streptozotocin-nicotinamide-induced diabetic nephropathy in rats.
Indian journal of pharmacology, , Volume: 46, Issue:6
Impact of the neutrophil response to granulocyte colony-stimulating factor on the risk of hemorrhage when used in combination with tissue plasminogen activator during the acute phase of experimental stroke.
Journal of neuroinflammation, , May-27, Volume: 11
2014
Cutting needle biopsy combined with immunohistochemical study of myeloperoxidase for the diagnosis of histiocytic necrotizing lymphadenitis.
Acta oto-laryngologica, , Volume: 133, Issue:12
2013
Comparative evaluation of different doses of PPAR-γ agonist alone and in combination with sulfasalazine in experimentally induced inflammatory bowel disease in rats.
Pharmacological reports : PR, , Volume: 65, Issue:4
2013
Amaranthus roxburghianus root extract in combination with piperine as a potential treatment of ulcerative colitis in mice.
Journal of integrative medicine, , Volume: 11, Issue:3
2013
Evaluation of new scaffolds of myeloperoxidase inhibitors by rational design combined with high-throughput virtual screening.
Journal of medicinal chemistry, , Aug-23, Volume: 55, Issue:16
2012
Time-dependent oxidative stress responses of submerged macrophyte Vallisneria natans seedlings exposed to ammonia in combination with microcystin under laboratory conditions.
Bulletin of environmental contamination and toxicology, , Volume: 89, Issue:1
2012
Comparative evaluation of different doses of green tea extract alone and in combination with sulfasalazine in experimentally induced inflammatory bowel disease in rats.
Digestive diseases and sciences, , Volume: 56, Issue:5
2011
[Effect of cadmium, alone or in combination with CaCl2, on the growth, antioxidative enzyme activity and cadmium absorption of Solanum nigrum L. var pauciflorum hairy roots].
Sheng wu gong cheng xue bao = Chinese journal of biotechnology, , Volume: 26, Issue:2
2010
Curcumin alone and in combination with augmentin protects against pulmonary inflammation and acute lung injury generated during Klebsiella pneumoniae B5055-induced lung infection in BALB/c mice.
Journal of medical microbiology, , Volume: 59, Issue:Pt 4
2010
Protective effects of emodin combined with danshensu on experimental severe acute pancreatitis.
Inflammation research : official journal of the European Histamine Research Society ... [et al.], , Volume: 59, Issue:6
2010
[Influences of heavy metal cadmium alone and in combination with zinc on the growth and activities of antioxidant enzymes of Cucumis sativus hairy roots].
Sheng wu gong cheng xue bao = Chinese journal of biotechnology, , Volume: 25, Issue:1
2009
PET and macro- and microautoradiographic studies combined with immunohistochemistry for monitoring rat intestinal ulceration and healing processes.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine, , Volume: 50, Issue:2
2009
Human amniotic fluid mesenchymal stem cells in combination with hyperbaric oxygen augment peripheral nerve regeneration.
Neurochemical research, , Volume: 34, Issue:7
2009
Protective activity of geranium oil and its component, geraniol, in combination with vaginal washing against vaginal candidiasis in mice.
Biological & pharmaceutical bulletin, , Volume: 31, Issue:8
2008
Anti-inflammatory effect of thalidomide alone or in combination with augmentin in Klebsiella pneumoniae B5055 induced acute lung infection in BALB/c mice.
European journal of pharmacology, , Sep-11, Volume: 592, Issue:1-3
2008
Acute ethanol exposure combined with burn injury enhances IL-6 levels in the murine ileum.
Alcoholism, clinical and experimental research, , Volume: 31, Issue:10
2007
Helicobacter pylori seropositivity and the myeloperoxidase G-463A polymorphism in combination with interleukin-1B C-31T in Japanese health checkup examinees.
Japanese journal of clinical oncology, , Volume: 33, Issue:4
2003
Peroxidase expression in acute unclassified leukemias: ultrastructural studies in combination with immunophenotyping.
Leukemia & lymphoma, , Volume: 14, Issue:1-2
1994
Chronic effects of misoprostol in combination with the NSAID, diclofenac, on gastrointestinal tract of pigs. Relation to diarrheagenic activity, leukocyte infiltration, and mucosal leukotrienes.
Digestive diseases and sciences, , Volume: 40, Issue:7
1995
Synergistic cytolysis mediated by hydrogen peroxide combined with peptide defensins.
Cellular immunology, , Volume: 114, Issue:1
1988

Natural Sources (2)

ArticleYear
Graphene-Based Nanomaterials as Efficient Peroxidase Mimetic Catalysts for Biosensing Applications: An Overview.
Molecules (Basel, Switzerland), , Aug-04, Volume: 20, Issue:8
2015
Picroliv preconditioning protects the rat liver against ischemia-reperfusion injury.
European journal of pharmacology, , May-03, Volume: 395, Issue:3
2000